data_2mox_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mox _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.541 0.21 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -123.68 138.74 30.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.044 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 120.6 6.73 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.655 1.57 . . . . 0.0 112.688 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -113.58 146.01 40.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -108.3 132.55 53.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.362 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.21 112.32 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.6 -38.04 86.17 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 109.714 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -139.41 -177.97 5.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 56.0 p-10 -93.07 144.24 25.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.355 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -133.77 128.15 34.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.54 134.36 35.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -73.84 133.95 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.639 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -105.63 -26.43 11.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.2 p -130.63 169.73 15.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 809' ' ' LEU . 8.3 mp -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.473 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.94 -40.43 95.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.85 131.73 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.312 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.46 151.37 44.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.05 145.75 56.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.104 1.87 . . . . 0.0 113.036 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.86 140.81 42.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.276 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -118.47 142.4 47.61 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.423 0.63 . . . . 0.0 110.809 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -48.71 122.97 6.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.639 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.23 54.49 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.72 128.81 37.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.62 135.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.32 152.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.44 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 87.1 m-85 -113.01 119.55 38.28 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 22.5 mm -87.35 103.87 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.912 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -93.69 -7.23 44.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.657 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.24 132.61 2.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.147 0.499 . . . . 0.0 111.314 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -90.51 112.3 23.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.674 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.6 -49.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -159.47 178.16 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.23 -35.33 76.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.054 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -100.15 -6.1 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.883 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -130.35 135.01 47.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.317 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.1 152.61 40.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.464 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -127.83 137.8 52.49 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.62 -175.33 28.43 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -110.86 138.72 46.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.106 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.1 p-80 -143.18 133.32 24.39 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 51.54 31.79 8.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.418 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.19 90.3 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.743 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -115.44 155.23 27.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.0 p -120.61 143.74 31.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.999 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.86 -168.74 31.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 17.7 pt -126.38 154.22 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.701 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -163.69 156.09 15.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.63 118.93 5.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.115 1.877 . . . . 0.0 112.751 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -47.68 -19.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.3 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 63.8 p -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -6.21 21.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 45.1 pt -132.17 169.76 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.706 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -122.83 106.76 11.18 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.089 0.471 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.59 112.55 2.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.781 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.33 78.65 0.38 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.533 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.495 1.568 0 C-N-CA 122.675 2.25 . . . . 0.0 111.873 -179.625 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.57 149.98 41.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.707 0.289 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.59 155.95 27.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.38 133.62 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.71 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.1 133.99 56.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.969 0.414 . . . . 0.0 111.656 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -83.81 -25.61 30.24 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.28 146.61 38.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 34.2 m120 -52.93 139.93 26.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.412 ' CB ' ' CE1' ' A' ' 888' ' ' PHE . 26.6 t80 -131.88 130.86 42.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.909 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -131.72 89.9 2.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -74.47 171.02 53.39 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -133.92 12.82 3.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.615 0.245 . . . . 0.0 111.045 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 882' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 885' ' ' GLU . 82.8 p -130.73 159.01 38.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.742 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -62.55 -40.93 98.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.01 -26.3 38.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.528 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 81.2 mm-40 -103.45 120.79 41.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 8.0 mmt -93.24 172.26 8.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.543 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 93.0 p -121.87 148.91 44.12 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.109 0.48 . . . . 0.0 110.967 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.412 ' CE1' ' CB ' ' A' ' 878' ' ' PHE . 11.9 p90 -161.03 160.19 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.493 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 3.6 mtp-105 -95.06 170.25 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.198 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.701 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 24.1 ttpp -73.49 52.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 176.22 16.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.966 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 889' ' ' ARG . 14.9 mp0 -97.33 149.62 21.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.438 0.619 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -84.59 148.85 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.046 0.45 . . . . 0.0 110.513 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 872' ' ' ALA . 93.7 mt -132.57 144.54 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.504 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.0 m -102.7 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.98 130.38 35.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.074 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.44 -54.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.111 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . 0.54 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 34.6 ptt-85 -166.05 165.04 18.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 901' ' ' ASP . 35.0 tt0 -99.92 120.27 39.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.761 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.23 -46.83 95.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.982 0.42 . . . . 0.0 111.094 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 899' ' ' GLN . 12.9 t70 -144.79 -95.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.011 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 98.7 mt-10 -132.49 -45.54 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.698 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.31 8.13 35.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -131.58 148.64 52.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.593 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -154.87 161.86 41.3 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.66 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.54 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 88.2 tt0 -109.61 137.84 46.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.33 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.71 172.11 31.81 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -149.99 156.31 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.339 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -77.4 139.55 64.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.37 137.93 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.103 1.202 . . . . 0.0 111.122 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.402 ' C ' ' HG1' ' A' ' 912' ' ' THR . . . 96.73 -10.35 66.46 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 911' ' ' GLY . 1.4 m 69.33 25.69 5.51 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 89.6 p -67.25 -38.99 86.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.46 150.27 44.99 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.264 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -145.56 142.68 29.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.257 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -179.34 -179.62 48.76 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.397 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -119.87 150.91 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.943 0.401 . . . . 0.0 111.121 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -163.63 160.89 17.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.38 139.49 49.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.14 1.893 . . . . 0.0 113.124 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.75 -38.96 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.028 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 69.2 p -57.85 -11.3 2.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.576 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.95 0.66 32.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.99 158.25 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 111.194 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.97 131.71 56.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.692 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.4 -45.79 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.599 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.71 121.75 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.895 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 . . . . . 0 CA--C 1.532 0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.139 179.607 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 795' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.635 0.255 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -132.77 95.72 19.25 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.77 140.45 93.37 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.04 1.827 . . . . 0.0 112.099 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -133.54 154.2 51.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -116.4 135.04 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.774 0.321 . . . . 0.0 110.646 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -79.18 127.06 31.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.869 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.23 -14.97 20.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.207 0.527 . . . . 0.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -151.84 167.31 28.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.6 p-10 -91.49 133.89 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.63 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -127.71 128.66 45.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -93.27 135.68 34.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.62 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.566 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -100.37 -22.67 14.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.993 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 87.5 m -128.05 162.81 25.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.27 -42.84 87.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.106 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.3 -39.35 90.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.195 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.79 149.12 48.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 840' ' ' GLY . 2.2 pp -125.79 151.22 70.67 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . 0.509 ' O ' ' NE2' ' A' ' 835' ' ' HIS . 74.5 Cg_endo -74.45 141.32 28.22 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.667 1.578 . . . . 0.0 112.102 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.16 148.76 52.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.061 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -120.18 135.26 55.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.339 0.59 . . . . 0.0 109.936 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 816' ' ' LYS . 0.0 OUTLIER -43.38 124.39 3.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.176 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.64 -21.02 48.04 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.675 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.56 134.78 51.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 29.1 mm -93.58 129.57 43.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.156 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.53 153.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 88.6 m-85 -113.6 121.62 44.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.23 129.3 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.737 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -109.46 -16.15 14.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -168.42 142.47 3.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 111.46 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.33 136.5 33.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.142 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.4 -50.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 109.876 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -149.61 179.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.925 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.46 -36.37 80.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.908 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -104.58 -1.51 26.4 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -126.96 139.34 53.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.359 0.599 . . . . 0.0 111.609 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.408 ' CE1' ' NE ' ' A' ' 844' ' ' ARG . 12.7 m-85 -125.6 156.92 38.39 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.584 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 1.6 tp10 -124.43 139.9 53.45 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -168.75 -173.21 36.34 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -116.78 150.59 38.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 813' ' ' PRO . 0.5 OUTLIER -155.88 134.51 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.521 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.9 t-80 51.22 31.83 7.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.77 80.05 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 839' ' ' VAL . 44.0 tpt85 -121.09 135.09 55.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 838' ' ' ARG . 99.6 t -112.65 129.23 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.496 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -166.96 -154.56 8.5 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.09 160.83 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 117.062 0.431 . . . . 0.0 110.877 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -160.8 152.8 16.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 845' ' ' THR . 60.6 Cg_endo -73.75 121.67 7.2 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.077 1.852 . . . . 0.0 112.623 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . 0.408 ' NE ' ' CE1' ' A' ' 831' ' ' TYR . 3.4 ttm180 -50.56 -10.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.519 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 843' ' ' PRO . 62.6 p -80.51 -10.85 59.73 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.474 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -102.9 -3.98 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.666 0.269 . . . . 0.0 111.231 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.21 173.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -114.66 161.48 18.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.72 103.98 12.29 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.8 tp 53.38 77.91 0.42 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.688 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 C-N-CA 122.132 1.888 . . . . 0.0 111.879 -179.471 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.29 160.98 31.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.28 150.24 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.94 123.07 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.297 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.06 117.06 6.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -69.57 -35.27 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.498 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -130.27 142.22 50.56 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.887 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -47.85 134.24 13.43 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.62 134.33 52.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.426 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -128.71 100.51 5.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.73 155.39 52.87 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -116.78 -0.29 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.11 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.6 p -127.29 158.02 38.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.896 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -65.24 -32.38 74.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.919 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.4 m -70.66 -26.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.052 0.453 . . . . 0.0 109.829 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.37 113.5 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.944 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 28.0 ttt -84.23 135.77 34.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 90.3 p -82.84 153.87 24.95 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.082 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -161.9 161.02 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -100.07 160.52 14.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.569 0.7 . . . . 0.0 112.754 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -58.4 130.24 45.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.24 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.15 1.64 89.53 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -72.17 139.7 48.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.24 141.9 30.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 86.7 mt -132.85 147.96 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.8 m -99.61 129.62 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.54 119.38 25.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.906 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.36 -53.14 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.12 165.68 17.57 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.814 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . 0.409 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.4 mp0 -98.27 112.82 24.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.454 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.27 -24.6 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.858 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -155.84 174.55 15.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.535 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.17 -32.18 73.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.052 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -113.95 2.06 14.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -134.02 151.88 51.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.478 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.409 ' CB ' HE21 ' A' ' 899' ' ' GLN . 31.8 p90 -150.94 158.33 44.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.034 0.445 . . . . 0.0 110.429 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.1 135.9 41.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.292 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.05 178.21 29.43 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -147.41 157.66 43.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.494 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.89 135.45 59.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.578 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -45.94 137.81 12.68 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 120.898 1.065 . . . . 0.0 111.377 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.59 62.22 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.92 34.7 1.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.61 0.243 . . . . 0.0 111.084 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.3 t -61.29 -46.49 90.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.638 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -171.34 149.39 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.54 144.44 37.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -164.8 170.51 39.91 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.2 pt -116.33 147.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.154 0.502 . . . . 0.0 111.224 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.0 159.59 29.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.16 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.2 137.64 29.07 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.473 2.116 . . . . 0.0 113.919 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 920' ' ' ILE . 88.3 mt -61.31 -35.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.488 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 96.4 m -53.92 -42.8 69.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.218 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.7 -0.22 33.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.308 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 920' ' ' ILE . 13.9 t -125.18 147.89 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.14 0.495 . . . . 0.0 110.674 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.8 121.28 41.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.202 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.11 116.95 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.385 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.23 -47.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.84 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.93 133.24 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 . . . . . 0 CA--C 1.535 0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.349 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 31.5 mmm . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -128.89 98.55 24.09 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 119.553 -0.261 . . . . 0.0 110.89 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.92 138.69 26.25 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.419 1.413 . . . . 0.0 112.244 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.04 47.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -104.89 137.22 43.0 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.296 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -82.52 121.22 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -95.19 -12.86 25.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.159 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.42 141.79 43.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.53 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 58.3 p-10 -68.52 150.04 48.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 814' ' ' LEU . 90.2 t80 -147.64 128.67 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.28 130.63 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -63.35 132.3 51.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.419 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.69 -32.93 10.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.18 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 808' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 810' ' ' LYS . 92.4 m -128.96 138.16 51.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.494 ' CD1' HH21 ' A' ' 838' ' ' ARG . 0.8 OUTLIER -36.7 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.894 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 808' ' ' THR . 87.9 tttt -60.96 -48.43 81.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 808' ' ' THR . 3.2 mt-10 -72.79 165.56 24.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 110.621 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.38 81.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 146.81 61.6 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.927 1.751 . . . . 0.0 111.542 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 804' ' ' PHE . 2.6 tp -140.75 132.4 27.21 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 817' ' ' GLY . 35.3 tp60 -96.36 147.54 23.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 110.808 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -64.01 36.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 176.17 19.16 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.111 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.54 168.91 10.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.515 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.432 ' O ' ' ND1' ' A' ' 835' ' ' HIS . 35.8 mm -108.76 136.16 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.95 151.47 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.9 115.73 26.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 94.2 mt -74.92 134.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 823' ' ' TYR . 1.8 p90 -128.7 -5.24 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.264 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -170.32 125.31 0.75 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.5 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -80.32 125.85 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.5 mm -78.49 -52.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.12 175.92 9.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.906 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -60.1 -18.48 47.38 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.28 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.01 -52.25 2.7 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.043 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -70.52 151.35 45.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -131.01 148.62 52.77 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.21 135.2 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.59 27.14 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -110.48 141.38 43.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.949 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.432 ' ND1' ' O ' ' A' ' 819' ' ' ILE . 81.6 t60 -164.49 135.54 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.928 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.8 t-80 62.92 31.5 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.236 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.46 18.71 78.54 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . 0.494 HH21 ' CD1' ' A' ' 809' ' ' LEU . 12.2 tpt180 -136.5 154.55 50.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.33 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.8 p -129.0 141.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.38 -140.55 2.96 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.25 152.84 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.793 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.92 127.91 3.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.61 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.62 137.6 73.86 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.446 1.431 . . . . 0.0 111.994 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.51 -29.24 68.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.643 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 79.1 p -69.83 -15.66 63.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.392 . . . . 0.0 110.83 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.35 -2.24 55.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.76 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 29.8 pt -137.4 173.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.237 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 851' ' ' PRO . 11.3 tm-20 -124.14 106.32 10.24 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.95 113.78 2.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.5 mt 46.5 82.18 0.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.084 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . 0.529 ' N ' ' OE1' ' A' ' 848' ' ' GLU . 73.0 Cg_endo . . . . . 0 N--CA 1.492 1.382 0 C-N-CA 122.185 1.923 . . . . 0.0 112.015 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.35 153.84 41.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.85 146.56 22.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 38.9 mm -117.08 121.91 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.47 125.92 25.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.479 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -72.61 -36.96 68.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.978 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.94 151.04 52.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.773 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -55.25 145.85 20.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -150.9 135.96 17.54 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.25 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -133.43 116.26 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.482 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.0 145.47 33.66 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.98 -2.22 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.739 0.304 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 882' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 885' ' ' GLU . 58.8 p -133.6 163.83 28.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -61.31 -39.19 89.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.177 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.21 -43.67 93.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.629 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . 0.454 ' O ' ' NH2' ' A' ' 914' ' ' ARG . 80.2 mm-40 -76.41 144.87 39.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.808 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 17.6 ttm -98.5 152.08 19.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 34.6 t -121.25 127.9 51.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.46 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.26 161.79 42.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -102.68 165.37 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.7 138.15 58.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.52 0.15 89.3 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.007 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -81.01 147.12 30.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.105 0.452 . . . . 0.0 110.253 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -95.35 132.47 40.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.1 0.476 . . . . 0.0 111.041 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 147.21 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.973 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.2 m -98.44 127.79 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.098 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 23.7 mt -92.25 126.51 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.727 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.0 mt -105.56 -48.47 3.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.545 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -160.53 154.34 22.61 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.166 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . 0.53 ' OE1' ' CD2' ' A' ' 905' ' ' TYR . 2.0 mp0 -89.94 113.91 25.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.773 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.1 -39.91 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -156.11 -176.71 6.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.314 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.94 -37.24 86.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.83 -4.29 25.09 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -112.55 151.96 29.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 111.666 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.53 ' CD2' ' OE1' ' A' ' 899' ' ' GLN . 1.5 m-85 -140.5 137.04 33.53 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -104.86 135.61 45.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.85 -178.94 32.36 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.587 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . 0.622 HH22 ' HG1' ' A' ' 912' ' ' THR . 17.3 ptm180 -148.22 158.02 43.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.507 -0.346 . . . . 0.0 110.364 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 79.2 mt -93.89 138.73 22.63 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.13 141.08 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.366 1.377 . . . . 0.0 111.807 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.64 76.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.622 ' HG1' HH22 ' A' ' 908' ' ' ARG . 1.4 m 68.83 32.96 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.637 0.256 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.3 m -62.33 -42.48 99.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' A' ' 885' ' ' GLU . 77.6 ttt180 -166.69 144.65 5.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -127.55 142.83 51.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 177.56 -173.77 46.39 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.69 155.4 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.496 . . . . 0.0 111.117 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -156.35 151.21 20.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.13 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 144.57 51.66 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.223 1.948 . . . . 0.0 113.68 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.53 -37.52 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.37 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.479 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -56.06 -39.54 72.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.07 -1.1 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.22 159.62 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.67 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -108.75 127.24 53.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.186 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 75.9 t -101.47 101.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -65.55 -45.77 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -135.83 150.58 49.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.958 179.567 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.615 0.245 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -130.81 94.34 28.95 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.373 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 850' ' ' LEU . 33.6 Cg_exo -59.27 138.29 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.989 1.793 . . . . 0.0 111.786 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -130.38 153.3 48.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.83 135.62 54.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.272 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -76.57 111.37 11.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -35.28 79.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.068 0.461 . . . . 0.0 109.79 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -144.12 175.35 10.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.538 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 65.2 t0 -78.56 120.51 23.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.48 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -115.05 123.63 49.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.66 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.9 142.11 28.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.384 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -69.65 140.58 53.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.302 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -109.39 -31.74 7.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.05 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 63.7 p -129.41 171.01 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.376 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.81 -41.72 96.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.41 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.95 -38.35 90.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.395 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.17 122.98 27.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 11.1 mp -107.19 154.37 40.52 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.446 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.17 146.82 71.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.904 1.736 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 803' ' ' ASP . 0.2 OUTLIER -125.91 153.18 44.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -126.73 138.34 53.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.57 0.7 . . . . 0.0 110.926 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.09 125.42 10.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.277 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.65 -28.74 14.53 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.489 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 66.8 t0 -57.67 135.2 56.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.007 0.432 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 38.7 mm -99.15 133.51 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.09 151.12 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 76.9 m-85 -109.28 113.7 26.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 96.5 mt -82.03 130.95 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -104.51 -38.46 6.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.793 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -156.14 155.16 32.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 42.4 tt0 -82.84 130.73 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.553 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 7.5 mm -81.38 -46.23 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 109.63 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 3.5 t70 -148.11 178.77 8.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.046 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.43 -36.09 79.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -109.57 11.75 24.67 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -132.51 143.0 49.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -125.01 150.96 46.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.302 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.28 141.22 51.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -165.94 -175.14 36.11 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.31 140.7 36.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.037 0.446 . . . . 0.0 110.748 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -151.47 141.99 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 50.1 t-80 48.24 31.36 2.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.93 16.23 80.81 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.818 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -132.88 157.46 45.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.66 0.267 . . . . 0.0 111.065 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.12 129.17 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.087 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -154.78 -156.12 7.58 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.447 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.7 pp -124.54 154.73 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 117.347 0.573 . . . . 0.0 110.173 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 841' ' ' ILE . 3.8 m-85 -148.4 126.61 5.93 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.748 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.64 125.39 16.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.073 1.182 . . . . 0.0 111.81 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -54.6 -20.32 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.56 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.8 p -77.06 -12.55 59.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.95 -3.92 24.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.247 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.03 171.97 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 86.9 tt0 -114.23 160.51 18.94 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 18.4 mt -108.84 100.52 9.72 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 797' ' ' PRO . 53.8 tp 49.03 79.07 0.36 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.86 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 N--CA 1.496 1.64 0 C-N-CA 122.623 2.215 . . . . 0.0 111.443 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -127.92 155.39 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 110.502 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -160.82 146.64 14.71 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.4 130.49 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.006 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -53.45 125.32 17.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.5 -40.91 73.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.431 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 877' ' ' ASN . 0.1 OUTLIER -145.09 148.86 34.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.64 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 98.7 m-20 -41.72 132.46 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.292 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 878' ' ' PHE . 46.4 t80 -134.57 131.13 37.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.43 117.84 26.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -84.43 -179.58 51.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 882' ' ' THR . 24.5 p30 -130.81 -40.18 1.21 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 882' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 881' ' ' ASP . 65.3 p -86.32 163.46 17.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -64.97 -34.39 78.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 110.149 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.18 -41.04 91.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 45.1 tp10 -81.38 130.97 35.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.152 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 14.6 mmt -101.33 164.66 11.67 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 887' ' ' SER . . . . . 0.423 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 35.5 t -127.23 146.18 50.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.198 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.47 177.8 7.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.165 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -113.15 163.57 14.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.291 0.567 . . . . 0.0 111.503 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.55 139.88 52.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.811 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.39 -8.23 77.39 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -75.89 138.46 41.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.244 0.522 . . . . 0.0 110.285 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -81.46 143.33 32.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.116 0.484 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 872' ' ' ALA . 88.7 mt -130.29 138.32 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.685 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.5 m -97.35 128.87 44.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.783 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.12 119.83 27.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.644 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.2 mt -99.23 -49.98 4.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -167.0 165.16 15.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.147 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . 0.412 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.7 mp0 -99.41 115.71 29.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.34 -25.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -159.77 173.75 15.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.83 -38.58 88.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -106.28 3.06 27.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -133.4 151.25 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.876 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.412 ' CB ' HE21 ' A' ' 899' ' ' GLN . 28.1 p90 -150.97 158.61 44.35 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.002 0.43 . . . . 0.0 110.581 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.528 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.4 tt0 -99.13 133.29 43.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.719 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.74 173.84 29.39 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.517 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -154.31 160.59 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.097 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . 0.503 ' CD1' ' NH2' ' A' ' 914' ' ' ARG . 84.5 mt -74.54 138.83 74.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -47.99 -14.03 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.395 1.397 . . . . 0.0 112.456 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 913' ' ' SER . . . -87.09 0.33 85.93 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.465 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 30.6 p 54.63 8.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 911' ' ' GLY . 89.5 p -71.88 -30.42 65.39 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.503 ' NH2' ' CD1' ' A' ' 909' ' ' ILE . 96.4 mtm-85 -139.47 149.75 44.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.853 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.528 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 66.4 tt0 -147.96 140.91 24.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.507 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.38 -178.19 47.6 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.504 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 46.3 pt -114.8 146.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -156.87 159.78 31.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.62 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 137.96 35.08 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.502 2.135 . . . . 0.0 114.21 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.06 -36.69 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.835 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.0 m -57.52 -44.69 85.29 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . 0.622 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -70.82 0.66 6.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.057 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 922' ' ' TYR . 27.3 m -130.48 156.96 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.481 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -107.1 127.24 53.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.168 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.69 119.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.256 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 30.2 mm -91.36 -48.01 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.627 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.05 146.86 50.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.405 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -135.97 131.35 18.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.43 146.07 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 111.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -148.11 157.3 43.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . 0.402 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 73.8 ttt180 -122.96 131.15 53.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -76.57 123.13 25.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -94.06 -16.05 24.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.262 0.553 . . . . 0.0 110.046 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -135.4 139.7 44.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.517 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.3 p30 -73.88 154.73 39.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.491 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 114.92 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -79.04 130.98 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.52 131.02 39.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.74 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -108.39 -26.4 10.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.25 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.3 p -134.74 170.34 15.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.941 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 809' ' ' LEU . 8.7 mp -61.12 -37.43 82.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 98.3 mttt -60.23 -38.79 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.01 148.18 22.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.246 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.23 156.33 69.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.44 141.53 42.7 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.319 1.346 . . . . 0.0 112.155 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.05 143.18 34.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 817' ' ' GLY . 62.4 tt0 -103.95 143.03 33.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.341 0.591 . . . . 0.0 110.322 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -61.06 37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.444 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 173.16 21.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 835' ' ' HIS . 3.7 m-20 -97.28 161.21 13.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.5 130.4 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 2.1 p -129.63 136.88 58.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.179 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.7 m-85 -95.86 121.1 37.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.943 0.402 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.1 136.26 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.515 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -98.74 -39.35 8.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.745 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . 0.495 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 26.0 pttm -159.25 155.98 27.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.046 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.688 HE21 ' N ' ' A' ' 827' ' ' ASP . 3.1 tm0? -82.6 118.93 23.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.53 -46.65 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.688 ' N ' HE21 ' A' ' 825' ' ' GLN . 6.3 t0 -150.32 179.38 8.17 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.33 -38.41 83.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.629 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -111.66 13.54 21.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.803 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -131.59 143.59 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 112.091 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -134.02 152.2 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.707 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.495 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 4.2 tt0 -123.1 134.71 54.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.39 178.5 36.4 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -107.91 148.83 29.09 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 111.033 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.542 ' NE2' ' OD2' ' A' ' 818' ' ' ASP . 83.5 t60 -169.69 137.47 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.088 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 18.6 t60 58.53 32.94 22.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.305 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.83 16.58 79.28 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -132.7 154.88 49.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.115 0.483 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.6 134.9 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -160.69 -140.91 2.99 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.4 pt -135.46 154.3 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.71 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -157.99 150.68 18.08 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 143.8 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.148 1.898 . . . . 0.0 113.459 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.47 -35.56 72.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.065 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 76.3 p -63.22 -16.06 59.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.121 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -94.66 -2.66 50.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.407 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 1.3 pp -142.13 165.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.738 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.98 118.0 22.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.0 tp -69.81 113.98 7.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.368 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 29.4 tp 56.75 73.96 0.74 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.494 1.508 0 C-N-CA 121.947 1.764 . . . . 0.0 111.719 -179.222 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 871' ' ' GLU . 48.2 mp0 -134.92 146.48 49.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -147.62 149.88 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.6 126.38 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 111.255 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.75 113.96 1.87 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -63.64 -37.02 85.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -129.53 148.13 51.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.323 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -56.81 125.2 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -115.19 128.43 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.563 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.95 109.77 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.474 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.32 145.24 32.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -103.09 -21.57 13.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.831 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.3 p -112.63 159.29 19.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -64.12 -31.26 72.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.343 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 8.7 m -71.41 -24.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.435 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.91 111.55 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.174 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.57 159.35 29.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 887' ' ' SER . . . . . 0.402 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 99.3 p -123.9 153.27 41.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.935 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.18 176.44 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -104.16 150.16 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.14 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -46.68 133.1 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 97.46 -9.05 64.59 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.068 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.0 131.04 45.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -76.52 138.07 40.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.71 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 93.7 mt -130.59 144.95 36.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.754 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.0 m -102.03 125.72 48.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 86.7 mt -79.81 87.37 5.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.06 -44.6 91.95 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.819 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -168.56 162.42 12.03 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.664 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.26 109.6 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.99 -27.16 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.065 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -158.81 174.89 14.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.32 -36.79 83.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.122 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -109.44 1.84 20.17 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -130.56 148.64 52.38 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.461 ' CE1' ' O ' ' A' ' 918' ' ' PHE . 28.2 p90 -151.08 156.88 41.98 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.737 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -104.37 130.62 52.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -146.99 178.22 24.77 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.835 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.98 161.26 42.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.991 -0.605 . . . . 0.0 109.964 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . 0.486 ' C ' ' H ' ' A' ' 911' ' ' GLY . 78.7 mt -74.97 137.28 72.9 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.24 -11.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.297 1.332 . . . . 0.0 112.16 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 909' ' ' ILE . . . -80.91 -4.23 90.48 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.399 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 20.1 p 50.83 34.97 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.349 0.119 . . . . 0.0 111.145 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.3 m -111.61 -26.56 8.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.705 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.65 152.52 51.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -149.57 145.98 27.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.177 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.23 -179.31 47.49 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.349 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.6 pt -112.16 140.99 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.5 145.11 17.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.062 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.93 142.74 47.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.95 1.766 . . . . 0.0 112.736 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 33.9 mt -69.9 -8.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.9 m -59.87 -44.47 94.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -97.7 8.48 44.61 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.855 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 11.2 t -122.82 145.2 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 120.85 0.357 . . . . 0.0 110.226 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.85 115.36 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.076 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.09 106.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.717 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.33 -46.22 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.486 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.22 149.85 41.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.105 179.299 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 C--O 1.23 0.035 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -127.94 143.09 46.51 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 147.72 34.44 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.896 1.731 . . . . 0.0 112.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -135.47 155.16 50.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -121.89 133.67 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.408 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -84.2 121.58 27.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.287 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -74.43 -29.56 61.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.976 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.28 173.09 11.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.197 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.9 p-10 -89.33 135.69 33.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.14 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -127.08 133.26 50.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.327 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -92.99 139.29 30.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.61 21.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -65.95 -41.47 91.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.1 p -136.96 166.21 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.928 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -50.88 -33.34 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.28 -39.79 91.7 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.461 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . 0.459 ' OE2' ' CG1' ' A' ' 841' ' ' ILE . 0.2 OUTLIER -75.28 172.54 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.7 134.11 20.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.93 145.54 50.67 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.106 1.204 . . . . 0.0 111.467 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.31 144.55 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.92 139.78 51.09 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.261 0.553 . . . . 0.0 110.252 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.08 122.06 7.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.813 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.76 38.4 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.308 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.532 ' OD2' ' CE1' ' A' ' 835' ' ' HIS . 35.8 t70 -62.77 140.57 58.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.11 132.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.27 154.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.235 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.441 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 90.7 m-85 -114.07 121.71 44.67 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 3.4 mm -85.6 127.07 40.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.474 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.3 p90 -120.91 -5.93 9.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.071 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -173.38 129.13 0.44 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.212 0.53 . . . . 0.0 111.478 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -80.66 135.79 36.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.33 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.2 mm -87.49 -52.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.361 . . . . 0.0 110.284 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.527 ' OD1' ' NE2' ' A' ' 828' ' ' GLN . 6.0 t0 -150.51 179.2 8.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . 0.527 ' NE2' ' OD1' ' A' ' 827' ' ' ASP . 4.3 mp0 -60.77 -37.56 82.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 4.0 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.81 142.0 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.354 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.646 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 31.3 p90 -136.26 165.59 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.229 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -133.36 140.35 47.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -158.44 -179.29 33.2 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -106.63 144.87 32.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 111.442 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.532 ' CE1' ' OD2' ' A' ' 818' ' ' ASP . 6.5 t60 -168.52 140.85 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.214 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.24 19.97 11.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 82.47 1.41 90.46 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.779 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.43 164.21 20.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.103 0.452 . . . . 0.0 110.262 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.63 132.59 70.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.123 0.487 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -143.24 -155.25 6.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.459 ' CG1' ' OE2' ' A' ' 811' ' ' GLU . 1.4 pp -134.32 155.12 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.088 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -166.1 160.17 12.72 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.85 121.85 8.28 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.75 2.3 . . . . 0.0 112.734 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 828' ' ' GLN . 48.3 ptt85 -56.4 -22.03 28.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.031 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.07 -8.21 47.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.13 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.43 -0.39 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . 0.487 ' CD1' ' CZ ' ' A' ' 831' ' ' TYR . 11.7 pt -138.73 174.55 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -113.38 157.51 21.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.2 100.14 7.93 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.027 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.0 tt 49.51 61.72 13.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.306 -1.705 0 C-N-CA 122.49 2.127 . . . . 0.0 112.153 -179.424 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -118.22 148.83 42.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -155.08 147.69 24.24 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.432 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.21 131.66 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.518 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.46 135.16 57.2 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.085 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.55 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 55.5 mtmt -87.08 -23.03 25.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.855 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -142.5 144.26 32.9 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -49.36 152.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -143.1 130.8 21.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.33 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -128.44 97.28 4.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.721 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.44 178.14 52.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -131.05 -1.88 4.06 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.213 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 47.6 p -129.58 158.88 38.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -62.82 -27.37 69.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.975 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 18.3 m -68.14 -20.65 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -108.75 131.48 54.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.132 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 13.5 tpt -109.18 129.78 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.7 p -76.35 158.27 31.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.553 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 12.9 p90 -168.31 166.08 12.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.971 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . 0.405 ' H ' ' CD ' ' A' ' 892' ' ' GLU . 29.6 mmm-85 -103.67 163.55 12.24 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.55 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 53.5 tttp -67.09 58.17 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 172.84 12.8 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.829 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 888' ' ' PHE . 96.8 mt-10 -94.1 151.99 19.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.612 0.706 . . . . 0.0 109.736 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.46 146.75 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.5 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.5 mt -133.02 145.59 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.821 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.9 m -102.35 124.67 48.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.63 130.72 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.429 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.44 -58.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -163.56 164.66 24.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 115.37 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.579 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.45 -27.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.734 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 1.6 t70 -156.13 172.53 18.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.973 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . 0.426 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 60.7 mp0 -63.51 -28.84 70.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . 0.624 ' ND2' ' NE1' ' A' ' 904' ' ' TRP . 16.6 p-10 -117.95 4.05 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . 0.624 ' NE1' ' ND2' ' A' ' 903' ' ' ASN . 91.7 m95 -132.32 150.23 52.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.677 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -152.97 159.15 42.9 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.546 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.7 tt0 -102.39 132.68 48.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.179 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -151.45 169.94 31.02 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -148.47 155.79 41.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.038 0.447 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.27 139.89 87.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.85 138.99 20.13 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.937 1.092 . . . . 0.0 111.113 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 94.72 -9.65 70.93 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.7 p 69.78 33.22 2.98 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.651 0.262 . . . . 0.0 111.031 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.4 t -60.23 -45.46 93.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -163.36 139.66 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.791 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.546 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 26.0 tt0 -103.78 149.82 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.059 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -166.54 169.48 40.62 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.358 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -123.14 147.17 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.861 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -159.17 166.17 16.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.301 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.62 137.8 61.13 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.836 1.691 . . . . 0.0 113.487 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.29 -42.22 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.282 0.563 . . . . 0.0 110.42 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.0 m -57.77 -16.97 12.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.33 2.01 54.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.881 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.86 164.09 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.179 0.514 . . . . 0.0 110.663 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 67.9 t0 -115.04 132.82 56.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . 0.452 ' N ' ' OD1' ' A' ' 924' ' ' ASP . 99.5 t -104.09 99.86 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.538 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.54 -46.34 95.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -138.13 131.95 31.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.662 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 CA--C 1.532 0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.72 148.37 69.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.436 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.82 145.83 25.82 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.098 1.866 . . . . 0.0 111.798 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -140.83 155.59 46.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -117.99 132.29 56.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -71.28 117.9 13.4 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.942 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -38.57 86.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.31 0.576 . . . . 0.0 109.466 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -141.83 174.56 10.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.2 p-10 -83.29 138.26 33.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . 0.563 ' CE2' ' OE2' ' A' ' 811' ' ' GLU . 60.5 t80 -129.07 131.46 47.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -99.22 137.91 37.06 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.037 0.446 . . . . 0.0 111.606 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -65.37 136.09 56.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.336 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . 0.42 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 77.0 mt-30 -109.5 -25.09 10.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.693 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 64.1 p -129.2 167.6 17.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.03 -42.53 98.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.544 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.94 -42.14 97.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.463 . . . . 0.0 109.76 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . 0.563 ' OE2' ' CE2' ' A' ' 804' ' ' PHE . 41.0 tt0 -66.97 131.28 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.931 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 96.1 mt -115.52 150.33 44.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.449 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.26 148.71 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.103 1.869 . . . . 0.0 112.824 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.62 145.7 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -120.34 143.02 48.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.59 0.709 . . . . 0.0 111.489 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -53.09 124.39 14.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.075 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.83 -20.41 49.32 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.583 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.54 140.47 58.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.8 mm -96.68 131.36 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.97 156.23 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.187 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.451 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.8 m-85 -117.34 116.43 27.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.965 0.412 . . . . 0.0 111.4 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.89 131.93 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.0 OUTLIER -128.52 -4.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.238 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -170.44 125.29 0.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.208 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 830' ' ' TRP . 59.9 tp60 -81.54 124.61 29.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.749 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.8 mm -80.79 -52.98 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.192 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.62 178.28 9.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.14 -37.85 81.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.4 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -105.91 8.07 32.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.637 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . 0.542 ' O ' ' NE2' ' A' ' 825' ' ' GLN . 5.4 m-90 -140.12 145.19 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.102 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -140.7 166.28 25.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.946 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -130.61 136.52 48.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.887 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -154.41 -165.44 13.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -118.9 139.16 52.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -151.3 148.53 28.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.376 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 86.2 t60 47.87 30.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.263 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.25 16.41 80.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.792 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.28 160.22 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.015 0.436 . . . . 0.0 111.083 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.38 132.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.921 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -155.46 -154.73 7.04 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 46.8 pt -130.48 149.81 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.913 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -151.27 171.75 6.14 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -81.36 124.21 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.846 1.698 . . . . 0.0 113.074 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -57.01 -33.69 67.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.649 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.5 p -71.86 -9.99 59.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.739 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -96.51 -1.0 48.11 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.85 174.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.11 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -113.47 159.87 19.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.13 105.87 13.08 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.695 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 39.0 tp 58.28 74.66 0.6 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.139 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo . . . . . 0 C--N 1.304 -1.766 0 C-N-CA 122.888 2.392 . . . . 0.0 111.443 -179.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.31 153.81 47.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.95 150.34 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.45 125.49 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -62.66 128.57 36.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.538 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 12.8 mtmt -74.49 -37.89 63.02 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.651 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -130.61 153.79 48.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.232 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -52.64 152.57 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 58.2 t80 -146.59 137.32 24.01 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.571 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -136.59 99.69 4.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.811 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.81 156.52 50.71 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -118.82 2.23 11.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.736 0.303 . . . . 0.0 110.53 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 69.7 p -132.52 162.37 31.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.99 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.11 -40.28 97.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.34 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 9.7 m -62.34 -32.4 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -83.34 146.24 28.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 67.0 ttp -105.54 130.96 53.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 92.8 p -88.86 131.52 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 43.9 p90 -158.62 164.11 36.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.484 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -117.68 162.02 18.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.235 0.54 . . . . 0.0 111.567 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 65.4 tttp -56.84 136.98 55.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.221 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.78 88.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.041 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -82.62 147.26 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.994 0.397 . . . . 0.0 110.461 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -84.19 141.2 31.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 894' ' ' ILE . 94.2 mt -129.54 139.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.4 m -103.22 126.15 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.6 mt -82.69 125.22 30.98 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.56 -28.87 9.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.314 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -179.68 141.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -88.91 113.47 24.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.16 -43.89 91.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -160.72 -179.69 7.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.64 -22.77 66.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -117.82 13.83 14.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.653 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -140.37 149.67 42.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.08 29.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.433 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -100.61 132.54 45.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.5 179.03 35.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.327 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -148.86 156.48 42.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.315 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.2 mt -84.25 142.43 40.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.87 138.99 25.89 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.952 1.101 . . . . 0.0 111.191 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.59 71.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.92 29.59 8.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.234 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.7 m -62.19 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.616 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -143.52 154.45 43.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.005 0.431 . . . . 0.0 111.459 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -144.96 138.77 27.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.045 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.45 -169.91 43.03 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.49 159.33 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.094 0.473 . . . . 0.0 111.617 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -160.07 152.75 17.72 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.746 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.44 137.19 45.94 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.568 1.512 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 922' ' ' TYR . 6.3 mt -54.69 -76.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.567 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 920' ' ' ILE . 22.4 m -25.53 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 920' ' ' ILE . 1.6 m-85 -72.22 1.49 7.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 920' ' ' ILE . 33.8 m -135.31 158.96 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.063 0.459 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -104.37 118.32 36.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.429 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 73.0 t -95.03 101.49 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.806 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.6 mp -70.36 -43.18 78.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.273 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -133.04 139.63 47.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.437 -179.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 19.1 mmm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.558 0.218 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -154.07 105.22 2.45 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.41 139.77 18.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.785 1.657 . . . . 0.0 112.388 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.23 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -109.18 143.16 38.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -81.65 126.48 31.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . 0.447 ' O ' ' CD ' ' A' ' 816' ' ' LYS . 38.4 ttpt -97.74 -20.13 17.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.826 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -146.76 177.7 8.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.14 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -90.99 178.02 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.768 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 814' ' ' LEU . 29.4 t80 -149.04 132.88 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.671 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -106.19 107.74 18.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -67.13 137.67 56.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.174 0.512 . . . . 0.0 110.857 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -106.55 -23.19 12.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.15 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 808' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 809' ' ' LEU . 0.6 OUTLIER -127.08 165.64 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.181 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.416 ' H ' HG22 ' A' ' 808' ' ' THR . 90.4 mt -60.64 -38.68 85.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.856 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -59.45 -44.15 93.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.46 136.15 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.492 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.9 122.47 33.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.889 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 50.6 Cg_exo -55.01 140.64 79.99 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.109 1.206 . . . . 0.0 112.457 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 804' ' ' PHE . 20.7 mt -128.34 149.75 50.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.593 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -122.5 138.17 54.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.209 0.528 . . . . 0.0 109.956 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 801' ' ' LYS . 36.7 ttpt -46.62 125.32 6.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.089 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 104.45 -24.34 29.07 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.589 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.28 125.88 25.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.985 0.422 . . . . 0.0 110.947 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 23.5 mm -85.93 133.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.09 153.37 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.443 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.9 m-85 -109.15 114.86 28.94 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 31.1 mm -85.6 129.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.477 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -111.16 -27.91 8.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.346 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . 0.508 ' HZ2' ' CD ' ' A' ' 832' ' ' GLU . 25.7 pttm -158.9 156.14 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.345 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 61.9 tt0 -94.49 110.43 22.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.569 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.4 -47.03 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 7.3 t0 -149.85 178.08 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . 0.483 ' O ' ' CZ ' ' A' ' 844' ' ' ARG . 99.1 mm-40 -59.99 -37.61 80.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.455 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -108.51 0.55 20.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -123.97 134.1 53.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 160.13 23.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.508 ' CD ' ' HZ2' ' A' ' 824' ' ' LYS . 20.9 tt0 -128.86 140.55 51.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.584 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.87 -177.69 36.08 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -107.05 141.74 37.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.046 0.451 . . . . 0.0 111.353 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.479 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.3 OUTLIER -149.9 144.71 26.09 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 51.2 t-80 50.02 30.37 4.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.1 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.29 18.41 79.82 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -133.03 156.33 47.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.385 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.77 145.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.289 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -169.71 -162.34 21.8 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 27.3 pt -128.22 159.39 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -166.8 154.56 8.93 Favored Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.064 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 845' ' ' THR . 51.9 Cg_endo -69.71 115.66 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.352 2.035 . . . . 0.0 112.66 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . 0.483 ' CZ ' ' O ' ' A' ' 828' ' ' GLN . 37.9 ptt180 -51.93 -6.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.552 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 843' ' ' PRO . 1.6 t -80.86 -5.83 57.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.616 -0.434 . . . . 0.0 112.089 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 846' ' ' TYR . 0.1 OUTLIER -106.37 -1.22 23.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.921 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 846' ' ' TYR . 45.1 pt -126.76 175.68 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.838 0.351 . . . . 0.0 111.371 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.0 160.01 19.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.75 101.62 9.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 51.8 tp 55.04 76.23 0.53 Allowed Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.988 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.306 -1.664 0 C-N-CA 122.688 2.258 . . . . 0.0 111.664 -179.526 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -136.1 141.83 44.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 0.0 110.496 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -150.87 155.52 39.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 57.1 mt -126.66 131.09 71.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 110.641 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.92 123.04 15.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.458 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -69.26 -37.33 77.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.959 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.3 151.06 50.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.361 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -57.48 131.86 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -127.14 128.74 46.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.59 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.32 108.15 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.759 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . 0.454 ' H ' ' CB ' ' A' ' 887' ' ' SER . . . -65.83 142.46 43.58 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 56.4 t0 -100.56 -22.62 14.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 61.0 p -130.97 165.74 22.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.03 0.443 . . . . 0.0 111.123 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.78 -37.56 82.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.563 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.32 -43.37 89.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.394 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -91.06 103.54 16.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 886' ' ' MET . . . . . 0.492 ' CE ' ' O ' ' A' ' 887' ' ' SER . 2.0 tmt? -71.28 131.55 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 887' ' ' SER . . . . . 0.492 ' O ' ' CE ' ' A' ' 886' ' ' MET . 83.2 p -80.13 154.19 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 0.0 110.986 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.01 160.05 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.593 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -105.78 165.32 11.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.003 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.63 136.2 56.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.191 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.58 -6.61 77.6 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.9 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.04 141.73 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.462 0.631 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -89.6 139.22 30.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.212 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.78 149.42 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.514 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.1 m -100.13 127.9 46.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.64 118.79 24.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.18 -46.58 5.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -163.41 156.01 18.29 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.936 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -98.94 118.68 36.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.323 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.41 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.9 t -61.48 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 902' ' ' GLU . 13.3 p30 -153.68 -104.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . 0.53 ' H ' ' CG ' ' A' ' 901' ' ' ASP . 99.0 mt-10 -121.71 -38.43 2.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.37 9.36 18.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.704 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -134.03 147.46 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.41 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 14.7 p90 -157.72 163.81 37.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -115.96 142.19 47.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.166 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.45 178.86 31.01 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -149.48 158.97 44.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.494 -0.353 . . . . 0.0 110.331 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 909' ' ' ILE . 50.4 mm -65.86 137.86 96.23 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 -11.64 15.21 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.697 1.598 . . . . 0.0 112.531 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.445 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . -83.69 -3.0 89.8 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 57.7 p 53.93 65.97 1.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.208 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.4 m -131.46 -38.49 1.18 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.443 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.24 157.5 46.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.859 0.362 . . . . 0.0 111.329 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -142.81 146.42 34.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.71 176.52 45.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.507 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.49 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 42.5 pt -115.52 145.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.493 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -155.68 159.43 31.62 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.566 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.03 139.11 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.697 2.264 . . . . 0.0 113.828 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.18 -37.81 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.517 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 74.4 p -53.04 -24.13 9.09 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.891 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.07 2.26 55.16 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.38 158.15 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.118 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -107.31 127.13 53.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.033 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.86 125.38 42.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.265 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.88 -53.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.364 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.64 126.47 32.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.645 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.848 0.356 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -131.56 96.69 20.55 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.37 140.15 93.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.898 1.732 . . . . 0.0 111.826 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -139.85 156.02 46.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.087 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -114.48 139.82 49.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -81.78 131.72 35.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.13 0.491 . . . . 0.0 110.764 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 802' ' ' PHE . 17.2 mmmt -98.27 -13.23 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 801' ' ' LYS . 47.9 m-85 -152.18 166.79 30.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 112.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 36.0 t70 -86.61 129.8 34.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.072 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -127.81 116.47 20.24 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 110.109 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.21 142.46 31.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.578 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -82.56 122.53 28.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.641 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -95.74 -25.48 16.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.898 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.5 p -134.85 169.67 17.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.37 -37.62 84.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.108 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . 0.487 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 68.7 mttm -65.11 -12.07 46.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.612 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -113.34 140.35 48.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.543 ' CD2' ' H ' ' A' ' 812' ' ' LEU . 1.6 pt? -117.14 149.62 44.69 Favored Pre-proline 0 N--CA 1.467 0.415 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.66 140.01 38.34 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.556 1.504 . . . . 0.0 111.52 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . 0.491 ' CD1' ' OH ' ' A' ' 846' ' ' TYR . 11.0 mt -137.38 146.66 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.675 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -119.08 135.66 54.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 816' ' ' LYS . 8.9 ptmm? -42.24 123.23 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.599 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 99.78 -20.76 47.97 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.208 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 67.3 t0 -55.11 139.27 42.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 41.7 mm -94.95 126.01 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.172 0.511 . . . . 0.0 110.589 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.21 148.62 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.0 m-85 -108.45 123.2 48.49 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.94 129.59 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.923 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.38 -27.6 12.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.475 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -160.43 157.28 27.42 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -93.97 111.29 22.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.4 mm -61.13 -46.9 95.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.156 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.94 178.91 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.88 -36.37 76.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.954 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.84 -1.65 16.44 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -119.9 131.28 55.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -119.3 157.35 28.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.791 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -128.29 138.88 52.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.31 -173.18 28.53 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -123.95 155.79 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.207 0.527 . . . . 0.0 111.456 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.6 OUTLIER -170.61 131.24 0.89 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.933 178.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.1 t-80 65.9 24.56 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 80.22 4.11 89.79 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -112.86 141.84 46.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.974 0.416 . . . . 0.0 110.558 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.59 143.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.543 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -169.53 -139.98 2.85 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 29.9 pt -138.97 162.75 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.462 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -169.72 153.98 5.22 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.831 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 845' ' ' THR . 50.5 Cg_endo -71.11 116.87 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.946 1.764 . . . . 0.0 112.54 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -51.52 -5.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.217 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 843' ' ' PRO . 81.4 p -82.11 -7.3 59.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 846' ' ' TYR . 0.1 OUTLIER -105.41 0.42 26.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.574 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . 0.479 ' CG2' ' CE2' ' A' ' 846' ' ' TYR . 42.8 pt -130.19 174.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.507 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 97.6 mt-10 -116.0 160.05 20.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.63 105.25 15.2 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 2.7 tt 42.57 75.24 0.65 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.513 . . . . 0.0 110.099 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.497 1.708 0 C-N-CA 123.056 2.504 . . . . 0.0 112.221 -179.406 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.53 155.12 44.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.668 0.27 . . . . 0.0 110.537 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.01 27.01 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 46.3 mm -118.7 125.3 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -61.33 133.08 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.711 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 56.8 mtmt -81.95 -38.95 24.42 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.904 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.41 150.86 49.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.466 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 45.6 p-10 -45.64 151.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 75.1 t80 -142.05 131.92 24.36 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.521 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -131.15 103.48 6.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.55 150.57 45.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.84 -1.41 34.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.341 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 57.8 p -133.15 162.75 30.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -61.04 -39.25 89.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.796 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.41 -40.74 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.752 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.24 108.41 19.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 11.0 mmt -80.42 160.67 25.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.8 p -109.39 149.76 29.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.057 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 29.1 p90 -156.76 161.09 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.384 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -105.24 156.17 18.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 111.14 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -50.44 137.4 19.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.45 -3.82 82.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.717 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -77.01 140.99 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.536 0.668 . . . . 0.0 110.746 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.71 142.32 31.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.51 147.02 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -104.44 128.67 52.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.952 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.11 124.74 31.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.636 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.39 -56.11 2.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -158.53 153.73 25.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -94.31 114.38 26.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 69.3 t -70.36 -43.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.491 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -151.65 -176.93 5.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.15 -38.66 83.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.242 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -111.6 10.53 21.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -133.8 149.47 51.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 13.8 p90 -154.9 159.41 40.45 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.033 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -105.78 134.95 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.988 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -155.55 175.79 33.32 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.495 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -152.83 159.2 43.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . 0.499 ' CG2' ' H ' ' A' ' 911' ' ' GLY . 1.7 mp -63.59 135.18 96.15 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.84 -15.53 38.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.229 1.286 . . . . 0.0 112.161 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.499 ' H ' ' CG2' ' A' ' 909' ' ' ILE . . . -83.87 -4.01 88.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 7.1 m 60.13 72.38 0.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.4 t -139.36 -39.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.972 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -131.25 149.03 52.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.448 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -146.52 143.23 28.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.29 -172.32 45.08 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.503 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.5 pt -119.67 148.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.134 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -156.91 162.08 28.31 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.729 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.32 137.59 37.11 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.335 2.024 . . . . 0.0 113.745 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.17 -38.8 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 71.5 p -55.81 -16.5 4.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.66 2.58 41.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.57 156.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.204 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.48 124.47 48.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.284 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.98 130.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.809 0.338 . . . . 0.0 110.246 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.58 -54.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.19 147.39 52.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.3 mpp? . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.038 0.446 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -125.76 97.71 35.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.073 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 850' ' ' LEU . 48.6 Cg_exo -57.12 138.03 84.46 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.858 1.706 . . . . 0.0 111.915 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -129.62 151.85 49.78 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -113.99 135.51 53.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.208 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -77.99 128.76 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -96.52 -18.34 19.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.282 0.563 . . . . 0.0 109.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -149.91 172.16 15.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.6 p-10 -90.98 135.27 33.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.045 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -118.46 123.44 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.787 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -89.07 132.29 34.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.476 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -80.95 129.09 34.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -105.54 -25.75 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.309 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.8 p -129.29 169.43 14.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.494 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 809' ' ' LEU . 8.2 mp -61.15 -39.99 92.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.7 -38.75 88.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.83 126.14 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.006 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.9 151.68 44.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.51 144.4 66.79 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.84 1.693 . . . . 0.0 113.231 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.75 146.54 43.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.046 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.83 137.49 53.37 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.364 0.602 . . . . 0.0 110.876 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 816' ' ' LYS . 15.9 ptmt -44.91 122.61 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.95 -20.25 51.07 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.419 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.9 t0 -55.75 133.22 50.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.359 . . . . 0.0 110.834 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.451 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 30.9 mm -91.21 128.58 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.57 155.0 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.521 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 65.5 m-85 -112.09 117.47 32.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.4 mt -81.28 125.83 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -119.6 -9.3 9.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.8 ttpp -167.27 131.96 1.95 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 111.367 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.614 HE21 ' N ' ' A' ' 827' ' ' ASP . 10.4 tm0? -83.97 136.78 33.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . 0.485 ' C ' ' NE2' ' A' ' 825' ' ' GLN . 4.9 mm -91.98 -67.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.614 ' N ' HE21 ' A' ' 825' ' ' GLN . 61.1 m-20 -133.95 176.67 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.18 -35.41 77.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.068 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -101.51 -1.03 34.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.268 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -131.86 136.15 47.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.201 0.524 . . . . 0.0 111.082 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.76 160.5 28.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.843 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 6.3 tt0 -129.84 141.1 50.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.12 -176.28 34.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.27 138.83 42.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.506 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 15.2 p-80 -146.07 131.92 19.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.794 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 51.67 37.43 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.616 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.77 78.85 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.73 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.27 152.36 48.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.222 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.45 132.67 64.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.258 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -159.55 -165.15 15.96 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.451 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 46.6 pt -128.38 156.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.844 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.451 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -164.09 156.25 14.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.413 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 845' ' ' THR . 40.0 Cg_endo -69.7 117.96 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.979 1.786 . . . . 0.0 112.549 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.61 -13.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.404 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 843' ' ' PRO . 80.6 p -79.54 -6.66 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -103.81 -4.46 23.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.6 pt -135.11 172.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 77.4 mm-40 -112.98 162.84 15.41 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -108.06 104.22 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.33 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 797' ' ' PRO . 2.8 tt 41.53 77.71 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 C-N-CA 122.643 2.228 . . . . 0.0 111.586 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.57 150.3 48.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.46 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 53.3 mt -131.6 132.58 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.464 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -51.23 128.47 22.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.429 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 33.2 ttpt -81.05 -41.15 23.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.145 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 877' ' ' ASN . 0.2 OUTLIER -149.59 131.88 15.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.024 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 26.2 m120 -26.28 114.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.717 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -117.21 129.12 55.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.706 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -110.94 118.82 37.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.977 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.09 139.37 26.91 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.86 -38.93 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 882' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 885' ' ' GLU . 71.0 p -135.36 170.85 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.007 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -58.23 -21.59 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.6 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.93 -42.67 93.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.7 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 882' ' ' THR . 41.5 mp0 -88.15 128.68 35.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.591 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 886' ' ' MET . . . . . 0.609 ' SD ' ' CD2' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -78.32 133.0 37.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.0 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 887' ' ' SER . . . . . 0.602 ' N ' ' SD ' ' A' ' 886' ' ' MET . 67.3 m -106.37 138.27 42.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 110.862 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -155.69 176.41 12.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.063 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -112.38 158.93 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.593 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.682 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 65.1 tttp -47.25 144.09 2.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.983 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.38 87.3 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.258 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -76.72 144.29 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -91.07 139.87 30.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 894' ' ' ILE . 96.6 mt -130.61 142.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.925 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.4 m -94.93 126.61 40.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 91.5 mt -86.7 126.85 34.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.5 mt -107.3 -52.51 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.292 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -165.5 164.39 19.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.385 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.65 115.68 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.27 -45.18 76.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -152.12 -170.9 3.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.48 -40.86 92.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.36 15.82 19.1 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -129.24 149.96 50.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.021 0.439 . . . . 0.0 112.096 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 142.93 26.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.722 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.84 135.89 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.93 178.54 34.18 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.506 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -151.09 158.16 43.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.837 0.351 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 89.5 mt -80.18 141.49 54.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.7 140.29 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.942 1.095 . . . . 0.0 111.504 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 93.03 -7.58 76.37 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.3 m 67.89 28.2 7.05 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.704 0.288 . . . . 0.0 110.773 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 98.3 p -63.61 -28.15 69.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -164.58 150.74 10.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -138.95 143.41 38.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.297 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.44 -179.48 48.35 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.468 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 41.9 pt -105.32 156.91 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -161.89 152.48 14.66 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.731 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.67 142.46 58.41 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.9 1.733 . . . . 0.0 112.837 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 922' ' ' TYR . 0.1 OUTLIER -72.47 -26.05 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.138 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 4.3 t -69.59 8.43 0.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.543 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . 0.641 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -127.6 4.11 6.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.19 148.79 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.925 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -102.87 126.25 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.272 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.9 t -82.99 125.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 35.3 mm -103.73 -52.3 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.524 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -137.55 134.06 35.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.237 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 928' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 795' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.694 0.283 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . 0.41 ' HE ' HD11 ' A' ' 849' ' ' LEU . 95.9 mtm-85 -133.73 149.27 71.5 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.52 128.26 10.2 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.225 1.95 . . . . 0.0 111.929 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -124.13 146.58 48.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -109.29 140.23 43.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.295 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -89.76 115.61 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -77.43 -20.99 53.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.447 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.17 170.01 17.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.5 p-10 -85.25 131.85 34.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.171 0.51 . . . . 0.0 110.382 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 843' ' ' PRO . 75.0 t80 -105.92 129.55 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -100.29 116.82 33.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.03 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -64.18 132.21 49.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.83 -31.16 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 81.6 p -131.81 161.24 33.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -38.69 57.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.344 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -44.47 95.35 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.68 134.98 52.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 17.0 tp -109.93 127.09 27.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.15 147.01 65.86 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.343 1.362 . . . . 0.0 112.769 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 66.3 mt -114.65 152.75 31.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.85 139.06 52.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.333 0.587 . . . . 0.0 110.241 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.94 118.9 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.152 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.89 -21.42 40.37 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.968 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 35.4 t70 -61.77 141.35 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.031 0.443 . . . . 0.0 111.405 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 10.7 mm -97.58 132.41 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.779 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.25 153.16 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.45 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.47 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 79.7 m-85 -110.91 114.03 27.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 4.2 mm -82.85 128.92 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.084 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.51 -44.92 7.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.259 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -160.49 153.55 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.981 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.49 110.25 18.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.235 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . 0.41 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.1 mm -62.78 -46.89 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.597 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -148.08 178.65 8.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -60.09 -37.5 80.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -112.79 18.36 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.565 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -142.71 150.0 39.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.533 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.536 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 35.0 p90 -147.79 168.5 21.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.767 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.8 tp10 -129.33 139.91 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.487 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -163.99 -177.22 36.58 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -113.44 152.17 30.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.971 0.415 . . . . 0.0 111.027 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.2 OUTLIER -165.21 132.96 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.963 178.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.4 t-80 64.34 28.09 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.831 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.76 20.53 79.77 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -134.65 152.04 51.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.458 0.647 . . . . 0.0 112.278 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.33 154.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.745 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . 0.47 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -175.73 176.44 47.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.57 145.71 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 117.403 0.602 . . . . 0.0 109.504 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -156.97 165.13 19.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.092 -177.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.459 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 58.1 Cg_endo -73.15 129.44 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.701 2.267 . . . . 0.0 112.401 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 846' ' ' TYR . 61.8 ttp85 -61.77 -37.79 85.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.413 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 3.3 t -59.19 3.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . 0.551 ' H ' ' C ' ' A' ' 844' ' ' ARG . 0.4 OUTLIER -110.25 -2.33 16.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . 0.409 ' CD1' ' CZ ' ' A' ' 831' ' ' TYR . 36.8 pt -133.94 175.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -116.48 161.76 18.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . 0.41 HD11 ' HE ' ' A' ' 796' ' ' ARG . 53.0 tp -121.31 96.73 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.841 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 4.0 tt 40.14 70.27 1.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.485 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 C-N-CA 121.902 1.735 . . . . 0.0 112.202 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 927' ' ' LYS . 79.2 mm-40 -125.63 151.17 46.87 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.69 147.1 18.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.1 129.16 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.84 122.55 13.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -70.6 -36.27 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -135.4 154.5 51.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -53.54 138.58 33.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.1 129.0 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.51 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -116.75 109.3 16.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.424 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.13 149.12 43.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -106.41 -47.5 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.751 0.31 . . . . 0.0 111.116 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 74.6 p -81.31 162.01 23.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.351 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.95 -39.43 94.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.67 -23.97 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -98.26 129.11 44.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 30.5 mmm -94.82 178.83 5.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.771 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 88.6 p -131.29 149.86 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -160.63 163.31 32.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.26 165.05 11.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.954 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.12 136.35 57.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.28 -5.94 81.03 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.908 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.83 141.28 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.655 0.728 . . . . 0.0 110.379 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -86.16 141.87 29.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.088 0.47 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.76 147.81 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.495 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.7 m -102.34 127.85 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.82 122.81 30.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . 0.408 ' CD2' ' NH1' ' A' ' 908' ' ' ARG . 85.8 mt -101.52 -47.01 4.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -166.52 165.3 16.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.878 0.37 . . . . 0.0 111.31 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -104.04 118.45 36.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 63.4 t -61.94 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.645 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 77.1 m-20 -144.09 -104.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.9 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -126.09 -34.85 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.678 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.08 7.85 16.84 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.605 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -131.34 148.64 52.69 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.979 0.175 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -153.56 160.14 42.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.113 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.7 136.69 47.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.71 179.19 30.99 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.404 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . 0.408 ' NH1' ' CD2' ' A' ' 897' ' ' LEU . 32.3 ptt-85 -148.37 158.22 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 0.0 110.258 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.77 140.55 86.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.75 138.53 33.19 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.181 1.101 . . . . 0.0 111.112 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 102.04 -18.17 52.63 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 71.98 73.33 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.9 t -120.91 -48.07 2.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.69 149.83 51.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.524 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -136.83 143.79 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.48 176.09 46.14 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.37 147.9 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.211 0.529 . . . . 0.0 111.387 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.57 159.12 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.918 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.06 139.55 39.45 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.566 2.177 . . . . 0.0 114.48 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.41 -38.06 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.467 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.468 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -52.6 -38.8 60.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.29 0.83 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.11 159.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 110.965 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -108.82 125.66 52.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.99 103.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.698 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -65.04 -42.4 94.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.64 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 871' ' ' GLU . 7.0 ptmm? -145.18 159.09 43.54 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.157 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.136 179.647 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.656 0.265 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.72 149.76 63.36 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.866 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.09 105.06 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.308 2.005 . . . . 0.0 111.995 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -105.53 144.12 32.73 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.623 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -111.42 134.14 53.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -76.5 120.95 22.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . 0.513 ' NZ ' ' CE2' ' A' ' 802' ' ' PHE . 19.5 ttpp -89.07 -29.19 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . 0.513 ' CE2' ' NZ ' ' A' ' 801' ' ' LYS . 54.1 m-85 -135.03 152.57 51.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.436 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.8 p-10 -75.35 146.54 40.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.077 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -134.59 133.24 39.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -99.61 132.42 44.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.342 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -68.67 139.8 55.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.96 -30.94 13.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.382 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 29.9 p -137.06 178.4 7.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.43 -38.41 87.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.274 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -60.6 -40.68 92.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.374 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.61 142.45 29.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.874 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.35 152.76 58.11 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.819 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.32 148.26 67.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.982 1.788 . . . . 0.0 113.098 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.11 145.39 51.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.54 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -124.85 137.91 54.28 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.472 0.654 . . . . 0.0 111.723 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.07 127.63 10.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.399 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.53 -19.32 54.17 Favored Glycine 0 C--N 1.318 -0.422 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.129 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.33 122.39 18.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.363 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.53 135.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.176 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.17 154.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.4 m-85 -114.96 112.47 22.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.793 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.46 133.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.696 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -96.85 -47.79 5.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.775 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -163.95 153.78 14.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.269 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 59.3 tt0 -74.88 108.38 7.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.357 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.8 mm -64.75 -45.96 93.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.894 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 5.2 t0 -140.49 177.34 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.456 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -57.09 -27.06 61.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.382 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.27 -30.67 4.87 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.736 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -85.54 168.09 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.47 . . . . 0.0 111.719 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 24.0 p90 -153.39 169.09 23.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -131.5 138.41 48.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.044 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.64 -175.45 31.66 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.04 137.18 46.47 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.564 0.221 . . . . 0.0 110.611 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.3 p-80 -142.07 138.77 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 53.4 t-80 52.46 26.79 4.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.95 4.48 90.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.823 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.33 161.24 19.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.63 0.252 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.72 153.68 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.754 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -179.76 -172.56 43.94 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.5 pp -125.27 142.45 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.363 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -148.74 154.83 41.04 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.404 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.18 134.19 33.08 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.787 1.658 . . . . 0.0 111.98 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -60.57 -41.8 95.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.74 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 71.3 p -59.52 -11.54 4.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.635 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -92.73 -2.53 55.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.99 165.46 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.873 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.21 120.94 28.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.208 0.528 . . . . 0.0 111.737 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.3 103.95 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.544 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 4.8 tt 42.79 87.04 0.12 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.271 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo . . . . . 0 N--CA 1.498 1.765 0 C-N-CA 122.686 2.258 . . . . 0.0 112.204 -179.303 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -129.54 157.3 42.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.87 153.1 29.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.32 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -52.56 137.55 30.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.533 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 3.3 ttpm? -83.82 -41.93 16.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -129.33 150.91 50.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 47.9 p-10 -55.5 153.27 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -151.13 131.81 14.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.859 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.59 108.21 14.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . 0.494 ' N ' ' OG ' ' A' ' 887' ' ' SER . . . -91.93 -176.84 42.43 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -145.68 -40.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.915 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 79.3 p -79.18 160.42 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.028 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -70.06 -30.17 67.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.1 -13.57 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 64.6 mm-40 -113.38 133.07 55.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.785 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 7.4 tpt -106.02 116.97 32.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.803 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 887' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 880' ' ' GLY . 50.1 m -73.82 144.11 45.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -154.73 157.16 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -106.61 150.28 26.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.319 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 66.1 tttp -44.55 139.99 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.066 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 83.7 0.86 90.01 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.407 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.33 148.63 43.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.18 0.49 . . . . 0.0 110.679 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -91.44 128.97 37.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.229 0.537 . . . . 0.0 110.718 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.76 148.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.41 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -106.36 127.28 53.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.863 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.38 124.61 29.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.697 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.6 mt -101.19 -52.86 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.27 164.54 22.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . 0.405 HE21 ' CB ' ' A' ' 905' ' ' TYR . 0.5 OUTLIER -96.9 111.88 23.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.439 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 78.8 t -69.41 -42.41 81.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.299 0.571 . . . . 0.0 110.016 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -152.97 -174.99 5.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.871 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -61.54 -38.1 86.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.237 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -117.02 14.65 15.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.77 147.64 51.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 16.1 p90 -155.04 160.67 41.21 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.112 0.482 . . . . 0.0 110.975 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.429 ' CD ' ' NE2' ' A' ' 915' ' ' GLN . 42.0 tt0 -107.02 133.74 51.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -144.96 165.73 27.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . 0.591 HH12 ' H ' ' A' ' 911' ' ' GLY . 5.3 ppt_? -150.81 158.83 44.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.446 . . . . 0.0 110.501 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 14.4 mm -78.9 132.68 63.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.78 137.24 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.259 1.128 . . . . 0.0 111.267 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.591 ' H ' HH12 ' A' ' 908' ' ' ARG . . . 99.56 -9.55 60.66 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.9 p 71.58 30.43 2.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.1 m -62.17 -40.65 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.187 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -161.76 152.73 18.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.429 ' NE2' ' CD ' ' A' ' 906' ' ' GLU . 63.2 tt0 -132.33 147.75 52.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.35 43.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.853 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 918' ' ' PHE . 45.5 pt -119.57 147.01 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.91 0.385 . . . . 0.0 111.174 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -163.74 163.58 15.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.775 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.53 140.84 48.78 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.281 1.987 . . . . 0.0 113.321 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.45 -30.93 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.51 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 68.0 p -61.32 -21.43 63.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.651 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.67 1.65 56.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 14.7 m -135.34 160.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.913 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 66.5 t0 -114.79 130.62 56.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.399 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' A' ' 924' ' ' ASP . 5.8 m -94.81 148.57 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.89 -38.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -146.55 130.8 17.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.452 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.186 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 822' ' ' ILE . 63.1 tpp . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -138.24 148.66 60.57 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.399 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.95 156.23 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.404 2.069 . . . . 0.0 112.308 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -153.56 159.3 42.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -133.01 136.89 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -75.26 116.54 16.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.65 -37.54 86.77 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.92 173.07 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 57.2 t0 -77.43 109.45 11.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.599 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.14 126.76 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -95.23 111.69 23.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.68 57.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.072 0.463 . . . . 0.0 110.992 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 -31.2 8.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.906 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 60.8 p -133.07 162.4 31.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.376 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -55.94 -31.73 63.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.716 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -62.09 -39.69 93.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.289 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -96.57 126.89 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.325 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.5 mm? -103.44 151.69 38.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.633 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.78 142.54 48.14 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.573 1.515 . . . . 0.0 112.679 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . 0.461 ' O ' ' OD1' ' A' ' 803' ' ' ASP . 92.6 mt -127.06 161.7 27.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -123.66 136.6 54.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.417 0.627 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.18 121.85 5.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.457 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.06 11.05 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.938 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 68.3 t0 -48.04 136.38 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.325 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 7.1 mm -101.86 125.32 56.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.86 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.71 156.65 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.293 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -112.12 125.62 54.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.64 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . 0.449 ' O ' ' SD ' ' A' ' 795' ' ' MET . 75.6 mt -88.0 123.47 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.215 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 832' ' ' GLU . 8.0 p90 -111.43 -3.83 15.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.27 133.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -87.25 128.09 35.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.292 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.36 -46.35 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.03 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -152.65 179.43 8.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.637 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.91 -37.52 76.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -107.68 -8.6 16.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.79 141.07 42.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 0.0 112.031 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -129.44 151.44 50.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.558 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.42 ' OE2' ' OH ' ' A' ' 823' ' ' TYR . 3.7 tt0 -125.74 139.64 53.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -157.99 180.0 33.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 837' ' ' GLY . 12.7 tm-20 -115.26 125.45 53.33 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.0 p80 -132.39 138.02 47.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 82.3 t60 50.78 32.05 6.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 834' ' ' GLU . . . 75.46 13.3 83.02 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -118.61 148.16 42.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.8 127.34 75.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 0.0 111.541 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -147.97 -179.78 24.22 Favored Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.415 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 30.8 pt -124.29 143.4 37.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.101 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.0 OUTLIER -145.75 149.11 38.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.676 -179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 845' ' ' THR . 72.1 Cg_endo -75.62 137.54 20.49 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.251 1.967 . . . . 0.0 111.197 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -55.51 3.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.595 ' H ' ' C ' ' A' ' 843' ' ' PRO . 0.2 OUTLIER -90.74 -15.83 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.685 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 -5.45 16.17 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.268 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 45.9 pt -133.52 173.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.551 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -131.29 155.12 47.72 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 8.1 tp -105.31 107.63 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.197 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 4.6 tt 49.9 76.71 0.52 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.305 -1.748 0 C-N-CA 122.989 2.459 . . . . 0.0 111.845 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . 0.532 ' OE2' ' NE ' ' A' ' 893' ' ' ARG . 88.0 tt0 -138.31 150.59 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.766 0.317 . . . . 0.0 110.203 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.12 42.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.99 121.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.073 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.5 4.03 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.5 mtmt -70.36 -36.79 74.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.63 152.62 50.69 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.253 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 878' ' ' PHE . 61.6 t-20 -54.69 136.14 46.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.709 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.632 ' CD2' ' CE1' ' A' ' 888' ' ' PHE . 90.3 t80 -129.52 132.04 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.76 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.06 106.95 13.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -71.01 139.58 29.89 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -107.01 -3.18 20.35 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 68.4 p -132.69 160.84 35.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.235 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -61.51 -41.96 98.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.54 -25.38 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.92 108.23 20.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 886' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 887' ' ' SER . 16.9 tmm? -79.74 135.02 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 887' ' ' SER . . . . . 0.512 ' O ' ' SD ' ' A' ' 886' ' ' MET . 33.9 t -82.6 132.28 35.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.716 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.632 ' CE1' ' CD2' ' A' ' 878' ' ' PHE . 45.5 p90 -142.18 154.51 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -103.54 163.89 12.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.063 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.46 132.73 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.5 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 96.33 -7.01 66.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.296 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.94 133.77 47.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.923 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.532 ' NE ' ' OE2' ' A' ' 871' ' ' GLU . 70.4 mtp85 -84.05 126.09 32.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 8.7 mm -114.88 143.45 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.106 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -98.28 127.81 44.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.98 116.21 22.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 110.943 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.75 -50.62 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -160.86 154.9 22.77 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.079 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 116.88 32.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.448 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 60.0 t -61.43 -46.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.779 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.9 m-20 -143.88 -104.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.989 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -129.04 -37.7 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -108.09 4.74 25.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.502 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -132.02 148.27 52.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -153.95 159.77 41.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.113 0.482 . . . . 0.0 110.882 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -107.47 135.12 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.65 177.84 30.14 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.288 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -150.84 160.3 43.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.24 128.84 86.93 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -49.13 138.86 27.83 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 120.161 1.093 . . . . 0.0 111.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 912' ' ' THR . . . 101.26 -17.84 55.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 911' ' ' GLY . 0.2 OUTLIER 79.18 86.0 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.898 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 25.4 t -129.25 -41.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.036 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -162.74 151.92 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.817 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -130.01 146.55 51.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.05 175.48 45.34 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.519 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.8 pt -114.1 142.37 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.899 0.38 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -152.67 157.96 33.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.889 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 136.63 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.117 1.878 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.25 -36.82 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.867 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.433 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 73.0 p -53.5 -29.85 38.26 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -91.85 2.38 56.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.984 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 16.9 t -127.19 148.97 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.308 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -99.98 121.31 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.44 123.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.156 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.06 -44.82 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.67 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -125.61 142.27 51.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.539 -179.6 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.8 mpp? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.76 0.314 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.96 149.44 73.13 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.02 153.8 57.71 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.394 2.063 . . . . 0.0 112.274 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -168.86 151.14 4.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -133.41 129.33 37.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.617 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -76.41 122.83 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' A' ' 848' ' ' GLU . 15.5 ttmm -91.24 -18.14 24.88 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.462 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.74 139.97 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.192 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.84 152.12 43.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.312 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . 0.443 ' CE1' ' CD ' ' A' ' 811' ' ' GLU . 47.5 t80 -126.87 129.09 47.55 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.466 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.61 121.1 35.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.1 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -62.26 134.99 57.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 110.793 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -110.96 -28.8 8.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 68.9 p -130.87 163.35 27.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.456 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.65 -34.75 67.62 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.99 -47.29 86.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.783 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . 0.443 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 8.1 tm-20 -86.78 123.66 32.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.114 0.483 . . . . 0.0 111.266 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -96.57 152.73 38.77 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.29 145.12 76.95 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.611 1.541 . . . . 0.0 112.511 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.89 151.42 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.29 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 817' ' ' GLY . 11.1 tt0 -102.89 147.76 26.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.461 0.648 . . . . 0.0 110.661 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -63.45 38.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.125 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 166.06 23.26 0.02 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -97.15 113.65 25.26 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.77 -0.253 . . . . 0.0 110.418 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.7 135.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.658 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.55 158.3 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.25 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.409 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 84.6 m-85 -108.41 115.83 30.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.403 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 33.4 mm -81.57 134.62 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.318 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -96.75 -39.68 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . 0.47 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 25.9 pttm -162.07 159.83 26.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.417 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -86.14 116.02 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 827' ' ' ASP . 48.5 mm -65.01 -48.73 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.284 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 826' ' ' ILE . 34.5 m-20 -147.62 177.5 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.18 -36.41 75.29 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.253 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -109.87 15.4 22.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -137.06 147.53 46.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 112.082 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.541 ' OH ' ' NH1' ' A' ' 844' ' ' ARG . 44.0 m-85 -133.87 150.99 51.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.32 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.47 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 3.7 tt0 -124.11 133.33 53.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.135 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.409 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -158.39 -175.77 29.69 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -113.79 149.93 34.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.556 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.3 p-80 -152.55 132.14 13.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.558 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 75.6 t60 48.84 34.01 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.581 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.88 1.63 90.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.863 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.18 147.83 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.86 135.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.635 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -158.27 -143.02 3.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 842' ' ' PHE . 45.5 pt -128.97 150.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 117.449 0.624 . . . . 0.0 110.748 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 841' ' ' ILE . 4.1 m-85 -144.24 131.0 10.21 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.842 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.38 148.21 72.91 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.532 1.488 . . . . 0.0 112.784 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . 0.541 ' NH1' ' OH ' ' A' ' 831' ' ' TYR . 60.2 ttt85 -59.74 -41.06 90.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.658 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 94.1 m -64.47 -22.47 66.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.341 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -91.93 -3.76 55.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.806 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 844' ' ' ARG . 1.3 pp -142.08 165.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.182 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' A' ' 801' ' ' LYS . 96.1 mt-10 -132.49 124.44 28.54 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.92 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.36 113.33 9.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.3 tt 53.15 76.02 0.57 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.34 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.804 2.336 . . . . 0.0 111.749 -179.864 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.94 151.75 41.49 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.917 0.389 . . . . 0.0 110.929 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.07 27.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.264 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 11.5 mm -122.23 127.45 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -47.31 131.17 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.497 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -72.93 -37.19 67.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.684 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 922' ' ' TYR . 0.2 OUTLIER -155.15 160.79 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.231 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.541 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 23.0 m120 -51.72 109.55 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -115.85 125.5 52.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.402 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -115.86 110.59 19.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.379 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -64.52 142.5 45.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.05 -22.93 28.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 66.3 p -129.85 164.15 24.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.621 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -59.87 -25.95 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.266 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.84 -45.3 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.64 141.79 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.7 tpt -103.24 130.71 50.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 142.07 27.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -158.6 160.84 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.538 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -89.57 158.12 17.77 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.521 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -66.08 56.25 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.689 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . -178.16 4.66 0.03 OUTLIER Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.725 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.96 150.52 20.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.551 0.675 . . . . 0.0 109.866 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -95.5 127.97 41.97 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.451 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.62 151.67 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.85 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.7 m -104.36 127.45 52.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.887 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 87.4 mt -90.16 127.7 36.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.535 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 87.9 mt -108.27 -53.56 2.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.702 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -156.34 150.28 25.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.985 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.14 106.94 18.82 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.51 -44.07 95.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -157.87 178.68 9.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.088 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.87 -30.99 71.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.959 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . 0.469 ' C ' ' CD1' ' A' ' 904' ' ' TRP . 98.3 m-20 -109.7 20.07 18.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.41 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 903' ' ' ASN . 74.3 m95 -146.83 151.61 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.96 138.09 26.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.545 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -102.11 133.16 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.02 178.43 35.19 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.952 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -151.16 157.81 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.96 141.76 78.75 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.45 139.85 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.06 1.057 . . . . 0.0 111.046 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.434 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.33 -9.26 69.58 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.7 p 69.83 31.99 3.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.663 0.268 . . . . 0.0 110.971 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.0 t -60.91 -44.22 97.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.11 146.81 15.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -121.19 151.05 40.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.278 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -175.02 176.12 47.13 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.182 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.467 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 45.2 pt -125.12 156.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.467 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.4 OUTLIER -166.48 162.69 11.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.661 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.67 147.85 90.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.806 1.671 . . . . 0.0 111.768 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 11.3 mt -76.37 -19.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 81.6 p -68.95 -10.69 58.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.591 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . 0.566 ' CD1' ' CE1' ' A' ' 876' ' ' PHE . 45.5 m-85 -108.23 7.59 27.47 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.04 159.42 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -117.38 131.75 56.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.54 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.99 98.81 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 926' ' ' ILE . 46.0 mm -70.67 -44.19 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.013 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.65 142.53 51.0 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.86 179.441 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . 0.458 ' HE ' ' CD2' ' A' ' 849' ' ' LEU . 13.9 tpt180 -129.8 121.13 19.83 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.09 138.9 21.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.702 1.601 . . . . 0.0 112.474 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -138.77 154.4 48.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -113.13 140.39 47.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.013 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -72.88 126.95 31.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -91.06 -8.86 47.76 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.258 0.552 . . . . 0.0 109.571 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.13 178.3 7.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.136 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.3 p-10 -98.53 139.57 34.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.569 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -129.56 129.58 44.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.232 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -95.31 135.13 37.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.562 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -76.42 138.04 40.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -114.38 -22.33 9.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.902 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.1 p -127.22 167.67 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.446 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.42 -41.4 97.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.771 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -63.01 -39.94 96.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.471 . . . . 0.0 109.864 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -74.76 131.89 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.265 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 9.1 mp -118.76 154.23 52.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.06 144.19 62.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.856 1.704 . . . . 0.0 112.346 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.65 141.45 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.212 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -122.66 139.85 53.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.438 0.637 . . . . 0.0 110.921 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.82 123.55 7.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.911 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 105.75 -24.33 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.412 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.2 t0 -61.9 135.67 57.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.799 0.333 . . . . 0.0 110.763 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.503 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 33.9 mm -93.9 130.57 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.46 152.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.46 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 86.6 m-85 -117.04 117.74 30.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.03 129.59 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -123.88 -9.67 7.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.274 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -165.18 133.59 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -82.69 138.01 34.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.633 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 9.8 mm -94.82 -57.64 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.477 ' O ' ' NH2' ' A' ' 844' ' ' ARG . 7.7 t0 -150.21 179.33 8.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.085 0.469 . . . . 0.0 109.795 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.59 -37.26 78.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.716 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -106.18 7.25 31.48 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -141.15 147.13 37.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.113 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 29.6 p90 -140.08 169.68 17.25 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.558 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.5 tp10 -128.54 139.19 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.134 0.493 . . . . 0.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.558 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -161.36 -175.45 32.4 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.89 135.62 49.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.693 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.8 OUTLIER -144.61 146.91 32.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.8 t-80 49.04 29.76 2.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.18 79.98 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -132.8 158.92 41.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.78 132.66 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.618 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . 0.465 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -164.29 -175.02 34.72 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.48 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 36.6 pt -115.15 149.65 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.515 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.3 OUTLIER -152.01 151.67 28.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 845' ' ' THR . 27.5 Cg_endo -67.88 112.08 2.59 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.797 1.665 . . . . 0.0 112.15 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 827' ' ' ASP . 19.1 ttm105 -47.69 -15.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.53 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.407 ' N ' ' C ' ' A' ' 843' ' ' PRO . 63.2 p -81.49 -2.25 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.735 0.303 . . . . 0.0 111.052 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.2 -2.91 26.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.004 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.5 pt -129.33 172.05 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.881 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 85.1 tt0 -110.31 159.73 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . 0.458 ' CD2' ' HE ' ' A' ' 796' ' ' ARG . 3.4 tt -113.49 104.36 12.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 36.5 tp 58.26 75.13 0.56 Allowed Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.785 . . . . 0.0 112.399 -179.146 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.783 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.0 160.93 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.88 146.0 17.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 89.8 mt -123.19 125.8 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.58 122.69 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.149 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 46.3 mtpt -70.38 -37.86 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -132.75 154.33 50.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.324 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.708 HD21 ' H ' ' A' ' 890' ' ' LYS . 33.6 m120 -54.25 146.19 15.91 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 89.0 t80 -141.43 137.12 31.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.031 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -123.64 105.4 9.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.183 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.5 155.15 52.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -115.13 -9.61 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.585 0.231 . . . . 0.0 111.503 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.3 p -128.54 160.56 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . 0.493 ' O ' ' SD ' ' A' ' 886' ' ' MET . 55.2 tt0 -61.55 -39.71 92.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.936 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.48 -42.05 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.521 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -88.36 103.27 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.689 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 886' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 883' ' ' GLN . 0.0 OUTLIER -80.89 133.59 35.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.237 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 84.4 p -73.06 157.4 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 111.053 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 41.1 p90 -160.38 162.94 33.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.474 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -112.95 161.84 16.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.301 0.572 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.708 ' H ' HD21 ' A' ' 877' ' ' ASN . 63.7 tttm -59.37 132.77 55.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.74 -8.01 78.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.694 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.31 139.82 48.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.24 0.52 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -85.21 143.4 28.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.956 0.408 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 894' ' ' ILE . 94.2 mt -131.99 148.8 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.738 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -101.53 129.16 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.987 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.26 115.21 24.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 111.149 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.97 -50.41 4.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.791 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -157.46 151.69 24.79 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.019 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.89 113.74 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.699 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.437 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 79.5 t -69.19 -43.16 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 110.31 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.438 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 19.3 t0 -153.56 -176.65 5.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.021 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 61.0 mp0 -61.13 -37.85 84.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.83 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.6 13.28 21.28 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.87 147.63 46.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.437 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 20.9 p90 -154.29 158.27 39.93 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.162 0.506 . . . . 0.0 110.965 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.23 133.3 52.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.04 178.6 30.83 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.334 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . 0.407 ' C ' ' CD ' ' A' ' 908' ' ' ARG . 0.0 OUTLIER -153.14 161.68 42.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.855 0.359 . . . . 0.0 110.385 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 13.1 mt -90.22 132.26 36.32 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.826 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -39.98 136.28 1.45 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.397 1.398 . . . . 0.0 111.757 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.21 -4.34 64.8 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.44 24.68 13.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.4 t -61.58 -45.07 95.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.95 146.73 45.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.489 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.2 tt0 -147.39 139.01 24.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 172.54 -170.28 43.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.7 pt -116.31 145.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.054 0.454 . . . . 0.0 111.014 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.37 153.38 30.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.038 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.04 137.52 41.2 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.057 1.838 . . . . 0.0 112.991 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.51 -38.68 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 93.7 m -51.96 -44.17 63.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.961 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.13 3.57 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.67 147.53 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.99 0.424 . . . . 0.0 110.285 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.71 120.99 42.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.504 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.76 124.65 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.505 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.89 -35.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -151.55 135.61 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.758 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.439 179.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -128.19 145.62 56.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.3 108.41 1.75 Allowed 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.956 1.77 . . . . 0.0 112.645 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -109.35 144.83 37.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -114.24 140.61 48.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.226 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -81.2 118.18 22.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -72.38 -27.48 62.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.077 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -142.39 178.15 7.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.558 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.09 139.28 30.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.057 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -127.08 125.86 42.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.34 132.55 34.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.2 139.03 49.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . 0.492 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 98.1 mm-40 -105.24 -29.18 10.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.069 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 808' ' ' THR . . . . . 0.453 ' H ' ' CG ' ' A' ' 811' ' ' GLU . 71.5 p -136.15 170.14 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.261 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.41 -35.25 77.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.166 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -59.93 -40.17 88.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.737 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 807' ' ' GLN . 10.8 pt-20 -98.4 129.4 45.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.613 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -102.08 152.19 38.18 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.58 149.98 68.7 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.304 2.003 . . . . 0.0 113.092 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.62 142.77 49.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.663 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.9 133.53 53.02 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.261 0.553 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -41.57 126.05 2.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.6 -24.17 32.49 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.385 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.53 121.35 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.2 mm -81.55 138.86 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.044 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.47 154.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.452 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -113.0 117.01 30.85 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 62.3 mt -82.04 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.179 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.17 -4.82 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -166.78 130.83 1.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 827' ' ' ASP . 4.0 tm0? -90.6 107.32 19.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.712 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.1 mm -60.77 -48.87 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.121 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.551 ' C ' HE21 ' A' ' 825' ' ' GLN . 1.3 t70 -155.56 176.98 11.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 26.0 mp0 -61.85 -35.83 79.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.779 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -102.13 -7.41 22.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.815 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -125.53 131.89 52.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.982 0.42 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -121.4 156.65 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.605 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -128.91 140.81 51.51 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.91 -174.18 31.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.44 136.31 48.27 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.577 0.227 . . . . 0.0 110.652 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 2.7 p80 -139.11 133.14 31.13 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 1.3 t60 50.2 31.8 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.243 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.27 4.45 90.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.538 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -112.63 161.87 16.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.01 140.89 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.52 30.31 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.79 155.02 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.131 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -161.53 153.82 16.7 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.576 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 845' ' ' THR . 56.6 Cg_endo -71.86 126.98 12.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.961 1.774 . . . . 0.0 112.714 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 2.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.757 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 845' ' ' THR . . . . . 0.514 ' H ' ' C ' ' A' ' 843' ' ' PRO . 73.8 p -91.05 -18.44 24.57 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.589 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.49 5.41 34.04 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.2 pt -130.27 168.28 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -134.71 113.27 11.5 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.988 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.81 118.19 11.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 21.6 tp 58.84 69.91 1.28 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.785 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.493 1.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.625 -179.257 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -128.15 150.41 50.0 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.54 146.32 16.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.05 125.21 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.19 120.56 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.359 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -69.22 -36.7 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -134.33 150.52 50.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.916 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -55.55 132.92 49.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -130.67 134.63 47.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 16.5 p30 -113.65 128.89 56.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.996 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.89 23.33 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -98.17 -12.73 21.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 110.731 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 62.0 p -133.07 165.08 25.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . 0.473 ' O ' ' CE ' ' A' ' 886' ' ' MET . 98.4 mt-30 -62.02 -39.73 93.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.113 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.82 -15.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.757 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -105.71 110.09 22.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.296 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 886' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 883' ' ' GLN . 39.1 mmt -81.01 152.69 27.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.262 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 96.7 p -108.9 155.01 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -159.3 161.61 35.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.779 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . 0.417 ' N ' ' CD ' ' A' ' 889' ' ' ARG . 1.4 mpt_? -96.44 165.86 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.593 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.53 135.89 57.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.19 82.63 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.607 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -72.38 140.61 48.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.516 0.658 . . . . 0.0 110.038 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -82.06 140.99 33.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.114 0.483 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 894' ' ' ILE . 90.8 mt -130.25 138.8 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.51 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.3 m -99.37 126.13 45.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.08 115.36 25.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.107 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.28 -37.36 6.03 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.535 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.48 134.61 18.13 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.181 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -103.1 118.27 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 901' ' ' ASP . 60.0 t -63.96 -41.21 91.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.098 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 900' ' ' VAL . 36.4 m-20 103.97 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.905 1.378 . . . . 0.0 110.335 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 901' ' ' ASP . 10.2 tt0 80.7 -69.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.766 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -169.43 23.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -135.88 151.04 49.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.505 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.85 155.11 35.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.21 0.529 . . . . 0.0 110.3 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.88 138.5 42.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.64 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.24 178.14 30.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.144 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -148.13 157.92 43.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.747 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.5 mt -80.35 142.14 54.11 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.27 139.2 16.53 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 120.312 1.147 . . . . 0.0 110.499 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.26 -5.06 67.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 9.1 p 61.3 23.55 13.76 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.535 -0.333 . . . . 0.0 111.532 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.6 m -62.39 -42.3 99.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.832 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -134.9 153.04 52.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.456 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -145.37 135.75 24.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.75 177.22 46.15 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.9 pt -112.45 144.05 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.629 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -151.3 155.78 34.74 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.474 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 140.2 41.97 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.058 1.839 . . . . 0.0 113.395 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.22 -37.57 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.486 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 98.9 m -56.31 -42.54 77.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -76.09 0.25 19.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.158 0.435 . . . . 0.0 111.96 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.15 158.97 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.159 0.504 . . . . 0.0 111.245 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -107.14 123.95 49.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.455 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.27 110.15 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.24 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 32.4 mm -86.01 -47.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.868 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 143.19 51.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.444 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.171 179.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -132.98 145.77 58.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.227 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.59 120.27 3.9 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.934 1.756 . . . . 0.0 112.431 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -120.42 152.0 38.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.27 133.93 55.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.951 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -77.22 113.98 15.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 816' ' ' LYS . 18.8 mmmt -69.68 -38.17 76.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.168 0.509 . . . . 0.0 110.056 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.4 167.52 20.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.093 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 137.6 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.333 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -133.75 131.38 39.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.441 ' O ' ' NE2' ' A' ' 807' ' ' GLN . 68.8 mttm -100.7 134.54 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -81.86 144.05 31.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.99 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . 0.441 ' NE2' ' O ' ' A' ' 805' ' ' LYS . 25.8 mp0 -98.52 -35.32 10.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.68 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 808' ' ' THR . . . . . 0.45 ' OG1' ' OE1' ' A' ' 811' ' ' GLU . 47.1 p -135.03 171.66 14.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.386 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.2 -24.65 43.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.175 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.28 -38.83 88.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.285 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . 0.45 ' OE1' ' OG1' ' A' ' 808' ' ' THR . 24.6 mp0 -101.12 156.44 17.42 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.7 pt? -127.21 147.68 62.91 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . 0.502 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 58.3 Cg_endo -72.44 140.25 32.97 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 113.033 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.72 145.0 51.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -120.13 139.98 51.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.281 0.562 . . . . 0.0 110.426 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 801' ' ' LYS . 12.4 ttmm -43.83 121.54 2.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.27 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.52 -20.65 49.59 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.578 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.32 136.16 57.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.937 0.399 . . . . 0.0 111.399 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.97 131.63 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.867 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.93 152.87 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.646 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -110.82 121.54 45.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.799 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 67.0 mt -91.38 131.06 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -104.51 -32.22 9.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.674 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -158.28 149.86 21.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.494 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.442 ' OE1' ' OH ' ' A' ' 831' ' ' TYR . 49.8 tt0 -88.48 110.77 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.285 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.36 -48.01 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.296 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.432 ' OD1' ' OE1' ' A' ' 828' ' ' GLN . 8.2 t0 -154.76 177.86 10.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . 0.432 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 25.5 mp0 -61.36 -36.35 79.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.754 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -103.73 -2.55 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.173 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -127.97 139.38 52.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.442 ' OH ' ' OE1' ' A' ' 825' ' ' GLN . 5.0 m-85 -126.03 158.27 35.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.314 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.451 ' O ' ' OE1' ' A' ' 832' ' ' GLU . 0.6 OUTLIER -129.05 138.96 52.2 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.15 -176.01 33.77 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -117.56 152.91 34.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.971 0.415 . . . . 0.0 111.458 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.0 OUTLIER -164.52 137.05 4.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.159 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 49.3 t-80 52.6 29.93 7.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.302 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.22 2.63 90.57 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.515 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.9 148.25 30.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.05 136.93 52.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -170.7 -137.83 2.38 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.5 pt -133.83 157.01 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.93 0.365 . . . . 0.0 111.641 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 6.6 p90 -157.72 135.77 7.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.181 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.27 124.85 17.05 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.125 1.216 . . . . 0.0 112.442 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -54.92 -20.42 8.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.4 p -72.46 -11.28 60.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.48 -1.76 40.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.244 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.45 171.03 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.992 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -131.88 110.19 10.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.869 0.366 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.64 116.29 8.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 32.4 tp 54.05 72.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.676 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 122.183 1.922 . . . . 0.0 112.123 -179.243 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.77 143.97 50.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.206 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -157.2 144.59 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.5 mt -123.02 128.19 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.822 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.09 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.946 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 44.7 mtpt -70.05 -37.82 75.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.816 0.341 . . . . 0.0 110.497 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.71 153.53 49.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -57.11 159.46 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 26.9 t80 -150.49 138.72 20.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.72 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 40.0 p30 -151.85 92.04 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -82.69 -174.24 49.98 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 49.4 t0 -135.66 -9.38 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 111.641 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 882' ' ' THR . . . . . 0.558 ' HG1' ' H ' ' A' ' 885' ' ' GLU . 71.5 p -79.26 174.3 11.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.98 0.419 . . . . 0.0 110.686 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.45 -0.93 57.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 -18.77 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.642 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . 0.558 ' H ' ' HG1' ' A' ' 882' ' ' THR . 3.0 pp20? -72.57 141.95 48.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.58 128.56 46.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 22.5 t -92.85 125.45 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.109 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 34.4 p90 -154.9 162.37 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 33.2 mtp-105 -112.18 161.67 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.347 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -59.42 136.54 58.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 893' ' ' ARG . . . 90.15 -4.91 83.14 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -76.87 142.79 40.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.179 0.489 . . . . 0.0 110.562 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 891' ' ' GLY . 12.6 mpt_? -82.4 142.12 32.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.251 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.2 mt -131.38 143.17 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.2 m -100.65 127.09 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.873 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.85 120.32 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.3 mt -100.18 -45.61 5.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -165.5 164.85 19.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.887 0.375 . . . . 0.0 111.134 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -103.58 116.95 33.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.404 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.8 t -61.86 -45.55 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.193 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.469 ' CG ' ' N ' ' A' ' 902' ' ' GLU . 34.4 t70 -148.56 -116.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.789 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . 0.469 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 99.7 mt-10 -114.32 -37.03 4.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.75 7.75 22.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.589 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -132.49 148.57 52.39 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.526 0.203 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' A' ' 918' ' ' PHE . 21.5 p90 -152.71 159.56 43.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.853 0.358 . . . . 0.0 110.283 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.69 136.79 48.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.32 178.39 30.38 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.547 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -151.79 159.75 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.7 mt -80.69 140.79 51.29 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.49 138.3 18.81 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 CA-C-N 120.148 1.088 . . . . 0.0 110.988 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.436 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 94.04 -6.91 73.0 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 2.2 p 66.51 28.05 9.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.715 0.293 . . . . 0.0 111.15 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 88.0 p -64.21 -24.17 67.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -165.26 152.85 11.03 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.686 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -144.02 147.19 33.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.676 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 179.04 -174.55 46.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.551 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 45.9 pt -109.94 154.72 11.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.219 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 918' ' ' PHE . 0.0 OUTLIER -165.23 151.87 9.18 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.908 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.82 140.65 29.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.17 1.913 . . . . 0.0 112.768 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.57 -32.05 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.801 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.538 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 97.9 m -57.9 -42.14 84.09 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -77.4 1.23 19.66 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.78 159.15 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -111.32 128.7 56.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.377 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 79.3 t -99.58 105.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.687 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.19 -45.74 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.31 140.41 39.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 CA--C 1.54 0.568 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.689 -179.916 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.73 0.3 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -158.77 98.46 1.69 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.19 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.824 1.683 . . . . 0.0 111.91 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -134.73 155.91 49.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -118.51 134.47 55.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.283 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -76.29 116.92 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -71.3 -30.03 65.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.46 175.67 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.465 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 805' ' ' LYS . 14.5 t70 -82.31 126.73 32.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.455 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -115.56 130.73 56.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.981 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 803' ' ' ASP . 38.2 mmtm -94.21 130.16 40.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.2 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -68.77 139.51 55.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.24 -35.63 10.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.242 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.9 p -135.42 162.54 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.1 pp -50.61 -32.87 20.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.46 -46.13 91.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.268 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.03 136.97 32.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.025 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 812' ' ' LEU . 2.4 mm? -110.67 150.72 42.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 152.02 50.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.219 1.946 . . . . 0.0 113.448 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 4.8 mt -133.96 157.21 46.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.917 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.56 141.01 50.67 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.422 0.63 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -47.62 123.35 5.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.79 44.19 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.886 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.539 ' OD1' ' NE2' ' A' ' 835' ' ' HIS . 19.8 t70 -58.03 143.28 43.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 28.2 mm -103.78 131.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.655 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 32.1 m -121.62 152.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.764 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.418 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 72.8 m-85 -111.94 113.58 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.36 127.14 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -119.33 -5.49 10.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.19 130.44 1.45 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.81 135.32 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.29 -48.92 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.42 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -152.48 178.98 8.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.13 -37.21 79.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.163 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -105.98 -0.43 24.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.929 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -124.5 137.94 54.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.491 0.662 . . . . 0.0 112.089 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.03 151.85 48.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.372 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -123.31 141.03 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.9 -163.51 14.92 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.49 150.13 49.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 111.008 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.539 ' NE2' ' OD1' ' A' ' 818' ' ' ASP . 1.2 t-80 -155.33 128.05 7.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.5 ' HD1' ' CD2' ' A' ' 835' ' ' HIS . 1.9 m80 52.38 24.04 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 92.09 -6.37 78.81 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . 0.436 ' NH2' ' CE1' ' A' ' 835' ' ' HIS . 12.0 ptp180 -98.08 151.9 19.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.337 0.568 . . . . 0.0 109.897 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.55 129.24 61.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.92 23.87 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 31.1 pt -105.74 152.15 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 117.338 0.569 . . . . 0.0 110.588 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.5 OUTLIER -139.79 114.78 7.95 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.8 128.57 21.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.474 1.45 . . . . 0.0 112.721 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -50.85 -20.28 1.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.533 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 65.7 p -87.1 -3.18 59.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.663 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -6.42 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.221 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 45.8 pt -134.25 172.1 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.013 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -117.83 160.61 21.1 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.87 107.67 18.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 41.3 tp 46.41 77.64 0.45 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.472 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.495 1.615 0 C-N-CA 121.947 1.765 . . . . 0.0 111.809 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.733 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -129.02 150.55 50.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.722 0.296 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -154.53 152.86 30.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . 0.444 HG23 HD13 ' A' ' 873' ' ' ILE . 23.2 mm -125.14 128.77 73.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -59.29 126.34 27.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.339 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 50.4 mtpt -73.85 -39.02 64.3 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -139.02 153.8 48.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.07 132.9 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -132.91 135.91 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.894 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -109.93 141.58 42.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.583 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.35 12.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -98.42 -12.15 21.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.25 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.4 p -132.99 163.31 29.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.28 -39.86 94.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.916 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.99 -25.01 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.843 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -98.2 127.47 44.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.8 tpt -105.07 123.59 48.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.937 0.399 . . . . 0.0 110.97 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 87.1 p -74.41 157.44 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.871 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -164.43 162.56 22.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -102.71 159.18 15.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -55.14 137.25 47.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.76 82.93 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.119 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -69.65 141.84 53.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.079 0.44 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -91.25 135.26 33.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.136 0.493 . . . . 0.0 111.111 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.49 148.03 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.517 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.1 m -99.81 127.07 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 86.5 mt -84.03 125.11 31.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 111.104 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 98.3 mt -103.19 -50.71 3.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.021 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 36.7 ptt-85 -165.93 165.24 18.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.22 119.17 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.545 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 53.3 t -61.2 -47.65 92.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.764 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.1 m-20 -144.2 -91.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.07 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -137.93 -46.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.537 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -102.1 7.46 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -133.23 149.39 52.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.688 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -153.57 161.78 41.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.054 0.455 . . . . 0.0 111.165 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 33.8 tt0 -109.96 139.2 45.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.867 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.47 176.24 28.29 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -144.62 156.23 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.782 0.325 . . . . 0.0 110.436 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.1 mt -103.21 107.67 56.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.066 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -54.09 135.28 63.66 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.35 1.367 . . . . 0.0 111.358 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 97.01 -22.31 41.45 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 74.6 p -127.58 -17.55 4.57 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.992 0.425 . . . . 0.0 110.022 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 57.5 m 51.61 36.57 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.216 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -86.25 98.09 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.522 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 53.6 tt0 -86.33 128.23 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.999 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -157.03 163.91 32.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.496 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.3 144.9 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.895 0.378 . . . . 0.0 111.068 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.496 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -158.49 164.28 21.69 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.857 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.39 137.06 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.412 2.074 . . . . 0.0 113.925 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 91.6 mt -60.77 -39.09 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.88 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.473 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 70.1 p -54.92 -22.48 15.07 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.757 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -95.11 0.85 54.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.6 m -132.3 157.88 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.13 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.43 121.83 45.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.19 103.95 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.831 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 926' ' ' ILE . 41.4 mm -72.38 -43.58 64.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.131 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -132.82 151.92 51.92 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.653 0.263 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -125.82 97.61 35.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.545 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.56 140.88 96.56 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.075 1.85 . . . . 0.0 111.905 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -135.17 155.83 50.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -117.54 133.66 55.72 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.451 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -79.41 127.07 31.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -91.99 -28.72 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.14 162.62 32.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.079 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.5 p-10 -75.94 137.77 40.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.457 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.27 129.02 55.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.003 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -96.03 124.98 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.88 50.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.7 -38.8 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.418 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 67.8 p -135.64 162.87 31.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.62 -34.35 7.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.21 -39.86 94.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.993 0.425 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.83 128.33 38.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.977 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 812' ' ' LEU . 2.1 mm? -108.71 150.09 40.32 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.649 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.74 151.43 63.49 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.203 1.935 . . . . 0.0 113.023 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 3.2 tp -135.82 151.26 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.612 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.19 137.86 53.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.47 0.652 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.42 126.27 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.66 -23.64 34.97 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.294 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.3 t0 -59.78 133.98 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . 0.47 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 44.7 mm -91.82 130.11 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.99 145.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.222 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.428 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 71.0 m-85 -107.51 104.86 14.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.6 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.45 130.89 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -100.35 -38.21 8.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.832 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -161.37 156.15 23.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.479 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.33 111.12 20.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.026 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . 0.408 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 48.0 mm -63.34 -47.35 92.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.278 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -148.88 177.12 9.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.62 -25.3 68.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -123.96 11.42 8.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -137.91 145.26 41.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . 0.408 ' HA ' ' H ' ' A' ' 826' ' ' ILE . 29.4 p90 -140.76 165.5 27.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -127.61 139.06 52.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.398 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.13 -172.24 29.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -111.83 138.84 47.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.779 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.496 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.4 p-80 -141.71 133.74 27.57 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 52.83 29.69 8.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.13 5.78 89.86 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.012 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -115.92 150.11 37.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.5 p -114.4 141.99 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.01 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -171.01 -158.62 15.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . 0.44 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 49.4 pt -126.45 149.63 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.76 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -151.4 154.03 33.08 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.45 125.8 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.623 1.548 . . . . 0.0 111.825 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -56.98 -27.67 61.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.174 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.8 p -66.82 -12.84 60.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.255 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -96.36 -1.32 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' A' ' 847' ' ' ILE . 1.4 pp -140.45 169.11 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.439 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -130.42 120.26 23.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.2 115.79 4.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.897 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 44.62 77.22 0.46 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.305 -1.745 0 C-N-CA 122.653 2.236 . . . . 0.0 111.334 179.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -135.04 147.17 49.56 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.503 0.192 . . . . 0.0 110.717 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -152.67 154.14 34.7 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 92.9 mt -124.74 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.754 0.312 . . . . 0.0 110.436 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.47 57.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.327 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -87.2 -29.67 21.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -137.94 145.48 42.07 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.708 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 877' ' ' ASN . 40.3 p-10 -51.34 122.14 7.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -117.05 125.86 51.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -119.81 105.6 11.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.301 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -65.26 137.97 38.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -102.89 1.14 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.9 p -130.5 163.09 27.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.01 -40.81 96.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 14.0 m -67.62 -25.36 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.572 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -97.42 136.39 37.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.185 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 886' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 915' ' ' GLN . 0.0 OUTLIER -107.24 168.05 9.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 41.5 t -118.44 136.16 53.95 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.942 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.92 162.05 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 891' ' ' GLY . 99.3 mtt180 -82.67 162.33 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.717 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 890' ' ' LYS . 10.6 pttt -73.09 42.36 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.267 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 889' ' ' ARG . . . -160.83 -0.38 0.07 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.069 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.68 143.18 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.795 0.798 . . . . 0.0 110.406 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -76.23 143.08 41.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.995 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 872' ' ' ALA . 92.0 mt -129.19 139.13 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.524 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.8 m -99.14 125.25 44.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.83 116.48 20.01 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.64 -46.07 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -166.18 164.61 17.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.984 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -103.91 118.41 36.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.413 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.4 t -65.26 -45.31 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.647 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -152.03 -125.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.769 0.318 . . . . 0.0 111.047 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.08 -25.11 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.339 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -135.47 18.93 3.35 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.599 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.51 146.95 51.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.733 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . 0.413 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 15.0 p90 -156.42 161.29 40.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.053 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.65 133.89 50.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.502 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -147.91 172.96 28.12 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.557 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -155.96 163.39 39.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.812 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 84.3 mt -94.01 139.26 22.55 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.96 141.52 36.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.214 1.112 . . . . 0.0 111.061 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.09 68.58 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.2 m 73.78 28.37 1.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 44.9 t -67.9 -50.14 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -135.19 148.07 49.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.082 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.488 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.6 tt0 -151.24 135.18 16.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.278 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 176.78 -174.89 47.37 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.0 pt -115.47 146.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.36 0.6 . . . . 0.0 111.456 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -161.75 158.82 22.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.677 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.05 140.43 45.34 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.489 2.126 . . . . 0.0 114.452 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.19 -32.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.269 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.7 m -57.62 -39.44 76.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.749 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.85 5.04 23.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.06 158.46 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.169 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -111.0 123.14 49.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.267 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 4.7 m -95.04 141.53 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.011 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.47 -37.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.265 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -136.49 136.29 39.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.523 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.718 179.155 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.957 0.408 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -135.6 148.89 67.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.452 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.57 116.31 4.45 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.942 1.762 . . . . 0.0 111.987 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -112.32 152.67 28.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -118.85 129.36 55.17 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.662 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.19 112.66 9.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.97 -35.43 78.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.121 0.486 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -137.81 162.63 33.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.668 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 803' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 31.1 t70 -73.71 138.31 44.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.412 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.03 119.02 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.07 0.462 . . . . 0.0 110.632 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -84.48 144.87 28.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -72.82 114.96 11.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.3 -39.92 89.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.449 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.9 p -134.29 162.26 32.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -34.1 14.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.61 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -61.0 -43.88 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.381 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -77.3 162.87 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.27 150.13 66.29 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.7 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.14 146.92 32.73 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.118 1.879 . . . . 0.0 111.997 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 814' ' ' LEU . . . . . 0.439 ' O ' ' OD1' ' A' ' 803' ' ' ASP . 13.0 mt -140.24 140.92 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.501 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -120.64 139.55 52.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.521 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -43.8 124.02 3.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.215 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.61 -19.44 53.59 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.09 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.8 136.0 57.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.936 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.88 134.31 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.81 157.96 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 821' ' ' TYR . . . . . 0.43 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 98.1 m-85 -115.12 111.14 20.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.475 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 822' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 822' ' ' ILE . 30.4 mm -79.73 96.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -85.29 -14.97 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.06 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 824' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.3 tttm -162.86 131.7 4.06 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.785 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 825' ' ' GLN . . . . . 0.679 HE21 ' N ' ' A' ' 827' ' ' ASP . 6.3 tm0? -85.12 127.46 34.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.31 -56.44 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.015 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 827' ' ' ASP . . . . . 0.679 ' N ' HE21 ' A' ' 825' ' ' GLN . 4.7 t70 -151.73 177.4 10.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.375 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.45 -23.72 67.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.377 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -111.74 -3.66 14.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.417 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -131.71 134.98 46.48 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.277 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.21 160.35 28.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.887 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 832' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 9.7 tt0 -136.31 135.94 39.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 833' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.25 -165.58 15.3 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -120.27 139.09 53.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.506 0.193 . . . . 0.0 110.898 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 835' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.4 p-80 -143.68 134.46 25.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 71.9 t60 50.21 31.95 5.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.71 3.27 90.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.919 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -109.65 155.68 21.18 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.2 t -124.21 135.01 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.08 -157.33 10.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 48.0 pt -131.42 154.13 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.226 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.53 148.9 14.45 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.83 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 126.11 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.303 1.335 . . . . 0.0 113.075 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -56.54 -28.04 59.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.76 -13.44 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -93.82 -0.79 55.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.61 167.08 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.9 126.71 27.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 12.1 tp -78.46 113.65 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.2 tp 51.97 73.49 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.305 -1.725 0 C-N-CA 122.466 2.111 . . . . 0.0 111.812 -179.582 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -116.82 151.52 36.34 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -152.82 146.98 25.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 7.5 mm -125.3 127.95 72.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.01 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.27 129.48 40.11 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 875' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -85.37 -31.98 22.65 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -137.0 146.01 44.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.173 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 877' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 877' ' ' ASN . 40.0 p-10 -52.38 117.76 3.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -112.51 125.07 53.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.722 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -110.91 106.1 15.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -68.15 141.97 38.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -94.76 -9.43 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 60.9 p -134.15 163.27 29.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -61.58 -38.45 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.949 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.16 -41.8 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.084 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -87.37 104.73 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.64 146.07 50.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 97.7 p -107.85 151.82 25.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.1 OUTLIER -164.68 176.48 8.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.723 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -105.49 172.8 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.25 136.43 57.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.046 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 88.72 1.12 80.82 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.037 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.67 139.84 42.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.767 0.783 . . . . 0.0 109.949 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.39 141.39 35.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.099 0.476 . . . . 0.0 111.149 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.48 144.2 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.1 m -103.41 128.16 50.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.917 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.15 126.92 34.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.784 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.6 mt -108.73 -55.09 2.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -159.14 153.73 24.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.229 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -93.13 115.9 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.764 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 900' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 57.0 t -61.89 -47.46 93.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 901' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 88.5 m-20 -143.39 -102.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -130.83 -38.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.493 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -107.19 5.22 27.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.57 150.34 52.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.764 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.08 159.98 43.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.507 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.6 tt0 -103.12 133.91 47.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.499 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.72 30.35 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.167 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -149.8 157.34 43.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.957 0.408 . . . . 0.0 110.451 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 49.5 mm -80.06 141.12 54.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.83 139.62 24.58 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.972 1.114 . . . . 0.0 111.184 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 911' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 93.96 -8.08 73.31 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 912' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.7 p 67.71 28.35 7.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 111.129 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 96.0 p -63.78 -26.51 68.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.23 153.45 13.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 915' ' ' GLN . . . . . 0.507 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 46.2 tt0 -142.72 142.51 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.572 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.12 48.17 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 917' ' ' ILE . . . . . 0.519 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 43.9 pt -117.74 145.24 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -153.27 166.07 16.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.19 132.74 35.15 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 122.345 2.03 . . . . 0.0 114.425 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.79 -40.14 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.993 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 921' ' ' THR . . . . . 0.507 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 68.1 p -61.15 -25.46 67.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 922' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -82.6 -2.09 52.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.541 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 923' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 922' ' ' TYR . 27.6 m -129.43 155.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.494 0.664 . . . . 0.0 112.229 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.081 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.71 99.46 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.273 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 926' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 926' ' ' ILE . 1.8 mp -64.62 -47.3 89.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -139.94 146.53 39.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.88 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.193 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 789' ' ' HIS . 3.6 pm0 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.492 ' H ' ' HG2' ' A' ' 788' ' ' GLN . 62.9 t-80 -65.67 -37.43 86.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.327 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 51.5 ttp 76.47 59.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.786 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.2 t -151.15 148.89 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.289 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 88.98 63.13 1.33 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 69.3 m -61.28 147.05 45.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -66.98 142.29 57.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.42 167.09 18.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.466 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -123.68 138.74 30.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.044 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 120.6 6.73 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.655 1.57 . . . . 0.0 112.688 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -113.58 146.01 40.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -108.3 132.55 53.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.362 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.21 112.32 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.6 -38.04 86.17 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 109.714 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -139.41 -177.97 5.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 56.0 p-10 -93.07 144.24 25.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.355 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -133.77 128.15 34.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.54 134.36 35.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -73.84 133.95 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.639 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -105.63 -26.43 11.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.2 p -130.63 169.73 15.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 809' ' ' LEU . 8.3 mp -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.473 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.94 -40.43 95.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.85 131.73 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.312 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.46 151.37 44.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.05 145.75 56.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.104 1.87 . . . . 0.0 113.036 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.86 140.81 42.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.276 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -118.47 142.4 47.61 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.423 0.63 . . . . 0.0 110.809 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -48.71 122.97 6.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.639 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.23 54.49 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.72 128.81 37.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.62 135.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.32 152.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.44 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 87.1 m-85 -113.01 119.55 38.28 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 22.5 mm -87.35 103.87 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.912 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -93.69 -7.23 44.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.657 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.24 132.61 2.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.147 0.499 . . . . 0.0 111.314 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -90.51 112.3 23.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.674 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.6 -49.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -159.47 178.16 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.23 -35.33 76.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.054 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -100.15 -6.1 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.883 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -130.35 135.01 47.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.317 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -123.1 152.61 40.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.464 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -127.83 137.8 52.49 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.62 -175.33 28.43 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -110.86 138.72 46.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.106 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.1 p-80 -143.18 133.32 24.39 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 51.54 31.79 8.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.418 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.19 90.3 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.743 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -115.44 155.23 27.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.0 p -120.61 143.74 31.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.999 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.86 -168.74 31.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 17.7 pt -126.38 154.22 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.701 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -163.69 156.09 15.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.63 118.93 5.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.115 1.877 . . . . 0.0 112.751 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -47.68 -19.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.3 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 63.8 p -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -6.21 21.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 45.1 pt -132.17 169.76 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.706 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -122.83 106.76 11.18 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.089 0.471 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.59 112.55 2.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.781 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.33 78.65 0.38 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.533 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.54 152.17 57.11 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.675 2.25 . . . . 0.0 111.873 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 151.21 75.76 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.31 2.007 . . . . 0.0 111.814 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -99.78 121.67 41.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.73 -12.23 45.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.251 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.29 142.99 28.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.939 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.67 66.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 63.79 70.7 0.67 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.533 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.08 -21.6 66.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.367 2.711 . . . . 0.0 112.702 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 59.08 39.45 23.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 41.04 -129.49 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.649 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.47 176.09 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.45 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 4.4 t -148.28 144.03 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.586 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.28 -22.53 60.42 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.055 1.837 . . . . 0.0 112.217 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.86 -169.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 55.08 40.97 32.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.521 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 34.2 m -131.93 159.11 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.575 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.83 152.85 34.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.71 133.69 29.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -82.0 143.78 31.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.616 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -75.06 156.06 48.54 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.57 149.98 41.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.707 0.289 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.59 155.95 27.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.38 133.62 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.71 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.1 133.99 56.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.969 0.414 . . . . 0.0 111.656 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -83.81 -25.61 30.24 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.28 146.61 38.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 34.2 m120 -52.93 139.93 26.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.412 ' CB ' ' CE1' ' A' ' 888' ' ' PHE . 26.6 t80 -131.88 130.86 42.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.909 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -131.72 89.9 2.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -74.47 171.02 53.39 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -133.92 12.82 3.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.615 0.245 . . . . 0.0 111.045 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 882' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 885' ' ' GLU . 82.8 p -130.73 159.01 38.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.742 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -62.55 -40.93 98.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.01 -26.3 38.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.528 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 81.2 mm-40 -103.45 120.79 41.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 8.0 mmt -93.24 172.26 8.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.543 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 93.0 p -121.87 148.91 44.12 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.109 0.48 . . . . 0.0 110.967 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.412 ' CE1' ' CB ' ' A' ' 878' ' ' PHE . 11.9 p90 -161.03 160.19 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.493 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 3.6 mtp-105 -95.06 170.25 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.198 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.701 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 24.1 ttpp -73.49 52.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 176.22 16.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.966 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 889' ' ' ARG . 14.9 mp0 -97.33 149.62 21.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.438 0.619 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -84.59 148.85 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.046 0.45 . . . . 0.0 110.513 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 872' ' ' ALA . 93.7 mt -132.57 144.54 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.504 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.0 m -102.7 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.98 130.38 35.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.074 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.44 -54.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.111 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . 0.54 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 34.6 ptt-85 -166.05 165.04 18.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 901' ' ' ASP . 35.0 tt0 -99.92 120.27 39.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.761 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.23 -46.83 95.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.982 0.42 . . . . 0.0 111.094 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 899' ' ' GLN . 12.9 t70 -144.79 -95.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.011 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 98.7 mt-10 -132.49 -45.54 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.698 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.31 8.13 35.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -131.58 148.64 52.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.593 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -154.87 161.86 41.3 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.66 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.54 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 88.2 tt0 -109.61 137.84 46.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.33 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.71 172.11 31.81 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -149.99 156.31 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.339 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -77.4 139.55 64.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.37 137.93 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.103 1.202 . . . . 0.0 111.122 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.402 ' C ' ' HG1' ' A' ' 912' ' ' THR . . . 96.73 -10.35 66.46 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 911' ' ' GLY . 1.4 m 69.33 25.69 5.51 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 89.6 p -67.25 -38.99 86.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.46 150.27 44.99 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.264 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -145.56 142.68 29.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.257 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -179.34 -179.62 48.76 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.397 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -119.87 150.91 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.943 0.401 . . . . 0.0 111.121 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -163.63 160.89 17.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.38 139.49 49.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.14 1.893 . . . . 0.0 113.124 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.75 -38.96 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.028 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 69.2 p -57.85 -11.3 2.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.576 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.95 0.66 32.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 10.7 m -132.99 158.25 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 111.194 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.97 131.71 56.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.692 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.4 -45.79 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.599 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.71 121.75 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.895 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.77 149.68 88.17 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.52 151.15 64.52 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.103 1.869 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.66 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -123.77 137.08 54.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.391 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -157.78 165.37 35.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.625 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 49.6 m 56.07 44.43 25.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -167.69 176.23 42.44 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 67.2 m -124.9 144.25 50.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.91 0.33 56.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 795' ' ' MET . 0.5 OUTLIER -144.67 166.08 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -132.77 95.72 19.25 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.77 140.45 93.37 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.04 1.827 . . . . 0.0 112.099 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -133.54 154.2 51.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -116.4 135.04 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.774 0.321 . . . . 0.0 110.646 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -79.18 127.06 31.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.869 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.23 -14.97 20.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.207 0.527 . . . . 0.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -151.84 167.31 28.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.6 p-10 -91.49 133.89 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.63 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -127.71 128.66 45.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -93.27 135.68 34.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.62 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.566 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -100.37 -22.67 14.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.993 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 87.5 m -128.05 162.81 25.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.27 -42.84 87.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.106 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.3 -39.35 90.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.195 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.79 149.12 48.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 840' ' ' GLY . 2.2 pp -125.79 151.22 70.67 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . 0.509 ' O ' ' NE2' ' A' ' 835' ' ' HIS . 74.5 Cg_endo -74.45 141.32 28.22 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.667 1.578 . . . . 0.0 112.102 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.16 148.76 52.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.061 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -120.18 135.26 55.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.339 0.59 . . . . 0.0 109.936 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . 0.494 ' NZ ' ' CB ' ' A' ' 816' ' ' LYS . 0.0 OUTLIER -43.38 124.39 3.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.176 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.64 -21.02 48.04 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.675 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.56 134.78 51.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 29.1 mm -93.58 129.57 43.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.156 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.53 153.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 88.6 m-85 -113.6 121.62 44.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.23 129.3 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.737 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -109.46 -16.15 14.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -168.42 142.47 3.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 111.46 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.33 136.5 33.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.142 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.4 -50.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 109.876 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -149.61 179.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.925 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.46 -36.37 80.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.908 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -104.58 -1.51 26.4 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -126.96 139.34 53.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.359 0.599 . . . . 0.0 111.609 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.408 ' CE1' ' NE ' ' A' ' 844' ' ' ARG . 12.7 m-85 -125.6 156.92 38.39 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.584 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 1.6 tp10 -124.43 139.9 53.45 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -168.75 -173.21 36.34 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -116.78 150.59 38.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 813' ' ' PRO . 0.5 OUTLIER -155.88 134.51 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.521 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.9 t-80 51.22 31.83 7.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.77 80.05 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 839' ' ' VAL . 44.0 tpt85 -121.09 135.09 55.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 838' ' ' ARG . 99.6 t -112.65 129.23 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.496 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -166.96 -154.56 8.5 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.09 160.83 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 117.062 0.431 . . . . 0.0 110.877 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -160.8 152.8 16.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 845' ' ' THR . 60.6 Cg_endo -73.75 121.67 7.2 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.077 1.852 . . . . 0.0 112.623 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . 0.408 ' NE ' ' CE1' ' A' ' 831' ' ' TYR . 3.4 ttm180 -50.56 -10.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.519 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 843' ' ' PRO . 62.6 p -80.51 -10.85 59.73 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.474 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -102.9 -3.98 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.666 0.269 . . . . 0.0 111.231 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 42.6 pt -136.21 173.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -114.66 161.48 18.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.72 103.98 12.29 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.8 tp 53.38 77.91 0.42 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.688 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.29 162.92 39.24 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.132 1.888 . . . . 0.0 111.879 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.31 138.53 55.52 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.738 1.625 . . . . 0.0 111.649 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -114.75 124.57 52.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.34 -38.16 90.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.401 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.83 140.14 58.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 169.78 17.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.259 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 857' ' ' GLN . 19.1 mp0 -69.51 148.86 97.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.41 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.35 -19.85 49.29 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.329 2.019 . . . . 0.0 112.286 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.41 144.57 54.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.528 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -127.84 150.96 49.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 861' ' ' LEU . 0.1 OUTLIER -73.2 89.11 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 5.7 t -145.82 143.3 19.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.261 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 150.36 66.82 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.142 1.894 . . . . 0.0 112.355 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.06 160.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -161.12 -39.69 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.657 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 2.1 t 55.41 19.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.299 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 3.8 mp -62.49 -41.45 98.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.769 0.318 . . . . 0.0 110.799 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 50.54 45.42 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.48 -173.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.167 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -73.38 167.54 54.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.29 160.98 31.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.28 150.24 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.94 123.07 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.297 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.06 117.06 6.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -69.57 -35.27 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.498 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -130.27 142.22 50.56 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.887 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -47.85 134.24 13.43 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.62 134.33 52.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.426 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -128.71 100.51 5.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.73 155.39 52.87 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 58.3 p30 -116.78 -0.29 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.11 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.6 p -127.29 158.02 38.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.896 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -65.24 -32.38 74.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.919 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.4 m -70.66 -26.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.052 0.453 . . . . 0.0 109.829 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.37 113.5 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.944 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 28.0 ttt -84.23 135.77 34.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 90.3 p -82.84 153.87 24.95 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.082 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -161.9 161.02 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -100.07 160.52 14.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.569 0.7 . . . . 0.0 112.754 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -58.4 130.24 45.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.24 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.15 1.64 89.53 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -72.17 139.7 48.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.24 141.9 30.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 86.7 mt -132.85 147.96 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.8 m -99.61 129.62 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.54 119.38 25.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.906 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.36 -53.14 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.12 165.68 17.57 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.814 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . 0.409 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.4 mp0 -98.27 112.82 24.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.454 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.27 -24.6 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.858 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -155.84 174.55 15.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.535 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.17 -32.18 73.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.052 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -113.95 2.06 14.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -134.02 151.88 51.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.478 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.409 ' CB ' HE21 ' A' ' 899' ' ' GLN . 31.8 p90 -150.94 158.33 44.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.034 0.445 . . . . 0.0 110.429 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.1 135.9 41.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.292 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.05 178.21 29.43 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -147.41 157.66 43.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.494 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.89 135.45 59.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.578 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -45.94 137.81 12.68 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 120.898 1.065 . . . . 0.0 111.377 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.59 62.22 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.92 34.7 1.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.61 0.243 . . . . 0.0 111.084 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.3 t -61.29 -46.49 90.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.638 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -171.34 149.39 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.54 144.44 37.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -164.8 170.51 39.91 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.2 pt -116.33 147.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.154 0.502 . . . . 0.0 111.224 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.0 159.59 29.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.16 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.2 137.64 29.07 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.473 2.116 . . . . 0.0 113.919 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 920' ' ' ILE . 88.3 mt -61.31 -35.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.488 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 96.4 m -53.92 -42.8 69.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.218 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.7 -0.22 33.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.308 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 920' ' ' ILE . 13.9 t -125.18 147.89 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.14 0.495 . . . . 0.0 110.674 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.8 121.28 41.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.202 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.11 116.95 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.385 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.23 -47.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.84 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.93 133.24 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -71.04 150.1 94.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.349 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.66 152.82 59.51 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.087 1.858 . . . . 0.0 112.156 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.383 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 58.19 65.96 1.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.92 143.4 57.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.1 t -148.17 149.83 32.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.71 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 92.46 -7.75 77.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 66.6 m -126.9 143.68 51.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 110.507 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . 0.495 ' O ' ' SD ' ' A' ' 795' ' ' MET . 98.9 mt-10 -135.34 146.06 48.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 794' ' ' GLU . 31.5 mmm -130.15 164.41 24.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -128.89 98.55 24.09 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 119.553 -0.261 . . . . 0.0 110.89 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.92 138.69 26.25 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.419 1.413 . . . . 0.0 112.244 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.04 47.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -104.89 137.22 43.0 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.296 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -82.52 121.22 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -95.19 -12.86 25.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.159 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.42 141.79 43.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.53 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 58.3 p-10 -68.52 150.04 48.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 814' ' ' LEU . 90.2 t80 -147.64 128.67 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.28 130.63 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -63.35 132.3 51.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.419 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.69 -32.93 10.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.18 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 808' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 810' ' ' LYS . 92.4 m -128.96 138.16 51.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.494 ' CD1' HH21 ' A' ' 838' ' ' ARG . 0.8 OUTLIER -36.7 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.894 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 808' ' ' THR . 87.9 tttt -60.96 -48.43 81.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 808' ' ' THR . 3.2 mt-10 -72.79 165.56 24.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 110.621 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.38 81.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 146.81 61.6 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.927 1.751 . . . . 0.0 111.542 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 804' ' ' PHE . 2.6 tp -140.75 132.4 27.21 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 817' ' ' GLY . 35.3 tp60 -96.36 147.54 23.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 110.808 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -64.01 36.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 176.17 19.16 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.111 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.54 168.91 10.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.515 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.432 ' O ' ' ND1' ' A' ' 835' ' ' HIS . 35.8 mm -108.76 136.16 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.95 151.47 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.9 115.73 26.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 94.2 mt -74.92 134.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 823' ' ' TYR . 1.8 p90 -128.7 -5.24 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.264 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -170.32 125.31 0.75 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.5 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -80.32 125.85 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.5 mm -78.49 -52.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.12 175.92 9.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.906 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -60.1 -18.48 47.38 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.28 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.01 -52.25 2.7 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.043 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -70.52 151.35 45.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -131.01 148.62 52.77 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.21 135.2 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.59 27.14 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -110.48 141.38 43.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.949 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.432 ' ND1' ' O ' ' A' ' 819' ' ' ILE . 81.6 t60 -164.49 135.54 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.928 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.8 t-80 62.92 31.5 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.236 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.46 18.71 78.54 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . 0.494 HH21 ' CD1' ' A' ' 809' ' ' LEU . 12.2 tpt180 -136.5 154.55 50.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.33 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.8 p -129.0 141.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.632 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.38 -140.55 2.96 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.25 152.84 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.793 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -156.92 127.91 3.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.61 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.62 137.6 73.86 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.446 1.431 . . . . 0.0 111.994 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.51 -29.24 68.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.643 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 79.1 p -69.83 -15.66 63.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.392 . . . . 0.0 110.83 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.35 -2.24 55.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.76 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 29.8 pt -137.4 173.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.237 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 851' ' ' PRO . 11.3 tm-20 -124.14 106.32 10.24 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.95 113.78 2.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.94 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.5 mt 46.5 82.18 0.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.084 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . 0.529 ' N ' ' OE1' ' A' ' 848' ' ' GLU . 73.0 Cg_endo -78.11 159.46 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 122.185 1.923 . . . . 0.0 112.015 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 146.48 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.108 . . . . 0.0 112.041 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -125.15 -11.71 6.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.517 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.84 142.5 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -118.64 122.42 42.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.269 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -142.82 40.92 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.613 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -130.07 65.47 75.51 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.728 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.5 145.74 38.23 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.392 2.061 . . . . 0.0 112.088 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 146.13 48.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.646 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -143.28 129.35 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.93 128.29 54.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.459 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 4.2 t -153.19 143.95 15.86 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.02 149.08 64.71 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.99 1.793 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.23 -45.5 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -76.0 150.84 37.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.55 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.34 124.88 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.345 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.54 97.82 7.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -137.6 132.83 33.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -115.52 139.35 50.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.447 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -70.7 155.51 52.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.35 153.84 41.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.85 146.56 22.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 38.9 mm -117.08 121.91 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.47 125.92 25.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.479 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -72.61 -36.96 68.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.978 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.94 151.04 52.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.773 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -55.25 145.85 20.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -150.9 135.96 17.54 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.25 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -133.43 116.26 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.482 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.0 145.47 33.66 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.98 -2.22 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.739 0.304 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 882' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 885' ' ' GLU . 58.8 p -133.6 163.83 28.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -61.31 -39.19 89.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.177 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.21 -43.67 93.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.629 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . 0.454 ' O ' ' NH2' ' A' ' 914' ' ' ARG . 80.2 mm-40 -76.41 144.87 39.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.808 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 17.6 ttm -98.5 152.08 19.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 34.6 t -121.25 127.9 51.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.46 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.26 161.79 42.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -102.68 165.37 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.7 138.15 58.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.52 0.15 89.3 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.007 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -81.01 147.12 30.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.105 0.452 . . . . 0.0 110.253 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -95.35 132.47 40.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.1 0.476 . . . . 0.0 111.041 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 147.21 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.973 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.2 m -98.44 127.79 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.098 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 23.7 mt -92.25 126.51 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.727 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.0 mt -105.56 -48.47 3.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.545 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -160.53 154.34 22.61 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.166 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . 0.53 ' OE1' ' CD2' ' A' ' 905' ' ' TYR . 2.0 mp0 -89.94 113.91 25.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.773 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.1 -39.91 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -156.11 -176.71 6.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.314 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.94 -37.24 86.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.83 -4.29 25.09 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -112.55 151.96 29.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 111.666 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.53 ' CD2' ' OE1' ' A' ' 899' ' ' GLN . 1.5 m-85 -140.5 137.04 33.53 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -104.86 135.61 45.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.85 -178.94 32.36 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.587 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . 0.622 HH22 ' HG1' ' A' ' 912' ' ' THR . 17.3 ptm180 -148.22 158.02 43.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.507 -0.346 . . . . 0.0 110.364 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 79.2 mt -93.89 138.73 22.63 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.13 141.08 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.366 1.377 . . . . 0.0 111.807 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.64 76.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.622 ' HG1' HH22 ' A' ' 908' ' ' ARG . 1.4 m 68.83 32.96 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.637 0.256 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.3 m -62.33 -42.48 99.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' A' ' 885' ' ' GLU . 77.6 ttt180 -166.69 144.65 5.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -127.55 142.83 51.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 177.56 -173.77 46.39 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.69 155.4 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.496 . . . . 0.0 111.117 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -156.35 151.21 20.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.13 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 144.57 51.66 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.223 1.948 . . . . 0.0 113.68 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.53 -37.52 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.37 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.479 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -56.06 -39.54 72.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.07 -1.1 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.22 159.62 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.67 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -108.75 127.24 53.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.186 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 75.9 t -101.47 101.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -65.55 -45.77 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -135.83 150.58 49.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -103.54 148.61 36.01 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.958 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.54 152.15 65.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.162 1.908 . . . . 0.0 112.232 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . 0.597 ' H ' ' CD1' ' A' ' 930' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.589 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . 0.468 ' H2 ' ' H ' ' A' ' 789' ' ' HIS . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.468 ' H ' ' H2 ' ' A' ' 788' ' ' GLN . 56.6 p-80 -137.99 31.08 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.6 mtm -71.79 138.51 48.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.754 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 99.8 p -97.38 1.36 49.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.551 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 793' ' ' SER . . . -64.6 81.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 792' ' ' GLY . 1.5 p 76.76 122.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.0 -4.47 56.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.499 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -152.37 164.01 38.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.596 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -130.81 94.34 28.95 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.373 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 850' ' ' LEU . 33.6 Cg_exo -59.27 138.29 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.989 1.793 . . . . 0.0 111.786 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -130.38 153.3 48.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.83 135.62 54.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.272 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -76.57 111.37 11.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -35.28 79.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.068 0.461 . . . . 0.0 109.79 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -144.12 175.35 10.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.538 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 65.2 t0 -78.56 120.51 23.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.48 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -115.05 123.63 49.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.66 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.9 142.11 28.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.384 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -69.65 140.58 53.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.302 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -109.39 -31.74 7.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.05 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 63.7 p -129.41 171.01 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.376 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.81 -41.72 96.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.41 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.95 -38.35 90.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.395 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.17 122.98 27.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 11.1 mp -107.19 154.37 40.52 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.446 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.17 146.82 71.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.904 1.736 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 803' ' ' ASP . 0.2 OUTLIER -125.91 153.18 44.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -126.73 138.34 53.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.57 0.7 . . . . 0.0 110.926 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.09 125.42 10.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.277 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.65 -28.74 14.53 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.489 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 66.8 t0 -57.67 135.2 56.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.007 0.432 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 38.7 mm -99.15 133.51 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.1 m -125.09 151.12 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 76.9 m-85 -109.28 113.7 26.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 96.5 mt -82.03 130.95 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -104.51 -38.46 6.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.793 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -156.14 155.16 32.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 42.4 tt0 -82.84 130.73 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.553 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 7.5 mm -81.38 -46.23 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 109.63 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 3.5 t70 -148.11 178.77 8.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.046 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.43 -36.09 79.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -109.57 11.75 24.67 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -132.51 143.0 49.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -125.01 150.96 46.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.302 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.28 141.22 51.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -165.94 -175.14 36.11 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.31 140.7 36.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.037 0.446 . . . . 0.0 110.748 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -151.47 141.99 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 50.1 t-80 48.24 31.36 2.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.93 16.23 80.81 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.818 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -132.88 157.46 45.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.66 0.267 . . . . 0.0 111.065 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.12 129.17 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.087 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -154.78 -156.12 7.58 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.447 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.7 pp -124.54 154.73 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 117.347 0.573 . . . . 0.0 110.173 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 841' ' ' ILE . 3.8 m-85 -148.4 126.61 5.93 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.748 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.64 125.39 16.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.073 1.182 . . . . 0.0 111.81 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -54.6 -20.32 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.56 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.8 p -77.06 -12.55 59.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.95 -3.92 24.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.247 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.03 171.97 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 86.9 tt0 -114.23 160.51 18.94 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 18.4 mt -108.84 100.52 9.72 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 797' ' ' PRO . 53.8 tp 49.03 79.07 0.36 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.86 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.25 153.53 45.96 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.623 2.215 . . . . 0.0 111.443 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.51 65.08 1.66 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.174 1.916 . . . . 0.0 112.034 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.82 25.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.162 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.07 -45.81 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt 37.83 -148.69 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 176.31 -103.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 110.25 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . 0.447 ' O ' ' OE1' ' A' ' 857' ' ' GLN . 3.2 tm0? -141.36 75.93 22.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.29 144.39 95.95 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.085 2.523 . . . . 0.0 112.538 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -116.79 145.48 43.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.545 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.12 140.05 52.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.31 157.12 17.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 95.0 m -82.53 122.89 79.04 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.16 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 157.71 42.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.884 1.723 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.69 161.19 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.145 0.498 . . . . 0.0 110.95 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -156.28 171.59 19.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 8.3 p -49.38 -25.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 27.8 mt 55.89 -102.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -67.55 132.32 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.51 150.19 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.461 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -71.04 167.18 51.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -127.92 155.39 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 110.502 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -160.82 146.64 14.71 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.4 130.49 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.006 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -53.45 125.32 17.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.5 -40.91 73.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.431 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 877' ' ' ASN . 0.1 OUTLIER -145.09 148.86 34.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.64 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 98.7 m-20 -41.72 132.46 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.292 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 878' ' ' PHE . 46.4 t80 -134.57 131.13 37.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.43 117.84 26.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -84.43 -179.58 51.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 882' ' ' THR . 24.5 p30 -130.81 -40.18 1.21 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 882' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 881' ' ' ASP . 65.3 p -86.32 163.46 17.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -64.97 -34.39 78.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 110.149 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.18 -41.04 91.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 45.1 tp10 -81.38 130.97 35.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.152 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 14.6 mmt -101.33 164.66 11.67 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' SER . . . . . 0.423 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 35.5 t -127.23 146.18 50.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.198 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.47 177.8 7.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.165 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -113.15 163.57 14.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.291 0.567 . . . . 0.0 111.503 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.55 139.88 52.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.811 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.39 -8.23 77.39 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -75.89 138.46 41.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.244 0.522 . . . . 0.0 110.285 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -81.46 143.33 32.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.116 0.484 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 872' ' ' ALA . 88.7 mt -130.29 138.32 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.685 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.5 m -97.35 128.87 44.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.783 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.12 119.83 27.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.644 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.2 mt -99.23 -49.98 4.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -167.0 165.16 15.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.147 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . 0.412 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.7 mp0 -99.41 115.71 29.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.34 -25.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -159.77 173.75 15.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.83 -38.58 88.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -106.28 3.06 27.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -133.4 151.25 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.876 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.412 ' CB ' HE21 ' A' ' 899' ' ' GLN . 28.1 p90 -150.97 158.61 44.35 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.002 0.43 . . . . 0.0 110.581 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.528 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.4 tt0 -99.13 133.29 43.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.719 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.74 173.84 29.39 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.517 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -154.31 160.59 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.097 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . 0.503 ' CD1' ' NH2' ' A' ' 914' ' ' ARG . 84.5 mt -74.54 138.83 74.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -47.99 -14.03 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.395 1.397 . . . . 0.0 112.456 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 913' ' ' SER . . . -87.09 0.33 85.93 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.465 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 30.6 p 54.63 8.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 911' ' ' GLY . 89.5 p -71.88 -30.42 65.39 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.503 ' NH2' ' CD1' ' A' ' 909' ' ' ILE . 96.4 mtm-85 -139.47 149.75 44.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.853 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.528 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 66.4 tt0 -147.96 140.91 24.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.507 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.38 -178.19 47.6 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.504 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 46.3 pt -114.8 146.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -156.87 159.78 31.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.62 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 137.96 35.08 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.502 2.135 . . . . 0.0 114.21 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.06 -36.69 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.835 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.0 m -57.52 -44.69 85.29 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . 0.622 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -70.82 0.66 6.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.057 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 922' ' ' TYR . 27.3 m -130.48 156.96 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.481 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -107.1 127.24 53.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.168 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.69 119.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.256 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 30.2 mm -91.36 -48.01 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.627 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.05 146.86 50.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.55 148.83 95.41 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.405 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -22.76 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.213 1.942 . . . . 0.0 112.02 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.534 -179.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -68.22 -18.59 64.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 67.4 mtt -69.36 -27.06 65.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 70.7 m -56.92 141.84 43.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.029 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -127.46 -32.72 0.65 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.2 t -65.54 139.82 58.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.629 0.252 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.97 124.24 52.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.654 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -161.26 157.57 25.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -135.97 131.35 18.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.43 146.07 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 111.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -148.11 157.3 43.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . 0.402 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 73.8 ttt180 -122.96 131.15 53.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -76.57 123.13 25.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -94.06 -16.05 24.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.262 0.553 . . . . 0.0 110.046 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -135.4 139.7 44.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.517 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.3 p30 -73.88 154.73 39.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.491 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 114.92 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -79.04 130.98 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.52 131.02 39.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.74 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -108.39 -26.4 10.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.25 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.3 p -134.74 170.34 15.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.941 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 809' ' ' LEU . 8.7 mp -61.12 -37.43 82.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 98.3 mttt -60.23 -38.79 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.01 148.18 22.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.246 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.23 156.33 69.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.44 141.53 42.7 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.319 1.346 . . . . 0.0 112.155 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.05 143.18 34.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . 0.467 ' C ' ' H ' ' A' ' 817' ' ' GLY . 62.4 tt0 -103.95 143.03 33.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.341 0.591 . . . . 0.0 110.322 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -61.06 37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.444 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 173.16 21.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 835' ' ' HIS . 3.7 m-20 -97.28 161.21 13.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.5 130.4 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 2.1 p -129.63 136.88 58.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.179 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.7 m-85 -95.86 121.1 37.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.943 0.402 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.1 136.26 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.515 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -98.74 -39.35 8.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.745 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . 0.495 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 26.0 pttm -159.25 155.98 27.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.046 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.688 HE21 ' N ' ' A' ' 827' ' ' ASP . 3.1 tm0? -82.6 118.93 23.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.53 -46.65 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.688 ' N ' HE21 ' A' ' 825' ' ' GLN . 6.3 t0 -150.32 179.38 8.17 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.33 -38.41 83.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.629 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -111.66 13.54 21.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.803 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -131.59 143.59 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 112.091 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -134.02 152.2 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.707 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.495 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 4.2 tt0 -123.1 134.71 54.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.39 178.5 36.4 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -107.91 148.83 29.09 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 111.033 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.542 ' NE2' ' OD2' ' A' ' 818' ' ' ASP . 83.5 t60 -169.69 137.47 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.088 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 18.6 t60 58.53 32.94 22.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.305 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.83 16.58 79.28 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -132.7 154.88 49.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.115 0.483 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.6 134.9 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -160.69 -140.91 2.99 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.4 pt -135.46 154.3 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.71 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -157.99 150.68 18.08 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 143.8 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.148 1.898 . . . . 0.0 113.459 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.47 -35.56 72.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.065 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 76.3 p -63.22 -16.06 59.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.121 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -94.66 -2.66 50.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.407 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 1.3 pp -142.13 165.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.738 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.98 118.0 22.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.0 tp -69.81 113.98 7.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.368 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 29.4 tp 56.75 73.96 0.74 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.15 165.52 29.98 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.947 1.764 . . . . 0.0 111.719 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.6 134.44 33.26 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.851 1.701 . . . . 0.0 112.145 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -151.97 38.92 0.6 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.967 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -63.19 -39.76 95.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.51 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 53.45 44.17 30.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 68.48 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 45.43 66.18 5.59 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.467 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.13 138.48 71.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.535 2.157 . . . . 0.0 112.227 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -117.8 12.06 13.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -93.22 20.99 6.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 58.2 tp 52.16 91.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.505 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 11.7 t -151.47 146.36 18.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.165 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.08 139.47 42.48 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.53 1.487 . . . . 0.0 111.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.403 ' CG2' ' H ' ' A' ' 865' ' ' GLN . 0.3 OUTLIER -66.81 -83.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . 0.403 ' H ' ' CG2' ' A' ' 864' ' ' VAL . 98.0 mt-30 -76.87 150.08 36.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.39 125.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.486 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 87.2 mt -111.27 143.75 41.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.24 143.93 46.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.68 162.98 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -66.96 172.57 29.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 871' ' ' GLU . 48.2 mp0 -134.92 146.48 49.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -147.62 149.88 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.6 126.38 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 111.255 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.75 113.96 1.87 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -63.64 -37.02 85.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -129.53 148.13 51.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.323 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -56.81 125.2 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -115.19 128.43 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.563 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.95 109.77 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.474 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.32 145.24 32.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -103.09 -21.57 13.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.831 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.3 p -112.63 159.29 19.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -64.12 -31.26 72.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.343 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 8.7 m -71.41 -24.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.435 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.91 111.55 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.174 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.57 159.35 29.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' SER . . . . . 0.402 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 99.3 p -123.9 153.27 41.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.935 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.18 176.44 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -104.16 150.16 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.14 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -46.68 133.1 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 97.46 -9.05 64.59 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.068 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.0 131.04 45.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -76.52 138.07 40.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.71 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 93.7 mt -130.59 144.95 36.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.754 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.0 m -102.03 125.72 48.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 86.7 mt -79.81 87.37 5.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.06 -44.6 91.95 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.819 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -168.56 162.42 12.03 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.664 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.26 109.6 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.99 -27.16 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.065 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -158.81 174.89 14.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.32 -36.79 83.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.122 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -109.44 1.84 20.17 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -130.56 148.64 52.38 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.461 ' CE1' ' O ' ' A' ' 918' ' ' PHE . 28.2 p90 -151.08 156.88 41.98 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.737 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -104.37 130.62 52.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -146.99 178.22 24.77 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.835 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.98 161.26 42.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.991 -0.605 . . . . 0.0 109.964 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . 0.486 ' C ' ' H ' ' A' ' 911' ' ' GLY . 78.7 mt -74.97 137.28 72.9 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.24 -11.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.297 1.332 . . . . 0.0 112.16 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 909' ' ' ILE . . . -80.91 -4.23 90.48 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.399 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 20.1 p 50.83 34.97 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.349 0.119 . . . . 0.0 111.145 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.3 m -111.61 -26.56 8.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.705 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.65 152.52 51.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -149.57 145.98 27.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.177 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.23 -179.31 47.49 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.349 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.6 pt -112.16 140.99 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.5 145.11 17.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.062 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.93 142.74 47.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.95 1.766 . . . . 0.0 112.736 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 33.9 mt -69.9 -8.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.581 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.9 m -59.87 -44.47 94.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -97.7 8.48 44.61 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.855 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 11.2 t -122.82 145.2 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 120.85 0.357 . . . . 0.0 110.226 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.85 115.36 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.076 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.09 106.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.717 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.33 -46.22 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.486 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.22 149.85 41.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -72.5 153.64 91.8 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.105 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 151.73 70.41 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.442 2.095 . . . . 0.0 112.174 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.501 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . 0.472 ' C ' ' H ' ' A' ' 790' ' ' MET . 92.0 mm-40 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.46 ' CG ' ' O ' ' A' ' 789' ' ' HIS . 86.4 t60 58.37 3.16 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.634 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' MET . . . . . 0.472 ' H ' ' C ' ' A' ' 788' ' ' GLN . 94.9 mmm -65.52 -39.14 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.381 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 97.1 p -153.08 164.82 37.32 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.863 0.363 . . . . 0.0 111.559 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -168.09 160.19 33.66 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.3 t -65.37 137.43 57.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.832 0.349 . . . . 0.0 110.713 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -149.49 134.34 17.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.271 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.84 146.29 42.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.102 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -127.94 143.09 46.51 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 147.72 34.44 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.896 1.731 . . . . 0.0 112.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -135.47 155.16 50.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -121.89 133.67 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.408 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -84.2 121.58 27.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.287 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -74.43 -29.56 61.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.976 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.28 173.09 11.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.197 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.9 p-10 -89.33 135.69 33.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.14 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -127.08 133.26 50.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.327 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -92.99 139.29 30.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.61 21.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -65.95 -41.47 91.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.1 p -136.96 166.21 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.928 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -50.88 -33.34 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.28 -39.79 91.7 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.461 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . 0.459 ' OE2' ' CG1' ' A' ' 841' ' ' ILE . 0.2 OUTLIER -75.28 172.54 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.7 134.11 20.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.93 145.54 50.67 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.106 1.204 . . . . 0.0 111.467 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.31 144.55 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.92 139.78 51.09 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.261 0.553 . . . . 0.0 110.252 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.08 122.06 7.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.813 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.76 38.4 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.308 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.532 ' OD2' ' CE1' ' A' ' 835' ' ' HIS . 35.8 t70 -62.77 140.57 58.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.11 132.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.27 154.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.235 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.441 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 90.7 m-85 -114.07 121.71 44.67 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 3.4 mm -85.6 127.07 40.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.474 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.3 p90 -120.91 -5.93 9.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.071 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -173.38 129.13 0.44 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.212 0.53 . . . . 0.0 111.478 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -80.66 135.79 36.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.33 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.2 mm -87.49 -52.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.361 . . . . 0.0 110.284 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.527 ' OD1' ' NE2' ' A' ' 828' ' ' GLN . 6.0 t0 -150.51 179.2 8.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . 0.527 ' NE2' ' OD1' ' A' ' 827' ' ' ASP . 4.3 mp0 -60.77 -37.56 82.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 4.0 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.81 142.0 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.354 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.646 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 31.3 p90 -136.26 165.59 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.229 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -133.36 140.35 47.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -158.44 -179.29 33.2 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -106.63 144.87 32.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 111.442 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.532 ' CE1' ' OD2' ' A' ' 818' ' ' ASP . 6.5 t60 -168.52 140.85 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.214 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.24 19.97 11.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 82.47 1.41 90.46 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.779 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.43 164.21 20.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.103 0.452 . . . . 0.0 110.262 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.63 132.59 70.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.123 0.487 . . . . 0.0 111.211 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -143.24 -155.25 6.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.459 ' CG1' ' OE2' ' A' ' 811' ' ' GLU . 1.4 pp -134.32 155.12 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.088 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -166.1 160.17 12.72 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.85 121.85 8.28 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.75 2.3 . . . . 0.0 112.734 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 828' ' ' GLN . 48.3 ptt85 -56.4 -22.03 28.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.031 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.07 -8.21 47.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.13 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.43 -0.39 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . 0.487 ' CD1' ' CZ ' ' A' ' 831' ' ' TYR . 11.7 pt -138.73 174.55 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -113.38 157.51 21.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.2 100.14 7.93 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.027 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.0 tt 49.51 61.72 13.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.16 164.9 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.49 2.127 . . . . 0.0 112.153 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.26 133.54 42.34 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.918 1.745 . . . . 0.0 112.232 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -108.24 -9.03 15.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.472 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.89 135.52 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -124.79 148.92 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.372 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.87 88.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -119.33 150.22 49.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.321 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.04 154.34 62.64 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.33 2.02 . . . . 0.0 112.448 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -61.5 131.87 51.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -64.16 132.64 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.305 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.2 tp 61.79 105.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 64.0 p -133.16 158.09 76.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.99 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.24 138.4 79.3 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.425 1.417 . . . . 0.0 112.154 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.83 -44.88 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.116 0.484 . . . . 0.0 110.22 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -53.62 136.68 38.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.915 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 94.0 t -97.72 -55.03 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 869' ' ' TYR . 57.3 tp -137.55 132.75 33.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.088 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -62.29 -40.45 96.32 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.628 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' A' ' 867' ' ' LEU . 97.8 m-85 -127.66 137.09 52.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -80.44 163.37 46.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -118.22 148.83 42.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -155.08 147.69 24.24 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.432 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.21 131.66 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.518 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.46 135.16 57.2 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.085 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.55 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 55.5 mtmt -87.08 -23.03 25.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.855 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -142.5 144.26 32.9 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -49.36 152.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -143.1 130.8 21.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.33 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -128.44 97.28 4.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.721 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.44 178.14 52.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -131.05 -1.88 4.06 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.213 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 47.6 p -129.58 158.88 38.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -62.82 -27.37 69.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.975 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 18.3 m -68.14 -20.65 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -108.75 131.48 54.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.132 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 13.5 tpt -109.18 129.78 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.7 p -76.35 158.27 31.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.553 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 12.9 p90 -168.31 166.08 12.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.971 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . 0.405 ' H ' ' CD ' ' A' ' 892' ' ' GLU . 29.6 mmm-85 -103.67 163.55 12.24 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.55 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 53.5 tttp -67.09 58.17 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 172.84 12.8 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.829 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 888' ' ' PHE . 96.8 mt-10 -94.1 151.99 19.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.612 0.706 . . . . 0.0 109.736 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.46 146.75 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.5 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.5 mt -133.02 145.59 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.821 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.9 m -102.35 124.67 48.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.63 130.72 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.429 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.44 -58.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -163.56 164.66 24.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 115.37 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.579 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.45 -27.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.734 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 1.6 t70 -156.13 172.53 18.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.973 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . 0.426 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 60.7 mp0 -63.51 -28.84 70.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . 0.624 ' ND2' ' NE1' ' A' ' 904' ' ' TRP . 16.6 p-10 -117.95 4.05 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . 0.624 ' NE1' ' ND2' ' A' ' 903' ' ' ASN . 91.7 m95 -132.32 150.23 52.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.677 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -152.97 159.15 42.9 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.546 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.7 tt0 -102.39 132.68 48.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.179 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -151.45 169.94 31.02 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -148.47 155.79 41.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.038 0.447 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.27 139.89 87.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.85 138.99 20.13 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.937 1.092 . . . . 0.0 111.113 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 94.72 -9.65 70.93 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.7 p 69.78 33.22 2.98 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.651 0.262 . . . . 0.0 111.031 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.4 t -60.23 -45.46 93.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -163.36 139.66 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.791 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.546 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 26.0 tt0 -103.78 149.82 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.059 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -166.54 169.48 40.62 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.358 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -123.14 147.17 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.861 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -159.17 166.17 16.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.301 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.62 137.8 61.13 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.836 1.691 . . . . 0.0 113.487 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.29 -42.22 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.282 0.563 . . . . 0.0 110.42 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.0 m -57.77 -16.97 12.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.33 2.01 54.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.881 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.86 164.09 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.179 0.514 . . . . 0.0 110.663 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 67.9 t0 -115.04 132.82 56.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . 0.452 ' N ' ' OD1' ' A' ' 924' ' ' ASP . 99.5 t -104.09 99.86 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.538 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.54 -46.34 95.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -138.13 131.95 31.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.662 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -73.8 149.25 87.89 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.62 -22.97 50.01 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.077 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.424 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -68.01 -17.03 64.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.509 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -65.36 -12.17 49.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 40.7 t -60.15 140.0 57.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.596 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 101.94 144.76 15.21 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' SER . . . . . 0.416 ' O ' ' SD ' ' A' ' 795' ' ' MET . 53.7 m 52.67 35.9 19.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.145 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.08 139.22 58.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.411 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 793' ' ' SER . 0.0 OUTLIER -140.43 159.37 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.374 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.72 148.37 69.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.436 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.82 145.83 25.82 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.098 1.866 . . . . 0.0 111.798 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -140.83 155.59 46.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -117.99 132.29 56.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -71.28 117.9 13.4 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.942 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -38.57 86.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.31 0.576 . . . . 0.0 109.466 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -141.83 174.56 10.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.2 p-10 -83.29 138.26 33.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . 0.563 ' CE2' ' OE2' ' A' ' 811' ' ' GLU . 60.5 t80 -129.07 131.46 47.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -99.22 137.91 37.06 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.037 0.446 . . . . 0.0 111.606 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -65.37 136.09 56.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.336 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . 0.42 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 77.0 mt-30 -109.5 -25.09 10.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.693 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 64.1 p -129.2 167.6 17.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.03 -42.53 98.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.544 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.94 -42.14 97.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.463 . . . . 0.0 109.76 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . 0.563 ' OE2' ' CE2' ' A' ' 804' ' ' PHE . 41.0 tt0 -66.97 131.28 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.931 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 96.1 mt -115.52 150.33 44.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.449 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.26 148.71 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.103 1.869 . . . . 0.0 112.824 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.62 145.7 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -120.34 143.02 48.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.59 0.709 . . . . 0.0 111.489 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -53.09 124.39 14.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.075 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.83 -20.41 49.32 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.583 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.54 140.47 58.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.8 mm -96.68 131.36 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.97 156.23 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.187 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.451 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.8 m-85 -117.34 116.43 27.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.965 0.412 . . . . 0.0 111.4 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.89 131.93 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.0 OUTLIER -128.52 -4.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.238 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -170.44 125.29 0.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.208 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 830' ' ' TRP . 59.9 tp60 -81.54 124.61 29.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.749 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.8 mm -80.79 -52.98 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.192 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.62 178.28 9.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.14 -37.85 81.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.4 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -105.91 8.07 32.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.637 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . 0.542 ' O ' ' NE2' ' A' ' 825' ' ' GLN . 5.4 m-90 -140.12 145.19 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.102 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -140.7 166.28 25.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.946 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -130.61 136.52 48.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.887 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -154.41 -165.44 13.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -118.9 139.16 52.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -151.3 148.53 28.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.376 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 86.2 t60 47.87 30.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.263 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.25 16.41 80.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.792 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.28 160.22 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.015 0.436 . . . . 0.0 111.083 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.38 132.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.921 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -155.46 -154.73 7.04 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 46.8 pt -130.48 149.81 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.913 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -151.27 171.75 6.14 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -81.36 124.21 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.846 1.698 . . . . 0.0 113.074 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -57.01 -33.69 67.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.649 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.5 p -71.86 -9.99 59.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.739 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -96.51 -1.0 48.11 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.85 174.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.11 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -113.47 159.87 19.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.13 105.87 13.08 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.695 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 39.0 tp 58.28 74.66 0.6 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.139 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.99 150.99 52.41 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.888 2.392 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.58 146.31 73.25 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.048 1.832 . . . . 0.0 111.716 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -157.46 159.56 37.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.42 -35.72 81.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 64.59 25.2 13.13 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.524 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -104.16 -3.01 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.78 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -132.9 151.51 78.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.737 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.34 153.69 61.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.325 2.017 . . . . 0.0 112.563 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.85 -23.67 67.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -116.86 128.49 55.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.98 123.42 22.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.033 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 49.4 p -133.91 76.28 65.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.839 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -58.0 141.44 96.18 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.878 2.385 . . . . 0.0 111.901 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.452 ' CG1' ' H ' ' A' ' 865' ' ' GLN . 1.8 t 61.92 -139.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.351 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . 0.452 ' H ' ' CG1' ' A' ' 864' ' ' VAL . 19.7 pt20 29.12 -149.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.652 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 865' ' ' GLN . 84.4 t 41.33 92.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.798 0.333 . . . . 0.0 110.467 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 141.13 41.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.485 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 868' ' ' GLU . 46.2 mp0 -122.31 -163.4 1.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -60.62 153.53 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.389 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -65.43 170.77 26.23 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.31 153.81 47.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.95 150.34 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.45 125.49 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -62.66 128.57 36.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.538 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 12.8 mtmt -74.49 -37.89 63.02 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.651 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -130.61 153.79 48.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.232 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -52.64 152.57 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 58.2 t80 -146.59 137.32 24.01 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.571 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -136.59 99.69 4.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.811 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.81 156.52 50.71 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -118.82 2.23 11.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.736 0.303 . . . . 0.0 110.53 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 69.7 p -132.52 162.37 31.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.99 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.11 -40.28 97.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.34 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 9.7 m -62.34 -32.4 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -83.34 146.24 28.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.105 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 67.0 ttp -105.54 130.96 53.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 92.8 p -88.86 131.52 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 43.9 p90 -158.62 164.11 36.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.484 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -117.68 162.02 18.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.235 0.54 . . . . 0.0 111.567 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 65.4 tttp -56.84 136.98 55.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.221 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.78 88.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.041 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -82.62 147.26 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.994 0.397 . . . . 0.0 110.461 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -84.19 141.2 31.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 894' ' ' ILE . 94.2 mt -129.54 139.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.4 m -103.22 126.15 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.6 mt -82.69 125.22 30.98 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.56 -28.87 9.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.314 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -179.68 141.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -88.91 113.47 24.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.16 -43.89 91.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -160.72 -179.69 7.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.64 -22.77 66.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -117.82 13.83 14.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.653 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -140.37 149.67 42.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.08 29.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.433 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -100.61 132.54 45.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.5 179.03 35.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.327 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -148.86 156.48 42.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.315 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.2 mt -84.25 142.43 40.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.87 138.99 25.89 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.952 1.101 . . . . 0.0 111.191 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.59 71.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.92 29.59 8.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.234 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.7 m -62.19 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.616 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -143.52 154.45 43.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.005 0.431 . . . . 0.0 111.459 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -144.96 138.77 27.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.045 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.45 -169.91 43.03 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.49 159.33 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.094 0.473 . . . . 0.0 111.617 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -160.07 152.75 17.72 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.746 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.44 137.19 45.94 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.568 1.512 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 922' ' ' TYR . 6.3 mt -54.69 -76.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.567 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 920' ' ' ILE . 22.4 m -25.53 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 920' ' ' ILE . 1.6 m-85 -72.22 1.49 7.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 920' ' ' ILE . 33.8 m -135.31 158.96 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.063 0.459 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -104.37 118.32 36.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.429 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 73.0 t -95.03 101.49 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.806 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.6 mp -70.36 -43.18 78.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.273 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -133.04 139.63 47.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.71 86.82 45.6 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.437 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.67 155.94 39.95 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.31 2.007 . . . . 0.0 112.509 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.614 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -101.18 8.3 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.418 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 22.7 mmt 57.13 23.01 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 86.6 p -71.86 -16.72 62.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.685 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -86.96 -0.58 85.51 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 74.3 m -61.53 -40.84 96.12 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 39.98 -157.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.452 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 19.1 mmm -71.48 -64.47 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -154.07 105.22 2.45 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.41 139.77 18.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.785 1.657 . . . . 0.0 112.388 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -136.68 151.23 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -109.18 143.16 38.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -81.65 126.48 31.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . 0.447 ' O ' ' CD ' ' A' ' 816' ' ' LYS . 38.4 ttpt -97.74 -20.13 17.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.826 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -146.76 177.7 8.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.14 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -90.99 178.02 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.768 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 814' ' ' LEU . 29.4 t80 -149.04 132.88 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.671 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -106.19 107.74 18.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -67.13 137.67 56.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.174 0.512 . . . . 0.0 110.857 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -106.55 -23.19 12.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.15 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 808' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 809' ' ' LEU . 0.6 OUTLIER -127.08 165.64 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.181 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.416 ' H ' HG22 ' A' ' 808' ' ' THR . 90.4 mt -60.64 -38.68 85.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.856 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -59.45 -44.15 93.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.46 136.15 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.492 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.9 122.47 33.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.889 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 50.6 Cg_exo -55.01 140.64 79.99 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.109 1.206 . . . . 0.0 112.457 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 804' ' ' PHE . 20.7 mt -128.34 149.75 50.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.593 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -122.5 138.17 54.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.209 0.528 . . . . 0.0 109.956 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 801' ' ' LYS . 36.7 ttpt -46.62 125.32 6.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.089 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 104.45 -24.34 29.07 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.589 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.28 125.88 25.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.985 0.422 . . . . 0.0 110.947 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 23.5 mm -85.93 133.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.09 153.37 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.443 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.9 m-85 -109.15 114.86 28.94 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 31.1 mm -85.6 129.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.477 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -111.16 -27.91 8.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.346 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . 0.508 ' HZ2' ' CD ' ' A' ' 832' ' ' GLU . 25.7 pttm -158.9 156.14 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.345 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 61.9 tt0 -94.49 110.43 22.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.569 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.4 -47.03 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 7.3 t0 -149.85 178.08 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . 0.483 ' O ' ' CZ ' ' A' ' 844' ' ' ARG . 99.1 mm-40 -59.99 -37.61 80.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.455 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -108.51 0.55 20.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -123.97 134.1 53.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 160.13 23.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.508 ' CD ' ' HZ2' ' A' ' 824' ' ' LYS . 20.9 tt0 -128.86 140.55 51.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.584 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.87 -177.69 36.08 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -107.05 141.74 37.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.046 0.451 . . . . 0.0 111.353 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.479 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.3 OUTLIER -149.9 144.71 26.09 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 51.2 t-80 50.02 30.37 4.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.1 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.29 18.41 79.82 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -133.03 156.33 47.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.385 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.77 145.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.289 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -169.71 -162.34 21.8 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 27.3 pt -128.22 159.39 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.664 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -166.8 154.56 8.93 Favored Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.064 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 845' ' ' THR . 51.9 Cg_endo -69.71 115.66 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.352 2.035 . . . . 0.0 112.66 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . 0.483 ' CZ ' ' O ' ' A' ' 828' ' ' GLN . 37.9 ptt180 -51.93 -6.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.552 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 843' ' ' PRO . 1.6 t -80.86 -5.83 57.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.616 -0.434 . . . . 0.0 112.089 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 846' ' ' TYR . 0.1 OUTLIER -106.37 -1.22 23.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.921 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 846' ' ' TYR . 45.1 pt -126.76 175.68 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.838 0.351 . . . . 0.0 111.371 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.0 160.01 19.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.75 101.62 9.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 51.8 tp 55.04 76.23 0.53 Allowed Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.988 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.54 152.19 56.92 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.688 2.258 . . . . 0.0 111.664 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.17 148.32 74.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.221 1.947 . . . . 0.0 111.869 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 855' ' ' LYS . . . -154.06 159.19 41.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -71.05 9.56 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 853' ' ' ALA . 16.5 ptpt -55.07 -23.36 19.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -100.32 134.28 43.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.516 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -132.44 78.46 67.7 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.565 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.37 144.02 96.84 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.836 2.357 . . . . 0.0 112.258 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.02 -7.92 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.182 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -61.94 -39.63 92.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.11 114.1 28.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 95.2 m -131.98 65.34 75.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.41 147.7 47.27 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.32 2.013 . . . . 0.0 112.075 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.74 -57.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.475 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.46 132.03 54.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.879 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.93 -2.81 9.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.608 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 60.5 tp -76.96 125.33 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.218 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 55.87 44.74 25.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -130.58 123.31 29.24 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -149.37 176.78 27.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -136.1 141.83 44.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 0.0 110.496 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -150.87 155.52 39.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 57.1 mt -126.66 131.09 71.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 110.641 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.92 123.04 15.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.458 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -69.26 -37.33 77.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.959 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.3 151.06 50.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.361 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -57.48 131.86 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -127.14 128.74 46.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.59 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.32 108.15 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.759 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . 0.454 ' H ' ' CB ' ' A' ' 887' ' ' SER . . . -65.83 142.46 43.58 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 56.4 t0 -100.56 -22.62 14.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 61.0 p -130.97 165.74 22.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.03 0.443 . . . . 0.0 111.123 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.78 -37.56 82.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.563 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.32 -43.37 89.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.394 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -91.06 103.54 16.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' MET . . . . . 0.492 ' CE ' ' O ' ' A' ' 887' ' ' SER . 2.0 tmt? -71.28 131.55 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' SER . . . . . 0.492 ' O ' ' CE ' ' A' ' 886' ' ' MET . 83.2 p -80.13 154.19 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 0.0 110.986 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.01 160.05 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.593 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -105.78 165.32 11.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.003 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.63 136.2 56.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.191 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.58 -6.61 77.6 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.9 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.04 141.73 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.462 0.631 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -89.6 139.22 30.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.212 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.78 149.42 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.514 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.1 m -100.13 127.9 46.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.64 118.79 24.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.18 -46.58 5.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -163.41 156.01 18.29 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.936 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -98.94 118.68 36.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.323 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.41 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.9 t -61.48 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 902' ' ' GLU . 13.3 p30 -153.68 -104.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . 0.53 ' H ' ' CG ' ' A' ' 901' ' ' ASP . 99.0 mt-10 -121.71 -38.43 2.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.37 9.36 18.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.704 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -134.03 147.46 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.41 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 14.7 p90 -157.72 163.81 37.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -115.96 142.19 47.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.166 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.45 178.86 31.01 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -149.48 158.97 44.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.494 -0.353 . . . . 0.0 110.331 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . 0.455 HG21 HD11 ' A' ' 909' ' ' ILE . 50.4 mm -65.86 137.86 96.23 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 -11.64 15.21 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.697 1.598 . . . . 0.0 112.531 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.445 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . -83.69 -3.0 89.8 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 57.7 p 53.93 65.97 1.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.208 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.4 m -131.46 -38.49 1.18 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.443 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.24 157.5 46.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.859 0.362 . . . . 0.0 111.329 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -142.81 146.42 34.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.71 176.52 45.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.507 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.49 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 42.5 pt -115.52 145.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.493 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -155.68 159.43 31.62 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.566 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.03 139.11 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.697 2.264 . . . . 0.0 113.828 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.18 -37.81 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.517 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 74.4 p -53.04 -24.13 9.09 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.891 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.07 2.26 55.16 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.38 158.15 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.118 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -107.31 127.13 53.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.033 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.86 125.38 42.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.265 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.88 -53.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.364 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.64 126.47 32.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -70.7 148.0 94.73 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.18 -20.65 37.29 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.214 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.46 179.902 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -60.3 -46.22 90.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -60.77 159.34 11.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 46.8 t -139.75 149.97 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.491 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.7 96.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.6 t -134.22 132.79 40.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -134.3 145.82 49.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.528 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 23.3 ptp -148.76 157.74 43.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.666 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -131.56 96.69 20.55 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.37 140.15 93.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.898 1.732 . . . . 0.0 111.826 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -139.85 156.02 46.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.087 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -114.48 139.82 49.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -81.78 131.72 35.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.13 0.491 . . . . 0.0 110.764 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 802' ' ' PHE . 17.2 mmmt -98.27 -13.23 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 801' ' ' LYS . 47.9 m-85 -152.18 166.79 30.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 112.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 36.0 t70 -86.61 129.8 34.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.072 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -127.81 116.47 20.24 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 110.109 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.21 142.46 31.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.578 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -82.56 122.53 28.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.641 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -95.74 -25.48 16.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.898 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.5 p -134.85 169.67 17.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.37 -37.62 84.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.108 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . 0.487 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 68.7 mttm -65.11 -12.07 46.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.612 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -113.34 140.35 48.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.543 ' CD2' ' H ' ' A' ' 812' ' ' LEU . 1.6 pt? -117.14 149.62 44.69 Favored Pre-proline 0 N--CA 1.467 0.415 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.66 140.01 38.34 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.556 1.504 . . . . 0.0 111.52 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . 0.491 ' CD1' ' OH ' ' A' ' 846' ' ' TYR . 11.0 mt -137.38 146.66 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.675 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -119.08 135.66 54.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 816' ' ' LYS . 8.9 ptmm? -42.24 123.23 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.599 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 99.78 -20.76 47.97 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.208 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 67.3 t0 -55.11 139.27 42.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 41.7 mm -94.95 126.01 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.172 0.511 . . . . 0.0 110.589 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.21 148.62 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.0 m-85 -108.45 123.2 48.49 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 24.2 mm -92.94 129.59 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.923 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.38 -27.6 12.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.475 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -160.43 157.28 27.42 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -93.97 111.29 22.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.4 mm -61.13 -46.9 95.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.156 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.94 178.91 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.88 -36.37 76.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.954 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.84 -1.65 16.44 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -119.9 131.28 55.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -119.3 157.35 28.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.791 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -128.29 138.88 52.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.31 -173.18 28.53 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -123.95 155.79 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.207 0.527 . . . . 0.0 111.456 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.6 OUTLIER -170.61 131.24 0.89 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.933 178.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.1 t-80 65.9 24.56 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 80.22 4.11 89.79 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -112.86 141.84 46.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.974 0.416 . . . . 0.0 110.558 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.59 143.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.543 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -169.53 -139.98 2.85 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 29.9 pt -138.97 162.75 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.462 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -169.72 153.98 5.22 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.831 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 845' ' ' THR . 50.5 Cg_endo -71.11 116.87 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.946 1.764 . . . . 0.0 112.54 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -51.52 -5.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.217 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 843' ' ' PRO . 81.4 p -82.11 -7.3 59.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 846' ' ' TYR . 0.1 OUTLIER -105.41 0.42 26.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.574 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . 0.479 ' CG2' ' CE2' ' A' ' 846' ' ' TYR . 42.8 pt -130.19 174.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.507 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 97.6 mt-10 -116.0 160.05 20.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.63 105.25 15.2 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 2.7 tt 42.57 75.24 0.65 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.513 . . . . 0.0 110.099 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.82 153.82 47.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.056 2.504 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.11 151.49 72.75 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.412 2.075 . . . . 0.0 111.863 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 854' ' ' GLU . . . -63.24 147.76 50.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 853' ' ' ALA . 18.5 pm0 -49.43 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.845 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt 58.87 38.63 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -79.93 170.44 16.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.312 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 857' ' ' GLN . 4.4 mp0 -63.74 149.4 92.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.087 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.07 154.91 69.69 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.298 1.999 . . . . 0.0 112.341 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . 0.433 ' HZ3' ' CD2' ' A' ' 861' ' ' LEU . 23.3 pttp -60.55 -20.0 59.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 66.32 105.25 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . 0.433 ' CD2' ' HZ3' ' A' ' 859' ' ' LYS . 0.1 OUTLIER -99.38 -23.57 15.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 861' ' ' LEU . 1.3 p 50.28 68.33 3.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.632 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.49 152.09 59.73 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.207 1.938 . . . . 0.0 112.255 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 865' ' ' GLN . 31.3 m -131.11 -130.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . 0.475 ' N ' ' CG2' ' A' ' 864' ' ' VAL . 97.0 mt-30 57.51 155.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 867' ' ' LEU . 59.7 t -61.56 -44.95 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 866' ' ' VAL . 3.5 tp 74.37 165.32 0.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.4 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 871' ' ' GLU . 88.4 tt0 53.47 95.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.354 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -83.69 -107.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.823 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -79.75 167.33 51.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 868' ' ' GLU . 79.1 mm-40 -127.53 155.12 44.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.668 0.27 . . . . 0.0 110.537 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.01 27.01 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 46.3 mm -118.7 125.3 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -61.33 133.08 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.711 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 56.8 mtmt -81.95 -38.95 24.42 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.904 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.41 150.86 49.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.466 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 45.6 p-10 -45.64 151.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 75.1 t80 -142.05 131.92 24.36 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.521 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -131.15 103.48 6.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.55 150.57 45.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.84 -1.41 34.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.341 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 57.8 p -133.15 162.75 30.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -61.04 -39.25 89.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.796 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.41 -40.74 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.752 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.24 108.41 19.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 11.0 mmt -80.42 160.67 25.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.8 p -109.39 149.76 29.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.057 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 29.1 p90 -156.76 161.09 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.384 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -105.24 156.17 18.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 111.14 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -50.44 137.4 19.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.45 -3.82 82.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.717 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -77.01 140.99 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.536 0.668 . . . . 0.0 110.746 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.71 142.32 31.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.51 147.02 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -104.44 128.67 52.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.952 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.11 124.74 31.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.636 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.39 -56.11 2.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -158.53 153.73 25.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -94.31 114.38 26.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 69.3 t -70.36 -43.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.491 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -151.65 -176.93 5.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.15 -38.66 83.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.242 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -111.6 10.53 21.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -133.8 149.47 51.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 13.8 p90 -154.9 159.41 40.45 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.033 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -105.78 134.95 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.988 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -155.55 175.79 33.32 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.495 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -152.83 159.2 43.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . 0.499 ' CG2' ' H ' ' A' ' 911' ' ' GLY . 1.7 mp -63.59 135.18 96.15 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.84 -15.53 38.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.229 1.286 . . . . 0.0 112.161 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.499 ' H ' ' CG2' ' A' ' 909' ' ' ILE . . . -83.87 -4.01 88.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 7.1 m 60.13 72.38 0.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.4 t -139.36 -39.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.972 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -131.25 149.03 52.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.448 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -146.52 143.23 28.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.29 -172.32 45.08 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.503 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.5 pt -119.67 148.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.134 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -156.91 162.08 28.31 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.729 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.32 137.59 37.11 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.335 2.024 . . . . 0.0 113.745 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.17 -38.8 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.527 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 71.5 p -55.81 -16.5 4.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.66 2.58 41.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.57 156.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.204 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.48 124.47 48.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.284 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.98 130.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.809 0.338 . . . . 0.0 110.246 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.58 -54.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.19 147.39 52.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -73.62 152.96 89.59 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.19 -38.72 51.6 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.852 1.701 . . . . 0.0 112.313 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 40.0 tp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.578 -179.572 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.42 -47.39 86.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.729 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 65.3 mtt -96.6 -52.18 4.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.8 m 46.55 38.18 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.85 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -104.0 -173.72 25.45 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 63.0 m -138.5 151.6 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.672 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 794' ' ' GLU . 48.8 mp0 -98.26 139.65 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.3 mpp? -112.69 156.63 22.44 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.038 0.446 . . . . 0.0 110.941 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -125.76 97.71 35.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.073 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 850' ' ' LEU . 48.6 Cg_exo -57.12 138.03 84.46 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.858 1.706 . . . . 0.0 111.915 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -129.62 151.85 49.78 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -113.99 135.51 53.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.208 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -77.99 128.76 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -96.52 -18.34 19.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.282 0.563 . . . . 0.0 109.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -149.91 172.16 15.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.6 p-10 -90.98 135.27 33.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.045 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -118.46 123.44 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.787 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -89.07 132.29 34.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.476 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -80.95 129.09 34.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -105.54 -25.75 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.309 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.8 p -129.29 169.43 14.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.494 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 809' ' ' LEU . 8.2 mp -61.15 -39.99 92.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.7 -38.75 88.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -81.83 126.14 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.006 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -113.9 151.68 44.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.51 144.4 66.79 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.84 1.693 . . . . 0.0 113.231 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.75 146.54 43.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.046 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.83 137.49 53.37 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.364 0.602 . . . . 0.0 110.876 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 816' ' ' LYS . 15.9 ptmt -44.91 122.61 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.95 -20.25 51.07 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.419 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.9 t0 -55.75 133.22 50.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.359 . . . . 0.0 110.834 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.451 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 30.9 mm -91.21 128.58 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.57 155.0 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.521 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 65.5 m-85 -112.09 117.47 32.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.4 mt -81.28 125.83 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -119.6 -9.3 9.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.8 ttpp -167.27 131.96 1.95 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 111.367 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.614 HE21 ' N ' ' A' ' 827' ' ' ASP . 10.4 tm0? -83.97 136.78 33.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . 0.485 ' C ' ' NE2' ' A' ' 825' ' ' GLN . 4.9 mm -91.98 -67.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.614 ' N ' HE21 ' A' ' 825' ' ' GLN . 61.1 m-20 -133.95 176.67 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.18 -35.41 77.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.068 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -101.51 -1.03 34.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.268 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -131.86 136.15 47.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.201 0.524 . . . . 0.0 111.082 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -124.76 160.5 28.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.843 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.537 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 6.3 tt0 -129.84 141.1 50.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.12 -176.28 34.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.27 138.83 42.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.506 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 15.2 p-80 -146.07 131.92 19.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.794 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 51.67 37.43 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.616 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.77 78.85 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.73 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.27 152.36 48.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.222 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.45 132.67 64.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.258 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -159.55 -165.15 15.96 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.451 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 46.6 pt -128.38 156.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.844 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.451 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -164.09 156.25 14.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.413 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 845' ' ' THR . 40.0 Cg_endo -69.7 117.96 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.979 1.786 . . . . 0.0 112.549 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.61 -13.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.404 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 843' ' ' PRO . 80.6 p -79.54 -6.66 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -103.81 -4.46 23.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.6 pt -135.11 172.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 77.4 mm-40 -112.98 162.84 15.41 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -108.06 104.22 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.33 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 797' ' ' PRO . 2.8 tt 41.53 77.71 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.89 158.24 25.6 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.643 2.228 . . . . 0.0 111.586 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.87 135.6 28.74 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.678 1.586 . . . . 0.0 111.827 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -68.22 140.59 56.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.081 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -158.02 66.18 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.15 -39.55 94.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.639 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 52.14 -179.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.402 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -130.14 70.74 82.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.28 56.37 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.699 2.266 . . . . 0.0 112.041 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -102.95 -43.6 5.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.52 -18.76 65.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 85.3 mt -88.6 108.52 19.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 864' ' ' VAL . 82.3 p -149.81 161.01 32.73 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.527 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.27 -29.37 56.95 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.484 1.456 . . . . 0.0 112.191 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 862' ' ' THR . 23.2 m -124.58 161.26 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.006 0.432 . . . . 0.0 111.32 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -135.28 150.02 49.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 87.7 t -120.0 127.11 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.578 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 88.5 mt -111.97 142.94 43.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.445 ' OE2' ' NZ ' ' A' ' 927' ' ' LYS . 88.3 tt0 -90.56 132.8 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -128.64 151.86 49.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -70.12 165.47 51.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.57 150.3 48.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.46 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 53.3 mt -131.6 132.58 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.464 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -51.23 128.47 22.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.429 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 33.2 ttpt -81.05 -41.15 23.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.145 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 877' ' ' ASN . 0.2 OUTLIER -149.59 131.88 15.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.024 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 26.2 m120 -26.28 114.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.717 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -117.21 129.12 55.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.706 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -110.94 118.82 37.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.977 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.09 139.37 26.91 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.86 -38.93 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 882' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 885' ' ' GLU . 71.0 p -135.36 170.85 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.007 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -58.23 -21.59 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.6 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.93 -42.67 93.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.7 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 882' ' ' THR . 41.5 mp0 -88.15 128.68 35.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.591 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' MET . . . . . 0.609 ' SD ' ' CD2' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -78.32 133.0 37.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.0 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' SER . . . . . 0.602 ' N ' ' SD ' ' A' ' 886' ' ' MET . 67.3 m -106.37 138.27 42.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 110.862 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -155.69 176.41 12.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.063 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -112.38 158.93 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.593 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.682 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 65.1 tttp -47.25 144.09 2.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.983 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.38 87.3 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.258 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -76.72 144.29 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -91.07 139.87 30.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 894' ' ' ILE . 96.6 mt -130.61 142.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.925 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.4 m -94.93 126.61 40.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 91.5 mt -86.7 126.85 34.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.5 mt -107.3 -52.51 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.292 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -165.5 164.39 19.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.385 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.65 115.68 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.27 -45.18 76.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -152.12 -170.9 3.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.48 -40.86 92.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.36 15.82 19.1 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -129.24 149.96 50.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.021 0.439 . . . . 0.0 112.096 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 142.93 26.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.722 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.84 135.89 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.93 178.54 34.18 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.506 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -151.09 158.16 43.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.837 0.351 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 89.5 mt -80.18 141.49 54.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.7 140.29 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.942 1.095 . . . . 0.0 111.504 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 93.03 -7.58 76.37 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.3 m 67.89 28.2 7.05 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.704 0.288 . . . . 0.0 110.773 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 98.3 p -63.61 -28.15 69.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -164.58 150.74 10.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -138.95 143.41 38.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.297 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.44 -179.48 48.35 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.468 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 41.9 pt -105.32 156.91 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -161.89 152.48 14.66 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.731 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.67 142.46 58.41 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.9 1.733 . . . . 0.0 112.837 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 922' ' ' TYR . 0.1 OUTLIER -72.47 -26.05 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.138 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 4.3 t -69.59 8.43 0.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.543 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . 0.641 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -127.6 4.11 6.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 20.5 m -121.19 148.79 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.925 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -102.87 126.25 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.272 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.9 t -82.99 125.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 35.3 mm -103.73 -52.3 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.524 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . 0.445 ' NZ ' ' OE2' ' A' ' 868' ' ' GLU . 64.6 tttm -137.55 134.06 35.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 928' ' ' ARG . 0.7 OUTLIER -71.61 153.5 93.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.44 -38.82 64.38 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.882 1.721 . . . . 0.0 112.506 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.436 -179.587 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.05 -47.99 83.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 63.5 tpp -141.07 131.38 25.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.897 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 44.0 t -148.26 127.01 12.57 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.227 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -63.54 -40.22 98.48 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 73.5 m -62.0 -40.02 94.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.689 0.281 . . . . 0.0 111.19 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.71 149.87 49.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.734 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 795' ' ' MET . 0.0 OUTLIER -145.73 161.65 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.467 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . 0.41 ' HE ' HD11 ' A' ' 849' ' ' LEU . 95.9 mtm-85 -133.73 149.27 71.5 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.52 128.26 10.2 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.225 1.95 . . . . 0.0 111.929 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -124.13 146.58 48.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -109.29 140.23 43.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.295 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -89.76 115.61 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -77.43 -20.99 53.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.447 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.17 170.01 17.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.5 p-10 -85.25 131.85 34.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.171 0.51 . . . . 0.0 110.382 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 843' ' ' PRO . 75.0 t80 -105.92 129.55 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -100.29 116.82 33.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.03 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -64.18 132.21 49.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.83 -31.16 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 81.6 p -131.81 161.24 33.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -38.69 57.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.344 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -44.47 95.35 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.68 134.98 52.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 17.0 tp -109.93 127.09 27.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.15 147.01 65.86 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.343 1.362 . . . . 0.0 112.769 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 66.3 mt -114.65 152.75 31.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.85 139.06 52.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.333 0.587 . . . . 0.0 110.241 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.94 118.9 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.152 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.89 -21.42 40.37 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.968 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 35.4 t70 -61.77 141.35 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.031 0.443 . . . . 0.0 111.405 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 10.7 mm -97.58 132.41 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.779 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.25 153.16 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.45 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.47 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 79.7 m-85 -110.91 114.03 27.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 4.2 mm -82.85 128.92 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.084 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.51 -44.92 7.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.259 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -160.49 153.55 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.981 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.49 110.25 18.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.235 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . 0.41 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.1 mm -62.78 -46.89 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.597 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -148.08 178.65 8.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -60.09 -37.5 80.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -112.79 18.36 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.565 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -142.71 150.0 39.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.533 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.536 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 35.0 p90 -147.79 168.5 21.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.767 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.8 tp10 -129.33 139.91 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.487 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -163.99 -177.22 36.58 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -113.44 152.17 30.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.971 0.415 . . . . 0.0 111.027 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.2 OUTLIER -165.21 132.96 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.963 178.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.4 t-80 64.34 28.09 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.831 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.76 20.53 79.77 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -134.65 152.04 51.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.458 0.647 . . . . 0.0 112.278 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.33 154.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.745 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . 0.47 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -175.73 176.44 47.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.57 145.71 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 117.403 0.602 . . . . 0.0 109.504 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -156.97 165.13 19.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.092 -177.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.459 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 58.1 Cg_endo -73.15 129.44 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.701 2.267 . . . . 0.0 112.401 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 846' ' ' TYR . 61.8 ttp85 -61.77 -37.79 85.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.413 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 3.3 t -59.19 3.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . 0.551 ' H ' ' C ' ' A' ' 844' ' ' ARG . 0.4 OUTLIER -110.25 -2.33 16.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . 0.409 ' CD1' ' CZ ' ' A' ' 831' ' ' TYR . 36.8 pt -133.94 175.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -116.48 161.76 18.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . 0.41 HD11 ' HE ' ' A' ' 796' ' ' ARG . 53.0 tp -121.31 96.73 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.841 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 4.0 tt 40.14 70.27 1.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.485 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.83 159.22 54.13 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.902 1.735 . . . . 0.0 112.202 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 853' ' ' ALA . 57.2 Cg_endo -70.23 147.86 60.77 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 852' ' ' PRO . . . 42.46 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.486 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -159.02 158.34 32.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 856' ' ' ALA . 72.1 mmtt -123.73 136.81 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.906 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 855' ' ' LYS . . . 57.32 150.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.096 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . 0.442 ' OE1' ' N ' ' A' ' 857' ' ' GLN . 28.6 mp0 -131.85 148.43 69.87 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.7 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.55 -28.52 38.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.998 1.798 . . . . 0.0 112.235 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -153.48 134.37 13.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -131.41 22.47 4.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.71 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.05 -7.77 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 863' ' ' PRO . 0.2 OUTLIER -65.74 -41.53 48.28 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.926 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 862' ' ' THR . 65.0 Cg_endo -88.44 64.33 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.447 2.098 . . . . 0.0 112.659 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.4 m -97.93 -30.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.246 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -84.08 149.41 26.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.534 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.13 82.17 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -90.57 -62.17 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.599 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 60.5 mp0 45.72 43.63 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 56.19 -103.48 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.586 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -142.95 169.52 25.62 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 927' ' ' LYS . 79.2 mm-40 -125.63 151.17 46.87 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.69 147.1 18.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.1 129.16 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.84 122.55 13.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -70.6 -36.27 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -135.4 154.5 51.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -53.54 138.58 33.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.1 129.0 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.51 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -116.75 109.3 16.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.424 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.13 149.12 43.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -106.41 -47.5 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.751 0.31 . . . . 0.0 111.116 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 74.6 p -81.31 162.01 23.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.351 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.95 -39.43 94.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.0 m -66.67 -23.97 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -98.26 129.11 44.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 30.5 mmm -94.82 178.83 5.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.771 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 88.6 p -131.29 149.86 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -160.63 163.31 32.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.26 165.05 11.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.954 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.12 136.35 57.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.28 -5.94 81.03 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.908 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.83 141.28 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.655 0.728 . . . . 0.0 110.379 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -86.16 141.87 29.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.088 0.47 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.76 147.81 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.495 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.7 m -102.34 127.85 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.82 122.81 30.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.114 -178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . 0.408 ' CD2' ' NH1' ' A' ' 908' ' ' ARG . 85.8 mt -101.52 -47.01 4.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -166.52 165.3 16.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.878 0.37 . . . . 0.0 111.31 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -104.04 118.45 36.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 63.4 t -61.94 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.645 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 77.1 m-20 -144.09 -104.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.9 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -126.09 -34.85 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.678 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.08 7.85 16.84 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.605 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -131.34 148.64 52.69 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.979 0.175 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -153.56 160.14 42.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.113 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.7 136.69 47.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.71 179.19 30.99 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.404 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . 0.408 ' NH1' ' CD2' ' A' ' 897' ' ' LEU . 32.3 ptt-85 -148.37 158.22 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 0.0 110.258 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.77 140.55 86.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.75 138.53 33.19 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.181 1.101 . . . . 0.0 111.112 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 102.04 -18.17 52.63 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 71.98 73.33 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.9 t -120.91 -48.07 2.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.69 149.83 51.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.524 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -136.83 143.79 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.48 176.09 46.14 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.37 147.9 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.211 0.529 . . . . 0.0 111.387 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.57 159.12 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.918 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.06 139.55 39.45 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.566 2.177 . . . . 0.0 114.48 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.41 -38.06 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.467 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.468 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -52.6 -38.8 60.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.29 0.83 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.11 159.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 110.965 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -108.82 125.66 52.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 95.8 t -99.99 103.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.698 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -65.04 -42.4 94.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.64 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 871' ' ' GLU . 7.0 ptmm? -145.18 159.09 43.54 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.157 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 -98.8 153.06 38.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.136 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.84 -25.07 60.58 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 112.569 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.576 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -137.35 43.7 2.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.611 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 66.3 mtt 55.63 42.78 29.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.635 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 41.3 t -65.46 138.92 58.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.668 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 75.64 17.49 80.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.7 t -60.69 -45.9 92.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -146.91 129.74 16.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm -151.0 150.47 30.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.531 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.72 149.76 63.36 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.866 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.09 105.06 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.308 2.005 . . . . 0.0 111.995 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -105.53 144.12 32.73 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.623 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -111.42 134.14 53.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -76.5 120.95 22.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . 0.513 ' NZ ' ' CE2' ' A' ' 802' ' ' PHE . 19.5 ttpp -89.07 -29.19 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . 0.513 ' CE2' ' NZ ' ' A' ' 801' ' ' LYS . 54.1 m-85 -135.03 152.57 51.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.436 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.8 p-10 -75.35 146.54 40.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.077 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -134.59 133.24 39.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -99.61 132.42 44.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.342 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -68.67 139.8 55.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.96 -30.94 13.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.382 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 29.9 p -137.06 178.4 7.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.43 -38.41 87.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.274 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -60.6 -40.68 92.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.374 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.61 142.45 29.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.874 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.35 152.76 58.11 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.819 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.32 148.26 67.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.982 1.788 . . . . 0.0 113.098 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.11 145.39 51.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.54 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -124.85 137.91 54.28 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.472 0.654 . . . . 0.0 111.723 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.07 127.63 10.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.399 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.53 -19.32 54.17 Favored Glycine 0 C--N 1.318 -0.422 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.129 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.33 122.39 18.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.363 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.53 135.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.176 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.17 154.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.4 m-85 -114.96 112.47 22.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.793 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.46 133.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.696 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -96.85 -47.79 5.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.775 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -163.95 153.78 14.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.269 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 59.3 tt0 -74.88 108.38 7.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.357 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.8 mm -64.75 -45.96 93.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.894 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 5.2 t0 -140.49 177.34 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.456 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -57.09 -27.06 61.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.382 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.27 -30.67 4.87 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.736 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -85.54 168.09 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.47 . . . . 0.0 111.719 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 24.0 p90 -153.39 169.09 23.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -131.5 138.41 48.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.044 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.64 -175.45 31.66 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.04 137.18 46.47 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.564 0.221 . . . . 0.0 110.611 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.3 p-80 -142.07 138.77 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 53.4 t-80 52.46 26.79 4.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.95 4.48 90.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.823 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.33 161.24 19.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.63 0.252 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.3 p -110.72 153.68 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.754 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -179.76 -172.56 43.94 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.5 pp -125.27 142.45 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.363 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -148.74 154.83 41.04 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.404 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.18 134.19 33.08 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.787 1.658 . . . . 0.0 111.98 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -60.57 -41.8 95.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.74 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 71.3 p -59.52 -11.54 4.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.635 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -92.73 -2.53 55.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 37.6 pt -133.99 165.46 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.873 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.21 120.94 28.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.208 0.528 . . . . 0.0 111.737 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.3 103.95 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.544 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 4.8 tt 42.79 87.04 0.12 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.271 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.86 151.44 48.71 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.686 2.258 . . . . 0.0 112.204 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 853' ' ' ALA . 56.8 Cg_endo -69.59 157.65 59.96 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.567 2.178 . . . . 0.0 111.811 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 852' ' ' PRO . . . 80.52 59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.311 0.576 . . . . 0.0 110.307 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.43 153.54 26.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -131.02 149.51 52.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -71.14 145.25 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . 0.403 HE22 ' HD3' ' A' ' 859' ' ' LYS . 1.2 pp0? -98.9 158.38 32.46 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.036 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.54 140.84 64.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.82 1.68 . . . . 0.0 112.501 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . 0.403 ' HD3' HE22 ' A' ' 857' ' ' GLN . 2.9 mmmm -126.92 148.54 50.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.695 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -67.2 159.92 28.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.584 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.59 139.85 40.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 58.8 p -136.05 73.02 59.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.723 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.24 141.37 94.54 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.893 2.395 . . . . 0.0 112.185 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 865' ' ' GLN . 26.8 m -144.63 -125.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.275 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . 0.458 ' N ' ' CG2' ' A' ' 864' ' ' VAL . 98.7 mt-30 54.97 47.29 22.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.17 174.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.166 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 97.26 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 110.5 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -63.59 -41.12 98.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -72.56 146.88 46.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.697 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -74.97 172.67 53.15 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -129.54 157.3 42.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.87 153.1 29.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.32 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -52.56 137.55 30.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.533 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 3.3 ttpm? -83.82 -41.93 16.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -129.33 150.91 50.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 47.9 p-10 -55.5 153.27 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -151.13 131.81 14.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.859 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.59 108.21 14.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . 0.494 ' N ' ' OG ' ' A' ' 887' ' ' SER . . . -91.93 -176.84 42.43 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -145.68 -40.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.915 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 79.3 p -79.18 160.42 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.028 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -70.06 -30.17 67.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.1 -13.57 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 64.6 mm-40 -113.38 133.07 55.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.785 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 7.4 tpt -106.02 116.97 32.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.803 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 887' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 880' ' ' GLY . 50.1 m -73.82 144.11 45.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -154.73 157.16 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -106.61 150.28 26.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.319 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.533 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 66.1 tttp -44.55 139.99 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.066 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 83.7 0.86 90.01 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.407 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.33 148.63 43.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.18 0.49 . . . . 0.0 110.679 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -91.44 128.97 37.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.229 0.537 . . . . 0.0 110.718 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.76 148.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.41 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -106.36 127.28 53.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.863 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.38 124.61 29.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.697 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.6 mt -101.19 -52.86 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.27 164.54 22.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . 0.405 HE21 ' CB ' ' A' ' 905' ' ' TYR . 0.5 OUTLIER -96.9 111.88 23.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.439 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 78.8 t -69.41 -42.41 81.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.299 0.571 . . . . 0.0 110.016 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -152.97 -174.99 5.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.871 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -61.54 -38.1 86.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.237 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -117.02 14.65 15.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.77 147.64 51.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 16.1 p90 -155.04 160.67 41.21 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.112 0.482 . . . . 0.0 110.975 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.429 ' CD ' ' NE2' ' A' ' 915' ' ' GLN . 42.0 tt0 -107.02 133.74 51.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -144.96 165.73 27.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . 0.591 HH12 ' H ' ' A' ' 911' ' ' GLY . 5.3 ppt_? -150.81 158.83 44.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.446 . . . . 0.0 110.501 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 14.4 mm -78.9 132.68 63.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.78 137.24 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.259 1.128 . . . . 0.0 111.267 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.591 ' H ' HH12 ' A' ' 908' ' ' ARG . . . 99.56 -9.55 60.66 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.9 p 71.58 30.43 2.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.1 m -62.17 -40.65 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.187 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -161.76 152.73 18.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.429 ' NE2' ' CD ' ' A' ' 906' ' ' GLU . 63.2 tt0 -132.33 147.75 52.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.35 43.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.853 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 918' ' ' PHE . 45.5 pt -119.57 147.01 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.91 0.385 . . . . 0.0 111.174 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -163.74 163.58 15.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.775 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.53 140.84 48.78 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.281 1.987 . . . . 0.0 113.321 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.45 -30.93 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.51 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 68.0 p -61.32 -21.43 63.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.651 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.67 1.65 56.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 14.7 m -135.34 160.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.913 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 66.5 t0 -114.79 130.62 56.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.399 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . 0.403 ' N ' ' OD1' ' A' ' 924' ' ' ASP . 5.8 m -94.81 148.57 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.89 -38.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -146.55 130.8 17.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.452 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -73.83 158.83 85.52 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.186 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.32 143.62 93.31 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.573 1.516 . . . . 0.0 112.138 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 3.4 tp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.472 179.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.23 -46.79 88.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 25.4 mmt 44.9 -101.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 8.2 t 59.19 -139.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -101.57 -151.59 24.61 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.4 t -129.79 -67.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.0 110.444 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -113.39 126.27 55.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.04 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 822' ' ' ILE . 63.1 tpp -142.39 134.84 27.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.178 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -138.24 148.66 60.57 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.399 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.95 156.23 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.404 2.069 . . . . 0.0 112.308 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -153.56 159.3 42.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -133.01 136.89 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -75.26 116.54 16.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 110.47 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.65 -37.54 86.77 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.92 173.07 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 57.2 t0 -77.43 109.45 11.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.599 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.14 126.76 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -95.23 111.69 23.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.68 57.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.072 0.463 . . . . 0.0 110.992 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 -31.2 8.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.906 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 60.8 p -133.07 162.4 31.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.376 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -55.94 -31.73 63.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.716 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -62.09 -39.69 93.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.289 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -96.57 126.89 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.325 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.5 mm? -103.44 151.69 38.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.633 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.78 142.54 48.14 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.573 1.515 . . . . 0.0 112.679 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . 0.461 ' O ' ' OD1' ' A' ' 803' ' ' ASP . 92.6 mt -127.06 161.7 27.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -123.66 136.6 54.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.417 0.627 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.18 121.85 5.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.457 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.06 11.05 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.938 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 68.3 t0 -48.04 136.38 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.325 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 7.1 mm -101.86 125.32 56.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.86 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.71 156.65 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.293 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -112.12 125.62 54.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.64 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . 0.449 ' O ' ' SD ' ' A' ' 795' ' ' MET . 75.6 mt -88.0 123.47 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.215 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 832' ' ' GLU . 8.0 p90 -111.43 -3.83 15.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.27 133.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -87.25 128.09 35.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.292 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.36 -46.35 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.03 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -152.65 179.43 8.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.637 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.91 -37.52 76.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -107.68 -8.6 16.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.79 141.07 42.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 0.0 112.031 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -129.44 151.44 50.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.558 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.42 ' OE2' ' OH ' ' A' ' 823' ' ' TYR . 3.7 tt0 -125.74 139.64 53.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -157.99 180.0 33.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 837' ' ' GLY . 12.7 tm-20 -115.26 125.45 53.33 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.0 p80 -132.39 138.02 47.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 82.3 t60 50.78 32.05 6.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 834' ' ' GLU . . . 75.46 13.3 83.02 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -118.61 148.16 42.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.8 127.34 75.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 0.0 111.541 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -147.97 -179.78 24.22 Favored Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.415 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 30.8 pt -124.29 143.4 37.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.101 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.0 OUTLIER -145.75 149.11 38.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.676 -179.453 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' A' ' 845' ' ' THR . 72.1 Cg_endo -75.62 137.54 20.49 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.251 1.967 . . . . 0.0 111.197 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -55.51 3.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.595 ' H ' ' C ' ' A' ' 843' ' ' PRO . 0.2 OUTLIER -90.74 -15.83 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.685 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 -5.45 16.17 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.268 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 45.9 pt -133.52 173.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.551 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -131.29 155.12 47.72 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 8.1 tp -105.31 107.63 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.197 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 4.6 tt 49.9 76.71 0.52 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 153.42 51.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.989 2.459 . . . . 0.0 111.845 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.74 151.11 74.62 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.465 2.11 . . . . 0.0 112.227 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -111.01 142.8 42.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -98.9 130.28 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.673 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -96.24 -0.55 49.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.645 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -81.6 0.27 39.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.935 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -67.43 153.29 95.12 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.095 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -52.24 138.77 54.73 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.704 1.602 . . . . 0.0 112.249 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.01 134.1 51.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.543 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -60.9 166.85 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.288 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.1 mp -51.22 143.45 11.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.69 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.498 ' O ' ' CG2' ' A' ' 862' ' ' THR . 11.2 t -131.27 78.28 72.63 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.661 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -58.02 142.54 96.82 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.842 2.361 . . . . 0.0 112.226 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.09 160.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -157.04 163.9 38.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.415 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 86.0 t -102.98 118.2 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 2.2 tt -169.36 118.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.362 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 897' ' ' LEU . 99.7 mt-10 -121.14 133.87 55.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 869' ' ' TYR . 34.7 t80 -149.52 40.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -69.88 168.62 46.76 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . 0.532 ' OE2' ' NE ' ' A' ' 893' ' ' ARG . 88.0 tt0 -138.31 150.59 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.766 0.317 . . . . 0.0 110.203 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -143.43 153.12 42.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.99 121.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.073 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.5 4.03 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.5 mtmt -70.36 -36.79 74.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.63 152.62 50.69 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.253 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 878' ' ' PHE . 61.6 t-20 -54.69 136.14 46.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.709 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.632 ' CD2' ' CE1' ' A' ' 888' ' ' PHE . 90.3 t80 -129.52 132.04 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.76 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.06 106.95 13.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -71.01 139.58 29.89 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -107.01 -3.18 20.35 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 68.4 p -132.69 160.84 35.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.235 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -61.51 -41.96 98.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.54 -25.38 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.92 108.23 20.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 886' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 887' ' ' SER . 16.9 tmm? -79.74 135.02 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 887' ' ' SER . . . . . 0.512 ' O ' ' SD ' ' A' ' 886' ' ' MET . 33.9 t -82.6 132.28 35.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.716 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.632 ' CE1' ' CD2' ' A' ' 878' ' ' PHE . 45.5 p90 -142.18 154.51 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -103.54 163.89 12.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.063 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.46 132.73 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.5 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 96.33 -7.01 66.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.296 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -69.94 133.77 47.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.923 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.532 ' NE ' ' OE2' ' A' ' 871' ' ' GLU . 70.4 mtp85 -84.05 126.09 32.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 8.7 mm -114.88 143.45 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.106 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -98.28 127.81 44.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.98 116.21 22.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 110.943 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . 0.423 ' O ' ' OE1' ' A' ' 868' ' ' GLU . 95.7 mt -100.75 -50.62 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.443 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -160.86 154.9 22.77 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.079 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 116.88 32.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.448 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 60.0 t -61.43 -46.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.779 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.9 m-20 -143.88 -104.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.989 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -129.04 -37.7 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -108.09 4.74 25.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.502 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -132.02 148.27 52.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -153.95 159.77 41.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.113 0.482 . . . . 0.0 110.882 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -107.47 135.12 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.65 177.84 30.14 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.288 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -150.84 160.3 43.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.24 128.84 86.93 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -49.13 138.86 27.83 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 120.161 1.093 . . . . 0.0 111.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 912' ' ' THR . . . 101.26 -17.84 55.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 911' ' ' GLY . 0.2 OUTLIER 79.18 86.0 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.898 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 25.4 t -129.25 -41.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.036 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -162.74 151.92 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.817 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -130.01 146.55 51.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.05 175.48 45.34 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.519 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.8 pt -114.1 142.37 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.899 0.38 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -152.67 157.96 33.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.889 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 136.63 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.117 1.878 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.25 -36.82 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.867 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.433 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 73.0 p -53.5 -29.85 38.26 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -91.85 2.38 56.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.984 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 16.9 t -127.19 148.97 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.308 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -99.98 121.31 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.44 123.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.156 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.06 -44.82 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.67 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -125.61 142.27 51.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.5 74.61 69.15 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.65 151.93 47.38 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.526 2.151 . . . . 0.0 112.307 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.462 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.75 40.91 30.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.596 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -147.66 159.38 43.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.702 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 97.7 p -155.4 164.4 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.593 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 91.05 -5.79 81.68 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 5.7 t 61.49 73.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.522 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.81 143.0 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.671 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.8 mpp? -116.62 156.58 26.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.96 149.44 73.13 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.02 153.8 57.71 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.394 2.063 . . . . 0.0 112.274 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -168.86 151.14 4.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -133.41 129.33 37.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.617 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -76.41 122.83 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' A' ' 848' ' ' GLU . 15.5 ttmm -91.24 -18.14 24.88 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.462 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.74 139.97 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.192 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.84 152.12 43.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.312 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . 0.443 ' CE1' ' CD ' ' A' ' 811' ' ' GLU . 47.5 t80 -126.87 129.09 47.55 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.466 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.61 121.1 35.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.1 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -62.26 134.99 57.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 110.793 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -110.96 -28.8 8.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 68.9 p -130.87 163.35 27.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.456 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.65 -34.75 67.62 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.99 -47.29 86.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.783 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . 0.443 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 8.1 tm-20 -86.78 123.66 32.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.114 0.483 . . . . 0.0 111.266 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -96.57 152.73 38.77 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.29 145.12 76.95 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.611 1.541 . . . . 0.0 112.511 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.89 151.42 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.29 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 817' ' ' GLY . 11.1 tt0 -102.89 147.76 26.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.461 0.648 . . . . 0.0 110.661 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -63.45 38.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.125 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 166.06 23.26 0.02 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -97.15 113.65 25.26 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.77 -0.253 . . . . 0.0 110.418 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.7 135.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.658 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.55 158.3 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.25 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.409 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 84.6 m-85 -108.41 115.83 30.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.403 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 33.4 mm -81.57 134.62 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.318 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -96.75 -39.68 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . 0.47 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 25.9 pttm -162.07 159.83 26.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.417 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -86.14 116.02 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 827' ' ' ASP . 48.5 mm -65.01 -48.73 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.284 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 826' ' ' ILE . 34.5 m-20 -147.62 177.5 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.18 -36.41 75.29 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.253 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -109.87 15.4 22.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -137.06 147.53 46.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 112.082 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.541 ' OH ' ' NH1' ' A' ' 844' ' ' ARG . 44.0 m-85 -133.87 150.99 51.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.32 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.47 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 3.7 tt0 -124.11 133.33 53.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.135 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.409 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -158.39 -175.77 29.69 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -113.79 149.93 34.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.556 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.3 p-80 -152.55 132.14 13.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.558 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 75.6 t60 48.84 34.01 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.581 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.88 1.63 90.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.863 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.18 147.83 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.86 135.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.635 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -158.27 -143.02 3.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 842' ' ' PHE . 45.5 pt -128.97 150.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 117.449 0.624 . . . . 0.0 110.748 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' A' ' 841' ' ' ILE . 4.1 m-85 -144.24 131.0 10.21 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.842 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.38 148.21 72.91 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.532 1.488 . . . . 0.0 112.784 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . 0.541 ' NH1' ' OH ' ' A' ' 831' ' ' TYR . 60.2 ttt85 -59.74 -41.06 90.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.658 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 94.1 m -64.47 -22.47 66.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.341 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -91.93 -3.76 55.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.806 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 844' ' ' ARG . 1.3 pp -142.08 165.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.182 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' A' ' 801' ' ' LYS . 96.1 mt-10 -132.49 124.44 28.54 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.92 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.36 113.33 9.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.329 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.3 tt 53.15 76.02 0.57 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.34 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.12 153.48 52.02 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.804 2.336 . . . . 0.0 111.749 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.51 153.15 74.35 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.399 2.066 . . . . 0.0 111.987 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -60.16 148.81 34.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.511 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -126.23 145.32 50.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -81.63 144.74 31.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.493 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -102.0 113.04 25.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.147 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -138.12 73.08 45.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.34 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.28 69.54 7.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.727 2.284 . . . . 0.0 112.099 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.42 119.14 24.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.57 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -159.79 163.93 34.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -74.25 118.33 17.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 110.379 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 6.9 t -64.47 139.04 97.63 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.83 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.112 1.875 . . . . 0.0 112.246 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.49 167.7 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.752 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -131.39 149.8 52.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.513 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 80.8 t -119.29 120.79 64.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.693 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 2.5 mt -157.03 17.22 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 871' ' ' GLU . 99.6 mt-10 -125.6 143.24 51.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.746 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.49 -42.28 7.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -150.51 168.15 30.36 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 868' ' ' GLU . 79.5 mm-40 -122.94 151.75 41.49 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.917 0.389 . . . . 0.0 110.929 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.07 151.07 27.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.264 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 11.5 mm -122.23 127.45 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -47.31 131.17 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.497 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -72.93 -37.19 67.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.684 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 922' ' ' TYR . 0.2 OUTLIER -155.15 160.79 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.231 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.541 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 23.0 m120 -51.72 109.55 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -115.85 125.5 52.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.402 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -115.86 110.59 19.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.379 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -64.52 142.5 45.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.05 -22.93 28.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 66.3 p -129.85 164.15 24.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.621 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -59.87 -25.95 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.266 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.84 -45.3 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.64 141.79 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.7 tpt -103.24 130.71 50.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 142.07 27.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -158.6 160.84 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.538 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -89.57 158.12 17.77 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.521 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -66.08 56.25 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.689 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . -178.16 4.66 0.03 OUTLIER Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.725 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.96 150.52 20.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.551 0.675 . . . . 0.0 109.866 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -95.5 127.97 41.97 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.451 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.62 151.67 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.85 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.7 m -104.36 127.45 52.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.887 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 87.4 mt -90.16 127.7 36.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.535 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 87.9 mt -108.27 -53.56 2.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.702 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -156.34 150.28 25.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.985 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.14 106.94 18.82 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.51 -44.07 95.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -157.87 178.68 9.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.088 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.87 -30.99 71.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.959 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . 0.469 ' C ' ' CD1' ' A' ' 904' ' ' TRP . 98.3 m-20 -109.7 20.07 18.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.41 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 903' ' ' ASN . 74.3 m95 -146.83 151.61 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.96 138.09 26.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.545 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -102.11 133.16 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.02 178.43 35.19 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.952 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 20.9 ptp180 -151.16 157.81 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.96 141.76 78.75 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.45 139.85 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.06 1.057 . . . . 0.0 111.046 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.434 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.33 -9.26 69.58 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.7 p 69.83 31.99 3.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.663 0.268 . . . . 0.0 110.971 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.0 t -60.91 -44.22 97.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.11 146.81 15.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -121.19 151.05 40.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.278 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -175.02 176.12 47.13 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.182 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.467 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 45.2 pt -125.12 156.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.467 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.4 OUTLIER -166.48 162.69 11.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.661 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.67 147.85 90.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.806 1.671 . . . . 0.0 111.768 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 11.3 mt -76.37 -19.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 81.6 p -68.95 -10.69 58.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.591 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . 0.566 ' CD1' ' CE1' ' A' ' 876' ' ' PHE . 45.5 m-85 -108.23 7.59 27.47 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.04 159.42 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -117.38 131.75 56.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.54 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.99 98.81 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.278 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 926' ' ' ILE . 46.0 mm -70.67 -44.19 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.013 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.65 142.53 51.0 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -73.94 152.08 88.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.86 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.52 72.89 5.38 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.937 1.758 . . . . 0.0 112.315 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 24.1 tp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.522 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 791' ' ' SER . 20.9 tm0? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -61.18 -47.42 86.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.77 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 98.4 mtp -63.97 -40.87 97.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.863 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 788' ' ' GLN . 66.7 m -127.49 139.76 52.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.748 0.309 . . . . 0.0 110.86 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -92.68 99.26 2.51 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 45.3 t -119.94 128.21 53.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.856 0.36 . . . . 0.0 110.345 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.69 153.42 37.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -126.04 160.38 30.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . 0.458 ' HE ' ' CD2' ' A' ' 849' ' ' LEU . 13.9 tpt180 -129.8 121.13 19.83 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.09 138.9 21.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.702 1.601 . . . . 0.0 112.474 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 848' ' ' GLU . . . -138.77 154.4 48.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -113.13 140.39 47.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.013 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -72.88 126.95 31.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -91.06 -8.86 47.76 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.258 0.552 . . . . 0.0 109.571 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.13 178.3 7.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.136 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.3 p-10 -98.53 139.57 34.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.569 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -129.56 129.58 44.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.232 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -95.31 135.13 37.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.562 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -76.42 138.04 40.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -114.38 -22.33 9.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.902 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.1 p -127.22 167.67 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.446 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.42 -41.4 97.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.771 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -63.01 -39.94 96.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.471 . . . . 0.0 109.864 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -74.76 131.89 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.265 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 9.1 mp -118.76 154.23 52.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.06 144.19 62.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.856 1.704 . . . . 0.0 112.346 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.65 141.45 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.212 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -122.66 139.85 53.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.438 0.637 . . . . 0.0 110.921 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.82 123.55 7.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.911 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 105.75 -24.33 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.412 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.2 t0 -61.9 135.67 57.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.799 0.333 . . . . 0.0 110.763 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.503 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 33.9 mm -93.9 130.57 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.46 152.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.46 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 86.6 m-85 -117.04 117.74 30.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.03 129.59 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -123.88 -9.67 7.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.274 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -165.18 133.59 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -82.69 138.01 34.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.633 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 9.8 mm -94.82 -57.64 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.477 ' O ' ' NH2' ' A' ' 844' ' ' ARG . 7.7 t0 -150.21 179.33 8.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.085 0.469 . . . . 0.0 109.795 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.59 -37.26 78.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.716 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -106.18 7.25 31.48 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -141.15 147.13 37.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.113 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 29.6 p90 -140.08 169.68 17.25 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.558 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.5 tp10 -128.54 139.19 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.134 0.493 . . . . 0.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.558 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -161.36 -175.45 32.4 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.89 135.62 49.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.693 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.8 OUTLIER -144.61 146.91 32.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.8 t-80 49.04 29.76 2.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.18 79.98 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -132.8 158.92 41.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.0 t -106.78 132.66 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.618 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . 0.465 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -164.29 -175.02 34.72 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.48 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 36.6 pt -115.15 149.65 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.515 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.3 OUTLIER -152.01 151.67 28.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 845' ' ' THR . 27.5 Cg_endo -67.88 112.08 2.59 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.797 1.665 . . . . 0.0 112.15 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 827' ' ' ASP . 19.1 ttm105 -47.69 -15.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.53 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.407 ' N ' ' C ' ' A' ' 843' ' ' PRO . 63.2 p -81.49 -2.25 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.735 0.303 . . . . 0.0 111.052 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.2 -2.91 26.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.004 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.5 pt -129.33 172.05 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.881 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 798' ' ' ALA . 85.1 tt0 -110.31 159.73 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . 0.458 ' CD2' ' HE ' ' A' ' 796' ' ' ARG . 3.4 tt -113.49 104.36 12.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 36.5 tp 58.26 75.13 0.56 Allowed Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.78 158.78 52.36 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.785 . . . . 0.0 112.399 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 147.29 60.49 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.667 2.244 . . . . 0.0 112.444 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -74.91 147.37 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.987 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 60.14 85.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.38 -22.56 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.621 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -63.39 142.83 58.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.719 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -139.67 66.28 34.25 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 860' ' ' LYS . 58.9 Cg_endo -71.95 -15.55 29.38 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.694 2.263 . . . . 0.0 112.868 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 57.77 -81.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 858' ' ' PRO . 48.1 mmtm -72.43 150.85 42.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.32 -39.09 91.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.43 ' OG1' ' OE1' ' A' ' 865' ' ' GLN . 79.2 p -128.7 149.44 72.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.68 -23.15 42.77 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.162 1.908 . . . . 0.0 112.68 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 10.9 t -129.62 133.11 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.449 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . 0.43 ' OE1' ' OG1' ' A' ' 862' ' ' THR . 1.3 mt-30 -170.53 121.73 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.688 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.88 127.71 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.01 -40.84 97.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.5 83.38 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.266 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -140.54 130.02 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -144.77 164.17 27.85 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.0 160.93 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.88 146.0 17.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 89.8 mt -123.19 125.8 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.58 122.69 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.149 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 46.3 mtpt -70.38 -37.86 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -132.75 154.33 50.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.324 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.708 HD21 ' H ' ' A' ' 890' ' ' LYS . 33.6 m120 -54.25 146.19 15.91 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 89.0 t80 -141.43 137.12 31.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.031 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -123.64 105.4 9.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.183 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.5 155.15 52.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -115.13 -9.61 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.585 0.231 . . . . 0.0 111.503 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.3 p -128.54 160.56 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . 0.493 ' O ' ' SD ' ' A' ' 886' ' ' MET . 55.2 tt0 -61.55 -39.71 92.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.936 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.48 -42.05 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.521 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -88.36 103.27 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.689 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 886' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 883' ' ' GLN . 0.0 OUTLIER -80.89 133.59 35.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.237 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 84.4 p -73.06 157.4 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 111.053 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 41.1 p90 -160.38 162.94 33.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.474 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -112.95 161.84 16.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.301 0.572 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.708 ' H ' HD21 ' A' ' 877' ' ' ASN . 63.7 tttm -59.37 132.77 55.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.74 -8.01 78.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.694 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.31 139.82 48.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.24 0.52 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -85.21 143.4 28.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.956 0.408 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 894' ' ' ILE . 94.2 mt -131.99 148.8 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.738 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -101.53 129.16 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.987 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.26 115.21 24.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 111.149 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.97 -50.41 4.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.791 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -157.46 151.69 24.79 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.019 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.89 113.74 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.699 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.437 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 79.5 t -69.19 -43.16 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 110.31 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.438 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 19.3 t0 -153.56 -176.65 5.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.021 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 61.0 mp0 -61.13 -37.85 84.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.83 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.6 13.28 21.28 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.87 147.63 46.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.437 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 20.9 p90 -154.29 158.27 39.93 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.162 0.506 . . . . 0.0 110.965 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.23 133.3 52.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.04 178.6 30.83 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.334 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . 0.407 ' C ' ' CD ' ' A' ' 908' ' ' ARG . 0.0 OUTLIER -153.14 161.68 42.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.855 0.359 . . . . 0.0 110.385 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 13.1 mt -90.22 132.26 36.32 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.826 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -39.98 136.28 1.45 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.397 1.398 . . . . 0.0 111.757 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.21 -4.34 64.8 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.44 24.68 13.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.4 t -61.58 -45.07 95.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.95 146.73 45.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.489 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.2 tt0 -147.39 139.01 24.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 172.54 -170.28 43.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.7 pt -116.31 145.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.054 0.454 . . . . 0.0 111.014 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.37 153.38 30.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.038 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.04 137.52 41.2 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.057 1.838 . . . . 0.0 112.991 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.51 -38.68 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 93.7 m -51.96 -44.17 63.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.961 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.13 3.57 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.67 147.53 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.99 0.424 . . . . 0.0 110.285 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.71 120.99 42.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.504 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.76 124.65 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.505 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.89 -35.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -151.55 135.61 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.758 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -70.88 149.38 95.01 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.439 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.28 -21.33 41.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.044 1.83 . . . . 0.0 111.853 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.482 179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -129.62 139.78 51.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.9 mtm -112.38 107.19 15.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.335 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 62.8 m -132.74 144.11 50.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.24 84.93 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.0 t -158.18 147.62 19.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.319 . . . . 0.0 110.42 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -150.66 146.59 26.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.566 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 63.6 mtt -136.39 158.36 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -128.19 145.62 56.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.3 108.41 1.75 Allowed 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.956 1.77 . . . . 0.0 112.645 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -109.35 144.83 37.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -114.24 140.61 48.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.226 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -81.2 118.18 22.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -72.38 -27.48 62.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.077 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -142.39 178.15 7.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.558 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.09 139.28 30.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.057 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -127.08 125.86 42.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.34 132.55 34.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.2 139.03 49.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . 0.492 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 98.1 mm-40 -105.24 -29.18 10.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.069 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 808' ' ' THR . . . . . 0.453 ' H ' ' CG ' ' A' ' 811' ' ' GLU . 71.5 p -136.15 170.14 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.261 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.41 -35.25 77.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.166 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -59.93 -40.17 88.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.737 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 807' ' ' GLN . 10.8 pt-20 -98.4 129.4 45.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.613 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -102.08 152.19 38.18 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.58 149.98 68.7 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.304 2.003 . . . . 0.0 113.092 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.62 142.77 49.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.663 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.9 133.53 53.02 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.261 0.553 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -41.57 126.05 2.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.6 -24.17 32.49 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.385 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.53 121.35 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.2 mm -81.55 138.86 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.044 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.47 154.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.452 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -113.0 117.01 30.85 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 62.3 mt -82.04 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.179 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.17 -4.82 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -166.78 130.83 1.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 827' ' ' ASP . 4.0 tm0? -90.6 107.32 19.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.712 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.1 mm -60.77 -48.87 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.121 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.551 ' C ' HE21 ' A' ' 825' ' ' GLN . 1.3 t70 -155.56 176.98 11.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 26.0 mp0 -61.85 -35.83 79.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.779 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -102.13 -7.41 22.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.815 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -125.53 131.89 52.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.982 0.42 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -121.4 156.65 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.605 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -128.91 140.81 51.51 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.91 -174.18 31.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.44 136.31 48.27 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.577 0.227 . . . . 0.0 110.652 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 2.7 p80 -139.11 133.14 31.13 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 1.3 t60 50.2 31.8 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.243 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.27 4.45 90.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.538 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -112.63 161.87 16.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.01 140.89 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.52 30.31 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.79 155.02 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.131 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -161.53 153.82 16.7 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.576 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 845' ' ' THR . 56.6 Cg_endo -71.86 126.98 12.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.961 1.774 . . . . 0.0 112.714 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 2.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.757 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 845' ' ' THR . . . . . 0.514 ' H ' ' C ' ' A' ' 843' ' ' PRO . 73.8 p -91.05 -18.44 24.57 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.589 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.49 5.41 34.04 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 43.2 pt -130.27 168.28 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -134.71 113.27 11.5 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.988 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.81 118.19 11.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.959 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 21.6 tp 58.84 69.91 1.28 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.785 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.5 161.66 41.83 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.625 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 853' ' ' ALA . 51.5 Cg_exo -46.08 175.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.349 2.033 . . . . 0.0 112.127 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 852' ' ' PRO . . . 82.41 47.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.669 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 856' ' ' ALA . 88.5 tt0 -92.27 116.06 28.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.502 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 50.39 9.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.995 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 854' ' ' GLU . . . -62.67 -40.2 96.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.656 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -130.3 76.53 77.62 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.701 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.33 138.49 79.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.728 2.285 . . . . 0.0 112.253 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -118.84 -15.9 9.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.436 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.82 -43.24 98.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.51 99.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.157 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 51.8 p -71.15 150.55 94.63 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.309 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.41 156.61 54.33 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.254 1.969 . . . . 0.0 112.028 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.76 160.39 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.42 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -138.18 153.11 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.706 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.5 t -114.48 124.88 71.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.424 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.3 13.31 3.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.525 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.67 -39.82 95.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.45 141.46 51.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -80.99 168.13 50.52 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -128.15 150.41 50.0 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.54 146.32 16.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.05 125.21 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.19 120.56 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.359 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -69.22 -36.7 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -134.33 150.52 50.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.916 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -55.55 132.92 49.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -130.67 134.63 47.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 16.5 p30 -113.65 128.89 56.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.996 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.89 23.33 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -98.17 -12.73 21.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 110.731 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 62.0 p -133.07 165.08 25.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . 0.473 ' O ' ' CE ' ' A' ' 886' ' ' MET . 98.4 mt-30 -62.02 -39.73 93.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.113 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.82 -15.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.757 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -105.71 110.09 22.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.296 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 886' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 883' ' ' GLN . 39.1 mmt -81.01 152.69 27.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.262 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 96.7 p -108.9 155.01 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -159.3 161.61 35.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.779 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . 0.417 ' N ' ' CD ' ' A' ' 889' ' ' ARG . 1.4 mpt_? -96.44 165.86 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.593 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.53 135.89 57.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.19 82.63 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.607 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -72.38 140.61 48.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.516 0.658 . . . . 0.0 110.038 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -82.06 140.99 33.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.114 0.483 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 894' ' ' ILE . 90.8 mt -130.25 138.8 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.51 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.3 m -99.37 126.13 45.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.08 115.36 25.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.107 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.28 -37.36 6.03 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.535 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.48 134.61 18.13 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.181 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -103.1 118.27 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 901' ' ' ASP . 60.0 t -63.96 -41.21 91.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.098 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 900' ' ' VAL . 36.4 m-20 103.97 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.905 1.378 . . . . 0.0 110.335 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 901' ' ' ASP . 10.2 tt0 80.7 -69.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.766 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -169.43 23.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -135.88 151.04 49.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.505 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -153.85 155.11 35.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.21 0.529 . . . . 0.0 110.3 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.88 138.5 42.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.64 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.24 178.14 30.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.144 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -148.13 157.92 43.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.747 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.5 mt -80.35 142.14 54.11 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.27 139.2 16.53 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 120.312 1.147 . . . . 0.0 110.499 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.26 -5.06 67.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 9.1 p 61.3 23.55 13.76 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.535 -0.333 . . . . 0.0 111.532 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.6 m -62.39 -42.3 99.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.832 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -134.9 153.04 52.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.456 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -145.37 135.75 24.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.75 177.22 46.15 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.9 pt -112.45 144.05 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.629 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -151.3 155.78 34.74 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.474 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 140.2 41.97 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.058 1.839 . . . . 0.0 113.395 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.22 -37.57 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.486 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 98.9 m -56.31 -42.54 77.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -76.09 0.25 19.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.158 0.435 . . . . 0.0 111.96 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.15 158.97 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.159 0.504 . . . . 0.0 111.245 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -107.14 123.95 49.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.455 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.27 110.15 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.24 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 32.4 mm -86.01 -47.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.868 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 143.19 51.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.444 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -75.17 153.08 86.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.171 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.74 -38.59 56.75 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.507 1.471 . . . . 0.0 111.93 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.331 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -99.94 7.54 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.3 mtm -75.0 144.95 42.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.255 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 83.4 p -70.74 159.37 34.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.504 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -139.9 -145.54 4.7 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 83.3 p -69.75 155.86 39.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.913 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -165.3 151.39 9.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.763 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 24.8 ptp -140.83 153.96 46.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -132.98 145.77 58.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.227 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.59 120.27 3.9 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.934 1.756 . . . . 0.0 112.431 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -120.42 152.0 38.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.27 133.93 55.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.951 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -77.22 113.98 15.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . 0.527 ' O ' ' NZ ' ' A' ' 816' ' ' LYS . 18.8 mmmt -69.68 -38.17 76.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.168 0.509 . . . . 0.0 110.056 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.4 167.52 20.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.093 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 137.6 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.333 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -133.75 131.38 39.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.441 ' O ' ' NE2' ' A' ' 807' ' ' GLN . 68.8 mttm -100.7 134.54 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -81.86 144.05 31.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.99 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . 0.441 ' NE2' ' O ' ' A' ' 805' ' ' LYS . 25.8 mp0 -98.52 -35.32 10.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.68 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 808' ' ' THR . . . . . 0.45 ' OG1' ' OE1' ' A' ' 811' ' ' GLU . 47.1 p -135.03 171.66 14.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.386 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.2 -24.65 43.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.175 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.28 -38.83 88.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.285 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . 0.45 ' OE1' ' OG1' ' A' ' 808' ' ' THR . 24.6 mp0 -101.12 156.44 17.42 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.7 pt? -127.21 147.68 62.91 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . 0.502 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 58.3 Cg_endo -72.44 140.25 32.97 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 113.033 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.72 145.0 51.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -120.13 139.98 51.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.281 0.562 . . . . 0.0 110.426 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 801' ' ' LYS . 12.4 ttmm -43.83 121.54 2.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.27 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.52 -20.65 49.59 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.578 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.32 136.16 57.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.937 0.399 . . . . 0.0 111.399 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.97 131.63 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.867 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.93 152.87 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.646 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -110.82 121.54 45.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.799 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 67.0 mt -91.38 131.06 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -104.51 -32.22 9.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.674 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -158.28 149.86 21.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.494 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.442 ' OE1' ' OH ' ' A' ' 831' ' ' TYR . 49.8 tt0 -88.48 110.77 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.285 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.36 -48.01 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.296 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.432 ' OD1' ' OE1' ' A' ' 828' ' ' GLN . 8.2 t0 -154.76 177.86 10.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . 0.432 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 25.5 mp0 -61.36 -36.35 79.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.754 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -103.73 -2.55 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.173 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -127.97 139.38 52.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.442 ' OH ' ' OE1' ' A' ' 825' ' ' GLN . 5.0 m-85 -126.03 158.27 35.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.314 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.451 ' O ' ' OE1' ' A' ' 832' ' ' GLU . 0.6 OUTLIER -129.05 138.96 52.2 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.15 -176.01 33.77 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -117.56 152.91 34.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.971 0.415 . . . . 0.0 111.458 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.0 OUTLIER -164.52 137.05 4.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.159 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 49.3 t-80 52.6 29.93 7.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.302 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.22 2.63 90.57 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.515 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.9 148.25 30.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.05 136.93 52.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -170.7 -137.83 2.38 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.5 pt -133.83 157.01 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.93 0.365 . . . . 0.0 111.641 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 6.6 p90 -157.72 135.77 7.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.181 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.27 124.85 17.05 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.125 1.216 . . . . 0.0 112.442 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -54.92 -20.42 8.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.4 p -72.46 -11.28 60.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.48 -1.76 40.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.244 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.45 171.03 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.992 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -131.88 110.19 10.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.869 0.366 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.64 116.29 8.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 32.4 tp 54.05 72.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.676 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.38 164.54 35.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.183 1.922 . . . . 0.0 112.123 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.82 140.88 37.19 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.995 1.797 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -66.84 78.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.456 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -97.01 6.02 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.392 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -58.43 -22.32 53.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.224 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 73.58 -69.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 45.05 69.42 2.55 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.48 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.66 143.54 89.04 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -73.41 80.12 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp 49.85 100.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.918 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 862' ' ' THR . 91.9 mt -70.61 148.79 47.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 861' ' ' LEU . 61.9 p -31.09 96.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 123.631 0.582 . . . . 0.0 111.243 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 156.83 29.38 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.021 1.814 . . . . 0.0 111.98 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.79 142.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.562 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.32 171.97 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.374 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.43 123.6 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.204 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.83 4.9 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.08 -6.29 52.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.233 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.39 152.61 40.77 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.54 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -156.89 172.06 34.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.77 143.97 50.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.206 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -157.2 144.59 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.5 mt -123.02 128.19 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.822 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.09 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.946 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 44.7 mtpt -70.05 -37.82 75.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.816 0.341 . . . . 0.0 110.497 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.71 153.53 49.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -57.11 159.46 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 26.9 t80 -150.49 138.72 20.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.72 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 40.0 p30 -151.85 92.04 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -82.69 -174.24 49.98 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 49.4 t0 -135.66 -9.38 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 111.641 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 882' ' ' THR . . . . . 0.558 ' HG1' ' H ' ' A' ' 885' ' ' GLU . 71.5 p -79.26 174.3 11.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.98 0.419 . . . . 0.0 110.686 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.45 -0.93 57.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 -18.77 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.642 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . 0.558 ' H ' ' HG1' ' A' ' 882' ' ' THR . 3.0 pp20? -72.57 141.95 48.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.58 128.56 46.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 22.5 t -92.85 125.45 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.109 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 34.4 p90 -154.9 162.37 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 33.2 mtp-105 -112.18 161.67 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.347 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -59.42 136.54 58.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 893' ' ' ARG . . . 90.15 -4.91 83.14 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -76.87 142.79 40.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.179 0.489 . . . . 0.0 110.562 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 891' ' ' GLY . 12.6 mpt_? -82.4 142.12 32.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.251 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.2 mt -131.38 143.17 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.2 m -100.65 127.09 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.873 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.85 120.32 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.3 mt -100.18 -45.61 5.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -165.5 164.85 19.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.887 0.375 . . . . 0.0 111.134 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -103.58 116.95 33.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.404 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.8 t -61.86 -45.55 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.193 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.469 ' CG ' ' N ' ' A' ' 902' ' ' GLU . 34.4 t70 -148.56 -116.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.789 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . 0.469 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 99.7 mt-10 -114.32 -37.03 4.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.75 7.75 22.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.589 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -132.49 148.57 52.39 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.526 0.203 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' A' ' 918' ' ' PHE . 21.5 p90 -152.71 159.56 43.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.853 0.358 . . . . 0.0 110.283 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.69 136.79 48.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.32 178.39 30.38 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.547 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -151.79 159.75 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.7 mt -80.69 140.79 51.29 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.49 138.3 18.81 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 CA-C-N 120.148 1.088 . . . . 0.0 110.988 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.436 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 94.04 -6.91 73.0 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 2.2 p 66.51 28.05 9.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.715 0.293 . . . . 0.0 111.15 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 88.0 p -64.21 -24.17 67.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -165.26 152.85 11.03 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.686 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -144.02 147.19 33.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.676 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 179.04 -174.55 46.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.551 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 45.9 pt -109.94 154.72 11.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.219 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 918' ' ' PHE . 0.0 OUTLIER -165.23 151.87 9.18 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.908 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.82 140.65 29.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.17 1.913 . . . . 0.0 112.768 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 90.1 mt -61.57 -32.05 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.801 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.538 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 97.9 m -57.9 -42.14 84.09 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -77.4 1.23 19.66 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.78 159.15 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -111.32 128.7 56.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.377 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 79.3 t -99.58 105.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.687 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.19 -45.74 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.31 140.41 39.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -91.16 126.21 55.81 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.689 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.76 150.89 62.85 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.708 1.605 . . . . 0.0 112.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.481 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -63.39 -39.85 95.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 98.3 mtp -96.47 139.54 32.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.549 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 68.0 m -134.19 -117.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 82.75 1.14 90.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 91.3 p -63.94 -38.33 90.7 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.692 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.92 -19.69 7.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 64.2 mtt -83.34 153.12 24.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -158.77 98.46 1.69 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.19 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.824 1.683 . . . . 0.0 111.91 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -134.73 155.91 49.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -118.51 134.47 55.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.283 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -76.29 116.92 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -71.3 -30.03 65.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.46 175.67 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.465 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 805' ' ' LYS . 14.5 t70 -82.31 126.73 32.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.455 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -115.56 130.73 56.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.981 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 803' ' ' ASP . 38.2 mmtm -94.21 130.16 40.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.2 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -68.77 139.51 55.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.24 -35.63 10.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.242 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.9 p -135.42 162.54 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.1 pp -50.61 -32.87 20.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.46 -46.13 91.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.268 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.03 136.97 32.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.025 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 812' ' ' LEU . 2.4 mm? -110.67 150.72 42.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 152.02 50.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.219 1.946 . . . . 0.0 113.448 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 4.8 mt -133.96 157.21 46.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.917 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.56 141.01 50.67 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.422 0.63 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -47.62 123.35 5.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.79 44.19 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.886 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.539 ' OD1' ' NE2' ' A' ' 835' ' ' HIS . 19.8 t70 -58.03 143.28 43.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 28.2 mm -103.78 131.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.655 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 32.1 m -121.62 152.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.764 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.418 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 72.8 m-85 -111.94 113.58 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.36 127.14 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -119.33 -5.49 10.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.19 130.44 1.45 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.81 135.32 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.29 -48.92 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.42 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -152.48 178.98 8.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.13 -37.21 79.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.163 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -105.98 -0.43 24.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.929 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -124.5 137.94 54.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.491 0.662 . . . . 0.0 112.089 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -128.03 151.85 48.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.372 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -123.31 141.03 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.9 -163.51 14.92 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.49 150.13 49.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 111.008 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.539 ' NE2' ' OD1' ' A' ' 818' ' ' ASP . 1.2 t-80 -155.33 128.05 7.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.5 ' HD1' ' CD2' ' A' ' 835' ' ' HIS . 1.9 m80 52.38 24.04 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 92.09 -6.37 78.81 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . 0.436 ' NH2' ' CE1' ' A' ' 835' ' ' HIS . 12.0 ptp180 -98.08 151.9 19.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.337 0.568 . . . . 0.0 109.897 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.55 129.24 61.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.92 23.87 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 31.1 pt -105.74 152.15 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 117.338 0.569 . . . . 0.0 110.588 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.5 OUTLIER -139.79 114.78 7.95 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.8 128.57 21.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.474 1.45 . . . . 0.0 112.721 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -50.85 -20.28 1.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.533 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 65.7 p -87.1 -3.18 59.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.663 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -6.42 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.221 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 45.8 pt -134.25 172.1 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.013 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -117.83 160.61 21.1 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.87 107.67 18.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 41.3 tp 46.41 77.64 0.45 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.472 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.67 162.12 42.1 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.947 1.765 . . . . 0.0 111.809 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.04 133.78 47.52 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.811 1.674 . . . . 0.0 112.337 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -107.32 -2.53 20.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.371 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -62.55 -178.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.927 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.99 153.0 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.261 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -139.21 60.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -135.42 149.54 69.88 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.92 152.47 63.34 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.251 1.967 . . . . 0.0 112.159 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.07 143.44 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -107.61 118.96 38.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.988 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 862' ' ' THR . 87.2 mt -111.15 -50.37 2.94 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 862' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 861' ' ' LEU . 67.0 p 35.17 70.79 0.91 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -58.36 143.05 98.0 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.869 2.38 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' A' ' 866' ' ' VAL . 0.7 OUTLIER -95.77 -60.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.488 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 73.82 -12.92 0.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.423 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 864' ' ' VAL . 94.3 t -79.21 128.03 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.014 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.33 143.4 30.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.155 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 869' ' ' TYR . 88.5 tt0 -61.05 123.07 16.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.54 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 868' ' ' GLU . 20.3 m-85 40.92 -169.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -103.69 173.13 21.62 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -129.02 150.55 50.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.722 0.296 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -154.53 152.86 30.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . 0.444 HG23 HD13 ' A' ' 873' ' ' ILE . 23.2 mm -125.14 128.77 73.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -59.29 126.34 27.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.339 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 50.4 mtpt -73.85 -39.02 64.3 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -139.02 153.8 48.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.07 132.9 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -132.91 135.91 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.894 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -109.93 141.58 42.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.583 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.35 12.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -98.42 -12.15 21.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.25 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.4 p -132.99 163.31 29.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.28 -39.86 94.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.916 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.99 -25.01 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.843 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -98.2 127.47 44.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.8 tpt -105.07 123.59 48.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.937 0.399 . . . . 0.0 110.97 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 87.1 p -74.41 157.44 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.871 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -164.43 162.56 22.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -102.71 159.18 15.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -55.14 137.25 47.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.76 82.93 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.119 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -69.65 141.84 53.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.079 0.44 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -91.25 135.26 33.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.136 0.493 . . . . 0.0 111.111 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.49 148.03 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.517 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.1 m -99.81 127.07 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 86.5 mt -84.03 125.11 31.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 111.104 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 98.3 mt -103.19 -50.71 3.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.021 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 36.7 ptt-85 -165.93 165.24 18.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.22 119.17 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.545 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 53.3 t -61.2 -47.65 92.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.764 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.1 m-20 -144.2 -91.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.07 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -137.93 -46.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.537 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -102.1 7.46 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -133.23 149.39 52.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.688 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -153.57 161.78 41.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.054 0.455 . . . . 0.0 111.165 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 33.8 tt0 -109.96 139.2 45.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.867 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.47 176.24 28.29 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -144.62 156.23 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.782 0.325 . . . . 0.0 110.436 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.1 mt -103.21 107.67 56.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.066 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -54.09 135.28 63.66 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.35 1.367 . . . . 0.0 111.358 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 97.01 -22.31 41.45 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 74.6 p -127.58 -17.55 4.57 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.992 0.425 . . . . 0.0 110.022 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 57.5 m 51.61 36.57 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.216 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -86.25 98.09 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.522 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 53.6 tt0 -86.33 128.23 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.999 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -157.03 163.91 32.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.496 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.3 144.9 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.895 0.378 . . . . 0.0 111.068 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.496 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -158.49 164.28 21.69 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.857 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.39 137.06 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.412 2.074 . . . . 0.0 113.925 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 91.6 mt -60.77 -39.09 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.88 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.473 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 70.1 p -54.92 -22.48 15.07 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.757 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -95.11 0.85 54.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.6 m -132.3 157.88 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.13 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.43 121.83 45.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 67.5 t -90.19 103.95 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.831 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 926' ' ' ILE . 41.4 mm -72.38 -43.58 64.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.131 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -132.82 151.92 51.92 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -101.41 148.06 34.67 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.5 153.42 60.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.224 1.949 . . . . 0.0 112.606 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 56.3 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.503 179.701 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -70.61 -16.41 62.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 99.0 mtp 43.26 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 95.9 p -64.7 -16.96 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.49 95.09 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 88.1 p -148.87 158.78 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.563 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.68 161.68 34.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -68.21 158.32 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.581 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -125.82 97.61 35.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.545 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.56 140.88 96.56 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.075 1.85 . . . . 0.0 111.905 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -135.17 155.83 50.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -117.54 133.66 55.72 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.451 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -79.41 127.07 31.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -91.99 -28.72 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.14 162.62 32.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.079 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.5 p-10 -75.94 137.77 40.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.457 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.27 129.02 55.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.003 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -96.03 124.98 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -70.72 137.88 50.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.7 -38.8 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.418 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 67.8 p -135.64 162.87 31.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.62 -34.35 7.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.21 -39.86 94.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.993 0.425 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.83 128.33 38.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.977 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 812' ' ' LEU . 2.1 mm? -108.71 150.09 40.32 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.649 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.74 151.43 63.49 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.203 1.935 . . . . 0.0 113.023 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 3.2 tp -135.82 151.26 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.612 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.19 137.86 53.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.47 0.652 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.42 126.27 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.66 -23.64 34.97 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.294 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.3 t0 -59.78 133.98 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . 0.47 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 44.7 mm -91.82 130.11 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.99 145.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.222 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.428 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 71.0 m-85 -107.51 104.86 14.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.6 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.45 130.89 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -100.35 -38.21 8.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.832 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -161.37 156.15 23.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.479 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.33 111.12 20.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.026 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . 0.408 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 48.0 mm -63.34 -47.35 92.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.278 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -148.88 177.12 9.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.62 -25.3 68.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -123.96 11.42 8.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -137.91 145.26 41.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . 0.408 ' HA ' ' H ' ' A' ' 826' ' ' ILE . 29.4 p90 -140.76 165.5 27.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -127.61 139.06 52.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.398 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.13 -172.24 29.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -111.83 138.84 47.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.779 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.496 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.4 p-80 -141.71 133.74 27.57 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 52.83 29.69 8.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.13 5.78 89.86 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.012 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -115.92 150.11 37.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.5 p -114.4 141.99 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.01 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -171.01 -158.62 15.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . 0.44 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 49.4 pt -126.45 149.63 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.76 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . 0.597 ' N ' ' CD1' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -151.4 154.03 33.08 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.45 125.8 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.623 1.548 . . . . 0.0 111.825 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -56.98 -27.67 61.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.174 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.8 p -66.82 -12.84 60.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.255 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -96.36 -1.32 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' A' ' 847' ' ' ILE . 1.4 pp -140.45 169.11 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.439 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -130.42 120.26 23.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.2 115.79 4.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.897 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 44.62 77.22 0.46 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.89 161.09 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.653 2.236 . . . . 0.0 111.334 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.67 137.9 33.27 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.888 1.725 . . . . 0.0 112.033 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -101.19 48.88 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.525 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.5 -39.04 92.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.505 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 856' ' ' ALA . 63.1 mttp -61.75 -39.62 92.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 855' ' ' LYS . . . 77.34 -169.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.496 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . 0.414 ' N ' ' CD ' ' A' ' 858' ' ' PRO . 96.0 mt-30 47.79 55.96 17.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 857' ' ' GLN . 58.8 Cg_endo -71.21 153.48 62.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.894 2.396 . . . . 0.0 111.906 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -90.58 109.92 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -94.95 -0.17 54.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.361 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.64 144.14 49.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 149.32 44.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . 0.532 ' C ' ' H ' ' A' ' 865' ' ' GLN . 19.0 Cg_endo -62.02 -71.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.06 1.84 . . . . 0.0 112.228 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.4 t 67.51 -38.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . 0.532 ' H ' ' C ' ' A' ' 863' ' ' PRO . 20.1 pt20 -68.17 146.37 53.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.11 150.08 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.119 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.36 -12.54 19.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.48 -23.32 63.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -121.62 145.98 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.989 0.423 . . . . 0.0 111.364 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -84.32 179.47 51.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -135.04 147.17 49.56 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.503 0.192 . . . . 0.0 110.717 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -152.67 154.14 34.7 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 92.9 mt -124.74 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.754 0.312 . . . . 0.0 110.436 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.47 57.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.327 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -87.2 -29.67 21.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -137.94 145.48 42.07 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.708 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 877' ' ' ASN . 40.3 p-10 -51.34 122.14 7.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -117.05 125.86 51.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -119.81 105.6 11.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.301 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -65.26 137.97 38.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -102.89 1.14 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.9 p -130.5 163.09 27.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.01 -40.81 96.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 14.0 m -67.62 -25.36 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.572 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -97.42 136.39 37.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.185 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 886' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 915' ' ' GLN . 0.0 OUTLIER -107.24 168.05 9.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 41.5 t -118.44 136.16 53.95 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.942 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.92 162.05 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 891' ' ' GLY . 99.3 mtt180 -82.67 162.33 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.717 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 890' ' ' LYS . 10.6 pttt -73.09 42.36 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.267 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 889' ' ' ARG . . . -160.83 -0.38 0.07 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.069 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.68 143.18 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.795 0.798 . . . . 0.0 110.406 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -76.23 143.08 41.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.995 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 872' ' ' ALA . 92.0 mt -129.19 139.13 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.524 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.8 m -99.14 125.25 44.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.83 116.48 20.01 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.64 -46.07 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -166.18 164.61 17.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.984 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -103.91 118.41 36.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.413 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.4 t -65.26 -45.31 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.647 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -152.03 -125.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.769 0.318 . . . . 0.0 111.047 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.08 -25.11 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.339 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -135.47 18.93 3.35 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.599 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.51 146.95 51.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.733 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . 0.413 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 15.0 p90 -156.42 161.29 40.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.053 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.65 133.89 50.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.502 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -147.91 172.96 28.12 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.557 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -155.96 163.39 39.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.812 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 84.3 mt -94.01 139.26 22.55 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.96 141.52 36.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.214 1.112 . . . . 0.0 111.061 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.09 68.58 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.2 m 73.78 28.37 1.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 44.9 t -67.9 -50.14 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -135.19 148.07 49.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.082 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.488 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.6 tt0 -151.24 135.18 16.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.278 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 176.78 -174.89 47.37 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.0 pt -115.47 146.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.36 0.6 . . . . 0.0 111.456 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -161.75 158.82 22.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.677 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.05 140.43 45.34 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.489 2.126 . . . . 0.0 114.452 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.19 -32.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.269 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.7 m -57.62 -39.44 76.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.749 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.85 5.04 23.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.06 158.46 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.169 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -111.0 123.14 49.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.267 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 4.7 m -95.04 141.53 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.011 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.47 -37.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.265 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -136.49 136.29 39.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.523 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -78.8 148.72 73.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.718 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.2 -23.71 45.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.069 1.846 . . . . 0.0 112.169 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -106.65 12.7 29.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.519 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' MET . . . . . 0.511 ' O ' ' CB ' ' A' ' 791' ' ' SER . 66.2 mtt -127.91 154.28 45.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.677 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 790' ' ' MET . 3.7 p 86.85 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.69 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 83.3 1.31 90.38 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 794' ' ' GLU . 0.0 OUTLIER -178.5 -6.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.013 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 793' ' ' SER . 88.5 tt0 -62.16 -40.35 95.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm -49.02 136.28 14.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.637 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -135.6 148.89 67.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.452 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.57 116.31 4.45 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.942 1.762 . . . . 0.0 111.987 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -112.32 152.67 28.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -118.85 129.36 55.17 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.662 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.19 112.66 9.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.97 -35.43 78.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.121 0.486 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -137.81 162.63 33.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.668 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 803' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 31.1 t70 -73.71 138.31 44.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.412 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.03 119.02 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.07 0.462 . . . . 0.0 110.632 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -84.48 144.87 28.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -72.82 114.96 11.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.3 -39.92 89.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.449 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.9 p -134.29 162.26 32.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -34.1 14.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.61 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -61.0 -43.88 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.381 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -77.3 162.87 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.27 150.13 66.29 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.7 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.14 146.92 32.73 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.118 1.879 . . . . 0.0 111.997 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 814' ' ' LEU . . . . . 0.439 ' O ' ' OD1' ' A' ' 803' ' ' ASP . 13.0 mt -140.24 140.92 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.501 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -120.64 139.55 52.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.521 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -43.8 124.02 3.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.215 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.61 -19.44 53.59 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.09 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.8 136.0 57.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.936 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.88 134.31 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.81 157.96 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 821' ' ' TYR . . . . . 0.43 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 98.1 m-85 -115.12 111.14 20.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.475 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 822' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 822' ' ' ILE . 30.4 mm -79.73 96.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -85.29 -14.97 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.06 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 824' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.3 tttm -162.86 131.7 4.06 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.785 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 825' ' ' GLN . . . . . 0.679 HE21 ' N ' ' A' ' 827' ' ' ASP . 6.3 tm0? -85.12 127.46 34.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.31 -56.44 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.015 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 827' ' ' ASP . . . . . 0.679 ' N ' HE21 ' A' ' 825' ' ' GLN . 4.7 t70 -151.73 177.4 10.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.375 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.45 -23.72 67.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.377 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -111.74 -3.66 14.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.417 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -131.71 134.98 46.48 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.277 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.21 160.35 28.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.887 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 832' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 9.7 tt0 -136.31 135.94 39.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 833' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.25 -165.58 15.3 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -120.27 139.09 53.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.506 0.193 . . . . 0.0 110.898 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 835' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.4 p-80 -143.68 134.46 25.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 71.9 t60 50.21 31.95 5.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.71 3.27 90.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.919 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -109.65 155.68 21.18 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.2 t -124.21 135.01 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.08 -157.33 10.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 48.0 pt -131.42 154.13 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.226 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.53 148.9 14.45 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.83 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 126.11 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.303 1.335 . . . . 0.0 113.075 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -56.54 -28.04 59.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.76 -13.44 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -93.82 -0.79 55.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 847' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.61 167.08 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.9 126.71 27.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 12.1 tp -78.46 113.65 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.2 tp 51.97 73.49 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.37 117.3 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.466 2.111 . . . . 0.0 111.812 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 142.42 94.63 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.627 1.551 . . . . 0.0 112.159 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 853' ' ' ALA . . . . . 0.49 ' CB ' ' HZ1' ' A' ' 855' ' ' LYS . . . -66.07 146.07 55.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.047 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.56 79.25 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.721 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 855' ' ' LYS . . . . . 0.49 ' HZ1' ' CB ' ' A' ' 853' ' ' ALA . 38.8 mmtm -93.34 -4.0 52.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -103.03 129.03 49.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.489 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 46.5 64.91 7.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.648 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.56 141.45 83.14 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.374 2.05 . . . . 0.0 112.043 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.58 143.28 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -94.75 1.37 55.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.674 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.16 134.3 56.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 110.692 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 44.3 p -74.18 160.03 82.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.631 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 143.05 76.99 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.663 1.575 . . . . 0.0 112.638 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 864' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 866' ' ' VAL . 76.6 t -61.52 -44.31 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.463 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -57.06 88.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.537 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 864' ' ' VAL . 61.0 t -63.54 -43.42 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 867' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 868' ' ' GLU . 87.2 mt -59.78 -66.87 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.208 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 868' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 867' ' ' LEU . 14.8 mt-10 55.85 125.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.143 0.497 . . . . 0.0 111.338 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -71.85 145.53 48.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -71.15 156.07 52.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -116.82 151.52 36.34 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -152.82 146.98 25.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 7.5 mm -125.3 127.95 72.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.01 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.27 129.48 40.11 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 875' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -85.37 -31.98 22.65 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -137.0 146.01 44.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.173 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 877' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.0 p-10 -52.38 117.76 3.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -112.51 125.07 53.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.722 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -110.91 106.1 15.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -68.15 141.97 38.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -94.76 -9.43 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 60.9 p -134.15 163.27 29.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -61.58 -38.45 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.949 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.16 -41.8 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.084 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -87.37 104.73 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.64 146.07 50.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 97.7 p -107.85 151.82 25.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.932 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.1 OUTLIER -164.68 176.48 8.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.723 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -105.49 172.8 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.25 136.43 57.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.046 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 88.72 1.12 80.82 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.037 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.67 139.84 42.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.767 0.783 . . . . 0.0 109.949 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.39 141.39 35.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.099 0.476 . . . . 0.0 111.149 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.48 144.2 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.831 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.1 m -103.41 128.16 50.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.917 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.15 126.92 34.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.784 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.6 mt -108.73 -55.09 2.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -159.14 153.73 24.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.229 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -93.13 115.9 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.764 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 900' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 57.0 t -61.89 -47.46 93.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 901' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 88.5 m-20 -143.39 -102.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -130.83 -38.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.493 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -107.19 5.22 27.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.57 150.34 52.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.764 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -152.08 159.98 43.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.507 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.6 tt0 -103.12 133.91 47.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.499 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.72 30.35 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.167 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -149.8 157.34 43.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.957 0.408 . . . . 0.0 110.451 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 49.5 mm -80.06 141.12 54.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.83 139.62 24.58 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.972 1.114 . . . . 0.0 111.184 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 93.96 -8.08 73.31 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 1.7 p 67.71 28.35 7.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 111.129 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 96.0 p -63.78 -26.51 68.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.23 153.45 13.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' GLN . . . . . 0.507 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 46.2 tt0 -142.72 142.51 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.572 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.12 48.17 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' ILE . . . . . 0.519 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 43.9 pt -117.74 145.24 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -153.27 166.07 16.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.19 132.74 35.15 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 122.345 2.03 . . . . 0.0 114.425 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.79 -40.14 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.993 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' THR . . . . . 0.507 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 68.1 p -61.15 -25.46 67.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' TYR . . . . . 0.674 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -82.6 -2.09 52.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.541 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 922' ' ' TYR . 27.6 m -129.43 155.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.494 0.664 . . . . 0.0 112.229 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.081 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 78.3 t -90.71 99.46 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.273 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 926' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -64.62 -47.3 89.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -139.94 146.53 39.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.88 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.32 148.78 93.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.193 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.86 -23.56 54.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.119 1.879 . . . . 0.0 112.209 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.543 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.541 0.21 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.67 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 89.9 mtm180 -123.68 138.74 30.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.044 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 120.6 6.73 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.655 1.57 . . . . 0.0 112.688 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -113.58 146.01 40.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -108.3 132.55 53.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.362 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -73.21 112.32 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.6 -38.04 86.17 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 109.714 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -139.41 -177.97 5.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 56.0 p-10 -93.07 144.24 25.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.355 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -133.77 128.15 34.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.54 134.36 35.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -73.84 133.95 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -105.63 -26.43 11.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.2 p -130.63 169.73 15.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.3 mp -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.473 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.94 -40.43 95.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.509 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.0 mt-10 -79.85 131.73 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.312 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.46 151.37 44.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 813' ' ' PRO . . . . . 0.73 ' O ' HD12 ' A' ' 814' ' ' LEU . 57.3 Cg_endo -70.05 145.75 56.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.104 1.87 . . . . 0.0 113.036 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.832 HD21 HG11 ' A' ' 820' ' ' VAL . 1.6 mp -136.86 140.81 42.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.276 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -118.47 142.4 47.61 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.423 0.63 . . . . 0.0 110.809 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -48.71 122.97 6.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.639 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.23 54.49 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.72 128.81 37.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.62 135.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.832 HG11 HD21 ' A' ' 814' ' ' LEU . 31.1 m -131.32 152.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.44 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 87.1 m-85 -113.01 119.55 38.28 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 832' ' ' GLU . 22.5 mm -87.35 103.87 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -93.69 -7.23 44.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.657 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.24 132.61 2.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.147 0.499 . . . . 0.0 111.314 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -90.51 112.3 23.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.674 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.6 -49.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -159.47 178.16 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.23 -35.33 76.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.054 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -100.15 -6.1 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.883 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -130.35 135.01 47.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.317 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.428 ' HD2' HG21 ' A' ' 822' ' ' ILE . 4.5 m-85 -123.1 152.61 40.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.464 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 822' ' ' ILE . 13.9 tt0 -127.83 137.8 52.49 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.62 -175.33 28.43 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -110.86 138.72 46.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.106 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.1 p-80 -143.18 133.32 24.39 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 51.54 31.79 8.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.418 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.19 90.3 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.743 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -115.44 155.23 27.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.0 p -120.61 143.74 31.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.999 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.86 -168.74 31.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 17.7 pt -126.38 154.22 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.701 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -163.69 156.09 15.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.63 118.93 5.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.115 1.877 . . . . 0.0 112.751 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -47.68 -19.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.3 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 63.8 p -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -6.21 21.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.1 pt -132.17 169.76 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.706 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -122.83 106.76 11.18 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.089 0.471 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.67 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 59.2 tp -61.59 112.55 2.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.781 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.33 78.65 0.38 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.533 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.495 1.568 0 C-N-CA 122.675 2.25 . . . . 0.0 111.873 -179.625 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.57 149.98 41.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.707 0.289 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.59 155.95 27.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.38 133.62 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.71 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.1 133.99 56.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.969 0.414 . . . . 0.0 111.656 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -83.81 -25.61 30.24 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.28 146.61 38.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -52.93 139.93 26.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.412 ' CB ' ' CE1' ' A' ' 888' ' ' PHE . 26.6 t80 -131.88 130.86 42.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.909 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -131.72 89.9 2.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -74.47 171.02 53.39 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -133.92 12.82 3.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.615 0.245 . . . . 0.0 111.045 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 882' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 885' ' ' GLU . 82.8 p -130.73 159.01 38.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.742 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -62.55 -40.93 98.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.62 HG23 ' HG2' ' A' ' 885' ' ' GLU . 15.7 m -66.01 -26.3 38.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.528 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.2 mm-40 -103.45 120.79 41.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 8.0 mmt -93.24 172.26 8.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.543 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 93.0 p -121.87 148.91 44.12 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.109 0.48 . . . . 0.0 110.967 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.412 ' CE1' ' CB ' ' A' ' 878' ' ' PHE . 11.9 p90 -161.03 160.19 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.493 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 3.6 mtp-105 -95.06 170.25 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.198 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -73.49 52.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.122 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 176.22 16.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.966 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 889' ' ' ARG . 14.9 mp0 -97.33 149.62 21.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.438 0.619 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -84.59 148.85 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.046 0.45 . . . . 0.0 110.513 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 872' ' ' ALA . 93.7 mt -132.57 144.54 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.504 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.0 m -102.7 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.98 130.38 35.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.074 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.44 -54.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.111 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 898' ' ' ARG . . . . . 0.54 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 34.6 ptt-85 -166.05 165.04 18.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 899' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 901' ' ' ASP . 35.0 tt0 -99.92 120.27 39.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.761 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.411 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.1 t -62.23 -46.83 95.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.982 0.42 . . . . 0.0 111.094 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 899' ' ' GLN . 12.9 t70 -144.79 -95.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.011 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 98.7 mt-10 -132.49 -45.54 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.698 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.31 8.13 35.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -131.58 148.64 52.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.593 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.669 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.1 p90 -154.87 161.86 41.3 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.66 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.54 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 88.2 tt0 -109.61 137.84 46.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.33 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.71 172.11 31.81 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -149.99 156.31 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.339 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 914' ' ' ARG . 87.6 mt -77.4 139.55 64.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.37 137.93 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.103 1.202 . . . . 0.0 111.122 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.73 -10.35 66.46 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 69.33 25.69 5.51 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 89.6 p -67.25 -38.99 86.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.518 ' HB2' HD12 ' A' ' 909' ' ' ILE . 99.7 mtt180 -139.46 150.27 44.99 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.264 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -145.56 142.68 29.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.257 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -179.34 -179.62 48.76 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.397 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -119.87 150.91 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.943 0.401 . . . . 0.0 111.121 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -163.63 160.89 17.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.38 139.49 49.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.14 1.893 . . . . 0.0 113.124 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.75 -38.96 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.028 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 69.2 p -57.85 -11.3 2.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.576 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.95 0.66 32.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.669 HG11 ' OH ' ' A' ' 905' ' ' TYR . 10.7 m -132.99 158.25 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 111.194 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.97 131.71 56.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.692 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.4 -45.79 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.599 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.71 121.75 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.895 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 . . . . . 0 CA--C 1.532 0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.139 179.607 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 795' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.635 0.255 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -132.77 95.72 19.25 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.77 140.45 93.37 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.04 1.827 . . . . 0.0 112.099 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -133.54 154.2 51.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -116.4 135.04 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.774 0.321 . . . . 0.0 110.646 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -79.18 127.06 31.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.869 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.23 -14.97 20.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.207 0.527 . . . . 0.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -151.84 167.31 28.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.6 p-10 -91.49 133.89 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.63 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -127.71 128.66 45.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -93.27 135.68 34.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.62 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.566 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -100.37 -22.67 14.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.993 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 808' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 809' ' ' LEU . 87.5 m -128.05 162.81 25.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.34 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.541 ' N ' HG22 ' A' ' 808' ' ' THR . 60.7 tp -58.27 -42.84 87.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.106 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.3 -39.35 90.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.195 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.79 149.12 48.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.821 ' O ' HD12 ' A' ' 812' ' ' LEU . 2.2 pp -125.79 151.22 70.67 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 813' ' ' PRO . . . . . 0.509 ' O ' ' NE2' ' A' ' 835' ' ' HIS . 74.5 Cg_endo -74.45 141.32 28.22 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.667 1.578 . . . . 0.0 112.102 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.16 148.76 52.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.061 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -120.18 135.26 55.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.339 0.59 . . . . 0.0 109.936 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 816' ' ' LYS . . . . . 0.494 ' HB3' ' HZ2' ' A' ' 816' ' ' LYS . 0.0 OUTLIER -43.38 124.39 3.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.176 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.64 -21.02 48.04 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.675 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.56 134.78 51.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 29.1 mm -93.58 129.57 43.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.156 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 798' ' ' ALA . 29.9 m -124.53 153.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 88.6 m-85 -113.6 121.62 44.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 832' ' ' GLU . 70.1 mt -91.23 129.3 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -109.46 -16.15 14.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -168.42 142.47 3.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 111.46 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 825' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 827' ' ' ASP . 52.4 tt0 -85.33 136.5 33.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.142 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.4 -50.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 109.876 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.406 ' C ' HE21 ' A' ' 825' ' ' GLN . 7.0 t0 -149.61 179.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.925 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.46 -36.37 80.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.908 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -104.58 -1.51 26.4 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -126.96 139.34 53.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.359 0.599 . . . . 0.0 111.609 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.535 ' HD2' HD13 ' A' ' 822' ' ' ILE . 12.7 m-85 -125.6 156.92 38.39 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.584 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 822' ' ' ILE . 1.6 tp10 -124.43 139.9 53.45 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -168.75 -173.21 36.34 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -116.78 150.59 38.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 813' ' ' PRO . 0.5 OUTLIER -155.88 134.51 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.521 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.9 t-80 51.22 31.83 7.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.77 80.05 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 838' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 839' ' ' VAL . 44.0 tpt85 -121.09 135.09 55.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 838' ' ' ARG . 99.6 t -112.65 129.23 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.496 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.793 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.96 -154.56 8.5 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.09 160.83 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 117.062 0.431 . . . . 0.0 110.877 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -160.8 152.8 16.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 845' ' ' THR . 60.6 Cg_endo -73.75 121.67 7.2 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.077 1.852 . . . . 0.0 112.623 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 844' ' ' ARG . . . . . 0.408 ' NE ' ' CE1' ' A' ' 831' ' ' TYR . 3.4 ttm180 -50.56 -10.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.519 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 843' ' ' PRO . 62.6 p -80.51 -10.85 59.73 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.474 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -102.9 -3.98 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.666 0.269 . . . . 0.0 111.231 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 800' ' ' ALA . 42.6 pt -136.21 173.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.544 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 80.2 tt0 -114.66 161.48 18.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.72 103.98 12.29 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.8 tp 53.38 77.91 0.42 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.688 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 C-N-CA 122.132 1.888 . . . . 0.0 111.879 -179.471 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.29 160.98 31.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.441 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -155.28 150.24 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.94 123.07 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.297 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.06 117.06 6.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -69.57 -35.27 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.498 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -130.27 142.22 50.56 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.887 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -47.85 134.24 13.43 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 888' ' ' PHE . 66.9 t80 -124.62 134.33 52.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.426 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -128.71 100.51 5.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.73 155.39 52.87 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 881' ' ' ASP . . . . . 0.798 ' OD1' HG23 ' A' ' 882' ' ' THR . 58.3 p30 -116.78 -0.29 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.11 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 882' ' ' THR . . . . . 0.798 HG23 ' OD1' ' A' ' 881' ' ' ASP . 70.6 p -127.29 158.02 38.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -65.24 -32.38 74.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.919 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 885' ' ' GLU . 12.4 m -70.66 -26.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.052 0.453 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.466 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.7 mt-10 -98.37 113.5 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.944 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.723 ' SD ' HD13 ' A' ' 909' ' ' ILE . 28.0 ttt -84.23 135.77 34.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 90.3 p -82.84 153.87 24.95 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.082 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 878' ' ' PHE . 16.9 p90 -161.9 161.02 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -100.07 160.52 14.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.569 0.7 . . . . 0.0 112.754 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -58.4 130.24 45.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.24 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.15 1.64 89.53 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -72.17 139.7 48.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.24 141.9 30.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 86.7 mt -132.85 147.96 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.8 m -99.61 129.62 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.54 119.38 25.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.906 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.36 -53.14 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.12 165.68 17.57 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.814 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -98.27 112.82 24.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.454 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.423 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 10.2 p -81.27 -24.6 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.858 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -155.84 174.55 15.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.535 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.17 -32.18 73.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.052 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -113.95 2.06 14.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -134.02 151.88 51.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.478 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.423 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 31.8 p90 -150.94 158.33 44.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.034 0.445 . . . . 0.0 110.429 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.1 135.9 41.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.292 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.05 178.21 29.43 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -147.41 157.66 43.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.494 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.723 HD13 ' SD ' ' A' ' 886' ' ' MET . 1.5 mp -78.89 135.45 59.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.578 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -45.94 137.81 12.68 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 120.898 1.065 . . . . 0.0 111.377 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.59 62.22 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.92 34.7 1.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.61 0.243 . . . . 0.0 111.084 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.3 t -61.29 -46.49 90.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.638 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -171.34 149.39 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.54 144.44 37.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -164.8 170.51 39.91 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.2 pt -116.33 147.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.154 0.502 . . . . 0.0 111.224 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.0 159.59 29.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.16 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.2 137.64 29.07 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.473 2.116 . . . . 0.0 113.919 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 923' ' ' VAL . 88.3 mt -61.31 -35.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.488 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 96.4 m -53.92 -42.8 69.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.218 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.7 -0.22 33.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.308 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.441 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.9 t -125.18 147.89 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.14 0.495 . . . . 0.0 110.674 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.8 121.28 41.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.202 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.11 116.95 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.385 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.23 -47.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.84 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.93 133.24 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 . . . . . 0 CA--C 1.535 0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.349 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 31.5 mmm . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -128.89 98.55 24.09 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 119.553 -0.261 . . . . 0.0 110.89 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.92 138.69 26.25 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.419 1.413 . . . . 0.0 112.244 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.04 47.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 799' ' ' ARG . . . . . 0.438 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 75.2 ttt180 -104.89 137.22 43.0 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.296 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.668 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -82.52 121.22 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -95.19 -12.86 25.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.159 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 802' ' ' PHE . . . . . 0.402 ' HB2' ' CD2' ' A' ' 846' ' ' TYR . 97.6 m-85 -136.42 141.79 43.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.53 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 58.3 p-10 -68.52 150.04 48.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 804' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 814' ' ' LEU . 90.2 t80 -147.64 128.67 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.28 130.63 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -63.35 132.3 51.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.419 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.69 -32.93 10.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.18 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 808' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 810' ' ' LYS . 92.4 m -128.96 138.16 51.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.505 ' CD1' HH21 ' A' ' 838' ' ' ARG . 0.8 OUTLIER -36.7 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.894 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 810' ' ' LYS . . . . . 0.499 ' H ' HG22 ' A' ' 808' ' ' THR . 87.9 tttt -60.96 -48.43 81.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 808' ' ' THR . 3.2 mt-10 -72.79 165.56 24.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 110.621 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 812' ' ' LEU . 0.5 OUTLIER -132.73 155.38 81.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 146.81 61.6 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.927 1.751 . . . . 0.0 111.542 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.843 HD11 HG11 ' A' ' 820' ' ' VAL . 2.6 tp -140.75 132.4 27.21 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 815' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 35.3 tp60 -96.36 147.54 23.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 110.808 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -64.01 36.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 176.17 19.16 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.111 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.54 168.91 10.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.515 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.432 ' O ' ' ND1' ' A' ' 835' ' ' HIS . 35.8 mm -108.76 136.16 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 814' ' ' LEU . 25.7 m -129.95 151.47 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.9 115.73 26.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 94.2 mt -74.92 134.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 823' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 823' ' ' TYR . 1.8 p90 -128.7 -5.24 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.264 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -170.32 125.31 0.75 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.5 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -80.32 125.85 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.5 mm -78.49 -52.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.12 175.92 9.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.906 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -60.1 -18.48 47.38 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.28 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.01 -52.25 2.7 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.043 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 830' ' ' TRP . . . . . 0.414 ' HE1' ' HG3' ' A' ' 843' ' ' PRO . 23.2 m-90 -70.52 151.35 45.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 849' ' ' LEU . 62.8 m-85 -131.01 148.62 52.77 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.21 135.2 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -153.47 -177.59 27.14 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -110.48 141.38 43.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.949 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.664 ' HB2' HG12 ' A' ' 820' ' ' VAL . 81.6 t60 -164.49 135.54 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.928 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.8 t-80 62.92 31.5 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.236 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.46 18.71 78.54 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 838' ' ' ARG . . . . . 0.505 HH21 ' CD1' ' A' ' 809' ' ' LEU . 12.2 tpt180 -136.5 154.55 50.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.33 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 833' ' ' GLY . 13.8 p -129.0 141.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.38 -140.55 2.96 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.25 152.84 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.793 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 847' ' ' ILE . 3.5 p90 -156.92 127.91 3.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.61 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.414 ' HG3' ' HE1' ' A' ' 830' ' ' TRP . 50.1 Cg_exo -54.62 137.6 73.86 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.446 1.431 . . . . 0.0 111.994 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.51 -29.24 68.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.643 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 79.1 p -69.83 -15.66 63.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.392 . . . . 0.0 110.83 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 846' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 802' ' ' PHE . 0.6 OUTLIER -93.35 -2.24 55.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.76 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 800' ' ' ALA . 29.8 pt -137.4 173.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.237 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 851' ' ' PRO . 11.3 tm-20 -124.14 106.32 10.24 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 831' ' ' TYR . 17.9 mt -59.95 113.78 2.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.94 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.5 mt 46.5 82.18 0.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.084 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 851' ' ' PRO . . . . . 0.529 ' N ' ' OE1' ' A' ' 848' ' ' GLU . 73.0 Cg_endo . . . . . 0 N--CA 1.492 1.382 0 C-N-CA 122.185 1.923 . . . . 0.0 112.015 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.35 153.84 41.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.85 146.56 22.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 38.9 mm -117.08 121.91 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.47 125.92 25.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.479 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -72.61 -36.96 68.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.978 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.94 151.04 52.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.773 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -55.25 145.85 20.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -150.9 135.96 17.54 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.25 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -133.43 116.26 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.482 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.0 145.47 33.66 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.98 -2.22 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.739 0.304 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 58.8 p -133.6 163.83 28.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -61.31 -39.19 89.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.177 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.21 -43.67 93.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.629 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.454 ' O ' ' NH2' ' A' ' 914' ' ' ARG . 80.2 mm-40 -76.41 144.87 39.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.808 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 17.6 ttm -98.5 152.08 19.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.43 ' H ' ' HD3' ' A' ' 914' ' ' ARG . 34.6 t -121.25 127.9 51.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.46 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.26 161.79 42.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.1 mtm-85 -102.68 165.37 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.7 138.15 58.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.52 0.15 89.3 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.007 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 78.9 mm-40 -81.01 147.12 30.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.105 0.452 . . . . 0.0 110.253 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -95.35 132.47 40.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.1 0.476 . . . . 0.0 111.041 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 147.21 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.973 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.2 m -98.44 127.79 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.098 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 23.7 mt -92.25 126.51 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.727 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.0 mt -105.56 -48.47 3.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.545 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -160.53 154.34 22.61 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.166 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 899' ' ' GLN . . . . . 0.53 ' OE1' ' CD2' ' A' ' 905' ' ' TYR . 2.0 mp0 -89.94 113.91 25.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.773 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 917' ' ' ILE . 62.2 t -65.1 -39.91 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -156.11 -176.71 6.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.314 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.94 -37.24 86.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 903' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 920' ' ' ILE . 12.8 t-20 -102.83 -4.29 25.09 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -112.55 151.96 29.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 111.666 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.53 ' CD2' ' OE1' ' A' ' 899' ' ' GLN . 1.5 m-85 -140.5 137.04 33.53 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -104.86 135.61 45.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.85 -178.94 32.36 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.587 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.521 ' NH2' ' OG1' ' A' ' 912' ' ' THR . 17.3 ptm180 -148.22 158.02 43.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.507 -0.346 . . . . 0.0 110.364 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 79.2 mt -93.89 138.73 22.63 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.13 141.08 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.366 1.377 . . . . 0.0 111.807 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.64 76.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.521 ' OG1' ' NH2' ' A' ' 908' ' ' ARG . 1.4 m 68.83 32.96 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.637 0.256 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.3 m -62.33 -42.48 99.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' A' ' 885' ' ' GLU . 77.6 ttt180 -166.69 144.65 5.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -127.55 142.83 51.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 177.56 -173.77 46.39 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 900' ' ' VAL . 39.6 pt -111.69 155.4 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.496 . . . . 0.0 111.117 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -156.35 151.21 20.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.13 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 144.57 51.66 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.223 1.948 . . . . 0.0 113.68 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 903' ' ' ASN . 87.5 mt -60.53 -37.52 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.37 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.479 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -56.06 -39.54 72.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.07 -1.1 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.22 159.62 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.67 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -108.75 127.24 53.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.186 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 75.9 t -101.47 101.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -65.55 -45.77 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -135.83 150.58 49.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.958 179.567 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.615 0.245 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -130.81 94.34 28.95 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.373 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.27 138.29 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.989 1.793 . . . . 0.0 111.786 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -130.38 153.3 48.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.83 135.62 54.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.272 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 814' ' ' LEU . . . -76.57 111.37 11.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -35.28 79.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.068 0.461 . . . . 0.0 109.79 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -144.12 175.35 10.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.538 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 65.2 t0 -78.56 120.51 23.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.48 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -115.05 123.63 49.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.66 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.9 142.11 28.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.384 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -69.65 140.58 53.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.302 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -109.39 -31.74 7.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.05 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 63.7 p -129.41 171.01 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.376 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.81 -41.72 96.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.41 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.95 -38.35 90.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.395 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.563 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 31.9 tt0 -80.17 122.98 27.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.1 mp -107.19 154.37 40.52 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.446 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.17 146.82 71.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.904 1.736 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -125.91 153.18 44.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -126.73 138.34 53.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.57 0.7 . . . . 0.0 110.926 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.09 125.42 10.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.277 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.65 -28.74 14.53 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.489 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 66.8 t0 -57.67 135.2 56.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.007 0.432 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 38.7 mm -99.15 133.51 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 798' ' ' ALA . 22.1 m -125.09 151.12 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.055 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 76.9 m-85 -109.28 113.7 26.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 96.5 mt -82.03 130.95 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -104.51 -38.46 6.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.793 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -156.14 155.16 32.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 825' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 16.3 tt0 -82.84 130.73 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.553 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 7.5 mm -81.38 -46.23 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 109.63 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 3.5 t70 -148.11 178.77 8.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.046 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.43 -36.09 79.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -109.57 11.75 24.67 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -132.51 143.0 49.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -125.01 150.96 46.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.302 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.28 141.22 51.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -165.94 -175.14 36.11 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.31 140.7 36.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.037 0.446 . . . . 0.0 110.748 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 835' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -151.47 141.99 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 50.1 t-80 48.24 31.36 2.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.93 16.23 80.81 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.818 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -132.88 157.46 45.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.66 0.267 . . . . 0.0 111.065 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.12 129.17 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.087 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -154.78 -156.12 7.58 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.447 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.7 pp -124.54 154.73 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 117.347 0.573 . . . . 0.0 110.173 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 814' ' ' LEU . 3.8 m-85 -148.4 126.61 5.93 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.748 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.64 125.39 16.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.073 1.182 . . . . 0.0 111.81 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -54.6 -20.32 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.56 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.8 p -77.06 -12.55 59.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.95 -3.92 24.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.247 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.9 pt -136.03 171.97 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.559 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 86.9 tt0 -114.23 160.51 18.94 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 18.4 mt -108.84 100.52 9.72 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 53.8 tp 49.03 79.07 0.36 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.86 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 N--CA 1.496 1.64 0 C-N-CA 122.623 2.215 . . . . 0.0 111.443 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -127.92 155.39 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 110.502 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -160.82 146.64 14.71 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.4 130.49 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.006 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 874' ' ' ALA . . . . . 0.701 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -53.45 125.32 17.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.867 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.5 -40.91 73.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.431 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 876' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 877' ' ' ASN . 0.1 OUTLIER -145.09 148.86 34.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.64 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 98.7 m-20 -41.72 132.46 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.292 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 878' ' ' PHE . 46.4 t80 -134.57 131.13 37.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.43 117.84 26.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -84.43 -179.58 51.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 881' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 882' ' ' THR . 24.5 p30 -130.81 -40.18 1.21 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 882' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 881' ' ' ASP . 65.3 p -86.32 163.46 17.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -64.97 -34.39 78.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 110.149 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.18 -41.04 91.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 45.1 tp10 -81.38 130.97 35.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.152 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 14.6 mmt -101.33 164.66 11.67 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.423 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 35.5 t -127.23 146.18 50.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.198 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.47 177.8 7.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.165 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -113.15 163.57 14.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.291 0.567 . . . . 0.0 111.503 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.55 139.88 52.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.811 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.39 -8.23 77.39 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -75.89 138.46 41.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.244 0.522 . . . . 0.0 110.285 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -81.46 143.33 32.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.116 0.484 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 872' ' ' ALA . 88.7 mt -130.29 138.32 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.685 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.5 m -97.35 128.87 44.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.783 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.12 119.83 27.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.644 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 908' ' ' ARG . 90.2 mt -99.23 -49.98 4.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -167.0 165.16 15.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.147 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.41 115.71 29.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.4 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 32.7 m -82.34 -25.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -159.77 173.75 15.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.83 -38.58 88.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -106.28 3.06 27.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -133.4 151.25 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.876 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.4 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 28.1 p90 -150.97 158.61 44.35 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.002 0.43 . . . . 0.0 110.581 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.528 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.4 tt0 -99.13 133.29 43.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.719 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.74 173.84 29.39 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.517 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.417 ' HD3' HD11 ' A' ' 897' ' ' LEU . 40.5 ptt180 -154.31 160.59 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.097 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.503 ' CD1' ' NH2' ' A' ' 914' ' ' ARG . 84.5 mt -74.54 138.83 74.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -47.99 -14.03 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.395 1.397 . . . . 0.0 112.456 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -87.09 0.33 85.93 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.465 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 30.6 p 54.63 8.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 911' ' ' GLY . 89.5 p -71.88 -30.42 65.39 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.503 ' NH2' ' CD1' ' A' ' 909' ' ' ILE . 96.4 mtm-85 -139.47 149.75 44.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.853 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 915' ' ' GLN . . . . . 0.528 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 66.4 tt0 -147.96 140.91 24.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.507 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.38 -178.19 47.6 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.504 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 46.3 pt -114.8 146.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -156.87 159.78 31.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.62 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 137.96 35.08 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.502 2.135 . . . . 0.0 114.21 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.06 -36.69 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.835 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.0 m -57.52 -44.69 85.29 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 922' ' ' TYR . . . . . 0.697 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -70.82 0.66 6.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.057 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.3 m -130.48 156.96 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.481 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -107.1 127.24 53.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.168 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.69 119.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.256 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 30.2 mm -91.36 -48.01 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.627 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.05 146.86 50.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.405 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.826 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 78.0 mtp180 -135.97 131.35 18.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.43 146.07 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 111.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.499 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -148.11 157.3 43.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 799' ' ' ARG . . . . . 0.465 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 73.8 ttt180 -122.96 131.15 53.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.611 ' CB ' HD12 ' A' ' 814' ' ' LEU . . . -76.57 123.13 25.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -94.06 -16.05 24.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.262 0.553 . . . . 0.0 110.046 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -135.4 139.7 44.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.517 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.3 p30 -73.88 154.73 39.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.491 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 114.92 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -79.04 130.98 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.52 131.02 39.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.74 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -108.39 -26.4 10.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.25 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.3 p -134.74 170.34 15.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.941 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.7 mp -61.12 -37.43 82.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 810' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 98.3 mttt -60.23 -38.79 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.01 148.18 22.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.246 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.3 pt? -125.23 156.33 69.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 813' ' ' PRO . . . . . 0.555 ' O ' HD22 ' A' ' 814' ' ' LEU . 50.6 Cg_endo -70.44 141.53 42.7 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.319 1.346 . . . . 0.0 112.155 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.611 HD12 ' CB ' ' A' ' 800' ' ' ALA . 0.3 OUTLIER -141.05 143.18 34.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.719 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 815' ' ' GLN . . . . . 0.598 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 62.4 tt0 -103.95 143.03 33.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.341 0.591 . . . . 0.0 110.322 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -61.06 37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.444 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 173.16 21.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 835' ' ' HIS . 3.7 m-20 -97.28 161.21 13.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.5 130.4 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 2.1 p -129.63 136.88 58.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.179 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.7 m-85 -95.86 121.1 37.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.943 0.402 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 831' ' ' TYR . 71.7 mt -87.1 136.26 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -98.74 -39.35 8.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.745 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 824' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 26.0 pttm -159.25 155.98 27.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.046 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.6 118.93 23.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.53 -46.65 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.32 179.38 8.17 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.33 -38.41 83.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.629 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -111.66 13.54 21.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.803 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -131.59 143.59 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 112.091 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 822' ' ' ILE . 35.1 m-85 -134.02 152.2 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.707 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 4.2 tt0 -123.1 134.71 54.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.39 178.5 36.4 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -107.91 148.83 29.09 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 111.033 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.542 ' NE2' ' OD2' ' A' ' 818' ' ' ASP . 83.5 t60 -169.69 137.47 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.088 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 18.6 t60 58.53 32.94 22.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.305 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.83 16.58 79.28 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -132.7 154.88 49.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.115 0.483 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.6 134.9 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -160.69 -140.91 2.99 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.4 pt -135.46 154.3 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.71 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.418 ' CD2' HG21 ' A' ' 847' ' ' ILE . 9.2 p90 -157.99 150.68 18.08 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 143.8 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.148 1.898 . . . . 0.0 113.459 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.47 -35.56 72.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.065 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 76.3 p -63.22 -16.06 59.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.121 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -94.66 -2.66 50.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.407 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.499 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.3 pp -142.13 165.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.738 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.98 118.0 22.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.826 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 60.0 tp -69.81 113.98 7.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.368 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 29.4 tp 56.75 73.96 0.74 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.494 1.508 0 C-N-CA 121.947 1.764 . . . . 0.0 111.719 -179.222 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 871' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 871' ' ' GLU . 48.2 mp0 -134.92 146.48 49.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.482 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -147.62 149.88 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 873' ' ' ILE . . . . . 0.421 ' C ' HG13 ' A' ' 923' ' ' VAL . 91.5 mt -123.6 126.38 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 111.255 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.75 113.96 1.87 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -63.64 -37.02 85.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -129.53 148.13 51.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.323 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -56.81 125.2 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -115.19 128.43 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.563 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.95 109.77 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.474 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 880' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -75.32 145.24 32.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -103.09 -21.57 13.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.831 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.3 p -112.63 159.29 19.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -64.12 -31.26 72.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.343 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 884' ' ' VAL . 8.7 m -71.41 -24.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.435 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.91 111.55 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.174 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.57 159.35 29.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 99.3 p -123.9 153.27 41.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.935 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.18 176.44 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -104.16 150.16 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.14 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -46.68 133.1 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 97.46 -9.05 64.59 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.068 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.0 131.04 45.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -76.52 138.07 40.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.71 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 93.7 mt -130.59 144.95 36.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.754 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.0 m -102.03 125.72 48.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 925' ' ' VAL . 86.7 mt -79.81 87.37 5.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 908' ' ' ARG . 92.8 mt -64.06 -44.6 91.95 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.819 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -168.56 162.42 12.03 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.664 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.26 109.6 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.42 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.5 p -74.99 -27.16 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.065 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -158.81 174.89 14.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.32 -36.79 83.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.122 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -109.44 1.84 20.17 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -130.56 148.64 52.38 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.461 ' CE1' ' O ' ' A' ' 918' ' ' PHE . 28.2 p90 -151.08 156.88 41.98 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.737 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -104.37 130.62 52.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -146.99 178.22 24.77 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.835 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.693 ' HG2' HD11 ' A' ' 897' ' ' LEU . 0.3 OUTLIER -149.98 161.26 42.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.991 -0.605 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 911' ' ' GLY . 78.7 mt -74.97 137.28 72.9 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.24 -11.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.297 1.332 . . . . 0.0 112.16 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 909' ' ' ILE . . . -80.91 -4.23 90.48 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.399 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 20.1 p 50.83 34.97 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.349 0.119 . . . . 0.0 111.145 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.3 m -111.61 -26.56 8.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.705 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.65 152.52 51.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -149.57 145.98 27.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.177 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.23 -179.31 47.49 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.349 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.6 pt -112.16 140.99 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.5 145.11 17.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.062 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.93 142.74 47.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.95 1.766 . . . . 0.0 112.736 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.9 mt -69.9 -8.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.581 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.9 m -59.87 -44.47 94.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 922' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 923' ' ' VAL . 8.6 p90 -97.7 8.48 44.61 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.855 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.482 HG12 ' HB1' ' A' ' 872' ' ' ALA . 11.2 t -122.82 145.2 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 120.85 0.357 . . . . 0.0 110.226 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.85 115.36 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.076 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 896' ' ' LEU . 97.0 t -84.09 106.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.717 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.33 -46.22 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.486 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 927' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 926' ' ' ILE . 67.4 mttm -141.22 149.85 41.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.105 179.299 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 C--O 1.23 0.035 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -127.94 143.09 46.51 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 147.72 34.44 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.896 1.731 . . . . 0.0 112.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -135.47 155.16 50.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -121.89 133.67 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.408 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.484 ' HB2' HD22 ' A' ' 814' ' ' LEU . . . -84.2 121.58 27.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -74.43 -29.56 61.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.976 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.28 173.09 11.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.197 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.9 p-10 -89.33 135.69 33.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.14 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -127.08 133.26 50.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.327 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -92.99 139.29 30.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 811' ' ' GLU . . . -75.43 120.61 21.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -65.95 -41.47 91.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 808' ' ' THR . . . . . 0.485 ' H ' ' HG2' ' A' ' 811' ' ' GLU . 72.1 p -136.96 166.21 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.928 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -50.88 -33.34 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.28 -39.79 91.7 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.461 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 808' ' ' THR . 0.2 OUTLIER -75.28 172.54 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.458 HD12 ' HD2' ' A' ' 813' ' ' PRO . 12.0 tp -135.7 134.11 20.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 813' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 812' ' ' LEU . 57.8 Cg_endo -70.93 145.54 50.67 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.106 1.204 . . . . 0.0 111.467 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 820' ' ' VAL . 0.7 OUTLIER -126.31 144.55 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.92 139.78 51.09 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.261 0.553 . . . . 0.0 110.252 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.08 122.06 7.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.813 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.76 38.4 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.308 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.532 ' OD2' ' CE1' ' A' ' 835' ' ' HIS . 35.8 t70 -62.77 140.57 58.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.11 132.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.5 m -123.27 154.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.235 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.441 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 90.7 m-85 -114.07 121.71 44.67 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 822' ' ' ILE . 3.4 mm -85.6 127.07 40.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.474 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 823' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.3 p90 -120.91 -5.93 9.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.071 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -173.38 129.13 0.44 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.212 0.53 . . . . 0.0 111.478 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -80.66 135.79 36.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.33 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.403 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.2 mm -87.49 -52.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.361 . . . . 0.0 110.284 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -150.51 179.2 8.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 828' ' ' GLN . . . . . 0.52 ' O ' ' NE ' ' A' ' 844' ' ' ARG . 19.9 mp0 -60.77 -37.56 82.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 4.0 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.81 142.0 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.354 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.646 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 31.3 p90 -136.26 165.59 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.229 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -133.36 140.35 47.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.504 ' O ' HG13 ' A' ' 839' ' ' VAL . . . -158.44 -179.29 33.2 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 834' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 821' ' ' TYR . 88.5 tt0 -106.63 144.87 32.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 111.442 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.685 ' HB2' HG12 ' A' ' 820' ' ' VAL . 6.5 t60 -168.52 140.85 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.214 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.24 19.97 11.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 82.47 1.41 90.46 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.779 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.43 164.21 20.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.103 0.452 . . . . 0.0 110.262 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 833' ' ' GLY . 57.3 t -122.63 132.59 70.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.123 0.487 . . . . 0.0 111.211 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -143.24 -155.25 6.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.459 ' CG1' ' OE2' ' A' ' 811' ' ' GLU . 1.4 pp -134.32 155.12 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.088 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -166.1 160.17 12.72 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.85 121.85 8.28 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.75 2.3 . . . . 0.0 112.734 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 844' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 828' ' ' GLN . 48.3 ptt85 -56.4 -22.03 28.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.031 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.07 -8.21 47.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.13 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.43 -0.39 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.625 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 11.7 pt -138.73 174.55 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 52.7 mt-10 -113.38 157.51 21.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.2 100.14 7.93 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.027 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.0 tt 49.51 61.72 13.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.306 -1.705 0 C-N-CA 122.49 2.127 . . . . 0.0 112.153 -179.424 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -118.22 148.83 42.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -155.08 147.69 24.24 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.432 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.21 131.66 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.518 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.46 135.16 57.2 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.085 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.453 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 55.5 mtmt -87.08 -23.03 25.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.855 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -142.5 144.26 32.9 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -49.36 152.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -143.1 130.8 21.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.33 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -128.44 97.28 4.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.721 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.44 178.14 52.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -131.05 -1.88 4.06 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.213 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 47.6 p -129.58 158.88 38.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -62.82 -27.37 69.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.975 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 885' ' ' GLU . 18.3 m -68.14 -20.65 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.3 mt-10 -108.75 131.48 54.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.132 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 13.5 tpt -109.18 129.78 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.7 p -76.35 158.27 31.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.553 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 12.9 p90 -168.31 166.08 12.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.971 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 891' ' ' GLY . 29.6 mmm-85 -103.67 163.55 12.24 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 890' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 53.5 tttp -67.09 58.17 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 891' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . 172.84 12.8 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.829 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 888' ' ' PHE . 96.8 mt-10 -94.1 151.99 19.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.612 0.706 . . . . 0.0 109.736 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.46 146.75 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.5 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.5 mt -133.02 145.59 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.821 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.9 m -102.35 124.67 48.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.633 HD11 HG13 ' A' ' 925' ' ' VAL . 88.7 mt -82.63 130.72 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.429 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.44 -58.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -163.56 164.66 24.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -99.1 115.37 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.579 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.427 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.2 p -81.45 -27.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.734 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 1.6 t70 -156.13 172.53 18.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.973 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.426 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 60.7 mp0 -63.51 -28.84 70.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 903' ' ' ASN . . . . . 0.624 ' ND2' ' NE1' ' A' ' 904' ' ' TRP . 16.6 p-10 -117.95 4.05 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 904' ' ' TRP . . . . . 0.624 ' NE1' ' ND2' ' A' ' 903' ' ' ASN . 91.7 m95 -132.32 150.23 52.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.677 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.489 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.7 p90 -152.97 159.15 42.9 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.7 tt0 -102.39 132.68 48.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.179 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -151.45 169.94 31.02 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -148.47 155.79 41.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.038 0.447 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.27 139.89 87.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.85 138.99 20.13 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.937 1.092 . . . . 0.0 111.113 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.564 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.72 -9.65 70.93 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.78 33.22 2.98 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.651 0.262 . . . . 0.0 111.031 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.4 t -60.23 -45.46 93.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -163.36 139.66 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.791 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 915' ' ' GLN . . . . . 0.546 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 26.0 tt0 -103.78 149.82 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.059 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -166.54 169.48 40.62 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.358 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 906' ' ' GLU . 46.4 pt -123.14 147.17 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.861 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -159.17 166.17 16.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.301 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.62 137.8 61.13 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.836 1.691 . . . . 0.0 113.487 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.29 -42.22 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.282 0.563 . . . . 0.0 110.42 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.0 m -57.77 -16.97 12.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.33 2.01 54.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.881 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.489 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.2 m -138.86 164.09 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.179 0.514 . . . . 0.0 110.663 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 924' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 67.9 t0 -115.04 132.82 56.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 896' ' ' LEU . 99.5 t -104.09 99.86 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.538 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.671 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.54 -46.34 95.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 927' ' ' LYS . . . . . 0.409 ' HG3' HG22 ' A' ' 926' ' ' ILE . 46.8 mtmt -138.13 131.95 31.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 CA--C 1.532 0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.72 148.37 69.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.436 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.82 145.83 25.82 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.098 1.866 . . . . 0.0 111.798 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.516 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -140.83 155.59 46.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 78.2 ttt180 -117.99 132.29 56.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -71.28 117.9 13.4 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.942 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -38.57 86.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.31 0.576 . . . . 0.0 109.466 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -141.83 174.56 10.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.2 p-10 -83.29 138.26 33.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 804' ' ' PHE . . . . . 0.563 ' CE2' ' OE2' ' A' ' 811' ' ' GLU . 60.5 t80 -129.07 131.46 47.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -99.22 137.91 37.06 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.037 0.446 . . . . 0.0 111.606 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -65.37 136.09 56.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.336 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 807' ' ' GLN . . . . . 0.44 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 77.0 mt-30 -109.5 -25.09 10.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.693 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 64.1 p -129.2 167.6 17.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 809' ' ' LEU . 93.0 mt -61.03 -42.53 98.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.544 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.94 -42.14 97.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.463 . . . . 0.0 109.76 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.563 ' OE2' ' CE2' ' A' ' 804' ' ' PHE . 41.0 tt0 -66.97 131.28 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.931 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 96.1 mt -115.52 150.33 44.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.449 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.26 148.71 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.103 1.869 . . . . 0.0 112.824 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.706 HD23 ' CE2' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -133.62 145.7 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -120.34 143.02 48.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.59 0.709 . . . . 0.0 111.489 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -53.09 124.39 14.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.075 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 99.83 -20.41 49.32 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.583 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.54 140.47 58.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.8 mm -96.68 131.36 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.1 m -125.97 156.23 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.451 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.8 m-85 -117.34 116.43 27.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.965 0.412 . . . . 0.0 111.4 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.89 131.93 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 823' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.0 OUTLIER -128.52 -4.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.238 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -170.44 125.29 0.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.208 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 825' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 830' ' ' TRP . 59.9 tp60 -81.54 124.61 29.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.749 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.432 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.8 mm -80.79 -52.98 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.62 178.28 9.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.14 -37.85 81.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.4 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -105.91 8.07 32.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.637 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 830' ' ' TRP . . . . . 0.542 ' O ' ' NE2' ' A' ' 825' ' ' GLN . 5.4 m-90 -140.12 145.19 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.102 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.744 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 29.4 p90 -140.7 166.28 25.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.946 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -130.61 136.52 48.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.887 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -154.41 -165.44 13.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -118.9 139.16 52.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -151.3 148.53 28.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.376 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 50.9 t-80 47.87 30.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.263 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.25 16.41 80.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.792 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.28 160.22 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.015 0.436 . . . . 0.0 111.083 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.38 132.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.921 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -155.46 -154.73 7.04 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 46.8 pt -130.48 149.81 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.913 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.706 ' CE2' HD23 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -151.27 171.75 6.14 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -81.36 124.21 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.846 1.698 . . . . 0.0 113.074 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -57.01 -33.69 67.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.649 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.5 p -71.86 -9.99 59.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.739 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -96.51 -1.0 48.11 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.744 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.9 pt -132.85 174.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.11 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.7 mt-10 -113.47 159.87 19.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.13 105.87 13.08 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.695 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 39.0 tp 58.28 74.66 0.6 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.139 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo . . . . . 0 C--N 1.304 -1.766 0 C-N-CA 122.888 2.392 . . . . 0.0 111.443 -179.693 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.31 153.81 47.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.95 150.34 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.45 125.49 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 874' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -62.66 128.57 36.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.415 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 12.8 mtmt -74.49 -37.89 63.02 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.651 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -130.61 153.79 48.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.232 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -52.64 152.57 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 58.2 t80 -146.59 137.32 24.01 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.571 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -136.59 99.69 4.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.811 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.81 156.52 50.71 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -118.82 2.23 11.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.736 0.303 . . . . 0.0 110.53 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 69.7 p -132.52 162.37 31.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.99 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.11 -40.28 97.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.34 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.422 HG23 ' HG2' ' A' ' 885' ' ' GLU . 9.7 m -62.34 -32.4 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.791 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.422 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.1 mm-40 -83.34 146.24 28.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.105 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 67.0 ttp -105.54 130.96 53.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 92.8 p -88.86 131.52 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 43.9 p90 -158.62 164.11 36.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.484 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.448 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 25.2 mmt85 -117.68 162.02 18.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.235 0.54 . . . . 0.0 111.567 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 890' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 65.4 tttp -56.84 136.98 55.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.221 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.78 88.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.041 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 76.2 mm-40 -82.62 147.26 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.994 0.397 . . . . 0.0 110.461 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -84.19 141.2 31.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.54 139.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.4 m -103.22 126.15 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.433 HD11 HG13 ' A' ' 925' ' ' VAL . 88.6 mt -82.69 125.22 30.98 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.56 -28.87 9.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.314 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -179.68 141.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -88.91 113.47 24.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.16 -43.89 91.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -160.72 -179.69 7.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.3 pt-20 -62.64 -22.77 66.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -117.82 13.83 14.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.653 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -140.37 149.67 42.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.08 29.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.433 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -100.61 132.54 45.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.5 179.03 35.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.327 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -148.86 156.48 42.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.315 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.2 mt -84.25 142.43 40.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.87 138.99 25.89 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.952 1.101 . . . . 0.0 111.191 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.59 71.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.92 29.59 8.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.234 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.7 m -62.19 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.616 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -143.52 154.45 43.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.005 0.431 . . . . 0.0 111.459 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -144.96 138.77 27.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.045 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.45 -169.91 43.03 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.49 159.33 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.094 0.473 . . . . 0.0 111.617 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -160.07 152.75 17.72 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.746 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.44 137.19 45.94 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.568 1.512 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.758 ' O ' HG22 ' A' ' 923' ' ' VAL . 6.3 mt -54.69 -76.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.567 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 920' ' ' ILE . 22.4 m -25.53 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 922' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 920' ' ' ILE . 1.6 m-85 -72.22 1.49 7.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.8 m -135.31 158.96 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.063 0.459 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -104.37 118.32 36.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.429 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.433 HG13 HD11 ' A' ' 896' ' ' LEU . 73.0 t -95.03 101.49 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.806 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.6 mp -70.36 -43.18 78.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.273 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -133.04 139.63 47.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.437 -179.779 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 19.1 mmm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.558 0.218 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -154.07 105.22 2.45 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.41 139.77 18.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.785 1.657 . . . . 0.0 112.388 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 847' ' ' ILE . . . -136.68 151.23 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -109.18 143.16 38.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.65 126.48 31.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 801' ' ' LYS . . . . . 0.447 ' O ' ' CD ' ' A' ' 816' ' ' LYS . 38.4 ttpt -97.74 -20.13 17.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.826 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -146.76 177.7 8.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.14 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -90.99 178.02 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.768 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 804' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 814' ' ' LEU . 29.4 t80 -149.04 132.88 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.671 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -106.19 107.74 18.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -67.13 137.67 56.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.174 0.512 . . . . 0.0 110.857 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -106.55 -23.19 12.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.15 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.08 165.64 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.181 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.64 -38.68 85.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.856 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -59.45 -44.15 93.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.46 136.15 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.492 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.9 122.47 33.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.889 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 813' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 50.6 Cg_exo -55.01 140.64 79.99 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.109 1.206 . . . . 0.0 112.457 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.912 HD13 ' OH ' ' A' ' 846' ' ' TYR . 20.7 mt -128.34 149.75 50.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.593 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -122.5 138.17 54.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.209 0.528 . . . . 0.0 109.956 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 816' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 801' ' ' LYS . 36.7 ttpt -46.62 125.32 6.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.089 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 104.45 -24.34 29.07 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.589 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.28 125.88 25.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.985 0.422 . . . . 0.0 110.947 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 23.5 mm -85.93 133.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.09 153.37 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.443 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.9 m-85 -109.15 114.86 28.94 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 31.1 mm -85.6 129.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.477 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -111.16 -27.91 8.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.346 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 824' ' ' LYS . . . . . 0.458 ' NZ ' ' CD ' ' A' ' 832' ' ' GLU . 25.7 pttm -158.9 156.14 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.345 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 825' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 61.9 tt0 -94.49 110.43 22.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.569 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.4 -47.03 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 7.3 t0 -149.85 178.08 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 828' ' ' GLN . . . . . 0.483 ' O ' ' CZ ' ' A' ' 844' ' ' ARG . 99.1 mm-40 -59.99 -37.61 80.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.455 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -108.51 0.55 20.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -123.97 134.1 53.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 160.13 23.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.458 ' CD ' ' NZ ' ' A' ' 824' ' ' LYS . 20.9 tt0 -128.86 140.55 51.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.584 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.87 -177.69 36.08 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -107.05 141.74 37.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.046 0.451 . . . . 0.0 111.353 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.479 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.3 OUTLIER -149.9 144.71 26.09 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 51.2 t-80 50.02 30.37 4.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.1 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.29 18.41 79.82 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -133.03 156.33 47.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.385 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.77 145.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.289 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -169.71 -162.34 21.8 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 841' ' ' ILE . 27.3 pt -128.22 159.39 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -166.8 154.56 8.93 Favored Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.064 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 845' ' ' THR . 51.9 Cg_endo -69.71 115.66 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.352 2.035 . . . . 0.0 112.66 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 844' ' ' ARG . . . . . 0.483 ' CZ ' ' O ' ' A' ' 828' ' ' GLN . 37.9 ptt180 -51.93 -6.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.552 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 843' ' ' PRO . 1.6 t -80.86 -5.83 57.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.616 -0.434 . . . . 0.0 112.089 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 846' ' ' TYR . . . . . 0.912 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -106.37 -1.22 23.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.921 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.649 HG23 ' CE2' ' A' ' 846' ' ' TYR . 45.1 pt -126.76 175.68 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.838 0.351 . . . . 0.0 111.371 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.506 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.3 mt-10 -114.0 160.01 19.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.75 101.62 9.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 51.8 tp 55.04 76.23 0.53 Allowed Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.988 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.306 -1.664 0 C-N-CA 122.688 2.258 . . . . 0.0 111.664 -179.526 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -136.1 141.83 44.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 0.0 110.496 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -150.87 155.52 39.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 57.1 mt -126.66 131.09 71.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 110.641 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.92 123.04 15.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.458 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -69.26 -37.33 77.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.959 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.3 151.06 50.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.361 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.407 HD21 ' NH1' ' A' ' 889' ' ' ARG . 59.2 t-20 -57.48 131.86 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -127.14 128.74 46.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.59 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.32 108.15 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.759 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 880' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 887' ' ' SER . . . -65.83 142.46 43.58 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 881' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 56.4 t0 -100.56 -22.62 14.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 61.0 p -130.97 165.74 22.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.03 0.443 . . . . 0.0 111.123 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.78 -37.56 82.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.563 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.32 -43.37 89.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.394 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -91.06 103.54 16.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.492 ' CE ' ' O ' ' A' ' 887' ' ' SER . 2.0 tmt? -71.28 131.55 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.517 ' CB ' ' H ' ' A' ' 880' ' ' GLY . 83.2 p -80.13 154.19 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 0.0 110.986 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.01 160.05 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.593 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 75.7 mtp85 -105.78 165.32 11.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.003 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.63 136.2 56.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.191 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.58 -6.61 77.6 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.9 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 72.9 mm-40 -74.04 141.73 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.462 0.631 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -89.6 139.22 30.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.212 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.78 149.42 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.514 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.1 m -100.13 127.9 46.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.64 118.79 24.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.18 -46.58 5.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -163.41 156.01 18.29 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.936 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -98.94 118.68 36.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.323 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.46 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.9 t -61.48 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 902' ' ' GLU . 13.3 p30 -153.68 -104.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 901' ' ' ASP . 99.0 mt-10 -121.71 -38.43 2.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.37 9.36 18.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.704 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -134.03 147.46 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.46 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 14.7 p90 -157.72 163.81 37.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -115.96 142.19 47.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.166 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.45 178.86 31.01 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -149.48 158.97 44.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.494 -0.353 . . . . 0.0 110.331 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 911' ' ' GLY . 50.4 mm -65.86 137.86 96.23 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 -11.64 15.21 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.697 1.598 . . . . 0.0 112.531 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.547 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.69 -3.0 89.8 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 57.7 p 53.93 65.97 1.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.208 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.4 m -131.46 -38.49 1.18 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.443 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.24 157.5 46.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.859 0.362 . . . . 0.0 111.329 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -142.81 146.42 34.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.71 176.52 45.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.507 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.49 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 42.5 pt -115.52 145.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.493 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -155.68 159.43 31.62 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.566 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.03 139.11 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.697 2.264 . . . . 0.0 113.828 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.448 ' HA ' HG22 ' A' ' 923' ' ' VAL . 89.7 mt -64.18 -37.81 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.517 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 74.4 p -53.04 -24.13 9.09 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.891 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.07 2.26 55.16 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 920' ' ' ILE . 4.8 m -131.38 158.15 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.118 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -107.31 127.13 53.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.033 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.86 125.38 42.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.265 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 926' ' ' ILE . 1.7 mp -92.88 -53.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.64 126.47 32.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.645 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.848 0.356 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -131.56 96.69 20.55 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.37 140.15 93.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.898 1.732 . . . . 0.0 111.826 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -139.85 156.02 46.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.087 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -114.48 139.82 49.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.78 131.72 35.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.13 0.491 . . . . 0.0 110.764 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 801' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 802' ' ' PHE . 17.2 mmmt -98.27 -13.23 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 802' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 801' ' ' LYS . 47.9 m-85 -152.18 166.79 30.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 112.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 36.0 t70 -86.61 129.8 34.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.072 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -127.81 116.47 20.24 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 110.109 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.21 142.46 31.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.578 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -82.56 122.53 28.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.641 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -95.74 -25.48 16.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.898 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.5 p -134.85 169.67 17.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.37 -37.62 84.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.108 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 810' ' ' LYS . . . . . 0.487 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 68.7 mttm -65.11 -12.07 46.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.612 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.412 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.6 mt-10 -113.34 140.35 48.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.889 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.6 pt? -117.14 149.62 44.69 Favored Pre-proline 0 N--CA 1.467 0.415 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.66 140.01 38.34 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.556 1.504 . . . . 0.0 111.52 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 846' ' ' TYR . 11.0 mt -137.38 146.66 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.675 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -119.08 135.66 54.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 816' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 816' ' ' LYS . 8.9 ptmm? -42.24 123.23 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.599 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 99.78 -20.76 47.97 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.208 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 67.3 t0 -55.11 139.27 42.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 41.7 mm -94.95 126.01 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.172 0.511 . . . . 0.0 110.589 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.431 ' CG1' HD21 ' A' ' 814' ' ' LEU . 0.2 OUTLIER -120.21 148.62 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.255 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.0 m-85 -108.45 123.2 48.49 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 832' ' ' GLU . 24.2 mm -92.94 129.59 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.923 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.38 -27.6 12.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.475 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -160.43 157.28 27.42 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -93.97 111.29 22.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.4 mm -61.13 -46.9 95.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.156 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.94 178.91 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -59.88 -36.37 76.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.954 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.84 -1.65 16.44 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -119.9 131.28 55.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.416 ' CD2' HG21 ' A' ' 822' ' ' ILE . 3.0 m-85 -119.3 157.35 28.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.791 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 822' ' ' ILE . 18.0 tt0 -128.29 138.88 52.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.31 -173.18 28.53 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -123.95 155.79 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.207 0.527 . . . . 0.0 111.456 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.6 OUTLIER -170.61 131.24 0.89 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.933 178.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.1 t-80 65.9 24.56 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 80.22 4.11 89.79 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 838' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 838' ' ' ARG . 1.7 tpm_? -112.86 141.84 46.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.974 0.416 . . . . 0.0 110.558 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.59 143.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.543 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -169.53 -139.98 2.85 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 29.9 pt -138.97 162.75 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.462 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -169.72 153.98 5.22 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.831 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 845' ' ' THR . 50.5 Cg_endo -71.11 116.87 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.946 1.764 . . . . 0.0 112.54 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -51.52 -5.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.217 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 843' ' ' PRO . 81.4 p -82.11 -7.3 59.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 846' ' ' TYR . . . . . 0.914 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -105.41 0.42 26.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.574 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.684 HG23 ' CE2' ' A' ' 846' ' ' TYR . 42.8 pt -130.19 174.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.507 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.62 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 97.6 mt-10 -116.0 160.05 20.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.63 105.25 15.2 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.7 tt 42.57 75.24 0.65 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.513 . . . . 0.0 110.099 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.497 1.708 0 C-N-CA 123.056 2.504 . . . . 0.0 112.221 -179.406 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.53 155.12 44.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.668 0.27 . . . . 0.0 110.537 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.01 27.01 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 46.3 mm -118.7 125.3 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -61.33 133.08 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.711 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 56.8 mtmt -81.95 -38.95 24.42 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.904 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.41 150.86 49.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.466 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 45.6 p-10 -45.64 151.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 75.1 t80 -142.05 131.92 24.36 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.521 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -131.15 103.48 6.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.55 150.57 45.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.84 -1.41 34.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.341 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 57.8 p -133.15 162.75 30.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -61.04 -39.25 89.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.796 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.41 -40.74 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.752 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.24 108.41 19.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 11.0 mmt -80.42 160.67 25.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.8 p -109.39 149.76 29.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.057 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 29.1 p90 -156.76 161.09 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.384 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 42.1 ttm180 -105.24 156.17 18.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 111.14 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -50.44 137.4 19.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.45 -3.82 82.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.717 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 67.9 mm-40 -77.01 140.99 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.536 0.668 . . . . 0.0 110.746 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.71 142.32 31.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.51 147.02 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -104.44 128.67 52.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.952 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.11 124.74 31.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.636 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.39 -56.11 2.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -158.53 153.73 25.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -94.31 114.38 26.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 69.3 t -70.36 -43.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.491 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -151.65 -176.93 5.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.15 -38.66 83.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.242 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -111.6 10.53 21.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -133.8 149.47 51.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.502 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.8 p90 -154.9 159.41 40.45 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.033 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -105.78 134.95 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.988 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -155.55 175.79 33.32 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.495 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -152.83 159.2 43.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 911' ' ' GLY . 1.7 mp -63.59 135.18 96.15 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.84 -15.53 38.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.229 1.286 . . . . 0.0 112.161 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.673 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.87 -4.01 88.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 7.1 m 60.13 72.38 0.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.4 t -139.36 -39.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.972 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 909' ' ' ILE . 88.9 mtm180 -131.25 149.03 52.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.448 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -146.52 143.23 28.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.29 -172.32 45.08 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.503 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.5 pt -119.67 148.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.134 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -156.91 162.08 28.31 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.729 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.32 137.59 37.11 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.335 2.024 . . . . 0.0 113.745 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.17 -38.8 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 71.5 p -55.81 -16.5 4.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.66 2.58 41.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.502 HG11 ' OH ' ' A' ' 905' ' ' TYR . 17.0 m -131.57 156.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.204 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.48 124.47 48.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.284 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.98 130.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.809 0.338 . . . . 0.0 110.246 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.58 -54.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.19 147.39 52.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.3 mpp? . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.038 0.446 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -125.76 97.71 35.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.073 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 797' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 850' ' ' LEU . 48.6 Cg_exo -57.12 138.03 84.46 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.858 1.706 . . . . 0.0 111.915 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -129.62 151.85 49.78 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -113.99 135.51 53.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.208 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -77.99 128.76 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -96.52 -18.34 19.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.282 0.563 . . . . 0.0 109.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -149.91 172.16 15.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.6 p-10 -90.98 135.27 33.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.045 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -118.46 123.44 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.787 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -89.07 132.29 34.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.476 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -80.95 129.09 34.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -105.54 -25.75 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.309 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.8 p -129.29 169.43 14.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.494 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.2 mp -61.15 -39.99 92.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.7 -38.75 88.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.609 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 96.9 mt-10 -81.83 126.14 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.9 151.68 44.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.51 144.4 66.79 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.84 1.693 . . . . 0.0 113.231 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 820' ' ' VAL . 1.5 tp -137.75 146.54 43.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.046 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.83 137.49 53.37 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.364 0.602 . . . . 0.0 110.876 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 816' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 816' ' ' LYS . 15.9 ptmt -44.91 122.61 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.95 -20.25 51.07 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.419 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.9 t0 -55.75 133.22 50.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.359 . . . . 0.0 110.834 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.451 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 30.9 mm -91.21 128.58 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.4 m -127.57 155.0 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.521 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 65.5 m-85 -112.09 117.47 32.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.408 HD13 ' HD2' ' A' ' 831' ' ' TYR . 68.4 mt -81.28 125.83 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -119.6 -9.3 9.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -167.27 131.96 1.95 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 111.367 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.97 136.78 33.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.98 -67.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.829 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -133.95 176.67 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.18 -35.41 77.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.068 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -101.51 -1.03 34.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.268 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -131.86 136.15 47.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.201 0.524 . . . . 0.0 111.082 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.408 ' HD2' HD13 ' A' ' 822' ' ' ILE . 2.8 m-85 -124.76 160.5 28.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.843 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 841' ' ' ILE . 6.3 tt0 -129.84 141.1 50.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.12 -176.28 34.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.27 138.83 42.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.506 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 15.2 p-80 -146.07 131.92 19.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.794 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 51.67 37.43 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.616 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.77 78.85 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.73 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.27 152.36 48.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.222 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.45 132.67 64.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.258 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -159.55 -165.15 15.96 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 832' ' ' GLU . 46.6 pt -128.38 156.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.844 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.451 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -164.09 156.25 14.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.413 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 845' ' ' THR . 40.0 Cg_endo -69.7 117.96 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.979 1.786 . . . . 0.0 112.549 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.61 -13.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.404 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 843' ' ' PRO . 80.6 p -79.54 -6.66 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -103.81 -4.46 23.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.6 pt -135.11 172.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.593 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 77.4 mm-40 -112.98 162.84 15.41 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -108.06 104.22 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.33 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.8 tt 41.53 77.71 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 C-N-CA 122.643 2.228 . . . . 0.0 111.586 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.57 150.3 48.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 896' ' ' LEU . . . -156.38 156.46 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 53.3 mt -131.6 132.58 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.464 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -51.23 128.47 22.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -81.05 -41.15 23.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.145 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 876' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 877' ' ' ASN . 0.2 OUTLIER -149.59 131.88 15.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.024 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 876' ' ' PHE . 59.7 m-80 -26.28 114.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.717 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -117.21 129.12 55.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.706 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -110.94 118.82 37.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.977 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.09 139.37 26.91 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.86 -38.93 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.0 p -135.36 170.85 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.007 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -58.23 -21.59 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.6 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.93 -42.67 93.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.7 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -88.15 128.68 35.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.591 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.609 ' SD ' ' CD2' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -78.32 133.0 37.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.0 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.602 ' N ' ' SD ' ' A' ' 886' ' ' MET . 67.3 m -106.37 138.27 42.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 110.862 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -155.69 176.41 12.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.063 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.4 mtm-85 -112.38 158.93 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.593 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -47.25 144.09 2.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.983 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.38 87.3 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.258 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 12.0 mm-40 -76.72 144.29 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -91.07 139.87 30.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.61 142.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.925 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.4 m -94.93 126.61 40.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 872' ' ' ALA . 91.5 mt -86.7 126.85 34.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.845 HD11 ' HE ' ' A' ' 908' ' ' ARG . 90.5 mt -107.3 -52.51 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -165.5 164.39 19.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.385 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.65 115.68 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.759 HG12 ' OD2' ' A' ' 901' ' ' ASP . 58.1 t -70.27 -45.18 76.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.759 ' OD2' HG12 ' A' ' 900' ' ' VAL . 3.0 m-20 -152.12 -170.9 3.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.48 -40.86 92.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.36 15.82 19.1 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -129.24 149.96 50.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.021 0.439 . . . . 0.0 112.096 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 142.93 26.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.722 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.84 135.89 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.93 178.54 34.18 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.506 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 897' ' ' LEU . 19.6 ptp180 -151.09 158.16 43.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.837 0.351 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 89.5 mt -80.18 141.49 54.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.7 140.29 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.942 1.095 . . . . 0.0 111.504 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 93.03 -7.58 76.37 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.3 m 67.89 28.2 7.05 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.704 0.288 . . . . 0.0 110.773 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 98.3 p -63.61 -28.15 69.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -164.58 150.74 10.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -138.95 143.41 38.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.297 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.44 -179.48 48.35 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.468 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 917' ' ' ILE . 41.9 pt -105.32 156.91 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 923' ' ' VAL . 21.2 p90 -161.89 152.48 14.66 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.67 142.46 58.41 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.9 1.733 . . . . 0.0 112.837 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 920' ' ' ILE . 0.1 OUTLIER -72.47 -26.05 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.138 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 4.3 t -69.59 8.43 0.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.543 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 922' ' ' TYR . . . . . 0.641 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -127.6 4.11 6.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 918' ' ' PHE . 20.5 m -121.19 148.79 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.925 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -102.87 126.25 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.272 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.9 t -82.99 125.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 35.3 mm -103.73 -52.3 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.524 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -137.55 134.06 35.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.237 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 928' ' ' ARG . . . . . 0.446 ' H ' ' HD3' ' A' ' 928' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 795' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.694 0.283 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.526 ' HE ' HD11 ' A' ' 849' ' ' LEU . 95.9 mtm-85 -133.73 149.27 71.5 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.52 128.26 10.2 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.225 1.95 . . . . 0.0 111.929 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -124.13 146.58 48.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -109.29 140.23 43.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.295 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -89.76 115.61 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -77.43 -20.99 53.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.447 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.17 170.01 17.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.5 p-10 -85.25 131.85 34.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.171 0.51 . . . . 0.0 110.382 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 804' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 843' ' ' PRO . 75.0 t80 -105.92 129.55 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -100.29 116.82 33.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.03 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -64.18 132.21 49.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.83 -31.16 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 81.6 p -131.81 161.24 33.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -38.69 57.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.344 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -44.47 95.35 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.68 134.98 52.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 17.0 tp -109.93 127.09 27.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.15 147.01 65.86 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.343 1.362 . . . . 0.0 112.769 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 842' ' ' PHE . 66.3 mt -114.65 152.75 31.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.85 139.06 52.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.333 0.587 . . . . 0.0 110.241 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.94 118.9 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.152 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.89 -21.42 40.37 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.968 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.77 141.35 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.031 0.443 . . . . 0.0 111.405 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 10.7 mm -97.58 132.41 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.779 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.721 HG12 ' HB2' ' A' ' 835' ' ' HIS . 33.9 m -125.25 153.16 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.47 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 79.7 m-85 -110.91 114.03 27.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 831' ' ' TYR . 4.2 mm -82.85 128.92 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.084 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.51 -44.92 7.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.259 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -160.49 153.55 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.981 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.49 110.25 18.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.235 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.458 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.1 mm -62.78 -46.89 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.597 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -148.08 178.65 8.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -60.09 -37.5 80.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -112.79 18.36 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.565 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -142.71 150.0 39.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.533 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.685 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 35.0 p90 -147.79 168.5 21.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.767 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.8 tp10 -129.33 139.91 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.487 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -163.99 -177.22 36.58 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -113.44 152.17 30.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.971 0.415 . . . . 0.0 111.027 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.721 ' HB2' HG12 ' A' ' 820' ' ' VAL . 1.0 OUTLIER -165.21 132.96 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.963 178.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 835' ' ' HIS . 47.4 t-80 64.34 28.09 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.831 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.76 20.53 79.77 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -134.65 152.04 51.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.458 0.647 . . . . 0.0 112.278 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 840' ' ' GLY . 76.8 t -100.33 154.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.47 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -175.73 176.44 47.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.57 145.71 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 117.403 0.602 . . . . 0.0 109.504 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -156.97 165.13 19.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.092 -177.488 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.459 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 58.1 Cg_endo -73.15 129.44 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.701 2.267 . . . . 0.0 112.401 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 844' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 846' ' ' TYR . 61.8 ttp85 -61.77 -37.79 85.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.413 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 3.3 t -59.19 3.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 846' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 844' ' ' ARG . 0.4 OUTLIER -110.25 -2.33 16.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.685 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.8 pt -133.94 175.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -116.48 161.76 18.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.526 HD11 ' HE ' ' A' ' 796' ' ' ARG . 53.0 tp -121.31 96.73 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.841 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.0 tt 40.14 70.27 1.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.485 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 C-N-CA 121.902 1.735 . . . . 0.0 112.202 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 871' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 927' ' ' LYS . 79.2 mm-40 -125.63 151.17 46.87 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.69 147.1 18.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.1 129.16 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.84 122.55 13.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -70.6 -36.27 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -135.4 154.5 51.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -53.54 138.58 33.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.1 129.0 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.51 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -116.75 109.3 16.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.424 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.13 149.12 43.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -106.41 -47.5 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.751 0.31 . . . . 0.0 111.116 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 74.6 p -81.31 162.01 23.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.351 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.95 -39.43 94.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.454 HG23 ' HG3' ' A' ' 885' ' ' GLU . 15.0 m -66.67 -23.97 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.454 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.5 mt-10 -98.26 129.11 44.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 30.5 mmm -94.82 178.83 5.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.771 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 88.6 p -131.29 149.86 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -160.63 163.31 32.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.26 165.05 11.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.954 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.12 136.35 57.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.28 -5.94 81.03 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.908 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.83 141.28 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.655 0.728 . . . . 0.0 110.379 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -86.16 141.87 29.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.088 0.47 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.76 147.81 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.495 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.7 m -102.34 127.85 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.502 HD11 HG13 ' A' ' 925' ' ' VAL . 78.7 mt -85.82 122.81 30.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.114 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.866 HD21 ' NH1' ' A' ' 908' ' ' ARG . 85.8 mt -101.52 -47.01 4.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -166.52 165.3 16.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.878 0.37 . . . . 0.0 111.31 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -104.04 118.45 36.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.406 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 63.4 t -61.94 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.645 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 77.1 m-20 -144.09 -104.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.9 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -126.09 -34.85 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.678 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.08 7.85 16.84 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.605 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -131.34 148.64 52.69 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.979 0.175 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.406 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 26.3 p90 -153.56 160.14 42.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.113 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.7 136.69 47.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.71 179.19 30.99 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.404 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.866 ' NH1' HD21 ' A' ' 897' ' ' LEU . 32.3 ptt-85 -148.37 158.22 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 0.0 110.258 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.77 140.55 86.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.75 138.53 33.19 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.181 1.101 . . . . 0.0 111.112 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 102.04 -18.17 52.63 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 71.98 73.33 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.9 t -120.91 -48.07 2.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.69 149.83 51.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.524 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.83 143.79 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.48 176.09 46.14 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.37 147.9 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.211 0.529 . . . . 0.0 111.387 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.57 159.12 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.918 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.06 139.55 39.45 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.566 2.177 . . . . 0.0 114.48 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.41 -38.06 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.467 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.468 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -52.6 -38.8 60.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.29 0.83 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.11 159.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 110.965 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -108.82 125.66 52.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 896' ' ' LEU . 95.8 t -99.99 103.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -65.04 -42.4 94.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.64 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 927' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 871' ' ' GLU . 7.0 ptmm? -145.18 159.09 43.54 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.157 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.136 179.647 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.656 0.265 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.72 149.76 63.36 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.866 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.09 105.06 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.308 2.005 . . . . 0.0 111.995 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.622 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -105.53 144.12 32.73 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.623 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -111.42 134.14 53.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.5 120.95 22.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 801' ' ' LYS . . . . . 0.458 ' NZ ' ' CE2' ' A' ' 802' ' ' PHE . 19.5 ttpp -89.07 -29.19 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 802' ' ' PHE . . . . . 0.458 ' CE2' ' NZ ' ' A' ' 801' ' ' LYS . 54.1 m-85 -135.03 152.57 51.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.436 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.8 p-10 -75.35 146.54 40.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.077 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -134.59 133.24 39.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -99.61 132.42 44.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.342 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.67 139.8 55.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.96 -30.94 13.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.382 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 29.9 p -137.06 178.4 7.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.43 -38.41 87.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.274 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -60.6 -40.68 92.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.374 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.723 ' C ' HD12 ' A' ' 812' ' ' LEU . 7.1 mt-10 -84.61 142.45 29.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.874 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.2 mp -121.35 152.76 58.11 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.32 148.26 67.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.982 1.788 . . . . 0.0 113.098 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.742 HD13 ' CE2' ' A' ' 842' ' ' PHE . 1.1 tp -131.11 145.39 51.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.54 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -124.85 137.91 54.28 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.472 0.654 . . . . 0.0 111.723 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.07 127.63 10.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.399 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.53 -19.32 54.17 Favored Glycine 0 C--N 1.318 -0.422 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.129 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.33 122.39 18.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.363 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.53 135.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.176 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 798' ' ' ALA . 32.9 m -130.17 154.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.4 m-85 -114.96 112.47 22.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.793 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.46 133.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.696 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -96.85 -47.79 5.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.775 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -163.95 153.78 14.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.269 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 825' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 59.3 tt0 -74.88 108.38 7.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.357 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.401 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.8 mm -64.75 -45.96 93.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.894 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 5.2 t0 -140.49 177.34 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.456 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -57.09 -27.06 61.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.382 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.27 -30.67 4.87 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.736 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -85.54 168.09 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.47 . . . . 0.0 111.719 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.697 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 24.0 p90 -153.39 169.09 23.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -131.5 138.41 48.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.044 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.64 -175.45 31.66 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.04 137.18 46.47 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.564 0.221 . . . . 0.0 110.611 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.3 p-80 -142.07 138.77 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 53.4 t-80 52.46 26.79 4.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.95 4.48 90.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.823 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.33 161.24 19.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.63 0.252 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.674 ' O ' HD22 ' A' ' 812' ' ' LEU . 10.3 p -110.72 153.68 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.754 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 839' ' ' VAL . . . -179.76 -172.56 43.94 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.5 pp -125.27 142.45 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.363 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.742 ' CE2' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -148.74 154.83 41.04 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.404 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.18 134.19 33.08 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.787 1.658 . . . . 0.0 111.98 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -60.57 -41.8 95.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.74 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 71.3 p -59.52 -11.54 4.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.635 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -92.73 -2.53 55.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.697 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 37.6 pt -133.99 165.46 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.873 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.21 120.94 28.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.208 0.528 . . . . 0.0 111.737 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.3 103.95 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.544 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.8 tt 42.79 87.04 0.12 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.271 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo . . . . . 0 N--CA 1.498 1.765 0 C-N-CA 122.686 2.258 . . . . 0.0 112.204 -179.303 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -129.54 157.3 42.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.87 153.1 29.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.32 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -52.56 137.55 30.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 3.3 ttpm? -83.82 -41.93 16.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -129.33 150.91 50.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 47.9 p-10 -55.5 153.27 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -151.13 131.81 14.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.859 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.59 108.21 14.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 880' ' ' GLY . . . . . 0.47 ' N ' ' OG ' ' A' ' 887' ' ' SER . . . -91.93 -176.84 42.43 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -145.68 -40.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.915 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 79.3 p -79.18 160.42 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.028 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -70.06 -30.17 67.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.1 -13.57 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 64.6 mm-40 -113.38 133.07 55.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.785 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 7.4 tpt -106.02 116.97 32.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.803 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 880' ' ' GLY . 50.1 m -73.82 144.11 45.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -154.73 157.16 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.461 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 15.9 tpp180 -106.61 150.28 26.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.319 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 890' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 66.1 tttp -44.55 139.99 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.066 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 83.7 0.86 90.01 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.407 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 7.1 mm-40 -73.33 148.63 43.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.18 0.49 . . . . 0.0 110.679 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -91.44 128.97 37.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.229 0.537 . . . . 0.0 110.718 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.76 148.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.41 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -106.36 127.28 53.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.863 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.38 124.61 29.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.697 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.485 HD11 ' HG2' ' A' ' 908' ' ' ARG . 86.6 mt -101.19 -52.86 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.27 164.54 22.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.9 111.88 23.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.49 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 78.8 t -69.41 -42.41 81.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.299 0.571 . . . . 0.0 110.016 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -152.97 -174.99 5.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.871 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -61.54 -38.1 86.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.237 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -117.02 14.65 15.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.77 147.64 51.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.648 ' OH ' HG11 ' A' ' 923' ' ' VAL . 16.1 p90 -155.04 160.67 41.21 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.112 0.482 . . . . 0.0 110.975 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -107.02 133.74 51.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.726 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -144.96 165.73 27.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.615 HH12 ' H ' ' A' ' 911' ' ' GLY . 5.3 ppt_? -150.81 158.83 44.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.446 . . . . 0.0 110.501 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 14.4 mm -78.9 132.68 63.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.78 137.24 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.259 1.128 . . . . 0.0 111.267 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.615 ' H ' HH12 ' A' ' 908' ' ' ARG . . . 99.56 -9.55 60.66 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.9 p 71.58 30.43 2.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.1 m -62.17 -40.65 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.187 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -161.76 152.73 18.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -132.33 147.75 52.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.35 43.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.853 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 918' ' ' PHE . 45.5 pt -119.57 147.01 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.91 0.385 . . . . 0.0 111.174 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -163.74 163.58 15.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.775 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.53 140.84 48.78 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.281 1.987 . . . . 0.0 113.321 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.45 -30.93 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.51 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 68.0 p -61.32 -21.43 63.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.651 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.67 1.65 56.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.648 HG11 ' OH ' ' A' ' 905' ' ' TYR . 14.7 m -135.34 160.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.913 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 924' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 66.5 t0 -114.79 130.62 56.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.399 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 926' ' ' ILE . 5.8 m -94.81 148.57 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -113.89 -38.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -146.55 130.8 17.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.452 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.186 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 822' ' ' ILE . 63.1 tpp . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -138.24 148.66 60.57 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.399 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.95 156.23 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.404 2.069 . . . . 0.0 112.308 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -153.56 159.3 42.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -133.01 136.89 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -75.26 116.54 16.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 110.47 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.65 -37.54 86.77 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.92 173.07 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 57.2 t0 -77.43 109.45 11.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.599 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.14 126.76 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -95.23 111.69 23.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -61.29 134.68 57.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.072 0.463 . . . . 0.0 110.992 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 -31.2 8.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.906 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 60.8 p -133.07 162.4 31.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.376 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -55.94 -31.73 63.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.716 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -62.09 -39.69 93.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.289 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.534 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 98.9 mt-10 -96.57 126.89 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.325 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.5 mm? -103.44 151.69 38.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.633 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.78 142.54 48.14 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.573 1.515 . . . . 0.0 112.679 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 842' ' ' PHE . 92.6 mt -127.06 161.7 27.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -123.66 136.6 54.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.417 0.627 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.18 121.85 5.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.457 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.06 11.05 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.938 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 68.3 t0 -48.04 136.38 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.325 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 7.1 mm -101.86 125.32 56.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.86 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.71 156.65 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.293 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -112.12 125.62 54.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.64 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 832' ' ' GLU . 75.6 mt -88.0 123.47 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.215 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -111.43 -3.83 15.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.27 133.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -87.25 128.09 35.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.292 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.36 -46.35 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.03 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -152.65 179.43 8.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.637 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.91 -37.52 76.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -107.68 -8.6 16.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.79 141.07 42.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 0.0 112.031 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.496 ' CD2' HD13 ' A' ' 822' ' ' ILE . 43.3 m-85 -129.44 151.44 50.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.558 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 822' ' ' ILE . 3.7 tt0 -125.74 139.64 53.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -157.99 180.0 33.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 834' ' ' GLU . . . . . 0.483 ' OE2' ' N ' ' A' ' 837' ' ' GLY . 12.7 tm-20 -115.26 125.45 53.33 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.0 p80 -132.39 138.02 47.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 82.3 t60 50.78 32.05 6.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 837' ' ' GLY . . . . . 0.483 ' N ' ' OE2' ' A' ' 834' ' ' GLU . . . 75.46 13.3 83.02 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -118.61 148.16 42.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.8 127.34 75.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 0.0 111.541 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -147.97 -179.78 24.22 Favored Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.415 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 30.8 pt -124.29 143.4 37.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.101 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.487 ' CE1' HD11 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -145.75 149.11 38.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.676 -179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.556 ' C ' ' H ' ' A' ' 845' ' ' THR . 72.1 Cg_endo -75.62 137.54 20.49 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.251 1.967 . . . . 0.0 111.197 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -55.51 3.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 843' ' ' PRO . 0.2 OUTLIER -90.74 -15.83 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.685 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 -5.45 16.17 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.268 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.9 pt -133.52 173.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.551 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -131.29 155.12 47.72 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 8.1 tp -105.31 107.63 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.197 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.6 tt 49.9 76.71 0.52 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.305 -1.748 0 C-N-CA 122.989 2.459 . . . . 0.0 111.845 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 871' ' ' GLU . . . . . 0.532 ' OE2' ' NE ' ' A' ' 893' ' ' ARG . 88.0 tt0 -138.31 150.59 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.766 0.317 . . . . 0.0 110.203 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -143.43 153.12 42.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.99 121.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.073 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.5 4.03 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.5 mtmt -70.36 -36.79 74.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.63 152.62 50.69 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.253 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 878' ' ' PHE . 61.6 t-20 -54.69 136.14 46.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.709 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.632 ' CD2' ' CE1' ' A' ' 888' ' ' PHE . 90.3 t80 -129.52 132.04 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.76 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.06 106.95 13.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -71.01 139.58 29.89 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -107.01 -3.18 20.35 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 68.4 p -132.69 160.84 35.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.235 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -61.51 -41.96 98.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 885' ' ' GLU . 14.7 m -65.54 -25.38 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 885' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.8 mt-10 -99.92 108.23 20.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 887' ' ' SER . 16.9 tmm? -79.74 135.02 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.512 ' O ' ' SD ' ' A' ' 886' ' ' MET . 33.9 t -82.6 132.28 35.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.716 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.632 ' CE1' ' CD2' ' A' ' 878' ' ' PHE . 45.5 p90 -142.18 154.51 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.439 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 89.8 mtm180 -103.54 163.89 12.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.063 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.46 132.73 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.5 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 96.33 -7.01 66.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.296 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 71.2 mm-40 -69.94 133.77 47.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.923 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.532 ' NE ' ' OE2' ' A' ' 871' ' ' GLU . 70.4 mtp85 -84.05 126.09 32.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 8.7 mm -114.88 143.45 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.106 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -98.28 127.81 44.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.98 116.21 22.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 110.943 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.75 -50.62 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -160.86 154.9 22.77 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.079 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 116.88 32.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.448 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 60.0 t -61.43 -46.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.779 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.9 m-20 -143.88 -104.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.989 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -129.04 -37.7 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -108.09 4.74 25.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.502 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -132.02 148.27 52.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.42 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 16.2 p90 -153.95 159.77 41.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.113 0.482 . . . . 0.0 110.882 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -107.47 135.12 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.65 177.84 30.14 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.288 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -150.84 160.3 43.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.24 128.84 86.93 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -49.13 138.86 27.83 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 120.161 1.093 . . . . 0.0 111.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 912' ' ' THR . . . 101.26 -17.84 55.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 911' ' ' GLY . 0.2 OUTLIER 79.18 86.0 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.898 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 25.4 t -129.25 -41.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.036 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -162.74 151.92 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.817 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -130.01 146.55 51.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.05 175.48 45.34 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.519 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.8 pt -114.1 142.37 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.899 0.38 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -152.67 157.96 33.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.889 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 136.63 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.117 1.878 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.25 -36.82 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.867 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.433 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 73.0 p -53.5 -29.85 38.26 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -91.85 2.38 56.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.984 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.443 HG12 ' HB1' ' A' ' 872' ' ' ALA . 16.9 t -127.19 148.97 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.308 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -99.98 121.31 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.44 123.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.156 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -97.06 -44.82 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.67 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -125.61 142.27 51.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.539 -179.6 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.8 mpp? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.76 0.314 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.96 149.44 73.13 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.02 153.8 57.71 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.394 2.063 . . . . 0.0 112.274 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -168.86 151.14 4.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -133.41 129.33 37.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.617 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 815' ' ' GLN . . . -76.41 122.83 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 801' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 848' ' ' GLU . 15.5 ttmm -91.24 -18.14 24.88 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.462 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.74 139.97 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.192 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.84 152.12 43.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.312 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 804' ' ' PHE . . . . . 0.443 ' CE1' ' CD ' ' A' ' 811' ' ' GLU . 47.5 t80 -126.87 129.09 47.55 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.466 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.61 121.1 35.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.1 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -62.26 134.99 57.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 110.793 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -110.96 -28.8 8.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 68.9 p -130.87 163.35 27.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.456 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.65 -34.75 67.62 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.99 -47.29 86.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.783 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.443 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 8.1 tm-20 -86.78 123.66 32.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.114 0.483 . . . . 0.0 111.266 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -96.57 152.73 38.77 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.29 145.12 76.95 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.611 1.541 . . . . 0.0 112.511 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 842' ' ' PHE . 1.2 tp -131.89 151.42 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 815' ' ' GLN . . . . . 0.625 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 11.1 tt0 -102.89 147.76 26.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.461 0.648 . . . . 0.0 110.661 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -63.45 38.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.125 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 166.06 23.26 0.02 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 820' ' ' VAL . 65.3 t0 -97.15 113.65 25.26 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.77 -0.253 . . . . 0.0 110.418 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.7 135.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.658 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 814' ' ' LEU . 30.7 m -131.55 158.3 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.25 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.409 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 84.6 m-85 -108.41 115.83 30.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.403 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 33.4 mm -81.57 134.62 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.318 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -96.75 -39.68 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 824' ' ' LYS . . . . . 0.47 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 25.9 pttm -162.07 159.83 26.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.417 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -86.14 116.02 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 827' ' ' ASP . 48.5 mm -65.01 -48.73 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.284 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 826' ' ' ILE . 34.5 m-20 -147.62 177.5 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.18 -36.41 75.29 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.253 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -109.87 15.4 22.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -137.06 147.53 46.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 112.082 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.541 ' OH ' ' NH1' ' A' ' 844' ' ' ARG . 44.0 m-85 -133.87 150.99 51.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.32 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.47 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 3.7 tt0 -124.11 133.33 53.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.135 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -158.39 -175.77 29.69 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -113.79 149.93 34.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.556 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -152.55 132.14 13.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.558 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 75.6 t60 48.84 34.01 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.581 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.88 1.63 90.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.863 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.18 147.83 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.451 ' O ' HD23 ' A' ' 812' ' ' LEU . 7.4 p -135.86 135.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.635 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 812' ' ' LEU . . . -158.27 -143.02 3.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 842' ' ' PHE . 45.5 pt -128.97 150.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 117.449 0.624 . . . . 0.0 110.748 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' A' ' 814' ' ' LEU . 4.1 m-85 -144.24 131.0 10.21 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.842 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.38 148.21 72.91 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.532 1.488 . . . . 0.0 112.784 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 844' ' ' ARG . . . . . 0.541 ' NH1' ' OH ' ' A' ' 831' ' ' TYR . 60.2 ttt85 -59.74 -41.06 90.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.658 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 94.1 m -64.47 -22.47 66.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.341 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -91.93 -3.76 55.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.806 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 844' ' ' ARG . 1.3 pp -142.08 165.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.182 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 801' ' ' LYS . 96.1 mt-10 -132.49 124.44 28.54 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.92 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 850' ' ' LEU . 2.4 tt -72.36 113.33 9.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.329 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.556 ' N ' HD23 ' A' ' 849' ' ' LEU . 3.3 tt 53.15 76.02 0.57 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.804 2.336 . . . . 0.0 111.749 -179.864 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.94 151.75 41.49 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.917 0.389 . . . . 0.0 110.929 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 924' ' ' ASP . . . -155.07 151.07 27.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.264 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 11.5 mm -122.23 127.45 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -47.31 131.17 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.497 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 22.4 ttpp -72.93 -37.19 67.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.684 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 876' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 922' ' ' TYR . 0.2 OUTLIER -155.15 160.79 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.231 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.541 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 63.3 m-20 -51.72 109.55 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -115.85 125.5 52.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.402 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -115.86 110.59 19.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.379 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -64.52 142.5 45.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.05 -22.93 28.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 66.3 p -129.85 164.15 24.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.621 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -59.87 -25.95 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.266 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.84 -45.3 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.64 141.79 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.7 tpt -103.24 130.71 50.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 142.07 27.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -158.6 160.84 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.538 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 891' ' ' GLY . 38.9 ttm180 -89.57 158.12 17.77 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -66.08 56.25 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.689 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 891' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . -178.16 4.66 0.03 OUTLIER Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.725 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.96 150.52 20.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.551 0.675 . . . . 0.0 109.866 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -95.5 127.97 41.97 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.451 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.62 151.67 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.85 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.7 m -104.36 127.45 52.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.887 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 925' ' ' VAL . 87.4 mt -90.16 127.7 36.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.535 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.755 HD11 ' HE ' ' A' ' 908' ' ' ARG . 87.9 mt -108.27 -53.56 2.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.702 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -156.34 150.28 25.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.985 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.14 106.94 18.82 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.51 -44.07 95.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -157.87 178.68 9.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.088 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 920' ' ' ILE . 80.9 mm-40 -61.87 -30.99 71.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 903' ' ' ASN . . . . . 0.469 ' C ' ' CD1' ' A' ' 904' ' ' TRP . 98.3 m-20 -109.7 20.07 18.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.41 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 904' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 903' ' ' ASN . 74.3 m95 -146.83 151.61 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.96 138.09 26.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.545 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -102.11 133.16 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.02 178.43 35.19 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.952 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.755 ' HE ' HD11 ' A' ' 897' ' ' LEU . 20.9 ptp180 -151.16 157.81 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.96 141.76 78.75 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.45 139.85 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.06 1.057 . . . . 0.0 111.046 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 912' ' ' THR . . . 95.33 -9.26 69.58 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.83 31.99 3.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.663 0.268 . . . . 0.0 110.971 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.0 t -60.91 -44.22 97.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.11 146.81 15.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -121.19 151.05 40.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.278 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -175.02 176.12 47.13 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.182 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.467 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 45.2 pt -125.12 156.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.467 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.4 OUTLIER -166.48 162.69 11.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.661 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.67 147.85 90.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.806 1.671 . . . . 0.0 111.768 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 902' ' ' GLU . 11.3 mt -76.37 -19.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 81.6 p -68.95 -10.69 58.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.591 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 922' ' ' TYR . . . . . 0.566 ' CD1' ' CE1' ' A' ' 876' ' ' PHE . 45.5 m-85 -108.23 7.59 27.47 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 920' ' ' ILE . 18.8 m -137.04 159.42 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.408 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 924' ' ' ASP . . . . . 0.412 ' O ' ' HB1' ' A' ' 872' ' ' ALA . 98.1 m-20 -117.38 131.75 56.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.54 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 896' ' ' LEU . 62.9 t -99.99 98.81 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.278 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.67 -44.19 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.013 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.65 142.53 51.0 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.86 179.441 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.531 ' HE ' HD21 ' A' ' 849' ' ' LEU . 13.9 tpt180 -129.8 121.13 19.83 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.09 138.9 21.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.702 1.601 . . . . 0.0 112.474 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -138.77 154.4 48.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -113.13 140.39 47.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.013 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -72.88 126.95 31.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -91.06 -8.86 47.76 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.258 0.552 . . . . 0.0 109.571 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.13 178.3 7.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.136 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.3 p-10 -98.53 139.57 34.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.569 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -129.56 129.58 44.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.232 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -95.31 135.13 37.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.562 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -76.42 138.04 40.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -114.38 -22.33 9.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.902 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.1 p -127.22 167.67 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.446 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.42 -41.4 97.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.771 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -63.01 -39.94 96.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.471 . . . . 0.0 109.864 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.523 ' C ' HD12 ' A' ' 812' ' ' LEU . 95.6 mt-10 -74.76 131.89 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.265 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 811' ' ' GLU . 9.1 mp -118.76 154.23 52.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.06 144.19 62.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.856 1.704 . . . . 0.0 112.346 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.54 HD12 ' CD2' ' A' ' 842' ' ' PHE . 1.3 mt -137.65 141.45 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.212 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -122.66 139.85 53.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.438 0.637 . . . . 0.0 110.921 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.82 123.55 7.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.911 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 105.75 -24.33 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.412 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.2 t0 -61.9 135.67 57.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.799 0.333 . . . . 0.0 110.763 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.503 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 33.9 mm -93.9 130.57 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.555 HG12 ' HB2' ' A' ' 835' ' ' HIS . 28.6 m -123.46 152.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.46 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 86.6 m-85 -117.04 117.74 30.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.03 129.59 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -123.88 -9.67 7.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.274 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -165.18 133.59 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -82.69 138.01 34.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.633 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 9.8 mm -94.82 -57.64 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.477 ' O ' ' NH2' ' A' ' 844' ' ' ARG . 7.7 t0 -150.21 179.33 8.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.085 0.469 . . . . 0.0 109.795 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.59 -37.26 78.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.716 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -106.18 7.25 31.48 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -141.15 147.13 37.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.113 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 29.6 p90 -140.08 169.68 17.25 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.558 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.5 tp10 -128.54 139.19 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.134 0.493 . . . . 0.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.558 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -161.36 -175.45 32.4 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.89 135.62 49.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.693 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.555 ' HB2' HG12 ' A' ' 820' ' ' VAL . 0.8 OUTLIER -144.61 146.91 32.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.8 t-80 49.04 29.76 2.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.18 79.98 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -132.8 158.92 41.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 832' ' ' GLU . 92.0 t -106.78 132.66 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.618 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.465 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -164.29 -175.02 34.72 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.48 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 36.6 pt -115.15 149.65 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.515 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.54 ' CD2' HD12 ' A' ' 814' ' ' LEU . 0.3 OUTLIER -152.01 151.67 28.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 845' ' ' THR . 27.5 Cg_endo -67.88 112.08 2.59 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.797 1.665 . . . . 0.0 112.15 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 844' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 827' ' ' ASP . 19.1 ttm105 -47.69 -15.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.53 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.407 ' N ' ' C ' ' A' ' 843' ' ' PRO . 63.2 p -81.49 -2.25 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.735 0.303 . . . . 0.0 111.052 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.2 -2.91 26.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.004 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.5 pt -129.33 172.05 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.881 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 85.1 tt0 -110.31 159.73 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.531 HD21 ' HE ' ' A' ' 796' ' ' ARG . 3.4 tt -113.49 104.36 12.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 36.5 tp 58.26 75.13 0.56 Allowed Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.785 . . . . 0.0 112.399 -179.146 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.783 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.0 160.93 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -158.88 146.0 17.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 89.8 mt -123.19 125.8 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.58 122.69 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.149 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 46.3 mtpt -70.38 -37.86 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -132.75 154.33 50.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.324 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -54.25 146.19 15.91 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 89.0 t80 -141.43 137.12 31.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.031 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -123.64 105.4 9.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.183 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.5 155.15 52.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 881' ' ' ASP . . . . . 0.419 ' OD1' HG23 ' A' ' 882' ' ' THR . 51.6 p-10 -115.13 -9.61 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.585 0.231 . . . . 0.0 111.503 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 882' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 881' ' ' ASP . 72.3 p -128.54 160.56 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 883' ' ' GLN . . . . . 0.493 ' O ' ' SD ' ' A' ' 886' ' ' MET . 55.2 tt0 -61.55 -39.71 92.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.936 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.48 -42.05 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.521 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -88.36 103.27 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.689 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 883' ' ' GLN . 0.0 OUTLIER -80.89 133.59 35.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.237 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 84.4 p -73.06 157.4 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 111.053 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 41.1 p90 -160.38 162.94 33.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.474 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -112.95 161.84 16.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.301 0.572 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -59.37 132.77 55.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.837 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.74 -8.01 78.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.694 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.31 139.82 48.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.24 0.52 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -85.21 143.4 28.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.956 0.408 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -131.99 148.8 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.738 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 895' ' ' THR . . . . . 0.449 HG21 ' NH1' ' A' ' 908' ' ' ARG . 97.3 m -101.53 129.16 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.987 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.26 115.21 24.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 111.149 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.97 -50.41 4.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.791 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -157.46 151.69 24.79 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.019 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.89 113.74 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.699 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 79.5 t -69.19 -43.16 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 110.31 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.438 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 19.3 t0 -153.56 -176.65 5.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.021 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 61.0 mp0 -61.13 -37.85 84.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.83 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.6 13.28 21.28 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.87 147.63 46.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.487 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 20.9 p90 -154.29 158.27 39.93 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.162 0.506 . . . . 0.0 110.965 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.23 133.3 52.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.04 178.6 30.83 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.334 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.449 ' NH1' HG21 ' A' ' 895' ' ' THR . 0.0 OUTLIER -153.14 161.68 42.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.855 0.359 . . . . 0.0 110.385 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 13.1 mt -90.22 132.26 36.32 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.826 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -39.98 136.28 1.45 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.397 1.398 . . . . 0.0 111.757 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.21 -4.34 64.8 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.44 24.68 13.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.4 t -61.58 -45.07 95.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.95 146.73 45.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 915' ' ' GLN . . . . . 0.489 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.2 tt0 -147.39 139.01 24.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 172.54 -170.28 43.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.7 pt -116.31 145.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.054 0.454 . . . . 0.0 111.014 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.37 153.38 30.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.038 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.04 137.52 41.2 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.057 1.838 . . . . 0.0 112.991 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.51 -38.68 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.465 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 93.7 m -51.96 -44.17 63.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.961 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.13 3.57 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.4 t -125.67 147.53 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.99 0.424 . . . . 0.0 110.285 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.71 120.99 42.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.504 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.76 124.65 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.505 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -87.89 -35.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -151.55 135.61 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.758 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.439 179.823 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -128.19 145.62 56.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.3 108.41 1.75 Allowed 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.956 1.77 . . . . 0.0 112.645 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -109.35 144.83 37.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -114.24 140.61 48.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.226 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.2 118.18 22.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.428 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -72.38 -27.48 62.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.077 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -142.39 178.15 7.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.558 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.09 139.28 30.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.057 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -127.08 125.86 42.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.34 132.55 34.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -71.2 139.03 49.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 807' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 98.1 mm-40 -105.24 -29.18 10.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.069 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 808' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 811' ' ' GLU . 71.5 p -136.15 170.14 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.261 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 809' ' ' LEU . 91.2 mt -61.41 -35.25 77.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.166 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -59.93 -40.17 88.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.737 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 10.8 pt-20 -98.4 129.4 45.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.613 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -102.08 152.19 38.18 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.58 149.98 68.7 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.304 2.003 . . . . 0.0 113.092 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.62 142.77 49.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.663 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.9 133.53 53.02 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.261 0.553 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -41.57 126.05 2.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.6 -24.17 32.49 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.385 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.53 121.35 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.2 mm -81.55 138.86 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.044 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.47 154.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.452 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -113.0 117.01 30.85 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.433 HD13 ' HD2' ' A' ' 831' ' ' TYR . 62.3 mt -82.04 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.17 -4.82 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -166.78 130.83 1.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 825' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 827' ' ' ASP . 4.0 tm0? -90.6 107.32 19.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.712 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.1 mm -60.77 -48.87 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.121 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.587 ' C ' HE21 ' A' ' 825' ' ' GLN . 1.3 t70 -155.56 176.98 11.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 828' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 26.0 mp0 -61.85 -35.83 79.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.779 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -102.13 -7.41 22.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.815 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -125.53 131.89 52.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.982 0.42 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.433 ' HD2' HD13 ' A' ' 822' ' ' ILE . 3.3 m-85 -121.4 156.65 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.605 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -128.91 140.81 51.51 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.91 -174.18 31.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.44 136.31 48.27 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.577 0.227 . . . . 0.0 110.652 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 2.7 p80 -139.11 133.14 31.13 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 1.3 t60 50.2 31.8 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.243 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.27 4.45 90.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.538 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -112.63 161.87 16.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.01 140.89 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.52 30.31 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.79 155.02 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.131 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -161.53 153.82 16.7 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.576 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 843' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 845' ' ' THR . 56.6 Cg_endo -71.86 126.98 12.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.961 1.774 . . . . 0.0 112.714 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 2.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.757 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 845' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 843' ' ' PRO . 73.8 p -91.05 -18.44 24.57 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.589 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.49 5.41 34.04 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.2 pt -130.27 168.28 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -134.71 113.27 11.5 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.988 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 849' ' ' LEU . 3.1 mp -68.81 118.19 11.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.959 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 850' ' ' LEU . 21.6 tp 58.84 69.91 1.28 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.785 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.493 1.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.625 -179.257 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -128.15 150.41 50.0 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.54 146.32 16.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.05 125.21 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 874' ' ' ALA . . . . . 0.661 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -55.19 120.56 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.359 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -69.22 -36.7 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -134.33 150.52 50.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.916 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -55.55 132.92 49.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -130.67 134.63 47.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 879' ' ' ASN . . . . . 0.542 ' O ' ' ND2' ' A' ' 879' ' ' ASN . 0.4 OUTLIER -113.65 128.89 56.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.996 178.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 880' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -77.95 139.89 23.33 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -98.17 -12.73 21.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 110.731 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 62.0 p -133.07 165.08 25.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 883' ' ' GLN . . . . . 0.473 ' O ' ' CE ' ' A' ' 886' ' ' MET . 98.4 mt-30 -62.02 -39.73 93.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.113 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 884' ' ' VAL . 2.9 t -66.82 -15.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.757 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -105.71 110.09 22.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.296 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 883' ' ' GLN . 39.1 mmt -81.01 152.69 27.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.262 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 96.7 p -108.9 155.01 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -159.3 161.61 35.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.779 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 1.4 mpt_? -96.44 165.86 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.593 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.53 135.89 57.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.19 82.63 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.607 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 77.2 mm-40 -72.38 140.61 48.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.516 0.658 . . . . 0.0 110.038 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -82.06 140.99 33.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.114 0.483 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 872' ' ' ALA . 90.8 mt -130.25 138.8 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.51 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.3 m -99.37 126.13 45.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.08 115.36 25.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.107 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.28 -37.36 6.03 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.535 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.48 134.61 18.13 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.181 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -103.1 118.27 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 901' ' ' ASP . 60.0 t -63.96 -41.21 91.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.098 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 900' ' ' VAL . 36.4 m-20 103.97 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.905 1.378 . . . . 0.0 110.335 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 901' ' ' ASP . 10.2 tt0 80.7 -69.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.766 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -169.43 23.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -135.88 151.04 49.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.505 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.438 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 29.4 p90 -153.85 155.11 35.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.21 0.529 . . . . 0.0 110.3 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.88 138.5 42.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.64 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.24 178.14 30.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.144 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -148.13 157.92 43.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.747 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 914' ' ' ARG . 93.5 mt -80.35 142.14 54.11 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.27 139.2 16.53 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 120.312 1.147 . . . . 0.0 110.499 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.26 -5.06 67.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 9.1 p 61.3 23.55 13.76 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.535 -0.333 . . . . 0.0 111.532 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.6 m -62.39 -42.3 99.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.832 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 909' ' ' ILE . 36.7 mmt180 -134.9 153.04 52.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.456 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -145.37 135.75 24.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.75 177.22 46.15 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.9 pt -112.45 144.05 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.629 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -151.3 155.78 34.74 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.474 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 140.2 41.97 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.058 1.839 . . . . 0.0 113.395 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.22 -37.57 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.486 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 98.9 m -56.31 -42.54 77.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -76.09 0.25 19.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.158 0.435 . . . . 0.0 111.96 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.6 m -132.15 158.97 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.159 0.504 . . . . 0.0 111.245 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -107.14 123.95 49.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.455 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.27 110.15 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.24 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 32.4 mm -86.01 -47.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.868 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 143.19 51.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.444 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.171 179.854 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -132.98 145.77 58.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.227 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.59 120.27 3.9 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.934 1.756 . . . . 0.0 112.431 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -120.42 152.0 38.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 74.8 ttt180 -118.27 133.93 55.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.951 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -77.22 113.98 15.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 801' ' ' LYS . . . . . 0.479 ' O ' ' NZ ' ' A' ' 816' ' ' LYS . 18.8 mmmt -69.68 -38.17 76.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.168 0.509 . . . . 0.0 110.056 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.4 167.52 20.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.093 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 137.6 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.333 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -133.75 131.38 39.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.441 ' O ' ' NE2' ' A' ' 807' ' ' GLN . 68.8 mttm -100.7 134.54 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -81.86 144.05 31.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.99 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 807' ' ' GLN . . . . . 0.441 ' NE2' ' O ' ' A' ' 805' ' ' LYS . 25.8 mp0 -98.52 -35.32 10.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.68 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 47.1 p -135.03 171.66 14.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.386 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.2 -24.65 43.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.175 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.28 -38.83 88.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.285 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.409 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 24.6 mp0 -101.12 156.44 17.42 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.7 pt? -127.21 147.68 62.91 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 813' ' ' PRO . . . . . 0.502 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 58.3 Cg_endo -72.44 140.25 32.97 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 113.033 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.72 145.0 51.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -120.13 139.98 51.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.281 0.562 . . . . 0.0 110.426 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 816' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 801' ' ' LYS . 12.4 ttmm -43.83 121.54 2.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.27 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 98.52 -20.65 49.59 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.578 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.32 136.16 57.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.937 0.399 . . . . 0.0 111.399 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.97 131.63 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.867 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.0 m -124.93 152.87 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.646 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -110.82 121.54 45.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.799 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.501 HD13 ' HD2' ' A' ' 831' ' ' TYR . 67.0 mt -91.38 131.06 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -104.51 -32.22 9.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.674 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -158.28 149.86 21.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.494 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -88.48 110.77 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.285 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.36 -48.01 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.296 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 827' ' ' ASP . . . . . 0.432 ' OD1' ' OE1' ' A' ' 828' ' ' GLN . 8.2 t0 -154.76 177.86 10.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 828' ' ' GLN . . . . . 0.432 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 25.5 mp0 -61.36 -36.35 79.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.754 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -103.73 -2.55 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.173 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -127.97 139.38 52.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.501 ' HD2' HD13 ' A' ' 822' ' ' ILE . 5.0 m-85 -126.03 158.27 35.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.314 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 822' ' ' ILE . 0.6 OUTLIER -129.05 138.96 52.2 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.15 -176.01 33.77 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -117.56 152.91 34.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.971 0.415 . . . . 0.0 111.458 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.0 OUTLIER -164.52 137.05 4.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.159 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 49.3 t-80 52.6 29.93 7.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.302 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.22 2.63 90.57 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.515 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.9 148.25 30.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.05 136.93 52.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -170.7 -137.83 2.38 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.409 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 47.5 pt -133.83 157.01 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.93 0.365 . . . . 0.0 111.641 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 6.6 p90 -157.72 135.77 7.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.181 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.27 124.85 17.05 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.125 1.216 . . . . 0.0 112.442 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -54.92 -20.42 8.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.4 p -72.46 -11.28 60.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.48 -1.76 40.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.244 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.588 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -135.45 171.03 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.992 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -131.88 110.19 10.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.869 0.366 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.64 116.29 8.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 32.4 tp 54.05 72.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.676 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 122.183 1.922 . . . . 0.0 112.123 -179.243 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.77 143.97 50.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.206 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -157.2 144.59 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.5 mt -123.02 128.19 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.822 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.09 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.946 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 44.7 mtpt -70.05 -37.82 75.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.816 0.341 . . . . 0.0 110.497 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.71 153.53 49.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -57.11 159.46 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 878' ' ' PHE . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 26.9 t80 -150.49 138.72 20.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.72 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 879' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 40.0 p30 -151.85 92.04 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -82.69 -174.24 49.98 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 881' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 49.4 t0 -135.66 -9.38 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 111.641 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.5 p -79.26 174.3 11.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.98 0.419 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.45 -0.93 57.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 -18.77 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.642 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -72.57 141.95 48.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.58 128.56 46.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 22.5 t -92.85 125.45 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.109 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 34.4 p90 -154.9 162.37 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 33.2 mtp-105 -112.18 161.67 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.347 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -59.42 136.54 58.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 891' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 893' ' ' ARG . . . 90.15 -4.91 83.14 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 75.8 mm-40 -76.87 142.79 40.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.179 0.489 . . . . 0.0 110.562 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 891' ' ' GLY . 12.6 mpt_? -82.4 142.12 32.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.251 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.2 mt -131.38 143.17 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.2 m -100.65 127.09 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.873 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.581 HD11 HG13 ' A' ' 925' ' ' VAL . 81.6 mt -86.85 120.32 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.3 mt -100.18 -45.61 5.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -165.5 164.85 19.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.887 0.375 . . . . 0.0 111.134 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 899' ' ' GLN . . . . . 0.596 ' NE2' HD11 ' A' ' 920' ' ' ILE . 2.1 tp60 -103.58 116.95 33.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.761 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.434 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.8 t -61.86 -45.55 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.193 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 902' ' ' GLU . 34.4 t70 -148.56 -116.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.789 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.471 ' H ' ' CG ' ' A' ' 901' ' ' ASP . 99.7 mt-10 -114.32 -37.03 4.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.75 7.75 22.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.589 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -132.49 148.57 52.39 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.526 0.203 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.514 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.5 p90 -152.71 159.56 43.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.853 0.358 . . . . 0.0 110.283 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.69 136.79 48.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.32 178.39 30.38 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.547 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -151.79 159.75 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.7 mt -80.69 140.79 51.29 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.49 138.3 18.81 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 CA-C-N 120.148 1.088 . . . . 0.0 110.988 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.5 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.04 -6.91 73.0 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 911' ' ' GLY . 2.2 p 66.51 28.05 9.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.715 0.293 . . . . 0.0 111.15 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 88.0 p -64.21 -24.17 67.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -165.26 152.85 11.03 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.686 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.02 147.19 33.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.676 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 179.04 -174.55 46.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.551 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 45.9 pt -109.94 154.72 11.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.219 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 918' ' ' PHE . 0.0 OUTLIER -165.23 151.87 9.18 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.908 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.82 140.65 29.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.17 1.913 . . . . 0.0 112.768 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.596 HD11 ' NE2' ' A' ' 899' ' ' GLN . 90.1 mt -61.57 -32.05 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.801 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 97.9 m -57.9 -42.14 84.09 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -77.4 1.23 19.66 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.514 HG11 ' OH ' ' A' ' 905' ' ' TYR . 3.5 m -133.78 159.15 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.494 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -111.32 128.7 56.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.377 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 896' ' ' LEU . 79.3 t -99.58 105.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.687 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 926' ' ' ILE . 2.5 mp -62.19 -45.74 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 927' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 926' ' ' ILE . 98.2 mttt -138.31 140.41 39.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 CA--C 1.54 0.568 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.689 -179.916 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.73 0.3 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -158.77 98.46 1.69 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.19 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.824 1.683 . . . . 0.0 111.91 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.514 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -134.73 155.91 49.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -118.51 134.47 55.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.283 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 800' ' ' ALA . . . . . 0.534 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.29 116.92 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -71.3 -30.03 65.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.46 175.67 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.465 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 805' ' ' LYS . 14.5 t70 -82.31 126.73 32.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.455 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -115.56 130.73 56.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.981 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 803' ' ' ASP . 38.2 mmtm -94.21 130.16 40.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.2 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.77 139.51 55.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.24 -35.63 10.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.242 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.9 p -135.42 162.54 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.1 pp -50.61 -32.87 20.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.46 -46.13 91.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.268 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.848 ' OE2' HD11 ' A' ' 841' ' ' ILE . 2.7 mt-10 -90.03 136.97 32.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.025 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.4 mm? -110.67 150.72 42.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 152.02 50.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.219 1.946 . . . . 0.0 113.448 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 820' ' ' VAL . 4.8 mt -133.96 157.21 46.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.917 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.56 141.01 50.67 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.422 0.63 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -47.62 123.35 5.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.79 44.19 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.886 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.539 ' OD1' ' NE2' ' A' ' 835' ' ' HIS . 19.8 t70 -58.03 143.28 43.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 28.2 mm -103.78 131.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.655 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 814' ' ' LEU . 32.1 m -121.62 152.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.764 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.418 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 72.8 m-85 -111.94 113.58 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 832' ' ' GLU . 73.0 mt -81.36 127.14 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -119.33 -5.49 10.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.19 130.44 1.45 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.81 135.32 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 832' ' ' GLU . 48.9 mm -88.29 -48.92 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.42 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -152.48 178.98 8.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.13 -37.21 79.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.163 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -105.98 -0.43 24.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.929 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 830' ' ' TRP . . . . . 0.462 ' CE3' HD12 ' A' ' 841' ' ' ILE . 79.4 m95 -124.5 137.94 54.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.491 0.662 . . . . 0.0 112.089 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 822' ' ' ILE . 28.9 m-85 -128.03 151.85 48.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.372 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.506 ' OE1' HD11 ' A' ' 826' ' ' ILE . 9.0 tt0 -123.31 141.03 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -161.9 -163.51 14.92 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.49 150.13 49.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 111.008 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.6 ' HB2' HG12 ' A' ' 820' ' ' VAL . 1.2 t-80 -155.33 128.05 7.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.449 ' CB ' HH21 ' A' ' 838' ' ' ARG . 1.9 m80 52.38 24.04 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 92.09 -6.37 78.81 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 838' ' ' ARG . . . . . 0.449 HH21 ' CB ' ' A' ' 836' ' ' HIS . 12.0 ptp180 -98.08 151.9 19.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.337 0.568 . . . . 0.0 109.897 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 839' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 833' ' ' GLY . 9.2 p -131.55 129.24 61.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.92 23.87 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.848 HD11 ' OE2' ' A' ' 811' ' ' GLU . 31.1 pt -105.74 152.15 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 117.338 0.569 . . . . 0.0 110.588 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.5 OUTLIER -139.79 114.78 7.95 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.8 128.57 21.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.474 1.45 . . . . 0.0 112.721 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -50.85 -20.28 1.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.533 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 65.7 p -87.1 -3.18 59.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.663 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -6.42 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.221 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.8 pt -134.25 172.1 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.013 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -117.83 160.61 21.1 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.87 107.67 18.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 41.3 tp 46.41 77.64 0.45 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.472 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.495 1.615 0 C-N-CA 121.947 1.765 . . . . 0.0 111.809 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.733 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -129.02 150.55 50.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.722 0.296 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.496 ' O ' HD13 ' A' ' 873' ' ' ILE . . . -154.53 152.86 30.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 873' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 872' ' ' ALA . 23.2 mm -125.14 128.77 73.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -59.29 126.34 27.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.339 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 50.4 mtpt -73.85 -39.02 64.3 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -139.02 153.8 48.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.07 132.9 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -132.91 135.91 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.894 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -109.93 141.58 42.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.583 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.35 12.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -98.42 -12.15 21.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.25 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.4 p -132.99 163.31 29.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.28 -39.86 94.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.916 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.99 -25.01 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.843 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -98.2 127.47 44.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.8 tpt -105.07 123.59 48.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.937 0.399 . . . . 0.0 110.97 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 87.1 p -74.41 157.44 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.871 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -164.43 162.56 22.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 889' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 27.9 mmt180 -102.71 159.18 15.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.92 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -55.14 137.25 47.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.76 82.93 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.119 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 892' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 11.9 mm-40 -69.65 141.84 53.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.079 0.44 . . . . 0.0 110.712 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -91.25 135.26 33.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.136 0.493 . . . . 0.0 111.111 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.49 148.03 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.517 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.1 m -99.81 127.07 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.474 ' CD1' HG13 ' A' ' 925' ' ' VAL . 86.5 mt -84.03 125.11 31.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 111.104 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 98.3 mt -103.19 -50.71 3.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.021 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 898' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 36.7 ptt-85 -165.93 165.24 18.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.22 119.17 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.545 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 53.3 t -61.2 -47.65 92.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.764 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.1 m-20 -144.2 -91.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.07 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.427 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.2 tp10 -137.93 -46.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -102.1 7.46 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -133.23 149.39 52.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.688 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.505 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.4 p90 -153.57 161.78 41.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.054 0.455 . . . . 0.0 111.165 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 33.8 tt0 -109.96 139.2 45.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.867 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.47 176.24 28.29 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -144.62 156.23 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.782 0.325 . . . . 0.0 110.436 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 909' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 914' ' ' ARG . 92.1 mt -103.21 107.67 56.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.066 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -54.09 135.28 63.66 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.35 1.367 . . . . 0.0 111.358 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 97.01 -22.31 41.45 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 74.6 p -127.58 -17.55 4.57 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.992 0.425 . . . . 0.0 110.022 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 57.5 m 51.61 36.57 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.216 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.457 ' HB2' HD12 ' A' ' 909' ' ' ILE . 11.3 mmp_? -86.25 98.09 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -86.33 128.23 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -157.03 163.91 32.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.496 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.3 144.9 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.895 0.378 . . . . 0.0 111.068 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.496 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -158.49 164.28 21.69 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.857 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.39 137.06 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.412 2.074 . . . . 0.0 113.925 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 902' ' ' GLU . 91.6 mt -60.77 -39.09 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.88 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 70.1 p -54.92 -22.48 15.07 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.757 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -95.11 0.85 54.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.505 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.6 m -132.3 157.88 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.13 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.43 121.83 45.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 896' ' ' LEU . 67.5 t -90.19 103.95 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 41.4 mm -72.38 -43.58 64.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.131 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -132.82 151.92 51.92 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.703 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.653 0.263 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.514 ' HB3' HD21 ' A' ' 849' ' ' LEU . 98.8 mtt180 -125.82 97.61 35.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.545 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.56 140.88 96.56 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.075 1.85 . . . . 0.0 111.905 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -135.17 155.83 50.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -117.54 133.66 55.72 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.451 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -79.41 127.07 31.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -91.99 -28.72 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.14 162.62 32.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.079 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.5 p-10 -75.94 137.77 40.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.457 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.27 129.02 55.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.003 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -96.03 124.98 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 806' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -70.72 137.88 50.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.7 -38.8 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.418 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 67.8 p -135.64 162.87 31.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.62 -34.35 7.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.21 -39.86 94.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.993 0.425 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.643 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 3.6 mt-10 -92.83 128.33 38.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.977 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.1 mm? -108.71 150.09 40.32 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.649 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.74 151.43 63.49 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.203 1.935 . . . . 0.0 113.023 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 3.2 tp -135.82 151.26 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.612 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.19 137.86 53.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.47 0.652 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.42 126.27 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.66 -23.64 34.97 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.294 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 818' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.3 t0 -59.78 133.98 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 819' ' ' ILE . . . . . 0.47 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 44.7 mm -91.82 130.11 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 798' ' ' ALA . 0.0 OUTLIER -118.99 145.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.222 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.428 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 71.0 m-85 -107.51 104.86 14.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.6 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.45 130.89 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -100.35 -38.21 8.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.832 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -161.37 156.15 23.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.479 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.33 111.12 20.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.026 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 826' ' ' ILE . . . . . 0.456 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 48.0 mm -63.34 -47.35 92.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.278 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -148.88 177.12 9.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.62 -25.3 68.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -123.96 11.42 8.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -137.91 145.26 41.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.495 ' OH ' HG21 ' A' ' 847' ' ' ILE . 29.4 p90 -140.76 165.5 27.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -127.61 139.06 52.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.398 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.13 -172.24 29.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -111.83 138.84 47.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.779 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.496 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.4 p-80 -141.71 133.74 27.57 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 836' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 52.83 29.69 8.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.13 5.78 89.86 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.012 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -115.92 150.11 37.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.5 p -114.4 141.99 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.01 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -171.01 -158.62 15.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.44 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 49.4 pt -126.45 149.63 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.76 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 842' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -151.4 154.03 33.08 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.45 125.8 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.623 1.548 . . . . 0.0 111.825 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -56.98 -27.67 61.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.174 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.8 p -66.82 -12.84 60.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.255 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -96.36 -1.32 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.893 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -140.45 169.11 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.439 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 848' ' ' GLU . . . . . 0.636 ' N ' HD12 ' A' ' 847' ' ' ILE . 82.1 tt0 -130.42 120.26 23.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 796' ' ' ARG . 2.9 tt -63.2 115.79 4.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.897 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 850' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 849' ' ' LEU . 0.2 OUTLIER 44.62 77.22 0.46 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.305 -1.745 0 C-N-CA 122.653 2.236 . . . . 0.0 111.334 179.872 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -135.04 147.17 49.56 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.503 0.192 . . . . 0.0 110.717 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -152.67 154.14 34.7 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 92.9 mt -124.74 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.754 0.312 . . . . 0.0 110.436 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.47 57.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.327 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -87.2 -29.67 21.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -137.94 145.48 42.07 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.708 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.3 p-10 -51.34 122.14 7.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -117.05 125.86 51.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -119.81 105.6 11.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.301 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -65.26 137.97 38.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -102.89 1.14 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.9 p -130.5 163.09 27.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -62.01 -40.81 96.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 884' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 884' ' ' VAL . 14.0 m -67.62 -25.36 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.572 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -97.42 136.39 37.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.185 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 886' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 915' ' ' GLN . 0.0 OUTLIER -107.24 168.05 9.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 41.5 t -118.44 136.16 53.95 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.942 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.92 162.05 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -82.67 162.33 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.717 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 890' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 890' ' ' LYS . 10.6 pttt -73.09 42.36 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.267 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . -160.83 -0.38 0.07 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.069 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.68 143.18 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.795 0.798 . . . . 0.0 110.406 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -76.23 143.08 41.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.995 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 872' ' ' ALA . 92.0 mt -129.19 139.13 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.524 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.8 m -99.14 125.25 44.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.83 116.48 20.01 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 897' ' ' LEU . . . . . 0.563 HD11 ' HD2' ' A' ' 908' ' ' ARG . 86.6 mt -97.64 -46.07 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -166.18 164.61 17.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.984 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -103.91 118.41 36.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.465 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.4 t -65.26 -45.31 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.647 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -152.03 -125.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.769 0.318 . . . . 0.0 111.047 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.08 -25.11 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.339 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -135.47 18.93 3.35 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.599 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.51 146.95 51.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.733 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.465 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 15.0 p90 -156.42 161.29 40.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.053 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.65 133.89 50.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.502 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -147.91 172.96 28.12 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.557 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 908' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 897' ' ' LEU . 8.7 ptm180 -155.96 163.39 39.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.812 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 84.3 mt -94.01 139.26 22.55 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.96 141.52 36.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.214 1.112 . . . . 0.0 111.061 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.09 68.58 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.498 HG23 HH21 ' A' ' 908' ' ' ARG . 1.2 m 73.78 28.37 1.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 44.9 t -67.9 -50.14 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -135.19 148.07 49.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.082 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 915' ' ' GLN . . . . . 0.488 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.6 tt0 -151.24 135.18 16.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.278 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 176.78 -174.89 47.37 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.0 pt -115.47 146.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.36 0.6 . . . . 0.0 111.456 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -161.75 158.82 22.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.677 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.05 140.43 45.34 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.489 2.126 . . . . 0.0 114.452 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.19 -32.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.269 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.7 m -57.62 -39.44 76.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.749 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.85 5.04 23.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.06 158.46 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.169 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -111.0 123.14 49.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.267 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.483 ' C ' HD12 ' A' ' 926' ' ' ILE . 4.7 m -95.04 141.53 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.011 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -107.47 -37.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.265 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -136.49 136.29 39.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.523 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.718 179.155 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.957 0.408 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.713 ' HB2' HD11 ' A' ' 849' ' ' LEU . 25.3 mmt180 -135.6 148.89 67.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.57 116.31 4.45 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.942 1.762 . . . . 0.0 111.987 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 798' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -112.32 152.67 28.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -118.85 129.36 55.17 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.662 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.19 112.66 9.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.97 -35.43 78.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.121 0.486 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -137.81 162.63 33.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.668 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 803' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 31.1 t70 -73.71 138.31 44.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.412 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.03 119.02 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.07 0.462 . . . . 0.0 110.632 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -84.48 144.87 28.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -72.82 114.96 11.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.3 -39.92 89.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.449 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.9 p -134.29 162.26 32.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -34.1 14.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.61 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -61.0 -43.88 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.381 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 811' ' ' GLU . . . . . 0.435 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 7.9 mt-10 -77.3 162.87 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 812' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 840' ' ' GLY . 3.9 pp -125.27 150.13 66.29 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.7 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.14 146.92 32.73 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.118 1.879 . . . . 0.0 111.997 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 814' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 820' ' ' VAL . 13.0 mt -140.24 140.92 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.501 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -120.64 139.55 52.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.521 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -43.8 124.02 3.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.215 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.61 -19.44 53.59 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.09 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.8 136.0 57.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.936 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.88 134.31 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 820' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 798' ' ' ALA . 35.4 m -128.81 157.96 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 821' ' ' TYR . . . . . 0.43 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 98.1 m-85 -115.12 111.14 20.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.475 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 822' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 831' ' ' TYR . 30.4 mm -79.73 96.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -85.29 -14.97 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.06 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 824' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.3 tttm -162.86 131.7 4.06 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.785 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.12 127.46 34.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.31 -56.44 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.015 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -151.73 177.4 10.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.45 -23.72 67.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.377 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -111.74 -3.66 14.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.417 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -131.71 134.98 46.48 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.277 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 831' ' ' TYR . . . . . 0.499 ' CD2' HG21 ' A' ' 822' ' ' ILE . 1.3 m-85 -124.21 160.35 28.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.887 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 832' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 9.7 tt0 -136.31 135.94 39.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 833' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.25 -165.58 15.3 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -120.27 139.09 53.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.506 0.193 . . . . 0.0 110.898 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 835' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.4 p-80 -143.68 134.46 25.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 71.9 t60 50.21 31.95 5.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.71 3.27 90.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.919 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -109.65 155.68 21.18 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.2 t -124.21 135.01 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 840' ' ' GLY . . . . . 0.859 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.08 -157.33 10.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 841' ' ' ILE . . . . . 0.435 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 48.0 pt -131.42 154.13 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.226 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.53 148.9 14.45 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.83 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 126.11 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.303 1.335 . . . . 0.0 113.075 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -56.54 -28.04 59.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.76 -13.44 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -93.82 -0.79 55.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 847' ' ' ILE . . . . . 0.446 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.5 pp -139.61 167.08 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.9 126.71 27.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 849' ' ' LEU . . . . . 0.713 HD11 ' HB2' ' A' ' 796' ' ' ARG . 12.1 tp -78.46 113.65 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.2 tp 51.97 73.49 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.305 -1.725 0 C-N-CA 122.466 2.111 . . . . 0.0 111.812 -179.582 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -116.82 151.52 36.34 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 872' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 894' ' ' ILE . . . -152.82 146.98 25.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 7.5 mm -125.3 127.95 72.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.01 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 874' ' ' ALA . . . . . 0.429 ' HB1' ' HE1' ' A' ' 922' ' ' TYR . . . -64.27 129.48 40.11 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 875' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -85.37 -31.98 22.65 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -137.0 146.01 44.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.173 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 877' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.0 p-10 -52.38 117.76 3.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -112.51 125.07 53.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.722 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -110.91 106.1 15.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 880' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -68.15 141.97 38.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -94.76 -9.43 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 60.9 p -134.15 163.27 29.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -61.58 -38.45 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.949 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.16 -41.8 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.084 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -87.37 104.73 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.64 146.07 50.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 887' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 97.7 p -107.85 151.82 25.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.1 OUTLIER -164.68 176.48 8.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.723 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -105.49 172.8 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.25 136.43 57.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.046 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 88.72 1.12 80.82 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.037 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.67 139.84 42.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.767 0.783 . . . . 0.0 109.949 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.39 141.39 35.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.099 0.476 . . . . 0.0 111.149 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 894' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 872' ' ' ALA . 96.6 mt -133.48 144.2 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.831 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.1 m -103.41 128.16 50.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.917 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.499 HD11 HG13 ' A' ' 925' ' ' VAL . 85.3 mt -85.15 126.92 34.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.6 mt -108.73 -55.09 2.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -159.14 153.73 24.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.229 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -93.13 115.9 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.764 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 900' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 57.0 t -61.89 -47.46 93.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 901' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 88.5 m-20 -143.39 -102.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 902' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 920' ' ' ILE . 24.3 pt-20 -130.83 -38.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.493 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -107.19 5.22 27.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.57 150.34 52.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.764 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 905' ' ' TYR . . . . . 0.48 ' OH ' HG11 ' A' ' 923' ' ' VAL . 25.7 p90 -152.08 159.98 43.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.6 tt0 -103.12 133.91 47.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.499 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.72 30.35 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.167 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -149.8 157.34 43.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.957 0.408 . . . . 0.0 110.451 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 49.5 mm -80.06 141.12 54.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.83 139.62 24.58 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.972 1.114 . . . . 0.0 111.184 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 911' ' ' GLY . . . . . 0.536 ' C ' HG23 ' A' ' 912' ' ' THR . . . 93.96 -8.08 73.31 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 912' ' ' THR . . . . . 0.536 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 67.71 28.35 7.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 111.129 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 96.0 p -63.78 -26.51 68.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.23 153.45 13.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 915' ' ' GLN . . . . . 0.507 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 46.2 tt0 -142.72 142.51 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.572 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.12 48.17 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 917' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 906' ' ' GLU . 43.9 pt -117.74 145.24 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -153.27 166.07 16.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.19 132.74 35.15 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 122.345 2.03 . . . . 0.0 114.425 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 920' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 902' ' ' GLU . 96.4 mt -59.79 -40.14 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.993 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 921' ' ' THR . . . . . 0.507 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 68.1 p -61.15 -25.46 67.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 922' ' ' TYR . . . . . 0.7 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -82.6 -2.09 52.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.541 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 923' ' ' VAL . . . . . 0.7 HG13 ' CD2' ' A' ' 922' ' ' TYR . 27.6 m -129.43 155.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.494 0.664 . . . . 0.0 112.229 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.081 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 925' ' ' VAL . . . . . 0.499 HG13 HD11 ' A' ' 896' ' ' LEU . 78.3 t -90.71 99.46 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.273 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 926' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -64.62 -47.3 89.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 927' ' ' LYS . . . . . 0.481 ' HG3' HG22 ' A' ' 926' ' ' ILE . 59.8 mtpt -139.94 146.53 39.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.88 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.193 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 788' ' ' GLN . . . . . 0.805 HE21 ' N ' ' A' ' 788' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.492 ' H ' ' HG2' ' A' ' 788' ' ' GLN . 62.9 t-80 -65.67 -37.43 86.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.327 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 51.5 ttp 76.47 59.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.786 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.2 t -151.15 148.89 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.289 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 88.98 63.13 1.33 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 69.3 m -61.28 147.05 45.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -66.98 142.29 57.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.42 167.09 18.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.466 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.67 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 89.9 mtm180 -123.68 138.74 30.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.044 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 120.6 6.73 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.655 1.57 . . . . 0.0 112.688 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -113.58 146.01 40.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -108.3 132.55 53.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.362 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -73.21 112.32 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.6 -38.04 86.17 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 109.714 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -139.41 -177.97 5.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 56.0 p-10 -93.07 144.24 25.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.355 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -133.77 128.15 34.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.54 134.36 35.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -73.84 133.95 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -105.63 -26.43 11.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.2 p -130.63 169.73 15.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.3 mp -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.473 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.94 -40.43 95.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.509 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.0 mt-10 -79.85 131.73 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.312 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.46 151.37 44.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 813' ' ' PRO . . . . . 0.73 ' O ' HD12 ' A' ' 814' ' ' LEU . 57.3 Cg_endo -70.05 145.75 56.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.104 1.87 . . . . 0.0 113.036 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.832 HD21 HG11 ' A' ' 820' ' ' VAL . 1.6 mp -136.86 140.81 42.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.276 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -118.47 142.4 47.61 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.423 0.63 . . . . 0.0 110.809 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -48.71 122.97 6.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.639 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.23 54.49 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.72 128.81 37.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.62 135.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.832 HG11 HD21 ' A' ' 814' ' ' LEU . 31.1 m -131.32 152.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.44 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 87.1 m-85 -113.01 119.55 38.28 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 832' ' ' GLU . 22.5 mm -87.35 103.87 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -93.69 -7.23 44.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.657 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.24 132.61 2.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.147 0.499 . . . . 0.0 111.314 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -90.51 112.3 23.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.674 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.6 -49.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -159.47 178.16 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.23 -35.33 76.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.054 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -100.15 -6.1 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.883 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -130.35 135.01 47.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.317 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.428 ' HD2' HG21 ' A' ' 822' ' ' ILE . 4.5 m-85 -123.1 152.61 40.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.464 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 822' ' ' ILE . 13.9 tt0 -127.83 137.8 52.49 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.62 -175.33 28.43 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -110.86 138.72 46.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.106 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.1 p-80 -143.18 133.32 24.39 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 51.54 31.79 8.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.418 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.19 90.3 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.743 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -115.44 155.23 27.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.0 p -120.61 143.74 31.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.999 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.86 -168.74 31.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 17.7 pt -126.38 154.22 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.701 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -163.69 156.09 15.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.63 118.93 5.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.115 1.877 . . . . 0.0 112.751 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -47.68 -19.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.3 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 63.8 p -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -6.21 21.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.1 pt -132.17 169.76 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.706 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -122.83 106.76 11.18 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.089 0.471 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.67 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 59.2 tp -61.59 112.55 2.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.781 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.33 78.65 0.38 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.533 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.54 152.17 57.11 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.675 2.25 . . . . 0.0 111.873 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 151.21 75.76 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.31 2.007 . . . . 0.0 111.814 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -99.78 121.67 41.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.73 -12.23 45.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.251 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.29 142.99 28.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.939 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.67 66.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 63.79 70.7 0.67 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.533 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.08 -21.6 66.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.367 2.711 . . . . 0.0 112.702 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 59.08 39.45 23.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 41.04 -129.49 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.649 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 861' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 861' ' ' LEU . 0.5 OUTLIER -161.47 176.09 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.45 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 4.4 t -148.28 144.03 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.586 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.28 -22.53 60.42 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.055 1.837 . . . . 0.0 112.217 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 866' ' ' VAL . 0.0 OUTLIER -101.86 -169.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 55.08 40.97 32.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.521 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 864' ' ' VAL . 34.2 m -131.93 159.11 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.83 152.85 34.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.71 133.69 29.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -82.0 143.78 31.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.616 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -75.06 156.06 48.54 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.57 149.98 41.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.707 0.289 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.59 155.95 27.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.38 133.62 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.71 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.1 133.99 56.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.969 0.414 . . . . 0.0 111.656 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -83.81 -25.61 30.24 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.28 146.61 38.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -52.93 139.93 26.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.412 ' CB ' ' CE1' ' A' ' 888' ' ' PHE . 26.6 t80 -131.88 130.86 42.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.909 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -131.72 89.9 2.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -74.47 171.02 53.39 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -133.92 12.82 3.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.615 0.245 . . . . 0.0 111.045 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 882' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 885' ' ' GLU . 82.8 p -130.73 159.01 38.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.742 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -62.55 -40.93 98.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.62 HG23 ' HG2' ' A' ' 885' ' ' GLU . 15.7 m -66.01 -26.3 38.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.528 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.2 mm-40 -103.45 120.79 41.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 8.0 mmt -93.24 172.26 8.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.543 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 93.0 p -121.87 148.91 44.12 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.109 0.48 . . . . 0.0 110.967 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.412 ' CE1' ' CB ' ' A' ' 878' ' ' PHE . 11.9 p90 -161.03 160.19 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.493 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 3.6 mtp-105 -95.06 170.25 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.198 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -73.49 52.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.122 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 176.22 16.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.966 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 889' ' ' ARG . 14.9 mp0 -97.33 149.62 21.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.438 0.619 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -84.59 148.85 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.046 0.45 . . . . 0.0 110.513 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 872' ' ' ALA . 93.7 mt -132.57 144.54 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.504 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.0 m -102.7 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.98 130.38 35.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.074 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.44 -54.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.111 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 898' ' ' ARG . . . . . 0.54 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 34.6 ptt-85 -166.05 165.04 18.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 899' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 901' ' ' ASP . 35.0 tt0 -99.92 120.27 39.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.761 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.411 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.1 t -62.23 -46.83 95.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.982 0.42 . . . . 0.0 111.094 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 899' ' ' GLN . 12.9 t70 -144.79 -95.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.011 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 98.7 mt-10 -132.49 -45.54 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.698 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.31 8.13 35.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -131.58 148.64 52.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.593 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.669 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.1 p90 -154.87 161.86 41.3 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.66 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.54 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 88.2 tt0 -109.61 137.84 46.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.33 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.71 172.11 31.81 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -149.99 156.31 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.339 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 914' ' ' ARG . 87.6 mt -77.4 139.55 64.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.37 137.93 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.103 1.202 . . . . 0.0 111.122 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.73 -10.35 66.46 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 69.33 25.69 5.51 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 89.6 p -67.25 -38.99 86.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.518 ' HB2' HD12 ' A' ' 909' ' ' ILE . 99.7 mtt180 -139.46 150.27 44.99 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.264 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -145.56 142.68 29.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.257 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -179.34 -179.62 48.76 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.397 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -119.87 150.91 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.943 0.401 . . . . 0.0 111.121 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -163.63 160.89 17.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.38 139.49 49.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.14 1.893 . . . . 0.0 113.124 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.75 -38.96 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.028 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 69.2 p -57.85 -11.3 2.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.576 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.95 0.66 32.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.669 HG11 ' OH ' ' A' ' 905' ' ' TYR . 10.7 m -132.99 158.25 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 111.194 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.97 131.71 56.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.692 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.4 -45.79 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.599 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.71 121.75 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.895 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.77 149.68 88.17 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.52 151.15 64.52 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.103 1.869 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.66 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -123.77 137.08 54.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.391 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -157.78 165.37 35.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.625 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 49.6 m 56.07 44.43 25.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -167.69 176.23 42.44 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 67.2 m -124.9 144.25 50.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.91 0.33 56.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 795' ' ' MET . 0.5 OUTLIER -144.67 166.08 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -132.77 95.72 19.25 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.77 140.45 93.37 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.04 1.827 . . . . 0.0 112.099 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -133.54 154.2 51.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -116.4 135.04 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.774 0.321 . . . . 0.0 110.646 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -79.18 127.06 31.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.869 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.23 -14.97 20.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.207 0.527 . . . . 0.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -151.84 167.31 28.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.6 p-10 -91.49 133.89 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.63 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -127.71 128.66 45.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -93.27 135.68 34.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.62 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.566 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -100.37 -22.67 14.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.993 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 808' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 809' ' ' LEU . 87.5 m -128.05 162.81 25.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.34 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.541 ' N ' HG22 ' A' ' 808' ' ' THR . 60.7 tp -58.27 -42.84 87.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.106 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.3 -39.35 90.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.195 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.79 149.12 48.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.821 ' O ' HD12 ' A' ' 812' ' ' LEU . 2.2 pp -125.79 151.22 70.67 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 813' ' ' PRO . . . . . 0.509 ' O ' ' NE2' ' A' ' 835' ' ' HIS . 74.5 Cg_endo -74.45 141.32 28.22 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.667 1.578 . . . . 0.0 112.102 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.16 148.76 52.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.061 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -120.18 135.26 55.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.339 0.59 . . . . 0.0 109.936 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 816' ' ' LYS . . . . . 0.494 ' HB3' ' HZ2' ' A' ' 816' ' ' LYS . 0.0 OUTLIER -43.38 124.39 3.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.176 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.64 -21.02 48.04 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.675 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.56 134.78 51.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 29.1 mm -93.58 129.57 43.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.156 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 798' ' ' ALA . 29.9 m -124.53 153.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 88.6 m-85 -113.6 121.62 44.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 832' ' ' GLU . 70.1 mt -91.23 129.3 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -109.46 -16.15 14.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -168.42 142.47 3.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 111.46 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 825' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 827' ' ' ASP . 52.4 tt0 -85.33 136.5 33.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.142 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.4 -50.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 109.876 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.406 ' C ' HE21 ' A' ' 825' ' ' GLN . 7.0 t0 -149.61 179.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.925 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.46 -36.37 80.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.908 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -104.58 -1.51 26.4 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -126.96 139.34 53.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.359 0.599 . . . . 0.0 111.609 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.535 ' HD2' HD13 ' A' ' 822' ' ' ILE . 12.7 m-85 -125.6 156.92 38.39 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.584 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 822' ' ' ILE . 1.6 tp10 -124.43 139.9 53.45 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -168.75 -173.21 36.34 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -116.78 150.59 38.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 813' ' ' PRO . 0.5 OUTLIER -155.88 134.51 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.521 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.9 t-80 51.22 31.83 7.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.77 80.05 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 838' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 839' ' ' VAL . 44.0 tpt85 -121.09 135.09 55.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 838' ' ' ARG . 99.6 t -112.65 129.23 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.496 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.793 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.96 -154.56 8.5 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.09 160.83 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 117.062 0.431 . . . . 0.0 110.877 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -160.8 152.8 16.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 845' ' ' THR . 60.6 Cg_endo -73.75 121.67 7.2 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.077 1.852 . . . . 0.0 112.623 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 844' ' ' ARG . . . . . 0.408 ' NE ' ' CE1' ' A' ' 831' ' ' TYR . 3.4 ttm180 -50.56 -10.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.519 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 843' ' ' PRO . 62.6 p -80.51 -10.85 59.73 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.474 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -102.9 -3.98 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.666 0.269 . . . . 0.0 111.231 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 800' ' ' ALA . 42.6 pt -136.21 173.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.544 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 80.2 tt0 -114.66 161.48 18.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.72 103.98 12.29 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.8 tp 53.38 77.91 0.42 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.688 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.29 162.92 39.24 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.132 1.888 . . . . 0.0 111.879 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.31 138.53 55.52 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.738 1.625 . . . . 0.0 111.649 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -114.75 124.57 52.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.34 -38.16 90.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.401 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 856' ' ' ALA . 60.5 mtpt -62.83 140.14 58.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 855' ' ' LYS . . . 169.78 17.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 857' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 857' ' ' GLN . 19.1 mp0 -69.51 148.86 97.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.41 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.35 -19.85 49.29 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.329 2.019 . . . . 0.0 112.286 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.41 144.57 54.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.528 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -127.84 150.96 49.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 861' ' ' LEU . . . . . 0.639 ' H ' HD23 ' A' ' 861' ' ' LEU . 0.1 OUTLIER -73.2 89.11 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 5.7 t -145.82 143.3 19.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.261 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 150.36 66.82 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.142 1.894 . . . . 0.0 112.355 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.06 160.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.434 ' HB2' HD13 ' A' ' 867' ' ' LEU . 26.5 pt20 -161.12 -39.69 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.657 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 2.1 t 55.41 19.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.299 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 865' ' ' GLN . 3.8 mp -62.49 -41.45 98.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.769 0.318 . . . . 0.0 110.799 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 50.54 45.42 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.48 -173.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.167 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -73.38 167.54 54.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.29 160.98 31.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.441 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -155.28 150.24 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.94 123.07 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.297 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.06 117.06 6.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -69.57 -35.27 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.498 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -130.27 142.22 50.56 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.887 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -47.85 134.24 13.43 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 888' ' ' PHE . 66.9 t80 -124.62 134.33 52.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.426 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -128.71 100.51 5.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.73 155.39 52.87 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 881' ' ' ASP . . . . . 0.798 ' OD1' HG23 ' A' ' 882' ' ' THR . 58.3 p30 -116.78 -0.29 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.11 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 882' ' ' THR . . . . . 0.798 HG23 ' OD1' ' A' ' 881' ' ' ASP . 70.6 p -127.29 158.02 38.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -65.24 -32.38 74.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.919 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 885' ' ' GLU . 12.4 m -70.66 -26.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.052 0.453 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.466 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.7 mt-10 -98.37 113.5 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.944 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.723 ' SD ' HD13 ' A' ' 909' ' ' ILE . 28.0 ttt -84.23 135.77 34.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 90.3 p -82.84 153.87 24.95 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.082 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 878' ' ' PHE . 16.9 p90 -161.9 161.02 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -100.07 160.52 14.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.569 0.7 . . . . 0.0 112.754 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -58.4 130.24 45.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.24 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.15 1.64 89.53 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -72.17 139.7 48.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.24 141.9 30.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 86.7 mt -132.85 147.96 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.8 m -99.61 129.62 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.54 119.38 25.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.906 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.36 -53.14 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.12 165.68 17.57 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.814 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -98.27 112.82 24.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.454 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.423 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 10.2 p -81.27 -24.6 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.858 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -155.84 174.55 15.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.535 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.17 -32.18 73.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.052 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -113.95 2.06 14.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -134.02 151.88 51.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.478 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.423 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 31.8 p90 -150.94 158.33 44.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.034 0.445 . . . . 0.0 110.429 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.1 135.9 41.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.292 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.05 178.21 29.43 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -147.41 157.66 43.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.494 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.723 HD13 ' SD ' ' A' ' 886' ' ' MET . 1.5 mp -78.89 135.45 59.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.578 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -45.94 137.81 12.68 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 120.898 1.065 . . . . 0.0 111.377 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.59 62.22 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.92 34.7 1.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.61 0.243 . . . . 0.0 111.084 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.3 t -61.29 -46.49 90.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.638 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -171.34 149.39 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.54 144.44 37.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -164.8 170.51 39.91 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.2 pt -116.33 147.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.154 0.502 . . . . 0.0 111.224 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.0 159.59 29.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.16 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.2 137.64 29.07 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.473 2.116 . . . . 0.0 113.919 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 923' ' ' VAL . 88.3 mt -61.31 -35.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.488 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 96.4 m -53.92 -42.8 69.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.218 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.7 -0.22 33.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.308 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.441 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.9 t -125.18 147.89 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.14 0.495 . . . . 0.0 110.674 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.8 121.28 41.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.202 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.11 116.95 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.385 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.23 -47.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.84 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.93 133.24 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -71.04 150.1 94.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.349 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.66 152.82 59.51 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.087 1.858 . . . . 0.0 112.156 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.383 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 58.19 65.96 1.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.92 143.4 57.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.1 t -148.17 149.83 32.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.71 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 92.46 -7.75 77.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 66.6 m -126.9 143.68 51.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 110.507 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 794' ' ' GLU . . . . . 0.495 ' O ' ' SD ' ' A' ' 795' ' ' MET . 98.9 mt-10 -135.34 146.06 48.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 794' ' ' GLU . 31.5 mmm -130.15 164.41 24.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -128.89 98.55 24.09 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 119.553 -0.261 . . . . 0.0 110.89 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.92 138.69 26.25 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.419 1.413 . . . . 0.0 112.244 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.04 47.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 799' ' ' ARG . . . . . 0.438 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 75.2 ttt180 -104.89 137.22 43.0 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.296 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.668 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -82.52 121.22 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -95.19 -12.86 25.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.159 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 802' ' ' PHE . . . . . 0.402 ' HB2' ' CD2' ' A' ' 846' ' ' TYR . 97.6 m-85 -136.42 141.79 43.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.53 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 58.3 p-10 -68.52 150.04 48.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 804' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 814' ' ' LEU . 90.2 t80 -147.64 128.67 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.28 130.63 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -63.35 132.3 51.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.419 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.69 -32.93 10.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.18 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 808' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 810' ' ' LYS . 92.4 m -128.96 138.16 51.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.505 ' CD1' HH21 ' A' ' 838' ' ' ARG . 0.8 OUTLIER -36.7 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.894 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 810' ' ' LYS . . . . . 0.499 ' H ' HG22 ' A' ' 808' ' ' THR . 87.9 tttt -60.96 -48.43 81.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 808' ' ' THR . 3.2 mt-10 -72.79 165.56 24.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 110.621 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 812' ' ' LEU . 0.5 OUTLIER -132.73 155.38 81.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 146.81 61.6 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.927 1.751 . . . . 0.0 111.542 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.843 HD11 HG11 ' A' ' 820' ' ' VAL . 2.6 tp -140.75 132.4 27.21 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 815' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 35.3 tp60 -96.36 147.54 23.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 110.808 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -64.01 36.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 176.17 19.16 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.111 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.54 168.91 10.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.515 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.432 ' O ' ' ND1' ' A' ' 835' ' ' HIS . 35.8 mm -108.76 136.16 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 814' ' ' LEU . 25.7 m -129.95 151.47 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.9 115.73 26.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 94.2 mt -74.92 134.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 823' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 823' ' ' TYR . 1.8 p90 -128.7 -5.24 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.264 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -170.32 125.31 0.75 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.5 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -80.32 125.85 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.5 mm -78.49 -52.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.12 175.92 9.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.906 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -60.1 -18.48 47.38 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.28 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.01 -52.25 2.7 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.043 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 830' ' ' TRP . . . . . 0.414 ' HE1' ' HG3' ' A' ' 843' ' ' PRO . 23.2 m-90 -70.52 151.35 45.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 849' ' ' LEU . 62.8 m-85 -131.01 148.62 52.77 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.21 135.2 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -153.47 -177.59 27.14 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -110.48 141.38 43.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.949 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.664 ' HB2' HG12 ' A' ' 820' ' ' VAL . 81.6 t60 -164.49 135.54 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.928 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.8 t-80 62.92 31.5 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.236 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.46 18.71 78.54 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 838' ' ' ARG . . . . . 0.505 HH21 ' CD1' ' A' ' 809' ' ' LEU . 12.2 tpt180 -136.5 154.55 50.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.33 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 833' ' ' GLY . 13.8 p -129.0 141.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.38 -140.55 2.96 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.25 152.84 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.793 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 847' ' ' ILE . 3.5 p90 -156.92 127.91 3.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.61 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.414 ' HG3' ' HE1' ' A' ' 830' ' ' TRP . 50.1 Cg_exo -54.62 137.6 73.86 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.446 1.431 . . . . 0.0 111.994 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.51 -29.24 68.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.643 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 79.1 p -69.83 -15.66 63.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.392 . . . . 0.0 110.83 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 846' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 802' ' ' PHE . 0.6 OUTLIER -93.35 -2.24 55.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.76 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 800' ' ' ALA . 29.8 pt -137.4 173.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.237 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 851' ' ' PRO . 11.3 tm-20 -124.14 106.32 10.24 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 831' ' ' TYR . 17.9 mt -59.95 113.78 2.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.94 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.5 mt 46.5 82.18 0.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.084 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 851' ' ' PRO . . . . . 0.529 ' N ' ' OE1' ' A' ' 848' ' ' GLU . 73.0 Cg_endo -78.11 159.46 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 122.185 1.923 . . . . 0.0 112.015 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 146.48 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.108 . . . . 0.0 112.041 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -125.15 -11.71 6.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.517 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.84 142.5 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -118.64 122.42 42.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.269 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -142.82 40.92 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.613 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -130.07 65.47 75.51 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.728 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.5 145.74 38.23 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.392 2.061 . . . . 0.0 112.088 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 146.13 48.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.646 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 860' ' ' LYS . . . . . 0.529 ' C ' HD12 ' A' ' 861' ' ' LEU . 65.0 tttp -143.28 129.35 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.38 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 861' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 860' ' ' LYS . 8.7 mp -118.93 128.29 54.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.459 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 4.2 t -153.19 143.95 15.86 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.02 149.08 64.71 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.99 1.793 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.23 -45.5 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -76.0 150.84 37.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.55 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.34 124.88 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.345 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.54 97.82 7.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -137.6 132.83 33.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -115.52 139.35 50.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.447 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -70.7 155.51 52.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.35 153.84 41.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.85 146.56 22.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 38.9 mm -117.08 121.91 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.47 125.92 25.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.479 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -72.61 -36.96 68.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.978 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.94 151.04 52.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.773 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -55.25 145.85 20.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -150.9 135.96 17.54 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.25 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -133.43 116.26 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.482 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.0 145.47 33.66 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.98 -2.22 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.739 0.304 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 58.8 p -133.6 163.83 28.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -61.31 -39.19 89.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.177 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.21 -43.67 93.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.629 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.454 ' O ' ' NH2' ' A' ' 914' ' ' ARG . 80.2 mm-40 -76.41 144.87 39.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.808 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 17.6 ttm -98.5 152.08 19.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.43 ' H ' ' HD3' ' A' ' 914' ' ' ARG . 34.6 t -121.25 127.9 51.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.46 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.26 161.79 42.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.1 mtm-85 -102.68 165.37 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.7 138.15 58.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.52 0.15 89.3 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.007 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 78.9 mm-40 -81.01 147.12 30.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.105 0.452 . . . . 0.0 110.253 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -95.35 132.47 40.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.1 0.476 . . . . 0.0 111.041 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 147.21 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.973 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.2 m -98.44 127.79 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.098 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 23.7 mt -92.25 126.51 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.727 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.0 mt -105.56 -48.47 3.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.545 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -160.53 154.34 22.61 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.166 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' GLN . . . . . 0.53 ' OE1' ' CD2' ' A' ' 905' ' ' TYR . 2.0 mp0 -89.94 113.91 25.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.773 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 917' ' ' ILE . 62.2 t -65.1 -39.91 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -156.11 -176.71 6.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.314 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.94 -37.24 86.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 903' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 920' ' ' ILE . 12.8 t-20 -102.83 -4.29 25.09 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -112.55 151.96 29.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 111.666 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.53 ' CD2' ' OE1' ' A' ' 899' ' ' GLN . 1.5 m-85 -140.5 137.04 33.53 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -104.86 135.61 45.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.85 -178.94 32.36 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.587 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.521 ' NH2' ' OG1' ' A' ' 912' ' ' THR . 17.3 ptm180 -148.22 158.02 43.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.507 -0.346 . . . . 0.0 110.364 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 79.2 mt -93.89 138.73 22.63 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.13 141.08 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.366 1.377 . . . . 0.0 111.807 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.64 76.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.521 ' OG1' ' NH2' ' A' ' 908' ' ' ARG . 1.4 m 68.83 32.96 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.637 0.256 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.3 m -62.33 -42.48 99.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' A' ' 885' ' ' GLU . 77.6 ttt180 -166.69 144.65 5.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -127.55 142.83 51.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 177.56 -173.77 46.39 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 900' ' ' VAL . 39.6 pt -111.69 155.4 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.496 . . . . 0.0 111.117 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -156.35 151.21 20.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.13 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 144.57 51.66 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.223 1.948 . . . . 0.0 113.68 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 903' ' ' ASN . 87.5 mt -60.53 -37.52 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.37 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.479 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -56.06 -39.54 72.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.07 -1.1 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.22 159.62 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.67 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -108.75 127.24 53.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.186 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 75.9 t -101.47 101.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -65.55 -45.77 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -135.83 150.58 49.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -103.54 148.61 36.01 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.958 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.54 152.15 65.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.162 1.908 . . . . 0.0 112.232 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 930' ' ' LEU . . . . . 0.688 ' H ' HD12 ' A' ' 930' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.589 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -137.99 31.08 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.6 mtm -71.79 138.51 48.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.754 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 99.8 p -97.38 1.36 49.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.551 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 792' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 793' ' ' SER . . . -64.6 81.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 793' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 792' ' ' GLY . 1.5 p 76.76 122.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.0 -4.47 56.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.499 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -152.37 164.01 38.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.596 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -130.81 94.34 28.95 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.373 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.27 138.29 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.989 1.793 . . . . 0.0 111.786 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -130.38 153.3 48.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.83 135.62 54.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.272 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 814' ' ' LEU . . . -76.57 111.37 11.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -35.28 79.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.068 0.461 . . . . 0.0 109.79 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -144.12 175.35 10.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.538 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 65.2 t0 -78.56 120.51 23.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.48 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -115.05 123.63 49.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.66 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.9 142.11 28.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.384 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -69.65 140.58 53.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.302 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -109.39 -31.74 7.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.05 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 63.7 p -129.41 171.01 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.376 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.81 -41.72 96.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.41 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.95 -38.35 90.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.395 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.563 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 31.9 tt0 -80.17 122.98 27.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.1 mp -107.19 154.37 40.52 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.446 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.17 146.82 71.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.904 1.736 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -125.91 153.18 44.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -126.73 138.34 53.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.57 0.7 . . . . 0.0 110.926 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.09 125.42 10.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.277 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.65 -28.74 14.53 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.489 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 66.8 t0 -57.67 135.2 56.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.007 0.432 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 38.7 mm -99.15 133.51 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 798' ' ' ALA . 22.1 m -125.09 151.12 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.055 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 76.9 m-85 -109.28 113.7 26.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 96.5 mt -82.03 130.95 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -104.51 -38.46 6.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.793 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -156.14 155.16 32.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 825' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 16.3 tt0 -82.84 130.73 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.553 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 7.5 mm -81.38 -46.23 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 109.63 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 3.5 t70 -148.11 178.77 8.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.046 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.43 -36.09 79.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -109.57 11.75 24.67 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -132.51 143.0 49.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -125.01 150.96 46.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.302 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.28 141.22 51.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -165.94 -175.14 36.11 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.31 140.7 36.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.037 0.446 . . . . 0.0 110.748 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 835' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -151.47 141.99 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 50.1 t-80 48.24 31.36 2.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.93 16.23 80.81 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.818 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -132.88 157.46 45.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.66 0.267 . . . . 0.0 111.065 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.12 129.17 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.087 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -154.78 -156.12 7.58 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.447 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.7 pp -124.54 154.73 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 117.347 0.573 . . . . 0.0 110.173 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 814' ' ' LEU . 3.8 m-85 -148.4 126.61 5.93 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.748 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.64 125.39 16.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.073 1.182 . . . . 0.0 111.81 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -54.6 -20.32 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.56 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.8 p -77.06 -12.55 59.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.95 -3.92 24.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.247 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.9 pt -136.03 171.97 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.559 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 86.9 tt0 -114.23 160.51 18.94 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 18.4 mt -108.84 100.52 9.72 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 53.8 tp 49.03 79.07 0.36 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.86 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.25 153.53 45.96 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.623 2.215 . . . . 0.0 111.443 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.51 65.08 1.66 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.174 1.916 . . . . 0.0 112.034 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.82 25.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.162 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.07 -45.81 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 856' ' ' ALA . 55.6 mtpt 37.83 -148.69 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 855' ' ' LYS . . . 176.31 -103.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 110.25 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 857' ' ' GLN . . . . . 0.447 ' O ' ' OE1' ' A' ' 857' ' ' GLN . 3.2 tm0? -141.36 75.93 22.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.29 144.39 95.95 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.085 2.523 . . . . 0.0 112.538 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -116.79 145.48 43.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.545 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.12 140.05 52.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.31 157.12 17.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 95.0 m -82.53 122.89 79.04 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.16 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 157.71 42.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.884 1.723 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.69 161.19 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.145 0.498 . . . . 0.0 110.95 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 867' ' ' LEU . 19.2 pt20 -156.28 171.59 19.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 8.3 p -49.38 -25.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.443 ' H ' ' HG3' ' A' ' 865' ' ' GLN . 27.8 mt 55.89 -102.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -67.55 132.32 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.51 150.19 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.461 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -71.04 167.18 51.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -127.92 155.39 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 110.502 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -160.82 146.64 14.71 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.4 130.49 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.006 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 874' ' ' ALA . . . . . 0.701 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -53.45 125.32 17.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.867 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.5 -40.91 73.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.431 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 876' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 877' ' ' ASN . 0.1 OUTLIER -145.09 148.86 34.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.64 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 98.7 m-20 -41.72 132.46 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.292 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 878' ' ' PHE . 46.4 t80 -134.57 131.13 37.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.43 117.84 26.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -84.43 -179.58 51.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 881' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 882' ' ' THR . 24.5 p30 -130.81 -40.18 1.21 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 882' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 881' ' ' ASP . 65.3 p -86.32 163.46 17.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -64.97 -34.39 78.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 110.149 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.18 -41.04 91.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 45.1 tp10 -81.38 130.97 35.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.152 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 14.6 mmt -101.33 164.66 11.67 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.423 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 35.5 t -127.23 146.18 50.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.198 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.47 177.8 7.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.165 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -113.15 163.57 14.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.291 0.567 . . . . 0.0 111.503 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.55 139.88 52.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.811 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.39 -8.23 77.39 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -75.89 138.46 41.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.244 0.522 . . . . 0.0 110.285 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -81.46 143.33 32.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.116 0.484 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 872' ' ' ALA . 88.7 mt -130.29 138.32 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.685 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.5 m -97.35 128.87 44.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.783 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.12 119.83 27.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.644 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 908' ' ' ARG . 90.2 mt -99.23 -49.98 4.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -167.0 165.16 15.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.147 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -99.41 115.71 29.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.4 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 32.7 m -82.34 -25.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -159.77 173.75 15.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.83 -38.58 88.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -106.28 3.06 27.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -133.4 151.25 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.876 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.4 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 28.1 p90 -150.97 158.61 44.35 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.002 0.43 . . . . 0.0 110.581 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.528 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.4 tt0 -99.13 133.29 43.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.719 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.74 173.84 29.39 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.517 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.417 ' HD3' HD11 ' A' ' 897' ' ' LEU . 40.5 ptt180 -154.31 160.59 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.097 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.503 ' CD1' ' NH2' ' A' ' 914' ' ' ARG . 84.5 mt -74.54 138.83 74.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -47.99 -14.03 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.395 1.397 . . . . 0.0 112.456 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -87.09 0.33 85.93 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.465 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 30.6 p 54.63 8.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 911' ' ' GLY . 89.5 p -71.88 -30.42 65.39 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.503 ' NH2' ' CD1' ' A' ' 909' ' ' ILE . 96.4 mtm-85 -139.47 149.75 44.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.853 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 915' ' ' GLN . . . . . 0.528 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 66.4 tt0 -147.96 140.91 24.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.507 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.38 -178.19 47.6 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.504 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 46.3 pt -114.8 146.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -156.87 159.78 31.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.62 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 137.96 35.08 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.502 2.135 . . . . 0.0 114.21 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.06 -36.69 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.835 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.0 m -57.52 -44.69 85.29 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' TYR . . . . . 0.697 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -70.82 0.66 6.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.057 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.3 m -130.48 156.96 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.481 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -107.1 127.24 53.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.168 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.69 119.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.256 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 30.2 mm -91.36 -48.01 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.627 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.05 146.86 50.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.55 148.83 95.41 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.405 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -22.76 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.213 1.942 . . . . 0.0 112.02 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.534 -179.858 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -68.22 -18.59 64.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 67.4 mtt -69.36 -27.06 65.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 70.7 m -56.92 141.84 43.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.029 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -127.46 -32.72 0.65 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.2 t -65.54 139.82 58.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.629 0.252 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.97 124.24 52.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.654 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -161.26 157.57 25.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.826 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 78.0 mtp180 -135.97 131.35 18.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.43 146.07 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 111.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.499 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -148.11 157.3 43.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 799' ' ' ARG . . . . . 0.465 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 73.8 ttt180 -122.96 131.15 53.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.611 ' CB ' HD12 ' A' ' 814' ' ' LEU . . . -76.57 123.13 25.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -94.06 -16.05 24.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.262 0.553 . . . . 0.0 110.046 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -135.4 139.7 44.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.517 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.3 p30 -73.88 154.73 39.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.491 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 114.92 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -79.04 130.98 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.52 131.02 39.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.74 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -108.39 -26.4 10.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.25 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.3 p -134.74 170.34 15.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.941 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.7 mp -61.12 -37.43 82.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 810' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 98.3 mttt -60.23 -38.79 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.01 148.18 22.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.246 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.3 pt? -125.23 156.33 69.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 813' ' ' PRO . . . . . 0.555 ' O ' HD22 ' A' ' 814' ' ' LEU . 50.6 Cg_endo -70.44 141.53 42.7 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.319 1.346 . . . . 0.0 112.155 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.611 HD12 ' CB ' ' A' ' 800' ' ' ALA . 0.3 OUTLIER -141.05 143.18 34.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.719 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 815' ' ' GLN . . . . . 0.598 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 62.4 tt0 -103.95 143.03 33.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.341 0.591 . . . . 0.0 110.322 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -61.06 37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.444 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 173.16 21.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 835' ' ' HIS . 3.7 m-20 -97.28 161.21 13.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.5 130.4 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 2.1 p -129.63 136.88 58.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.179 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.7 m-85 -95.86 121.1 37.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.943 0.402 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 831' ' ' TYR . 71.7 mt -87.1 136.26 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -98.74 -39.35 8.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.745 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 824' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 26.0 pttm -159.25 155.98 27.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.046 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.6 118.93 23.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.53 -46.65 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.32 179.38 8.17 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.33 -38.41 83.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.629 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -111.66 13.54 21.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.803 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -131.59 143.59 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 112.091 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 822' ' ' ILE . 35.1 m-85 -134.02 152.2 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.707 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 4.2 tt0 -123.1 134.71 54.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.39 178.5 36.4 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -107.91 148.83 29.09 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 111.033 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.542 ' NE2' ' OD2' ' A' ' 818' ' ' ASP . 83.5 t60 -169.69 137.47 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.088 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 18.6 t60 58.53 32.94 22.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.305 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.83 16.58 79.28 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -132.7 154.88 49.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.115 0.483 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.6 134.9 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -160.69 -140.91 2.99 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.4 pt -135.46 154.3 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.71 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.418 ' CD2' HG21 ' A' ' 847' ' ' ILE . 9.2 p90 -157.99 150.68 18.08 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 143.8 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.148 1.898 . . . . 0.0 113.459 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.47 -35.56 72.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.065 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 76.3 p -63.22 -16.06 59.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.121 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -94.66 -2.66 50.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.407 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.499 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.3 pp -142.13 165.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.738 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.98 118.0 22.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.826 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 60.0 tp -69.81 113.98 7.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.368 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 29.4 tp 56.75 73.96 0.74 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.15 165.52 29.98 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.947 1.764 . . . . 0.0 111.719 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.6 134.44 33.26 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.851 1.701 . . . . 0.0 112.145 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -151.97 38.92 0.6 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.967 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -63.19 -39.76 95.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.51 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 856' ' ' ALA . 46.4 mmtm 53.45 44.17 30.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 855' ' ' LYS . . . 68.48 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 45.43 66.18 5.59 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.467 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.13 138.48 71.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.535 2.157 . . . . 0.0 112.227 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -117.8 12.06 13.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -93.22 20.99 6.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 58.2 tp 52.16 91.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.505 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 11.7 t -151.47 146.36 18.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.165 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.08 139.47 42.48 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.53 1.487 . . . . 0.0 111.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.663 HG23 ' H ' ' A' ' 865' ' ' GLN . 0.3 OUTLIER -66.81 -83.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.663 ' H ' HG23 ' A' ' 864' ' ' VAL . 98.0 mt-30 -76.87 150.08 36.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.39 125.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.486 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 87.2 mt -111.27 143.75 41.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.24 143.93 46.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.68 162.98 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -66.96 172.57 29.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 871' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 871' ' ' GLU . 48.2 mp0 -134.92 146.48 49.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.482 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -147.62 149.88 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 873' ' ' ILE . . . . . 0.421 ' C ' HG13 ' A' ' 923' ' ' VAL . 91.5 mt -123.6 126.38 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 111.255 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.75 113.96 1.87 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -63.64 -37.02 85.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -129.53 148.13 51.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.323 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -56.81 125.2 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -115.19 128.43 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.563 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.95 109.77 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.474 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 880' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -75.32 145.24 32.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -103.09 -21.57 13.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.831 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.3 p -112.63 159.29 19.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -64.12 -31.26 72.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.343 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 884' ' ' VAL . 8.7 m -71.41 -24.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.435 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.91 111.55 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.174 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.57 159.35 29.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 99.3 p -123.9 153.27 41.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.935 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.18 176.44 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -104.16 150.16 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.14 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -46.68 133.1 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 97.46 -9.05 64.59 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.068 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.0 131.04 45.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -76.52 138.07 40.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.71 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 93.7 mt -130.59 144.95 36.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.754 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.0 m -102.03 125.72 48.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 925' ' ' VAL . 86.7 mt -79.81 87.37 5.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 908' ' ' ARG . 92.8 mt -64.06 -44.6 91.95 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.819 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -168.56 162.42 12.03 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.664 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.26 109.6 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.42 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.5 p -74.99 -27.16 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.065 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -158.81 174.89 14.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.32 -36.79 83.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.122 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -109.44 1.84 20.17 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -130.56 148.64 52.38 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.461 ' CE1' ' O ' ' A' ' 918' ' ' PHE . 28.2 p90 -151.08 156.88 41.98 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.737 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -104.37 130.62 52.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -146.99 178.22 24.77 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.835 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.693 ' HG2' HD11 ' A' ' 897' ' ' LEU . 0.3 OUTLIER -149.98 161.26 42.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.991 -0.605 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 911' ' ' GLY . 78.7 mt -74.97 137.28 72.9 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.24 -11.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.297 1.332 . . . . 0.0 112.16 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 909' ' ' ILE . . . -80.91 -4.23 90.48 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.399 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 20.1 p 50.83 34.97 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.349 0.119 . . . . 0.0 111.145 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.3 m -111.61 -26.56 8.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.705 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.65 152.52 51.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -149.57 145.98 27.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.177 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.23 -179.31 47.49 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.349 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.6 pt -112.16 140.99 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.5 145.11 17.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.062 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.93 142.74 47.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.95 1.766 . . . . 0.0 112.736 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.9 mt -69.9 -8.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.581 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.9 m -59.87 -44.47 94.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 923' ' ' VAL . 8.6 p90 -97.7 8.48 44.61 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.855 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.482 HG12 ' HB1' ' A' ' 872' ' ' ALA . 11.2 t -122.82 145.2 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 120.85 0.357 . . . . 0.0 110.226 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.85 115.36 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.076 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 896' ' ' LEU . 97.0 t -84.09 106.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.717 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.33 -46.22 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.486 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 927' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 926' ' ' ILE . 67.4 mttm -141.22 149.85 41.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -72.5 153.64 91.8 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.105 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 151.73 70.41 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.442 2.095 . . . . 0.0 112.174 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.501 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 788' ' ' GLN . . . . . 0.429 ' C ' ' H ' ' A' ' 790' ' ' MET . 92.0 mm-40 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.46 ' CG ' ' O ' ' A' ' 789' ' ' HIS . 86.4 t60 58.37 3.16 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.634 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 790' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 788' ' ' GLN . 94.9 mmm -65.52 -39.14 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.381 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 97.1 p -153.08 164.82 37.32 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.863 0.363 . . . . 0.0 111.559 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -168.09 160.19 33.66 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.3 t -65.37 137.43 57.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.832 0.349 . . . . 0.0 110.713 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -149.49 134.34 17.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.271 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.84 146.29 42.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.102 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -127.94 143.09 46.51 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 147.72 34.44 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.896 1.731 . . . . 0.0 112.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -135.47 155.16 50.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -121.89 133.67 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.408 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.484 ' HB2' HD22 ' A' ' 814' ' ' LEU . . . -84.2 121.58 27.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -74.43 -29.56 61.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.976 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.28 173.09 11.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.197 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.9 p-10 -89.33 135.69 33.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.14 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -127.08 133.26 50.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.327 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -92.99 139.29 30.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 811' ' ' GLU . . . -75.43 120.61 21.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -65.95 -41.47 91.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 808' ' ' THR . . . . . 0.485 ' H ' ' HG2' ' A' ' 811' ' ' GLU . 72.1 p -136.96 166.21 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.928 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -50.88 -33.34 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.28 -39.79 91.7 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.461 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 808' ' ' THR . 0.2 OUTLIER -75.28 172.54 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.458 HD12 ' HD2' ' A' ' 813' ' ' PRO . 12.0 tp -135.7 134.11 20.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 813' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 812' ' ' LEU . 57.8 Cg_endo -70.93 145.54 50.67 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.106 1.204 . . . . 0.0 111.467 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 820' ' ' VAL . 0.7 OUTLIER -126.31 144.55 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.92 139.78 51.09 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.261 0.553 . . . . 0.0 110.252 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.08 122.06 7.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.813 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.76 38.4 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.308 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.532 ' OD2' ' CE1' ' A' ' 835' ' ' HIS . 35.8 t70 -62.77 140.57 58.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.11 132.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.5 m -123.27 154.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.235 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.441 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 90.7 m-85 -114.07 121.71 44.67 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 822' ' ' ILE . 3.4 mm -85.6 127.07 40.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.474 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 823' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.3 p90 -120.91 -5.93 9.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.071 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -173.38 129.13 0.44 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.212 0.53 . . . . 0.0 111.478 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -80.66 135.79 36.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.33 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.403 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.2 mm -87.49 -52.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.361 . . . . 0.0 110.284 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -150.51 179.2 8.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 828' ' ' GLN . . . . . 0.52 ' O ' ' NE ' ' A' ' 844' ' ' ARG . 19.9 mp0 -60.77 -37.56 82.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 4.0 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.81 142.0 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.354 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.646 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 31.3 p90 -136.26 165.59 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.229 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -133.36 140.35 47.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.504 ' O ' HG13 ' A' ' 839' ' ' VAL . . . -158.44 -179.29 33.2 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 834' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 821' ' ' TYR . 88.5 tt0 -106.63 144.87 32.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 111.442 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.685 ' HB2' HG12 ' A' ' 820' ' ' VAL . 6.5 t60 -168.52 140.85 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.214 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.24 19.97 11.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 82.47 1.41 90.46 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.779 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.43 164.21 20.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.103 0.452 . . . . 0.0 110.262 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 833' ' ' GLY . 57.3 t -122.63 132.59 70.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.123 0.487 . . . . 0.0 111.211 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -143.24 -155.25 6.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.459 ' CG1' ' OE2' ' A' ' 811' ' ' GLU . 1.4 pp -134.32 155.12 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.088 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -166.1 160.17 12.72 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.85 121.85 8.28 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.75 2.3 . . . . 0.0 112.734 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 844' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 828' ' ' GLN . 48.3 ptt85 -56.4 -22.03 28.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.031 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.07 -8.21 47.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.13 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.43 -0.39 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.625 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 11.7 pt -138.73 174.55 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 52.7 mt-10 -113.38 157.51 21.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.2 100.14 7.93 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.027 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.0 tt 49.51 61.72 13.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.16 164.9 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.49 2.127 . . . . 0.0 112.153 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.26 133.54 42.34 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.918 1.745 . . . . 0.0 112.232 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -108.24 -9.03 15.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.472 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.89 135.52 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -124.79 148.92 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.372 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.87 88.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -119.33 150.22 49.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.321 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.04 154.34 62.64 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.33 2.02 . . . . 0.0 112.448 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -61.5 131.87 51.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -64.16 132.64 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.305 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.2 tp 61.79 105.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 64.0 p -133.16 158.09 76.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.99 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.24 138.4 79.3 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.425 1.417 . . . . 0.0 112.154 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.83 -44.88 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.116 0.484 . . . . 0.0 110.22 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -53.62 136.68 38.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.915 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 94.0 t -97.72 -55.03 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 869' ' ' TYR . 57.3 tp -137.55 132.75 33.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.088 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -62.29 -40.45 96.32 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.628 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 869' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' A' ' 867' ' ' LEU . 97.8 m-85 -127.66 137.09 52.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -80.44 163.37 46.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -118.22 148.83 42.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -155.08 147.69 24.24 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.432 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.21 131.66 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.518 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.46 135.16 57.2 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.085 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.453 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 55.5 mtmt -87.08 -23.03 25.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.855 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -142.5 144.26 32.9 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -49.36 152.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -143.1 130.8 21.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.33 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -128.44 97.28 4.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.721 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.44 178.14 52.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -131.05 -1.88 4.06 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.213 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 47.6 p -129.58 158.88 38.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -62.82 -27.37 69.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.975 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 885' ' ' GLU . 18.3 m -68.14 -20.65 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.3 mt-10 -108.75 131.48 54.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.132 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 13.5 tpt -109.18 129.78 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.7 p -76.35 158.27 31.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.553 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 12.9 p90 -168.31 166.08 12.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.971 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 891' ' ' GLY . 29.6 mmm-85 -103.67 163.55 12.24 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 890' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 53.5 tttp -67.09 58.17 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 891' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . 172.84 12.8 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.829 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 888' ' ' PHE . 96.8 mt-10 -94.1 151.99 19.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.612 0.706 . . . . 0.0 109.736 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.46 146.75 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.5 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.5 mt -133.02 145.59 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.821 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.9 m -102.35 124.67 48.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.633 HD11 HG13 ' A' ' 925' ' ' VAL . 88.7 mt -82.63 130.72 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.429 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.44 -58.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -163.56 164.66 24.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -99.1 115.37 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.579 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.427 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.2 p -81.45 -27.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.734 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 1.6 t70 -156.13 172.53 18.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.973 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.426 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 60.7 mp0 -63.51 -28.84 70.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 903' ' ' ASN . . . . . 0.624 ' ND2' ' NE1' ' A' ' 904' ' ' TRP . 16.6 p-10 -117.95 4.05 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 904' ' ' TRP . . . . . 0.624 ' NE1' ' ND2' ' A' ' 903' ' ' ASN . 91.7 m95 -132.32 150.23 52.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.677 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.489 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.7 p90 -152.97 159.15 42.9 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.7 tt0 -102.39 132.68 48.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.179 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -151.45 169.94 31.02 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -148.47 155.79 41.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.038 0.447 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.27 139.89 87.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.85 138.99 20.13 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.937 1.092 . . . . 0.0 111.113 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.564 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.72 -9.65 70.93 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.78 33.22 2.98 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.651 0.262 . . . . 0.0 111.031 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.4 t -60.23 -45.46 93.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -163.36 139.66 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.791 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 915' ' ' GLN . . . . . 0.546 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 26.0 tt0 -103.78 149.82 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.059 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -166.54 169.48 40.62 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.358 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 906' ' ' GLU . 46.4 pt -123.14 147.17 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.861 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -159.17 166.17 16.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.301 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.62 137.8 61.13 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.836 1.691 . . . . 0.0 113.487 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.29 -42.22 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.282 0.563 . . . . 0.0 110.42 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.0 m -57.77 -16.97 12.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.33 2.01 54.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.881 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.489 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.2 m -138.86 164.09 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.179 0.514 . . . . 0.0 110.663 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 924' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 67.9 t0 -115.04 132.82 56.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 896' ' ' LEU . 99.5 t -104.09 99.86 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.538 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.671 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.54 -46.34 95.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 927' ' ' LYS . . . . . 0.409 ' HG3' HG22 ' A' ' 926' ' ' ILE . 46.8 mtmt -138.13 131.95 31.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -73.8 149.25 87.89 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.62 -22.97 50.01 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.077 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.424 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -68.01 -17.03 64.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.509 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -65.36 -12.17 49.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 40.7 t -60.15 140.0 57.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.596 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 101.94 144.76 15.21 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 793' ' ' SER . . . . . 0.416 ' O ' ' SD ' ' A' ' 795' ' ' MET . 53.7 m 52.67 35.9 19.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.145 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.08 139.22 58.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.411 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 793' ' ' SER . 0.0 OUTLIER -140.43 159.37 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.374 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.72 148.37 69.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.436 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.82 145.83 25.82 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.098 1.866 . . . . 0.0 111.798 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.516 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -140.83 155.59 46.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 78.2 ttt180 -117.99 132.29 56.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -71.28 117.9 13.4 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.942 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -38.57 86.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.31 0.576 . . . . 0.0 109.466 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -141.83 174.56 10.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.2 p-10 -83.29 138.26 33.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 804' ' ' PHE . . . . . 0.563 ' CE2' ' OE2' ' A' ' 811' ' ' GLU . 60.5 t80 -129.07 131.46 47.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -99.22 137.91 37.06 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.037 0.446 . . . . 0.0 111.606 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -65.37 136.09 56.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.336 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 807' ' ' GLN . . . . . 0.44 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 77.0 mt-30 -109.5 -25.09 10.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.693 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 64.1 p -129.2 167.6 17.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 809' ' ' LEU . 93.0 mt -61.03 -42.53 98.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.544 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.94 -42.14 97.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.463 . . . . 0.0 109.76 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.563 ' OE2' ' CE2' ' A' ' 804' ' ' PHE . 41.0 tt0 -66.97 131.28 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.931 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 96.1 mt -115.52 150.33 44.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.449 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.26 148.71 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.103 1.869 . . . . 0.0 112.824 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.706 HD23 ' CE2' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -133.62 145.7 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -120.34 143.02 48.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.59 0.709 . . . . 0.0 111.489 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -53.09 124.39 14.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.075 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 99.83 -20.41 49.32 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.583 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.54 140.47 58.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.8 mm -96.68 131.36 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.1 m -125.97 156.23 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.451 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.8 m-85 -117.34 116.43 27.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.965 0.412 . . . . 0.0 111.4 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.89 131.93 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 823' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.0 OUTLIER -128.52 -4.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.238 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -170.44 125.29 0.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.208 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 825' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 830' ' ' TRP . 59.9 tp60 -81.54 124.61 29.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.749 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.432 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.8 mm -80.79 -52.98 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.62 178.28 9.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.14 -37.85 81.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.4 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -105.91 8.07 32.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.637 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 830' ' ' TRP . . . . . 0.542 ' O ' ' NE2' ' A' ' 825' ' ' GLN . 5.4 m-90 -140.12 145.19 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.102 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.744 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 29.4 p90 -140.7 166.28 25.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.946 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -130.61 136.52 48.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.887 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -154.41 -165.44 13.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -118.9 139.16 52.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -151.3 148.53 28.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.376 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 50.9 t-80 47.87 30.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.263 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.25 16.41 80.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.792 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.28 160.22 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.015 0.436 . . . . 0.0 111.083 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.38 132.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.921 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -155.46 -154.73 7.04 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 46.8 pt -130.48 149.81 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.913 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.706 ' CE2' HD23 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -151.27 171.75 6.14 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -81.36 124.21 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.846 1.698 . . . . 0.0 113.074 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -57.01 -33.69 67.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.649 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.5 p -71.86 -9.99 59.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.739 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -96.51 -1.0 48.11 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.744 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.9 pt -132.85 174.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.11 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.7 mt-10 -113.47 159.87 19.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.13 105.87 13.08 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.695 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 39.0 tp 58.28 74.66 0.6 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.139 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.99 150.99 52.41 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.888 2.392 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.58 146.31 73.25 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.048 1.832 . . . . 0.0 111.716 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -157.46 159.56 37.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.42 -35.72 81.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 64.59 25.2 13.13 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.524 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -104.16 -3.01 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.78 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -132.9 151.51 78.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.737 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.34 153.69 61.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.325 2.017 . . . . 0.0 112.563 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.85 -23.67 67.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -116.86 128.49 55.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.98 123.42 22.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.033 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 49.4 p -133.91 76.28 65.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.839 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.451 ' C ' HG23 ' A' ' 864' ' ' VAL . 45.1 Cg_exo -58.0 141.44 96.18 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.878 2.385 . . . . 0.0 111.901 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 865' ' ' GLN . 1.8 t 61.92 -139.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.351 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.634 ' HG3' HG23 ' A' ' 866' ' ' VAL . 19.7 pt20 29.12 -149.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.652 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.634 HG23 ' HG3' ' A' ' 865' ' ' GLN . 84.4 t 41.33 92.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.798 0.333 . . . . 0.0 110.467 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 141.13 41.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.485 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 868' ' ' GLU . 46.2 mp0 -122.31 -163.4 1.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -60.62 153.53 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.389 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -65.43 170.77 26.23 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.31 153.81 47.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.95 150.34 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.45 125.49 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 874' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -62.66 128.57 36.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.415 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 12.8 mtmt -74.49 -37.89 63.02 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.651 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -130.61 153.79 48.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.232 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -52.64 152.57 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 58.2 t80 -146.59 137.32 24.01 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.571 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -136.59 99.69 4.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.811 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.81 156.52 50.71 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -118.82 2.23 11.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.736 0.303 . . . . 0.0 110.53 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 69.7 p -132.52 162.37 31.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.99 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.11 -40.28 97.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.34 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.422 HG23 ' HG2' ' A' ' 885' ' ' GLU . 9.7 m -62.34 -32.4 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.791 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.422 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.1 mm-40 -83.34 146.24 28.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.105 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 67.0 ttp -105.54 130.96 53.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 92.8 p -88.86 131.52 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 43.9 p90 -158.62 164.11 36.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.484 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.448 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 25.2 mmt85 -117.68 162.02 18.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.235 0.54 . . . . 0.0 111.567 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 890' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 65.4 tttp -56.84 136.98 55.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.221 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.78 88.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.041 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 76.2 mm-40 -82.62 147.26 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.994 0.397 . . . . 0.0 110.461 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -84.19 141.2 31.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.54 139.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.4 m -103.22 126.15 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.433 HD11 HG13 ' A' ' 925' ' ' VAL . 88.6 mt -82.69 125.22 30.98 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.56 -28.87 9.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.314 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -179.68 141.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -88.91 113.47 24.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.16 -43.89 91.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -160.72 -179.69 7.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.3 pt-20 -62.64 -22.77 66.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -117.82 13.83 14.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.653 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -140.37 149.67 42.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.08 29.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.433 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -100.61 132.54 45.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.5 179.03 35.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.327 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -148.86 156.48 42.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.315 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.2 mt -84.25 142.43 40.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.87 138.99 25.89 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.952 1.101 . . . . 0.0 111.191 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.59 71.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.92 29.59 8.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.234 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.7 m -62.19 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.616 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -143.52 154.45 43.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.005 0.431 . . . . 0.0 111.459 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -144.96 138.77 27.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.045 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.45 -169.91 43.03 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.49 159.33 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.094 0.473 . . . . 0.0 111.617 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -160.07 152.75 17.72 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.746 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.44 137.19 45.94 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.568 1.512 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.758 ' O ' HG22 ' A' ' 923' ' ' VAL . 6.3 mt -54.69 -76.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.567 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 920' ' ' ILE . 22.4 m -25.53 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 922' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 920' ' ' ILE . 1.6 m-85 -72.22 1.49 7.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.8 m -135.31 158.96 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.063 0.459 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -104.37 118.32 36.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.429 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.433 HG13 HD11 ' A' ' 896' ' ' LEU . 73.0 t -95.03 101.49 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.806 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.6 mp -70.36 -43.18 78.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.273 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -133.04 139.63 47.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.71 86.82 45.6 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.437 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.67 155.94 39.95 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.31 2.007 . . . . 0.0 112.509 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.614 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -101.18 8.3 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.418 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 22.7 mmt 57.13 23.01 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 86.6 p -71.86 -16.72 62.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.685 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -86.96 -0.58 85.51 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 74.3 m -61.53 -40.84 96.12 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 39.98 -157.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.452 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 19.1 mmm -71.48 -64.47 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -154.07 105.22 2.45 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.41 139.77 18.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.785 1.657 . . . . 0.0 112.388 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 847' ' ' ILE . . . -136.68 151.23 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -109.18 143.16 38.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.65 126.48 31.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 801' ' ' LYS . . . . . 0.447 ' O ' ' CD ' ' A' ' 816' ' ' LYS . 38.4 ttpt -97.74 -20.13 17.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.826 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -146.76 177.7 8.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.14 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -90.99 178.02 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.768 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 804' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 814' ' ' LEU . 29.4 t80 -149.04 132.88 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.671 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -106.19 107.74 18.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -67.13 137.67 56.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.174 0.512 . . . . 0.0 110.857 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -106.55 -23.19 12.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.15 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.08 165.64 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.181 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.64 -38.68 85.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.856 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -59.45 -44.15 93.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.46 136.15 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.492 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.9 122.47 33.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.889 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 813' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 50.6 Cg_exo -55.01 140.64 79.99 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.109 1.206 . . . . 0.0 112.457 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.912 HD13 ' OH ' ' A' ' 846' ' ' TYR . 20.7 mt -128.34 149.75 50.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.593 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -122.5 138.17 54.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.209 0.528 . . . . 0.0 109.956 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 816' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 801' ' ' LYS . 36.7 ttpt -46.62 125.32 6.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.089 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 104.45 -24.34 29.07 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.589 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.28 125.88 25.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.985 0.422 . . . . 0.0 110.947 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 23.5 mm -85.93 133.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.09 153.37 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.443 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.9 m-85 -109.15 114.86 28.94 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 31.1 mm -85.6 129.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.477 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -111.16 -27.91 8.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.346 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 824' ' ' LYS . . . . . 0.458 ' NZ ' ' CD ' ' A' ' 832' ' ' GLU . 25.7 pttm -158.9 156.14 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.345 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 825' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 61.9 tt0 -94.49 110.43 22.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.569 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.4 -47.03 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 7.3 t0 -149.85 178.08 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 828' ' ' GLN . . . . . 0.483 ' O ' ' CZ ' ' A' ' 844' ' ' ARG . 99.1 mm-40 -59.99 -37.61 80.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.455 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -108.51 0.55 20.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -123.97 134.1 53.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 160.13 23.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.458 ' CD ' ' NZ ' ' A' ' 824' ' ' LYS . 20.9 tt0 -128.86 140.55 51.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.584 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.87 -177.69 36.08 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -107.05 141.74 37.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.046 0.451 . . . . 0.0 111.353 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.479 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.3 OUTLIER -149.9 144.71 26.09 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 51.2 t-80 50.02 30.37 4.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.1 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.29 18.41 79.82 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -133.03 156.33 47.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.385 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.77 145.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.289 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -169.71 -162.34 21.8 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 841' ' ' ILE . 27.3 pt -128.22 159.39 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -166.8 154.56 8.93 Favored Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.064 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 845' ' ' THR . 51.9 Cg_endo -69.71 115.66 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.352 2.035 . . . . 0.0 112.66 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 844' ' ' ARG . . . . . 0.483 ' CZ ' ' O ' ' A' ' 828' ' ' GLN . 37.9 ptt180 -51.93 -6.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.552 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 843' ' ' PRO . 1.6 t -80.86 -5.83 57.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.616 -0.434 . . . . 0.0 112.089 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 846' ' ' TYR . . . . . 0.912 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -106.37 -1.22 23.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.921 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.649 HG23 ' CE2' ' A' ' 846' ' ' TYR . 45.1 pt -126.76 175.68 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.838 0.351 . . . . 0.0 111.371 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.506 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.3 mt-10 -114.0 160.01 19.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.75 101.62 9.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 51.8 tp 55.04 76.23 0.53 Allowed Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.988 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.54 152.19 56.92 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.688 2.258 . . . . 0.0 111.664 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.17 148.32 74.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.221 1.947 . . . . 0.0 111.869 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 853' ' ' ALA . . . . . 0.56 ' HB3' ' HE3' ' A' ' 855' ' ' LYS . . . -154.06 159.19 41.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -71.05 9.56 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.56 ' HE3' ' HB3' ' A' ' 853' ' ' ALA . 16.5 ptpt -55.07 -23.36 19.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -100.32 134.28 43.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.516 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -132.44 78.46 67.7 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.565 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.37 144.02 96.84 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.836 2.357 . . . . 0.0 112.258 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.02 -7.92 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.182 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -61.94 -39.63 92.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.11 114.1 28.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 862' ' ' THR . 95.2 m -131.98 65.34 75.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.41 147.7 47.27 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.32 2.013 . . . . 0.0 112.075 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.74 -57.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.475 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.46 132.03 54.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.879 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.93 -2.81 9.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.608 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 60.5 tp -76.96 125.33 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.218 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 55.87 44.74 25.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -130.58 123.31 29.24 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -149.37 176.78 27.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -136.1 141.83 44.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 0.0 110.496 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -150.87 155.52 39.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 57.1 mt -126.66 131.09 71.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 110.641 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.92 123.04 15.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.458 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -69.26 -37.33 77.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.959 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.3 151.06 50.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.361 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.407 HD21 ' NH1' ' A' ' 889' ' ' ARG . 59.2 t-20 -57.48 131.86 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -127.14 128.74 46.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.59 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.32 108.15 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.759 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 880' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 887' ' ' SER . . . -65.83 142.46 43.58 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 881' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 56.4 t0 -100.56 -22.62 14.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 61.0 p -130.97 165.74 22.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.03 0.443 . . . . 0.0 111.123 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.78 -37.56 82.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.563 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.32 -43.37 89.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.394 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -91.06 103.54 16.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.492 ' CE ' ' O ' ' A' ' 887' ' ' SER . 2.0 tmt? -71.28 131.55 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.517 ' CB ' ' H ' ' A' ' 880' ' ' GLY . 83.2 p -80.13 154.19 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 0.0 110.986 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.01 160.05 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.593 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 75.7 mtp85 -105.78 165.32 11.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.003 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.63 136.2 56.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.191 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.58 -6.61 77.6 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.9 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 72.9 mm-40 -74.04 141.73 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.462 0.631 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -89.6 139.22 30.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.212 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.78 149.42 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.514 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.1 m -100.13 127.9 46.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.64 118.79 24.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.18 -46.58 5.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -163.41 156.01 18.29 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.936 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -98.94 118.68 36.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.323 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.46 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.9 t -61.48 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 902' ' ' GLU . 13.3 p30 -153.68 -104.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 901' ' ' ASP . 99.0 mt-10 -121.71 -38.43 2.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.37 9.36 18.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.704 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -134.03 147.46 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.46 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 14.7 p90 -157.72 163.81 37.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -115.96 142.19 47.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.166 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.45 178.86 31.01 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -149.48 158.97 44.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.494 -0.353 . . . . 0.0 110.331 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 911' ' ' GLY . 50.4 mm -65.86 137.86 96.23 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 -11.64 15.21 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.697 1.598 . . . . 0.0 112.531 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.547 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.69 -3.0 89.8 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 57.7 p 53.93 65.97 1.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.208 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.4 m -131.46 -38.49 1.18 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.443 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.24 157.5 46.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.859 0.362 . . . . 0.0 111.329 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -142.81 146.42 34.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.71 176.52 45.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.507 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.49 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 42.5 pt -115.52 145.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.493 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -155.68 159.43 31.62 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.566 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.03 139.11 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.697 2.264 . . . . 0.0 113.828 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.448 ' HA ' HG22 ' A' ' 923' ' ' VAL . 89.7 mt -64.18 -37.81 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.517 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 74.4 p -53.04 -24.13 9.09 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.891 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.07 2.26 55.16 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 920' ' ' ILE . 4.8 m -131.38 158.15 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.118 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -107.31 127.13 53.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.033 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.86 125.38 42.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.265 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 926' ' ' ILE . 1.7 mp -92.88 -53.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.64 126.47 32.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -70.7 148.0 94.73 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.18 -20.65 37.29 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.214 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.46 179.902 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -60.3 -46.22 90.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -60.77 159.34 11.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 46.8 t -139.75 149.97 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.491 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.7 96.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.6 t -134.22 132.79 40.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -134.3 145.82 49.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.528 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 23.3 ptp -148.76 157.74 43.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.666 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -131.56 96.69 20.55 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.37 140.15 93.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.898 1.732 . . . . 0.0 111.826 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -139.85 156.02 46.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.087 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -114.48 139.82 49.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.78 131.72 35.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.13 0.491 . . . . 0.0 110.764 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 801' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 802' ' ' PHE . 17.2 mmmt -98.27 -13.23 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 802' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 801' ' ' LYS . 47.9 m-85 -152.18 166.79 30.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 112.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 36.0 t70 -86.61 129.8 34.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.072 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -127.81 116.47 20.24 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 110.109 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.21 142.46 31.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.578 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -82.56 122.53 28.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.641 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -95.74 -25.48 16.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.898 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.5 p -134.85 169.67 17.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.37 -37.62 84.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.108 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 810' ' ' LYS . . . . . 0.487 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 68.7 mttm -65.11 -12.07 46.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.612 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.412 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.6 mt-10 -113.34 140.35 48.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.889 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.6 pt? -117.14 149.62 44.69 Favored Pre-proline 0 N--CA 1.467 0.415 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.66 140.01 38.34 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.556 1.504 . . . . 0.0 111.52 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 846' ' ' TYR . 11.0 mt -137.38 146.66 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.675 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -119.08 135.66 54.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 816' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 816' ' ' LYS . 8.9 ptmm? -42.24 123.23 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.599 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 99.78 -20.76 47.97 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.208 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 67.3 t0 -55.11 139.27 42.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 41.7 mm -94.95 126.01 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.172 0.511 . . . . 0.0 110.589 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.431 ' CG1' HD21 ' A' ' 814' ' ' LEU . 0.2 OUTLIER -120.21 148.62 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.255 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.0 m-85 -108.45 123.2 48.49 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 832' ' ' GLU . 24.2 mm -92.94 129.59 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.923 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.38 -27.6 12.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.475 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -160.43 157.28 27.42 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -93.97 111.29 22.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.4 mm -61.13 -46.9 95.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.156 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.94 178.91 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -59.88 -36.37 76.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.954 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.84 -1.65 16.44 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -119.9 131.28 55.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.416 ' CD2' HG21 ' A' ' 822' ' ' ILE . 3.0 m-85 -119.3 157.35 28.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.791 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 822' ' ' ILE . 18.0 tt0 -128.29 138.88 52.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.31 -173.18 28.53 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -123.95 155.79 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.207 0.527 . . . . 0.0 111.456 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.6 OUTLIER -170.61 131.24 0.89 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.933 178.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.1 t-80 65.9 24.56 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 80.22 4.11 89.79 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 838' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 838' ' ' ARG . 1.7 tpm_? -112.86 141.84 46.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.974 0.416 . . . . 0.0 110.558 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.59 143.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.543 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -169.53 -139.98 2.85 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 29.9 pt -138.97 162.75 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.462 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -169.72 153.98 5.22 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.831 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 845' ' ' THR . 50.5 Cg_endo -71.11 116.87 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.946 1.764 . . . . 0.0 112.54 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -51.52 -5.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.217 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 843' ' ' PRO . 81.4 p -82.11 -7.3 59.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 846' ' ' TYR . . . . . 0.914 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -105.41 0.42 26.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.574 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.684 HG23 ' CE2' ' A' ' 846' ' ' TYR . 42.8 pt -130.19 174.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.507 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.62 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 97.6 mt-10 -116.0 160.05 20.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.63 105.25 15.2 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.7 tt 42.57 75.24 0.65 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.513 . . . . 0.0 110.099 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.82 153.82 47.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.056 2.504 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.11 151.49 72.75 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.412 2.075 . . . . 0.0 111.863 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 853' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 854' ' ' GLU . . . -63.24 147.76 50.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 854' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 853' ' ' ALA . 18.5 pm0 -49.43 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.845 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt 58.87 38.63 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -79.93 170.44 16.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.312 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 857' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 857' ' ' GLN . 13.0 mp0 -63.74 149.4 92.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.087 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.07 154.91 69.69 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.298 1.999 . . . . 0.0 112.341 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -60.55 -20.0 59.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 66.32 105.25 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 861' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 861' ' ' LEU . 0.1 OUTLIER -99.38 -23.57 15.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 861' ' ' LEU . 1.3 p 50.28 68.33 3.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.632 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.49 152.09 59.73 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.207 1.938 . . . . 0.0 112.255 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.639 HG23 ' N ' ' A' ' 865' ' ' GLN . 31.3 m -131.11 -130.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.639 ' N ' HG23 ' A' ' 864' ' ' VAL . 97.0 mt-30 57.51 155.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 867' ' ' LEU . 59.7 t -61.56 -44.95 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 866' ' ' VAL . 3.5 tp 74.37 165.32 0.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.4 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 871' ' ' GLU . 88.4 tt0 53.47 95.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.354 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -83.69 -107.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.823 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -79.75 167.33 51.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 871' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 868' ' ' GLU . 79.1 mm-40 -127.53 155.12 44.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.668 0.27 . . . . 0.0 110.537 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.01 27.01 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 46.3 mm -118.7 125.3 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -61.33 133.08 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.711 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 56.8 mtmt -81.95 -38.95 24.42 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.904 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.41 150.86 49.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.466 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 45.6 p-10 -45.64 151.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 75.1 t80 -142.05 131.92 24.36 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.521 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -131.15 103.48 6.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.55 150.57 45.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.84 -1.41 34.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.341 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 57.8 p -133.15 162.75 30.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -61.04 -39.25 89.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.796 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.41 -40.74 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.752 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.24 108.41 19.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 11.0 mmt -80.42 160.67 25.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.8 p -109.39 149.76 29.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.057 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 29.1 p90 -156.76 161.09 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.384 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 42.1 ttm180 -105.24 156.17 18.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 111.14 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -50.44 137.4 19.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.45 -3.82 82.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.717 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 67.9 mm-40 -77.01 140.99 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.536 0.668 . . . . 0.0 110.746 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.71 142.32 31.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.51 147.02 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -104.44 128.67 52.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.952 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.11 124.74 31.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.636 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.39 -56.11 2.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -158.53 153.73 25.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -94.31 114.38 26.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 69.3 t -70.36 -43.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.491 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -151.65 -176.93 5.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.15 -38.66 83.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.242 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -111.6 10.53 21.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -133.8 149.47 51.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.502 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.8 p90 -154.9 159.41 40.45 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.033 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -105.78 134.95 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.988 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -155.55 175.79 33.32 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.495 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -152.83 159.2 43.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 911' ' ' GLY . 1.7 mp -63.59 135.18 96.15 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.84 -15.53 38.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.229 1.286 . . . . 0.0 112.161 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.673 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.87 -4.01 88.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 7.1 m 60.13 72.38 0.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.4 t -139.36 -39.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.972 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 909' ' ' ILE . 88.9 mtm180 -131.25 149.03 52.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.448 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -146.52 143.23 28.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.29 -172.32 45.08 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.503 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.5 pt -119.67 148.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.134 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -156.91 162.08 28.31 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.729 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.32 137.59 37.11 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.335 2.024 . . . . 0.0 113.745 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.17 -38.8 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 71.5 p -55.81 -16.5 4.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.66 2.58 41.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.502 HG11 ' OH ' ' A' ' 905' ' ' TYR . 17.0 m -131.57 156.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.204 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.48 124.47 48.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.284 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.98 130.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.809 0.338 . . . . 0.0 110.246 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.58 -54.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.19 147.39 52.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -73.62 152.96 89.59 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.19 -38.72 51.6 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.852 1.701 . . . . 0.0 112.313 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 40.0 tp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.578 -179.572 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.42 -47.39 86.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.729 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 65.3 mtt -96.6 -52.18 4.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.8 m 46.55 38.18 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.85 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -104.0 -173.72 25.45 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 63.0 m -138.5 151.6 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.672 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 794' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 794' ' ' GLU . 48.8 mp0 -98.26 139.65 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.3 mpp? -112.69 156.63 22.44 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.038 0.446 . . . . 0.0 110.941 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -125.76 97.71 35.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.073 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 850' ' ' LEU . 48.6 Cg_exo -57.12 138.03 84.46 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.858 1.706 . . . . 0.0 111.915 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -129.62 151.85 49.78 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -113.99 135.51 53.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.208 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -77.99 128.76 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -96.52 -18.34 19.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.282 0.563 . . . . 0.0 109.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -149.91 172.16 15.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.6 p-10 -90.98 135.27 33.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.045 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -118.46 123.44 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.787 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -89.07 132.29 34.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.476 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -80.95 129.09 34.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -105.54 -25.75 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.309 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.8 p -129.29 169.43 14.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.494 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.2 mp -61.15 -39.99 92.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.7 -38.75 88.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.609 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 96.9 mt-10 -81.83 126.14 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.9 151.68 44.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.51 144.4 66.79 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.84 1.693 . . . . 0.0 113.231 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 820' ' ' VAL . 1.5 tp -137.75 146.54 43.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.046 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.83 137.49 53.37 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.364 0.602 . . . . 0.0 110.876 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 816' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 816' ' ' LYS . 15.9 ptmt -44.91 122.61 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.95 -20.25 51.07 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.419 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.9 t0 -55.75 133.22 50.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.359 . . . . 0.0 110.834 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.451 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 30.9 mm -91.21 128.58 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.4 m -127.57 155.0 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.521 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 65.5 m-85 -112.09 117.47 32.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.408 HD13 ' HD2' ' A' ' 831' ' ' TYR . 68.4 mt -81.28 125.83 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -119.6 -9.3 9.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -167.27 131.96 1.95 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 111.367 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.97 136.78 33.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.9 mm -91.98 -67.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.829 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -133.95 176.67 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.18 -35.41 77.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.068 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -101.51 -1.03 34.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.268 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -131.86 136.15 47.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.201 0.524 . . . . 0.0 111.082 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.408 ' HD2' HD13 ' A' ' 822' ' ' ILE . 2.8 m-85 -124.76 160.5 28.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.843 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 841' ' ' ILE . 6.3 tt0 -129.84 141.1 50.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.12 -176.28 34.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.27 138.83 42.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.506 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 15.2 p-80 -146.07 131.92 19.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.794 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 51.67 37.43 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.616 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.77 78.85 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.73 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.27 152.36 48.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.222 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.45 132.67 64.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.258 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -159.55 -165.15 15.96 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 832' ' ' GLU . 46.6 pt -128.38 156.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.844 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.451 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -164.09 156.25 14.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.413 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 845' ' ' THR . 40.0 Cg_endo -69.7 117.96 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.979 1.786 . . . . 0.0 112.549 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.61 -13.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.404 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 843' ' ' PRO . 80.6 p -79.54 -6.66 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -103.81 -4.46 23.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.6 pt -135.11 172.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.593 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 77.4 mm-40 -112.98 162.84 15.41 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -108.06 104.22 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.33 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.8 tt 41.53 77.71 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.89 158.24 25.6 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.643 2.228 . . . . 0.0 111.586 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.87 135.6 28.74 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.678 1.586 . . . . 0.0 111.827 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -68.22 140.59 56.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.081 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -158.02 66.18 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.15 -39.55 94.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.639 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 52.14 -179.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.402 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -130.14 70.74 82.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.28 56.37 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.699 2.266 . . . . 0.0 112.041 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -102.95 -43.6 5.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.52 -18.76 65.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 85.3 mt -88.6 108.52 19.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 864' ' ' VAL . 82.3 p -149.81 161.01 32.73 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.527 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.27 -29.37 56.95 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.484 1.456 . . . . 0.0 112.191 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 862' ' ' THR . 23.2 m -124.58 161.26 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.006 0.432 . . . . 0.0 111.32 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -135.28 150.02 49.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 87.7 t -120.0 127.11 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.578 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 88.5 mt -111.97 142.94 43.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.445 ' OE2' ' NZ ' ' A' ' 927' ' ' LYS . 88.3 tt0 -90.56 132.8 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -128.64 151.86 49.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -70.12 165.47 51.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.57 150.3 48.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 896' ' ' LEU . . . -156.38 156.46 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 53.3 mt -131.6 132.58 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.464 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -51.23 128.47 22.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -81.05 -41.15 23.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.145 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 876' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 877' ' ' ASN . 0.2 OUTLIER -149.59 131.88 15.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.024 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 876' ' ' PHE . 59.7 m-80 -26.28 114.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.717 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -117.21 129.12 55.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.706 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -110.94 118.82 37.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.977 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.09 139.37 26.91 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.86 -38.93 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.0 p -135.36 170.85 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.007 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -58.23 -21.59 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.6 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.93 -42.67 93.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.7 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -88.15 128.68 35.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.591 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.609 ' SD ' ' CD2' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -78.32 133.0 37.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.0 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.602 ' N ' ' SD ' ' A' ' 886' ' ' MET . 67.3 m -106.37 138.27 42.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 110.862 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -155.69 176.41 12.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.063 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.4 mtm-85 -112.38 158.93 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.593 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -47.25 144.09 2.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.983 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.38 87.3 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.258 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 12.0 mm-40 -76.72 144.29 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -91.07 139.87 30.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.61 142.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.925 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.4 m -94.93 126.61 40.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 872' ' ' ALA . 91.5 mt -86.7 126.85 34.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.845 HD11 ' HE ' ' A' ' 908' ' ' ARG . 90.5 mt -107.3 -52.51 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -165.5 164.39 19.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.385 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.65 115.68 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.759 HG12 ' OD2' ' A' ' 901' ' ' ASP . 58.1 t -70.27 -45.18 76.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.759 ' OD2' HG12 ' A' ' 900' ' ' VAL . 3.0 m-20 -152.12 -170.9 3.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.48 -40.86 92.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.36 15.82 19.1 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -129.24 149.96 50.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.021 0.439 . . . . 0.0 112.096 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 142.93 26.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.722 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.84 135.89 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.93 178.54 34.18 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.506 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 897' ' ' LEU . 19.6 ptp180 -151.09 158.16 43.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.837 0.351 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 89.5 mt -80.18 141.49 54.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.7 140.29 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.942 1.095 . . . . 0.0 111.504 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 93.03 -7.58 76.37 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.3 m 67.89 28.2 7.05 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.704 0.288 . . . . 0.0 110.773 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 98.3 p -63.61 -28.15 69.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -164.58 150.74 10.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -138.95 143.41 38.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.297 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.44 -179.48 48.35 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.468 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 917' ' ' ILE . 41.9 pt -105.32 156.91 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 923' ' ' VAL . 21.2 p90 -161.89 152.48 14.66 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.67 142.46 58.41 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.9 1.733 . . . . 0.0 112.837 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 920' ' ' ILE . 0.1 OUTLIER -72.47 -26.05 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.138 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 4.3 t -69.59 8.43 0.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.543 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' TYR . . . . . 0.641 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -127.6 4.11 6.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 918' ' ' PHE . 20.5 m -121.19 148.79 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.925 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -102.87 126.25 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.272 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.9 t -82.99 125.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 35.3 mm -103.73 -52.3 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.524 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 927' ' ' LYS . . . . . 0.565 ' HZ3' HD12 ' A' ' 930' ' ' LEU . 64.6 tttm -137.55 134.06 35.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 928' ' ' ARG . . . . . 0.446 ' H ' ' HD3' ' A' ' 928' ' ' ARG . 0.7 OUTLIER -71.61 153.5 93.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.44 -38.82 64.38 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.882 1.721 . . . . 0.0 112.506 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 930' ' ' LEU . . . . . 0.565 HD12 ' HZ3' ' A' ' 927' ' ' LYS . 87.3 mt . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.436 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.05 -47.99 83.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 63.5 tpp -141.07 131.38 25.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.897 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 44.0 t -148.26 127.01 12.57 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.227 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -63.54 -40.22 98.48 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 73.5 m -62.0 -40.02 94.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.689 0.281 . . . . 0.0 111.19 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.71 149.87 49.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.734 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 795' ' ' MET . 0.0 OUTLIER -145.73 161.65 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.467 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.526 ' HE ' HD11 ' A' ' 849' ' ' LEU . 95.9 mtm-85 -133.73 149.27 71.5 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.52 128.26 10.2 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.225 1.95 . . . . 0.0 111.929 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -124.13 146.58 48.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -109.29 140.23 43.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.295 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -89.76 115.61 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -77.43 -20.99 53.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.447 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.17 170.01 17.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.5 p-10 -85.25 131.85 34.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.171 0.51 . . . . 0.0 110.382 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 804' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 843' ' ' PRO . 75.0 t80 -105.92 129.55 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -100.29 116.82 33.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.03 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -64.18 132.21 49.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.83 -31.16 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 81.6 p -131.81 161.24 33.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -38.69 57.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.344 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -44.47 95.35 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.68 134.98 52.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 17.0 tp -109.93 127.09 27.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.15 147.01 65.86 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.343 1.362 . . . . 0.0 112.769 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 842' ' ' PHE . 66.3 mt -114.65 152.75 31.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.85 139.06 52.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.333 0.587 . . . . 0.0 110.241 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.94 118.9 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.152 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.89 -21.42 40.37 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.968 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.77 141.35 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.031 0.443 . . . . 0.0 111.405 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 10.7 mm -97.58 132.41 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.779 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.721 HG12 ' HB2' ' A' ' 835' ' ' HIS . 33.9 m -125.25 153.16 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.47 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 79.7 m-85 -110.91 114.03 27.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 831' ' ' TYR . 4.2 mm -82.85 128.92 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.084 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.51 -44.92 7.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.259 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -160.49 153.55 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.981 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.49 110.25 18.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.235 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.458 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.1 mm -62.78 -46.89 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.597 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -148.08 178.65 8.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -60.09 -37.5 80.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -112.79 18.36 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.565 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -142.71 150.0 39.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.533 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.685 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 35.0 p90 -147.79 168.5 21.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.767 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.8 tp10 -129.33 139.91 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.487 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -163.99 -177.22 36.58 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -113.44 152.17 30.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.971 0.415 . . . . 0.0 111.027 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.721 ' HB2' HG12 ' A' ' 820' ' ' VAL . 1.0 OUTLIER -165.21 132.96 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.963 178.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 835' ' ' HIS . 47.4 t-80 64.34 28.09 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.831 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.76 20.53 79.77 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -134.65 152.04 51.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.458 0.647 . . . . 0.0 112.278 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 840' ' ' GLY . 76.8 t -100.33 154.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.47 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -175.73 176.44 47.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.57 145.71 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 117.403 0.602 . . . . 0.0 109.504 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -156.97 165.13 19.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.092 -177.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.459 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 58.1 Cg_endo -73.15 129.44 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.701 2.267 . . . . 0.0 112.401 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 844' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 846' ' ' TYR . 61.8 ttp85 -61.77 -37.79 85.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.413 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 3.3 t -59.19 3.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 846' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 844' ' ' ARG . 0.4 OUTLIER -110.25 -2.33 16.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.685 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.8 pt -133.94 175.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -116.48 161.76 18.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.526 HD11 ' HE ' ' A' ' 796' ' ' ARG . 53.0 tp -121.31 96.73 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.841 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.0 tt 40.14 70.27 1.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.485 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.83 159.22 54.13 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.902 1.735 . . . . 0.0 112.202 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 852' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 853' ' ' ALA . 57.2 Cg_endo -70.23 147.86 60.77 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 853' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 852' ' ' PRO . . . 42.46 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.486 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -159.02 158.34 32.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 856' ' ' ALA . 72.1 mmtt -123.73 136.81 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.906 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 855' ' ' LYS . . . 57.32 150.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.096 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 857' ' ' GLN . . . . . 0.442 ' OE1' ' N ' ' A' ' 857' ' ' GLN . 28.6 mp0 -131.85 148.43 69.87 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.7 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.55 -28.52 38.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.998 1.798 . . . . 0.0 112.235 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -153.48 134.37 13.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -131.41 22.47 4.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.71 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.05 -7.77 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 863' ' ' PRO . 0.2 OUTLIER -65.74 -41.53 48.28 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.926 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 862' ' ' THR . 65.0 Cg_endo -88.44 64.33 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.447 2.098 . . . . 0.0 112.659 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.4 m -97.93 -30.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.246 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -84.08 149.41 26.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.534 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 866' ' ' VAL . 27.5 m -106.13 82.17 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -90.57 -62.17 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.599 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 60.5 mp0 45.72 43.63 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 56.19 -103.48 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.586 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -142.95 169.52 25.62 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 871' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 927' ' ' LYS . 79.2 mm-40 -125.63 151.17 46.87 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.69 147.1 18.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.1 129.16 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.84 122.55 13.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -70.6 -36.27 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -135.4 154.5 51.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -53.54 138.58 33.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.1 129.0 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.51 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -116.75 109.3 16.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.424 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.13 149.12 43.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -106.41 -47.5 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.751 0.31 . . . . 0.0 111.116 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 74.6 p -81.31 162.01 23.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.351 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.95 -39.43 94.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.454 HG23 ' HG3' ' A' ' 885' ' ' GLU . 15.0 m -66.67 -23.97 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.454 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.5 mt-10 -98.26 129.11 44.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 30.5 mmm -94.82 178.83 5.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.771 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 88.6 p -131.29 149.86 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -160.63 163.31 32.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.26 165.05 11.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.954 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.12 136.35 57.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.28 -5.94 81.03 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.908 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.83 141.28 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.655 0.728 . . . . 0.0 110.379 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -86.16 141.87 29.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.088 0.47 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.76 147.81 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.495 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.7 m -102.34 127.85 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.502 HD11 HG13 ' A' ' 925' ' ' VAL . 78.7 mt -85.82 122.81 30.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.114 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.866 HD21 ' NH1' ' A' ' 908' ' ' ARG . 85.8 mt -101.52 -47.01 4.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -166.52 165.3 16.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.878 0.37 . . . . 0.0 111.31 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -104.04 118.45 36.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.406 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 63.4 t -61.94 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.645 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 77.1 m-20 -144.09 -104.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.9 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -126.09 -34.85 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.678 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.08 7.85 16.84 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.605 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -131.34 148.64 52.69 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.979 0.175 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.406 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 26.3 p90 -153.56 160.14 42.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.113 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.7 136.69 47.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.627 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.71 179.19 30.99 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.404 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.866 ' NH1' HD21 ' A' ' 897' ' ' LEU . 32.3 ptt-85 -148.37 158.22 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 0.0 110.258 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.77 140.55 86.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.75 138.53 33.19 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.181 1.101 . . . . 0.0 111.112 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 102.04 -18.17 52.63 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 71.98 73.33 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.9 t -120.91 -48.07 2.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.69 149.83 51.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.524 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.83 143.79 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.48 176.09 46.14 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.37 147.9 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.211 0.529 . . . . 0.0 111.387 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.57 159.12 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.918 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.06 139.55 39.45 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.566 2.177 . . . . 0.0 114.48 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.41 -38.06 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.467 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.468 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -52.6 -38.8 60.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.29 0.83 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.11 159.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 110.965 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -108.82 125.66 52.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 896' ' ' LEU . 95.8 t -99.99 103.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -65.04 -42.4 94.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.64 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 927' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 871' ' ' GLU . 7.0 ptmm? -145.18 159.09 43.54 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.157 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 -98.8 153.06 38.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.136 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.84 -25.07 60.58 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 112.569 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.576 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -137.35 43.7 2.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.611 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 66.3 mtt 55.63 42.78 29.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.635 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 41.3 t -65.46 138.92 58.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.668 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 75.64 17.49 80.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.7 t -60.69 -45.9 92.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -146.91 129.74 16.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm -151.0 150.47 30.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.531 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.72 149.76 63.36 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.866 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.09 105.06 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.308 2.005 . . . . 0.0 111.995 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.622 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -105.53 144.12 32.73 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.623 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -111.42 134.14 53.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.5 120.95 22.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 801' ' ' LYS . . . . . 0.458 ' NZ ' ' CE2' ' A' ' 802' ' ' PHE . 19.5 ttpp -89.07 -29.19 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 802' ' ' PHE . . . . . 0.458 ' CE2' ' NZ ' ' A' ' 801' ' ' LYS . 54.1 m-85 -135.03 152.57 51.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.436 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.8 p-10 -75.35 146.54 40.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.077 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -134.59 133.24 39.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -99.61 132.42 44.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.342 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.67 139.8 55.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.96 -30.94 13.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.382 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 29.9 p -137.06 178.4 7.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.43 -38.41 87.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.274 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -60.6 -40.68 92.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.374 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.723 ' C ' HD12 ' A' ' 812' ' ' LEU . 7.1 mt-10 -84.61 142.45 29.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.874 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.2 mp -121.35 152.76 58.11 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.32 148.26 67.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.982 1.788 . . . . 0.0 113.098 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.742 HD13 ' CE2' ' A' ' 842' ' ' PHE . 1.1 tp -131.11 145.39 51.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.54 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -124.85 137.91 54.28 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.472 0.654 . . . . 0.0 111.723 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.07 127.63 10.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.399 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.53 -19.32 54.17 Favored Glycine 0 C--N 1.318 -0.422 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.129 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.33 122.39 18.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.363 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.53 135.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.176 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 798' ' ' ALA . 32.9 m -130.17 154.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.4 m-85 -114.96 112.47 22.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.793 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.46 133.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.696 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -96.85 -47.79 5.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.775 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -163.95 153.78 14.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.269 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 825' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 59.3 tt0 -74.88 108.38 7.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.357 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.401 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.8 mm -64.75 -45.96 93.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.894 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 5.2 t0 -140.49 177.34 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.456 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -57.09 -27.06 61.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.382 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.27 -30.67 4.87 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.736 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -85.54 168.09 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.47 . . . . 0.0 111.719 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.697 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 24.0 p90 -153.39 169.09 23.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -131.5 138.41 48.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.044 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.64 -175.45 31.66 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.04 137.18 46.47 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.564 0.221 . . . . 0.0 110.611 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.3 p-80 -142.07 138.77 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 53.4 t-80 52.46 26.79 4.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.95 4.48 90.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.823 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.33 161.24 19.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.63 0.252 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.674 ' O ' HD22 ' A' ' 812' ' ' LEU . 10.3 p -110.72 153.68 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.754 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 839' ' ' VAL . . . -179.76 -172.56 43.94 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.5 pp -125.27 142.45 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.363 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.742 ' CE2' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -148.74 154.83 41.04 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.404 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.18 134.19 33.08 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.787 1.658 . . . . 0.0 111.98 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -60.57 -41.8 95.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.74 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 71.3 p -59.52 -11.54 4.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.635 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -92.73 -2.53 55.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.697 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 37.6 pt -133.99 165.46 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.873 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.21 120.94 28.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.208 0.528 . . . . 0.0 111.737 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.3 103.95 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.544 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.8 tt 42.79 87.04 0.12 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.271 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.86 151.44 48.71 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.686 2.258 . . . . 0.0 112.204 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 852' ' ' PRO . . . . . 0.655 ' O ' ' HB3' ' A' ' 853' ' ' ALA . 56.8 Cg_endo -69.59 157.65 59.96 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.567 2.178 . . . . 0.0 111.811 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 853' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 852' ' ' PRO . . . 80.52 59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.311 0.576 . . . . 0.0 110.307 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.43 153.54 26.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -131.02 149.51 52.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -71.14 145.25 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 857' ' ' GLN . . . . . 0.426 HE22 ' HD3' ' A' ' 859' ' ' LYS . 1.2 pp0? -98.9 158.38 32.46 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.036 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.54 140.84 64.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.82 1.68 . . . . 0.0 112.501 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 859' ' ' LYS . . . . . 0.426 ' HD3' HE22 ' A' ' 857' ' ' GLN . 2.9 mmmm -126.92 148.54 50.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.695 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -67.2 159.92 28.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.584 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.59 139.85 40.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 58.8 p -136.05 73.02 59.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.723 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.24 141.37 94.54 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.893 2.395 . . . . 0.0 112.185 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.623 HG23 ' N ' ' A' ' 865' ' ' GLN . 26.8 m -144.63 -125.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.275 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.623 ' N ' HG23 ' A' ' 864' ' ' VAL . 98.7 mt-30 54.97 47.29 22.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.17 174.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.166 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 97.26 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 110.5 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.693 ' OE2' HD12 ' A' ' 930' ' ' LEU . 52.9 tp10 -63.59 -41.12 98.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -72.56 146.88 46.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.697 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -74.97 172.67 53.15 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -129.54 157.3 42.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.87 153.1 29.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.32 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -52.56 137.55 30.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 3.3 ttpm? -83.82 -41.93 16.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -129.33 150.91 50.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 47.9 p-10 -55.5 153.27 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -151.13 131.81 14.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.859 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.59 108.21 14.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 880' ' ' GLY . . . . . 0.47 ' N ' ' OG ' ' A' ' 887' ' ' SER . . . -91.93 -176.84 42.43 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -145.68 -40.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.915 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 79.3 p -79.18 160.42 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.028 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -70.06 -30.17 67.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.1 -13.57 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 64.6 mm-40 -113.38 133.07 55.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.785 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 7.4 tpt -106.02 116.97 32.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.803 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 880' ' ' GLY . 50.1 m -73.82 144.11 45.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -154.73 157.16 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.461 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 15.9 tpp180 -106.61 150.28 26.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.319 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 890' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 66.1 tttp -44.55 139.99 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.066 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 83.7 0.86 90.01 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.407 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 7.1 mm-40 -73.33 148.63 43.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.18 0.49 . . . . 0.0 110.679 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -91.44 128.97 37.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.229 0.537 . . . . 0.0 110.718 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.76 148.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.41 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -106.36 127.28 53.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.863 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.38 124.61 29.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.697 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.485 HD11 ' HG2' ' A' ' 908' ' ' ARG . 86.6 mt -101.19 -52.86 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.27 164.54 22.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -96.9 111.88 23.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.49 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 78.8 t -69.41 -42.41 81.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.299 0.571 . . . . 0.0 110.016 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -152.97 -174.99 5.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.871 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -61.54 -38.1 86.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.237 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -117.02 14.65 15.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.77 147.64 51.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.648 ' OH ' HG11 ' A' ' 923' ' ' VAL . 16.1 p90 -155.04 160.67 41.21 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.112 0.482 . . . . 0.0 110.975 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -107.02 133.74 51.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.726 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -144.96 165.73 27.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.615 HH12 ' H ' ' A' ' 911' ' ' GLY . 5.3 ppt_? -150.81 158.83 44.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.446 . . . . 0.0 110.501 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 14.4 mm -78.9 132.68 63.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.78 137.24 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.259 1.128 . . . . 0.0 111.267 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.615 ' H ' HH12 ' A' ' 908' ' ' ARG . . . 99.56 -9.55 60.66 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.9 p 71.58 30.43 2.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.1 m -62.17 -40.65 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.187 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -161.76 152.73 18.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -132.33 147.75 52.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.35 43.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.853 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 918' ' ' PHE . 45.5 pt -119.57 147.01 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.91 0.385 . . . . 0.0 111.174 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -163.74 163.58 15.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.775 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.53 140.84 48.78 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.281 1.987 . . . . 0.0 113.321 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.45 -30.93 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.51 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 68.0 p -61.32 -21.43 63.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.651 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.67 1.65 56.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.648 HG11 ' OH ' ' A' ' 905' ' ' TYR . 14.7 m -135.34 160.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.913 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 924' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 66.5 t0 -114.79 130.62 56.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.399 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 926' ' ' ILE . 5.8 m -94.81 148.57 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -113.89 -38.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -146.55 130.8 17.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.452 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -73.83 158.83 85.52 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.186 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.32 143.62 93.31 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.573 1.516 . . . . 0.0 112.138 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 930' ' ' LEU . . . . . 0.693 HD12 ' OE2' ' A' ' 868' ' ' GLU . 3.4 tp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.472 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.23 -46.79 88.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 25.4 mmt 44.9 -101.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 8.2 t 59.19 -139.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -101.57 -151.59 24.61 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.4 t -129.79 -67.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.0 110.444 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -113.39 126.27 55.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.04 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 822' ' ' ILE . 63.1 tpp -142.39 134.84 27.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.178 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -138.24 148.66 60.57 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.399 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.95 156.23 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.404 2.069 . . . . 0.0 112.308 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -153.56 159.3 42.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -133.01 136.89 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -75.26 116.54 16.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 110.47 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.65 -37.54 86.77 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.92 173.07 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 57.2 t0 -77.43 109.45 11.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.599 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.14 126.76 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -95.23 111.69 23.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -61.29 134.68 57.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.072 0.463 . . . . 0.0 110.992 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 -31.2 8.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.906 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 60.8 p -133.07 162.4 31.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.376 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -55.94 -31.73 63.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.716 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -62.09 -39.69 93.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.289 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.534 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 98.9 mt-10 -96.57 126.89 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.325 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.5 mm? -103.44 151.69 38.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.633 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.78 142.54 48.14 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.573 1.515 . . . . 0.0 112.679 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 842' ' ' PHE . 92.6 mt -127.06 161.7 27.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -123.66 136.6 54.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.417 0.627 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.18 121.85 5.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.457 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.06 11.05 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.938 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 68.3 t0 -48.04 136.38 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.325 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 7.1 mm -101.86 125.32 56.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.86 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.71 156.65 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.293 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -112.12 125.62 54.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.64 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 832' ' ' GLU . 75.6 mt -88.0 123.47 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.215 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -111.43 -3.83 15.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.27 133.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -87.25 128.09 35.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.292 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.36 -46.35 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.03 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -152.65 179.43 8.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.637 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.91 -37.52 76.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -107.68 -8.6 16.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.79 141.07 42.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 0.0 112.031 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.496 ' CD2' HD13 ' A' ' 822' ' ' ILE . 43.3 m-85 -129.44 151.44 50.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.558 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 822' ' ' ILE . 3.7 tt0 -125.74 139.64 53.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -157.99 180.0 33.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 834' ' ' GLU . . . . . 0.483 ' OE2' ' N ' ' A' ' 837' ' ' GLY . 12.7 tm-20 -115.26 125.45 53.33 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.0 p80 -132.39 138.02 47.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 82.3 t60 50.78 32.05 6.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 837' ' ' GLY . . . . . 0.483 ' N ' ' OE2' ' A' ' 834' ' ' GLU . . . 75.46 13.3 83.02 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -118.61 148.16 42.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.8 127.34 75.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 0.0 111.541 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -147.97 -179.78 24.22 Favored Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.415 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 30.8 pt -124.29 143.4 37.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.101 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.487 ' CE1' HD11 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -145.75 149.11 38.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.676 -179.453 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.556 ' C ' ' H ' ' A' ' 845' ' ' THR . 72.1 Cg_endo -75.62 137.54 20.49 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.251 1.967 . . . . 0.0 111.197 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -55.51 3.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 843' ' ' PRO . 0.2 OUTLIER -90.74 -15.83 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.685 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 -5.45 16.17 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.268 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.9 pt -133.52 173.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.551 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -131.29 155.12 47.72 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 8.1 tp -105.31 107.63 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.197 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.6 tt 49.9 76.71 0.52 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 153.42 51.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.989 2.459 . . . . 0.0 111.845 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.74 151.11 74.62 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.465 2.11 . . . . 0.0 112.227 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -111.01 142.8 42.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -98.9 130.28 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.673 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -96.24 -0.55 49.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.645 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -81.6 0.27 39.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.935 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -67.43 153.29 95.12 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.095 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -52.24 138.77 54.73 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.704 1.602 . . . . 0.0 112.249 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.01 134.1 51.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.543 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -60.9 166.85 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.288 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.1 mp -51.22 143.45 11.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.69 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 862' ' ' THR . 11.2 t -131.27 78.28 72.63 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.661 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -58.02 142.54 96.82 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.842 2.361 . . . . 0.0 112.226 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.09 160.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -157.04 163.9 38.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.415 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 86.0 t -102.98 118.2 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 868' ' ' GLU . 2.2 tt -169.36 118.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.362 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.61 ' N ' HD23 ' A' ' 867' ' ' LEU . 99.7 mt-10 -121.14 133.87 55.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 869' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 869' ' ' TYR . 34.7 t80 -149.52 40.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 870' ' ' GLY . . . . . 0.408 ' N ' ' HG3' ' A' ' 929' ' ' PRO . . . -69.88 168.62 46.76 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 871' ' ' GLU . . . . . 0.532 ' OE2' ' NE ' ' A' ' 893' ' ' ARG . 88.0 tt0 -138.31 150.59 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.766 0.317 . . . . 0.0 110.203 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -143.43 153.12 42.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.99 121.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.073 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.5 4.03 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.5 mtmt -70.36 -36.79 74.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.63 152.62 50.69 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.253 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 878' ' ' PHE . 61.6 t-20 -54.69 136.14 46.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.709 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.632 ' CD2' ' CE1' ' A' ' 888' ' ' PHE . 90.3 t80 -129.52 132.04 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.76 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.06 106.95 13.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -71.01 139.58 29.89 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -107.01 -3.18 20.35 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 68.4 p -132.69 160.84 35.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.235 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -61.51 -41.96 98.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 885' ' ' GLU . 14.7 m -65.54 -25.38 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 885' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.8 mt-10 -99.92 108.23 20.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 887' ' ' SER . 16.9 tmm? -79.74 135.02 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.512 ' O ' ' SD ' ' A' ' 886' ' ' MET . 33.9 t -82.6 132.28 35.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.716 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.632 ' CE1' ' CD2' ' A' ' 878' ' ' PHE . 45.5 p90 -142.18 154.51 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.439 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 89.8 mtm180 -103.54 163.89 12.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.063 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.46 132.73 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.5 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 96.33 -7.01 66.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.296 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 71.2 mm-40 -69.94 133.77 47.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.923 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.532 ' NE ' ' OE2' ' A' ' 871' ' ' GLU . 70.4 mtp85 -84.05 126.09 32.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 8.7 mm -114.88 143.45 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.106 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -98.28 127.81 44.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.98 116.21 22.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 110.943 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.423 ' O ' ' OE1' ' A' ' 868' ' ' GLU . 95.7 mt -100.75 -50.62 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.443 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -160.86 154.9 22.77 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.079 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 116.88 32.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.448 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 60.0 t -61.43 -46.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.779 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.9 m-20 -143.88 -104.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.989 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -129.04 -37.7 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -108.09 4.74 25.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.502 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -132.02 148.27 52.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.42 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 16.2 p90 -153.95 159.77 41.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.113 0.482 . . . . 0.0 110.882 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -107.47 135.12 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.65 177.84 30.14 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.288 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -150.84 160.3 43.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.24 128.84 86.93 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -49.13 138.86 27.83 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 120.161 1.093 . . . . 0.0 111.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 912' ' ' THR . . . 101.26 -17.84 55.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 911' ' ' GLY . 0.2 OUTLIER 79.18 86.0 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.898 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 25.4 t -129.25 -41.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.036 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -162.74 151.92 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.817 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -130.01 146.55 51.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.05 175.48 45.34 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.519 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.8 pt -114.1 142.37 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.899 0.38 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -152.67 157.96 33.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.889 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 136.63 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.117 1.878 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.25 -36.82 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.867 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.433 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 73.0 p -53.5 -29.85 38.26 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -91.85 2.38 56.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.984 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.443 HG12 ' HB1' ' A' ' 872' ' ' ALA . 16.9 t -127.19 148.97 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.308 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -99.98 121.31 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.44 123.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.156 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -97.06 -44.82 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.67 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -125.61 142.27 51.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.5 74.61 69.15 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 929' ' ' PRO . . . . . 0.408 ' HG3' ' N ' ' A' ' 870' ' ' GLY . 57.6 Cg_endo -73.65 151.93 47.38 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.526 2.151 . . . . 0.0 112.307 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.462 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.75 40.91 30.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.596 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -147.66 159.38 43.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.702 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 97.7 p -155.4 164.4 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.593 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 91.05 -5.79 81.68 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 5.7 t 61.49 73.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.522 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.81 143.0 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.671 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.8 mpp? -116.62 156.58 26.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.96 149.44 73.13 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.02 153.8 57.71 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.394 2.063 . . . . 0.0 112.274 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -168.86 151.14 4.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -133.41 129.33 37.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.617 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 815' ' ' GLN . . . -76.41 122.83 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 801' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 848' ' ' GLU . 15.5 ttmm -91.24 -18.14 24.88 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.462 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.74 139.97 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.192 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.84 152.12 43.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.312 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 804' ' ' PHE . . . . . 0.443 ' CE1' ' CD ' ' A' ' 811' ' ' GLU . 47.5 t80 -126.87 129.09 47.55 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.466 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.61 121.1 35.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.1 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -62.26 134.99 57.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 110.793 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -110.96 -28.8 8.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 68.9 p -130.87 163.35 27.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.456 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.65 -34.75 67.62 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.99 -47.29 86.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.783 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.443 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 8.1 tm-20 -86.78 123.66 32.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.114 0.483 . . . . 0.0 111.266 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -96.57 152.73 38.77 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.29 145.12 76.95 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.611 1.541 . . . . 0.0 112.511 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 842' ' ' PHE . 1.2 tp -131.89 151.42 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 815' ' ' GLN . . . . . 0.625 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 11.1 tt0 -102.89 147.76 26.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.461 0.648 . . . . 0.0 110.661 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -63.45 38.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.125 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 166.06 23.26 0.02 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 820' ' ' VAL . 65.3 t0 -97.15 113.65 25.26 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.77 -0.253 . . . . 0.0 110.418 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.7 135.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.658 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 814' ' ' LEU . 30.7 m -131.55 158.3 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.25 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.409 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 84.6 m-85 -108.41 115.83 30.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.403 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 33.4 mm -81.57 134.62 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.318 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -96.75 -39.68 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 824' ' ' LYS . . . . . 0.47 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 25.9 pttm -162.07 159.83 26.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.417 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -86.14 116.02 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 827' ' ' ASP . 48.5 mm -65.01 -48.73 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.284 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 826' ' ' ILE . 34.5 m-20 -147.62 177.5 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.18 -36.41 75.29 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.253 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -109.87 15.4 22.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -137.06 147.53 46.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 112.082 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.541 ' OH ' ' NH1' ' A' ' 844' ' ' ARG . 44.0 m-85 -133.87 150.99 51.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.32 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.47 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 3.7 tt0 -124.11 133.33 53.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.135 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -158.39 -175.77 29.69 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -113.79 149.93 34.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.556 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -152.55 132.14 13.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.558 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 75.6 t60 48.84 34.01 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.581 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.88 1.63 90.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.863 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.18 147.83 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.451 ' O ' HD23 ' A' ' 812' ' ' LEU . 7.4 p -135.86 135.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.635 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 812' ' ' LEU . . . -158.27 -143.02 3.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 842' ' ' PHE . 45.5 pt -128.97 150.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 117.449 0.624 . . . . 0.0 110.748 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' A' ' 814' ' ' LEU . 4.1 m-85 -144.24 131.0 10.21 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.842 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.38 148.21 72.91 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.532 1.488 . . . . 0.0 112.784 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 844' ' ' ARG . . . . . 0.541 ' NH1' ' OH ' ' A' ' 831' ' ' TYR . 60.2 ttt85 -59.74 -41.06 90.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.658 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 94.1 m -64.47 -22.47 66.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.341 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -91.93 -3.76 55.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.806 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 844' ' ' ARG . 1.3 pp -142.08 165.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.182 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 801' ' ' LYS . 96.1 mt-10 -132.49 124.44 28.54 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.92 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 850' ' ' LEU . 2.4 tt -72.36 113.33 9.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.329 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.556 ' N ' HD23 ' A' ' 849' ' ' LEU . 3.3 tt 53.15 76.02 0.57 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.12 153.48 52.02 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.804 2.336 . . . . 0.0 111.749 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.51 153.15 74.35 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.399 2.066 . . . . 0.0 111.987 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -60.16 148.81 34.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.511 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -126.23 145.32 50.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -81.63 144.74 31.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.493 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -102.0 113.04 25.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.147 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -138.12 73.08 45.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.34 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.28 69.54 7.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.727 2.284 . . . . 0.0 112.099 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.42 119.14 24.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.57 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -159.79 163.93 34.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -74.25 118.33 17.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 110.379 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 6.9 t -64.47 139.04 97.63 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.83 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.112 1.875 . . . . 0.0 112.246 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.49 167.7 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.752 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -131.39 149.8 52.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.513 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 80.8 t -119.29 120.79 64.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.693 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 2.5 mt -157.03 17.22 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 871' ' ' GLU . 99.6 mt-10 -125.6 143.24 51.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.746 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.49 -42.28 7.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -150.51 168.15 30.36 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 871' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 868' ' ' GLU . 79.5 mm-40 -122.94 151.75 41.49 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.917 0.389 . . . . 0.0 110.929 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 924' ' ' ASP . . . -155.07 151.07 27.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.264 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 11.5 mm -122.23 127.45 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -47.31 131.17 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.497 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 22.4 ttpp -72.93 -37.19 67.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.684 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 876' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 922' ' ' TYR . 0.2 OUTLIER -155.15 160.79 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.231 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.541 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 63.3 m-20 -51.72 109.55 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -115.85 125.5 52.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.402 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -115.86 110.59 19.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.379 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -64.52 142.5 45.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.05 -22.93 28.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 66.3 p -129.85 164.15 24.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.621 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -59.87 -25.95 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.266 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.84 -45.3 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.64 141.79 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.7 tpt -103.24 130.71 50.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 142.07 27.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -158.6 160.84 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.538 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 891' ' ' GLY . 38.9 ttm180 -89.57 158.12 17.77 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -66.08 56.25 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.689 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 891' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . -178.16 4.66 0.03 OUTLIER Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.725 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.96 150.52 20.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.551 0.675 . . . . 0.0 109.866 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -95.5 127.97 41.97 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.451 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.62 151.67 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.85 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.7 m -104.36 127.45 52.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.887 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 925' ' ' VAL . 87.4 mt -90.16 127.7 36.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.535 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.755 HD11 ' HE ' ' A' ' 908' ' ' ARG . 87.9 mt -108.27 -53.56 2.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.702 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -156.34 150.28 25.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.985 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.14 106.94 18.82 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.51 -44.07 95.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -157.87 178.68 9.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.088 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 920' ' ' ILE . 80.9 mm-40 -61.87 -30.99 71.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 903' ' ' ASN . . . . . 0.469 ' C ' ' CD1' ' A' ' 904' ' ' TRP . 98.3 m-20 -109.7 20.07 18.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.41 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 904' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 903' ' ' ASN . 74.3 m95 -146.83 151.61 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.96 138.09 26.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.545 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -102.11 133.16 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.02 178.43 35.19 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.952 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.755 ' HE ' HD11 ' A' ' 897' ' ' LEU . 20.9 ptp180 -151.16 157.81 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.96 141.76 78.75 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.45 139.85 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.06 1.057 . . . . 0.0 111.046 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 912' ' ' THR . . . 95.33 -9.26 69.58 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.83 31.99 3.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.663 0.268 . . . . 0.0 110.971 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.0 t -60.91 -44.22 97.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.11 146.81 15.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -121.19 151.05 40.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.278 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -175.02 176.12 47.13 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.182 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.467 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 45.2 pt -125.12 156.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.467 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.4 OUTLIER -166.48 162.69 11.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.661 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.67 147.85 90.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.806 1.671 . . . . 0.0 111.768 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 902' ' ' GLU . 11.3 mt -76.37 -19.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 81.6 p -68.95 -10.69 58.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.591 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 922' ' ' TYR . . . . . 0.566 ' CD1' ' CE1' ' A' ' 876' ' ' PHE . 45.5 m-85 -108.23 7.59 27.47 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 920' ' ' ILE . 18.8 m -137.04 159.42 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.408 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 924' ' ' ASP . . . . . 0.412 ' O ' ' HB1' ' A' ' 872' ' ' ALA . 98.1 m-20 -117.38 131.75 56.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.54 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 896' ' ' LEU . 62.9 t -99.99 98.81 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.278 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.67 -44.19 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.013 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.65 142.53 51.0 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -73.94 152.08 88.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.86 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.52 72.89 5.38 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.937 1.758 . . . . 0.0 112.315 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 930' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 930' ' ' LEU . 24.1 tp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.522 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 788' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 791' ' ' SER . 20.9 tm0? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -61.18 -47.42 86.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.77 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 98.4 mtp -63.97 -40.87 97.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.863 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 791' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 788' ' ' GLN . 66.7 m -127.49 139.76 52.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.748 0.309 . . . . 0.0 110.86 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -92.68 99.26 2.51 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 45.3 t -119.94 128.21 53.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.856 0.36 . . . . 0.0 110.345 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.69 153.42 37.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -126.04 160.38 30.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.531 ' HE ' HD21 ' A' ' 849' ' ' LEU . 13.9 tpt180 -129.8 121.13 19.83 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.09 138.9 21.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.702 1.601 . . . . 0.0 112.474 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -138.77 154.4 48.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -113.13 140.39 47.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.013 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -72.88 126.95 31.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -91.06 -8.86 47.76 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.258 0.552 . . . . 0.0 109.571 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.13 178.3 7.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.136 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.3 p-10 -98.53 139.57 34.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.569 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -129.56 129.58 44.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.232 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -95.31 135.13 37.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.562 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -76.42 138.04 40.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -114.38 -22.33 9.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.902 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.1 p -127.22 167.67 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.446 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.42 -41.4 97.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.771 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -63.01 -39.94 96.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.471 . . . . 0.0 109.864 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.523 ' C ' HD12 ' A' ' 812' ' ' LEU . 95.6 mt-10 -74.76 131.89 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.265 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 811' ' ' GLU . 9.1 mp -118.76 154.23 52.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.06 144.19 62.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.856 1.704 . . . . 0.0 112.346 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.54 HD12 ' CD2' ' A' ' 842' ' ' PHE . 1.3 mt -137.65 141.45 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.212 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -122.66 139.85 53.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.438 0.637 . . . . 0.0 110.921 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.82 123.55 7.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.911 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 105.75 -24.33 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.412 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.2 t0 -61.9 135.67 57.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.799 0.333 . . . . 0.0 110.763 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.503 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 33.9 mm -93.9 130.57 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.555 HG12 ' HB2' ' A' ' 835' ' ' HIS . 28.6 m -123.46 152.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.46 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 86.6 m-85 -117.04 117.74 30.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.03 129.59 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -123.88 -9.67 7.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.274 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -165.18 133.59 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -82.69 138.01 34.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.633 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 9.8 mm -94.82 -57.64 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.477 ' O ' ' NH2' ' A' ' 844' ' ' ARG . 7.7 t0 -150.21 179.33 8.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.085 0.469 . . . . 0.0 109.795 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.59 -37.26 78.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.716 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -106.18 7.25 31.48 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -141.15 147.13 37.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.113 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 29.6 p90 -140.08 169.68 17.25 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.558 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.5 tp10 -128.54 139.19 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.134 0.493 . . . . 0.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.558 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -161.36 -175.45 32.4 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.89 135.62 49.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.693 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.555 ' HB2' HG12 ' A' ' 820' ' ' VAL . 0.8 OUTLIER -144.61 146.91 32.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.8 t-80 49.04 29.76 2.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.18 79.98 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -132.8 158.92 41.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 832' ' ' GLU . 92.0 t -106.78 132.66 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.618 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.465 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -164.29 -175.02 34.72 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.48 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 36.6 pt -115.15 149.65 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.515 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.54 ' CD2' HD12 ' A' ' 814' ' ' LEU . 0.3 OUTLIER -152.01 151.67 28.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 845' ' ' THR . 27.5 Cg_endo -67.88 112.08 2.59 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.797 1.665 . . . . 0.0 112.15 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 844' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 827' ' ' ASP . 19.1 ttm105 -47.69 -15.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.53 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.407 ' N ' ' C ' ' A' ' 843' ' ' PRO . 63.2 p -81.49 -2.25 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.735 0.303 . . . . 0.0 111.052 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.2 -2.91 26.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.004 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.5 pt -129.33 172.05 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.881 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 85.1 tt0 -110.31 159.73 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.531 HD21 ' HE ' ' A' ' 796' ' ' ARG . 3.4 tt -113.49 104.36 12.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 36.5 tp 58.26 75.13 0.56 Allowed Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.78 158.78 52.36 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.785 . . . . 0.0 112.399 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 147.29 60.49 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.667 2.244 . . . . 0.0 112.444 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -74.91 147.37 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.987 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 60.14 85.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.38 -22.56 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.621 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -63.39 142.83 58.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.719 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -139.67 66.28 34.25 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 858' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 860' ' ' LYS . 58.9 Cg_endo -71.95 -15.55 29.38 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.694 2.263 . . . . 0.0 112.868 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 57.77 -81.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 860' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 858' ' ' PRO . 48.1 mmtm -72.43 150.85 42.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.32 -39.09 91.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 79.2 p -128.7 149.44 72.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.68 -23.15 42.77 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.162 1.908 . . . . 0.0 112.68 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 10.9 t -129.62 133.11 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.449 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -170.53 121.73 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.688 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.88 127.71 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 867' ' ' LEU . 4.1 mm? -62.01 -40.84 97.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.5 83.38 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.266 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -140.54 130.02 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -144.77 164.17 27.85 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.0 160.93 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -158.88 146.0 17.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 89.8 mt -123.19 125.8 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.58 122.69 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.149 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 46.3 mtpt -70.38 -37.86 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -132.75 154.33 50.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.324 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -54.25 146.19 15.91 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 89.0 t80 -141.43 137.12 31.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.031 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -123.64 105.4 9.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.183 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.5 155.15 52.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 881' ' ' ASP . . . . . 0.419 ' OD1' HG23 ' A' ' 882' ' ' THR . 51.6 p-10 -115.13 -9.61 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.585 0.231 . . . . 0.0 111.503 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 882' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 881' ' ' ASP . 72.3 p -128.54 160.56 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 883' ' ' GLN . . . . . 0.493 ' O ' ' SD ' ' A' ' 886' ' ' MET . 55.2 tt0 -61.55 -39.71 92.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.936 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.48 -42.05 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.521 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -88.36 103.27 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.689 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 883' ' ' GLN . 0.0 OUTLIER -80.89 133.59 35.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.237 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 84.4 p -73.06 157.4 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 111.053 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 41.1 p90 -160.38 162.94 33.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.474 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -112.95 161.84 16.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.301 0.572 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -59.37 132.77 55.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.837 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.74 -8.01 78.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.694 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.31 139.82 48.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.24 0.52 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -85.21 143.4 28.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.956 0.408 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -131.99 148.8 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.738 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 895' ' ' THR . . . . . 0.449 HG21 ' NH1' ' A' ' 908' ' ' ARG . 97.3 m -101.53 129.16 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.987 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.26 115.21 24.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 111.149 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.97 -50.41 4.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.791 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -157.46 151.69 24.79 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.019 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.89 113.74 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.699 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 79.5 t -69.19 -43.16 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 110.31 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.438 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 19.3 t0 -153.56 -176.65 5.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.021 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 61.0 mp0 -61.13 -37.85 84.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.83 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.6 13.28 21.28 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.87 147.63 46.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.487 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 20.9 p90 -154.29 158.27 39.93 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.162 0.506 . . . . 0.0 110.965 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.23 133.3 52.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.04 178.6 30.83 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.334 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.449 ' NH1' HG21 ' A' ' 895' ' ' THR . 0.0 OUTLIER -153.14 161.68 42.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.855 0.359 . . . . 0.0 110.385 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 13.1 mt -90.22 132.26 36.32 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.826 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -39.98 136.28 1.45 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.397 1.398 . . . . 0.0 111.757 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.21 -4.34 64.8 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.44 24.68 13.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.4 t -61.58 -45.07 95.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.95 146.73 45.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 915' ' ' GLN . . . . . 0.489 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.2 tt0 -147.39 139.01 24.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 172.54 -170.28 43.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.7 pt -116.31 145.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.054 0.454 . . . . 0.0 111.014 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.37 153.38 30.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.038 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.04 137.52 41.2 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.057 1.838 . . . . 0.0 112.991 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.51 -38.68 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.465 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 93.7 m -51.96 -44.17 63.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.961 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.13 3.57 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.4 t -125.67 147.53 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.99 0.424 . . . . 0.0 110.285 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.71 120.99 42.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.504 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.76 124.65 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.505 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -87.89 -35.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -151.55 135.61 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.758 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -70.88 149.38 95.01 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.439 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.28 -21.33 41.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.044 1.83 . . . . 0.0 111.853 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.482 179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -129.62 139.78 51.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.9 mtm -112.38 107.19 15.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.335 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 62.8 m -132.74 144.11 50.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.24 84.93 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.0 t -158.18 147.62 19.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.319 . . . . 0.0 110.42 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -150.66 146.59 26.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.566 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 63.6 mtt -136.39 158.36 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -128.19 145.62 56.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.3 108.41 1.75 Allowed 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.956 1.77 . . . . 0.0 112.645 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -109.35 144.83 37.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -114.24 140.61 48.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.226 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.2 118.18 22.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.428 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -72.38 -27.48 62.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.077 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -142.39 178.15 7.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.558 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.09 139.28 30.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.057 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -127.08 125.86 42.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.34 132.55 34.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -71.2 139.03 49.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 807' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 98.1 mm-40 -105.24 -29.18 10.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.069 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 808' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 811' ' ' GLU . 71.5 p -136.15 170.14 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.261 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 809' ' ' LEU . 91.2 mt -61.41 -35.25 77.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.166 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -59.93 -40.17 88.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.737 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 10.8 pt-20 -98.4 129.4 45.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.613 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -102.08 152.19 38.18 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.58 149.98 68.7 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.304 2.003 . . . . 0.0 113.092 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.62 142.77 49.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.663 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.9 133.53 53.02 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.261 0.553 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -41.57 126.05 2.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.6 -24.17 32.49 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.385 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.53 121.35 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.2 mm -81.55 138.86 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.044 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.47 154.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.452 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -113.0 117.01 30.85 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.433 HD13 ' HD2' ' A' ' 831' ' ' TYR . 62.3 mt -82.04 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.17 -4.82 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -166.78 130.83 1.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 825' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 827' ' ' ASP . 4.0 tm0? -90.6 107.32 19.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.712 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.1 mm -60.77 -48.87 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.121 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.587 ' C ' HE21 ' A' ' 825' ' ' GLN . 1.3 t70 -155.56 176.98 11.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 828' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 26.0 mp0 -61.85 -35.83 79.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.779 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -102.13 -7.41 22.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.815 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -125.53 131.89 52.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.982 0.42 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.433 ' HD2' HD13 ' A' ' 822' ' ' ILE . 3.3 m-85 -121.4 156.65 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.605 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -128.91 140.81 51.51 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.91 -174.18 31.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.44 136.31 48.27 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.577 0.227 . . . . 0.0 110.652 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 2.7 p80 -139.11 133.14 31.13 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 1.3 t60 50.2 31.8 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.243 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.27 4.45 90.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.538 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -112.63 161.87 16.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.01 140.89 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.52 30.31 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.79 155.02 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.131 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -161.53 153.82 16.7 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.576 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 843' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 845' ' ' THR . 56.6 Cg_endo -71.86 126.98 12.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.961 1.774 . . . . 0.0 112.714 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 2.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.757 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 845' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 843' ' ' PRO . 73.8 p -91.05 -18.44 24.57 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.589 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.49 5.41 34.04 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.2 pt -130.27 168.28 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -134.71 113.27 11.5 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.988 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 849' ' ' LEU . 3.1 mp -68.81 118.19 11.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.959 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 850' ' ' LEU . 21.6 tp 58.84 69.91 1.28 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.785 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.5 161.66 41.83 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.625 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 852' ' ' PRO . . . . . 0.654 ' O ' ' HB3' ' A' ' 853' ' ' ALA . 51.5 Cg_exo -46.08 175.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.349 2.033 . . . . 0.0 112.127 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 853' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 852' ' ' PRO . . . 82.41 47.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.669 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 854' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 856' ' ' ALA . 88.5 tt0 -92.27 116.06 28.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.502 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 50.39 9.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.995 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 854' ' ' GLU . . . -62.67 -40.2 96.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.656 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -130.3 76.53 77.62 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.701 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.33 138.49 79.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.728 2.285 . . . . 0.0 112.253 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -118.84 -15.9 9.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.436 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.82 -43.24 98.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.51 99.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.157 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 51.8 p -71.15 150.55 94.63 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.309 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.41 156.61 54.33 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.254 1.969 . . . . 0.0 112.028 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.76 160.39 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.42 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -138.18 153.11 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.706 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.5 t -114.48 124.88 71.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.424 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.3 13.31 3.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.525 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.67 -39.82 95.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.45 141.46 51.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -80.99 168.13 50.52 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -128.15 150.41 50.0 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.54 146.32 16.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.05 125.21 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 874' ' ' ALA . . . . . 0.661 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -55.19 120.56 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.359 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -69.22 -36.7 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -134.33 150.52 50.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.916 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -55.55 132.92 49.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -130.67 134.63 47.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 879' ' ' ASN . . . . . 0.542 ' O ' ' ND2' ' A' ' 879' ' ' ASN . 0.4 OUTLIER -113.65 128.89 56.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.996 178.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 880' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -77.95 139.89 23.33 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -98.17 -12.73 21.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 110.731 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 62.0 p -133.07 165.08 25.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 883' ' ' GLN . . . . . 0.473 ' O ' ' CE ' ' A' ' 886' ' ' MET . 98.4 mt-30 -62.02 -39.73 93.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.113 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 884' ' ' VAL . 2.9 t -66.82 -15.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.757 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -105.71 110.09 22.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.296 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 883' ' ' GLN . 39.1 mmt -81.01 152.69 27.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.262 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 96.7 p -108.9 155.01 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -159.3 161.61 35.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.779 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 1.4 mpt_? -96.44 165.86 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.593 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.53 135.89 57.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.19 82.63 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.607 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 77.2 mm-40 -72.38 140.61 48.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.516 0.658 . . . . 0.0 110.038 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -82.06 140.99 33.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.114 0.483 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 872' ' ' ALA . 90.8 mt -130.25 138.8 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.51 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.3 m -99.37 126.13 45.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.08 115.36 25.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.107 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.28 -37.36 6.03 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.535 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.48 134.61 18.13 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.181 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -103.1 118.27 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 901' ' ' ASP . 60.0 t -63.96 -41.21 91.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.098 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 900' ' ' VAL . 36.4 m-20 103.97 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.905 1.378 . . . . 0.0 110.335 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 901' ' ' ASP . 10.2 tt0 80.7 -69.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.766 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -169.43 23.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -135.88 151.04 49.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.505 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.438 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 29.4 p90 -153.85 155.11 35.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.21 0.529 . . . . 0.0 110.3 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.88 138.5 42.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.64 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.24 178.14 30.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.144 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -148.13 157.92 43.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.747 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 914' ' ' ARG . 93.5 mt -80.35 142.14 54.11 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.27 139.2 16.53 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 120.312 1.147 . . . . 0.0 110.499 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.26 -5.06 67.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 9.1 p 61.3 23.55 13.76 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.535 -0.333 . . . . 0.0 111.532 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.6 m -62.39 -42.3 99.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.832 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 909' ' ' ILE . 36.7 mmt180 -134.9 153.04 52.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.456 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -145.37 135.75 24.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.75 177.22 46.15 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.9 pt -112.45 144.05 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.629 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -151.3 155.78 34.74 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.474 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 140.2 41.97 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.058 1.839 . . . . 0.0 113.395 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.22 -37.57 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.486 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 98.9 m -56.31 -42.54 77.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -76.09 0.25 19.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.158 0.435 . . . . 0.0 111.96 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.6 m -132.15 158.97 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.159 0.504 . . . . 0.0 111.245 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -107.14 123.95 49.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.455 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.27 110.15 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.24 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 32.4 mm -86.01 -47.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.868 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 143.19 51.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.444 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -75.17 153.08 86.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.171 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.74 -38.59 56.75 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.507 1.471 . . . . 0.0 111.93 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.331 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -99.94 7.54 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.3 mtm -75.0 144.95 42.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.255 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 83.4 p -70.74 159.37 34.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.504 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -139.9 -145.54 4.7 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 83.3 p -69.75 155.86 39.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.913 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -165.3 151.39 9.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.763 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 24.8 ptp -140.83 153.96 46.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -132.98 145.77 58.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.227 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.59 120.27 3.9 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.934 1.756 . . . . 0.0 112.431 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -120.42 152.0 38.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 74.8 ttt180 -118.27 133.93 55.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.951 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -77.22 113.98 15.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 801' ' ' LYS . . . . . 0.479 ' O ' ' NZ ' ' A' ' 816' ' ' LYS . 18.8 mmmt -69.68 -38.17 76.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.168 0.509 . . . . 0.0 110.056 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.4 167.52 20.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.093 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 137.6 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.333 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -133.75 131.38 39.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.441 ' O ' ' NE2' ' A' ' 807' ' ' GLN . 68.8 mttm -100.7 134.54 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -81.86 144.05 31.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.99 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 807' ' ' GLN . . . . . 0.441 ' NE2' ' O ' ' A' ' 805' ' ' LYS . 25.8 mp0 -98.52 -35.32 10.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.68 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 47.1 p -135.03 171.66 14.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.386 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.2 -24.65 43.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.175 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.28 -38.83 88.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.285 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.409 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 24.6 mp0 -101.12 156.44 17.42 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.7 pt? -127.21 147.68 62.91 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 813' ' ' PRO . . . . . 0.502 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 58.3 Cg_endo -72.44 140.25 32.97 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 113.033 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.72 145.0 51.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -120.13 139.98 51.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.281 0.562 . . . . 0.0 110.426 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 816' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 801' ' ' LYS . 12.4 ttmm -43.83 121.54 2.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.27 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 98.52 -20.65 49.59 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.578 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.32 136.16 57.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.937 0.399 . . . . 0.0 111.399 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.97 131.63 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.867 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.0 m -124.93 152.87 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.646 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -110.82 121.54 45.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.799 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.501 HD13 ' HD2' ' A' ' 831' ' ' TYR . 67.0 mt -91.38 131.06 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -104.51 -32.22 9.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.674 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -158.28 149.86 21.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.494 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -88.48 110.77 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.285 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.36 -48.01 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.296 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 827' ' ' ASP . . . . . 0.432 ' OD1' ' OE1' ' A' ' 828' ' ' GLN . 8.2 t0 -154.76 177.86 10.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 828' ' ' GLN . . . . . 0.432 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 25.5 mp0 -61.36 -36.35 79.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.754 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -103.73 -2.55 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.173 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -127.97 139.38 52.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.501 ' HD2' HD13 ' A' ' 822' ' ' ILE . 5.0 m-85 -126.03 158.27 35.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.314 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 822' ' ' ILE . 0.6 OUTLIER -129.05 138.96 52.2 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.15 -176.01 33.77 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -117.56 152.91 34.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.971 0.415 . . . . 0.0 111.458 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.0 OUTLIER -164.52 137.05 4.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.159 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 49.3 t-80 52.6 29.93 7.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.302 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.22 2.63 90.57 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.515 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.9 148.25 30.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.05 136.93 52.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -170.7 -137.83 2.38 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.409 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 47.5 pt -133.83 157.01 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.93 0.365 . . . . 0.0 111.641 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 6.6 p90 -157.72 135.77 7.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.181 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.27 124.85 17.05 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.125 1.216 . . . . 0.0 112.442 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -54.92 -20.42 8.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.4 p -72.46 -11.28 60.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.48 -1.76 40.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.244 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.588 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -135.45 171.03 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.992 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -131.88 110.19 10.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.869 0.366 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.64 116.29 8.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 32.4 tp 54.05 72.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.676 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.38 164.54 35.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.183 1.922 . . . . 0.0 112.123 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.82 140.88 37.19 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.995 1.797 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -66.84 78.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.456 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -97.01 6.02 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.392 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 856' ' ' ALA . 23.4 pttp -58.43 -22.32 53.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.224 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 855' ' ' LYS . . . 73.58 -69.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 45.05 69.42 2.55 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.48 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 858' ' ' PRO . . . . . 0.4 ' CB ' HD21 ' A' ' 861' ' ' LEU . 49.5 Cg_exo -56.66 143.54 89.04 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.941 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -73.41 80.12 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp 49.85 100.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.918 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 861' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 862' ' ' THR . 91.9 mt -70.61 148.79 47.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 861' ' ' LEU . 61.9 p -31.09 96.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 123.631 0.582 . . . . 0.0 111.243 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 156.83 29.38 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.021 1.814 . . . . 0.0 111.98 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.79 142.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.562 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.32 171.97 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.374 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 868' ' ' GLU . 95.9 t -82.43 123.6 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.204 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.83 4.9 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.536 ' H ' HG12 ' A' ' 866' ' ' VAL . 99.6 mt-10 -77.08 -6.29 52.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.233 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.39 152.61 40.77 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.54 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -156.89 172.06 34.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.77 143.97 50.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.206 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -157.2 144.59 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.5 mt -123.02 128.19 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.822 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.09 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.946 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 44.7 mtpt -70.05 -37.82 75.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.816 0.341 . . . . 0.0 110.497 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.71 153.53 49.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -57.11 159.46 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 878' ' ' PHE . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 26.9 t80 -150.49 138.72 20.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.72 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 879' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 40.0 p30 -151.85 92.04 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -82.69 -174.24 49.98 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 881' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 49.4 t0 -135.66 -9.38 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 111.641 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.5 p -79.26 174.3 11.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.98 0.419 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.45 -0.93 57.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 -18.77 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.642 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -72.57 141.95 48.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.58 128.56 46.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 22.5 t -92.85 125.45 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.109 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 34.4 p90 -154.9 162.37 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 33.2 mtp-105 -112.18 161.67 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.347 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -59.42 136.54 58.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 891' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 893' ' ' ARG . . . 90.15 -4.91 83.14 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 75.8 mm-40 -76.87 142.79 40.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.179 0.489 . . . . 0.0 110.562 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 891' ' ' GLY . 12.6 mpt_? -82.4 142.12 32.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.251 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.2 mt -131.38 143.17 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.2 m -100.65 127.09 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.873 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.581 HD11 HG13 ' A' ' 925' ' ' VAL . 81.6 mt -86.85 120.32 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.3 mt -100.18 -45.61 5.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -165.5 164.85 19.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.887 0.375 . . . . 0.0 111.134 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 899' ' ' GLN . . . . . 0.596 ' NE2' HD11 ' A' ' 920' ' ' ILE . 2.1 tp60 -103.58 116.95 33.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.761 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.434 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.8 t -61.86 -45.55 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.193 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 902' ' ' GLU . 34.4 t70 -148.56 -116.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.789 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.471 ' H ' ' CG ' ' A' ' 901' ' ' ASP . 99.7 mt-10 -114.32 -37.03 4.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.75 7.75 22.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.589 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -132.49 148.57 52.39 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.526 0.203 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.514 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.5 p90 -152.71 159.56 43.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.853 0.358 . . . . 0.0 110.283 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -109.69 136.79 48.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.32 178.39 30.38 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.547 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -151.79 159.75 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.7 mt -80.69 140.79 51.29 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.49 138.3 18.81 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 CA-C-N 120.148 1.088 . . . . 0.0 110.988 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.5 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.04 -6.91 73.0 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 911' ' ' GLY . 2.2 p 66.51 28.05 9.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.715 0.293 . . . . 0.0 111.15 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 88.0 p -64.21 -24.17 67.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -165.26 152.85 11.03 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.686 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -144.02 147.19 33.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.676 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 179.04 -174.55 46.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.551 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 45.9 pt -109.94 154.72 11.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.219 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 918' ' ' PHE . 0.0 OUTLIER -165.23 151.87 9.18 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.908 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.82 140.65 29.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.17 1.913 . . . . 0.0 112.768 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.596 HD11 ' NE2' ' A' ' 899' ' ' GLN . 90.1 mt -61.57 -32.05 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.801 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 97.9 m -57.9 -42.14 84.09 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -77.4 1.23 19.66 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.514 HG11 ' OH ' ' A' ' 905' ' ' TYR . 3.5 m -133.78 159.15 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.494 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -111.32 128.7 56.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.377 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 896' ' ' LEU . 79.3 t -99.58 105.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.687 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 926' ' ' ILE . 2.5 mp -62.19 -45.74 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 927' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 926' ' ' ILE . 98.2 mttt -138.31 140.41 39.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -91.16 126.21 55.81 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.689 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.76 150.89 62.85 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.708 1.605 . . . . 0.0 112.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.481 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -63.39 -39.85 95.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 98.3 mtp -96.47 139.54 32.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.549 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 68.0 m -134.19 -117.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 82.75 1.14 90.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 91.3 p -63.94 -38.33 90.7 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.692 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.92 -19.69 7.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 64.2 mtt -83.34 153.12 24.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -158.77 98.46 1.69 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.19 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.824 1.683 . . . . 0.0 111.91 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.514 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -134.73 155.91 49.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -118.51 134.47 55.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.283 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 800' ' ' ALA . . . . . 0.534 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.29 116.92 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -71.3 -30.03 65.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.46 175.67 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.465 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 805' ' ' LYS . 14.5 t70 -82.31 126.73 32.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.455 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -115.56 130.73 56.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.981 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 803' ' ' ASP . 38.2 mmtm -94.21 130.16 40.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.2 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.77 139.51 55.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.24 -35.63 10.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.242 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.9 p -135.42 162.54 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.1 pp -50.61 -32.87 20.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.46 -46.13 91.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.268 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.848 ' OE2' HD11 ' A' ' 841' ' ' ILE . 2.7 mt-10 -90.03 136.97 32.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.025 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.4 mm? -110.67 150.72 42.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 152.02 50.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.219 1.946 . . . . 0.0 113.448 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 820' ' ' VAL . 4.8 mt -133.96 157.21 46.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.917 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.56 141.01 50.67 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.422 0.63 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -47.62 123.35 5.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.79 44.19 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.886 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.539 ' OD1' ' NE2' ' A' ' 835' ' ' HIS . 19.8 t70 -58.03 143.28 43.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 28.2 mm -103.78 131.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.655 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 814' ' ' LEU . 32.1 m -121.62 152.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.764 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.418 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 72.8 m-85 -111.94 113.58 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 832' ' ' GLU . 73.0 mt -81.36 127.14 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -119.33 -5.49 10.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.19 130.44 1.45 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.81 135.32 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 832' ' ' GLU . 48.9 mm -88.29 -48.92 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.42 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -152.48 178.98 8.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.13 -37.21 79.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.163 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -105.98 -0.43 24.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.929 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 830' ' ' TRP . . . . . 0.462 ' CE3' HD12 ' A' ' 841' ' ' ILE . 79.4 m95 -124.5 137.94 54.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.491 0.662 . . . . 0.0 112.089 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 822' ' ' ILE . 28.9 m-85 -128.03 151.85 48.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.372 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.506 ' OE1' HD11 ' A' ' 826' ' ' ILE . 9.0 tt0 -123.31 141.03 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -161.9 -163.51 14.92 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.49 150.13 49.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 111.008 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.6 ' HB2' HG12 ' A' ' 820' ' ' VAL . 1.2 t-80 -155.33 128.05 7.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.449 ' CB ' HH21 ' A' ' 838' ' ' ARG . 1.9 m80 52.38 24.04 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 92.09 -6.37 78.81 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 838' ' ' ARG . . . . . 0.449 HH21 ' CB ' ' A' ' 836' ' ' HIS . 12.0 ptp180 -98.08 151.9 19.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.337 0.568 . . . . 0.0 109.897 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 839' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 833' ' ' GLY . 9.2 p -131.55 129.24 61.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.92 23.87 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.848 HD11 ' OE2' ' A' ' 811' ' ' GLU . 31.1 pt -105.74 152.15 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 117.338 0.569 . . . . 0.0 110.588 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.5 OUTLIER -139.79 114.78 7.95 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.8 128.57 21.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.474 1.45 . . . . 0.0 112.721 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -50.85 -20.28 1.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.533 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 65.7 p -87.1 -3.18 59.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.663 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -6.42 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.221 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.8 pt -134.25 172.1 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.013 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -117.83 160.61 21.1 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.87 107.67 18.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 41.3 tp 46.41 77.64 0.45 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.472 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.67 162.12 42.1 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.947 1.765 . . . . 0.0 111.809 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.04 133.78 47.52 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.811 1.674 . . . . 0.0 112.337 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -107.32 -2.53 20.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.371 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -62.55 -178.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.927 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.99 153.0 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.261 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -139.21 60.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -135.42 149.54 69.88 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.92 152.47 63.34 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.251 1.967 . . . . 0.0 112.159 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.07 143.44 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 860' ' ' LYS . . . . . 0.515 ' NZ ' HG21 ' A' ' 862' ' ' THR . 65.0 tttp -107.61 118.96 38.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.988 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 861' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 862' ' ' THR . 87.2 mt -111.15 -50.37 2.94 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 862' ' ' THR . . . . . 0.515 HG21 ' NZ ' ' A' ' 860' ' ' LYS . 67.0 p 35.17 70.79 0.91 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -58.36 143.05 98.0 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.869 2.38 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 866' ' ' VAL . 0.7 OUTLIER -95.77 -60.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.488 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 73.82 -12.92 0.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.423 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 864' ' ' VAL . 94.3 t -79.21 128.03 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.014 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.33 143.4 30.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.155 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 869' ' ' TYR . 88.5 tt0 -61.05 123.07 16.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.54 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 869' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 868' ' ' GLU . 20.3 m-85 40.92 -169.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -103.69 173.13 21.62 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -129.02 150.55 50.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.722 0.296 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.496 ' O ' HD13 ' A' ' 873' ' ' ILE . . . -154.53 152.86 30.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 873' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 872' ' ' ALA . 23.2 mm -125.14 128.77 73.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -59.29 126.34 27.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.339 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 50.4 mtpt -73.85 -39.02 64.3 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -139.02 153.8 48.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.07 132.9 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -132.91 135.91 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.894 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -109.93 141.58 42.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.583 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.35 12.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -98.42 -12.15 21.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.25 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.4 p -132.99 163.31 29.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.28 -39.86 94.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.916 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.99 -25.01 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.843 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -98.2 127.47 44.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.8 tpt -105.07 123.59 48.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.937 0.399 . . . . 0.0 110.97 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 87.1 p -74.41 157.44 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.871 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -164.43 162.56 22.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 889' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 27.9 mmt180 -102.71 159.18 15.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.92 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -55.14 137.25 47.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.76 82.93 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.119 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 892' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 11.9 mm-40 -69.65 141.84 53.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.079 0.44 . . . . 0.0 110.712 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -91.25 135.26 33.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.136 0.493 . . . . 0.0 111.111 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.49 148.03 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.517 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.1 m -99.81 127.07 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.474 ' CD1' HG13 ' A' ' 925' ' ' VAL . 86.5 mt -84.03 125.11 31.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 111.104 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 98.3 mt -103.19 -50.71 3.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.021 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 898' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 36.7 ptt-85 -165.93 165.24 18.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.22 119.17 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.545 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 53.3 t -61.2 -47.65 92.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.764 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.1 m-20 -144.2 -91.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.07 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.427 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.2 tp10 -137.93 -46.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -102.1 7.46 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -133.23 149.39 52.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.688 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.505 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.4 p90 -153.57 161.78 41.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.054 0.455 . . . . 0.0 111.165 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 33.8 tt0 -109.96 139.2 45.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.867 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.47 176.24 28.29 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -144.62 156.23 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.782 0.325 . . . . 0.0 110.436 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 909' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 914' ' ' ARG . 92.1 mt -103.21 107.67 56.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.066 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -54.09 135.28 63.66 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.35 1.367 . . . . 0.0 111.358 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 97.01 -22.31 41.45 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 74.6 p -127.58 -17.55 4.57 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.992 0.425 . . . . 0.0 110.022 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 57.5 m 51.61 36.57 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.216 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.457 ' HB2' HD12 ' A' ' 909' ' ' ILE . 11.3 mmp_? -86.25 98.09 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -86.33 128.23 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.999 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -157.03 163.91 32.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.496 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.3 144.9 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.895 0.378 . . . . 0.0 111.068 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.496 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -158.49 164.28 21.69 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.857 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.39 137.06 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.412 2.074 . . . . 0.0 113.925 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 902' ' ' GLU . 91.6 mt -60.77 -39.09 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.88 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 70.1 p -54.92 -22.48 15.07 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.757 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -95.11 0.85 54.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.505 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.6 m -132.3 157.88 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.13 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.43 121.83 45.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 896' ' ' LEU . 67.5 t -90.19 103.95 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 41.4 mm -72.38 -43.58 64.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.131 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -132.82 151.92 51.92 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -101.41 148.06 34.67 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.5 153.42 60.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.224 1.949 . . . . 0.0 112.606 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 56.3 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.503 179.701 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -70.61 -16.41 62.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 99.0 mtp 43.26 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 95.9 p -64.7 -16.96 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.49 95.09 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 88.1 p -148.87 158.78 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.563 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.68 161.68 34.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -68.21 158.32 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.581 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.514 ' HB3' HD21 ' A' ' 849' ' ' LEU . 98.8 mtt180 -125.82 97.61 35.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.545 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.56 140.88 96.56 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.075 1.85 . . . . 0.0 111.905 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -135.17 155.83 50.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -117.54 133.66 55.72 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.451 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -79.41 127.07 31.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -91.99 -28.72 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.14 162.62 32.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.079 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.5 p-10 -75.94 137.77 40.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.457 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.27 129.02 55.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.003 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -96.03 124.98 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 806' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -70.72 137.88 50.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.7 -38.8 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.418 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 67.8 p -135.64 162.87 31.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.62 -34.35 7.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.21 -39.86 94.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.993 0.425 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.643 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 3.6 mt-10 -92.83 128.33 38.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.977 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.1 mm? -108.71 150.09 40.32 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.649 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.74 151.43 63.49 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.203 1.935 . . . . 0.0 113.023 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 3.2 tp -135.82 151.26 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.612 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.19 137.86 53.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.47 0.652 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.42 126.27 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.66 -23.64 34.97 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.294 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 818' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.3 t0 -59.78 133.98 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 819' ' ' ILE . . . . . 0.47 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 44.7 mm -91.82 130.11 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 798' ' ' ALA . 0.0 OUTLIER -118.99 145.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.222 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.428 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 71.0 m-85 -107.51 104.86 14.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.6 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.45 130.89 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -100.35 -38.21 8.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.832 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -161.37 156.15 23.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.479 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.33 111.12 20.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.026 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 826' ' ' ILE . . . . . 0.456 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 48.0 mm -63.34 -47.35 92.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.278 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -148.88 177.12 9.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.62 -25.3 68.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -123.96 11.42 8.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -137.91 145.26 41.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.495 ' OH ' HG21 ' A' ' 847' ' ' ILE . 29.4 p90 -140.76 165.5 27.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -127.61 139.06 52.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.398 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.13 -172.24 29.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -111.83 138.84 47.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.779 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.496 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.4 p-80 -141.71 133.74 27.57 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 836' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 52.83 29.69 8.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.13 5.78 89.86 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.012 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -115.92 150.11 37.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.5 p -114.4 141.99 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.01 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -171.01 -158.62 15.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.44 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 49.4 pt -126.45 149.63 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.76 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 842' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -151.4 154.03 33.08 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.45 125.8 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.623 1.548 . . . . 0.0 111.825 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -56.98 -27.67 61.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.174 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.8 p -66.82 -12.84 60.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.255 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -96.36 -1.32 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.893 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -140.45 169.11 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.439 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 848' ' ' GLU . . . . . 0.636 ' N ' HD12 ' A' ' 847' ' ' ILE . 82.1 tt0 -130.42 120.26 23.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 796' ' ' ARG . 2.9 tt -63.2 115.79 4.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.897 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 850' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 849' ' ' LEU . 0.2 OUTLIER 44.62 77.22 0.46 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.89 161.09 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.653 2.236 . . . . 0.0 111.334 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.67 137.9 33.27 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.888 1.725 . . . . 0.0 112.033 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -101.19 48.88 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.525 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.5 -39.04 92.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.505 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 855' ' ' LYS . . . . . 0.644 ' O ' ' HB3' ' A' ' 856' ' ' ALA . 63.1 mttp -61.75 -39.62 92.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 856' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 855' ' ' LYS . . . 77.34 -169.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.496 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 857' ' ' GLN . . . . . 0.414 ' N ' ' CD ' ' A' ' 858' ' ' PRO . 96.0 mt-30 47.79 55.96 17.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 858' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 857' ' ' GLN . 58.8 Cg_endo -71.21 153.48 62.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.894 2.396 . . . . 0.0 111.906 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -90.58 109.92 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -94.95 -0.17 54.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.361 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.64 144.14 49.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 149.32 44.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 865' ' ' GLN . 19.0 Cg_endo -62.02 -71.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.06 1.84 . . . . 0.0 112.228 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 863' ' ' PRO . 2.4 t 67.51 -38.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 865' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 863' ' ' PRO . 20.1 pt20 -68.17 146.37 53.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.11 150.08 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.119 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.36 -12.54 19.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.48 -23.32 63.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -121.62 145.98 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.989 0.423 . . . . 0.0 111.364 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -84.32 179.47 51.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -135.04 147.17 49.56 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.503 0.192 . . . . 0.0 110.717 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -152.67 154.14 34.7 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 92.9 mt -124.74 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.754 0.312 . . . . 0.0 110.436 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.47 57.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.327 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -87.2 -29.67 21.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -137.94 145.48 42.07 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.708 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.3 p-10 -51.34 122.14 7.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -117.05 125.86 51.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -119.81 105.6 11.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.301 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -65.26 137.97 38.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -102.89 1.14 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.9 p -130.5 163.09 27.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -62.01 -40.81 96.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 884' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 884' ' ' VAL . 14.0 m -67.62 -25.36 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.572 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -97.42 136.39 37.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.185 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 886' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 915' ' ' GLN . 0.0 OUTLIER -107.24 168.05 9.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 41.5 t -118.44 136.16 53.95 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.942 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.92 162.05 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -82.67 162.33 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.717 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 890' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 890' ' ' LYS . 10.6 pttt -73.09 42.36 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.267 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . -160.83 -0.38 0.07 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.069 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.68 143.18 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.795 0.798 . . . . 0.0 110.406 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -76.23 143.08 41.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.995 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 872' ' ' ALA . 92.0 mt -129.19 139.13 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.524 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.8 m -99.14 125.25 44.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.83 116.48 20.01 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 897' ' ' LEU . . . . . 0.563 HD11 ' HD2' ' A' ' 908' ' ' ARG . 86.6 mt -97.64 -46.07 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -166.18 164.61 17.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.984 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -103.91 118.41 36.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.465 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.4 t -65.26 -45.31 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.647 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -152.03 -125.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.769 0.318 . . . . 0.0 111.047 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.08 -25.11 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.339 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -135.47 18.93 3.35 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.599 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.51 146.95 51.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.733 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.465 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 15.0 p90 -156.42 161.29 40.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.053 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.65 133.89 50.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.502 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -147.91 172.96 28.12 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.557 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 908' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 897' ' ' LEU . 8.7 ptm180 -155.96 163.39 39.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.812 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 84.3 mt -94.01 139.26 22.55 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.96 141.52 36.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.214 1.112 . . . . 0.0 111.061 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.09 68.58 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.498 HG23 HH21 ' A' ' 908' ' ' ARG . 1.2 m 73.78 28.37 1.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 44.9 t -67.9 -50.14 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -135.19 148.07 49.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.082 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 915' ' ' GLN . . . . . 0.488 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.6 tt0 -151.24 135.18 16.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.278 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 176.78 -174.89 47.37 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.0 pt -115.47 146.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.36 0.6 . . . . 0.0 111.456 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -161.75 158.82 22.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.677 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.05 140.43 45.34 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.489 2.126 . . . . 0.0 114.452 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.19 -32.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.269 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.7 m -57.62 -39.44 76.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.749 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.85 5.04 23.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.06 158.46 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.169 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -111.0 123.14 49.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.267 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.483 ' C ' HD12 ' A' ' 926' ' ' ILE . 4.7 m -95.04 141.53 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.011 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -107.47 -37.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.265 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -136.49 136.29 39.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.523 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -78.8 148.72 73.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.718 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.2 -23.71 45.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.069 1.846 . . . . 0.0 112.169 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -106.65 12.7 29.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.519 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 790' ' ' MET . . . . . 0.511 ' O ' ' CB ' ' A' ' 791' ' ' SER . 66.2 mtt -127.91 154.28 45.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.677 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 791' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 790' ' ' MET . 3.7 p 86.85 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.69 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 83.3 1.31 90.38 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 793' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 794' ' ' GLU . 0.0 OUTLIER -178.5 -6.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.013 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 794' ' ' GLU . . . . . 0.429 ' H ' ' H ' ' A' ' 793' ' ' SER . 88.5 tt0 -62.16 -40.35 95.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm -49.02 136.28 14.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.637 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.713 ' HB2' HD11 ' A' ' 849' ' ' LEU . 25.3 mmt180 -135.6 148.89 67.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.57 116.31 4.45 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.942 1.762 . . . . 0.0 111.987 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 798' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -112.32 152.67 28.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -118.85 129.36 55.17 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.662 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.19 112.66 9.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.97 -35.43 78.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.121 0.486 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -137.81 162.63 33.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.668 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 803' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 31.1 t70 -73.71 138.31 44.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.412 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.03 119.02 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.07 0.462 . . . . 0.0 110.632 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -84.48 144.87 28.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -72.82 114.96 11.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.3 -39.92 89.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.449 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.9 p -134.29 162.26 32.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -34.1 14.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.61 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -61.0 -43.88 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.381 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 811' ' ' GLU . . . . . 0.435 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 7.9 mt-10 -77.3 162.87 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 812' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 840' ' ' GLY . 3.9 pp -125.27 150.13 66.29 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.7 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.14 146.92 32.73 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.118 1.879 . . . . 0.0 111.997 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 814' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 820' ' ' VAL . 13.0 mt -140.24 140.92 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.501 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -120.64 139.55 52.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.521 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -43.8 124.02 3.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.215 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.61 -19.44 53.59 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.09 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.8 136.0 57.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.936 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.88 134.31 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 820' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 798' ' ' ALA . 35.4 m -128.81 157.96 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 821' ' ' TYR . . . . . 0.43 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 98.1 m-85 -115.12 111.14 20.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.475 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 822' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 831' ' ' TYR . 30.4 mm -79.73 96.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -85.29 -14.97 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.06 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 824' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.3 tttm -162.86 131.7 4.06 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.785 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.12 127.46 34.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.31 -56.44 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.015 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -151.73 177.4 10.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.375 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.45 -23.72 67.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.377 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -111.74 -3.66 14.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.417 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -131.71 134.98 46.48 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.277 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 831' ' ' TYR . . . . . 0.499 ' CD2' HG21 ' A' ' 822' ' ' ILE . 1.3 m-85 -124.21 160.35 28.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.887 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 832' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 9.7 tt0 -136.31 135.94 39.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 833' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.25 -165.58 15.3 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -120.27 139.09 53.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.506 0.193 . . . . 0.0 110.898 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 835' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.4 p-80 -143.68 134.46 25.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 71.9 t60 50.21 31.95 5.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.71 3.27 90.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.919 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -109.65 155.68 21.18 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.2 t -124.21 135.01 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 840' ' ' GLY . . . . . 0.859 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.08 -157.33 10.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 841' ' ' ILE . . . . . 0.435 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 48.0 pt -131.42 154.13 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.226 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.53 148.9 14.45 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.83 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 126.11 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.303 1.335 . . . . 0.0 113.075 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -56.54 -28.04 59.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.76 -13.44 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -93.82 -0.79 55.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 847' ' ' ILE . . . . . 0.446 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.5 pp -139.61 167.08 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.9 126.71 27.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 849' ' ' LEU . . . . . 0.713 HD11 ' HB2' ' A' ' 796' ' ' ARG . 12.1 tp -78.46 113.65 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.2 tp 51.97 73.49 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.37 117.3 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.466 2.111 . . . . 0.0 111.812 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 142.42 94.63 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.627 1.551 . . . . 0.0 112.159 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -66.07 146.07 55.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.047 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.56 79.25 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.721 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -93.34 -4.0 52.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -103.03 129.03 49.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.489 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 46.5 64.91 7.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.648 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.56 141.45 83.14 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.374 2.05 . . . . 0.0 112.043 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.58 143.28 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -94.75 1.37 55.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.674 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.16 134.3 56.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 110.692 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 44.3 p -74.18 160.03 82.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.631 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 143.05 76.99 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.663 1.575 . . . . 0.0 112.638 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 864' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 866' ' ' VAL . 76.6 t -61.52 -44.31 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.463 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -57.06 88.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.537 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 864' ' ' VAL . 61.0 t -63.54 -43.42 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 867' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 868' ' ' GLU . 87.2 mt -59.78 -66.87 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.208 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 868' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 867' ' ' LEU . 14.8 mt-10 55.85 125.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.143 0.497 . . . . 0.0 111.338 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -71.85 145.53 48.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -71.15 156.07 52.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -116.82 151.52 36.34 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 872' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 894' ' ' ILE . . . -152.82 146.98 25.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 7.5 mm -125.3 127.95 72.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.01 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 874' ' ' ALA . . . . . 0.429 ' HB1' ' HE1' ' A' ' 922' ' ' TYR . . . -64.27 129.48 40.11 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 875' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -85.37 -31.98 22.65 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -137.0 146.01 44.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.173 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 877' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.0 p-10 -52.38 117.76 3.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -112.51 125.07 53.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.722 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -110.91 106.1 15.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 880' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -68.15 141.97 38.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -94.76 -9.43 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 60.9 p -134.15 163.27 29.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -61.58 -38.45 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.949 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.16 -41.8 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.084 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -87.37 104.73 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.64 146.07 50.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 887' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 97.7 p -107.85 151.82 25.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.1 OUTLIER -164.68 176.48 8.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.723 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -105.49 172.8 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.25 136.43 57.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.046 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 88.72 1.12 80.82 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.037 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.67 139.84 42.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.767 0.783 . . . . 0.0 109.949 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.39 141.39 35.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.099 0.476 . . . . 0.0 111.149 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 894' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 872' ' ' ALA . 96.6 mt -133.48 144.2 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.831 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.1 m -103.41 128.16 50.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.917 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.499 HD11 HG13 ' A' ' 925' ' ' VAL . 85.3 mt -85.15 126.92 34.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.6 mt -108.73 -55.09 2.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -159.14 153.73 24.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.229 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -93.13 115.9 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.764 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 900' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 57.0 t -61.89 -47.46 93.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 901' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 88.5 m-20 -143.39 -102.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 902' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 920' ' ' ILE . 24.3 pt-20 -130.83 -38.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.493 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -107.19 5.22 27.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.57 150.34 52.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.764 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 905' ' ' TYR . . . . . 0.48 ' OH ' HG11 ' A' ' 923' ' ' VAL . 25.7 p90 -152.08 159.98 43.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.6 tt0 -103.12 133.91 47.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.499 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.72 30.35 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.167 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -149.8 157.34 43.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.957 0.408 . . . . 0.0 110.451 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 49.5 mm -80.06 141.12 54.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.83 139.62 24.58 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.972 1.114 . . . . 0.0 111.184 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 911' ' ' GLY . . . . . 0.536 ' C ' HG23 ' A' ' 912' ' ' THR . . . 93.96 -8.08 73.31 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 912' ' ' THR . . . . . 0.536 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 67.71 28.35 7.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 111.129 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 96.0 p -63.78 -26.51 68.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.23 153.45 13.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 915' ' ' GLN . . . . . 0.507 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 46.2 tt0 -142.72 142.51 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.572 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.12 48.17 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 917' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 906' ' ' GLU . 43.9 pt -117.74 145.24 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -153.27 166.07 16.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.19 132.74 35.15 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 122.345 2.03 . . . . 0.0 114.425 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 920' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 902' ' ' GLU . 96.4 mt -59.79 -40.14 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.993 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 921' ' ' THR . . . . . 0.507 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 68.1 p -61.15 -25.46 67.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 922' ' ' TYR . . . . . 0.7 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -82.6 -2.09 52.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.541 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 923' ' ' VAL . . . . . 0.7 HG13 ' CD2' ' A' ' 922' ' ' TYR . 27.6 m -129.43 155.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.494 0.664 . . . . 0.0 112.229 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.081 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 925' ' ' VAL . . . . . 0.499 HG13 HD11 ' A' ' 896' ' ' LEU . 78.3 t -90.71 99.46 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.273 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 926' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -64.62 -47.3 89.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 927' ' ' LYS . . . . . 0.481 ' HG3' HG22 ' A' ' 926' ' ' ILE . 59.8 mtpt -139.94 146.53 39.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.88 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.32 148.78 93.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.193 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.86 -23.56 54.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.119 1.879 . . . . 0.0 112.209 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.543 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.541 0.21 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.67 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 89.9 mtm180 -123.68 138.74 30.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.044 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 120.6 6.73 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.655 1.57 . . . . 0.0 112.688 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -113.58 146.01 40.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -108.3 132.55 53.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.362 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -73.21 112.32 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.6 -38.04 86.17 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 109.714 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -139.41 -177.97 5.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 56.0 p-10 -93.07 144.24 25.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.355 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -133.77 128.15 34.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.54 134.36 35.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -73.84 133.95 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -105.63 -26.43 11.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.2 p -130.63 169.73 15.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.3 mp -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.473 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.94 -40.43 95.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.509 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.0 mt-10 -79.85 131.73 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.312 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.46 151.37 44.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . 0.73 ' O ' HD12 ' A' ' 814' ' ' LEU . 57.3 Cg_endo -70.05 145.75 56.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.104 1.87 . . . . 0.0 113.036 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.832 HD21 HG11 ' A' ' 820' ' ' VAL . 1.6 mp -136.86 140.81 42.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.276 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -118.47 142.4 47.61 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.423 0.63 . . . . 0.0 110.809 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -48.71 122.97 6.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.639 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.23 54.49 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.72 128.81 37.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.62 135.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.832 HG11 HD21 ' A' ' 814' ' ' LEU . 31.1 m -131.32 152.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.44 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 87.1 m-85 -113.01 119.55 38.28 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 832' ' ' GLU . 22.5 mm -87.35 103.87 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -93.69 -7.23 44.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.657 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.24 132.61 2.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.147 0.499 . . . . 0.0 111.314 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -90.51 112.3 23.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.674 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.6 -49.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -159.47 178.16 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.23 -35.33 76.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.054 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -100.15 -6.1 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.883 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -130.35 135.01 47.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.317 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.428 ' HD2' HG21 ' A' ' 822' ' ' ILE . 4.5 m-85 -123.1 152.61 40.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.464 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 822' ' ' ILE . 13.9 tt0 -127.83 137.8 52.49 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.62 -175.33 28.43 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -110.86 138.72 46.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.106 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.1 p-80 -143.18 133.32 24.39 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 51.54 31.79 8.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.418 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.19 90.3 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.743 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -115.44 155.23 27.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.0 p -120.61 143.74 31.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.999 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.86 -168.74 31.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 17.7 pt -126.38 154.22 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.701 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -163.69 156.09 15.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.63 118.93 5.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.115 1.877 . . . . 0.0 112.751 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -47.68 -19.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.3 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 63.8 p -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -6.21 21.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.1 pt -132.17 169.76 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.706 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -122.83 106.76 11.18 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.089 0.471 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.67 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 59.2 tp -61.59 112.55 2.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.781 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.33 78.65 0.38 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.533 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.495 1.568 0 C-N-CA 122.675 2.25 . . . . 0.0 111.873 -179.625 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.57 149.98 41.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.707 0.289 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.59 155.95 27.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.38 133.62 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.71 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.1 133.99 56.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.969 0.414 . . . . 0.0 111.656 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -83.81 -25.61 30.24 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.28 146.61 38.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.74 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 34.2 m120 -52.93 139.93 26.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.412 ' CB ' ' CE1' ' A' ' 888' ' ' PHE . 26.6 t80 -131.88 130.86 42.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.909 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -131.72 89.9 2.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -74.47 171.02 53.39 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -133.92 12.82 3.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.615 0.245 . . . . 0.0 111.045 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 885' ' ' GLU . 82.8 p -130.73 159.01 38.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.742 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -62.55 -40.93 98.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.62 HG23 ' HG2' ' A' ' 885' ' ' GLU . 15.7 m -66.01 -26.3 38.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.528 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.2 mm-40 -103.45 120.79 41.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 8.0 mmt -93.24 172.26 8.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.543 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 93.0 p -121.87 148.91 44.12 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.109 0.48 . . . . 0.0 110.967 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.412 ' CE1' ' CB ' ' A' ' 878' ' ' PHE . 11.9 p90 -161.03 160.19 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.493 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 3.6 mtp-105 -95.06 170.25 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.198 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.74 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 24.1 ttpp -73.49 52.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 176.22 16.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.966 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 889' ' ' ARG . 14.9 mp0 -97.33 149.62 21.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.438 0.619 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -84.59 148.85 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.046 0.45 . . . . 0.0 110.513 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 872' ' ' ALA . 93.7 mt -132.57 144.54 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.504 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.0 m -102.7 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.98 130.38 35.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.074 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.44 -54.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.111 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . 0.54 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 34.6 ptt-85 -166.05 165.04 18.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 901' ' ' ASP . 35.0 tt0 -99.92 120.27 39.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.761 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.411 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.1 t -62.23 -46.83 95.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.982 0.42 . . . . 0.0 111.094 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 899' ' ' GLN . 12.9 t70 -144.79 -95.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.011 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 98.7 mt-10 -132.49 -45.54 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.698 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.31 8.13 35.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -131.58 148.64 52.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.593 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.669 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.1 p90 -154.87 161.86 41.3 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.66 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.54 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 88.2 tt0 -109.61 137.84 46.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.33 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.71 172.11 31.81 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -149.99 156.31 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.339 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 914' ' ' ARG . 87.6 mt -77.4 139.55 64.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.37 137.93 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.103 1.202 . . . . 0.0 111.122 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.73 -10.35 66.46 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 69.33 25.69 5.51 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 89.6 p -67.25 -38.99 86.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.518 ' HB2' HD12 ' A' ' 909' ' ' ILE . 99.7 mtt180 -139.46 150.27 44.99 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.264 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -145.56 142.68 29.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.257 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -179.34 -179.62 48.76 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.397 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -119.87 150.91 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.943 0.401 . . . . 0.0 111.121 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -163.63 160.89 17.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.38 139.49 49.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.14 1.893 . . . . 0.0 113.124 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.75 -38.96 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.028 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 69.2 p -57.85 -11.3 2.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.576 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.95 0.66 32.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.669 HG11 ' OH ' ' A' ' 905' ' ' TYR . 10.7 m -132.99 158.25 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 111.194 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.97 131.71 56.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.692 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.4 -45.79 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.599 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.71 121.75 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.895 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 . . . . . 0 CA--C 1.532 0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.139 179.607 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 795' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.635 0.255 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -132.77 95.72 19.25 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.77 140.45 93.37 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.04 1.827 . . . . 0.0 112.099 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -133.54 154.2 51.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -116.4 135.04 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.774 0.321 . . . . 0.0 110.646 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -79.18 127.06 31.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.869 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.23 -14.97 20.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.207 0.527 . . . . 0.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -151.84 167.31 28.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.6 p-10 -91.49 133.89 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.63 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -127.71 128.66 45.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -93.27 135.68 34.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.62 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.566 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -100.37 -22.67 14.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.993 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 809' ' ' LEU . 87.5 m -128.05 162.81 25.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.34 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.541 ' N ' HG22 ' A' ' 808' ' ' THR . 60.7 tp -58.27 -42.84 87.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.106 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.3 -39.35 90.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.195 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.79 149.12 48.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.821 ' O ' HD12 ' A' ' 812' ' ' LEU . 2.2 pp -125.79 151.22 70.67 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . 0.509 ' O ' ' NE2' ' A' ' 835' ' ' HIS . 74.5 Cg_endo -74.45 141.32 28.22 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.667 1.578 . . . . 0.0 112.102 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.16 148.76 52.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.061 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -120.18 135.26 55.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.339 0.59 . . . . 0.0 109.936 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . 0.494 ' HB3' ' HZ2' ' A' ' 816' ' ' LYS . 0.0 OUTLIER -43.38 124.39 3.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.176 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.64 -21.02 48.04 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.675 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.56 134.78 51.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 29.1 mm -93.58 129.57 43.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.156 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 798' ' ' ALA . 29.9 m -124.53 153.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 88.6 m-85 -113.6 121.62 44.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 832' ' ' GLU . 70.1 mt -91.23 129.3 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -109.46 -16.15 14.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -168.42 142.47 3.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 111.46 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 827' ' ' ASP . 52.4 tt0 -85.33 136.5 33.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.142 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.4 -50.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 109.876 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.406 ' C ' HE21 ' A' ' 825' ' ' GLN . 7.0 t0 -149.61 179.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.925 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.46 -36.37 80.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.908 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -104.58 -1.51 26.4 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -126.96 139.34 53.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.359 0.599 . . . . 0.0 111.609 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.535 ' HD2' HD13 ' A' ' 822' ' ' ILE . 12.7 m-85 -125.6 156.92 38.39 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.584 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 822' ' ' ILE . 1.6 tp10 -124.43 139.9 53.45 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -168.75 -173.21 36.34 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -116.78 150.59 38.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 813' ' ' PRO . 0.5 OUTLIER -155.88 134.51 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.521 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.9 t-80 51.22 31.83 7.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.77 80.05 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 839' ' ' VAL . 44.0 tpt85 -121.09 135.09 55.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 838' ' ' ARG . 99.6 t -112.65 129.23 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.496 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.793 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.96 -154.56 8.5 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.09 160.83 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 117.062 0.431 . . . . 0.0 110.877 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -160.8 152.8 16.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 845' ' ' THR . 60.6 Cg_endo -73.75 121.67 7.2 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.077 1.852 . . . . 0.0 112.623 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . 0.408 ' NE ' ' CE1' ' A' ' 831' ' ' TYR . 3.4 ttm180 -50.56 -10.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.519 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 843' ' ' PRO . 62.6 p -80.51 -10.85 59.73 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.474 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -102.9 -3.98 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.666 0.269 . . . . 0.0 111.231 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 800' ' ' ALA . 42.6 pt -136.21 173.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.544 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 80.2 tt0 -114.66 161.48 18.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.72 103.98 12.29 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.8 tp 53.38 77.91 0.42 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.688 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 C-N-CA 122.132 1.888 . . . . 0.0 111.879 -179.471 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.29 160.98 31.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.441 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -155.28 150.24 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.94 123.07 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.297 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.06 117.06 6.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -69.57 -35.27 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.498 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -130.27 142.22 50.56 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.887 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' A' ' 889' ' ' ARG . 2.4 t-20 -47.85 134.24 13.43 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 888' ' ' PHE . 66.9 t80 -124.62 134.33 52.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.426 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -128.71 100.51 5.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.73 155.39 52.87 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . 0.798 ' OD1' HG23 ' A' ' 882' ' ' THR . 58.3 p30 -116.78 -0.29 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.11 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . 0.798 HG23 ' OD1' ' A' ' 881' ' ' ASP . 70.6 p -127.29 158.02 38.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -65.24 -32.38 74.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.919 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 885' ' ' GLU . 12.4 m -70.66 -26.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.052 0.453 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.466 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.7 mt-10 -98.37 113.5 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.944 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.723 ' SD ' HD13 ' A' ' 909' ' ' ILE . 28.0 ttt -84.23 135.77 34.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 90.3 p -82.84 153.87 24.95 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.082 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 878' ' ' PHE . 16.9 p90 -161.9 161.02 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.436 ' HA ' HD22 ' A' ' 877' ' ' ASN . 84.4 mtt85 -100.07 160.52 14.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.569 0.7 . . . . 0.0 112.754 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -58.4 130.24 45.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.24 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.15 1.64 89.53 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -72.17 139.7 48.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.24 141.9 30.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 86.7 mt -132.85 147.96 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.8 m -99.61 129.62 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.54 119.38 25.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.906 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.36 -53.14 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.12 165.68 17.57 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.814 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . 0.435 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.4 mp0 -98.27 112.82 24.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.454 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.423 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 10.2 p -81.27 -24.6 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.858 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -155.84 174.55 15.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.535 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.17 -32.18 73.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.052 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -113.95 2.06 14.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -134.02 151.88 51.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.478 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.435 ' CB ' HE21 ' A' ' 899' ' ' GLN . 31.8 p90 -150.94 158.33 44.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.034 0.445 . . . . 0.0 110.429 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.1 135.9 41.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.292 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.05 178.21 29.43 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -147.41 157.66 43.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.494 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.723 HD13 ' SD ' ' A' ' 886' ' ' MET . 1.5 mp -78.89 135.45 59.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.578 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -45.94 137.81 12.68 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 120.898 1.065 . . . . 0.0 111.377 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.59 62.22 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.92 34.7 1.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.61 0.243 . . . . 0.0 111.084 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.3 t -61.29 -46.49 90.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.638 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -171.34 149.39 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.54 144.44 37.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -164.8 170.51 39.91 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.2 pt -116.33 147.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.154 0.502 . . . . 0.0 111.224 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.0 159.59 29.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.16 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.2 137.64 29.07 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.473 2.116 . . . . 0.0 113.919 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 923' ' ' VAL . 88.3 mt -61.31 -35.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.488 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 96.4 m -53.92 -42.8 69.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.218 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.7 -0.22 33.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.308 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.441 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.9 t -125.18 147.89 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.14 0.495 . . . . 0.0 110.674 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.8 121.28 41.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.202 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.11 116.95 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.385 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.23 -47.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.84 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.93 133.24 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 . . . . . 0 CA--C 1.535 0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.349 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 31.5 mmm . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -128.89 98.55 24.09 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 119.553 -0.261 . . . . 0.0 110.89 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.92 138.69 26.25 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.419 1.413 . . . . 0.0 112.244 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.04 47.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . 0.438 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 75.2 ttt180 -104.89 137.22 43.0 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.296 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.668 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -82.52 121.22 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -95.19 -12.86 25.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.159 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . 0.402 ' HB2' ' CD2' ' A' ' 846' ' ' TYR . 97.6 m-85 -136.42 141.79 43.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.53 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 58.3 p-10 -68.52 150.04 48.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 814' ' ' LEU . 90.2 t80 -147.64 128.67 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.28 130.63 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -63.35 132.3 51.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.419 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.69 -32.93 10.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.18 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 810' ' ' LYS . 92.4 m -128.96 138.16 51.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.505 ' CD1' HH21 ' A' ' 838' ' ' ARG . 0.8 OUTLIER -36.7 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.894 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . 0.499 ' H ' HG22 ' A' ' 808' ' ' THR . 87.9 tttt -60.96 -48.43 81.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 808' ' ' THR . 3.2 mt-10 -72.79 165.56 24.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 110.621 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 812' ' ' LEU . 0.5 OUTLIER -132.73 155.38 81.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 146.81 61.6 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.927 1.751 . . . . 0.0 111.542 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.843 HD11 HG11 ' A' ' 820' ' ' VAL . 2.6 tp -140.75 132.4 27.21 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 35.3 tp60 -96.36 147.54 23.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 110.808 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -64.01 36.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 176.17 19.16 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.111 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.54 168.91 10.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.515 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.432 ' O ' ' ND1' ' A' ' 835' ' ' HIS . 35.8 mm -108.76 136.16 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 814' ' ' LEU . 25.7 m -129.95 151.47 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.9 115.73 26.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 94.2 mt -74.92 134.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 823' ' ' TYR . 1.8 p90 -128.7 -5.24 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.264 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -170.32 125.31 0.75 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.5 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -80.32 125.85 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.5 mm -78.49 -52.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.12 175.92 9.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.906 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -60.1 -18.48 47.38 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.28 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.01 -52.25 2.7 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.043 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . 0.414 ' HE1' ' HG3' ' A' ' 843' ' ' PRO . 23.2 m-90 -70.52 151.35 45.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 849' ' ' LEU . 62.8 m-85 -131.01 148.62 52.77 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.21 135.2 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -153.47 -177.59 27.14 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -110.48 141.38 43.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.949 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.664 ' HB2' HG12 ' A' ' 820' ' ' VAL . 81.6 t60 -164.49 135.54 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.928 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.8 t-80 62.92 31.5 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.236 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.46 18.71 78.54 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . 0.505 HH21 ' CD1' ' A' ' 809' ' ' LEU . 12.2 tpt180 -136.5 154.55 50.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.33 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 833' ' ' GLY . 13.8 p -129.0 141.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.38 -140.55 2.96 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.25 152.84 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.793 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 847' ' ' ILE . 3.5 p90 -156.92 127.91 3.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.61 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.414 ' HG3' ' HE1' ' A' ' 830' ' ' TRP . 50.1 Cg_exo -54.62 137.6 73.86 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.446 1.431 . . . . 0.0 111.994 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.51 -29.24 68.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.643 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 79.1 p -69.83 -15.66 63.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.392 . . . . 0.0 110.83 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 802' ' ' PHE . 0.6 OUTLIER -93.35 -2.24 55.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.76 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 800' ' ' ALA . 29.8 pt -137.4 173.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.237 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 851' ' ' PRO . 11.3 tm-20 -124.14 106.32 10.24 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 831' ' ' TYR . 17.9 mt -59.95 113.78 2.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.94 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.5 mt 46.5 82.18 0.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.084 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . 0.529 ' N ' ' OE1' ' A' ' 848' ' ' GLU . 73.0 Cg_endo . . . . . 0 N--CA 1.492 1.382 0 C-N-CA 122.185 1.923 . . . . 0.0 112.015 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.35 153.84 41.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.85 146.56 22.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 38.9 mm -117.08 121.91 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.47 125.92 25.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.479 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -72.61 -36.96 68.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.978 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.94 151.04 52.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.773 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -55.25 145.85 20.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -150.9 135.96 17.54 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.25 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -133.43 116.26 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.482 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.0 145.47 33.66 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.98 -2.22 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.739 0.304 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 58.8 p -133.6 163.83 28.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -61.31 -39.19 89.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.177 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.21 -43.67 93.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.629 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.454 ' O ' ' NH2' ' A' ' 914' ' ' ARG . 80.2 mm-40 -76.41 144.87 39.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.808 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 17.6 ttm -98.5 152.08 19.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.43 ' H ' ' HD3' ' A' ' 914' ' ' ARG . 34.6 t -121.25 127.9 51.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.46 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.26 161.79 42.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.1 mtm-85 -102.68 165.37 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.7 138.15 58.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.52 0.15 89.3 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.007 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 78.9 mm-40 -81.01 147.12 30.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.105 0.452 . . . . 0.0 110.253 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -95.35 132.47 40.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.1 0.476 . . . . 0.0 111.041 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 147.21 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.973 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.2 m -98.44 127.79 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.098 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 23.7 mt -92.25 126.51 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.727 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.0 mt -105.56 -48.47 3.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.545 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -160.53 154.34 22.61 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.166 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . 0.53 ' OE1' ' CD2' ' A' ' 905' ' ' TYR . 2.0 mp0 -89.94 113.91 25.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.773 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 917' ' ' ILE . 62.2 t -65.1 -39.91 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -156.11 -176.71 6.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.314 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.94 -37.24 86.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 920' ' ' ILE . 12.8 t-20 -102.83 -4.29 25.09 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -112.55 151.96 29.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 111.666 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.53 ' CD2' ' OE1' ' A' ' 899' ' ' GLN . 1.5 m-85 -140.5 137.04 33.53 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -104.86 135.61 45.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.85 -178.94 32.36 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.587 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.521 ' NH2' ' OG1' ' A' ' 912' ' ' THR . 17.3 ptm180 -148.22 158.02 43.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.507 -0.346 . . . . 0.0 110.364 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 79.2 mt -93.89 138.73 22.63 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.13 141.08 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.366 1.377 . . . . 0.0 111.807 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.64 76.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.521 ' OG1' ' NH2' ' A' ' 908' ' ' ARG . 1.4 m 68.83 32.96 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.637 0.256 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.3 m -62.33 -42.48 99.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' A' ' 885' ' ' GLU . 77.6 ttt180 -166.69 144.65 5.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -127.55 142.83 51.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 177.56 -173.77 46.39 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 900' ' ' VAL . 39.6 pt -111.69 155.4 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.496 . . . . 0.0 111.117 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -156.35 151.21 20.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.13 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 144.57 51.66 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.223 1.948 . . . . 0.0 113.68 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 903' ' ' ASN . 87.5 mt -60.53 -37.52 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.37 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.479 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -56.06 -39.54 72.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.07 -1.1 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.22 159.62 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.67 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -108.75 127.24 53.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.186 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 75.9 t -101.47 101.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -65.55 -45.77 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -135.83 150.58 49.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.958 179.567 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.615 0.245 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -130.81 94.34 28.95 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.373 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.27 138.29 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.989 1.793 . . . . 0.0 111.786 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -130.38 153.3 48.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.83 135.62 54.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.272 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 814' ' ' LEU . . . -76.57 111.37 11.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -35.28 79.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.068 0.461 . . . . 0.0 109.79 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -144.12 175.35 10.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.538 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 65.2 t0 -78.56 120.51 23.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.48 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -115.05 123.63 49.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.66 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.9 142.11 28.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.384 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -69.65 140.58 53.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.302 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -109.39 -31.74 7.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.05 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 63.7 p -129.41 171.01 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.376 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.81 -41.72 96.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.41 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.95 -38.35 90.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.395 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.563 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 31.9 tt0 -80.17 122.98 27.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.1 mp -107.19 154.37 40.52 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.446 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.17 146.82 71.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.904 1.736 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -125.91 153.18 44.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -126.73 138.34 53.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.57 0.7 . . . . 0.0 110.926 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.09 125.42 10.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.277 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.65 -28.74 14.53 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.489 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 66.8 t0 -57.67 135.2 56.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.007 0.432 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 38.7 mm -99.15 133.51 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 798' ' ' ALA . 22.1 m -125.09 151.12 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.055 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 76.9 m-85 -109.28 113.7 26.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 96.5 mt -82.03 130.95 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -104.51 -38.46 6.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.793 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -156.14 155.16 32.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 42.4 tt0 -82.84 130.73 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.553 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 7.5 mm -81.38 -46.23 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 109.63 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 3.5 t70 -148.11 178.77 8.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.046 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.43 -36.09 79.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -109.57 11.75 24.67 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -132.51 143.0 49.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -125.01 150.96 46.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.302 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.28 141.22 51.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -165.94 -175.14 36.11 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.31 140.7 36.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.037 0.446 . . . . 0.0 110.748 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -151.47 141.99 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 50.1 t-80 48.24 31.36 2.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.93 16.23 80.81 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.818 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -132.88 157.46 45.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.66 0.267 . . . . 0.0 111.065 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.12 129.17 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.087 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -154.78 -156.12 7.58 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.447 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.7 pp -124.54 154.73 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 117.347 0.573 . . . . 0.0 110.173 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 814' ' ' LEU . 3.8 m-85 -148.4 126.61 5.93 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.748 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.64 125.39 16.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.073 1.182 . . . . 0.0 111.81 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -54.6 -20.32 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.56 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.8 p -77.06 -12.55 59.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.95 -3.92 24.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.247 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.9 pt -136.03 171.97 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.559 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 86.9 tt0 -114.23 160.51 18.94 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 18.4 mt -108.84 100.52 9.72 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 53.8 tp 49.03 79.07 0.36 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.86 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 N--CA 1.496 1.64 0 C-N-CA 122.623 2.215 . . . . 0.0 111.443 179.833 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -127.92 155.39 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 110.502 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -160.82 146.64 14.71 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.4 130.49 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.006 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . 0.701 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -53.45 125.32 17.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.867 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.5 -40.91 73.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.431 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 877' ' ' ASN . 0.1 OUTLIER -145.09 148.86 34.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.64 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 98.7 m-20 -41.72 132.46 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.292 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 878' ' ' PHE . 46.4 t80 -134.57 131.13 37.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.43 117.84 26.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -84.43 -179.58 51.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 882' ' ' THR . 24.5 p30 -130.81 -40.18 1.21 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 881' ' ' ASP . 65.3 p -86.32 163.46 17.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -64.97 -34.39 78.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 110.149 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.18 -41.04 91.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 45.1 tp10 -81.38 130.97 35.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.152 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 14.6 mmt -101.33 164.66 11.67 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.423 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 35.5 t -127.23 146.18 50.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.198 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.47 177.8 7.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.165 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -113.15 163.57 14.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.291 0.567 . . . . 0.0 111.503 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.55 139.88 52.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.811 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.39 -8.23 77.39 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -75.89 138.46 41.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.244 0.522 . . . . 0.0 110.285 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -81.46 143.33 32.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.116 0.484 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 872' ' ' ALA . 88.7 mt -130.29 138.32 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.685 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.5 m -97.35 128.87 44.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.783 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.12 119.83 27.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.644 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 908' ' ' ARG . 90.2 mt -99.23 -49.98 4.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -167.0 165.16 15.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.147 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . 0.441 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.7 mp0 -99.41 115.71 29.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.4 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 32.7 m -82.34 -25.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -159.77 173.75 15.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.83 -38.58 88.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -106.28 3.06 27.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -133.4 151.25 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.876 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.441 ' CB ' HE21 ' A' ' 899' ' ' GLN . 28.1 p90 -150.97 158.61 44.35 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.002 0.43 . . . . 0.0 110.581 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.528 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.4 tt0 -99.13 133.29 43.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.719 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.74 173.84 29.39 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.517 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.417 ' HD3' HD11 ' A' ' 897' ' ' LEU . 40.5 ptt180 -154.31 160.59 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.097 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.503 ' CD1' ' NH2' ' A' ' 914' ' ' ARG . 84.5 mt -74.54 138.83 74.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -47.99 -14.03 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.395 1.397 . . . . 0.0 112.456 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -87.09 0.33 85.93 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.465 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 30.6 p 54.63 8.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 911' ' ' GLY . 89.5 p -71.88 -30.42 65.39 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.503 ' NH2' ' CD1' ' A' ' 909' ' ' ILE . 96.4 mtm-85 -139.47 149.75 44.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.853 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.528 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 66.4 tt0 -147.96 140.91 24.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.507 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.38 -178.19 47.6 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.504 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 46.3 pt -114.8 146.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -156.87 159.78 31.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.62 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 137.96 35.08 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.502 2.135 . . . . 0.0 114.21 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.06 -36.69 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.835 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.0 m -57.52 -44.69 85.29 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . 0.697 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -70.82 0.66 6.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.057 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.3 m -130.48 156.96 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.481 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -107.1 127.24 53.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.168 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.69 119.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.256 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 30.2 mm -91.36 -48.01 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.627 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.05 146.86 50.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.405 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 C--O 1.231 0.115 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.826 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 78.0 mtp180 -135.97 131.35 18.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.43 146.07 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 111.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.499 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -148.11 157.3 43.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . 0.465 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 73.8 ttt180 -122.96 131.15 53.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.611 ' CB ' HD12 ' A' ' 814' ' ' LEU . . . -76.57 123.13 25.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -94.06 -16.05 24.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.262 0.553 . . . . 0.0 110.046 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -135.4 139.7 44.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.517 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.3 p30 -73.88 154.73 39.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.491 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 114.92 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -79.04 130.98 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.52 131.02 39.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.74 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -108.39 -26.4 10.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.25 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.3 p -134.74 170.34 15.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.941 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.7 mp -61.12 -37.43 82.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 98.3 mttt -60.23 -38.79 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.01 148.18 22.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.246 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.3 pt? -125.23 156.33 69.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . 0.555 ' O ' HD22 ' A' ' 814' ' ' LEU . 50.6 Cg_endo -70.44 141.53 42.7 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.319 1.346 . . . . 0.0 112.155 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.611 HD12 ' CB ' ' A' ' 800' ' ' ALA . 0.3 OUTLIER -141.05 143.18 34.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.719 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . 0.598 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 62.4 tt0 -103.95 143.03 33.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.341 0.591 . . . . 0.0 110.322 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -61.06 37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.444 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 173.16 21.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 835' ' ' HIS . 3.7 m-20 -97.28 161.21 13.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.5 130.4 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 2.1 p -129.63 136.88 58.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.179 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.7 m-85 -95.86 121.1 37.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.943 0.402 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 831' ' ' TYR . 71.7 mt -87.1 136.26 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -98.74 -39.35 8.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.745 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 26.0 pttm -159.25 155.98 27.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.046 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.728 HE21 ' N ' ' A' ' 827' ' ' ASP . 3.1 tm0? -82.6 118.93 23.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.53 -46.65 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.728 ' N ' HE21 ' A' ' 825' ' ' GLN . 6.3 t0 -150.32 179.38 8.17 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.33 -38.41 83.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.629 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -111.66 13.54 21.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.803 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -131.59 143.59 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 112.091 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 822' ' ' ILE . 35.1 m-85 -134.02 152.2 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.707 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 4.2 tt0 -123.1 134.71 54.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.39 178.5 36.4 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -107.91 148.83 29.09 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 111.033 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.542 ' NE2' ' OD2' ' A' ' 818' ' ' ASP . 83.5 t60 -169.69 137.47 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.088 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 18.6 t60 58.53 32.94 22.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.305 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.83 16.58 79.28 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -132.7 154.88 49.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.115 0.483 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.6 134.9 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -160.69 -140.91 2.99 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.4 pt -135.46 154.3 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.71 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.418 ' CD2' HG21 ' A' ' 847' ' ' ILE . 9.2 p90 -157.99 150.68 18.08 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 143.8 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.148 1.898 . . . . 0.0 113.459 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.47 -35.56 72.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.065 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 76.3 p -63.22 -16.06 59.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.121 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -94.66 -2.66 50.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.407 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.499 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.3 pp -142.13 165.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.738 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.98 118.0 22.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.826 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 60.0 tp -69.81 113.98 7.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.368 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 29.4 tp 56.75 73.96 0.74 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.494 1.508 0 C-N-CA 121.947 1.764 . . . . 0.0 111.719 -179.222 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 871' ' ' GLU . 48.2 mp0 -134.92 146.48 49.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.482 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -147.62 149.88 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . 0.421 ' C ' HG13 ' A' ' 923' ' ' VAL . 91.5 mt -123.6 126.38 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 111.255 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.75 113.96 1.87 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -63.64 -37.02 85.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -129.53 148.13 51.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.323 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -56.81 125.2 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -115.19 128.43 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.563 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.95 109.77 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.474 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -75.32 145.24 32.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -103.09 -21.57 13.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.831 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.3 p -112.63 159.29 19.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -64.12 -31.26 72.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.343 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 884' ' ' VAL . 8.7 m -71.41 -24.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.435 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.91 111.55 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.174 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.57 159.35 29.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 99.3 p -123.9 153.27 41.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.935 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.18 176.44 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -104.16 150.16 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.14 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -46.68 133.1 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 97.46 -9.05 64.59 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.068 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.0 131.04 45.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -76.52 138.07 40.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.71 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 93.7 mt -130.59 144.95 36.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.754 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.0 m -102.03 125.72 48.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 925' ' ' VAL . 86.7 mt -79.81 87.37 5.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 908' ' ' ARG . 92.8 mt -64.06 -44.6 91.95 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.819 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -168.56 162.42 12.03 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.664 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.26 109.6 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.42 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.5 p -74.99 -27.16 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.065 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -158.81 174.89 14.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.32 -36.79 83.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.122 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -109.44 1.84 20.17 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -130.56 148.64 52.38 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.461 ' CE1' ' O ' ' A' ' 918' ' ' PHE . 28.2 p90 -151.08 156.88 41.98 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.737 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -104.37 130.62 52.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -146.99 178.22 24.77 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.835 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.693 ' HG2' HD11 ' A' ' 897' ' ' LEU . 0.3 OUTLIER -149.98 161.26 42.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.991 -0.605 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 911' ' ' GLY . 78.7 mt -74.97 137.28 72.9 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.24 -11.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.297 1.332 . . . . 0.0 112.16 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 909' ' ' ILE . . . -80.91 -4.23 90.48 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.399 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 20.1 p 50.83 34.97 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.349 0.119 . . . . 0.0 111.145 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.3 m -111.61 -26.56 8.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.705 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.65 152.52 51.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -149.57 145.98 27.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.177 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.23 -179.31 47.49 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.349 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.6 pt -112.16 140.99 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.5 145.11 17.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.062 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.93 142.74 47.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.95 1.766 . . . . 0.0 112.736 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.9 mt -69.9 -8.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.581 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.9 m -59.87 -44.47 94.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 923' ' ' VAL . 8.6 p90 -97.7 8.48 44.61 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.855 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.482 HG12 ' HB1' ' A' ' 872' ' ' ALA . 11.2 t -122.82 145.2 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 120.85 0.357 . . . . 0.0 110.226 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.85 115.36 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.076 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 896' ' ' LEU . 97.0 t -84.09 106.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.717 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.33 -46.22 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.486 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 926' ' ' ILE . 67.4 mttm -141.22 149.85 41.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.105 179.299 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 C--O 1.23 0.035 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -127.94 143.09 46.51 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 147.72 34.44 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.896 1.731 . . . . 0.0 112.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -135.47 155.16 50.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -121.89 133.67 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.408 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.484 ' HB2' HD22 ' A' ' 814' ' ' LEU . . . -84.2 121.58 27.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -74.43 -29.56 61.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.976 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.28 173.09 11.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.197 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.9 p-10 -89.33 135.69 33.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.14 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -127.08 133.26 50.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.327 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -92.99 139.29 30.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 811' ' ' GLU . . . -75.43 120.61 21.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -65.95 -41.47 91.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . 0.485 ' H ' ' HG2' ' A' ' 811' ' ' GLU . 72.1 p -136.96 166.21 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.928 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -50.88 -33.34 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.28 -39.79 91.7 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.461 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 808' ' ' THR . 0.2 OUTLIER -75.28 172.54 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.458 HD12 ' HD2' ' A' ' 813' ' ' PRO . 12.0 tp -135.7 134.11 20.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 812' ' ' LEU . 57.8 Cg_endo -70.93 145.54 50.67 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.106 1.204 . . . . 0.0 111.467 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 820' ' ' VAL . 0.7 OUTLIER -126.31 144.55 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.92 139.78 51.09 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.261 0.553 . . . . 0.0 110.252 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.08 122.06 7.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.813 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.76 38.4 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.308 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.532 ' OD2' ' CE1' ' A' ' 835' ' ' HIS . 35.8 t70 -62.77 140.57 58.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.11 132.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.5 m -123.27 154.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.235 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.441 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 90.7 m-85 -114.07 121.71 44.67 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 822' ' ' ILE . 3.4 mm -85.6 127.07 40.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.474 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.3 p90 -120.91 -5.93 9.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.071 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -173.38 129.13 0.44 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.212 0.53 . . . . 0.0 111.478 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -80.66 135.79 36.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.33 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.403 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.2 mm -87.49 -52.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.361 . . . . 0.0 110.284 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.527 ' OD1' ' NE2' ' A' ' 828' ' ' GLN . 6.0 t0 -150.51 179.2 8.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . 0.527 ' NE2' ' OD1' ' A' ' 827' ' ' ASP . 4.3 mp0 -60.77 -37.56 82.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 4.0 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.81 142.0 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.354 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.646 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 31.3 p90 -136.26 165.59 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.229 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -133.36 140.35 47.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.504 ' O ' HG13 ' A' ' 839' ' ' VAL . . . -158.44 -179.29 33.2 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 821' ' ' TYR . 88.5 tt0 -106.63 144.87 32.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 111.442 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.685 ' HB2' HG12 ' A' ' 820' ' ' VAL . 6.5 t60 -168.52 140.85 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.214 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.24 19.97 11.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 82.47 1.41 90.46 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.779 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.43 164.21 20.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.103 0.452 . . . . 0.0 110.262 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 833' ' ' GLY . 57.3 t -122.63 132.59 70.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.123 0.487 . . . . 0.0 111.211 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -143.24 -155.25 6.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.459 ' CG1' ' OE2' ' A' ' 811' ' ' GLU . 1.4 pp -134.32 155.12 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.088 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -166.1 160.17 12.72 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.85 121.85 8.28 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.75 2.3 . . . . 0.0 112.734 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 828' ' ' GLN . 48.3 ptt85 -56.4 -22.03 28.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.031 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.07 -8.21 47.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.13 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.43 -0.39 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.625 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 11.7 pt -138.73 174.55 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 52.7 mt-10 -113.38 157.51 21.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.2 100.14 7.93 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.027 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.0 tt 49.51 61.72 13.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.306 -1.705 0 C-N-CA 122.49 2.127 . . . . 0.0 112.153 -179.424 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -118.22 148.83 42.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -155.08 147.69 24.24 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.432 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.21 131.66 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.518 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.46 135.16 57.2 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.085 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.453 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 55.5 mtmt -87.08 -23.03 25.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.855 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -142.5 144.26 32.9 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -49.36 152.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -143.1 130.8 21.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.33 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -128.44 97.28 4.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.721 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.44 178.14 52.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -131.05 -1.88 4.06 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.213 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 47.6 p -129.58 158.88 38.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -62.82 -27.37 69.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.975 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 885' ' ' GLU . 18.3 m -68.14 -20.65 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.3 mt-10 -108.75 131.48 54.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.132 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 13.5 tpt -109.18 129.78 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.7 p -76.35 158.27 31.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.553 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 12.9 p90 -168.31 166.08 12.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.971 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 891' ' ' GLY . 29.6 mmm-85 -103.67 163.55 12.24 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 53.5 tttp -67.09 58.17 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . 172.84 12.8 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.829 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 888' ' ' PHE . 96.8 mt-10 -94.1 151.99 19.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.612 0.706 . . . . 0.0 109.736 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.46 146.75 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.5 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.5 mt -133.02 145.59 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.821 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.9 m -102.35 124.67 48.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.633 HD11 HG13 ' A' ' 925' ' ' VAL . 88.7 mt -82.63 130.72 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.429 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.44 -58.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -163.56 164.66 24.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 115.37 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.579 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.427 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.2 p -81.45 -27.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.734 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 1.6 t70 -156.13 172.53 18.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.973 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.426 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 60.7 mp0 -63.51 -28.84 70.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . 0.624 ' ND2' ' NE1' ' A' ' 904' ' ' TRP . 16.6 p-10 -117.95 4.05 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . 0.624 ' NE1' ' ND2' ' A' ' 903' ' ' ASN . 91.7 m95 -132.32 150.23 52.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.677 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.489 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.7 p90 -152.97 159.15 42.9 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.7 tt0 -102.39 132.68 48.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.179 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -151.45 169.94 31.02 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -148.47 155.79 41.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.038 0.447 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.27 139.89 87.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.85 138.99 20.13 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.937 1.092 . . . . 0.0 111.113 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.564 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.72 -9.65 70.93 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.78 33.22 2.98 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.651 0.262 . . . . 0.0 111.031 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.4 t -60.23 -45.46 93.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -163.36 139.66 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.791 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.546 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 26.0 tt0 -103.78 149.82 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.059 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -166.54 169.48 40.62 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.358 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 906' ' ' GLU . 46.4 pt -123.14 147.17 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.861 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -159.17 166.17 16.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.301 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.62 137.8 61.13 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.836 1.691 . . . . 0.0 113.487 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.29 -42.22 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.282 0.563 . . . . 0.0 110.42 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.0 m -57.77 -16.97 12.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.33 2.01 54.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.881 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.489 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.2 m -138.86 164.09 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.179 0.514 . . . . 0.0 110.663 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 67.9 t0 -115.04 132.82 56.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 896' ' ' LEU . 99.5 t -104.09 99.86 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.538 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.671 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.54 -46.34 95.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . 0.409 ' HG3' HG22 ' A' ' 926' ' ' ILE . 46.8 mtmt -138.13 131.95 31.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 . . . . . 0 CA--C 1.532 0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.72 148.37 69.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.436 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.82 145.83 25.82 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.098 1.866 . . . . 0.0 111.798 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.516 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -140.83 155.59 46.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 78.2 ttt180 -117.99 132.29 56.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -71.28 117.9 13.4 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.942 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -38.57 86.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.31 0.576 . . . . 0.0 109.466 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -141.83 174.56 10.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.2 p-10 -83.29 138.26 33.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . 0.563 ' CE2' ' OE2' ' A' ' 811' ' ' GLU . 60.5 t80 -129.07 131.46 47.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -99.22 137.91 37.06 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.037 0.446 . . . . 0.0 111.606 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -65.37 136.09 56.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.336 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . 0.44 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 77.0 mt-30 -109.5 -25.09 10.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.693 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 64.1 p -129.2 167.6 17.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 809' ' ' LEU . 93.0 mt -61.03 -42.53 98.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.544 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.94 -42.14 97.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.463 . . . . 0.0 109.76 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.563 ' OE2' ' CE2' ' A' ' 804' ' ' PHE . 41.0 tt0 -66.97 131.28 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.931 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 96.1 mt -115.52 150.33 44.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.449 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.26 148.71 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.103 1.869 . . . . 0.0 112.824 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.706 HD23 ' CE2' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -133.62 145.7 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -120.34 143.02 48.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.59 0.709 . . . . 0.0 111.489 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -53.09 124.39 14.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.075 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 99.83 -20.41 49.32 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.583 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.54 140.47 58.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.8 mm -96.68 131.36 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.1 m -125.97 156.23 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.451 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.8 m-85 -117.34 116.43 27.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.965 0.412 . . . . 0.0 111.4 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.89 131.93 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.0 OUTLIER -128.52 -4.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.238 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -170.44 125.29 0.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.208 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 830' ' ' TRP . 59.9 tp60 -81.54 124.61 29.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.749 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.432 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.8 mm -80.79 -52.98 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.62 178.28 9.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.14 -37.85 81.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.4 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -105.91 8.07 32.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.637 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . 0.542 ' O ' ' NE2' ' A' ' 825' ' ' GLN . 5.4 m-90 -140.12 145.19 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.102 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.744 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 29.4 p90 -140.7 166.28 25.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.946 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -130.61 136.52 48.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.887 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -154.41 -165.44 13.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -118.9 139.16 52.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -151.3 148.53 28.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.376 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 86.2 t60 47.87 30.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.263 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.25 16.41 80.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.792 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.28 160.22 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.015 0.436 . . . . 0.0 111.083 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.38 132.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.921 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -155.46 -154.73 7.04 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 46.8 pt -130.48 149.81 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.913 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.706 ' CE2' HD23 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -151.27 171.75 6.14 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -81.36 124.21 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.846 1.698 . . . . 0.0 113.074 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -57.01 -33.69 67.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.649 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.5 p -71.86 -9.99 59.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.739 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -96.51 -1.0 48.11 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.744 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.9 pt -132.85 174.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.11 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.7 mt-10 -113.47 159.87 19.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.13 105.87 13.08 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.695 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 39.0 tp 58.28 74.66 0.6 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.139 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo . . . . . 0 C--N 1.304 -1.766 0 C-N-CA 122.888 2.392 . . . . 0.0 111.443 -179.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.31 153.81 47.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.95 150.34 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.45 125.49 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -62.66 128.57 36.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.415 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 12.8 mtmt -74.49 -37.89 63.02 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.651 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -130.61 153.79 48.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.232 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -52.64 152.57 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 58.2 t80 -146.59 137.32 24.01 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.571 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -136.59 99.69 4.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.811 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.81 156.52 50.71 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -118.82 2.23 11.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.736 0.303 . . . . 0.0 110.53 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 69.7 p -132.52 162.37 31.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.99 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.11 -40.28 97.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.34 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.422 HG23 ' HG2' ' A' ' 885' ' ' GLU . 9.7 m -62.34 -32.4 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.791 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.422 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.1 mm-40 -83.34 146.24 28.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.105 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 67.0 ttp -105.54 130.96 53.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 92.8 p -88.86 131.52 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 43.9 p90 -158.62 164.11 36.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.484 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.448 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 25.2 mmt85 -117.68 162.02 18.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.235 0.54 . . . . 0.0 111.567 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 65.4 tttp -56.84 136.98 55.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.221 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.78 88.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.041 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 76.2 mm-40 -82.62 147.26 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.994 0.397 . . . . 0.0 110.461 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -84.19 141.2 31.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.54 139.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.4 m -103.22 126.15 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.433 HD11 HG13 ' A' ' 925' ' ' VAL . 88.6 mt -82.69 125.22 30.98 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.56 -28.87 9.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.314 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -179.68 141.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -88.91 113.47 24.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.16 -43.89 91.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -160.72 -179.69 7.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.3 pt-20 -62.64 -22.77 66.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -117.82 13.83 14.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.653 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -140.37 149.67 42.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.08 29.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.433 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -100.61 132.54 45.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.5 179.03 35.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.327 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -148.86 156.48 42.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.315 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.2 mt -84.25 142.43 40.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.87 138.99 25.89 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.952 1.101 . . . . 0.0 111.191 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.59 71.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.92 29.59 8.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.234 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.7 m -62.19 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.616 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -143.52 154.45 43.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.005 0.431 . . . . 0.0 111.459 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -144.96 138.77 27.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.045 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.45 -169.91 43.03 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.49 159.33 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.094 0.473 . . . . 0.0 111.617 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -160.07 152.75 17.72 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.746 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.44 137.19 45.94 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.568 1.512 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.758 ' O ' HG22 ' A' ' 923' ' ' VAL . 6.3 mt -54.69 -76.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.567 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 920' ' ' ILE . 22.4 m -25.53 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 920' ' ' ILE . 1.6 m-85 -72.22 1.49 7.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.8 m -135.31 158.96 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.063 0.459 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -104.37 118.32 36.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.429 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.433 HG13 HD11 ' A' ' 896' ' ' LEU . 73.0 t -95.03 101.49 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.806 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.6 mp -70.36 -43.18 78.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.273 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -133.04 139.63 47.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 . . . . . 0 CA--C 1.534 0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.437 -179.779 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 19.1 mmm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.558 0.218 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -154.07 105.22 2.45 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.41 139.77 18.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.785 1.657 . . . . 0.0 112.388 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 847' ' ' ILE . . . -136.68 151.23 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -109.18 143.16 38.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.65 126.48 31.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . 0.447 ' O ' ' CD ' ' A' ' 816' ' ' LYS . 38.4 ttpt -97.74 -20.13 17.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.826 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -146.76 177.7 8.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.14 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -90.99 178.02 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.768 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 814' ' ' LEU . 29.4 t80 -149.04 132.88 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.671 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -106.19 107.74 18.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -67.13 137.67 56.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.174 0.512 . . . . 0.0 110.857 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -106.55 -23.19 12.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.15 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.08 165.64 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.181 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.64 -38.68 85.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.856 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -59.45 -44.15 93.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.46 136.15 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.492 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.9 122.47 33.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.889 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 50.6 Cg_exo -55.01 140.64 79.99 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.109 1.206 . . . . 0.0 112.457 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.912 HD13 ' OH ' ' A' ' 846' ' ' TYR . 20.7 mt -128.34 149.75 50.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.593 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -122.5 138.17 54.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.209 0.528 . . . . 0.0 109.956 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 801' ' ' LYS . 36.7 ttpt -46.62 125.32 6.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.089 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 104.45 -24.34 29.07 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.589 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.28 125.88 25.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.985 0.422 . . . . 0.0 110.947 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 23.5 mm -85.93 133.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.09 153.37 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.443 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.9 m-85 -109.15 114.86 28.94 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 31.1 mm -85.6 129.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.477 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -111.16 -27.91 8.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.346 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . 0.458 ' NZ ' ' CD ' ' A' ' 832' ' ' GLU . 25.7 pttm -158.9 156.14 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.345 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 61.9 tt0 -94.49 110.43 22.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.569 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.4 -47.03 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 7.3 t0 -149.85 178.08 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . 0.483 ' O ' ' CZ ' ' A' ' 844' ' ' ARG . 99.1 mm-40 -59.99 -37.61 80.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.455 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -108.51 0.55 20.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -123.97 134.1 53.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 160.13 23.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.458 ' CD ' ' NZ ' ' A' ' 824' ' ' LYS . 20.9 tt0 -128.86 140.55 51.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.584 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.87 -177.69 36.08 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -107.05 141.74 37.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.046 0.451 . . . . 0.0 111.353 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.479 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.3 OUTLIER -149.9 144.71 26.09 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 51.2 t-80 50.02 30.37 4.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.1 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.29 18.41 79.82 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -133.03 156.33 47.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.385 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.77 145.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.289 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -169.71 -162.34 21.8 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 841' ' ' ILE . 27.3 pt -128.22 159.39 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -166.8 154.56 8.93 Favored Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.064 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 845' ' ' THR . 51.9 Cg_endo -69.71 115.66 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.352 2.035 . . . . 0.0 112.66 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . 0.483 ' CZ ' ' O ' ' A' ' 828' ' ' GLN . 37.9 ptt180 -51.93 -6.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.552 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 843' ' ' PRO . 1.6 t -80.86 -5.83 57.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.616 -0.434 . . . . 0.0 112.089 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . 0.912 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -106.37 -1.22 23.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.921 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.649 HG23 ' CE2' ' A' ' 846' ' ' TYR . 45.1 pt -126.76 175.68 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.838 0.351 . . . . 0.0 111.371 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.506 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.3 mt-10 -114.0 160.01 19.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.75 101.62 9.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 51.8 tp 55.04 76.23 0.53 Allowed Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.988 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.306 -1.664 0 C-N-CA 122.688 2.258 . . . . 0.0 111.664 -179.526 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -136.1 141.83 44.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 0.0 110.496 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -150.87 155.52 39.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 57.1 mt -126.66 131.09 71.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 110.641 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.92 123.04 15.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.458 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -69.26 -37.33 77.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.959 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.3 151.06 50.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.361 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.407 HD21 ' NH1' ' A' ' 889' ' ' ARG . 59.2 t-20 -57.48 131.86 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -127.14 128.74 46.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.59 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.32 108.15 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.759 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 887' ' ' SER . . . -65.83 142.46 43.58 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 56.4 t0 -100.56 -22.62 14.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 61.0 p -130.97 165.74 22.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.03 0.443 . . . . 0.0 111.123 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.78 -37.56 82.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.563 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.32 -43.37 89.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.394 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -91.06 103.54 16.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.492 ' CE ' ' O ' ' A' ' 887' ' ' SER . 2.0 tmt? -71.28 131.55 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.517 ' CB ' ' H ' ' A' ' 880' ' ' GLY . 83.2 p -80.13 154.19 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 0.0 110.986 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.01 160.05 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.593 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 75.7 mtp85 -105.78 165.32 11.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.003 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.63 136.2 56.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.191 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.58 -6.61 77.6 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.9 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 72.9 mm-40 -74.04 141.73 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.462 0.631 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -89.6 139.22 30.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.212 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.78 149.42 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.514 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.1 m -100.13 127.9 46.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.64 118.79 24.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.18 -46.58 5.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -163.41 156.01 18.29 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.936 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -98.94 118.68 36.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.323 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.46 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.9 t -61.48 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 902' ' ' GLU . 13.3 p30 -153.68 -104.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 901' ' ' ASP . 99.0 mt-10 -121.71 -38.43 2.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.37 9.36 18.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.704 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -134.03 147.46 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.46 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 14.7 p90 -157.72 163.81 37.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -115.96 142.19 47.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.166 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.45 178.86 31.01 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -149.48 158.97 44.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.494 -0.353 . . . . 0.0 110.331 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 911' ' ' GLY . 50.4 mm -65.86 137.86 96.23 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 -11.64 15.21 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.697 1.598 . . . . 0.0 112.531 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.547 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.69 -3.0 89.8 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 57.7 p 53.93 65.97 1.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.208 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.4 m -131.46 -38.49 1.18 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.443 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.24 157.5 46.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.859 0.362 . . . . 0.0 111.329 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -142.81 146.42 34.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.71 176.52 45.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.507 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.49 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 42.5 pt -115.52 145.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.493 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -155.68 159.43 31.62 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.566 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.03 139.11 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.697 2.264 . . . . 0.0 113.828 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.448 ' HA ' HG22 ' A' ' 923' ' ' VAL . 89.7 mt -64.18 -37.81 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.517 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 74.4 p -53.04 -24.13 9.09 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.891 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.07 2.26 55.16 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 920' ' ' ILE . 4.8 m -131.38 158.15 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.118 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -107.31 127.13 53.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.033 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.86 125.38 42.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.265 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 926' ' ' ILE . 1.7 mp -92.88 -53.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.64 126.47 32.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.645 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.848 0.356 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -131.56 96.69 20.55 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.37 140.15 93.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.898 1.732 . . . . 0.0 111.826 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -139.85 156.02 46.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.087 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -114.48 139.82 49.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.78 131.72 35.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.13 0.491 . . . . 0.0 110.764 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 802' ' ' PHE . 17.2 mmmt -98.27 -13.23 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 801' ' ' LYS . 47.9 m-85 -152.18 166.79 30.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 112.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 36.0 t70 -86.61 129.8 34.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.072 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -127.81 116.47 20.24 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 110.109 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.21 142.46 31.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.578 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -82.56 122.53 28.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.641 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -95.74 -25.48 16.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.898 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.5 p -134.85 169.67 17.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.37 -37.62 84.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.108 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . 0.487 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 68.7 mttm -65.11 -12.07 46.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.612 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.412 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.6 mt-10 -113.34 140.35 48.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.889 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.6 pt? -117.14 149.62 44.69 Favored Pre-proline 0 N--CA 1.467 0.415 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.66 140.01 38.34 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.556 1.504 . . . . 0.0 111.52 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 846' ' ' TYR . 11.0 mt -137.38 146.66 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.675 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -119.08 135.66 54.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 816' ' ' LYS . 8.9 ptmm? -42.24 123.23 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.599 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 99.78 -20.76 47.97 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.208 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 67.3 t0 -55.11 139.27 42.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 41.7 mm -94.95 126.01 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.172 0.511 . . . . 0.0 110.589 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.431 ' CG1' HD21 ' A' ' 814' ' ' LEU . 0.2 OUTLIER -120.21 148.62 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.255 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.0 m-85 -108.45 123.2 48.49 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 832' ' ' GLU . 24.2 mm -92.94 129.59 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.923 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.38 -27.6 12.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.475 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -160.43 157.28 27.42 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -93.97 111.29 22.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.4 mm -61.13 -46.9 95.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.156 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.94 178.91 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.88 -36.37 76.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.954 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.84 -1.65 16.44 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -119.9 131.28 55.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.416 ' CD2' HG21 ' A' ' 822' ' ' ILE . 3.0 m-85 -119.3 157.35 28.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.791 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 822' ' ' ILE . 18.0 tt0 -128.29 138.88 52.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.31 -173.18 28.53 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -123.95 155.79 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.207 0.527 . . . . 0.0 111.456 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.6 OUTLIER -170.61 131.24 0.89 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.933 178.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.1 t-80 65.9 24.56 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 80.22 4.11 89.79 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 838' ' ' ARG . 1.7 tpm_? -112.86 141.84 46.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.974 0.416 . . . . 0.0 110.558 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.59 143.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.543 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -169.53 -139.98 2.85 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 29.9 pt -138.97 162.75 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.462 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -169.72 153.98 5.22 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.831 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 845' ' ' THR . 50.5 Cg_endo -71.11 116.87 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.946 1.764 . . . . 0.0 112.54 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -51.52 -5.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.217 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 843' ' ' PRO . 81.4 p -82.11 -7.3 59.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . 0.914 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -105.41 0.42 26.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.574 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.684 HG23 ' CE2' ' A' ' 846' ' ' TYR . 42.8 pt -130.19 174.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.507 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.62 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 97.6 mt-10 -116.0 160.05 20.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.63 105.25 15.2 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.7 tt 42.57 75.24 0.65 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.513 . . . . 0.0 110.099 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.497 1.708 0 C-N-CA 123.056 2.504 . . . . 0.0 112.221 -179.406 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.53 155.12 44.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.668 0.27 . . . . 0.0 110.537 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.01 27.01 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 46.3 mm -118.7 125.3 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -61.33 133.08 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.711 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 56.8 mtmt -81.95 -38.95 24.42 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.904 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.41 150.86 49.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.466 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 45.6 p-10 -45.64 151.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 75.1 t80 -142.05 131.92 24.36 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.521 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -131.15 103.48 6.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.55 150.57 45.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.84 -1.41 34.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.341 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 57.8 p -133.15 162.75 30.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -61.04 -39.25 89.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.796 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.41 -40.74 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.752 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.24 108.41 19.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 11.0 mmt -80.42 160.67 25.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.8 p -109.39 149.76 29.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.057 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 29.1 p90 -156.76 161.09 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.384 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 42.1 ttm180 -105.24 156.17 18.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 111.14 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -50.44 137.4 19.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.45 -3.82 82.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.717 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 67.9 mm-40 -77.01 140.99 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.536 0.668 . . . . 0.0 110.746 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.71 142.32 31.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.51 147.02 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -104.44 128.67 52.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.952 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.11 124.74 31.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.636 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.39 -56.11 2.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -158.53 153.73 25.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -94.31 114.38 26.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 69.3 t -70.36 -43.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.491 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -151.65 -176.93 5.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.15 -38.66 83.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.242 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -111.6 10.53 21.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -133.8 149.47 51.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.502 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.8 p90 -154.9 159.41 40.45 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.033 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -105.78 134.95 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.988 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -155.55 175.79 33.32 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.495 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -152.83 159.2 43.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 911' ' ' GLY . 1.7 mp -63.59 135.18 96.15 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.84 -15.53 38.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.229 1.286 . . . . 0.0 112.161 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.673 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.87 -4.01 88.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 7.1 m 60.13 72.38 0.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.4 t -139.36 -39.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.972 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 909' ' ' ILE . 88.9 mtm180 -131.25 149.03 52.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.448 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -146.52 143.23 28.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.29 -172.32 45.08 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.503 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.5 pt -119.67 148.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.134 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -156.91 162.08 28.31 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.729 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.32 137.59 37.11 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.335 2.024 . . . . 0.0 113.745 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.17 -38.8 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 71.5 p -55.81 -16.5 4.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.66 2.58 41.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.502 HG11 ' OH ' ' A' ' 905' ' ' TYR . 17.0 m -131.57 156.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.204 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.48 124.47 48.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.284 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.98 130.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.809 0.338 . . . . 0.0 110.246 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.58 -54.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.19 147.39 52.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.3 mpp? . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.038 0.446 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -125.76 97.71 35.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.073 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 850' ' ' LEU . 48.6 Cg_exo -57.12 138.03 84.46 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.858 1.706 . . . . 0.0 111.915 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -129.62 151.85 49.78 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -113.99 135.51 53.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.208 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -77.99 128.76 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -96.52 -18.34 19.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.282 0.563 . . . . 0.0 109.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -149.91 172.16 15.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.6 p-10 -90.98 135.27 33.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.045 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -118.46 123.44 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.787 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -89.07 132.29 34.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.476 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -80.95 129.09 34.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -105.54 -25.75 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.309 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.8 p -129.29 169.43 14.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.494 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.2 mp -61.15 -39.99 92.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.7 -38.75 88.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.609 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 96.9 mt-10 -81.83 126.14 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.9 151.68 44.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.51 144.4 66.79 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.84 1.693 . . . . 0.0 113.231 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 820' ' ' VAL . 1.5 tp -137.75 146.54 43.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.046 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.83 137.49 53.37 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.364 0.602 . . . . 0.0 110.876 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 816' ' ' LYS . 15.9 ptmt -44.91 122.61 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.95 -20.25 51.07 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.419 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.9 t0 -55.75 133.22 50.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.359 . . . . 0.0 110.834 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.451 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 30.9 mm -91.21 128.58 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.4 m -127.57 155.0 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.521 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 65.5 m-85 -112.09 117.47 32.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.408 HD13 ' HD2' ' A' ' 831' ' ' TYR . 68.4 mt -81.28 125.83 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -119.6 -9.3 9.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -167.27 131.96 1.95 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 111.367 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.645 HE21 ' N ' ' A' ' 827' ' ' ASP . 10.4 tm0? -83.97 136.78 33.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.485 ' C ' ' NE2' ' A' ' 825' ' ' GLN . 4.9 mm -91.98 -67.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.645 ' N ' HE21 ' A' ' 825' ' ' GLN . 61.1 m-20 -133.95 176.67 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.18 -35.41 77.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.068 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -101.51 -1.03 34.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.268 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -131.86 136.15 47.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.201 0.524 . . . . 0.0 111.082 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.408 ' HD2' HD13 ' A' ' 822' ' ' ILE . 2.8 m-85 -124.76 160.5 28.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.843 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 841' ' ' ILE . 6.3 tt0 -129.84 141.1 50.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.12 -176.28 34.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.27 138.83 42.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.506 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 15.2 p-80 -146.07 131.92 19.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.794 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 51.67 37.43 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.616 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.77 78.85 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.73 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.27 152.36 48.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.222 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.45 132.67 64.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.258 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -159.55 -165.15 15.96 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 832' ' ' GLU . 46.6 pt -128.38 156.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.844 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.451 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -164.09 156.25 14.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.413 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 845' ' ' THR . 40.0 Cg_endo -69.7 117.96 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.979 1.786 . . . . 0.0 112.549 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.61 -13.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.404 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 843' ' ' PRO . 80.6 p -79.54 -6.66 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -103.81 -4.46 23.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.6 pt -135.11 172.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.593 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 77.4 mm-40 -112.98 162.84 15.41 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -108.06 104.22 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.33 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.8 tt 41.53 77.71 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 C-N-CA 122.643 2.228 . . . . 0.0 111.586 179.863 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.679 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.57 150.3 48.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 896' ' ' LEU . . . -156.38 156.46 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 53.3 mt -131.6 132.58 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.464 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -51.23 128.47 22.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -81.05 -41.15 23.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.145 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 877' ' ' ASN . 0.2 OUTLIER -149.59 131.88 15.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.024 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 26.2 m120 -26.28 114.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.717 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -117.21 129.12 55.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.706 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -110.94 118.82 37.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.977 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.09 139.37 26.91 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.86 -38.93 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.0 p -135.36 170.85 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.007 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -58.23 -21.59 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.6 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.93 -42.67 93.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.7 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -88.15 128.68 35.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.591 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.609 ' SD ' ' CD2' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -78.32 133.0 37.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.0 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.602 ' N ' ' SD ' ' A' ' 886' ' ' MET . 67.3 m -106.37 138.27 42.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 110.862 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -155.69 176.41 12.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.063 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.4 mtm-85 -112.38 158.93 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.593 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.706 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 65.1 tttp -47.25 144.09 2.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.983 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.38 87.3 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.258 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 12.0 mm-40 -76.72 144.29 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -91.07 139.87 30.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.61 142.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.925 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.4 m -94.93 126.61 40.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 872' ' ' ALA . 91.5 mt -86.7 126.85 34.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.845 HD11 ' HE ' ' A' ' 908' ' ' ARG . 90.5 mt -107.3 -52.51 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -165.5 164.39 19.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.385 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.65 115.68 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.759 HG12 ' OD2' ' A' ' 901' ' ' ASP . 58.1 t -70.27 -45.18 76.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.759 ' OD2' HG12 ' A' ' 900' ' ' VAL . 3.0 m-20 -152.12 -170.9 3.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.48 -40.86 92.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.36 15.82 19.1 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -129.24 149.96 50.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.021 0.439 . . . . 0.0 112.096 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 142.93 26.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.722 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.84 135.89 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.93 178.54 34.18 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.506 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 897' ' ' LEU . 19.6 ptp180 -151.09 158.16 43.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.837 0.351 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 89.5 mt -80.18 141.49 54.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.7 140.29 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.942 1.095 . . . . 0.0 111.504 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 93.03 -7.58 76.37 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.3 m 67.89 28.2 7.05 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.704 0.288 . . . . 0.0 110.773 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 98.3 p -63.61 -28.15 69.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -164.58 150.74 10.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -138.95 143.41 38.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.297 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.44 -179.48 48.35 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.468 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 917' ' ' ILE . 41.9 pt -105.32 156.91 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 923' ' ' VAL . 21.2 p90 -161.89 152.48 14.66 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.67 142.46 58.41 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.9 1.733 . . . . 0.0 112.837 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 920' ' ' ILE . 0.1 OUTLIER -72.47 -26.05 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.138 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 4.3 t -69.59 8.43 0.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.543 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . 0.641 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -127.6 4.11 6.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 918' ' ' PHE . 20.5 m -121.19 148.79 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.925 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -102.87 126.25 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.272 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.9 t -82.99 125.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 35.3 mm -103.73 -52.3 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.524 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -137.55 134.06 35.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.237 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . 0.446 ' H ' ' HD3' ' A' ' 928' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 795' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.694 0.283 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.526 ' HE ' HD11 ' A' ' 849' ' ' LEU . 95.9 mtm-85 -133.73 149.27 71.5 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.52 128.26 10.2 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.225 1.95 . . . . 0.0 111.929 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -124.13 146.58 48.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -109.29 140.23 43.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.295 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -89.76 115.61 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -77.43 -20.99 53.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.447 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.17 170.01 17.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.5 p-10 -85.25 131.85 34.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.171 0.51 . . . . 0.0 110.382 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 843' ' ' PRO . 75.0 t80 -105.92 129.55 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -100.29 116.82 33.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.03 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -64.18 132.21 49.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.83 -31.16 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 81.6 p -131.81 161.24 33.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -38.69 57.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.344 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -44.47 95.35 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.68 134.98 52.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 17.0 tp -109.93 127.09 27.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.15 147.01 65.86 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.343 1.362 . . . . 0.0 112.769 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 842' ' ' PHE . 66.3 mt -114.65 152.75 31.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.85 139.06 52.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.333 0.587 . . . . 0.0 110.241 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.94 118.9 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.152 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.89 -21.42 40.37 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.968 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 35.4 t70 -61.77 141.35 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.031 0.443 . . . . 0.0 111.405 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 10.7 mm -97.58 132.41 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.779 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.721 HG12 ' HB2' ' A' ' 835' ' ' HIS . 33.9 m -125.25 153.16 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.47 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 79.7 m-85 -110.91 114.03 27.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 831' ' ' TYR . 4.2 mm -82.85 128.92 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.084 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.51 -44.92 7.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.259 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -160.49 153.55 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.981 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.49 110.25 18.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.235 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.458 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.1 mm -62.78 -46.89 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.597 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -148.08 178.65 8.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -60.09 -37.5 80.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -112.79 18.36 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.565 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -142.71 150.0 39.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.533 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.685 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 35.0 p90 -147.79 168.5 21.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.767 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.8 tp10 -129.33 139.91 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.487 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -163.99 -177.22 36.58 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -113.44 152.17 30.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.971 0.415 . . . . 0.0 111.027 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.721 ' HB2' HG12 ' A' ' 820' ' ' VAL . 0.2 OUTLIER -165.21 132.96 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.963 178.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.4 t-80 64.34 28.09 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.831 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.76 20.53 79.77 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -134.65 152.04 51.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.458 0.647 . . . . 0.0 112.278 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 840' ' ' GLY . 76.8 t -100.33 154.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.47 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -175.73 176.44 47.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.57 145.71 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 117.403 0.602 . . . . 0.0 109.504 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -156.97 165.13 19.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.092 -177.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.459 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 58.1 Cg_endo -73.15 129.44 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.701 2.267 . . . . 0.0 112.401 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 846' ' ' TYR . 61.8 ttp85 -61.77 -37.79 85.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.413 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 3.3 t -59.19 3.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 844' ' ' ARG . 0.4 OUTLIER -110.25 -2.33 16.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.685 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.8 pt -133.94 175.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -116.48 161.76 18.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.526 HD11 ' HE ' ' A' ' 796' ' ' ARG . 53.0 tp -121.31 96.73 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.841 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.0 tt 40.14 70.27 1.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.485 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 C-N-CA 121.902 1.735 . . . . 0.0 112.202 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 927' ' ' LYS . 79.2 mm-40 -125.63 151.17 46.87 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.69 147.1 18.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.1 129.16 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.84 122.55 13.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -70.6 -36.27 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -135.4 154.5 51.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -53.54 138.58 33.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.1 129.0 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.51 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -116.75 109.3 16.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.424 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.13 149.12 43.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -106.41 -47.5 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.751 0.31 . . . . 0.0 111.116 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 74.6 p -81.31 162.01 23.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.351 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.95 -39.43 94.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.454 HG23 ' HG3' ' A' ' 885' ' ' GLU . 15.0 m -66.67 -23.97 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.454 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.5 mt-10 -98.26 129.11 44.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 30.5 mmm -94.82 178.83 5.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.771 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 88.6 p -131.29 149.86 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -160.63 163.31 32.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.26 165.05 11.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.954 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.12 136.35 57.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.28 -5.94 81.03 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.908 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.83 141.28 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.655 0.728 . . . . 0.0 110.379 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -86.16 141.87 29.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.088 0.47 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.76 147.81 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.495 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.7 m -102.34 127.85 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.502 HD11 HG13 ' A' ' 925' ' ' VAL . 78.7 mt -85.82 122.81 30.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.114 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.866 HD21 ' NH1' ' A' ' 908' ' ' ARG . 85.8 mt -101.52 -47.01 4.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -166.52 165.3 16.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.878 0.37 . . . . 0.0 111.31 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -104.04 118.45 36.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.406 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 63.4 t -61.94 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.645 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 77.1 m-20 -144.09 -104.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.9 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -126.09 -34.85 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.678 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.08 7.85 16.84 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.605 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -131.34 148.64 52.69 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.979 0.175 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.406 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 26.3 p90 -153.56 160.14 42.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.113 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.426 ' HG3' HE21 ' A' ' 915' ' ' GLN . 88.7 tt0 -107.7 136.69 47.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.71 179.19 30.99 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.404 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.866 ' NH1' HD21 ' A' ' 897' ' ' LEU . 32.3 ptt-85 -148.37 158.22 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 0.0 110.258 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.77 140.55 86.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.75 138.53 33.19 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.181 1.101 . . . . 0.0 111.112 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 102.04 -18.17 52.63 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 71.98 73.33 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.9 t -120.91 -48.07 2.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.69 149.83 51.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.524 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.426 HE21 ' HG3' ' A' ' 906' ' ' GLU . 14.0 tm0? -136.83 143.79 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.48 176.09 46.14 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.37 147.9 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.211 0.529 . . . . 0.0 111.387 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.57 159.12 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.918 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.06 139.55 39.45 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.566 2.177 . . . . 0.0 114.48 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.41 -38.06 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.467 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.468 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -52.6 -38.8 60.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.29 0.83 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.11 159.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 110.965 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -108.82 125.66 52.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 896' ' ' LEU . 95.8 t -99.99 103.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -65.04 -42.4 94.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.64 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 871' ' ' GLU . 7.0 ptmm? -145.18 159.09 43.54 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.157 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.136 179.647 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.656 0.265 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.72 149.76 63.36 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.866 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.09 105.06 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.308 2.005 . . . . 0.0 111.995 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.622 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -105.53 144.12 32.73 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.623 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -111.42 134.14 53.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.5 120.95 22.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . 0.458 ' NZ ' ' CE2' ' A' ' 802' ' ' PHE . 19.5 ttpp -89.07 -29.19 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . 0.458 ' CE2' ' NZ ' ' A' ' 801' ' ' LYS . 54.1 m-85 -135.03 152.57 51.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.436 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.8 p-10 -75.35 146.54 40.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.077 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -134.59 133.24 39.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -99.61 132.42 44.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.342 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.67 139.8 55.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.96 -30.94 13.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.382 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 29.9 p -137.06 178.4 7.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.43 -38.41 87.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.274 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -60.6 -40.68 92.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.374 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.723 ' C ' HD12 ' A' ' 812' ' ' LEU . 7.1 mt-10 -84.61 142.45 29.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.874 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.2 mp -121.35 152.76 58.11 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.32 148.26 67.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.982 1.788 . . . . 0.0 113.098 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.742 HD13 ' CE2' ' A' ' 842' ' ' PHE . 1.1 tp -131.11 145.39 51.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.54 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -124.85 137.91 54.28 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.472 0.654 . . . . 0.0 111.723 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.07 127.63 10.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.399 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.53 -19.32 54.17 Favored Glycine 0 C--N 1.318 -0.422 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.129 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.33 122.39 18.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.363 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.53 135.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.176 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 798' ' ' ALA . 32.9 m -130.17 154.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.4 m-85 -114.96 112.47 22.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.793 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.46 133.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.696 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -96.85 -47.79 5.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.775 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -163.95 153.78 14.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.269 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 59.3 tt0 -74.88 108.38 7.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.357 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.401 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.8 mm -64.75 -45.96 93.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.894 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 5.2 t0 -140.49 177.34 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.456 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -57.09 -27.06 61.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.382 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.27 -30.67 4.87 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.736 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -85.54 168.09 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.47 . . . . 0.0 111.719 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.697 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 24.0 p90 -153.39 169.09 23.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -131.5 138.41 48.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.044 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.64 -175.45 31.66 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.04 137.18 46.47 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.564 0.221 . . . . 0.0 110.611 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.3 p-80 -142.07 138.77 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 53.4 t-80 52.46 26.79 4.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.95 4.48 90.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.823 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.33 161.24 19.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.63 0.252 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.674 ' O ' HD22 ' A' ' 812' ' ' LEU . 10.3 p -110.72 153.68 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.754 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 839' ' ' VAL . . . -179.76 -172.56 43.94 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.5 pp -125.27 142.45 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.363 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.742 ' CE2' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -148.74 154.83 41.04 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.404 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.18 134.19 33.08 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.787 1.658 . . . . 0.0 111.98 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -60.57 -41.8 95.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.74 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 71.3 p -59.52 -11.54 4.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.635 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -92.73 -2.53 55.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.697 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 37.6 pt -133.99 165.46 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.873 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.21 120.94 28.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.208 0.528 . . . . 0.0 111.737 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.3 103.95 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.544 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.8 tt 42.79 87.04 0.12 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.271 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo . . . . . 0 N--CA 1.498 1.765 0 C-N-CA 122.686 2.258 . . . . 0.0 112.204 -179.303 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -129.54 157.3 42.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.87 153.1 29.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.32 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -52.56 137.55 30.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 3.3 ttpm? -83.82 -41.93 16.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -129.33 150.91 50.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 47.9 p-10 -55.5 153.27 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -151.13 131.81 14.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.859 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.59 108.21 14.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . 0.47 ' N ' ' OG ' ' A' ' 887' ' ' SER . . . -91.93 -176.84 42.43 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -145.68 -40.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.915 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 79.3 p -79.18 160.42 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.028 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -70.06 -30.17 67.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.1 -13.57 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 64.6 mm-40 -113.38 133.07 55.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.785 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 7.4 tpt -106.02 116.97 32.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.803 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 880' ' ' GLY . 50.1 m -73.82 144.11 45.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -154.73 157.16 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.461 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 15.9 tpp180 -106.61 150.28 26.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.319 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 66.1 tttp -44.55 139.99 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.066 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 83.7 0.86 90.01 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.407 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 7.1 mm-40 -73.33 148.63 43.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.18 0.49 . . . . 0.0 110.679 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -91.44 128.97 37.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.229 0.537 . . . . 0.0 110.718 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.76 148.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.41 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -106.36 127.28 53.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.863 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.38 124.61 29.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.697 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.498 HD12 HE21 ' A' ' 915' ' ' GLN . 86.6 mt -101.19 -52.86 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.27 164.54 22.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . 0.436 HE21 ' CB ' ' A' ' 905' ' ' TYR . 0.5 OUTLIER -96.9 111.88 23.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.49 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 78.8 t -69.41 -42.41 81.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.299 0.571 . . . . 0.0 110.016 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -152.97 -174.99 5.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.871 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -61.54 -38.1 86.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.237 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -117.02 14.65 15.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.77 147.64 51.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.648 ' OH ' HG11 ' A' ' 923' ' ' VAL . 16.1 p90 -155.04 160.67 41.21 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.112 0.482 . . . . 0.0 110.975 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.429 ' CD ' ' NE2' ' A' ' 915' ' ' GLN . 42.0 tt0 -107.02 133.74 51.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -144.96 165.73 27.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.615 HH12 ' H ' ' A' ' 911' ' ' GLY . 5.3 ppt_? -150.81 158.83 44.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.446 . . . . 0.0 110.501 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 14.4 mm -78.9 132.68 63.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.78 137.24 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.259 1.128 . . . . 0.0 111.267 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.615 ' H ' HH12 ' A' ' 908' ' ' ARG . . . 99.56 -9.55 60.66 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.9 p 71.58 30.43 2.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.1 m -62.17 -40.65 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.187 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -161.76 152.73 18.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.498 HE21 HD12 ' A' ' 897' ' ' LEU . 63.2 tt0 -132.33 147.75 52.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.35 43.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.853 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 918' ' ' PHE . 45.5 pt -119.57 147.01 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.91 0.385 . . . . 0.0 111.174 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -163.74 163.58 15.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.775 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.53 140.84 48.78 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.281 1.987 . . . . 0.0 113.321 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.45 -30.93 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.51 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 68.0 p -61.32 -21.43 63.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.651 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.67 1.65 56.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.648 HG11 ' OH ' ' A' ' 905' ' ' TYR . 14.7 m -135.34 160.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.913 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 66.5 t0 -114.79 130.62 56.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.399 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 926' ' ' ILE . 5.8 m -94.81 148.57 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -113.89 -38.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -146.55 130.8 17.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.452 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.186 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 822' ' ' ILE . 63.1 tpp . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -138.24 148.66 60.57 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.399 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.95 156.23 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.404 2.069 . . . . 0.0 112.308 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -153.56 159.3 42.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -133.01 136.89 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -75.26 116.54 16.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 110.47 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.65 -37.54 86.77 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.92 173.07 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 57.2 t0 -77.43 109.45 11.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.599 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.14 126.76 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -95.23 111.69 23.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -61.29 134.68 57.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.072 0.463 . . . . 0.0 110.992 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 -31.2 8.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.906 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 60.8 p -133.07 162.4 31.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.376 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -55.94 -31.73 63.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.716 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -62.09 -39.69 93.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.289 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.534 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 98.9 mt-10 -96.57 126.89 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.325 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.5 mm? -103.44 151.69 38.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.633 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.78 142.54 48.14 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.573 1.515 . . . . 0.0 112.679 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 842' ' ' PHE . 92.6 mt -127.06 161.7 27.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -123.66 136.6 54.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.417 0.627 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.18 121.85 5.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.457 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.06 11.05 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.938 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 68.3 t0 -48.04 136.38 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.325 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 7.1 mm -101.86 125.32 56.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.86 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.71 156.65 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.293 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -112.12 125.62 54.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.64 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 832' ' ' GLU . 75.6 mt -88.0 123.47 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.215 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -111.43 -3.83 15.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.27 133.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -87.25 128.09 35.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.292 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.36 -46.35 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.03 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -152.65 179.43 8.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.637 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.91 -37.52 76.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -107.68 -8.6 16.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.79 141.07 42.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 0.0 112.031 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.496 ' CD2' HD13 ' A' ' 822' ' ' ILE . 43.3 m-85 -129.44 151.44 50.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.558 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 822' ' ' ILE . 3.7 tt0 -125.74 139.64 53.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -157.99 180.0 33.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . 0.483 ' OE2' ' N ' ' A' ' 837' ' ' GLY . 12.7 tm-20 -115.26 125.45 53.33 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.0 p80 -132.39 138.02 47.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 82.3 t60 50.78 32.05 6.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . 0.483 ' N ' ' OE2' ' A' ' 834' ' ' GLU . . . 75.46 13.3 83.02 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -118.61 148.16 42.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.8 127.34 75.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 0.0 111.541 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -147.97 -179.78 24.22 Favored Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.415 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 30.8 pt -124.29 143.4 37.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.101 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.487 ' CE1' HD11 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -145.75 149.11 38.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.676 -179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.556 ' C ' ' H ' ' A' ' 845' ' ' THR . 72.1 Cg_endo -75.62 137.54 20.49 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.251 1.967 . . . . 0.0 111.197 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -55.51 3.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 843' ' ' PRO . 0.2 OUTLIER -90.74 -15.83 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.685 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 -5.45 16.17 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.268 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.9 pt -133.52 173.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.551 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -131.29 155.12 47.72 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 8.1 tp -105.31 107.63 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.197 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.6 tt 49.9 76.71 0.52 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--N 1.305 -1.748 0 C-N-CA 122.989 2.459 . . . . 0.0 111.845 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . 0.532 ' OE2' ' NE ' ' A' ' 893' ' ' ARG . 88.0 tt0 -138.31 150.59 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.766 0.317 . . . . 0.0 110.203 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -143.43 153.12 42.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.99 121.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.073 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.5 4.03 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.5 mtmt -70.36 -36.79 74.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.63 152.62 50.69 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.253 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 878' ' ' PHE . 61.6 t-20 -54.69 136.14 46.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.709 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.632 ' CD2' ' CE1' ' A' ' 888' ' ' PHE . 90.3 t80 -129.52 132.04 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.76 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.06 106.95 13.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -71.01 139.58 29.89 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -107.01 -3.18 20.35 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 68.4 p -132.69 160.84 35.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.235 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -61.51 -41.96 98.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 885' ' ' GLU . 14.7 m -65.54 -25.38 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.8 mt-10 -99.92 108.23 20.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 887' ' ' SER . 16.9 tmm? -79.74 135.02 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.512 ' O ' ' SD ' ' A' ' 886' ' ' MET . 33.9 t -82.6 132.28 35.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.716 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.632 ' CE1' ' CD2' ' A' ' 878' ' ' PHE . 45.5 p90 -142.18 154.51 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.439 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 89.8 mtm180 -103.54 163.89 12.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.063 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.46 132.73 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.5 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 96.33 -7.01 66.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.296 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 71.2 mm-40 -69.94 133.77 47.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.923 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.532 ' NE ' ' OE2' ' A' ' 871' ' ' GLU . 70.4 mtp85 -84.05 126.09 32.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 8.7 mm -114.88 143.45 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.106 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -98.28 127.81 44.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.98 116.21 22.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 110.943 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.75 -50.62 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -160.86 154.9 22.77 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.079 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 116.88 32.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.448 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 60.0 t -61.43 -46.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.779 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.9 m-20 -143.88 -104.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.989 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -129.04 -37.7 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -108.09 4.74 25.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.502 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -132.02 148.27 52.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.42 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 16.2 p90 -153.95 159.77 41.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.113 0.482 . . . . 0.0 110.882 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -107.47 135.12 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.65 177.84 30.14 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.288 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -150.84 160.3 43.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.24 128.84 86.93 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -49.13 138.86 27.83 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 120.161 1.093 . . . . 0.0 111.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 912' ' ' THR . . . 101.26 -17.84 55.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 911' ' ' GLY . 0.2 OUTLIER 79.18 86.0 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.898 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 25.4 t -129.25 -41.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.036 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -162.74 151.92 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.817 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -130.01 146.55 51.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.05 175.48 45.34 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.519 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.8 pt -114.1 142.37 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.899 0.38 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -152.67 157.96 33.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.889 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 136.63 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.117 1.878 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.25 -36.82 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.867 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.433 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 73.0 p -53.5 -29.85 38.26 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -91.85 2.38 56.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.984 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.443 HG12 ' HB1' ' A' ' 872' ' ' ALA . 16.9 t -127.19 148.97 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.308 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -99.98 121.31 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.44 123.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.156 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -97.06 -44.82 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.67 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -125.61 142.27 51.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.539 -179.6 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.8 mpp? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.76 0.314 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.96 149.44 73.13 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.02 153.8 57.71 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.394 2.063 . . . . 0.0 112.274 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -168.86 151.14 4.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -133.41 129.33 37.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.617 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 815' ' ' GLN . . . -76.41 122.83 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 848' ' ' GLU . 15.5 ttmm -91.24 -18.14 24.88 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.462 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.74 139.97 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.192 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.84 152.12 43.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.312 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . 0.443 ' CE1' ' CD ' ' A' ' 811' ' ' GLU . 47.5 t80 -126.87 129.09 47.55 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.466 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.61 121.1 35.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.1 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -62.26 134.99 57.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 110.793 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -110.96 -28.8 8.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 68.9 p -130.87 163.35 27.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.456 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.65 -34.75 67.62 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.99 -47.29 86.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.783 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.443 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 8.1 tm-20 -86.78 123.66 32.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.114 0.483 . . . . 0.0 111.266 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -96.57 152.73 38.77 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.29 145.12 76.95 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.611 1.541 . . . . 0.0 112.511 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 842' ' ' PHE . 1.2 tp -131.89 151.42 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . 0.625 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 11.1 tt0 -102.89 147.76 26.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.461 0.648 . . . . 0.0 110.661 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -63.45 38.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.125 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 166.06 23.26 0.02 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 820' ' ' VAL . 65.3 t0 -97.15 113.65 25.26 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.77 -0.253 . . . . 0.0 110.418 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.7 135.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.658 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 814' ' ' LEU . 30.7 m -131.55 158.3 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.25 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.409 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 84.6 m-85 -108.41 115.83 30.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.403 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 33.4 mm -81.57 134.62 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.318 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -96.75 -39.68 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . 0.47 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 25.9 pttm -162.07 159.83 26.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.417 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -86.14 116.02 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 827' ' ' ASP . 48.5 mm -65.01 -48.73 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.284 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 826' ' ' ILE . 34.5 m-20 -147.62 177.5 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.18 -36.41 75.29 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.253 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -109.87 15.4 22.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -137.06 147.53 46.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 112.082 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.541 ' OH ' ' NH1' ' A' ' 844' ' ' ARG . 44.0 m-85 -133.87 150.99 51.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.32 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.47 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 3.7 tt0 -124.11 133.33 53.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.135 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -158.39 -175.77 29.69 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -113.79 149.93 34.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.556 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.3 p-80 -152.55 132.14 13.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.558 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 75.6 t60 48.84 34.01 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.581 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.88 1.63 90.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.863 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.18 147.83 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.451 ' O ' HD23 ' A' ' 812' ' ' LEU . 7.4 p -135.86 135.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.635 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 812' ' ' LEU . . . -158.27 -143.02 3.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 842' ' ' PHE . 45.5 pt -128.97 150.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 117.449 0.624 . . . . 0.0 110.748 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' A' ' 814' ' ' LEU . 4.1 m-85 -144.24 131.0 10.21 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.842 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.38 148.21 72.91 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.532 1.488 . . . . 0.0 112.784 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . 0.541 ' NH1' ' OH ' ' A' ' 831' ' ' TYR . 60.2 ttt85 -59.74 -41.06 90.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.658 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 94.1 m -64.47 -22.47 66.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.341 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -91.93 -3.76 55.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.806 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 844' ' ' ARG . 1.3 pp -142.08 165.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.182 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 801' ' ' LYS . 96.1 mt-10 -132.49 124.44 28.54 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.92 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 850' ' ' LEU . 2.4 tt -72.36 113.33 9.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.329 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.556 ' N ' HD23 ' A' ' 849' ' ' LEU . 3.3 tt 53.15 76.02 0.57 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.804 2.336 . . . . 0.0 111.749 -179.864 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -122.94 151.75 41.49 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.917 0.389 . . . . 0.0 110.929 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 924' ' ' ASP . . . -155.07 151.07 27.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.264 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 11.5 mm -122.23 127.45 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -47.31 131.17 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.497 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 22.4 ttpp -72.93 -37.19 67.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.684 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 922' ' ' TYR . 0.2 OUTLIER -155.15 160.79 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.231 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.541 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 23.0 m120 -51.72 109.55 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -115.85 125.5 52.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.402 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -115.86 110.59 19.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.379 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -64.52 142.5 45.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.05 -22.93 28.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 66.3 p -129.85 164.15 24.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.621 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -59.87 -25.95 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.266 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.84 -45.3 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.64 141.79 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.7 tpt -103.24 130.71 50.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 142.07 27.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -158.6 160.84 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.538 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 891' ' ' GLY . 38.9 ttm180 -89.57 158.12 17.77 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.427 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 57.9 tttm -66.08 56.25 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.689 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . -178.16 4.66 0.03 OUTLIER Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.725 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.96 150.52 20.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.551 0.675 . . . . 0.0 109.866 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -95.5 127.97 41.97 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.451 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.62 151.67 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.85 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.7 m -104.36 127.45 52.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.887 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 925' ' ' VAL . 87.4 mt -90.16 127.7 36.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.535 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.755 HD11 ' HE ' ' A' ' 908' ' ' ARG . 87.9 mt -108.27 -53.56 2.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.702 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -156.34 150.28 25.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.985 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.14 106.94 18.82 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.51 -44.07 95.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -157.87 178.68 9.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.088 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 920' ' ' ILE . 80.9 mm-40 -61.87 -30.99 71.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . 0.469 ' C ' ' CD1' ' A' ' 904' ' ' TRP . 98.3 m-20 -109.7 20.07 18.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.41 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 903' ' ' ASN . 74.3 m95 -146.83 151.61 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.96 138.09 26.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.545 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -102.11 133.16 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.02 178.43 35.19 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.952 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.755 ' HE ' HD11 ' A' ' 897' ' ' LEU . 20.9 ptp180 -151.16 157.81 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.96 141.76 78.75 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.45 139.85 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.06 1.057 . . . . 0.0 111.046 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 912' ' ' THR . . . 95.33 -9.26 69.58 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.83 31.99 3.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.663 0.268 . . . . 0.0 110.971 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.0 t -60.91 -44.22 97.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.11 146.81 15.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -121.19 151.05 40.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.278 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -175.02 176.12 47.13 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.182 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.467 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 45.2 pt -125.12 156.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.467 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.4 OUTLIER -166.48 162.69 11.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.661 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.67 147.85 90.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.806 1.671 . . . . 0.0 111.768 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 902' ' ' GLU . 11.3 mt -76.37 -19.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 81.6 p -68.95 -10.69 58.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.591 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . 0.566 ' CD1' ' CE1' ' A' ' 876' ' ' PHE . 45.5 m-85 -108.23 7.59 27.47 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 920' ' ' ILE . 18.8 m -137.04 159.42 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.408 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . 0.412 ' O ' ' HB1' ' A' ' 872' ' ' ALA . 98.1 m-20 -117.38 131.75 56.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.54 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 896' ' ' LEU . 62.9 t -99.99 98.81 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.278 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.67 -44.19 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.013 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.65 142.53 51.0 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.86 179.441 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.531 ' HE ' HD21 ' A' ' 849' ' ' LEU . 13.9 tpt180 -129.8 121.13 19.83 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.09 138.9 21.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.702 1.601 . . . . 0.0 112.474 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -138.77 154.4 48.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -113.13 140.39 47.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.013 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -72.88 126.95 31.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -91.06 -8.86 47.76 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.258 0.552 . . . . 0.0 109.571 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.13 178.3 7.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.136 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.3 p-10 -98.53 139.57 34.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.569 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -129.56 129.58 44.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.232 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -95.31 135.13 37.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.562 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -76.42 138.04 40.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -114.38 -22.33 9.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.902 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.1 p -127.22 167.67 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.446 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.42 -41.4 97.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.771 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -63.01 -39.94 96.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.471 . . . . 0.0 109.864 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.523 ' C ' HD12 ' A' ' 812' ' ' LEU . 95.6 mt-10 -74.76 131.89 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.265 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 811' ' ' GLU . 9.1 mp -118.76 154.23 52.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.06 144.19 62.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.856 1.704 . . . . 0.0 112.346 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.54 HD12 ' CD2' ' A' ' 842' ' ' PHE . 1.3 mt -137.65 141.45 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.212 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -122.66 139.85 53.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.438 0.637 . . . . 0.0 110.921 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.82 123.55 7.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.911 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 105.75 -24.33 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.412 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.2 t0 -61.9 135.67 57.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.799 0.333 . . . . 0.0 110.763 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.503 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 33.9 mm -93.9 130.57 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.555 HG12 ' HB2' ' A' ' 835' ' ' HIS . 28.6 m -123.46 152.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.46 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 86.6 m-85 -117.04 117.74 30.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.03 129.59 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -123.88 -9.67 7.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.274 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -165.18 133.59 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -82.69 138.01 34.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.633 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 9.8 mm -94.82 -57.64 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.477 ' O ' ' NH2' ' A' ' 844' ' ' ARG . 7.7 t0 -150.21 179.33 8.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.085 0.469 . . . . 0.0 109.795 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.59 -37.26 78.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.716 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -106.18 7.25 31.48 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -141.15 147.13 37.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.113 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 29.6 p90 -140.08 169.68 17.25 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.558 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.5 tp10 -128.54 139.19 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.134 0.493 . . . . 0.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.558 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -161.36 -175.45 32.4 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.89 135.62 49.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.693 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.555 ' HB2' HG12 ' A' ' 820' ' ' VAL . 0.8 OUTLIER -144.61 146.91 32.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.8 t-80 49.04 29.76 2.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.18 79.98 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -132.8 158.92 41.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 832' ' ' GLU . 92.0 t -106.78 132.66 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.618 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.465 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -164.29 -175.02 34.72 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.48 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 36.6 pt -115.15 149.65 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.515 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.54 ' CD2' HD12 ' A' ' 814' ' ' LEU . 0.3 OUTLIER -152.01 151.67 28.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 845' ' ' THR . 27.5 Cg_endo -67.88 112.08 2.59 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.797 1.665 . . . . 0.0 112.15 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 827' ' ' ASP . 19.1 ttm105 -47.69 -15.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.53 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.407 ' N ' ' C ' ' A' ' 843' ' ' PRO . 63.2 p -81.49 -2.25 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.735 0.303 . . . . 0.0 111.052 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.2 -2.91 26.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.004 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.5 pt -129.33 172.05 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.881 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 85.1 tt0 -110.31 159.73 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.531 HD21 ' HE ' ' A' ' 796' ' ' ARG . 3.4 tt -113.49 104.36 12.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 36.5 tp 58.26 75.13 0.56 Allowed Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.785 . . . . 0.0 112.399 -179.146 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.783 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.0 160.93 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -158.88 146.0 17.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 89.8 mt -123.19 125.8 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.58 122.69 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.149 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 46.3 mtpt -70.38 -37.86 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -132.75 154.33 50.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.324 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 33.6 m120 -54.25 146.19 15.91 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 89.0 t80 -141.43 137.12 31.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.031 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -123.64 105.4 9.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.183 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.5 155.15 52.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . 0.419 ' OD1' HG23 ' A' ' 882' ' ' THR . 51.6 p-10 -115.13 -9.61 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.585 0.231 . . . . 0.0 111.503 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 881' ' ' ASP . 72.3 p -128.54 160.56 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . 0.493 ' O ' ' SD ' ' A' ' 886' ' ' MET . 55.2 tt0 -61.55 -39.71 92.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.936 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.48 -42.05 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.521 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -88.36 103.27 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.689 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 883' ' ' GLN . 0.0 OUTLIER -80.89 133.59 35.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.237 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 84.4 p -73.06 157.4 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 111.053 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 41.1 p90 -160.38 162.94 33.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.474 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -112.95 161.84 16.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.301 0.572 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.736 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 63.7 tttm -59.37 132.77 55.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.74 -8.01 78.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.694 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.31 139.82 48.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.24 0.52 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -85.21 143.4 28.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.956 0.408 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -131.99 148.8 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.738 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . 0.449 HG21 ' NH1' ' A' ' 908' ' ' ARG . 97.3 m -101.53 129.16 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.987 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.26 115.21 24.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 111.149 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.97 -50.41 4.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.791 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -157.46 151.69 24.79 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.019 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.89 113.74 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.699 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 79.5 t -69.19 -43.16 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 110.31 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.438 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 19.3 t0 -153.56 -176.65 5.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.021 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 61.0 mp0 -61.13 -37.85 84.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.83 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.6 13.28 21.28 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.87 147.63 46.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.487 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 20.9 p90 -154.29 158.27 39.93 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.162 0.506 . . . . 0.0 110.965 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.23 133.3 52.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.04 178.6 30.83 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.334 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.449 ' NH1' HG21 ' A' ' 895' ' ' THR . 0.0 OUTLIER -153.14 161.68 42.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.855 0.359 . . . . 0.0 110.385 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 13.1 mt -90.22 132.26 36.32 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.826 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -39.98 136.28 1.45 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.397 1.398 . . . . 0.0 111.757 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.21 -4.34 64.8 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.44 24.68 13.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.4 t -61.58 -45.07 95.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.95 146.73 45.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.489 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.2 tt0 -147.39 139.01 24.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 172.54 -170.28 43.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.7 pt -116.31 145.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.054 0.454 . . . . 0.0 111.014 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.37 153.38 30.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.038 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.04 137.52 41.2 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.057 1.838 . . . . 0.0 112.991 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.51 -38.68 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.465 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 93.7 m -51.96 -44.17 63.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.961 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.13 3.57 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.4 t -125.67 147.53 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.99 0.424 . . . . 0.0 110.285 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.71 120.99 42.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.504 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.76 124.65 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.505 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -87.89 -35.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -151.55 135.61 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.758 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.439 179.823 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -128.19 145.62 56.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.3 108.41 1.75 Allowed 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.956 1.77 . . . . 0.0 112.645 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -109.35 144.83 37.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -114.24 140.61 48.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.226 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.2 118.18 22.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.428 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -72.38 -27.48 62.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.077 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -142.39 178.15 7.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.558 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.09 139.28 30.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.057 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -127.08 125.86 42.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.34 132.55 34.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -71.2 139.03 49.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 98.1 mm-40 -105.24 -29.18 10.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.069 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 811' ' ' GLU . 71.5 p -136.15 170.14 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.261 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 809' ' ' LEU . 91.2 mt -61.41 -35.25 77.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.166 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -59.93 -40.17 88.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.737 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 10.8 pt-20 -98.4 129.4 45.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.613 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -102.08 152.19 38.18 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.58 149.98 68.7 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.304 2.003 . . . . 0.0 113.092 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.62 142.77 49.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.663 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.9 133.53 53.02 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.261 0.553 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -41.57 126.05 2.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.6 -24.17 32.49 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.385 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.53 121.35 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.2 mm -81.55 138.86 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.044 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.47 154.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.452 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -113.0 117.01 30.85 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.433 HD13 ' HD2' ' A' ' 831' ' ' TYR . 62.3 mt -82.04 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.17 -4.82 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -166.78 130.83 1.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 827' ' ' ASP . 4.0 tm0? -90.6 107.32 19.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.712 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.1 mm -60.77 -48.87 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.121 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.587 ' C ' HE21 ' A' ' 825' ' ' GLN . 1.3 t70 -155.56 176.98 11.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 26.0 mp0 -61.85 -35.83 79.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.779 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -102.13 -7.41 22.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.815 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -125.53 131.89 52.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.982 0.42 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.433 ' HD2' HD13 ' A' ' 822' ' ' ILE . 3.3 m-85 -121.4 156.65 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.605 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -128.91 140.81 51.51 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.91 -174.18 31.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.44 136.31 48.27 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.577 0.227 . . . . 0.0 110.652 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 2.7 p80 -139.11 133.14 31.13 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 1.3 t60 50.2 31.8 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.243 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.27 4.45 90.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.538 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -112.63 161.87 16.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.01 140.89 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.52 30.31 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.79 155.02 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.131 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -161.53 153.82 16.7 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.576 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 845' ' ' THR . 56.6 Cg_endo -71.86 126.98 12.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.961 1.774 . . . . 0.0 112.714 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 2.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.757 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 843' ' ' PRO . 73.8 p -91.05 -18.44 24.57 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.589 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.49 5.41 34.04 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.2 pt -130.27 168.28 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -134.71 113.27 11.5 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.988 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 849' ' ' LEU . 3.1 mp -68.81 118.19 11.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.959 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 850' ' ' LEU . 21.6 tp 58.84 69.91 1.28 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.785 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.493 1.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.625 -179.257 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -128.15 150.41 50.0 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.54 146.32 16.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.05 125.21 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . 0.661 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -55.19 120.56 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.359 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -69.22 -36.7 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -134.33 150.52 50.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.916 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -55.55 132.92 49.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -130.67 134.63 47.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 16.5 p30 -113.65 128.89 56.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.996 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -77.95 139.89 23.33 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -98.17 -12.73 21.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 110.731 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 62.0 p -133.07 165.08 25.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . 0.473 ' O ' ' CE ' ' A' ' 886' ' ' MET . 98.4 mt-30 -62.02 -39.73 93.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.113 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 884' ' ' VAL . 2.9 t -66.82 -15.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.757 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -105.71 110.09 22.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.296 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 883' ' ' GLN . 39.1 mmt -81.01 152.69 27.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.262 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 96.7 p -108.9 155.01 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -159.3 161.61 35.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.779 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 1.4 mpt_? -96.44 165.86 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.593 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.53 135.89 57.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.19 82.63 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.607 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 77.2 mm-40 -72.38 140.61 48.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.516 0.658 . . . . 0.0 110.038 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -82.06 140.99 33.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.114 0.483 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 872' ' ' ALA . 90.8 mt -130.25 138.8 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.51 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.3 m -99.37 126.13 45.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.08 115.36 25.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.107 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.28 -37.36 6.03 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.535 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.48 134.61 18.13 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.181 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -103.1 118.27 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 901' ' ' ASP . 60.0 t -63.96 -41.21 91.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.098 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 900' ' ' VAL . 36.4 m-20 103.97 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.905 1.378 . . . . 0.0 110.335 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 901' ' ' ASP . 10.2 tt0 80.7 -69.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.766 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -169.43 23.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -135.88 151.04 49.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.505 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.438 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 29.4 p90 -153.85 155.11 35.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.21 0.529 . . . . 0.0 110.3 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.88 138.5 42.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.64 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.24 178.14 30.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.144 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -148.13 157.92 43.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.747 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 914' ' ' ARG . 93.5 mt -80.35 142.14 54.11 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.27 139.2 16.53 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 120.312 1.147 . . . . 0.0 110.499 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.26 -5.06 67.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 9.1 p 61.3 23.55 13.76 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.535 -0.333 . . . . 0.0 111.532 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.6 m -62.39 -42.3 99.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.832 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 909' ' ' ILE . 36.7 mmt180 -134.9 153.04 52.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.456 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -145.37 135.75 24.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.75 177.22 46.15 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.9 pt -112.45 144.05 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.629 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -151.3 155.78 34.74 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.474 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 140.2 41.97 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.058 1.839 . . . . 0.0 113.395 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.22 -37.57 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.486 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 98.9 m -56.31 -42.54 77.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -76.09 0.25 19.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.158 0.435 . . . . 0.0 111.96 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.6 m -132.15 158.97 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.159 0.504 . . . . 0.0 111.245 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -107.14 123.95 49.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.455 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.27 110.15 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.24 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 32.4 mm -86.01 -47.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.868 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 143.19 51.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.444 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.171 179.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -132.98 145.77 58.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.227 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.59 120.27 3.9 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.934 1.756 . . . . 0.0 112.431 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -120.42 152.0 38.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 74.8 ttt180 -118.27 133.93 55.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.951 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -77.22 113.98 15.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . 0.479 ' O ' ' NZ ' ' A' ' 816' ' ' LYS . 18.8 mmmt -69.68 -38.17 76.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.168 0.509 . . . . 0.0 110.056 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.4 167.52 20.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.093 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 137.6 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.333 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -133.75 131.38 39.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.441 ' O ' ' NE2' ' A' ' 807' ' ' GLN . 68.8 mttm -100.7 134.54 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -81.86 144.05 31.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.99 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . 0.441 ' NE2' ' O ' ' A' ' 805' ' ' LYS . 25.8 mp0 -98.52 -35.32 10.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.68 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 47.1 p -135.03 171.66 14.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.386 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.2 -24.65 43.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.175 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.28 -38.83 88.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.285 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.409 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 24.6 mp0 -101.12 156.44 17.42 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.7 pt? -127.21 147.68 62.91 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . 0.502 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 58.3 Cg_endo -72.44 140.25 32.97 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 113.033 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.72 145.0 51.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -120.13 139.98 51.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.281 0.562 . . . . 0.0 110.426 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 801' ' ' LYS . 12.4 ttmm -43.83 121.54 2.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.27 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 98.52 -20.65 49.59 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.578 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.32 136.16 57.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.937 0.399 . . . . 0.0 111.399 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.97 131.63 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.867 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.0 m -124.93 152.87 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.646 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -110.82 121.54 45.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.799 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.501 HD13 ' HD2' ' A' ' 831' ' ' TYR . 67.0 mt -91.38 131.06 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -104.51 -32.22 9.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.674 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -158.28 149.86 21.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.494 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -88.48 110.77 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.285 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.36 -48.01 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.296 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.432 ' OD1' ' OE1' ' A' ' 828' ' ' GLN . 8.2 t0 -154.76 177.86 10.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . 0.432 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 25.5 mp0 -61.36 -36.35 79.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.754 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -103.73 -2.55 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.173 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -127.97 139.38 52.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.501 ' HD2' HD13 ' A' ' 822' ' ' ILE . 5.0 m-85 -126.03 158.27 35.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.314 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 822' ' ' ILE . 0.6 OUTLIER -129.05 138.96 52.2 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.15 -176.01 33.77 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -117.56 152.91 34.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.971 0.415 . . . . 0.0 111.458 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.0 OUTLIER -164.52 137.05 4.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.159 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 49.3 t-80 52.6 29.93 7.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.302 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.22 2.63 90.57 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.515 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.9 148.25 30.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.05 136.93 52.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -170.7 -137.83 2.38 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.409 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 47.5 pt -133.83 157.01 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.93 0.365 . . . . 0.0 111.641 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 6.6 p90 -157.72 135.77 7.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.181 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.27 124.85 17.05 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.125 1.216 . . . . 0.0 112.442 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -54.92 -20.42 8.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.4 p -72.46 -11.28 60.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.48 -1.76 40.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.244 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.588 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -135.45 171.03 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.992 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -131.88 110.19 10.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.869 0.366 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.64 116.29 8.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 32.4 tp 54.05 72.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.676 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 122.183 1.922 . . . . 0.0 112.123 -179.243 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.77 143.97 50.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.206 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -157.2 144.59 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.5 mt -123.02 128.19 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.822 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.09 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.946 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 44.7 mtpt -70.05 -37.82 75.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.816 0.341 . . . . 0.0 110.497 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.71 153.53 49.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -57.11 159.46 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 26.9 t80 -150.49 138.72 20.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.72 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 40.0 p30 -151.85 92.04 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -82.69 -174.24 49.98 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 49.4 t0 -135.66 -9.38 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 111.641 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.5 p -79.26 174.3 11.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.98 0.419 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.45 -0.93 57.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 -18.77 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.642 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -72.57 141.95 48.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.58 128.56 46.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 22.5 t -92.85 125.45 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.109 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 34.4 p90 -154.9 162.37 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 33.2 mtp-105 -112.18 161.67 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.347 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -59.42 136.54 58.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 893' ' ' ARG . . . 90.15 -4.91 83.14 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 75.8 mm-40 -76.87 142.79 40.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.179 0.489 . . . . 0.0 110.562 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 891' ' ' GLY . 12.6 mpt_? -82.4 142.12 32.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.251 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.2 mt -131.38 143.17 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.2 m -100.65 127.09 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.873 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.581 HD11 HG13 ' A' ' 925' ' ' VAL . 81.6 mt -86.85 120.32 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.3 mt -100.18 -45.61 5.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -165.5 164.85 19.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.887 0.375 . . . . 0.0 111.134 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . 0.596 ' NE2' HD11 ' A' ' 920' ' ' ILE . 2.1 tp60 -103.58 116.95 33.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.761 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.434 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.8 t -61.86 -45.55 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.193 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 902' ' ' GLU . 34.4 t70 -148.56 -116.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.789 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.471 ' H ' ' CG ' ' A' ' 901' ' ' ASP . 99.7 mt-10 -114.32 -37.03 4.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.75 7.75 22.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.589 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -132.49 148.57 52.39 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.526 0.203 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.514 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.5 p90 -152.71 159.56 43.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.853 0.358 . . . . 0.0 110.283 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.426 ' HG3' HE21 ' A' ' 915' ' ' GLN . 88.4 tt0 -109.69 136.79 48.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.32 178.39 30.38 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.547 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -151.79 159.75 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.7 mt -80.69 140.79 51.29 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.49 138.3 18.81 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 CA-C-N 120.148 1.088 . . . . 0.0 110.988 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.5 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.04 -6.91 73.0 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 911' ' ' GLY . 2.2 p 66.51 28.05 9.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.715 0.293 . . . . 0.0 111.15 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 88.0 p -64.21 -24.17 67.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -165.26 152.85 11.03 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.686 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.426 HE21 ' HG3' ' A' ' 906' ' ' GLU . 18.2 tm0? -144.02 147.19 33.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 179.04 -174.55 46.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.551 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 45.9 pt -109.94 154.72 11.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.219 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 918' ' ' PHE . 0.0 OUTLIER -165.23 151.87 9.18 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.908 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.82 140.65 29.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.17 1.913 . . . . 0.0 112.768 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.596 HD11 ' NE2' ' A' ' 899' ' ' GLN . 90.1 mt -61.57 -32.05 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.801 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 97.9 m -57.9 -42.14 84.09 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -77.4 1.23 19.66 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.514 HG11 ' OH ' ' A' ' 905' ' ' TYR . 3.5 m -133.78 159.15 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.494 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -111.32 128.7 56.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.377 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 896' ' ' LEU . 79.3 t -99.58 105.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.687 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 926' ' ' ILE . 2.5 mp -62.19 -45.74 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 926' ' ' ILE . 98.2 mttt -138.31 140.41 39.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 . . . . . 0 CA--C 1.54 0.568 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.689 -179.916 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.73 0.3 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -158.77 98.46 1.69 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.19 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.824 1.683 . . . . 0.0 111.91 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.514 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -134.73 155.91 49.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -118.51 134.47 55.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.283 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . 0.534 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.29 116.92 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -71.3 -30.03 65.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.46 175.67 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.465 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 805' ' ' LYS . 14.5 t70 -82.31 126.73 32.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.455 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -115.56 130.73 56.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.981 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 803' ' ' ASP . 38.2 mmtm -94.21 130.16 40.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.2 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.77 139.51 55.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.24 -35.63 10.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.242 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.9 p -135.42 162.54 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.1 pp -50.61 -32.87 20.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.46 -46.13 91.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.268 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.848 ' OE2' HD11 ' A' ' 841' ' ' ILE . 2.7 mt-10 -90.03 136.97 32.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.025 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.4 mm? -110.67 150.72 42.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 152.02 50.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.219 1.946 . . . . 0.0 113.448 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 820' ' ' VAL . 4.8 mt -133.96 157.21 46.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.917 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.56 141.01 50.67 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.422 0.63 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -47.62 123.35 5.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.79 44.19 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.886 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.539 ' OD1' ' NE2' ' A' ' 835' ' ' HIS . 19.8 t70 -58.03 143.28 43.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 28.2 mm -103.78 131.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.655 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 814' ' ' LEU . 32.1 m -121.62 152.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.764 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.418 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 72.8 m-85 -111.94 113.58 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 832' ' ' GLU . 73.0 mt -81.36 127.14 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -119.33 -5.49 10.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.19 130.44 1.45 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.81 135.32 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 832' ' ' GLU . 48.9 mm -88.29 -48.92 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.42 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -152.48 178.98 8.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.13 -37.21 79.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.163 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -105.98 -0.43 24.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.929 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . 0.462 ' CE3' HD12 ' A' ' 841' ' ' ILE . 79.4 m95 -124.5 137.94 54.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.491 0.662 . . . . 0.0 112.089 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 822' ' ' ILE . 28.9 m-85 -128.03 151.85 48.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.372 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.506 ' OE1' HD11 ' A' ' 826' ' ' ILE . 9.0 tt0 -123.31 141.03 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -161.9 -163.51 14.92 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.49 150.13 49.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 111.008 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.6 ' HB2' HG12 ' A' ' 820' ' ' VAL . 1.2 t-80 -155.33 128.05 7.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.449 ' CB ' HH21 ' A' ' 838' ' ' ARG . 1.9 m80 52.38 24.04 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 92.09 -6.37 78.81 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . 0.449 HH21 ' CB ' ' A' ' 836' ' ' HIS . 12.0 ptp180 -98.08 151.9 19.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.337 0.568 . . . . 0.0 109.897 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 833' ' ' GLY . 9.2 p -131.55 129.24 61.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.92 23.87 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.848 HD11 ' OE2' ' A' ' 811' ' ' GLU . 31.1 pt -105.74 152.15 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 117.338 0.569 . . . . 0.0 110.588 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.5 OUTLIER -139.79 114.78 7.95 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.8 128.57 21.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.474 1.45 . . . . 0.0 112.721 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -50.85 -20.28 1.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.533 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 65.7 p -87.1 -3.18 59.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.663 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -6.42 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.221 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.8 pt -134.25 172.1 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.013 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -117.83 160.61 21.1 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.87 107.67 18.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 41.3 tp 46.41 77.64 0.45 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.472 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.495 1.615 0 C-N-CA 121.947 1.765 . . . . 0.0 111.809 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.733 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -129.02 150.55 50.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.722 0.296 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.496 ' O ' HD13 ' A' ' 873' ' ' ILE . . . -154.53 152.86 30.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 872' ' ' ALA . 23.2 mm -125.14 128.77 73.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -59.29 126.34 27.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.339 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 50.4 mtpt -73.85 -39.02 64.3 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -139.02 153.8 48.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.07 132.9 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -132.91 135.91 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.894 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -109.93 141.58 42.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.583 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.35 12.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -98.42 -12.15 21.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.25 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.4 p -132.99 163.31 29.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.28 -39.86 94.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.916 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.99 -25.01 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.843 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -98.2 127.47 44.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.8 tpt -105.07 123.59 48.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.937 0.399 . . . . 0.0 110.97 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 87.1 p -74.41 157.44 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.871 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -164.43 162.56 22.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 27.9 mmt180 -102.71 159.18 15.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.92 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -55.14 137.25 47.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.76 82.93 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.119 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 11.9 mm-40 -69.65 141.84 53.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.079 0.44 . . . . 0.0 110.712 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -91.25 135.26 33.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.136 0.493 . . . . 0.0 111.111 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.49 148.03 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.517 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.1 m -99.81 127.07 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.474 ' CD1' HG13 ' A' ' 925' ' ' VAL . 86.5 mt -84.03 125.11 31.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 111.104 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 98.3 mt -103.19 -50.71 3.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.021 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 36.7 ptt-85 -165.93 165.24 18.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.22 119.17 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.545 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 53.3 t -61.2 -47.65 92.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.764 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.1 m-20 -144.2 -91.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.07 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.427 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.2 tp10 -137.93 -46.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -102.1 7.46 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -133.23 149.39 52.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.688 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.505 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.4 p90 -153.57 161.78 41.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.054 0.455 . . . . 0.0 111.165 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 33.8 tt0 -109.96 139.2 45.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.867 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.47 176.24 28.29 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -144.62 156.23 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.782 0.325 . . . . 0.0 110.436 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 914' ' ' ARG . 92.1 mt -103.21 107.67 56.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.066 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -54.09 135.28 63.66 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.35 1.367 . . . . 0.0 111.358 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 97.01 -22.31 41.45 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 74.6 p -127.58 -17.55 4.57 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.992 0.425 . . . . 0.0 110.022 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 57.5 m 51.61 36.57 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.216 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.457 ' HB2' HD12 ' A' ' 909' ' ' ILE . 11.3 mmp_? -86.25 98.09 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.522 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 53.6 tt0 -86.33 128.23 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.999 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -157.03 163.91 32.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.496 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.3 144.9 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.895 0.378 . . . . 0.0 111.068 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.496 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -158.49 164.28 21.69 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.857 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.39 137.06 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.412 2.074 . . . . 0.0 113.925 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 902' ' ' GLU . 91.6 mt -60.77 -39.09 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.88 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 70.1 p -54.92 -22.48 15.07 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.757 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -95.11 0.85 54.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.505 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.6 m -132.3 157.88 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.13 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.43 121.83 45.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 896' ' ' LEU . 67.5 t -90.19 103.95 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 41.4 mm -72.38 -43.58 64.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.131 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -132.82 151.92 51.92 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.653 0.263 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.514 ' HB3' HD21 ' A' ' 849' ' ' LEU . 98.8 mtt180 -125.82 97.61 35.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.545 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.56 140.88 96.56 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.075 1.85 . . . . 0.0 111.905 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -135.17 155.83 50.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -117.54 133.66 55.72 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.451 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -79.41 127.07 31.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -91.99 -28.72 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.14 162.62 32.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.079 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.5 p-10 -75.94 137.77 40.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.457 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.27 129.02 55.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.003 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -96.03 124.98 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -70.72 137.88 50.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.7 -38.8 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.418 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 67.8 p -135.64 162.87 31.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.62 -34.35 7.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.21 -39.86 94.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.993 0.425 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.643 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 3.6 mt-10 -92.83 128.33 38.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.977 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.1 mm? -108.71 150.09 40.32 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.649 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.74 151.43 63.49 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.203 1.935 . . . . 0.0 113.023 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 3.2 tp -135.82 151.26 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.612 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.19 137.86 53.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.47 0.652 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.42 126.27 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.66 -23.64 34.97 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.294 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.3 t0 -59.78 133.98 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . 0.47 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 44.7 mm -91.82 130.11 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 798' ' ' ALA . 0.0 OUTLIER -118.99 145.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.222 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.428 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 71.0 m-85 -107.51 104.86 14.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.6 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.45 130.89 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -100.35 -38.21 8.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.832 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -161.37 156.15 23.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.479 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.33 111.12 20.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.026 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . 0.456 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 48.0 mm -63.34 -47.35 92.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.278 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -148.88 177.12 9.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.62 -25.3 68.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -123.96 11.42 8.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -137.91 145.26 41.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.495 ' OH ' HG21 ' A' ' 847' ' ' ILE . 29.4 p90 -140.76 165.5 27.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -127.61 139.06 52.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.398 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.13 -172.24 29.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -111.83 138.84 47.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.779 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.496 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.4 p-80 -141.71 133.74 27.57 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 52.83 29.69 8.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.13 5.78 89.86 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.012 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -115.92 150.11 37.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.5 p -114.4 141.99 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.01 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -171.01 -158.62 15.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.44 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 49.4 pt -126.45 149.63 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.76 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -151.4 154.03 33.08 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.45 125.8 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.623 1.548 . . . . 0.0 111.825 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -56.98 -27.67 61.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.174 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.8 p -66.82 -12.84 60.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.255 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -96.36 -1.32 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.893 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -140.45 169.11 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.439 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . 0.636 ' N ' HD12 ' A' ' 847' ' ' ILE . 82.1 tt0 -130.42 120.26 23.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 796' ' ' ARG . 2.9 tt -63.2 115.79 4.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.897 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 849' ' ' LEU . 0.2 OUTLIER 44.62 77.22 0.46 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--N 1.305 -1.745 0 C-N-CA 122.653 2.236 . . . . 0.0 111.334 179.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -135.04 147.17 49.56 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.503 0.192 . . . . 0.0 110.717 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -152.67 154.14 34.7 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 92.9 mt -124.74 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.754 0.312 . . . . 0.0 110.436 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.47 57.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.327 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -87.2 -29.67 21.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -137.94 145.48 42.07 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.708 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.3 p-10 -51.34 122.14 7.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -117.05 125.86 51.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -119.81 105.6 11.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.301 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -65.26 137.97 38.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -102.89 1.14 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.9 p -130.5 163.09 27.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.01 -40.81 96.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 884' ' ' VAL . 14.0 m -67.62 -25.36 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.572 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -97.42 136.39 37.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.185 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 915' ' ' GLN . 0.0 OUTLIER -107.24 168.05 9.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 41.5 t -118.44 136.16 53.95 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.942 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.92 162.05 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -82.67 162.33 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.717 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 890' ' ' LYS . 10.6 pttt -73.09 42.36 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.267 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . -160.83 -0.38 0.07 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.069 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.68 143.18 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.795 0.798 . . . . 0.0 110.406 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -76.23 143.08 41.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.995 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 872' ' ' ALA . 92.0 mt -129.19 139.13 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.524 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.8 m -99.14 125.25 44.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.83 116.48 20.01 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . 0.563 HD11 ' HD2' ' A' ' 908' ' ' ARG . 86.6 mt -97.64 -46.07 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -166.18 164.61 17.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.984 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -103.91 118.41 36.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.465 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.4 t -65.26 -45.31 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.647 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -152.03 -125.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.769 0.318 . . . . 0.0 111.047 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.08 -25.11 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.339 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -135.47 18.93 3.35 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.599 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.51 146.95 51.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.733 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.465 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 15.0 p90 -156.42 161.29 40.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.053 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.65 133.89 50.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.502 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -147.91 172.96 28.12 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.557 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 897' ' ' LEU . 8.7 ptm180 -155.96 163.39 39.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.812 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 84.3 mt -94.01 139.26 22.55 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.96 141.52 36.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.214 1.112 . . . . 0.0 111.061 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.09 68.58 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.498 HG23 HH21 ' A' ' 908' ' ' ARG . 1.2 m 73.78 28.37 1.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 44.9 t -67.9 -50.14 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -135.19 148.07 49.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.082 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.488 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.6 tt0 -151.24 135.18 16.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.278 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 176.78 -174.89 47.37 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.0 pt -115.47 146.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.36 0.6 . . . . 0.0 111.456 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -161.75 158.82 22.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.677 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.05 140.43 45.34 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.489 2.126 . . . . 0.0 114.452 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.19 -32.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.269 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.7 m -57.62 -39.44 76.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.749 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.85 5.04 23.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.06 158.46 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.169 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -111.0 123.14 49.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.267 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.483 ' C ' HD12 ' A' ' 926' ' ' ILE . 4.7 m -95.04 141.53 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.011 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -107.47 -37.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.265 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -136.49 136.29 39.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.523 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.718 179.155 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.957 0.408 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.713 ' HB2' HD11 ' A' ' 849' ' ' LEU . 25.3 mmt180 -135.6 148.89 67.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.57 116.31 4.45 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.942 1.762 . . . . 0.0 111.987 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 798' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -112.32 152.67 28.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -118.85 129.36 55.17 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.662 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.19 112.66 9.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.97 -35.43 78.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.121 0.486 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -137.81 162.63 33.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.668 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 803' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 31.1 t70 -73.71 138.31 44.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.412 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.03 119.02 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.07 0.462 . . . . 0.0 110.632 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -84.48 144.87 28.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -72.82 114.96 11.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.3 -39.92 89.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.449 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.9 p -134.29 162.26 32.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -34.1 14.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.61 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -61.0 -43.88 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.381 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 811' ' ' GLU . . . . . 0.435 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 7.9 mt-10 -77.3 162.87 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 812' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 840' ' ' GLY . 3.9 pp -125.27 150.13 66.29 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.7 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.14 146.92 32.73 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.118 1.879 . . . . 0.0 111.997 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 814' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 820' ' ' VAL . 13.0 mt -140.24 140.92 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.501 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -120.64 139.55 52.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.521 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -43.8 124.02 3.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.215 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.61 -19.44 53.59 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.09 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.8 136.0 57.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.936 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.88 134.31 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 820' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 798' ' ' ALA . 35.4 m -128.81 157.96 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 821' ' ' TYR . . . . . 0.43 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 98.1 m-85 -115.12 111.14 20.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.475 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 822' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 831' ' ' TYR . 30.4 mm -79.73 96.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -85.29 -14.97 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.06 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 824' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.3 tttm -162.86 131.7 4.06 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.785 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 825' ' ' GLN . . . . . 0.711 HE21 ' N ' ' A' ' 827' ' ' ASP . 6.3 tm0? -85.12 127.46 34.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.31 -56.44 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.015 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 827' ' ' ASP . . . . . 0.711 ' N ' HE21 ' A' ' 825' ' ' GLN . 4.7 t70 -151.73 177.4 10.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.375 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.45 -23.72 67.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.377 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -111.74 -3.66 14.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.417 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -131.71 134.98 46.48 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.277 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 831' ' ' TYR . . . . . 0.499 ' CD2' HG21 ' A' ' 822' ' ' ILE . 1.3 m-85 -124.21 160.35 28.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.887 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 832' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 9.7 tt0 -136.31 135.94 39.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 833' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.25 -165.58 15.3 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -120.27 139.09 53.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.506 0.193 . . . . 0.0 110.898 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 835' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.4 p-80 -143.68 134.46 25.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 71.9 t60 50.21 31.95 5.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.71 3.27 90.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.919 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -109.65 155.68 21.18 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.2 t -124.21 135.01 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 840' ' ' GLY . . . . . 0.859 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.08 -157.33 10.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 841' ' ' ILE . . . . . 0.435 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 48.0 pt -131.42 154.13 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.226 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.53 148.9 14.45 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.83 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 126.11 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.303 1.335 . . . . 0.0 113.075 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -56.54 -28.04 59.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.76 -13.44 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -93.82 -0.79 55.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 847' ' ' ILE . . . . . 0.446 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.5 pp -139.61 167.08 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.9 126.71 27.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 849' ' ' LEU . . . . . 0.713 HD11 ' HB2' ' A' ' 796' ' ' ARG . 12.1 tp -78.46 113.65 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.2 tp 51.97 73.49 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.305 -1.725 0 C-N-CA 122.466 2.111 . . . . 0.0 111.812 -179.582 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -116.82 151.52 36.34 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 872' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 894' ' ' ILE . . . -152.82 146.98 25.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 7.5 mm -125.3 127.95 72.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.01 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 874' ' ' ALA . . . . . 0.429 ' HB1' ' HE1' ' A' ' 922' ' ' TYR . . . -64.27 129.48 40.11 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 875' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -85.37 -31.98 22.65 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -137.0 146.01 44.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.173 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 877' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.0 p-10 -52.38 117.76 3.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -112.51 125.07 53.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.722 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -110.91 106.1 15.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 880' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -68.15 141.97 38.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -94.76 -9.43 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 60.9 p -134.15 163.27 29.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -61.58 -38.45 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.949 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.16 -41.8 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.084 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -87.37 104.73 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.64 146.07 50.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 887' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 97.7 p -107.85 151.82 25.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.1 OUTLIER -164.68 176.48 8.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.723 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -105.49 172.8 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.25 136.43 57.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.046 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 88.72 1.12 80.82 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.037 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.67 139.84 42.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.767 0.783 . . . . 0.0 109.949 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.39 141.39 35.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.099 0.476 . . . . 0.0 111.149 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 894' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 872' ' ' ALA . 96.6 mt -133.48 144.2 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.831 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.1 m -103.41 128.16 50.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.917 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.499 HD11 HG13 ' A' ' 925' ' ' VAL . 85.3 mt -85.15 126.92 34.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.6 mt -108.73 -55.09 2.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -159.14 153.73 24.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.229 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -93.13 115.9 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.764 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 900' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 57.0 t -61.89 -47.46 93.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 901' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 88.5 m-20 -143.39 -102.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 902' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 920' ' ' ILE . 24.3 pt-20 -130.83 -38.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.493 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -107.19 5.22 27.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.57 150.34 52.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.764 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 905' ' ' TYR . . . . . 0.48 ' OH ' HG11 ' A' ' 923' ' ' VAL . 25.7 p90 -152.08 159.98 43.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.6 tt0 -103.12 133.91 47.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.499 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.72 30.35 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.167 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -149.8 157.34 43.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.957 0.408 . . . . 0.0 110.451 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 49.5 mm -80.06 141.12 54.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.83 139.62 24.58 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.972 1.114 . . . . 0.0 111.184 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 911' ' ' GLY . . . . . 0.536 ' C ' HG23 ' A' ' 912' ' ' THR . . . 93.96 -8.08 73.31 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 912' ' ' THR . . . . . 0.536 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 67.71 28.35 7.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 111.129 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 96.0 p -63.78 -26.51 68.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.23 153.45 13.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 915' ' ' GLN . . . . . 0.507 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 46.2 tt0 -142.72 142.51 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.572 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.12 48.17 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 917' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 906' ' ' GLU . 43.9 pt -117.74 145.24 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -153.27 166.07 16.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.19 132.74 35.15 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 122.345 2.03 . . . . 0.0 114.425 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 920' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 902' ' ' GLU . 96.4 mt -59.79 -40.14 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.993 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 921' ' ' THR . . . . . 0.507 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 68.1 p -61.15 -25.46 67.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 922' ' ' TYR . . . . . 0.7 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -82.6 -2.09 52.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.541 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 923' ' ' VAL . . . . . 0.7 HG13 ' CD2' ' A' ' 922' ' ' TYR . 27.6 m -129.43 155.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.494 0.664 . . . . 0.0 112.229 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.081 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 925' ' ' VAL . . . . . 0.499 HG13 HD11 ' A' ' 896' ' ' LEU . 78.3 t -90.71 99.46 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.273 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 926' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -64.62 -47.3 89.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 927' ' ' LYS . . . . . 0.481 ' HG3' HG22 ' A' ' 926' ' ' ILE . 59.8 mtpt -139.94 146.53 39.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.88 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.193 179.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 789' ' ' HIS . 3.6 pm0 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.492 ' H ' ' HG2' ' A' ' 788' ' ' GLN . 62.9 t-80 -65.67 -37.43 86.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.327 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 51.5 ttp 76.47 59.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.786 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.2 t -151.15 148.89 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.289 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 88.98 63.13 1.33 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 69.3 m -61.28 147.05 45.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -66.98 142.29 57.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.42 167.09 18.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.466 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.67 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 89.9 mtm180 -123.68 138.74 30.85 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.044 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 120.6 6.73 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.655 1.57 . . . . 0.0 112.688 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -113.58 146.01 40.37 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -108.3 132.55 53.58 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.362 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -73.21 112.32 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.6 -38.04 86.17 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 109.714 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -139.41 -177.97 5.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.591 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 56.0 p-10 -93.07 144.24 25.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.355 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -133.77 128.15 34.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.54 134.36 35.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.537 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -73.84 133.95 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -105.63 -26.43 11.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.2 p -130.63 169.73 15.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.256 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.3 mp -61.21 -39.75 91.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.473 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.94 -40.43 95.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.509 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.0 mt-10 -79.85 131.73 35.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.312 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.46 151.37 44.39 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . 0.73 ' O ' HD12 ' A' ' 814' ' ' LEU . 57.3 Cg_endo -70.05 145.75 56.36 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.104 1.87 . . . . 0.0 113.036 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.832 HD21 HG11 ' A' ' 820' ' ' VAL . 1.6 mp -136.86 140.81 42.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.276 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -118.47 142.4 47.61 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.423 0.63 . . . . 0.0 110.809 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -48.71 122.97 6.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.639 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.22 -18.23 54.49 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.986 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.72 128.81 37.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.62 135.6 25.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.832 HG11 HD21 ' A' ' 814' ' ' LEU . 31.1 m -131.32 152.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.44 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 87.1 m-85 -113.01 119.55 38.28 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 832' ' ' GLU . 22.5 mm -87.35 103.87 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.912 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -93.69 -7.23 44.34 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.657 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.24 132.61 2.99 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.147 0.499 . . . . 0.0 111.314 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -90.51 112.3 23.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.674 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 2.9 mm -60.6 -49.15 85.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -159.47 178.16 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -61.23 -35.33 76.94 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.054 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -100.15 -6.1 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.883 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -130.35 135.01 47.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.317 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.428 ' HD2' HG21 ' A' ' 822' ' ' ILE . 4.5 m-85 -123.1 152.61 40.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.464 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 822' ' ' ILE . 13.9 tt0 -127.83 137.8 52.49 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.62 -175.33 28.43 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -110.86 138.72 46.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.793 0.33 . . . . 0.0 111.106 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.1 p-80 -143.18 133.32 24.39 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.504 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 51.54 31.79 8.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.418 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.07 5.19 90.3 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.743 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -115.44 155.23 27.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 13.0 p -120.61 143.74 31.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.999 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.86 -168.74 31.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 842' ' ' PHE . 17.7 pt -126.38 154.22 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.701 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -163.69 156.09 15.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.381 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.63 118.93 5.93 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.115 1.877 . . . . 0.0 112.751 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -47.68 -19.46 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.3 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 63.8 p -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -103.96 -6.21 21.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.1 pt -132.17 169.76 21.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.706 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -122.83 106.76 11.18 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.089 0.471 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.67 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 59.2 tp -61.59 112.55 2.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.781 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 45.33 78.65 0.38 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.533 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.54 152.17 57.11 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.675 2.25 . . . . 0.0 111.873 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 151.21 75.76 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.31 2.007 . . . . 0.0 111.814 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -99.78 121.67 41.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -87.73 -12.23 45.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.251 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.29 142.99 28.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.939 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -65.64 -21.67 66.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 63.79 70.7 0.67 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.533 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.08 -21.6 66.19 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.367 2.711 . . . . 0.0 112.702 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 59.08 39.45 23.19 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.293 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 41.04 -129.49 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.649 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 861' ' ' LEU . 0.5 OUTLIER -161.47 176.09 11.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.45 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 4.4 t -148.28 144.03 18.23 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.586 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.28 -22.53 60.42 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.055 1.837 . . . . 0.0 112.217 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 866' ' ' VAL . 0.0 OUTLIER -101.86 -169.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.496 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 55.08 40.97 32.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.521 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 864' ' ' VAL . 34.2 m -131.93 159.11 43.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.575 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.83 152.85 34.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.718 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -140.71 133.69 29.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -82.0 143.78 31.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.616 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -75.06 156.06 48.54 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -120.57 149.98 41.6 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.707 0.289 . . . . 0.0 110.588 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.59 155.95 27.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 81.4 mt -133.38 133.62 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.71 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.1 133.99 56.62 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.969 0.414 . . . . 0.0 111.656 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -83.81 -25.61 30.24 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.375 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.28 146.61 38.78 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.74 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 34.2 m120 -52.93 139.93 26.12 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.412 ' CB ' ' CE1' ' A' ' 888' ' ' PHE . 26.6 t80 -131.88 130.86 42.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.909 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -131.72 89.9 2.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -74.47 171.02 53.39 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -133.92 12.82 3.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.615 0.245 . . . . 0.0 111.045 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 885' ' ' GLU . 82.8 p -130.73 159.01 38.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.742 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -62.55 -40.93 98.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.62 HG23 ' HG2' ' A' ' 885' ' ' GLU . 15.7 m -66.01 -26.3 38.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.528 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.62 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.2 mm-40 -103.45 120.79 41.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.335 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 8.0 mmt -93.24 172.26 8.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.543 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 93.0 p -121.87 148.91 44.12 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.109 0.48 . . . . 0.0 110.967 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.412 ' CE1' ' CB ' ' A' ' 878' ' ' PHE . 11.9 p90 -161.03 160.19 30.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.493 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 3.6 mtp-105 -95.06 170.25 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.198 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.74 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 24.1 ttpp -73.49 52.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 176.22 16.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.966 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 889' ' ' ARG . 14.9 mp0 -97.33 149.62 21.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.438 0.619 . . . . 0.0 110.105 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -84.59 148.85 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.046 0.45 . . . . 0.0 110.513 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 872' ' ' ALA . 93.7 mt -132.57 144.54 36.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.504 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.0 m -102.7 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.98 130.38 35.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.074 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.8 mt -109.44 -54.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.111 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . 0.54 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 34.6 ptt-85 -166.05 165.04 18.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.178 0.514 . . . . 0.0 111.221 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 901' ' ' ASP . 35.0 tt0 -99.92 120.27 39.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.761 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.411 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.1 t -62.23 -46.83 95.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 120.982 0.42 . . . . 0.0 111.094 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.532 ' O ' ' NE2' ' A' ' 899' ' ' GLN . 12.9 t70 -144.79 -95.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.011 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 901' ' ' ASP . 98.7 mt-10 -132.49 -45.54 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.698 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -104.31 8.13 35.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -131.58 148.64 52.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.593 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.669 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.1 p90 -154.87 161.86 41.3 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.66 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.54 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 88.2 tt0 -109.61 137.84 46.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.33 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.71 172.11 31.81 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -149.99 156.31 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.813 0.339 . . . . 0.0 110.666 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 914' ' ' ARG . 87.6 mt -77.4 139.55 64.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.37 137.93 14.08 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.103 1.202 . . . . 0.0 111.122 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.73 -10.35 66.46 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 69.33 25.69 5.51 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 89.6 p -67.25 -38.99 86.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.287 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.518 ' HB2' HD12 ' A' ' 909' ' ' ILE . 99.7 mtt180 -139.46 150.27 44.99 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.264 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -145.56 142.68 29.37 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.257 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -179.34 -179.62 48.76 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.397 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.475 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -119.87 150.91 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.943 0.401 . . . . 0.0 111.121 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.475 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -163.63 160.89 17.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.38 139.49 49.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.14 1.893 . . . . 0.0 113.124 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.9 mt -61.75 -38.96 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.028 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 69.2 p -57.85 -11.3 2.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.576 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -102.95 0.66 32.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.669 HG11 ' OH ' ' A' ' 905' ' ' TYR . 10.7 m -132.99 158.25 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 111.194 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -113.97 131.71 56.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.692 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.0 m -91.01 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.999 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.4 -45.79 7.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.599 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -146.71 121.75 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.895 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -73.77 149.68 88.17 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.139 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.52 151.15 64.52 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.103 1.869 . . . . 0.0 112.076 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.66 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -123.77 137.08 54.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.391 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -157.78 165.37 35.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.625 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 49.6 m 56.07 44.43 25.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -167.69 176.23 42.44 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 67.2 m -124.9 144.25 50.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.832 0.349 . . . . 0.0 110.829 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -93.91 0.33 56.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.701 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.589 ' N ' ' SD ' ' A' ' 795' ' ' MET . 0.5 OUTLIER -144.67 166.08 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 17.9 tpp180 -132.77 95.72 19.25 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.77 140.45 93.37 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.04 1.827 . . . . 0.0 112.099 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -133.54 154.2 51.04 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -116.4 135.04 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.774 0.321 . . . . 0.0 110.646 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.561 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -79.18 127.06 31.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.869 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -98.23 -14.97 20.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.207 0.527 . . . . 0.0 110.04 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -151.84 167.31 28.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.6 p-10 -91.49 133.89 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.63 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -127.71 128.66 45.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.911 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -93.27 135.68 34.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.382 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.62 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.566 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -100.37 -22.67 14.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.993 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 809' ' ' LEU . 87.5 m -128.05 162.81 25.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.34 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.541 ' N ' HG22 ' A' ' 808' ' ' THR . 60.7 tp -58.27 -42.84 87.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.106 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.3 -39.35 90.14 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.195 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.79 149.12 48.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.295 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.821 ' O ' HD12 ' A' ' 812' ' ' LEU . 2.2 pp -125.79 151.22 70.67 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . 0.509 ' O ' ' NE2' ' A' ' 835' ' ' HIS . 74.5 Cg_endo -74.45 141.32 28.22 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.667 1.578 . . . . 0.0 112.102 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.16 148.76 52.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.061 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -120.18 135.26 55.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.339 0.59 . . . . 0.0 109.936 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . 0.494 ' HB3' ' HZ2' ' A' ' 816' ' ' LYS . 0.0 OUTLIER -43.38 124.39 3.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.176 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.64 -21.02 48.04 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.675 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -55.56 134.78 51.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 29.1 mm -93.58 129.57 43.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.156 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 798' ' ' ALA . 29.9 m -124.53 153.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 88.6 m-85 -113.6 121.62 44.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.971 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 832' ' ' GLU . 70.1 mt -91.23 129.3 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -109.46 -16.15 14.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.136 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -168.42 142.47 3.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.087 0.47 . . . . 0.0 111.46 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 827' ' ' ASP . 52.4 tt0 -85.33 136.5 33.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.142 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.4 -50.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 109.876 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.406 ' C ' HE21 ' A' ' 825' ' ' GLN . 7.0 t0 -149.61 179.0 8.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.925 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.46 -36.37 80.24 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.908 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -104.58 -1.51 26.4 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -126.96 139.34 53.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.359 0.599 . . . . 0.0 111.609 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.535 ' HD2' HD13 ' A' ' 822' ' ' ILE . 12.7 m-85 -125.6 156.92 38.39 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.584 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.658 ' O ' HG23 ' A' ' 822' ' ' ILE . 1.6 tp10 -124.43 139.9 53.45 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -168.75 -173.21 36.34 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -116.78 150.59 38.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.509 ' NE2' ' O ' ' A' ' 813' ' ' PRO . 0.5 OUTLIER -155.88 134.51 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.521 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.9 t-80 51.22 31.83 7.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.699 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.77 80.05 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 839' ' ' VAL . 44.0 tpt85 -121.09 135.09 55.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 838' ' ' ARG . 99.6 t -112.65 129.23 68.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.496 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.793 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.96 -154.56 8.5 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.09 160.83 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 117.062 0.431 . . . . 0.0 110.877 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -160.8 152.8 16.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.619 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 845' ' ' THR . 60.6 Cg_endo -73.75 121.67 7.2 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.077 1.852 . . . . 0.0 112.623 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . 0.408 ' NE ' ' CE1' ' A' ' 831' ' ' TYR . 3.4 ttm180 -50.56 -10.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.519 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 843' ' ' PRO . 62.6 p -80.51 -10.85 59.73 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.474 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -102.9 -3.98 25.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.666 0.269 . . . . 0.0 111.231 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 800' ' ' ALA . 42.6 pt -136.21 173.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.984 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.544 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 80.2 tt0 -114.66 161.48 18.06 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 5.8 tp -111.72 103.98 12.29 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.288 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.8 tp 53.38 77.91 0.42 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.688 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.29 162.92 39.24 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.132 1.888 . . . . 0.0 111.879 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.31 138.53 55.52 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 121.738 1.625 . . . . 0.0 111.649 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -114.75 124.57 52.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.912 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.34 -38.16 90.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.401 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 856' ' ' ALA . 60.5 mtpt -62.83 140.14 58.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 855' ' ' LYS . . . 169.78 17.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.259 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 857' ' ' GLN . 19.1 mp0 -69.51 148.86 97.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.41 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.35 -19.85 49.29 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.329 2.019 . . . . 0.0 112.286 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -68.41 144.57 54.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.528 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -127.84 150.96 49.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.583 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . 0.639 ' H ' HD23 ' A' ' 861' ' ' LEU . 0.1 OUTLIER -73.2 89.11 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.232 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 5.7 t -145.82 143.3 19.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.261 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.97 150.36 66.82 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.142 1.894 . . . . 0.0 112.355 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.06 160.39 42.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.434 ' HB2' HD13 ' A' ' 867' ' ' LEU . 26.5 pt20 -161.12 -39.69 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.657 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 2.1 t 55.41 19.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.299 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 865' ' ' GLN . 3.8 mp -62.49 -41.45 98.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.769 0.318 . . . . 0.0 110.799 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 50.54 45.42 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.155 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.48 -173.24 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.167 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -73.38 167.54 54.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -129.29 160.98 31.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.441 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -155.28 150.24 26.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.94 123.07 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.297 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -64.06 117.06 6.54 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.488 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -69.57 -35.27 75.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.498 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -130.27 142.22 50.56 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.887 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' A' ' 889' ' ' ARG . 2.4 t-20 -47.85 134.24 13.43 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 888' ' ' PHE . 66.9 t80 -124.62 134.33 52.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.426 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -128.71 100.51 5.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.73 155.39 52.87 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . 0.798 ' OD1' HG23 ' A' ' 882' ' ' THR . 58.3 p30 -116.78 -0.29 12.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.11 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . 0.798 HG23 ' OD1' ' A' ' 881' ' ' ASP . 70.6 p -127.29 158.02 38.32 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -65.24 -32.38 74.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.919 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 885' ' ' GLU . 12.4 m -70.66 -26.27 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.052 0.453 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.466 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.7 mt-10 -98.37 113.5 25.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.944 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.723 ' SD ' HD13 ' A' ' 909' ' ' ILE . 28.0 ttt -84.23 135.77 34.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 90.3 p -82.84 153.87 24.95 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.082 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 878' ' ' PHE . 16.9 p90 -161.9 161.02 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.436 ' HA ' HD22 ' A' ' 877' ' ' ASN . 84.4 mtt85 -100.07 160.52 14.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.569 0.7 . . . . 0.0 112.754 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -58.4 130.24 45.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.24 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.15 1.64 89.53 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -72.17 139.7 48.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.24 141.9 30.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 86.7 mt -132.85 147.96 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.8 m -99.61 129.62 45.77 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.54 119.38 25.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.906 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.36 -53.14 3.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.889 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.12 165.68 17.57 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.814 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . 0.435 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.4 mp0 -98.27 112.82 24.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.454 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.423 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 10.2 p -81.27 -24.6 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.858 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -155.84 174.55 15.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.535 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.17 -32.18 73.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.052 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -113.95 2.06 14.91 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -134.02 151.88 51.61 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.478 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.435 ' CB ' HE21 ' A' ' 899' ' ' GLN . 31.8 p90 -150.94 158.33 44.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.034 0.445 . . . . 0.0 110.429 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -101.1 135.9 41.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.292 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.05 178.21 29.43 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -147.41 157.66 43.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.004 0.43 . . . . 0.0 110.494 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.723 HD13 ' SD ' ' A' ' 886' ' ' MET . 1.5 mp -78.89 135.45 59.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.578 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -45.94 137.81 12.68 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 120.898 1.065 . . . . 0.0 111.377 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 98.93 -10.59 62.22 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.92 34.7 1.07 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.61 0.243 . . . . 0.0 111.084 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.3 t -61.29 -46.49 90.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.638 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -171.34 149.39 2.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.54 144.44 37.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -164.8 170.51 39.91 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.2 pt -116.33 147.9 19.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.154 0.502 . . . . 0.0 111.224 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.0 159.59 29.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.16 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.2 137.64 29.07 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.473 2.116 . . . . 0.0 113.919 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 923' ' ' VAL . 88.3 mt -61.31 -35.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.268 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.488 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 96.4 m -53.92 -42.8 69.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.218 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.7 -0.22 33.2 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.308 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.441 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.9 t -125.18 147.89 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.14 0.495 . . . . 0.0 110.674 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -100.8 121.28 41.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.202 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.11 116.95 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.385 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 47.2 mm -80.23 -47.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.84 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -143.93 133.24 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -71.04 150.1 94.81 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.349 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.66 152.82 59.51 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.087 1.858 . . . . 0.0 112.156 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.383 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 58.19 65.96 1.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.5 mmt -65.92 143.4 57.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.284 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.1 t -148.17 149.83 32.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.71 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 92.46 -7.75 77.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 66.6 m -126.9 143.68 51.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 110.507 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . 0.495 ' O ' ' SD ' ' A' ' 795' ' ' MET . 98.9 mt-10 -135.34 146.06 48.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 794' ' ' GLU . 31.5 mmm -130.15 164.41 24.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -128.89 98.55 24.09 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-O 119.553 -0.261 . . . . 0.0 110.89 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.92 138.69 26.25 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.419 1.413 . . . . 0.0 112.244 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.04 47.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . 0.438 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 75.2 ttt180 -104.89 137.22 43.0 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.296 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.668 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -82.52 121.22 26.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -95.19 -12.86 25.61 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.159 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . 0.402 ' HB2' ' CD2' ' A' ' 846' ' ' TYR . 97.6 m-85 -136.42 141.79 43.63 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.53 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 58.3 p-10 -68.52 150.04 48.52 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 814' ' ' LEU . 90.2 t80 -147.64 128.67 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.432 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.28 130.63 46.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.042 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -63.35 132.3 51.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.419 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -99.69 -32.93 10.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.18 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 810' ' ' LYS . 92.4 m -128.96 138.16 51.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.708 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.505 ' CD1' HH21 ' A' ' 838' ' ' ARG . 0.8 OUTLIER -36.7 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.894 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . 0.499 ' H ' HG22 ' A' ' 808' ' ' THR . 87.9 tttt -60.96 -48.43 81.87 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 808' ' ' THR . 3.2 mt-10 -72.79 165.56 24.61 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 110.621 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.687 ' O ' HD23 ' A' ' 812' ' ' LEU . 0.5 OUTLIER -132.73 155.38 81.26 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.72 146.81 61.6 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.927 1.751 . . . . 0.0 111.542 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.843 HD11 HG11 ' A' ' 820' ' ' VAL . 2.6 tp -140.75 132.4 27.21 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 35.3 tp60 -96.36 147.54 23.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.971 0.415 . . . . 0.0 110.808 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -64.01 36.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 176.17 19.16 0.02 OUTLIER Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.111 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -93.54 168.91 10.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.515 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.432 ' O ' ' ND1' ' A' ' 835' ' ' HIS . 35.8 mm -108.76 136.16 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.843 HG11 HD11 ' A' ' 814' ' ' LEU . 25.7 m -129.95 151.47 35.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -116.9 115.73 26.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.848 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 94.2 mt -74.92 134.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 823' ' ' TYR . 1.8 p90 -128.7 -5.24 5.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 0.0 110.264 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -170.32 125.31 0.75 Allowed 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.5 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -80.32 125.85 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.713 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 5.5 mm -78.49 -52.84 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.12 175.92 9.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.906 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -60.1 -18.48 47.38 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.28 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -115.01 -52.25 2.7 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.043 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . 0.414 ' HE1' ' HG3' ' A' ' 843' ' ' PRO . 23.2 m-90 -70.52 151.35 45.17 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 849' ' ' LEU . 62.8 m-85 -131.01 148.62 52.77 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.957 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.21 135.2 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -153.47 -177.59 27.14 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -110.48 141.38 43.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.803 0.335 . . . . 0.0 110.949 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.664 ' HB2' HG12 ' A' ' 820' ' ' VAL . 81.6 t60 -164.49 135.54 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.928 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 46.8 t-80 62.92 31.5 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.236 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.46 18.71 78.54 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . 0.505 HH21 ' CD1' ' A' ' 809' ' ' LEU . 12.2 tpt180 -136.5 154.55 50.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.33 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 833' ' ' GLY . 13.8 p -129.0 141.75 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.632 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -168.38 -140.55 2.96 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.188 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 39.3 pt -131.25 152.84 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.793 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 847' ' ' ILE . 3.5 p90 -156.92 127.91 3.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.61 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.414 ' HG3' ' HE1' ' A' ' 830' ' ' TRP . 50.1 Cg_exo -54.62 137.6 73.86 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.446 1.431 . . . . 0.0 111.994 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.51 -29.24 68.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.643 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 79.1 p -69.83 -15.66 63.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.392 . . . . 0.0 110.83 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 802' ' ' PHE . 0.6 OUTLIER -93.35 -2.24 55.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.76 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 800' ' ' ALA . 29.8 pt -137.4 173.12 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.237 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 851' ' ' PRO . 11.3 tm-20 -124.14 106.32 10.24 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.769 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.402 HD11 ' CE2' ' A' ' 831' ' ' TYR . 17.9 mt -59.95 113.78 2.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.94 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 1.5 mt 46.5 82.18 0.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.084 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . 0.529 ' N ' ' OE1' ' A' ' 848' ' ' GLU . 73.0 Cg_endo -78.11 159.46 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 122.185 1.923 . . . . 0.0 112.015 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 146.48 55.41 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.463 2.108 . . . . 0.0 112.041 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -125.15 -11.71 6.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.517 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -80.84 142.5 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.752 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -118.64 122.42 42.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.269 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -142.82 40.92 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.613 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -130.07 65.47 75.51 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.728 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.5 145.74 38.23 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.392 2.061 . . . . 0.0 112.088 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 146.13 48.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.646 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . 0.529 ' C ' HD12 ' A' ' 861' ' ' LEU . 65.0 tttp -143.28 129.35 19.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.38 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 860' ' ' LYS . 8.7 mp -118.93 128.29 54.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.459 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 4.2 t -153.19 143.95 15.86 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.02 149.08 64.71 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.99 1.793 . . . . 0.0 112.207 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.23 -45.5 98.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -76.0 150.84 37.34 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.55 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.5 t -113.34 124.88 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.345 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.54 97.82 7.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.563 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -137.6 132.83 33.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.284 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -115.52 139.35 50.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.447 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -70.7 155.51 52.93 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -124.35 153.84 41.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.85 146.56 22.06 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 38.9 mm -117.08 121.91 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.47 125.92 25.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.479 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -72.61 -36.96 68.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.978 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -132.94 151.04 52.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.773 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -55.25 145.85 20.55 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -150.9 135.96 17.54 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.25 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -133.43 116.26 15.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.482 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -75.0 145.47 33.66 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.98 -2.22 43.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.739 0.304 . . . . 0.0 110.71 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 58.8 p -133.6 163.83 28.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.874 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -61.31 -39.19 89.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.177 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 57.4 t -60.21 -43.67 93.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.629 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.454 ' O ' ' NH2' ' A' ' 914' ' ' ARG . 80.2 mm-40 -76.41 144.87 39.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.808 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 17.6 ttm -98.5 152.08 19.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.43 ' H ' ' HD3' ' A' ' 914' ' ' ARG . 34.6 t -121.25 127.9 51.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.46 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.26 161.79 42.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.56 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.1 mtm-85 -102.68 165.37 11.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.903 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.7 138.15 58.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.307 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.52 0.15 89.3 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.007 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 78.9 mm-40 -81.01 147.12 30.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.105 0.452 . . . . 0.0 110.253 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -95.35 132.47 40.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.1 0.476 . . . . 0.0 111.041 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.66 147.21 22.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.973 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.2 m -98.44 127.79 44.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.098 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 23.7 mt -92.25 126.51 37.36 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.727 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 86.0 mt -105.56 -48.47 3.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.545 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -160.53 154.34 22.61 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.166 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . 0.53 ' OE1' ' CD2' ' A' ' 905' ' ' TYR . 2.0 mp0 -89.94 113.91 25.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.773 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 917' ' ' ILE . 62.2 t -65.1 -39.91 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -156.11 -176.71 6.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.314 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.94 -37.24 86.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 920' ' ' ILE . 12.8 t-20 -102.83 -4.29 25.09 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -112.55 151.96 29.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.98 0.419 . . . . 0.0 111.666 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.53 ' CD2' ' OE1' ' A' ' 899' ' ' GLN . 1.5 m-85 -140.5 137.04 33.53 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.218 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -104.86 135.61 45.9 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.85 -178.94 32.36 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.587 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.521 ' NH2' ' OG1' ' A' ' 912' ' ' THR . 17.3 ptm180 -148.22 158.02 43.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.507 -0.346 . . . . 0.0 110.364 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 79.2 mt -93.89 138.73 22.63 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -49.13 141.08 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.366 1.377 . . . . 0.0 111.807 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 92.91 -6.64 76.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.521 ' OG1' ' NH2' ' A' ' 908' ' ' ARG . 1.4 m 68.83 32.96 3.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.637 0.256 . . . . 0.0 110.853 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.3 m -62.33 -42.48 99.41 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.454 ' NH2' ' O ' ' A' ' 885' ' ' GLU . 77.6 ttt180 -166.69 144.65 5.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.184 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -127.55 142.83 51.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.075 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 177.56 -173.77 46.39 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.419 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 900' ' ' VAL . 39.6 pt -111.69 155.4 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.143 0.496 . . . . 0.0 111.117 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -156.35 151.21 20.77 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.13 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.28 144.57 51.66 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.223 1.948 . . . . 0.0 113.68 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 903' ' ' ASN . 87.5 mt -60.53 -37.52 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.37 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.479 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -56.06 -39.54 72.19 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.07 -1.1 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.22 159.62 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.67 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -108.75 127.24 53.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.186 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 75.9 t -101.47 101.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -65.55 -45.77 91.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -135.83 150.58 49.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -103.54 148.61 36.01 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.958 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.54 152.15 65.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.162 1.908 . . . . 0.0 112.232 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . 0.688 ' H ' HD12 ' A' ' 930' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.589 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -137.99 31.08 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.6 mtm -71.79 138.51 48.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.754 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 99.8 p -97.38 1.36 49.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.551 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 793' ' ' SER . . . -64.6 81.4 0.06 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 792' ' ' GLY . 1.5 p 76.76 122.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -91.0 -4.47 56.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.499 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -152.37 164.01 38.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.596 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -130.81 94.34 28.95 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.373 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.27 138.29 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.989 1.793 . . . . 0.0 111.786 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -130.38 153.3 48.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -118.83 135.62 54.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.781 0.324 . . . . 0.0 110.272 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 814' ' ' LEU . . . -76.57 111.37 11.98 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -66.72 -35.28 79.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.068 0.461 . . . . 0.0 109.79 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -144.12 175.35 10.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.538 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 65.2 t0 -78.56 120.51 23.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.48 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -115.05 123.63 49.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.66 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.9 142.11 28.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.384 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -69.65 140.58 53.66 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.302 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -109.39 -31.74 7.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.05 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 63.7 p -129.41 171.01 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.376 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.81 -41.72 96.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.41 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.95 -38.35 90.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 110.395 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.563 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 31.9 tt0 -80.17 122.98 27.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.463 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.1 mp -107.19 154.37 40.52 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.446 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.17 146.82 71.39 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.904 1.736 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.692 HD23 ' CE1' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -125.91 153.18 44.59 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -126.73 138.34 53.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.57 0.7 . . . . 0.0 110.926 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.09 125.42 10.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.277 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.65 -28.74 14.53 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.489 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 66.8 t0 -57.67 135.2 56.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.007 0.432 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.513 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 38.7 mm -99.15 133.51 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 798' ' ' ALA . 22.1 m -125.09 151.12 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.055 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 76.9 m-85 -109.28 113.7 26.75 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.371 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 96.5 mt -82.03 130.95 34.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.687 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -104.51 -38.46 6.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.793 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -156.14 155.16 32.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.557 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 42.4 tt0 -82.84 130.73 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.553 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 7.5 mm -81.38 -46.23 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 109.63 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 3.5 t70 -148.11 178.77 8.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.046 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -61.43 -36.09 79.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -109.57 11.75 24.67 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -132.51 143.0 49.45 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -125.01 150.96 46.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.302 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.28 141.22 51.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -165.94 -175.14 36.11 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -102.31 140.7 36.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.037 0.446 . . . . 0.0 110.748 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -151.47 141.99 22.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 50.1 t-80 48.24 31.36 2.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.93 16.23 80.81 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.818 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -132.88 157.46 45.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.66 0.267 . . . . 0.0 111.065 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.12 129.17 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.087 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -154.78 -156.12 7.58 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.447 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.7 pp -124.54 154.73 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 117.347 0.573 . . . . 0.0 110.173 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.692 ' CE1' HD23 ' A' ' 814' ' ' LEU . 3.8 m-85 -148.4 126.61 5.93 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.748 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.64 125.39 16.73 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.073 1.182 . . . . 0.0 111.81 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -54.6 -20.32 7.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.56 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.8 p -77.06 -12.55 59.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.11 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.95 -3.92 24.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.247 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.9 pt -136.03 171.97 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.559 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 86.9 tt0 -114.23 160.51 18.94 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 18.4 mt -108.84 100.52 9.72 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 53.8 tp 49.03 79.07 0.36 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.694 -0.403 . . . . 0.0 110.86 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.25 153.53 45.96 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.623 2.215 . . . . 0.0 111.443 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.51 65.08 1.66 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.174 1.916 . . . . 0.0 112.034 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -150.47 144.82 25.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.162 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -106.07 -45.81 4.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 856' ' ' ALA . 55.6 mtpt 37.83 -148.69 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.512 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 855' ' ' LYS . . . 176.31 -103.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.783 0.325 . . . . 0.0 110.25 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . 0.447 ' O ' ' OE1' ' A' ' 857' ' ' GLN . 3.2 tm0? -141.36 75.93 22.07 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.29 144.39 95.95 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.085 2.523 . . . . 0.0 112.538 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -116.79 145.48 43.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.545 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.12 140.05 52.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.31 157.12 17.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 95.0 m -82.53 122.89 79.04 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.16 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.05 157.71 42.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.884 1.723 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.69 161.19 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.145 0.498 . . . . 0.0 110.95 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 867' ' ' LEU . 19.2 pt20 -156.28 171.59 19.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.83 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 8.3 p -49.38 -25.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.443 ' H ' ' HG3' ' A' ' 865' ' ' GLN . 27.8 mt 55.89 -102.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -67.55 132.32 47.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.51 150.19 25.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.461 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -71.04 167.18 51.79 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -127.92 155.39 44.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 110.502 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -160.82 146.64 14.71 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 91.0 mt -122.4 130.49 74.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.006 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . 0.701 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -53.45 125.32 17.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.867 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -70.5 -40.91 73.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.431 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 877' ' ' ASN . 0.1 OUTLIER -145.09 148.86 34.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.64 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 98.7 m-20 -41.72 132.46 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.292 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.404 ' CD1' ' C ' ' A' ' 878' ' ' PHE . 46.4 t80 -134.57 131.13 37.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.616 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -123.43 117.84 26.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -84.43 -179.58 51.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 882' ' ' THR . 24.5 p30 -130.81 -40.18 1.21 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 881' ' ' ASP . 65.3 p -86.32 163.46 17.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -64.97 -34.39 78.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.06 0.457 . . . . 0.0 110.149 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 75.2 t -64.18 -41.04 91.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.661 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.434 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 45.1 tp10 -81.38 130.97 35.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.152 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 14.6 mmt -101.33 164.66 11.67 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.398 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.423 ' C ' ' CG ' ' A' ' 888' ' ' PHE . 35.5 t -127.23 146.18 50.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.198 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.47 177.8 7.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.165 -179.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -113.15 163.57 14.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.291 0.567 . . . . 0.0 111.503 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.55 139.88 52.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.811 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.39 -8.23 77.39 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -75.89 138.46 41.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.244 0.522 . . . . 0.0 110.285 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.8 mtm180 -81.46 143.33 32.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.116 0.484 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 872' ' ' ALA . 88.7 mt -130.29 138.32 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.685 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.5 m -97.35 128.87 44.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.783 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.12 119.83 27.76 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.644 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 908' ' ' ARG . 90.2 mt -99.23 -49.98 4.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -167.0 165.16 15.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.432 . . . . 0.0 111.147 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . 0.441 HE21 ' CB ' ' A' ' 905' ' ' TYR . 6.7 mp0 -99.41 115.71 29.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.535 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.4 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 32.7 m -82.34 -25.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -159.77 173.75 15.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.83 -38.58 88.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -106.28 3.06 27.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -133.4 151.25 51.81 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.876 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.441 ' CB ' HE21 ' A' ' 899' ' ' GLN . 28.1 p90 -150.97 158.61 44.35 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.002 0.43 . . . . 0.0 110.581 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.528 ' OE2' ' NE2' ' A' ' 915' ' ' GLN . 88.4 tt0 -99.13 133.29 43.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.719 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.74 173.84 29.39 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.517 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.417 ' HD3' HD11 ' A' ' 897' ' ' LEU . 40.5 ptt180 -154.31 160.59 41.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.275 -0.463 . . . . 0.0 110.097 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.503 ' CD1' ' NH2' ' A' ' 914' ' ' ARG . 84.5 mt -74.54 138.83 74.26 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -47.99 -14.03 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.395 1.397 . . . . 0.0 112.456 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -87.09 0.33 85.93 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.465 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 30.6 p 54.63 8.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 111.141 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 911' ' ' GLY . 89.5 p -71.88 -30.42 65.39 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.503 ' NH2' ' CD1' ' A' ' 909' ' ' ILE . 96.4 mtm-85 -139.47 149.75 44.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.853 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.528 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 66.4 tt0 -147.96 140.91 24.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.507 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.38 -178.19 47.6 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.504 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 46.3 pt -114.8 146.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.504 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -156.87 159.78 31.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.62 -179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.29 137.96 35.08 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.502 2.135 . . . . 0.0 114.21 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.06 -36.69 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.835 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.0 m -57.52 -44.69 85.29 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . 0.697 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -70.82 0.66 6.72 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.057 -179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.3 m -130.48 156.96 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.481 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -107.1 127.24 53.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.168 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 86.0 t -84.69 119.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.256 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 30.2 mm -91.36 -48.01 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.627 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.05 146.86 50.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -70.55 148.83 95.41 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.405 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -22.76 42.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.213 1.942 . . . . 0.0 112.02 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.534 -179.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -68.22 -18.59 64.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.761 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 67.4 mtt -69.36 -27.06 65.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 70.7 m -56.92 141.84 43.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.029 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -127.46 -32.72 0.65 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.2 t -65.54 139.82 58.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.629 0.252 . . . . 0.0 110.561 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -112.97 124.24 52.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.654 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -161.26 157.57 25.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.826 ' CZ ' HD21 ' A' ' 849' ' ' LEU . 78.0 mtp180 -135.97 131.35 18.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.43 146.07 30.76 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 111.919 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.499 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -148.11 157.3 43.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . 0.465 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 73.8 ttt180 -122.96 131.15 53.6 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.611 ' CB ' HD12 ' A' ' 814' ' ' LEU . . . -76.57 123.13 25.62 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -94.06 -16.05 24.19 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.262 0.553 . . . . 0.0 110.046 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -135.4 139.7 44.38 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.517 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.3 p30 -73.88 154.73 39.32 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.491 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -139.88 114.92 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -79.04 130.98 36.1 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -75.52 131.02 39.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.74 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -108.39 -26.4 10.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.25 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.3 p -134.74 170.34 15.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.941 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.7 mp -61.12 -37.43 82.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 98.3 mttt -60.23 -38.79 84.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.01 148.18 22.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.246 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.3 pt? -125.23 156.33 69.96 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . 0.555 ' O ' HD22 ' A' ' 814' ' ' LEU . 50.6 Cg_endo -70.44 141.53 42.7 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.319 1.346 . . . . 0.0 112.155 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.611 HD12 ' CB ' ' A' ' 800' ' ' ALA . 0.3 OUTLIER -141.05 143.18 34.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.719 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . 0.598 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 62.4 tt0 -103.95 143.03 33.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.341 0.591 . . . . 0.0 110.322 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -61.06 37.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.444 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 173.16 21.12 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 835' ' ' HIS . 3.7 m-20 -97.28 161.21 13.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 33.6 mm -101.5 130.4 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 2.1 p -129.63 136.88 58.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.179 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.7 m-85 -95.86 121.1 37.23 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.943 0.402 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.435 HD13 ' CD2' ' A' ' 831' ' ' TYR . 71.7 mt -87.1 136.26 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -98.74 -39.35 8.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.745 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 26.0 pttm -159.25 155.98 27.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.046 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.728 HE21 ' N ' ' A' ' 827' ' ' ASP . 3.1 tm0? -82.6 118.93 23.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.53 -46.65 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.728 ' N ' HE21 ' A' ' 825' ' ' GLN . 6.3 t0 -150.32 179.38 8.17 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.33 -38.41 83.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.629 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -111.66 13.54 21.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.803 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -131.59 143.59 50.45 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.268 0.556 . . . . 0.0 112.091 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.435 ' CD2' HD13 ' A' ' 822' ' ' ILE . 35.1 m-85 -134.02 152.2 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.707 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 4.2 tt0 -123.1 134.71 54.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.39 178.5 36.4 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -107.91 148.83 29.09 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 111.033 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.542 ' NE2' ' OD2' ' A' ' 818' ' ' ASP . 83.5 t60 -169.69 137.47 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.088 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 18.6 t60 58.53 32.94 22.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.305 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.83 16.58 79.28 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -132.7 154.88 49.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.115 0.483 . . . . 0.0 111.324 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.6 134.9 49.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -160.69 -140.91 2.99 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.4 pt -135.46 154.3 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.71 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.418 ' CD2' HG21 ' A' ' 847' ' ' ILE . 9.2 p90 -157.99 150.68 18.08 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.99 143.8 45.83 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.148 1.898 . . . . 0.0 113.459 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.47 -35.56 72.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.065 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 76.3 p -63.22 -16.06 59.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.121 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -94.66 -2.66 50.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.407 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.499 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.3 pp -142.13 165.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.738 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.98 118.0 22.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.083 0.468 . . . . 0.0 110.459 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.826 HD21 ' CZ ' ' A' ' 796' ' ' ARG . 60.0 tp -69.81 113.98 7.57 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.368 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 29.4 tp 56.75 73.96 0.74 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.15 165.52 29.98 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.947 1.764 . . . . 0.0 111.719 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.6 134.44 33.26 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.851 1.701 . . . . 0.0 112.145 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -151.97 38.92 0.6 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.967 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -63.19 -39.76 95.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.51 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 856' ' ' ALA . 46.4 mmtm 53.45 44.17 30.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 855' ' ' LYS . . . 68.48 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 45.43 66.18 5.59 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.467 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.13 138.48 71.36 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.535 2.157 . . . . 0.0 112.227 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -117.8 12.06 13.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.191 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -93.22 20.99 6.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 58.2 tp 52.16 91.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.505 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 11.7 t -151.47 146.36 18.84 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.165 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.08 139.47 42.48 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.53 1.487 . . . . 0.0 111.61 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.663 HG23 ' H ' ' A' ' 865' ' ' GLN . 0.3 OUTLIER -66.81 -83.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.663 ' H ' HG23 ' A' ' 864' ' ' VAL . 98.0 mt-30 -76.87 150.08 36.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.531 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.39 125.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.486 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 87.2 mt -111.27 143.75 41.54 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.349 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.24 143.93 46.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.68 162.98 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -66.96 172.57 29.27 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 871' ' ' GLU . 48.2 mp0 -134.92 146.48 49.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.482 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -147.62 149.88 33.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . 0.421 ' C ' HG13 ' A' ' 923' ' ' VAL . 91.5 mt -123.6 126.38 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 111.255 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.75 113.96 1.87 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -63.64 -37.02 85.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.214 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -129.53 148.13 51.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.323 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -56.81 125.2 21.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -115.19 128.43 56.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.563 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -112.95 109.77 19.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.474 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -75.32 145.24 32.93 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -103.09 -21.57 13.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.831 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.3 p -112.63 159.29 19.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -64.12 -31.26 72.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.343 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 884' ' ' VAL . 8.7 m -71.41 -24.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.435 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -97.91 111.55 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.174 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 6.1 tpt -77.57 159.35 29.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.256 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 99.3 p -123.9 153.27 41.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.935 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -164.18 176.44 9.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -104.16 150.16 24.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.14 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -46.68 133.1 10.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 97.46 -9.05 64.59 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.068 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.0 131.04 45.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.376 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 -76.52 138.07 40.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.71 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 93.7 mt -130.59 144.95 36.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.754 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.0 m -102.03 125.72 48.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.467 HD11 HG13 ' A' ' 925' ' ' VAL . 86.7 mt -79.81 87.37 5.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.693 HD11 ' HG2' ' A' ' 908' ' ' ARG . 92.8 mt -64.06 -44.6 91.95 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.819 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -168.56 162.42 12.03 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.664 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.26 109.6 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.42 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.5 p -74.99 -27.16 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.065 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -158.81 174.89 14.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.32 -36.79 83.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.122 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -109.44 1.84 20.17 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -130.56 148.64 52.38 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.523 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.461 ' CE1' ' O ' ' A' ' 918' ' ' PHE . 28.2 p90 -151.08 156.88 41.98 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.737 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -104.37 130.62 52.22 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -146.99 178.22 24.77 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.835 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.693 ' HG2' HD11 ' A' ' 897' ' ' LEU . 0.3 OUTLIER -149.98 161.26 42.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.991 -0.605 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.468 ' C ' ' H ' ' A' ' 911' ' ' GLY . 78.7 mt -74.97 137.28 72.9 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.24 -11.67 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.297 1.332 . . . . 0.0 112.16 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 909' ' ' ILE . . . -80.91 -4.23 90.48 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.399 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 20.1 p 50.83 34.97 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.349 0.119 . . . . 0.0 111.145 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.3 m -111.61 -26.56 8.96 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.705 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.65 152.52 51.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.913 0.387 . . . . 0.0 111.143 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -149.57 145.98 27.1 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.177 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.23 -179.31 47.49 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.349 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.6 pt -112.16 140.99 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.5 145.11 17.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.062 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.93 142.74 47.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.95 1.766 . . . . 0.0 112.736 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.9 mt -69.9 -8.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.581 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 98.9 m -59.87 -44.47 94.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 923' ' ' VAL . 8.6 p90 -97.7 8.48 44.61 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.855 -178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.482 HG12 ' HB1' ' A' ' 872' ' ' ALA . 11.2 t -122.82 145.2 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 120.85 0.357 . . . . 0.0 110.226 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -102.85 115.36 30.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.076 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 896' ' ' LEU . 97.0 t -84.09 106.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.717 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.33 -46.22 96.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.486 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 926' ' ' ILE . 67.4 mttm -141.22 149.85 41.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.535 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -72.5 153.64 91.8 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.105 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.53 151.73 70.41 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.442 2.095 . . . . 0.0 112.174 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.501 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . 0.429 ' C ' ' H ' ' A' ' 790' ' ' MET . 92.0 mm-40 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.46 ' CG ' ' O ' ' A' ' 789' ' ' HIS . 86.4 t60 58.37 3.16 0.25 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.634 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 788' ' ' GLN . 94.9 mmm -65.52 -39.14 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.381 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 97.1 p -153.08 164.82 37.32 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.863 0.363 . . . . 0.0 111.559 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -168.09 160.19 33.66 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.3 t -65.37 137.43 57.49 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.832 0.349 . . . . 0.0 110.713 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -149.49 134.34 17.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.271 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 66.5 mtt -74.84 146.29 42.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.102 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -127.94 143.09 46.51 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 147.72 34.44 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.896 1.731 . . . . 0.0 112.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -135.47 155.16 50.99 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -121.89 133.67 54.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.757 0.313 . . . . 0.0 110.408 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.484 ' HB2' HD22 ' A' ' 814' ' ' LEU . . . -84.2 121.58 27.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.287 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -74.43 -29.56 61.54 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.976 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.28 173.09 11.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.197 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 51.9 p-10 -89.33 135.69 33.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.14 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -127.08 133.26 50.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.327 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -92.99 139.29 30.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.329 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 811' ' ' GLU . . . -75.43 120.61 21.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -65.95 -41.47 91.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . 0.485 ' H ' ' HG2' ' A' ' 811' ' ' GLU . 72.1 p -136.96 166.21 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.928 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -50.88 -33.34 23.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.28 -39.79 91.7 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.461 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 808' ' ' THR . 0.2 OUTLIER -75.28 172.54 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.458 HD12 ' HD2' ' A' ' 813' ' ' PRO . 12.0 tp -135.7 134.11 20.58 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 812' ' ' LEU . 57.8 Cg_endo -70.93 145.54 50.67 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.106 1.204 . . . . 0.0 111.467 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 820' ' ' VAL . 0.7 OUTLIER -126.31 144.55 50.76 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.92 139.78 51.09 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.261 0.553 . . . . 0.0 110.252 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.08 122.06 7.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.813 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.59 -22.76 38.4 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.308 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.532 ' OD2' ' CE1' ' A' ' 835' ' ' HIS . 35.8 t70 -62.77 140.57 58.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.896 0.379 . . . . 0.0 110.957 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.11 132.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.5 m -123.27 154.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.235 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.441 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 90.7 m-85 -114.07 121.71 44.67 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.772 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 822' ' ' ILE . 3.4 mm -85.6 127.07 40.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.474 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . 0.419 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.3 p90 -120.91 -5.93 9.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.071 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -173.38 129.13 0.44 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.212 0.53 . . . . 0.0 111.478 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -80.66 135.79 36.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.33 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.403 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.2 mm -87.49 -52.18 11.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.857 0.361 . . . . 0.0 110.284 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.527 ' OD1' ' NE2' ' A' ' 828' ' ' GLN . 6.0 t0 -150.51 179.2 8.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . 0.527 ' NE2' ' OD1' ' A' ' 827' ' ' ASP . 4.3 mp0 -60.77 -37.56 82.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -106.04 4.0 28.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -132.81 142.0 48.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.156 0.503 . . . . 0.0 111.354 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.646 ' CZ ' ' CD1' ' A' ' 842' ' ' PHE . 31.3 p90 -136.26 165.59 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.229 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -133.36 140.35 47.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.504 ' O ' HG13 ' A' ' 839' ' ' VAL . . . -158.44 -179.29 33.2 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 821' ' ' TYR . 88.5 tt0 -106.63 144.87 32.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.157 0.503 . . . . 0.0 111.442 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.685 ' HB2' HG12 ' A' ' 820' ' ' VAL . 6.5 t60 -168.52 140.85 2.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.214 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 64.24 19.97 11.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.949 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 82.47 1.41 90.46 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.779 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -124.43 164.21 20.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.103 0.452 . . . . 0.0 110.262 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 833' ' ' GLY . 57.3 t -122.63 132.59 70.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.123 0.487 . . . . 0.0 111.211 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -143.24 -155.25 6.36 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.459 ' CG1' ' OE2' ' A' ' 811' ' ' GLU . 1.4 pp -134.32 155.12 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.088 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.684 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -166.1 160.17 12.72 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.85 121.85 8.28 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.75 2.3 . . . . 0.0 112.734 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 828' ' ' GLN . 48.3 ptt85 -56.4 -22.03 28.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.031 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.07 -8.21 47.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.13 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.43 -0.39 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.625 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 11.7 pt -138.73 174.55 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 52.7 mt-10 -113.38 157.51 21.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -115.2 100.14 7.93 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.027 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 3.0 tt 49.51 61.72 13.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.16 164.9 34.23 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.49 2.127 . . . . 0.0 112.153 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.26 133.54 42.34 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.918 1.745 . . . . 0.0 112.232 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -108.24 -9.03 15.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.472 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.89 135.52 55.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -124.79 148.92 47.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.372 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.87 88.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.83 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -119.33 150.22 49.02 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.321 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.04 154.34 62.64 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.33 2.02 . . . . 0.0 112.448 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -61.5 131.87 51.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -64.16 132.64 51.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.305 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.2 tp 61.79 105.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.69 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 64.0 p -133.16 158.09 76.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.99 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.24 138.4 79.3 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.425 1.417 . . . . 0.0 112.154 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.83 -44.88 99.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.116 0.484 . . . . 0.0 110.22 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -53.62 136.68 38.57 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.915 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 94.0 t -97.72 -55.03 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 869' ' ' TYR . 57.3 tp -137.55 132.75 33.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.088 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 61.1 mp0 -62.29 -40.45 96.32 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.628 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . 0.478 ' O ' ' CD2' ' A' ' 867' ' ' LEU . 97.8 m-85 -127.66 137.09 52.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -80.44 163.37 46.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -118.22 148.83 42.01 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -155.08 147.69 24.24 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.432 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.21 131.66 70.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.518 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.46 135.16 57.2 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.085 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.453 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 55.5 mtmt -87.08 -23.03 25.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.855 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -142.5 144.26 32.9 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -49.36 152.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -143.1 130.8 21.38 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.33 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -128.44 97.28 4.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.721 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -77.44 178.14 52.03 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -131.05 -1.88 4.06 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.213 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 47.6 p -129.58 158.88 38.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -62.82 -27.37 69.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.975 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 885' ' ' GLU . 18.3 m -68.14 -20.65 25.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.956 0.407 . . . . 0.0 110.032 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.526 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.3 mt-10 -108.75 131.48 54.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.132 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 13.5 tpt -109.18 129.78 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.811 0.339 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.7 p -76.35 158.27 31.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.553 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 892' ' ' GLU . 12.9 p90 -168.31 166.08 12.67 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.971 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 891' ' ' GLY . 29.6 mmm-85 -103.67 163.55 12.24 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 53.5 tttp -67.09 58.17 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . 172.84 12.8 0.02 OUTLIER Glycine 0 CA--C 1.532 1.129 0 C-N-CA 119.998 -1.096 . . . . 0.0 112.829 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' A' ' 888' ' ' PHE . 96.8 mt-10 -94.1 151.99 19.09 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.612 0.706 . . . . 0.0 109.736 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -87.46 146.75 25.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.086 0.47 . . . . 0.0 110.5 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.5 mt -133.02 145.59 33.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.821 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 92.9 m -102.35 124.67 48.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.633 HD11 HG13 ' A' ' 925' ' ' VAL . 88.7 mt -82.63 130.72 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.429 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.44 -58.12 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.614 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -163.56 164.66 24.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.943 0.402 . . . . 0.0 110.837 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 115.37 28.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.579 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.427 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 7.2 p -81.45 -27.05 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.734 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 1.6 t70 -156.13 172.53 18.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.973 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.426 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 60.7 mp0 -63.51 -28.84 70.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.023 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . 0.624 ' ND2' ' NE1' ' A' ' 904' ' ' TRP . 16.6 p-10 -117.95 4.05 12.14 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . 0.624 ' NE1' ' ND2' ' A' ' 903' ' ' ASN . 91.7 m95 -132.32 150.23 52.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 121.194 -0.202 . . . . 0.0 110.677 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.489 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.7 p90 -152.97 159.15 42.9 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.176 0.513 . . . . 0.0 110.681 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.7 tt0 -102.39 132.68 48.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.179 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -151.45 169.94 31.02 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -148.47 155.79 41.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.038 0.447 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.27 139.89 87.48 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.85 138.99 20.13 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.937 1.092 . . . . 0.0 111.113 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.564 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.72 -9.65 70.93 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.564 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.78 33.22 2.98 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-O 120.651 0.262 . . . . 0.0 111.031 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.4 t -60.23 -45.46 93.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -163.36 139.66 6.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.791 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.546 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 26.0 tt0 -103.78 149.82 24.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.059 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -166.54 169.48 40.62 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.358 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 906' ' ' GLU . 46.4 pt -123.14 147.17 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.861 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -159.17 166.17 16.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.301 179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.62 137.8 61.13 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.836 1.691 . . . . 0.0 113.487 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.29 -42.22 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.282 0.563 . . . . 0.0 110.42 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.0 m -57.77 -16.97 12.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.33 2.01 54.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.881 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.489 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.2 m -138.86 164.09 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.179 0.514 . . . . 0.0 110.663 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 67.9 t0 -115.04 132.82 56.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.842 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.633 HG13 HD11 ' A' ' 896' ' ' LEU . 99.5 t -104.09 99.86 9.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.538 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.671 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -63.54 -46.34 95.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.207 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . 0.409 ' HG3' HG22 ' A' ' 926' ' ' ILE . 46.8 mtmt -138.13 131.95 31.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.662 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -73.8 149.25 87.89 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.486 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.62 -22.97 50.01 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.129 1.886 . . . . 0.0 112.077 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.424 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -68.01 -17.03 64.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.509 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -65.36 -12.17 49.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.673 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 40.7 t -60.15 140.0 57.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.596 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 101.94 144.76 15.21 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . 0.416 ' O ' ' SD ' ' A' ' 795' ' ' MET . 53.7 m 52.67 35.9 19.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.145 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.08 139.22 58.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.411 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.416 ' SD ' ' O ' ' A' ' 793' ' ' SER . 0.0 OUTLIER -140.43 159.37 42.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.374 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -131.72 148.37 69.72 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.436 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.82 145.83 25.82 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.098 1.866 . . . . 0.0 111.798 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.516 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -140.83 155.59 46.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 78.2 ttt180 -117.99 132.29 56.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.577 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -71.28 117.9 13.4 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.942 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -38.57 86.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.31 0.576 . . . . 0.0 109.466 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -141.83 174.56 10.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.2 p-10 -83.29 138.26 33.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . 0.563 ' CE2' ' OE2' ' A' ' 811' ' ' GLU . 60.5 t80 -129.07 131.46 47.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.661 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -99.22 137.91 37.06 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.037 0.446 . . . . 0.0 111.606 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -65.37 136.09 56.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.336 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . 0.44 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 77.0 mt-30 -109.5 -25.09 10.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.693 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 64.1 p -129.2 167.6 17.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 809' ' ' LEU . 93.0 mt -61.03 -42.53 98.63 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.544 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -63.94 -42.14 97.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.463 . . . . 0.0 109.76 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.563 ' OE2' ' CE2' ' A' ' 804' ' ' PHE . 41.0 tt0 -66.97 131.28 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.931 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 96.1 mt -115.52 150.33 44.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.449 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.26 148.71 68.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.103 1.869 . . . . 0.0 112.824 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.706 HD23 ' CE2' ' A' ' 842' ' ' PHE . 0.2 OUTLIER -133.62 145.7 50.25 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -120.34 143.02 48.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.59 0.709 . . . . 0.0 111.489 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -53.09 124.39 14.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.075 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 99.83 -20.41 49.32 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.583 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.54 140.47 58.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 111.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.8 mm -96.68 131.36 43.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.523 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.1 m -125.97 156.23 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.187 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.451 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.8 m-85 -117.34 116.43 27.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.965 0.412 . . . . 0.0 111.4 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.89 131.93 33.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 823' ' ' TYR . 1.0 OUTLIER -128.52 -4.5 5.35 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.238 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -170.44 125.29 0.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.212 0.529 . . . . 0.0 111.208 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 830' ' ' TRP . 59.9 tp60 -81.54 124.61 29.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.749 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.432 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 5.8 mm -80.79 -52.98 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.62 178.28 9.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.14 -37.85 81.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.4 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -105.91 8.07 32.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.637 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . 0.542 ' O ' ' NE2' ' A' ' 825' ' ' GLN . 5.4 m-90 -140.12 145.19 37.28 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.102 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.744 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 29.4 p90 -140.7 166.28 25.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.946 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -130.61 136.52 48.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.887 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -154.41 -165.44 13.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -118.9 139.16 52.1 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.949 0.404 . . . . 0.0 111.272 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.4 OUTLIER -151.3 148.53 28.28 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.376 179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 86.2 t60 47.87 30.15 1.85 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.263 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 75.25 16.41 80.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.792 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.28 160.22 37.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.015 0.436 . . . . 0.0 111.083 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.38 132.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.921 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -155.46 -154.73 7.04 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 46.8 pt -130.48 149.81 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.986 -0.285 . . . . 0.0 110.913 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.706 ' CE2' HD23 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -151.27 171.75 6.14 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -81.36 124.21 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.846 1.698 . . . . 0.0 113.074 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -57.01 -33.69 67.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.649 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 81.5 p -71.86 -9.99 59.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.739 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -96.51 -1.0 48.11 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.744 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.9 pt -132.85 174.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.11 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.7 mt-10 -113.47 159.87 19.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 60.3 tp -116.13 105.87 13.08 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.463 -0.495 . . . . 0.0 109.695 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 39.0 tp 58.28 74.66 0.6 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.139 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.99 150.99 52.41 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.888 2.392 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.58 146.31 73.25 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.048 1.832 . . . . 0.0 111.716 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -157.46 159.56 37.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.42 -35.72 81.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 64.59 25.2 13.13 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.524 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -104.16 -3.01 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.78 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -132.9 151.51 78.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.737 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.34 153.69 61.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.325 2.017 . . . . 0.0 112.563 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.85 -23.67 67.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.067 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -116.86 128.49 55.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.5 tp -71.98 123.42 22.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.033 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 49.4 p -133.91 76.28 65.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.839 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.451 ' C ' HG23 ' A' ' 864' ' ' VAL . 45.1 Cg_exo -58.0 141.44 96.18 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.878 2.385 . . . . 0.0 111.901 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 865' ' ' GLN . 1.8 t 61.92 -139.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.351 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.634 ' HG3' HG23 ' A' ' 866' ' ' VAL . 19.7 pt20 29.12 -149.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.652 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.634 HG23 ' HG3' ' A' ' 865' ' ' GLN . 84.4 t 41.33 92.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.798 0.333 . . . . 0.0 110.467 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 141.13 41.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.485 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 868' ' ' GLU . 46.2 mp0 -122.31 -163.4 1.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.696 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -60.62 153.53 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.389 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -65.43 170.77 26.23 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -129.31 153.81 47.47 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.736 0.303 . . . . 0.0 110.473 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.95 150.34 28.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.45 125.49 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . 0.534 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -62.66 128.57 36.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.415 ' O ' ' NZ ' ' A' ' 890' ' ' LYS . 12.8 mtmt -74.49 -37.89 63.02 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.651 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -130.61 153.79 48.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.232 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -52.64 152.57 3.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.458 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 58.2 t80 -146.59 137.32 24.01 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.571 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -136.59 99.69 4.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.811 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.81 156.52 50.71 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -118.82 2.23 11.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.736 0.303 . . . . 0.0 110.53 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 69.7 p -132.52 162.37 31.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.99 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.11 -40.28 97.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.34 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.422 HG23 ' HG2' ' A' ' 885' ' ' GLU . 9.7 m -62.34 -32.4 54.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.791 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.422 ' HG2' HG23 ' A' ' 884' ' ' VAL . 81.1 mm-40 -83.34 146.24 28.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.105 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 67.0 ttp -105.54 130.96 53.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.72 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 92.8 p -88.86 131.52 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.024 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.458 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 43.9 p90 -158.62 164.11 36.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.484 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.448 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 25.2 mmt85 -117.68 162.02 18.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.235 0.54 . . . . 0.0 111.567 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 65.4 tttp -56.84 136.98 55.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.221 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.78 88.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.041 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 76.2 mm-40 -82.62 147.26 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.994 0.397 . . . . 0.0 110.461 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -84.19 141.2 31.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.988 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -129.54 139.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.4 m -103.22 126.15 50.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.433 HD11 HG13 ' A' ' 925' ' ' VAL . 88.6 mt -82.69 125.22 30.98 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.56 -28.87 9.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.314 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -179.68 141.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -88.91 113.47 24.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.16 -43.89 91.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.0 110.373 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -160.72 -179.69 7.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.259 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.3 pt-20 -62.64 -22.77 66.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.26 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -117.82 13.83 14.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.653 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -140.37 149.67 42.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.2 138.08 29.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.433 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -100.61 132.54 45.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.5 179.03 35.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.327 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -148.86 156.48 42.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.315 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 92.2 mt -84.25 142.43 40.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -48.87 138.99 25.89 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.952 1.101 . . . . 0.0 111.191 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.59 71.23 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 66.92 29.59 8.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.234 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.7 m -62.19 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.616 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -143.52 154.45 43.63 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.005 0.431 . . . . 0.0 111.459 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -144.96 138.77 27.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.045 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.45 -169.91 43.03 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 47.3 pt -111.49 159.33 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.094 0.473 . . . . 0.0 111.617 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -160.07 152.75 17.72 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.746 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.44 137.19 45.94 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.568 1.512 . . . . 0.0 112.268 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.758 ' O ' HG22 ' A' ' 923' ' ' VAL . 6.3 mt -54.69 -76.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.567 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 920' ' ' ILE . 22.4 m -25.53 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 920' ' ' ILE . 1.6 m-85 -72.22 1.49 7.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 920' ' ' ILE . 33.8 m -135.31 158.96 40.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.063 0.459 . . . . 0.0 111.479 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -104.37 118.32 36.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.429 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.433 HG13 HD11 ' A' ' 896' ' ' LEU . 73.0 t -95.03 101.49 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.806 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.6 mp -70.36 -43.18 78.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.273 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -133.04 139.63 47.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.71 86.82 45.6 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.437 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.67 155.94 39.95 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.31 2.007 . . . . 0.0 112.509 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.614 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -101.18 8.3 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.418 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 22.7 mmt 57.13 23.01 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.495 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 86.6 p -71.86 -16.72 62.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.685 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -86.96 -0.58 85.51 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 74.3 m -61.53 -40.84 96.12 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.563 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 39.98 -157.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.452 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 19.1 mmm -71.48 -64.47 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.999 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -154.07 105.22 2.45 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.41 139.77 18.73 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 C-N-CA 121.785 1.657 . . . . 0.0 112.388 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 847' ' ' ILE . . . -136.68 151.23 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -109.18 143.16 38.97 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.65 126.48 31.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . 0.447 ' O ' ' CD ' ' A' ' 816' ' ' LYS . 38.4 ttpt -97.74 -20.13 17.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.826 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -146.76 177.7 8.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.14 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -90.99 178.02 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.768 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 814' ' ' LEU . 29.4 t80 -149.04 132.88 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.671 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -106.19 107.74 18.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -67.13 137.67 56.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.174 0.512 . . . . 0.0 110.857 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -106.55 -23.19 12.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.15 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.08 165.64 19.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.181 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.64 -38.68 85.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.856 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -59.45 -44.15 93.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.46 136.15 51.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.492 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.9 122.47 33.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.889 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 50.6 Cg_exo -55.01 140.64 79.99 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.109 1.206 . . . . 0.0 112.457 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.912 HD13 ' OH ' ' A' ' 846' ' ' TYR . 20.7 mt -128.34 149.75 50.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.593 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -122.5 138.17 54.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.209 0.528 . . . . 0.0 109.956 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 801' ' ' LYS . 36.7 ttpt -46.62 125.32 6.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.089 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 104.45 -24.34 29.07 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.589 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.28 125.88 25.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.985 0.422 . . . . 0.0 110.947 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 23.5 mm -85.93 133.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.09 153.37 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.443 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 77.9 m-85 -109.15 114.86 28.94 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.069 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 31.1 mm -85.6 129.07 38.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.477 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -111.16 -27.91 8.51 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.346 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . 0.458 ' NZ ' ' CD ' ' A' ' 832' ' ' GLU . 25.7 pttm -158.9 156.14 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.345 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 61.9 tt0 -94.49 110.43 22.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.569 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.3 mm -61.4 -47.03 95.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.324 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 7.3 t0 -149.85 178.08 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . 0.483 ' O ' ' CZ ' ' A' ' 844' ' ' ARG . 99.1 mm-40 -59.99 -37.61 80.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.455 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -108.51 0.55 20.96 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -123.97 134.1 53.56 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.883 0.373 . . . . 0.0 111.539 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 160.13 23.78 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.458 ' CD ' ' NZ ' ' A' ' 824' ' ' LYS . 20.9 tt0 -128.86 140.55 51.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.584 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.87 -177.69 36.08 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -107.05 141.74 37.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.046 0.451 . . . . 0.0 111.353 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.479 ' O ' ' CD2' ' A' ' 835' ' ' HIS . 0.3 OUTLIER -149.9 144.71 26.09 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.52 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 51.2 t-80 50.02 30.37 4.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.1 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.29 18.41 79.82 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -133.03 156.33 47.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.385 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.77 145.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.289 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -169.71 -162.34 21.8 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 841' ' ' ILE . 27.3 pt -128.22 159.39 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -166.8 154.56 8.93 Favored Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.064 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 845' ' ' THR . 51.9 Cg_endo -69.71 115.66 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.352 2.035 . . . . 0.0 112.66 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . 0.483 ' CZ ' ' O ' ' A' ' 828' ' ' GLN . 37.9 ptt180 -51.93 -6.19 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.552 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 843' ' ' PRO . 1.6 t -80.86 -5.83 57.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.616 -0.434 . . . . 0.0 112.089 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . 0.912 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -106.37 -1.22 23.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.921 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.649 HG23 ' CE2' ' A' ' 846' ' ' TYR . 45.1 pt -126.76 175.68 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.838 0.351 . . . . 0.0 111.371 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.506 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 99.3 mt-10 -114.0 160.01 19.32 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.4 tp -111.75 101.62 9.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 51.8 tp 55.04 76.23 0.53 Allowed Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.581 -0.447 . . . . 0.0 109.988 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.54 152.19 56.92 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.688 2.258 . . . . 0.0 111.664 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.17 148.32 74.62 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.221 1.947 . . . . 0.0 111.869 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . 0.56 ' HB3' ' HE3' ' A' ' 855' ' ' LYS . . . -154.06 159.19 41.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -71.05 9.56 0.7 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.006 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.56 ' HE3' ' HB3' ' A' ' 853' ' ' ALA . 16.5 ptpt -55.07 -23.36 19.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -100.32 134.28 43.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.516 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -132.44 78.46 67.7 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.565 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.37 144.02 96.84 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.836 2.357 . . . . 0.0 112.258 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.02 -7.92 58.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.182 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -61.94 -39.63 92.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.597 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 85.8 mt -103.11 114.1 28.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.471 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 862' ' ' THR . 95.2 m -131.98 65.34 75.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.579 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.41 147.7 47.27 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.32 2.013 . . . . 0.0 112.075 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.74 -57.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.475 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -109.46 132.03 54.51 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.879 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.93 -2.81 9.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.608 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 60.5 tp -76.96 125.33 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.218 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 55.87 44.74 25.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.917 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -130.58 123.31 29.24 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -149.37 176.78 27.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -136.1 141.83 44.24 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 0.0 110.496 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -150.87 155.52 39.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 57.1 mt -126.66 131.09 71.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 0.0 110.641 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -58.92 123.04 15.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.458 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -69.26 -37.33 77.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.959 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.3 151.06 50.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.361 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.407 HD21 ' NH1' ' A' ' 889' ' ' ARG . 59.2 t-20 -57.48 131.86 51.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -127.14 128.74 46.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.59 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.32 108.15 18.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.759 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . 0.517 ' H ' ' CB ' ' A' ' 887' ' ' SER . . . -65.83 142.46 43.58 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 56.4 t0 -100.56 -22.62 14.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.68 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 61.0 p -130.97 165.74 22.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.03 0.443 . . . . 0.0 111.123 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.78 -37.56 82.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.563 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.32 -43.37 89.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.394 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -91.06 103.54 16.23 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.492 ' CE ' ' O ' ' A' ' 887' ' ' SER . 2.0 tmt? -71.28 131.55 43.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.517 ' CB ' ' H ' ' A' ' 880' ' ' GLY . 83.2 p -80.13 154.19 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 0.0 110.986 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.01 160.05 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.593 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.445 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 75.7 mtp85 -105.78 165.32 11.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.003 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.63 136.2 56.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.191 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 92.58 -6.61 77.6 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.9 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 72.9 mm-40 -74.04 141.73 45.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.462 0.631 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -89.6 139.22 30.76 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.212 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.78 149.42 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.514 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.1 m -100.13 127.9 46.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.64 118.79 24.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.18 -46.58 5.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -163.41 156.01 18.29 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.936 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -98.94 118.68 36.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.323 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.46 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.9 t -61.48 -45.63 98.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.585 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 902' ' ' GLU . 13.3 p30 -153.68 -104.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.335 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 901' ' ' ASP . 99.0 mt-10 -121.71 -38.43 2.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.137 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -113.37 9.36 18.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.704 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -134.03 147.46 50.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.164 -0.214 . . . . 0.0 110.783 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.46 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 14.7 p90 -157.72 163.81 37.76 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -115.96 142.19 47.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.166 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.45 178.86 31.01 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -149.48 158.97 44.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.494 -0.353 . . . . 0.0 110.331 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.547 HG22 ' H ' ' A' ' 911' ' ' GLY . 50.4 mm -65.86 137.86 96.23 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 -11.64 15.21 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.697 1.598 . . . . 0.0 112.531 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.547 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.69 -3.0 89.8 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 57.7 p 53.93 65.97 1.36 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.208 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 74.4 m -131.46 -38.49 1.18 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.443 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.24 157.5 46.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.859 0.362 . . . . 0.0 111.329 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -142.81 146.42 34.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.51 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.71 176.52 45.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.507 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.49 ' C ' ' CD1' ' A' ' 918' ' ' PHE . 42.5 pt -115.52 145.0 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 111.493 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -155.68 159.43 31.62 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.566 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.03 139.11 32.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.697 2.264 . . . . 0.0 113.828 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.448 ' HA ' HG22 ' A' ' 923' ' ' VAL . 89.7 mt -64.18 -37.81 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.517 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 74.4 p -53.04 -24.13 9.09 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.891 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.07 2.26 55.16 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 920' ' ' ILE . 4.8 m -131.38 158.15 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.118 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -107.31 127.13 53.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.033 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.86 125.38 42.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.265 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 926' ' ' ILE . 1.7 mp -92.88 -53.41 8.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.364 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.64 126.47 32.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -70.7 148.0 94.73 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.18 -20.65 37.29 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.214 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.46 179.902 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -60.3 -46.22 90.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -60.77 159.34 11.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.551 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 46.8 t -139.75 149.97 44.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.491 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.7 96.08 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.6 t -134.22 132.79 40.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.533 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -134.3 145.82 49.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.528 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 23.3 ptp -148.76 157.74 43.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.666 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -131.56 96.69 20.55 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.37 140.15 93.35 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.898 1.732 . . . . 0.0 111.826 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -139.85 156.02 46.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.087 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -114.48 139.82 49.23 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.78 131.72 35.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.13 0.491 . . . . 0.0 110.764 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 802' ' ' PHE . 17.2 mmmt -98.27 -13.23 20.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . 0.522 ' CD1' ' O ' ' A' ' 801' ' ' LYS . 47.9 m-85 -152.18 166.79 30.62 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 112.091 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 36.0 t70 -86.61 129.8 34.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.072 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -127.81 116.47 20.24 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 110.109 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.21 142.46 31.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.578 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -82.56 122.53 28.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.641 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -95.74 -25.48 16.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.898 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 72.5 p -134.85 169.67 17.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.682 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.37 -37.62 84.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.108 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . 0.487 ' O ' ' CA ' ' A' ' 840' ' ' GLY . 68.7 mttm -65.11 -12.07 46.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.612 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.412 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 99.6 mt-10 -113.34 140.35 48.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.889 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.6 pt? -117.14 149.62 44.69 Favored Pre-proline 0 N--CA 1.467 0.415 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.66 140.01 38.34 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.556 1.504 . . . . 0.0 111.52 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 846' ' ' TYR . 11.0 mt -137.38 146.66 44.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.675 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -119.08 135.66 54.53 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.336 0.589 . . . . 0.0 110.696 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 816' ' ' LYS . 8.9 ptmm? -42.24 123.23 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.599 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 99.78 -20.76 47.97 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.208 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 67.3 t0 -55.11 139.27 42.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 0.0 110.901 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 41.7 mm -94.95 126.01 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.172 0.511 . . . . 0.0 110.589 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.431 ' CG1' HD21 ' A' ' 814' ' ' LEU . 0.2 OUTLIER -120.21 148.62 23.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.255 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.415 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 83.0 m-85 -108.45 123.2 48.49 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 832' ' ' GLU . 24.2 mm -92.94 129.59 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.923 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.38 -27.6 12.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.475 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -160.43 157.28 27.42 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -93.97 111.29 22.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.4 mm -61.13 -46.9 95.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.156 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.94 178.91 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -59.88 -36.37 76.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.954 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -110.84 -1.65 16.44 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 37.9 m0 -119.9 131.28 55.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.416 ' CD2' HG21 ' A' ' 822' ' ' ILE . 3.0 m-85 -119.3 157.35 28.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.791 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 822' ' ' ILE . 18.0 tt0 -128.29 138.88 52.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.31 -173.18 28.53 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -123.95 155.79 37.53 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.207 0.527 . . . . 0.0 111.456 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.535 ' CD2' ' OD2' ' A' ' 818' ' ' ASP . 0.6 OUTLIER -170.61 131.24 0.89 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.933 178.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.1 t-80 65.9 24.56 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.782 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 80.22 4.11 89.79 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 838' ' ' ARG . 1.7 tpm_? -112.86 141.84 46.22 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 120.974 0.416 . . . . 0.0 110.558 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.59 143.74 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.543 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 810' ' ' LYS . . . -169.53 -139.98 2.85 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 29.9 pt -138.97 162.75 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.462 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -169.72 153.98 5.22 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.831 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 845' ' ' THR . 50.5 Cg_endo -71.11 116.87 4.87 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.946 1.764 . . . . 0.0 112.54 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -51.52 -5.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.399 -0.818 . . . . 0.0 112.217 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 843' ' ' PRO . 81.4 p -82.11 -7.3 59.61 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . 0.914 ' OH ' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -105.41 0.42 26.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.574 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.684 HG23 ' CE2' ' A' ' 846' ' ' TYR . 42.8 pt -130.19 174.81 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.801 0.334 . . . . 0.0 111.507 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.62 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 97.6 mt-10 -116.0 160.05 20.81 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.63 105.25 15.2 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.7 tt 42.57 75.24 0.65 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.178 0.513 . . . . 0.0 110.099 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.82 153.82 47.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.056 2.504 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.11 151.49 72.75 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.412 2.075 . . . . 0.0 111.863 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 854' ' ' GLU . . . -63.24 147.76 50.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 853' ' ' ALA . 18.5 pm0 -49.43 -178.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.845 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt 58.87 38.63 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.098 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -79.93 170.44 16.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.312 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 857' ' ' GLN . 4.4 mp0 -63.74 149.4 92.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.087 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.07 154.91 69.69 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.298 1.999 . . . . 0.0 112.341 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -60.55 -20.0 59.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 66.32 105.25 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 861' ' ' LEU . 0.1 OUTLIER -99.38 -23.57 15.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 861' ' ' LEU . 1.3 p 50.28 68.33 3.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.632 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.49 152.09 59.73 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.207 1.938 . . . . 0.0 112.255 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.639 HG23 ' N ' ' A' ' 865' ' ' GLN . 31.3 m -131.11 -130.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.639 ' N ' HG23 ' A' ' 864' ' ' VAL . 97.0 mt-30 57.51 155.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 867' ' ' LEU . 59.7 t -61.56 -44.95 99.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.608 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 866' ' ' VAL . 3.5 tp 74.37 165.32 0.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.4 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.456 ' CG ' ' OE2' ' A' ' 871' ' ' GLU . 88.4 tt0 53.47 95.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.354 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -83.69 -107.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.823 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -79.75 167.33 51.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . 0.456 ' OE2' ' CG ' ' A' ' 868' ' ' GLU . 79.1 mm-40 -127.53 155.12 44.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.668 0.27 . . . . 0.0 110.537 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.01 27.01 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 46.3 mm -118.7 125.3 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -61.33 133.08 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.711 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 56.8 mtmt -81.95 -38.95 24.42 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 110.904 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -135.41 150.86 49.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.466 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.418 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 45.6 p-10 -45.64 151.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.448 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 75.1 t80 -142.05 131.92 24.36 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.521 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -131.15 103.48 6.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.825 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.55 150.57 45.19 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -100.84 -1.41 34.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.341 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 57.8 p -133.15 162.75 30.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -61.04 -39.25 89.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.796 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.41 -40.74 85.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.752 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.24 108.41 19.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 11.0 mmt -80.42 160.67 25.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.764 0.316 . . . . 0.0 110.787 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.8 p -109.39 149.76 29.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.057 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 29.1 p90 -156.76 161.09 39.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.384 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 42.1 ttm180 -105.24 156.17 18.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.057 0.456 . . . . 0.0 111.14 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -50.44 137.4 19.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.45 -3.82 82.04 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.717 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 67.9 mm-40 -77.01 140.99 40.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.536 0.668 . . . . 0.0 110.746 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.71 142.32 31.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.51 147.02 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.841 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -104.44 128.67 52.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.952 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 85.6 mt -84.11 124.74 31.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.636 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.39 -56.11 2.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.178 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -158.53 153.73 25.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.892 0.377 . . . . 0.0 110.982 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -94.31 114.38 26.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.876 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 69.3 t -70.36 -43.44 78.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.491 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -151.65 -176.93 5.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.914 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.15 -38.66 83.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.242 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -111.6 10.53 21.15 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -133.8 149.47 51.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.446 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.502 ' OH ' HG11 ' A' ' 923' ' ' VAL . 13.8 p90 -154.9 159.41 40.45 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.033 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -105.78 134.95 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.988 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -155.55 175.79 33.32 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.495 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -152.83 159.2 43.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 911' ' ' GLY . 1.7 mp -63.59 135.18 96.15 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.84 -15.53 38.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.229 1.286 . . . . 0.0 112.161 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.673 ' H ' HG22 ' A' ' 909' ' ' ILE . . . -83.87 -4.01 88.95 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 7.1 m 60.13 72.38 0.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 31.4 t -139.36 -39.68 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.972 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 909' ' ' ILE . 88.9 mtm180 -131.25 149.03 52.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.448 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -146.52 143.23 28.78 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.449 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 173.29 -172.32 45.08 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.503 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.5 pt -119.67 148.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.239 0.542 . . . . 0.0 111.134 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.503 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -156.91 162.08 28.31 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.729 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.32 137.59 37.11 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.335 2.024 . . . . 0.0 113.745 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 98.1 mt -63.17 -38.8 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.517 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 71.5 p -55.81 -16.5 4.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -100.66 2.58 41.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.502 HG11 ' OH ' ' A' ' 905' ' ' TYR . 17.0 m -131.57 156.74 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.204 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.48 124.47 48.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.284 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 89.7 t -84.98 130.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.809 0.338 . . . . 0.0 110.246 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 31.2 mm -106.58 -54.69 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.725 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -131.19 147.39 52.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.742 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -73.62 152.96 89.59 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.19 -38.72 51.6 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.852 1.701 . . . . 0.0 112.313 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 40.0 tp . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.578 -179.572 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.42 -47.39 86.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.729 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 65.3 mtt -96.6 -52.18 4.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 48.8 m 46.55 38.18 5.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.85 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -104.0 -173.72 25.45 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 63.0 m -138.5 151.6 47.52 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.672 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 794' ' ' GLU . 48.8 mp0 -98.26 139.65 33.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.127 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.3 mpp? -112.69 156.63 22.44 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.038 0.446 . . . . 0.0 110.941 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -125.76 97.71 35.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.073 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 850' ' ' LEU . 48.6 Cg_exo -57.12 138.03 84.46 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.858 1.706 . . . . 0.0 111.915 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -129.62 151.85 49.78 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -113.99 135.51 53.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.208 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 817' ' ' GLY . . . -77.99 128.76 34.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -96.52 -18.34 19.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.282 0.563 . . . . 0.0 109.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -149.91 172.16 15.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.6 p-10 -90.98 135.27 33.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.045 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -118.46 123.44 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.787 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -89.07 132.29 34.85 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.476 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -80.95 129.09 34.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -105.54 -25.75 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.309 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.8 p -129.29 169.43 14.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.494 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 809' ' ' LEU . 8.2 mp -61.15 -39.99 92.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.66 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.7 -38.75 88.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.609 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 96.9 mt-10 -81.83 126.14 31.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.006 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.455 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.3 mm? -113.9 151.68 44.99 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.51 144.4 66.79 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.84 1.693 . . . . 0.0 113.231 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 820' ' ' VAL . 1.5 tp -137.75 146.54 43.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.046 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.83 137.49 53.37 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.364 0.602 . . . . 0.0 110.876 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . 0.451 ' CG ' ' O ' ' A' ' 816' ' ' LYS . 15.9 ptmt -44.91 122.61 3.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.871 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 98.95 -20.25 51.07 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.419 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.9 t0 -55.75 133.22 50.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.359 . . . . 0.0 110.834 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.451 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 30.9 mm -91.21 128.58 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 798' ' ' ALA . 31.4 m -127.57 155.0 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.521 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 65.5 m-85 -112.09 117.47 32.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.408 HD13 ' HD2' ' A' ' 831' ' ' TYR . 68.4 mt -81.28 125.83 39.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -119.6 -9.3 9.82 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -167.27 131.96 1.95 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.381 0.61 . . . . 0.0 111.367 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.645 HE21 ' N ' ' A' ' 827' ' ' ASP . 10.4 tm0? -83.97 136.78 33.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.846 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.485 ' C ' ' NE2' ' A' ' 825' ' ' GLN . 4.9 mm -91.98 -67.61 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.829 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.645 ' N ' HE21 ' A' ' 825' ' ' GLN . 61.1 m-20 -133.95 176.67 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.18 -35.41 77.07 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.068 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -101.51 -1.03 34.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.268 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -131.86 136.15 47.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.201 0.524 . . . . 0.0 111.082 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.408 ' HD2' HD13 ' A' ' 822' ' ' ILE . 2.8 m-85 -124.76 160.5 28.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.843 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 841' ' ' ILE . 6.3 tt0 -129.84 141.1 50.88 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.12 -176.28 34.03 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -107.27 138.83 42.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 110.506 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 15.2 p-80 -146.07 131.92 19.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.794 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 51.67 37.43 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.616 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.77 78.85 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.73 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.27 152.36 48.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.222 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 92.5 t -115.45 132.67 64.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.258 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -159.55 -165.15 15.96 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 832' ' ' GLU . 46.6 pt -128.38 156.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.844 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.451 ' CD2' ' C ' ' A' ' 841' ' ' ILE . 0.3 OUTLIER -164.09 156.25 14.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.413 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 845' ' ' THR . 40.0 Cg_endo -69.7 117.96 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.979 1.786 . . . . 0.0 112.549 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -49.61 -13.79 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.404 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 843' ' ' PRO . 80.6 p -79.54 -6.66 57.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -103.81 -4.46 23.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.6 pt -135.11 172.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.593 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 77.4 mm-40 -112.98 162.84 15.41 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.0 tp -108.06 104.22 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.33 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.435 HD23 ' C ' ' A' ' 850' ' ' LEU . 2.8 tt 41.53 77.71 0.42 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.89 158.24 25.6 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.643 2.228 . . . . 0.0 111.586 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.87 135.6 28.74 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.678 1.586 . . . . 0.0 111.827 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -68.22 140.59 56.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.081 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -158.02 66.18 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.15 -39.55 94.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.639 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . 52.14 -179.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.402 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -130.14 70.74 82.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.491 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.28 56.37 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.699 2.266 . . . . 0.0 112.041 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -102.95 -43.6 5.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -65.52 -18.76 65.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 85.3 mt -88.6 108.52 19.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 864' ' ' VAL . 82.3 p -149.81 161.01 32.73 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.527 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -54.27 -29.37 56.95 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.484 1.456 . . . . 0.0 112.191 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 862' ' ' THR . 23.2 m -124.58 161.26 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-O 121.006 0.432 . . . . 0.0 111.32 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -135.28 150.02 49.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 87.7 t -120.0 127.11 75.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.578 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 88.5 mt -111.97 142.94 43.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.445 ' OE2' ' NZ ' ' A' ' 927' ' ' LYS . 88.3 tt0 -90.56 132.8 35.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -128.64 151.86 49.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.334 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -70.12 165.47 51.2 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.57 150.3 48.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.947 0.403 . . . . 0.0 110.379 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 896' ' ' LEU . . . -156.38 156.46 33.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 53.3 mt -131.6 132.58 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.464 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -51.23 128.47 22.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -81.05 -41.15 23.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.145 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . 0.519 ' CE1' ' O ' ' A' ' 877' ' ' ASN . 0.2 OUTLIER -149.59 131.88 15.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.024 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 26.2 m120 -26.28 114.82 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.717 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -117.21 129.12 55.73 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.706 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -110.94 118.82 37.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.977 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -73.09 139.37 26.91 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -68.86 -38.93 80.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.0 p -135.36 170.85 15.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.007 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -58.23 -21.59 48.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.6 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.93 -42.67 93.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.7 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 41.5 mp0 -88.15 128.68 35.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.591 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.609 ' SD ' ' CD2' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -78.32 133.0 37.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.0 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.602 ' N ' ' SD ' ' A' ' 886' ' ' MET . 67.3 m -106.37 138.27 42.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.201 0.524 . . . . 0.0 110.862 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.0 OUTLIER -155.69 176.41 12.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.063 179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 96.4 mtm-85 -112.38 158.93 19.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.593 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.706 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 65.1 tttp -47.25 144.09 2.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.983 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 85.18 -3.38 87.3 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.258 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 12.0 mm-40 -76.72 144.29 39.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -91.07 139.87 30.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.61 142.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.925 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.4 m -94.93 126.61 40.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 872' ' ' ALA . 91.5 mt -86.7 126.85 34.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.845 HD11 ' HE ' ' A' ' 908' ' ' ARG . 90.5 mt -107.3 -52.51 2.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.292 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -165.5 164.39 19.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.385 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.65 115.68 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.759 HG12 ' OD2' ' A' ' 901' ' ' ASP . 58.1 t -70.27 -45.18 76.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.759 ' OD2' HG12 ' A' ' 900' ' ' VAL . 3.0 m-20 -152.12 -170.9 3.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.48 -40.86 92.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.36 15.82 19.1 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -129.24 149.96 50.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.021 0.439 . . . . 0.0 112.096 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 142.93 26.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.722 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -105.84 135.89 46.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -157.93 178.54 34.18 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.357 -0.925 . . . . 0.0 111.506 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 897' ' ' LEU . 19.6 ptp180 -151.09 158.16 43.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.837 0.351 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 89.5 mt -80.18 141.49 54.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.7 140.29 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 120.942 1.095 . . . . 0.0 111.504 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 93.03 -7.58 76.37 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.3 m 67.89 28.2 7.05 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.704 0.288 . . . . 0.0 110.773 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 98.3 p -63.61 -28.15 69.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.79 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -164.58 150.74 10.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.924 0.393 . . . . 0.0 111.078 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -138.95 143.41 38.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.297 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -178.44 -179.48 48.35 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.468 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 917' ' ' ILE . 41.9 pt -105.32 156.91 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 923' ' ' VAL . 21.2 p90 -161.89 152.48 14.66 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.731 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.67 142.46 58.41 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.9 1.733 . . . . 0.0 112.837 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 920' ' ' ILE . 0.1 OUTLIER -72.47 -26.05 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.138 -178.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 4.3 t -69.59 8.43 0.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.543 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . 0.641 ' CD1' ' O ' ' A' ' 922' ' ' TYR . 0.0 OUTLIER -127.6 4.11 6.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.477 HG11 ' CE1' ' A' ' 918' ' ' PHE . 20.5 m -121.19 148.79 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.925 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -102.87 126.25 49.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.272 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.9 t -82.99 125.45 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 35.3 mm -103.73 -52.3 8.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.524 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . 0.565 ' HZ3' HD12 ' A' ' 930' ' ' LEU . 64.6 tttm -137.55 134.06 35.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.237 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . 0.446 ' H ' ' HD3' ' A' ' 928' ' ' ARG . 0.7 OUTLIER -71.61 153.5 93.51 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.44 -38.82 64.38 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.882 1.721 . . . . 0.0 112.506 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . 0.565 HD12 ' HZ3' ' A' ' 927' ' ' LYS . 87.3 mt . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.436 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.05 -47.99 83.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 63.5 tpp -141.07 131.38 25.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.897 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 44.0 t -148.26 127.01 12.57 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.227 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -63.54 -40.22 98.48 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 73.5 m -62.0 -40.02 94.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.689 0.281 . . . . 0.0 111.19 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.71 149.87 49.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.734 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 795' ' ' MET . 0.0 OUTLIER -145.73 161.65 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.467 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.526 ' HE ' HD11 ' A' ' 849' ' ' LEU . 95.9 mtm-85 -133.73 149.27 71.5 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.52 128.26 10.2 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.225 1.95 . . . . 0.0 111.929 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -124.13 146.58 48.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -109.29 140.23 43.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.295 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -89.76 115.61 27.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -77.43 -20.99 53.7 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.447 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -146.17 170.01 17.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.736 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 52.5 p-10 -85.25 131.85 34.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.171 0.51 . . . . 0.0 110.382 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 843' ' ' PRO . 75.0 t80 -105.92 129.55 54.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.622 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -100.29 116.82 33.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.03 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -64.18 132.21 49.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.981 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.83 -31.16 19.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 81.6 p -131.81 161.24 33.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.0 pp -51.97 -38.69 57.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.344 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.29 -44.47 95.35 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -67.68 134.98 52.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . . . . . . . . . 17.0 tp -109.93 127.09 27.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.15 147.01 65.86 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.343 1.362 . . . . 0.0 112.769 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 842' ' ' PHE . 66.3 mt -114.65 152.75 31.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -118.85 139.06 52.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.333 0.587 . . . . 0.0 110.241 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.94 118.9 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.152 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 102.89 -21.42 40.37 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.968 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.535 ' OD2' ' CD2' ' A' ' 835' ' ' HIS . 35.4 t70 -61.77 141.35 57.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.031 0.443 . . . . 0.0 111.405 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 10.7 mm -97.58 132.41 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.779 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.721 HG12 ' HB2' ' A' ' 835' ' ' HIS . 33.9 m -125.25 153.16 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.45 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.47 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 79.7 m-85 -110.91 114.03 27.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 831' ' ' TYR . 4.2 mm -82.85 128.92 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.084 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -94.51 -44.92 7.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.259 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -160.49 153.55 21.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.981 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.49 110.25 18.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.235 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.458 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.1 mm -62.78 -46.89 95.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.597 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -148.08 178.65 8.36 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -60.09 -37.5 80.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.219 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -112.79 18.36 18.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.565 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -142.71 150.0 39.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.533 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.685 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 35.0 p90 -147.79 168.5 21.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.767 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.543 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.8 tp10 -129.33 139.91 51.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.487 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.543 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -163.99 -177.22 36.58 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -113.44 152.17 30.45 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.971 0.415 . . . . 0.0 111.027 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.721 ' HB2' HG12 ' A' ' 820' ' ' VAL . 0.2 OUTLIER -165.21 132.96 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.963 178.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 47.4 t-80 64.34 28.09 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.831 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 72.76 20.53 79.77 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -134.65 152.04 51.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.458 0.647 . . . . 0.0 112.278 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 840' ' ' GLY . 76.8 t -100.33 154.04 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.47 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -175.73 176.44 47.48 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 34.6 pt -124.57 145.71 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 117.403 0.602 . . . . 0.0 109.504 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.711 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.0 OUTLIER -156.97 165.13 19.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.092 -177.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.459 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 58.1 Cg_endo -73.15 129.44 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.701 2.267 . . . . 0.0 112.401 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 846' ' ' TYR . 61.8 ttp85 -61.77 -37.79 85.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.413 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 3.3 t -59.19 3.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 844' ' ' ARG . 0.4 OUTLIER -110.25 -2.33 16.85 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.685 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 36.8 pt -133.94 175.36 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 111.503 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -116.48 161.76 18.61 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.526 HD11 ' HE ' ' A' ' 796' ' ' ARG . 53.0 tp -121.31 96.73 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.841 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.0 tt 40.14 70.27 1.54 Allowed Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.485 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.83 159.22 54.13 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.902 1.735 . . . . 0.0 112.202 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 853' ' ' ALA . 57.2 Cg_endo -70.23 147.86 60.77 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 111.702 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 852' ' ' PRO . . . 42.46 -166.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.486 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -159.02 158.34 32.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.881 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 856' ' ' ALA . 72.1 mmtt -123.73 136.81 54.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.906 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 855' ' ' LYS . . . 57.32 150.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.867 0.365 . . . . 0.0 111.096 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . 0.442 ' OE1' ' N ' ' A' ' 857' ' ' GLN . 28.6 mp0 -131.85 148.43 69.87 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.7 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.55 -28.52 38.1 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.998 1.798 . . . . 0.0 112.235 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -153.48 134.37 13.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -131.41 22.47 4.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.71 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.05 -7.77 32.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 863' ' ' PRO . 0.2 OUTLIER -65.74 -41.53 48.28 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.926 -178.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 862' ' ' THR . 65.0 Cg_endo -88.44 64.33 3.15 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.447 2.098 . . . . 0.0 112.659 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 2.4 m -97.93 -30.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.246 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -84.08 149.41 26.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.534 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 866' ' ' VAL . 27.5 m -106.13 82.17 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -90.57 -62.17 1.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.599 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 60.5 mp0 45.72 43.63 9.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.413 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 56.19 -103.48 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.586 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -142.95 169.52 25.62 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 927' ' ' LYS . 79.2 mm-40 -125.63 151.17 46.87 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -158.69 147.1 18.41 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.3 mt -125.1 129.16 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.84 122.55 13.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.927 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.468 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.0 mtmt -70.6 -36.27 73.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.057 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -135.4 154.5 51.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.236 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -53.54 138.58 33.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -139.1 129.0 24.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.51 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -116.75 109.3 16.96 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.424 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -72.13 149.12 43.75 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -106.41 -47.5 3.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.751 0.31 . . . . 0.0 111.116 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 74.6 p -81.31 162.01 23.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 111.351 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.95 -39.43 94.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.454 HG23 ' HG3' ' A' ' 885' ' ' GLU . 15.0 m -66.67 -23.97 32.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.661 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.454 ' HG3' HG23 ' A' ' 884' ' ' VAL . 99.5 mt-10 -98.26 129.11 44.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 30.5 mmm -94.82 178.83 5.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.771 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 88.6 p -131.29 149.86 52.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -160.63 163.31 32.68 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -104.26 165.05 11.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.954 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.12 136.35 57.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.378 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.28 -5.94 81.03 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.908 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.83 141.28 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.655 0.728 . . . . 0.0 110.379 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -86.16 141.87 29.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.088 0.47 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.76 147.81 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.495 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.7 m -102.34 127.85 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.502 HD11 HG13 ' A' ' 925' ' ' VAL . 78.7 mt -85.82 122.81 30.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 111.114 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.866 HD21 ' NH1' ' A' ' 908' ' ' ARG . 85.8 mt -101.52 -47.01 4.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -166.52 165.3 16.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.878 0.37 . . . . 0.0 111.31 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -104.04 118.45 36.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.391 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.406 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 63.4 t -61.94 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.935 0.398 . . . . 0.0 110.645 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 77.1 m-20 -144.09 -104.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.9 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -126.09 -34.85 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.678 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -114.08 7.85 16.84 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.605 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -131.34 148.64 52.69 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 122.979 0.175 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.406 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 26.3 p90 -153.56 160.14 42.38 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.113 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.426 ' HG3' HE21 ' A' ' 915' ' ' GLN . 88.7 tt0 -107.7 136.69 47.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.71 179.19 30.99 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.404 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.866 ' NH1' HD21 ' A' ' 897' ' ' LEU . 32.3 ptt-85 -148.37 158.22 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.723 0.297 . . . . 0.0 110.258 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.77 140.55 86.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.75 138.53 33.19 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.181 1.101 . . . . 0.0 111.112 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 102.04 -18.17 52.63 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 1.4 m 71.98 73.33 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.9 t -120.91 -48.07 2.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.684 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -133.69 149.83 51.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.524 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.426 HE21 ' HG3' ' A' ' 906' ' ' GLU . 14.0 tm0? -136.83 143.79 43.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.48 176.09 46.14 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.495 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.37 147.9 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.211 0.529 . . . . 0.0 111.387 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.495 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -159.57 159.12 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.918 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.06 139.55 39.45 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.566 2.177 . . . . 0.0 114.48 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 95.3 mt -61.41 -38.06 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.467 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.468 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 97.9 m -52.6 -38.8 60.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.977 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.29 0.83 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.11 159.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.25 0.548 . . . . 0.0 110.965 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -108.82 125.66 52.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 896' ' ' LEU . 95.8 t -99.99 103.94 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.698 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -65.04 -42.4 94.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.64 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 871' ' ' GLU . 7.0 ptmm? -145.18 159.09 43.54 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.157 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 -98.8 153.06 38.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.136 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.84 -25.07 60.58 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 112.569 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.576 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -137.35 43.7 2.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.611 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 66.3 mtt 55.63 42.78 29.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.635 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 41.3 t -65.46 138.92 58.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.668 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 75.64 17.49 80.1 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.7 t -60.69 -45.9 92.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 0.0 110.278 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -146.91 129.74 16.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.312 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm -151.0 150.47 30.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.531 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -138.72 149.76 63.36 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.866 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -81.09 105.06 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.308 2.005 . . . . 0.0 111.995 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.622 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -105.53 144.12 32.73 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.021 -0.271 . . . . 0.0 110.623 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -111.42 134.14 53.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.569 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.5 120.95 22.43 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . 0.458 ' NZ ' ' CE2' ' A' ' 802' ' ' PHE . 19.5 ttpp -89.07 -29.19 19.59 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . 0.458 ' CE2' ' NZ ' ' A' ' 801' ' ' LYS . 54.1 m-85 -135.03 152.57 51.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.436 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 57.8 p-10 -75.35 146.54 40.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.077 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -134.59 133.24 39.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -99.61 132.42 44.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.342 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.67 139.8 55.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.931 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.96 -30.94 13.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.382 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 29.9 p -137.06 178.4 7.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.504 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.43 -38.41 87.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.274 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -60.6 -40.68 92.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.374 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.723 ' C ' HD12 ' A' ' 812' ' ' LEU . 7.1 mt-10 -84.61 142.45 29.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.874 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 811' ' ' GLU . 11.2 mp -121.35 152.76 58.11 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.32 148.26 67.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.982 1.788 . . . . 0.0 113.098 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.742 HD13 ' CE2' ' A' ' 842' ' ' PHE . 1.1 tp -131.11 145.39 51.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.54 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -124.85 137.91 54.28 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.472 0.654 . . . . 0.0 111.723 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.07 127.63 10.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.399 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.53 -19.32 54.17 Favored Glycine 0 C--N 1.318 -0.422 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.129 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.33 122.39 18.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.363 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.53 135.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.176 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 798' ' ' ALA . 32.9 m -130.17 154.31 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.977 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.458 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.4 m-85 -114.96 112.47 22.73 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.793 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.46 133.31 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.696 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -96.85 -47.79 5.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.775 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -163.95 153.78 14.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.269 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 827' ' ' ASP . 59.3 tt0 -74.88 108.38 7.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.357 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.401 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 4.8 mm -64.75 -45.96 93.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.894 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 825' ' ' GLN . 5.2 t0 -140.49 177.34 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.456 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -57.09 -27.06 61.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.382 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -119.27 -30.67 4.87 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.736 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 21.4 m0 -85.54 168.09 14.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.47 . . . . 0.0 111.719 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.697 ' CZ ' HD13 ' A' ' 847' ' ' ILE . 24.0 p90 -153.39 169.09 23.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -131.5 138.41 48.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.044 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -160.64 -175.45 31.66 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.729 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.04 137.18 46.47 Favored 'General case' 0 N--CA 1.46 0.067 0 CA-C-O 120.564 0.221 . . . . 0.0 110.611 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.3 p-80 -142.07 138.77 31.97 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 53.4 t-80 52.46 26.79 4.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.72 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.95 4.48 90.27 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.823 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -116.33 161.24 19.33 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.63 0.252 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.674 ' O ' HD22 ' A' ' 812' ' ' LEU . 10.3 p -110.72 153.68 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.754 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 839' ' ' VAL . . . -179.76 -172.56 43.94 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.45 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 1.5 pp -125.27 142.45 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.363 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.742 ' CE2' HD13 ' A' ' 814' ' ' LEU . 0.1 OUTLIER -148.74 154.83 41.04 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.404 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -67.18 134.19 33.08 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.787 1.658 . . . . 0.0 111.98 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -60.57 -41.8 95.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.74 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 71.3 p -59.52 -11.54 4.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.635 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -92.73 -2.53 55.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.697 HD13 ' CZ ' ' A' ' 831' ' ' TYR . 37.6 pt -133.99 165.46 31.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.873 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.21 120.94 28.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.208 0.528 . . . . 0.0 111.737 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.3 103.95 0.44 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.544 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.497 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.8 tt 42.79 87.04 0.12 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.271 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.86 151.44 48.71 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.686 2.258 . . . . 0.0 112.204 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . 0.655 ' O ' ' HB3' ' A' ' 853' ' ' ALA . 56.8 Cg_endo -69.59 157.65 59.96 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.567 2.178 . . . . 0.0 111.811 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 852' ' ' PRO . . . 80.52 59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.311 0.576 . . . . 0.0 110.307 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -61.43 153.54 26.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -131.02 149.51 52.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -71.14 145.25 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.817 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . 0.426 HE22 ' HD3' ' A' ' 859' ' ' LYS . 1.2 pp0? -98.9 158.38 32.46 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.036 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.54 140.84 64.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.82 1.68 . . . . 0.0 112.501 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . 0.426 ' HD3' HE22 ' A' ' 857' ' ' GLN . 2.9 mmmm -126.92 148.54 50.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.695 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -67.2 159.92 28.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.584 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.59 139.85 40.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.614 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 58.8 p -136.05 73.02 59.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.723 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.24 141.37 94.54 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.893 2.395 . . . . 0.0 112.185 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.623 HG23 ' N ' ' A' ' 865' ' ' GLN . 26.8 m -144.63 -125.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.275 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.623 ' N ' HG23 ' A' ' 864' ' ' VAL . 98.7 mt-30 54.97 47.29 22.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 33.4 m -59.17 174.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.166 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 97.26 8.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 0.0 110.5 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.693 ' OE2' HD12 ' A' ' 930' ' ' LEU . 52.9 tp10 -63.59 -41.12 98.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -72.56 146.88 46.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.697 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -74.97 172.67 53.15 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -129.54 157.3 42.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . . . . . . . . . . . -155.87 153.1 29.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 42.3 mm -117.32 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -52.56 137.55 30.1 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 3.3 ttpm? -83.82 -41.93 16.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -129.33 150.91 50.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 47.9 p-10 -55.5 153.27 7.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -151.13 131.81 14.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.859 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.59 108.21 14.21 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.541 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . 0.47 ' N ' ' OG ' ' A' ' 887' ' ' SER . . . -91.93 -176.84 42.43 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -145.68 -40.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.915 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 79.3 p -79.18 160.42 26.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.028 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -70.06 -30.17 67.36 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.099 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.1 -13.57 17.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.01 0.433 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 917' ' ' ILE . 64.6 mm-40 -113.38 133.07 55.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.785 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 7.4 tpt -106.02 116.97 32.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.803 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 880' ' ' GLY . 50.1 m -73.82 144.11 45.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -154.73 157.16 37.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.461 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 15.9 tpp180 -106.61 150.28 26.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.319 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 875' ' ' LYS . 66.1 tttp -44.55 139.99 2.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.066 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 83.7 0.86 90.01 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.407 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 7.1 mm-40 -73.33 148.63 43.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.18 0.49 . . . . 0.0 110.679 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -91.44 128.97 37.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.229 0.537 . . . . 0.0 110.718 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.76 148.87 30.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.41 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.3 m -106.36 127.28 53.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.863 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.38 124.61 29.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.697 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.498 HD12 HE21 ' A' ' 915' ' ' GLN . 86.6 mt -101.19 -52.86 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.715 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.27 164.54 22.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.014 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . 0.436 HE21 ' CB ' ' A' ' 905' ' ' TYR . 0.5 OUTLIER -96.9 111.88 23.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.49 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 78.8 t -69.41 -42.41 81.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.299 0.571 . . . . 0.0 110.016 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -152.97 -174.99 5.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.871 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -61.54 -38.1 86.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.237 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -117.02 14.65 15.05 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.77 147.64 51.3 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.991 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.648 ' OH ' HG11 ' A' ' 923' ' ' VAL . 16.1 p90 -155.04 160.67 41.21 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.112 0.482 . . . . 0.0 110.975 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.429 ' CD ' ' NE2' ' A' ' 915' ' ' GLN . 42.0 tt0 -107.02 133.74 51.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.726 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -144.96 165.73 27.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.615 HH12 ' H ' ' A' ' 911' ' ' GLY . 5.3 ppt_? -150.81 158.83 44.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.038 0.446 . . . . 0.0 110.501 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 14.4 mm -78.9 132.68 63.4 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -46.78 137.24 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 CA-C-N 120.259 1.128 . . . . 0.0 111.267 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.615 ' H ' HH12 ' A' ' 908' ' ' ARG . . . 99.56 -9.55 60.66 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.9 p 71.58 30.43 2.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 73.1 m -62.17 -40.65 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.187 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -161.76 152.73 18.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.928 0.394 . . . . 0.0 110.763 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.498 HE21 HD12 ' A' ' 897' ' ' LEU . 63.2 tt0 -132.33 147.75 52.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -169.13 173.35 43.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.853 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.474 ' O ' ' CD2' ' A' ' 918' ' ' PHE . 45.5 pt -119.57 147.01 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.91 0.385 . . . . 0.0 111.174 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -163.74 163.58 15.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.775 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.53 140.84 48.78 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.281 1.987 . . . . 0.0 113.321 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.45 -30.93 51.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.51 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 68.0 p -61.32 -21.43 63.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.651 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.67 1.65 56.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.648 HG11 ' OH ' ' A' ' 905' ' ' TYR . 14.7 m -135.34 160.45 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.913 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 925' ' ' VAL . 66.5 t0 -114.79 130.62 56.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.399 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 926' ' ' ILE . 5.8 m -94.81 148.57 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -113.89 -38.35 2.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -146.55 130.8 17.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.452 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -73.83 158.83 85.52 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.186 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.32 143.62 93.31 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.573 1.516 . . . . 0.0 112.138 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . 0.693 HD12 ' OE2' ' A' ' 868' ' ' GLU . 3.4 tp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.472 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -60.23 -46.79 88.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.637 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 25.4 mmt 44.9 -101.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 8.2 t 59.19 -139.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.584 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -101.57 -151.59 24.61 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 40.4 t -129.79 -67.11 0.77 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.0 110.444 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -113.39 126.27 55.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.04 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.449 ' SD ' ' O ' ' A' ' 822' ' ' ILE . 63.1 tpp -142.39 134.84 27.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.178 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -138.24 148.66 60.57 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.399 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.95 156.23 23.52 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.404 2.069 . . . . 0.0 112.308 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -153.56 159.3 42.15 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -133.01 136.89 46.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.429 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -75.26 116.54 16.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.961 0.41 . . . . 0.0 110.47 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -62.65 -37.54 86.77 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -144.92 173.07 12.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.398 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 57.2 t0 -77.43 109.45 11.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.599 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.14 126.76 33.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -95.23 111.69 23.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -61.29 134.68 57.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.072 0.463 . . . . 0.0 110.992 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.13 -31.2 8.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.906 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 60.8 p -133.07 162.4 31.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.376 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.4 pp -55.94 -31.73 63.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.716 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -62.09 -39.69 93.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.289 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.534 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 98.9 mt-10 -96.57 126.89 42.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.325 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 1.5 mm? -103.44 151.69 38.68 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.633 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.78 142.54 48.14 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.573 1.515 . . . . 0.0 112.679 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 842' ' ' PHE . 92.6 mt -127.06 161.7 27.8 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -123.66 136.6 54.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.417 0.627 . . . . 0.0 110.569 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -49.18 121.85 5.33 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.457 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.06 11.05 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.938 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 68.3 t0 -48.04 136.38 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.325 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 7.1 mm -101.86 125.32 56.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.86 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.71 156.65 23.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.293 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -112.12 125.62 54.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.64 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 832' ' ' GLU . 75.6 mt -88.0 123.47 40.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.215 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -111.43 -3.83 15.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -169.27 133.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -87.25 128.09 35.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.292 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.36 -46.35 23.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.03 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -152.65 179.43 8.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.637 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.91 -37.52 76.84 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.186 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -107.68 -8.6 16.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.79 141.07 42.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 0.0 112.031 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.496 ' CD2' HD13 ' A' ' 822' ' ' ILE . 43.3 m-85 -129.44 151.44 50.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.558 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 822' ' ' ILE . 3.7 tt0 -125.74 139.64 53.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . . . . . . . . . . . -157.99 180.0 33.29 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . 0.483 ' OE2' ' N ' ' A' ' 837' ' ' GLY . 12.7 tm-20 -115.26 125.45 53.33 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 3.0 p80 -132.39 138.02 47.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 82.3 t60 50.78 32.05 6.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.755 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . 0.483 ' N ' ' OE2' ' A' ' 834' ' ' GLU . . . 75.46 13.3 83.02 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -118.61 148.16 42.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 95.9 t -117.8 127.34 75.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 0.0 111.541 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -147.97 -179.78 24.22 Favored Glycine 0 CA--C 1.516 0.11 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.235 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.415 ' C ' ' CD1' ' A' ' 842' ' ' PHE . 30.8 pt -124.29 143.4 37.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.101 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.487 ' CE1' HD11 ' A' ' 814' ' ' LEU . 0.0 OUTLIER -145.75 149.11 38.69 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.676 -179.453 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.556 ' C ' ' H ' ' A' ' 845' ' ' THR . 72.1 Cg_endo -75.62 137.54 20.49 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.251 1.967 . . . . 0.0 111.197 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -55.51 3.93 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 843' ' ' PRO . 0.2 OUTLIER -90.74 -15.83 29.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.685 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 -5.45 16.17 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.268 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.429 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.9 pt -133.52 173.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.551 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -131.29 155.12 47.72 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 8.1 tp -105.31 107.63 18.72 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.197 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.429 HD23 ' C ' ' A' ' 850' ' ' LEU . 4.6 tt 49.9 76.71 0.52 Allowed Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.642 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 153.42 51.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.989 2.459 . . . . 0.0 111.845 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.74 151.11 74.62 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.465 2.11 . . . . 0.0 112.227 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -111.01 142.8 42.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.72 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -98.9 130.28 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.673 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -96.24 -0.55 49.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.645 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -81.6 0.27 39.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.935 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -67.43 153.29 95.12 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.095 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -52.24 138.77 54.73 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.704 1.602 . . . . 0.0 112.249 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.01 134.1 51.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.543 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -60.9 166.85 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.288 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.1 mp -51.22 143.45 11.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.69 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 862' ' ' THR . 11.2 t -131.27 78.28 72.63 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.661 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -58.02 142.54 96.82 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.842 2.361 . . . . 0.0 112.226 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.09 160.66 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -157.04 163.9 38.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.415 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 86.0 t -102.98 118.2 49.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.914 0.388 . . . . 0.0 110.3 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 868' ' ' GLU . 2.2 tt -169.36 118.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.362 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.61 ' N ' HD23 ' A' ' 867' ' ' LEU . 99.7 mt-10 -121.14 133.87 55.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.306 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 869' ' ' TYR . 34.7 t80 -149.52 40.49 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.179 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . 0.408 ' N ' ' HG3' ' A' ' 929' ' ' PRO . . . -69.88 168.62 46.76 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . 0.532 ' OE2' ' NE ' ' A' ' 893' ' ' ARG . 88.0 tt0 -138.31 150.59 46.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.766 0.317 . . . . 0.0 110.203 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.443 ' HB1' HG12 ' A' ' 923' ' ' VAL . . . -143.43 153.12 42.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.99 121.02 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.073 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.5 4.03 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.433 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.5 mtmt -70.36 -36.79 74.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.613 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.63 152.62 50.69 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.253 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 878' ' ' PHE . 61.6 t-20 -54.69 136.14 46.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.709 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.632 ' CD2' ' CE1' ' A' ' 888' ' ' PHE . 90.3 t80 -129.52 132.04 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.76 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.06 106.95 13.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.155 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -71.01 139.58 29.89 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -107.01 -3.18 20.35 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.076 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 68.4 p -132.69 160.84 35.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.235 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -61.51 -41.96 98.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 885' ' ' GLU . 14.7 m -65.54 -25.38 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 884' ' ' VAL . 98.8 mt-10 -99.92 108.23 20.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.512 ' SD ' ' O ' ' A' ' 887' ' ' SER . 16.9 tmm? -79.74 135.02 36.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.676 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.512 ' O ' ' SD ' ' A' ' 886' ' ' MET . 33.9 t -82.6 132.28 35.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.716 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.632 ' CE1' ' CD2' ' A' ' 878' ' ' PHE . 45.5 p90 -142.18 154.51 44.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.439 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 89.8 mtm180 -103.54 163.89 12.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.063 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -56.46 132.73 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.5 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 96.33 -7.01 66.2 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.296 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 71.2 mm-40 -69.94 133.77 47.66 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.923 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.532 ' NE ' ' OE2' ' A' ' 871' ' ' GLU . 70.4 mtp85 -84.05 126.09 32.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 8.7 mm -114.88 143.45 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.106 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 96.9 m -98.28 127.81 44.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.98 116.21 22.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 110.943 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.423 ' O ' ' OE1' ' A' ' 868' ' ' GLU . 95.7 mt -100.75 -50.62 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.443 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttt85 -160.86 154.9 22.77 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.079 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.1 116.88 32.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.448 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 60.0 t -61.43 -46.6 96.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.779 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.9 m-20 -143.88 -104.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.989 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -129.04 -37.7 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.418 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -108.09 4.74 25.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.502 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -132.02 148.27 52.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.42 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 16.2 p90 -153.95 159.77 41.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.113 0.482 . . . . 0.0 110.882 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -107.47 135.12 49.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.463 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -152.65 177.84 30.14 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.288 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 42.0 ptt180 -150.84 160.3 43.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.308 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 5.7 mm -73.24 128.84 86.93 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -49.13 138.86 27.83 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 CA-C-N 120.161 1.093 . . . . 0.0 111.087 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 912' ' ' THR . . . 101.26 -17.84 55.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 911' ' ' GLY . 0.2 OUTLIER 79.18 86.0 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.898 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 25.4 t -129.25 -41.13 1.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.036 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -162.74 151.92 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.817 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -130.01 146.55 51.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -172.05 175.48 45.34 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.519 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.8 pt -114.1 142.37 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.899 0.38 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -152.67 157.96 33.31 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.889 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 136.63 29.84 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.117 1.878 . . . . 0.0 113.143 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 84.2 mt -63.25 -36.82 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.867 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.433 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 73.0 p -53.5 -29.85 38.26 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -91.85 2.38 56.56 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.984 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.443 HG12 ' HB1' ' A' ' 872' ' ' ALA . 16.9 t -127.19 148.97 31.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.308 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -99.98 121.31 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.44 123.86 39.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.156 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -97.06 -44.82 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.67 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -125.61 142.27 51.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.057 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.5 74.61 69.15 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.539 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . 0.408 ' HG3' ' N ' ' A' ' 870' ' ' GLY . 57.6 Cg_endo -73.65 151.93 47.38 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.526 2.151 . . . . 0.0 112.307 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.462 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.75 40.91 30.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.596 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -147.66 159.38 43.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.702 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 97.7 p -155.4 164.4 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.593 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 91.05 -5.79 81.68 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 5.7 t 61.49 73.06 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.522 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -67.81 143.0 56.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.671 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 795' ' ' MET . 2.8 mpp? -116.62 156.58 26.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.96 149.44 73.13 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.48 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.02 153.8 57.71 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.394 2.063 . . . . 0.0 112.274 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -168.86 151.14 4.86 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -133.41 129.33 37.18 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.617 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 815' ' ' GLN . . . -76.41 122.83 25.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 848' ' ' GLU . 15.5 ttmm -91.24 -18.14 24.88 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.462 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -135.74 139.97 44.01 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.192 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.84 152.12 43.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.312 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . 0.443 ' CE1' ' CD ' ' A' ' 811' ' ' GLU . 47.5 t80 -126.87 129.09 47.55 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.466 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.61 121.1 35.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.1 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -62.26 134.99 57.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 110.793 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -110.96 -28.8 8.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 68.9 p -130.87 163.35 27.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.456 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -56.65 -34.75 67.62 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.168 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.99 -47.29 86.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.783 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.443 ' CD ' ' CE1' ' A' ' 804' ' ' PHE . 8.1 tm-20 -86.78 123.66 32.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.114 0.483 . . . . 0.0 111.266 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -96.57 152.73 38.77 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.879 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.29 145.12 76.95 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.611 1.541 . . . . 0.0 112.511 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 842' ' ' PHE . 1.2 tp -131.89 151.42 51.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . 0.625 ' O ' ' HB3' ' A' ' 800' ' ' ALA . 11.1 tt0 -102.89 147.76 26.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.461 0.648 . . . . 0.0 110.661 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -63.45 38.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.125 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 800' ' ' ALA . . . 166.06 23.26 0.02 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 820' ' ' VAL . 65.3 t0 -97.15 113.65 25.26 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.77 -0.253 . . . . 0.0 110.418 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.7 135.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.658 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 814' ' ' LEU . 30.7 m -131.55 158.3 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.25 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.409 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 84.6 m-85 -108.41 115.83 30.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.403 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 33.4 mm -81.57 134.62 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.318 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -96.75 -39.68 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . 0.47 ' NZ ' ' OE2' ' A' ' 832' ' ' GLU . 25.9 pttm -162.07 159.83 26.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.417 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -86.14 116.02 24.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.073 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 827' ' ' ASP . 48.5 mm -65.01 -48.73 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.284 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 826' ' ' ILE . 34.5 m-20 -147.62 177.5 9.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -59.18 -36.41 75.29 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.253 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -109.87 15.4 22.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -137.06 147.53 46.2 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.049 0.452 . . . . 0.0 112.082 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.541 ' OH ' ' NH1' ' A' ' 844' ' ' ARG . 44.0 m-85 -133.87 150.99 51.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.32 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.47 ' OE2' ' NZ ' ' A' ' 824' ' ' LYS . 3.7 tt0 -124.11 133.33 53.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.135 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -158.39 -175.77 29.69 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -113.79 149.93 34.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.556 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.3 p-80 -152.55 132.14 13.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.558 178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.441 ' CG ' ' O ' ' A' ' 836' ' ' HIS . 75.6 t60 48.84 34.01 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.581 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.88 1.63 90.31 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.863 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -109.18 147.83 31.89 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.451 ' O ' HD23 ' A' ' 812' ' ' LEU . 7.4 p -135.86 135.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.99 0.424 . . . . 0.0 111.635 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.4 ' HA3' ' H ' ' A' ' 812' ' ' LEU . . . -158.27 -143.02 3.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.458 ' O ' ' CD1' ' A' ' 842' ' ' PHE . 45.5 pt -128.97 150.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 117.449 0.624 . . . . 0.0 110.748 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.757 ' CD1' HD22 ' A' ' 814' ' ' LEU . 4.1 m-85 -144.24 131.0 10.21 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 120.321 -0.551 . . . . 0.0 110.842 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.38 148.21 72.91 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 121.532 1.488 . . . . 0.0 112.784 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . 0.541 ' NH1' ' OH ' ' A' ' 831' ' ' TYR . 60.2 ttt85 -59.74 -41.06 90.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.658 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 94.1 m -64.47 -22.47 66.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.341 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -91.93 -3.76 55.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.806 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 844' ' ' ARG . 1.3 pp -142.08 165.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.182 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 801' ' ' LYS . 96.1 mt-10 -132.49 124.44 28.54 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.92 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 850' ' ' LEU . 2.4 tt -72.36 113.33 9.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.329 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.556 ' N ' HD23 ' A' ' 849' ' ' LEU . 3.3 tt 53.15 76.02 0.57 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.34 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.12 153.48 52.02 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.804 2.336 . . . . 0.0 111.749 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.51 153.15 74.35 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.399 2.066 . . . . 0.0 111.987 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -60.16 148.81 34.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.511 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -126.23 145.32 50.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.581 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -81.63 144.74 31.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.493 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -102.0 113.04 25.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.147 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -138.12 73.08 45.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.34 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.28 69.54 7.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.727 2.284 . . . . 0.0 112.099 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.42 119.14 24.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.57 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -159.79 163.93 34.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -74.25 118.33 17.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 110.379 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 6.9 t -64.47 139.04 97.63 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.218 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.83 151.79 68.76 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.112 1.875 . . . . 0.0 112.246 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 17.5 m -132.49 167.7 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.752 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -131.39 149.8 52.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.513 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 80.8 t -119.29 120.79 64.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.693 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 2.5 mt -157.03 17.22 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.423 ' OE1' ' OE2' ' A' ' 871' ' ' GLU . 99.6 mt-10 -125.6 143.24 51.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.746 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -99.49 -42.28 7.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -150.51 168.15 30.36 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . 0.423 ' OE2' ' OE1' ' A' ' 868' ' ' GLU . 79.5 mm-40 -122.94 151.75 41.49 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.917 0.389 . . . . 0.0 110.929 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 924' ' ' ASP . . . -155.07 151.07 27.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.264 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 11.5 mm -122.23 127.45 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -47.31 131.17 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.497 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 22.4 ttpp -72.93 -37.19 67.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.684 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . 0.566 ' CE1' ' CD1' ' A' ' 922' ' ' TYR . 0.2 OUTLIER -155.15 160.79 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.231 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.541 ' O ' ' CE2' ' A' ' 876' ' ' PHE . 23.0 m120 -51.72 109.55 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -115.85 125.5 52.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.402 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -115.86 110.59 19.25 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.379 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -64.52 142.5 45.7 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.05 -22.93 28.8 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.88 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 66.3 p -129.85 164.15 24.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.621 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -59.87 -25.95 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.266 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.84 -45.3 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.076 0.465 . . . . 0.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.64 141.79 36.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.7 tpt -103.24 130.71 50.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 110.79 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 142.07 27.7 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.687 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -158.6 160.84 37.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.006 0.431 . . . . 0.0 111.538 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 891' ' ' GLY . 38.9 ttm180 -89.57 158.12 17.77 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.427 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 57.9 tttm -66.08 56.25 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.689 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 889' ' ' ARG . . . -178.16 4.66 0.03 OUTLIER Glycine 0 CA--C 1.533 1.213 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.725 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.96 150.52 20.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 117.551 0.675 . . . . 0.0 109.866 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -95.5 127.97 41.97 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.451 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.8 mt -111.62 151.67 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.85 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.7 m -104.36 127.45 52.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.887 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 925' ' ' VAL . 87.4 mt -90.16 127.7 36.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.535 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.755 HD11 ' HE ' ' A' ' 908' ' ' ARG . 87.9 mt -108.27 -53.56 2.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.702 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -156.34 150.28 25.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.985 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -90.14 106.94 18.82 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.51 -44.07 95.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -157.87 178.68 9.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.088 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 920' ' ' ILE . 80.9 mm-40 -61.87 -30.99 71.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . 0.469 ' C ' ' CD1' ' A' ' 904' ' ' TRP . 98.3 m-20 -109.7 20.07 18.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.41 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 903' ' ' ASN . 74.3 m95 -146.83 151.61 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.96 138.09 26.59 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.545 178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -102.11 133.16 47.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -159.02 178.43 35.19 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.952 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.755 ' HE ' HD11 ' A' ' 897' ' ' LEU . 20.9 ptp180 -151.16 157.81 43.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.96 141.76 78.75 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.45 139.85 28.7 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.06 1.057 . . . . 0.0 111.046 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.555 ' C ' HG23 ' A' ' 912' ' ' THR . . . 95.33 -9.26 69.58 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.555 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 69.83 31.99 3.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.663 0.268 . . . . 0.0 110.971 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 48.0 t -60.91 -44.22 97.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -160.11 146.81 15.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.753 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -121.19 151.05 40.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.278 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -175.02 176.12 47.13 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.182 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.467 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 45.2 pt -125.12 156.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 110.845 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.467 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.4 OUTLIER -166.48 162.69 11.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.661 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.67 147.85 90.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.806 1.671 . . . . 0.0 111.768 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 902' ' ' GLU . 11.3 mt -76.37 -19.89 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 81.6 p -68.95 -10.69 58.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.591 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . 0.566 ' CD1' ' CE1' ' A' ' 876' ' ' PHE . 45.5 m-85 -108.23 7.59 27.47 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 920' ' ' ILE . 18.8 m -137.04 159.42 36.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.408 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . 0.412 ' O ' ' HB1' ' A' ' 872' ' ' ALA . 98.1 m-20 -117.38 131.75 56.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.54 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 896' ' ' LEU . 62.9 t -99.99 98.81 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.278 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.67 -44.19 76.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.013 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -128.65 142.53 51.0 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.537 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -73.94 152.08 88.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.86 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.52 72.89 5.38 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.937 1.758 . . . . 0.0 112.315 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 930' ' ' LEU . 24.1 tp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.522 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 791' ' ' SER . 20.9 tm0? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -61.18 -47.42 86.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.77 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 98.4 mtp -63.97 -40.87 97.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.863 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 788' ' ' GLN . 66.7 m -127.49 139.76 52.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.748 0.309 . . . . 0.0 110.86 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -92.68 99.26 2.51 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 45.3 t -119.94 128.21 53.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.856 0.36 . . . . 0.0 110.345 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.69 153.42 37.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -126.04 160.38 30.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.009 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.531 ' HE ' HD21 ' A' ' 849' ' ' LEU . 13.9 tpt180 -129.8 121.13 19.83 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.09 138.9 21.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.702 1.601 . . . . 0.0 112.474 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 848' ' ' GLU . . . -138.77 154.4 48.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -113.13 140.39 47.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.013 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.562 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -72.88 126.95 31.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -91.06 -8.86 47.76 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.258 0.552 . . . . 0.0 109.571 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -164.13 178.3 7.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.136 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.3 p-10 -98.53 139.57 34.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.796 0.332 . . . . 0.0 110.569 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -129.56 129.58 44.63 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.232 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -95.31 135.13 37.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.562 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -76.42 138.04 40.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.532 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -114.38 -22.33 9.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.902 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.1 p -127.22 167.67 15.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.446 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.42 -41.4 97.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.771 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -63.01 -39.94 96.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.088 0.471 . . . . 0.0 109.864 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.523 ' C ' HD12 ' A' ' 812' ' ' LEU . 95.6 mt-10 -74.76 131.89 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.265 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 811' ' ' GLU . 9.1 mp -118.76 154.23 52.68 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.06 144.19 62.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.856 1.704 . . . . 0.0 112.346 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.54 HD12 ' CD2' ' A' ' 842' ' ' PHE . 1.3 mt -137.65 141.45 41.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.212 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -122.66 139.85 53.49 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.438 0.637 . . . . 0.0 110.921 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.82 123.55 7.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.911 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 105.75 -24.33 27.27 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.412 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.2 t0 -61.9 135.67 57.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.799 0.333 . . . . 0.0 110.763 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.503 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 33.9 mm -93.9 130.57 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.555 HG12 ' HB2' ' A' ' 835' ' ' HIS . 28.6 m -123.46 152.58 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.655 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.46 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 86.6 m-85 -117.04 117.74 30.46 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.815 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 65.3 mt -83.03 129.59 37.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -123.88 -9.67 7.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.274 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -165.18 133.59 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.266 0.555 . . . . 0.0 111.182 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -82.69 138.01 34.26 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.633 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 9.8 mm -94.82 -57.64 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.477 ' O ' ' NH2' ' A' ' 844' ' ' ARG . 7.7 t0 -150.21 179.33 8.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.085 0.469 . . . . 0.0 109.795 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -59.59 -37.26 78.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.716 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -106.18 7.25 31.48 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -141.15 147.13 37.94 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.113 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 842' ' ' PHE . 29.6 p90 -140.08 169.68 17.25 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.558 ' OE2' ' N ' ' A' ' 833' ' ' GLY . 2.5 tp10 -128.54 139.19 52.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.134 0.493 . . . . 0.0 109.798 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.558 ' N ' ' OE2' ' A' ' 832' ' ' GLU . . . -161.36 -175.45 32.4 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -108.89 135.62 49.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.693 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.555 ' HB2' HG12 ' A' ' 820' ' ' VAL . 0.8 OUTLIER -144.61 146.91 32.54 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.8 t-80 49.04 29.76 2.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.877 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.18 79.98 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -132.8 158.92 41.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.008 0.432 . . . . 0.0 111.371 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.448 HG13 ' OE2' ' A' ' 832' ' ' GLU . 92.0 t -106.78 132.66 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.618 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.465 ' O ' ' OE1' ' A' ' 832' ' ' GLU . . . -164.29 -175.02 34.72 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.48 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 36.6 pt -115.15 149.65 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.515 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.54 ' CD2' HD12 ' A' ' 814' ' ' LEU . 0.3 OUTLIER -152.01 151.67 28.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.407 ' C ' ' N ' ' A' ' 845' ' ' THR . 27.5 Cg_endo -67.88 112.08 2.59 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.797 1.665 . . . . 0.0 112.15 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 827' ' ' ASP . 19.1 ttm105 -47.69 -15.77 0.06 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.53 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.407 ' N ' ' C ' ' A' ' 843' ' ' PRO . 63.2 p -81.49 -2.25 49.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.735 0.303 . . . . 0.0 111.052 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.2 -2.91 26.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.004 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.5 pt -129.33 172.05 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.631 -0.427 . . . . 0.0 111.881 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.638 ' O ' ' HB1' ' A' ' 798' ' ' ALA . 85.1 tt0 -110.31 159.73 17.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.531 HD21 ' HE ' ' A' ' 796' ' ' ARG . 3.4 tt -113.49 104.36 12.19 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.627 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 36.5 tp 58.26 75.13 0.56 Allowed Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.648 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.78 158.78 52.36 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.785 . . . . 0.0 112.399 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.08 147.29 60.49 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.667 2.244 . . . . 0.0 112.444 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -74.91 147.37 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.987 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 60.14 85.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.38 -22.56 66.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.621 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -63.39 142.83 58.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.719 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -139.67 66.28 34.25 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.025 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 860' ' ' LYS . 58.9 Cg_endo -71.95 -15.55 29.38 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.694 2.263 . . . . 0.0 112.868 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 57.77 -81.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.597 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 858' ' ' PRO . 48.1 mmtm -72.43 150.85 42.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 93.7 mt -62.32 -39.09 91.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 79.2 p -128.7 149.44 72.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.68 -23.15 42.77 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.162 1.908 . . . . 0.0 112.68 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 10.9 t -129.62 133.11 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.449 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -170.53 121.73 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.688 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.88 127.71 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 867' ' ' LEU . 4.1 mm? -62.01 -40.84 97.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -81.5 83.38 7.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.266 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -140.54 130.02 24.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.377 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -144.77 164.17 27.85 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.0 160.93 28.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 923' ' ' VAL . . . -158.88 146.0 17.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 89.8 mt -123.19 125.8 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 110.7 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -55.58 122.69 11.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.149 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 46.3 mtpt -70.38 -37.86 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -132.75 154.33 50.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.324 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 890' ' ' LYS . 33.6 m120 -54.25 146.19 15.91 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.569 ' CD2' ' CE2' ' A' ' 888' ' ' PHE . 89.0 t80 -141.43 137.12 31.97 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.031 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -123.64 105.4 9.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.183 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -70.5 155.15 52.88 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . 0.419 ' OD1' HG23 ' A' ' 882' ' ' THR . 51.6 p-10 -115.13 -9.61 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.585 0.231 . . . . 0.0 111.503 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 881' ' ' ASP . 72.3 p -128.54 160.56 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . 0.493 ' O ' ' SD ' ' A' ' 886' ' ' MET . 55.2 tt0 -61.55 -39.71 92.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.936 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.48 -42.05 89.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.521 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -88.36 103.27 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.689 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 883' ' ' GLN . 0.0 OUTLIER -80.89 133.59 35.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.237 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 84.4 p -73.06 157.4 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.013 0.435 . . . . 0.0 111.053 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.569 ' CE2' ' CD2' ' A' ' 878' ' ' PHE . 41.1 p90 -160.38 162.94 33.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.474 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -112.95 161.84 16.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.301 0.572 . . . . 0.0 111.711 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.736 ' H ' ' ND2' ' A' ' 877' ' ' ASN . 63.7 tttm -59.37 132.77 55.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 91.74 -8.01 78.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.694 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.31 139.82 48.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.24 0.52 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -85.21 143.4 28.79 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.956 0.408 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 94.2 mt -131.99 148.8 32.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.738 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . 0.449 HG21 ' NH1' ' A' ' 908' ' ' ARG . 97.3 m -101.53 129.16 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.987 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.26 115.21 24.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 111.149 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.97 -50.41 4.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.791 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -157.46 151.69 24.79 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.019 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -95.89 113.74 25.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.699 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 79.5 t -69.19 -43.16 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.089 0.471 . . . . 0.0 110.31 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.438 ' OD1' ' OE1' ' A' ' 902' ' ' GLU . 19.3 t0 -153.56 -176.65 5.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.021 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.438 ' OE1' ' OD1' ' A' ' 901' ' ' ASP . 61.0 mp0 -61.13 -37.85 84.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.83 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -111.6 13.28 21.28 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.87 147.63 46.61 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.465 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.487 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 20.9 p90 -154.29 158.27 39.93 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.162 0.506 . . . . 0.0 110.965 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.23 133.3 52.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -154.04 178.6 30.83 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.334 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.449 ' NH1' HG21 ' A' ' 895' ' ' THR . 0.0 OUTLIER -153.14 161.68 42.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.855 0.359 . . . . 0.0 110.385 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 13.1 mt -90.22 132.26 36.32 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.826 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -39.98 136.28 1.45 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.397 1.398 . . . . 0.0 111.757 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 96.21 -4.34 64.8 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.44 24.68 13.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 47.4 t -61.58 -45.07 95.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.95 146.73 45.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.489 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.2 tt0 -147.39 139.01 24.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.277 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 172.54 -170.28 43.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 45.7 pt -116.31 145.03 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.054 0.454 . . . . 0.0 111.014 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -152.37 153.38 30.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.038 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.04 137.52 41.2 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.057 1.838 . . . . 0.0 112.991 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.51 -38.68 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.465 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 93.7 m -51.96 -44.17 63.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.961 -177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.13 3.57 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 872' ' ' ALA . 13.4 t -125.67 147.53 30.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.99 0.424 . . . . 0.0 110.285 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -103.71 120.99 42.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.504 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 3.1 m -83.76 124.65 39.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.505 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.7 mp -87.89 -35.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -151.55 135.61 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.758 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -70.88 149.38 95.01 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.439 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.28 -21.33 41.67 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.044 1.83 . . . . 0.0 111.853 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.482 179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -129.62 139.78 51.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.9 mtm -112.38 107.19 15.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.335 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 62.8 m -132.74 144.11 50.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.24 84.93 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 47.0 t -158.18 147.62 19.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.319 . . . . 0.0 110.42 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -150.66 146.59 26.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.566 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 63.6 mtt -136.39 158.36 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.075 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -128.19 145.62 56.24 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.3 108.41 1.75 Allowed 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.956 1.77 . . . . 0.0 112.645 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . . . . . . . . . . . -109.35 144.83 37.0 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -114.24 140.61 48.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.226 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.689 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -81.2 118.18 22.36 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.428 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -72.38 -27.48 62.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.077 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -142.39 178.15 7.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.558 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.09 139.28 30.73 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.057 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -127.08 125.86 42.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.34 132.55 34.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -71.2 139.03 49.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.238 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . 0.558 ' H ' ' CD ' ' A' ' 811' ' ' GLU . 98.1 mm-40 -105.24 -29.18 10.49 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.069 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 811' ' ' GLU . 71.5 p -136.15 170.14 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.261 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 809' ' ' LEU . 91.2 mt -61.41 -35.25 77.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.166 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -59.93 -40.17 88.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.737 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 10.8 pt-20 -98.4 129.4 45.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.613 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 812' ' ' LEU . 2.3 mm? -102.08 152.19 38.18 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.791 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.58 149.98 68.7 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.304 2.003 . . . . 0.0 113.092 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.62 142.77 49.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.663 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -124.9 133.53 53.02 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.261 0.553 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -41.57 126.05 2.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.553 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 101.6 -24.17 32.49 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.385 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.53 121.35 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.952 0.406 . . . . 0.0 110.51 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 40.2 mm -81.55 138.86 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.044 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.47 154.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.452 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -113.0 117.01 30.85 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.433 HD13 ' HD2' ' A' ' 831' ' ' TYR . 62.3 mt -82.04 129.29 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.179 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -125.17 -4.82 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -166.78 130.83 1.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.587 HE21 ' C ' ' A' ' 827' ' ' ASP . 4.0 tm0? -90.6 107.32 19.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.712 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 3.1 mm -60.77 -48.87 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.121 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.587 ' C ' HE21 ' A' ' 825' ' ' GLN . 1.3 t70 -155.56 176.98 11.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . 0.425 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 26.0 mp0 -61.85 -35.83 79.44 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.779 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -102.13 -7.41 22.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.815 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -125.53 131.89 52.7 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.982 0.42 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.433 ' HD2' HD13 ' A' ' 822' ' ' ILE . 3.3 m-85 -121.4 156.65 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.605 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -128.91 140.81 51.51 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -161.91 -174.18 31.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -108.44 136.31 48.27 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.577 0.227 . . . . 0.0 110.652 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 835' ' ' HIS . 2.7 p80 -139.11 133.14 31.13 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 1.3 t60 50.2 31.8 5.46 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.243 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.27 4.45 90.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.538 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -112.63 161.87 16.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.01 140.89 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 0.0 110.494 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.52 30.31 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . . . . . . . . . 47.0 pt -122.79 155.02 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.131 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -161.53 153.82 16.7 Favored Pre-proline 0 C--O 1.231 0.12 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.576 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 845' ' ' THR . 56.6 Cg_endo -71.86 126.98 12.46 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.961 1.774 . . . . 0.0 112.714 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.16 2.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.757 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 843' ' ' PRO . 73.8 p -91.05 -18.44 24.57 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.589 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.49 5.41 34.04 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 800' ' ' ALA . 43.2 pt -130.27 168.28 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -134.71 113.27 11.5 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.988 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 849' ' ' LEU . 3.1 mp -68.81 118.19 11.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.959 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 850' ' ' LEU . 21.6 tp 58.84 69.91 1.28 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.785 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.5 161.66 41.83 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.419 2.079 . . . . 0.0 112.625 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . 0.654 ' O ' ' HB3' ' A' ' 853' ' ' ALA . 51.5 Cg_exo -46.08 175.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.349 2.033 . . . . 0.0 112.127 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 852' ' ' PRO . . . 82.41 47.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.669 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 856' ' ' ALA . 88.5 tt0 -92.27 116.06 28.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.502 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 50.39 9.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.995 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 854' ' ' GLU . . . -62.67 -40.2 96.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 0.0 110.656 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -130.3 76.53 77.62 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.701 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.33 138.49 79.87 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.728 2.285 . . . . 0.0 112.253 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -118.84 -15.9 9.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.436 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.82 -43.24 98.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.496 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.51 99.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.157 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 51.8 p -71.15 150.55 94.63 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.309 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.41 156.61 54.33 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.254 1.969 . . . . 0.0 112.028 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.76 160.39 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.42 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -138.18 153.11 49.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.706 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.5 t -114.48 124.88 71.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.424 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.3 13.31 3.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.525 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.67 -39.82 95.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.45 141.46 51.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.633 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -80.99 168.13 50.52 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -128.15 150.41 50.0 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -159.54 146.32 16.58 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 85.8 mt -125.05 125.21 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . 0.661 ' HA ' HG12 ' A' ' 923' ' ' VAL . . . -55.19 120.56 7.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.359 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -69.22 -36.7 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.754 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -134.33 150.52 50.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.916 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -55.55 132.92 49.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -130.67 134.63 47.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 16.5 p30 -113.65 128.89 56.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.996 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -77.95 139.89 23.33 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -98.17 -12.73 21.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 110.731 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 62.0 p -133.07 165.08 25.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . 0.473 ' O ' ' CE ' ' A' ' 886' ' ' MET . 98.4 mt-30 -62.02 -39.73 93.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.113 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 884' ' ' VAL . 2.9 t -66.82 -15.79 20.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.757 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -105.71 110.09 22.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.296 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 883' ' ' GLN . 39.1 mmt -81.01 152.69 27.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.262 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.414 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 96.7 p -108.9 155.01 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -159.3 161.61 35.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.779 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 1.4 mpt_? -96.44 165.86 11.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.593 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.53 135.89 57.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.19 82.63 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.607 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 77.2 mm-40 -72.38 140.61 48.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.516 0.658 . . . . 0.0 110.038 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -82.06 140.99 33.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.114 0.483 . . . . 0.0 110.769 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 872' ' ' ALA . 90.8 mt -130.25 138.8 52.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.51 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 94.3 m -99.37 126.13 45.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.08 115.36 25.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.107 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.28 -37.36 6.03 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.535 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -149.48 134.61 18.13 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.181 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -103.1 118.27 36.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 901' ' ' ASP . 60.0 t -63.96 -41.21 91.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.098 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 900' ' ' VAL . 36.4 m-20 103.97 166.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.905 1.378 . . . . 0.0 110.335 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.479 ' CB ' ' O ' ' A' ' 901' ' ' ASP . 10.2 tt0 80.7 -69.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.766 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -169.43 23.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -135.88 151.04 49.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.505 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.438 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 29.4 p90 -153.85 155.11 35.14 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.21 0.529 . . . . 0.0 110.3 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.88 138.5 42.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.64 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.24 178.14 30.45 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.144 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -148.13 157.92 43.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.321 -0.44 . . . . 0.0 110.747 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.445 HD12 ' HB2' ' A' ' 914' ' ' ARG . 93.5 mt -80.35 142.14 54.11 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -47.27 139.2 16.53 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 CA-C-N 120.312 1.147 . . . . 0.0 110.499 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 912' ' ' THR . . . 95.26 -5.06 67.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 911' ' ' GLY . 9.1 p 61.3 23.55 13.76 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.535 -0.333 . . . . 0.0 111.532 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 66.6 m -62.39 -42.3 99.31 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.832 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.445 ' HB2' HD12 ' A' ' 909' ' ' ILE . 36.7 mmt180 -134.9 153.04 52.21 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.456 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -145.37 135.75 24.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -173.75 177.22 46.15 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.534 ' O ' ' CD1' ' A' ' 918' ' ' PHE . 46.9 pt -112.45 144.05 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.054 0.454 . . . . 0.0 111.629 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -151.3 155.78 34.74 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.474 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.79 140.2 41.97 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.058 1.839 . . . . 0.0 113.395 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.22 -37.57 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.569 -178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.486 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 98.9 m -56.31 -42.54 77.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -76.09 0.25 19.44 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.158 0.435 . . . . 0.0 111.96 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 874' ' ' ALA . 27.6 m -132.15 158.97 43.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.159 0.504 . . . . 0.0 111.245 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -107.14 123.95 49.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.455 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.27 110.15 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.24 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 32.4 mm -86.01 -47.75 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.868 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.42 143.19 51.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.444 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.9 mtp180 -75.17 153.08 86.33 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.171 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -50.74 -38.59 56.75 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.507 1.471 . . . . 0.0 111.93 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.331 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -99.94 7.54 44.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 79.3 mtm -75.0 144.95 42.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.255 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 83.4 p -70.74 159.37 34.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.504 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -139.9 -145.54 4.7 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 83.3 p -69.75 155.86 39.89 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.913 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -165.3 151.39 9.82 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.763 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 24.8 ptp -140.83 153.96 46.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.967 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -132.98 145.77 58.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.227 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.59 120.27 3.9 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.934 1.756 . . . . 0.0 112.431 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.588 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -120.42 152.0 38.53 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . 0.417 ' HE ' ' HA2' ' A' ' 817' ' ' GLY . 74.8 ttt180 -118.27 133.93 55.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.901 0.382 . . . . 0.0 110.951 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -77.22 113.98 15.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . 0.479 ' O ' ' NZ ' ' A' ' 816' ' ' LYS . 18.8 mmmt -69.68 -38.17 76.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.168 0.509 . . . . 0.0 110.056 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -133.4 167.52 20.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.093 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 137.6 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.333 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -133.75 131.38 39.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.641 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.441 ' O ' ' NE2' ' A' ' 807' ' ' GLN . 68.8 mttm -100.7 134.54 43.52 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -81.86 144.05 31.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.99 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . 0.441 ' NE2' ' O ' ' A' ' 805' ' ' LYS . 25.8 mp0 -98.52 -35.32 10.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.68 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 47.1 p -135.03 171.66 14.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.386 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.5 mp -56.2 -24.65 43.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.175 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.28 -38.83 88.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.285 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.409 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 24.6 mp0 -101.12 156.44 17.42 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.806 ' H ' HD23 ' A' ' 812' ' ' LEU . 1.7 pt? -127.21 147.68 62.91 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . 0.502 ' O ' ' CE1' ' A' ' 835' ' ' HIS . 58.3 Cg_endo -72.44 140.25 32.97 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 113.033 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 89.7 mt -128.72 145.0 51.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -120.13 139.98 51.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.281 0.562 . . . . 0.0 110.426 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 801' ' ' LYS . 12.4 ttmm -43.83 121.54 2.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.27 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . 0.417 ' HA2' ' HE ' ' A' ' 799' ' ' ARG . . . 98.52 -20.65 49.59 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.578 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.32 136.16 57.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.937 0.399 . . . . 0.0 111.399 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.97 131.63 42.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.867 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 798' ' ' ALA . 33.0 m -124.93 152.87 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.646 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.426 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 96.5 m-85 -110.82 121.54 45.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.799 178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.501 HD13 ' HD2' ' A' ' 831' ' ' TYR . 67.0 mt -91.38 131.06 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -104.51 -32.22 9.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.674 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -158.28 149.86 21.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.494 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -88.48 110.77 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.285 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.36 -48.01 88.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.296 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.432 ' OD1' ' OE1' ' A' ' 828' ' ' GLN . 8.2 t0 -154.76 177.86 10.78 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . 0.432 ' OE1' ' OD1' ' A' ' 827' ' ' ASP . 25.5 mp0 -61.36 -36.35 79.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.754 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -103.73 -2.55 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.173 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -127.97 139.38 52.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.501 ' HD2' HD13 ' A' ' 822' ' ' ILE . 5.0 m-85 -126.03 158.27 35.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.314 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 822' ' ' ILE . 0.6 OUTLIER -129.05 138.96 52.2 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.15 -176.01 33.77 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -117.56 152.91 34.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.971 0.415 . . . . 0.0 111.458 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 835' ' ' HIS . 0.0 OUTLIER -164.52 137.05 4.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.159 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 49.3 t-80 52.6 29.93 7.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.302 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.22 2.63 90.57 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.515 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -108.9 148.25 30.94 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.954 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.05 136.93 52.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -170.7 -137.83 2.38 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.409 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 47.5 pt -133.83 157.01 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.93 0.365 . . . . 0.0 111.641 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 6.6 p90 -157.72 135.77 7.4 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.181 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.27 124.85 17.05 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 121.125 1.216 . . . . 0.0 112.442 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -54.92 -20.42 8.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.4 p -72.46 -11.28 60.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -98.48 -1.76 40.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.244 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.588 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -135.45 171.03 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.992 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -131.88 110.19 10.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.869 0.366 . . . . 0.0 110.148 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 61.5 tp -67.64 116.29 8.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 32.4 tp 54.05 72.84 1.01 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.676 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.38 164.54 35.4 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.183 1.922 . . . . 0.0 112.123 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.82 140.88 37.19 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.995 1.797 . . . . 0.0 111.948 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -66.84 78.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.456 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -97.01 6.02 49.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.392 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 856' ' ' ALA . 23.4 pttp -58.43 -22.32 53.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.224 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 855' ' ' LYS . . . 73.58 -69.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 45.05 69.42 2.55 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.48 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . 0.4 ' CB ' HD21 ' A' ' 861' ' ' LEU . 49.5 Cg_exo -56.66 143.54 89.04 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.941 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -73.41 80.12 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp 49.85 100.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.918 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 862' ' ' THR . 91.9 mt -70.61 148.79 47.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 861' ' ' LEU . 61.9 p -31.09 96.16 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 123.631 0.582 . . . . 0.0 111.243 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.32 156.83 29.38 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.021 1.814 . . . . 0.0 111.98 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.79 142.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.562 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -178.32 171.97 1.57 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.374 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 868' ' ' GLU . 95.9 t -82.43 123.6 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.204 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.83 4.9 49.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.365 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.536 ' H ' HG12 ' A' ' 866' ' ' VAL . 99.6 mt-10 -77.08 -6.29 52.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.233 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.39 152.61 40.77 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.54 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -156.89 172.06 34.45 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -124.77 143.97 50.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.206 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -157.2 144.59 18.74 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 98.5 mt -123.02 128.19 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.822 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.09 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.946 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 921' ' ' THR . 44.7 mtpt -70.05 -37.82 75.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.816 0.341 . . . . 0.0 110.497 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -131.71 153.53 49.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.598 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -57.11 159.46 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 888' ' ' PHE . 26.9 t80 -150.49 138.72 20.29 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.72 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 879' ' ' ASN . 40.0 p30 -151.85 92.04 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -82.69 -174.24 49.98 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 881' ' ' ASP . 49.4 t0 -135.66 -9.38 2.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 111.641 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 71.5 p -79.26 174.3 11.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.98 0.419 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.45 -0.93 57.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.335 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 12.9 m -114.09 -18.77 7.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.642 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -72.57 141.95 48.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.911 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.58 128.56 46.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 22.5 t -92.85 125.45 37.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.953 0.406 . . . . 0.0 110.109 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 878' ' ' PHE . 34.4 p90 -154.9 162.37 41.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.865 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 33.2 mtp-105 -112.18 161.67 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.347 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -59.42 136.54 58.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . 0.519 ' O ' ' NH1' ' A' ' 893' ' ' ARG . . . 90.15 -4.91 83.14 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.647 178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 75.8 mm-40 -76.87 142.79 40.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.179 0.489 . . . . 0.0 110.562 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 891' ' ' GLY . 12.6 mpt_? -82.4 142.12 32.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.251 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 872' ' ' ALA . 96.2 mt -131.38 143.17 41.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.878 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 95.2 m -100.65 127.09 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.873 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.581 HD11 HG13 ' A' ' 925' ' ' VAL . 81.6 mt -86.85 120.32 28.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.791 0.329 . . . . 0.0 110.665 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.3 mt -100.18 -45.61 5.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -165.5 164.85 19.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.887 0.375 . . . . 0.0 111.134 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . 0.596 ' NE2' HD11 ' A' ' 920' ' ' ILE . 2.1 tp60 -103.58 116.95 33.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.761 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.434 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 58.8 t -61.86 -45.55 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.056 0.455 . . . . 0.0 110.193 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 902' ' ' GLU . 34.4 t70 -148.56 -116.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.789 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.471 ' H ' ' CG ' ' A' ' 901' ' ' ASP . 99.7 mt-10 -114.32 -37.03 4.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.937 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.75 7.75 22.21 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.589 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -132.49 148.57 52.39 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.526 0.203 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.514 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.5 p90 -152.71 159.56 43.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.853 0.358 . . . . 0.0 110.283 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.426 ' HG3' HE21 ' A' ' 915' ' ' GLN . 88.4 tt0 -109.69 136.79 48.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.556 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -153.32 178.39 30.38 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.547 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -151.79 159.75 43.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.817 0.342 . . . . 0.0 110.626 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 87.7 mt -80.69 140.79 51.29 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -47.49 138.3 18.81 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 CA-C-N 120.148 1.088 . . . . 0.0 110.988 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.5 ' C ' HG23 ' A' ' 912' ' ' THR . . . 94.04 -6.91 73.0 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 911' ' ' GLY . 2.2 p 66.51 28.05 9.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.715 0.293 . . . . 0.0 111.15 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 88.0 p -64.21 -24.17 67.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.064 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -165.26 152.85 11.03 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.001 0.429 . . . . 0.0 111.686 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.426 HE21 ' HG3' ' A' ' 906' ' ' GLU . 18.2 tm0? -144.02 147.19 33.51 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.676 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 179.04 -174.55 46.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.551 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . . . . . . . . . 45.9 pt -109.94 154.72 11.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.144 0.497 . . . . 0.0 111.219 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 918' ' ' PHE . 0.0 OUTLIER -165.23 151.87 9.18 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.908 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.82 140.65 29.3 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.17 1.913 . . . . 0.0 112.768 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.596 HD11 ' NE2' ' A' ' 899' ' ' GLN . 90.1 mt -61.57 -32.05 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.801 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.411 ' O ' ' NZ ' ' A' ' 875' ' ' LYS . 97.9 m -57.9 -42.14 84.09 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -77.4 1.23 19.66 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.514 HG11 ' OH ' ' A' ' 905' ' ' TYR . 3.5 m -133.78 159.15 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.494 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -111.32 128.7 56.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.377 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 896' ' ' LEU . 79.3 t -99.58 105.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.687 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 926' ' ' ILE . 2.5 mp -62.19 -45.74 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 926' ' ' ILE . 98.2 mttt -138.31 140.41 39.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.389 . . . . 0.0 110.806 178.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -91.16 126.21 55.81 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.689 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.76 150.89 62.85 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.708 1.605 . . . . 0.0 112.149 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.481 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -63.39 -39.85 95.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.539 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 98.3 mtp -96.47 139.54 32.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.549 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 68.0 m -134.19 -117.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.412 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 82.75 1.14 90.54 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 91.3 p -63.94 -38.33 90.7 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.692 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -120.92 -19.69 7.16 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 64.2 mtt -83.34 153.12 24.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -158.77 98.46 1.69 Allowed Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.19 140.63 93.36 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.824 1.683 . . . . 0.0 111.91 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.514 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -134.73 155.91 49.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -118.51 134.47 55.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.283 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . 0.534 ' HA ' HG22 ' A' ' 847' ' ' ILE . . . -76.29 116.92 17.45 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -71.3 -30.03 65.75 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -146.46 175.67 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.465 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.524 ' OD2' ' NZ ' ' A' ' 805' ' ' LYS . 14.5 t70 -82.31 126.73 32.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.455 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -115.56 130.73 56.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.981 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.524 ' NZ ' ' OD2' ' A' ' 803' ' ' ASP . 38.2 mmtm -94.21 130.16 40.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.2 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -68.77 139.51 55.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.24 -35.63 10.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.242 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 61.9 p -135.42 162.54 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 2.1 pp -50.61 -32.87 20.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.46 -46.13 91.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.268 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.848 ' OE2' HD11 ' A' ' 841' ' ' ILE . 2.7 mt-10 -90.03 136.97 32.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.025 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.4 mm? -110.67 150.72 42.15 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.11 152.02 50.37 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.219 1.946 . . . . 0.0 113.448 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.662 HD11 HG11 ' A' ' 820' ' ' VAL . 4.8 mt -133.96 157.21 46.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.917 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.56 141.01 50.67 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.422 0.63 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -47.62 123.35 5.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.89 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 98.93 -21.79 44.19 Favored Glycine 0 CA--C 1.522 0.525 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.886 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.539 ' OD1' ' NE2' ' A' ' 835' ' ' HIS . 19.8 t70 -58.03 143.28 43.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.921 0.391 . . . . 0.0 111.342 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 28.2 mm -103.78 131.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.655 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.662 HG11 HD11 ' A' ' 814' ' ' LEU . 32.1 m -121.62 152.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.764 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.418 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 72.8 m-85 -111.94 113.58 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.388 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 832' ' ' GLU . 73.0 mt -81.36 127.14 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -119.33 -5.49 10.38 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.19 130.44 1.45 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.862 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -81.81 135.32 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.352 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.506 HD11 ' OE1' ' A' ' 832' ' ' GLU . 48.9 mm -88.29 -48.92 14.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.42 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -152.48 178.98 8.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -60.13 -37.21 79.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.163 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -105.98 -0.43 24.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.929 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . 0.462 ' CE3' HD12 ' A' ' 841' ' ' ILE . 79.4 m95 -124.5 137.94 54.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.491 0.662 . . . . 0.0 112.089 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.445 ' CD2' HD13 ' A' ' 822' ' ' ILE . 28.9 m-85 -128.03 151.85 48.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.372 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.506 ' OE1' HD11 ' A' ' 826' ' ' ILE . 9.0 tt0 -123.31 141.03 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 839' ' ' VAL . . . -161.9 -163.51 14.92 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -127.49 150.13 49.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 111.008 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.6 ' HB2' HG12 ' A' ' 820' ' ' VAL . 1.2 t-80 -155.33 128.05 7.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.449 ' CB ' HH21 ' A' ' 838' ' ' ARG . 1.9 m80 52.38 24.04 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.934 0.397 . . . . 0.0 110.773 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 92.09 -6.37 78.81 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.311 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . 0.449 HH21 ' CB ' ' A' ' 836' ' ' HIS . 12.0 ptp180 -98.08 151.9 19.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 117.337 0.568 . . . . 0.0 109.897 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 833' ' ' GLY . 9.2 p -131.55 129.24 61.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 0.0 111.285 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.92 23.87 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.848 HD11 ' OE2' ' A' ' 811' ' ' GLU . 31.1 pt -105.74 152.15 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 117.338 0.569 . . . . 0.0 110.588 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 841' ' ' ILE . 0.5 OUTLIER -139.79 114.78 7.95 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.8 128.57 21.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.474 1.45 . . . . 0.0 112.721 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -50.85 -20.28 1.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.533 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 65.7 p -87.1 -3.18 59.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.663 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -6.42 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.565 0.221 . . . . 0.0 111.206 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.534 HG22 ' HA ' ' A' ' 800' ' ' ALA . 45.8 pt -134.25 172.1 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.013 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -117.83 160.61 21.1 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.87 107.67 18.51 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.959 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 41.3 tp 46.41 77.64 0.45 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.472 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.67 162.12 42.1 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.947 1.765 . . . . 0.0 111.809 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.04 133.78 47.52 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.811 1.674 . . . . 0.0 112.337 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -107.32 -2.53 20.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.371 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -62.55 -178.44 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.927 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.99 153.0 46.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.261 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -139.21 60.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -135.42 149.54 69.88 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.589 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.92 152.47 63.34 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.251 1.967 . . . . 0.0 112.159 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.07 143.44 47.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.62 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . 0.515 ' NZ ' HG21 ' A' ' 862' ' ' THR . 65.0 tttp -107.61 118.96 38.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.988 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 862' ' ' THR . 87.2 mt -111.15 -50.37 2.94 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.941 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . 0.515 HG21 ' NZ ' ' A' ' 860' ' ' LYS . 67.0 p 35.17 70.79 0.91 Allowed Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.227 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -58.36 143.05 98.0 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.869 2.38 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 866' ' ' VAL . 0.7 OUTLIER -95.77 -60.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.488 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 73.82 -12.92 0.8 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.423 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 864' ' ' VAL . 94.3 t -79.21 128.03 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.014 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 9.5 mp -100.33 143.4 30.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.155 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 869' ' ' TYR . 88.5 tt0 -61.05 123.07 16.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.54 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 868' ' ' GLU . 20.3 m-85 40.92 -169.85 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.026 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -103.69 173.13 21.62 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -129.02 150.55 50.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.722 0.296 . . . . 0.0 110.261 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.496 ' O ' HD13 ' A' ' 873' ' ' ILE . . . -154.53 152.86 30.58 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 872' ' ' ALA . 23.2 mm -125.14 128.77 73.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -59.29 126.34 27.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.339 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 923' ' ' VAL . 50.4 mtpt -73.85 -39.02 64.3 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -139.02 153.8 48.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.07 132.9 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -132.91 135.91 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.894 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -109.93 141.58 42.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.583 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -101.63 135.35 12.15 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -98.42 -12.15 21.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.25 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 72.4 p -132.99 163.31 29.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.073 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.28 -39.86 94.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.916 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.99 -25.01 36.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.843 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -98.2 127.47 44.16 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 16.8 tpt -105.07 123.59 48.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.937 0.399 . . . . 0.0 110.97 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 87.1 p -74.41 157.44 35.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.871 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -164.43 162.56 22.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.762 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 892' ' ' GLU . 27.9 mmt180 -102.71 159.18 15.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.92 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -55.14 137.25 47.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.291 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 90.23 -4.76 82.93 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.119 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 889' ' ' ARG . 11.9 mm-40 -69.65 141.84 53.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.079 0.44 . . . . 0.0 110.712 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 34.9 mtp-105 -91.25 135.26 33.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.136 0.493 . . . . 0.0 111.111 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.49 148.03 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.517 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 97.1 m -99.81 127.07 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.474 ' CD1' HG13 ' A' ' 925' ' ' VAL . 86.5 mt -84.03 125.11 31.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.902 0.382 . . . . 0.0 111.104 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 98.3 mt -103.19 -50.71 3.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.021 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . 0.535 ' NH2' ' OE1' ' A' ' 906' ' ' GLU . 36.7 ptt-85 -165.93 165.24 18.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.936 0.398 . . . . 0.0 111.339 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -101.22 119.17 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.545 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.449 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 53.3 t -61.2 -47.65 92.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.764 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 86.1 m-20 -144.2 -91.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.07 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.427 ' O ' HD12 ' A' ' 920' ' ' ILE . 12.2 tp10 -137.93 -46.31 0.53 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.537 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -102.1 7.46 41.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.305 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -133.23 149.39 52.0 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.688 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.505 ' OH ' HG11 ' A' ' 923' ' ' VAL . 21.4 p90 -153.57 161.78 41.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.054 0.455 . . . . 0.0 111.165 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.535 ' OE1' ' NH2' ' A' ' 898' ' ' ARG . 33.8 tt0 -109.96 139.2 45.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.867 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -149.47 176.24 28.29 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -144.62 156.23 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.782 0.325 . . . . 0.0 110.436 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 914' ' ' ARG . 92.1 mt -103.21 107.67 56.3 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.066 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -54.09 135.28 63.66 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.35 1.367 . . . . 0.0 111.358 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 97.01 -22.31 41.45 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . . . . . . . . . 74.6 p -127.58 -17.55 4.57 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.992 0.425 . . . . 0.0 110.022 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 57.5 m 51.61 36.57 17.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.216 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.457 ' HB2' HD12 ' A' ' 909' ' ' ILE . 11.3 mmp_? -86.25 98.09 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.522 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 53.6 tt0 -86.33 128.23 34.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.999 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -157.03 163.91 32.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.496 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 46.4 pt -116.3 144.9 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.895 0.378 . . . . 0.0 111.068 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.496 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -158.49 164.28 21.69 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.857 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.39 137.06 32.8 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.412 2.074 . . . . 0.0 113.925 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 902' ' ' GLU . 91.6 mt -60.77 -39.09 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.88 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 70.1 p -54.92 -22.48 15.07 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.757 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -95.11 0.85 54.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.505 HG11 ' OH ' ' A' ' 905' ' ' TYR . 4.6 m -132.3 157.88 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.13 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.43 121.83 45.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.833 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.474 HG13 ' CD1' ' A' ' 896' ' ' LEU . 67.5 t -90.19 103.95 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . . . . . . . . . 41.4 mm -72.38 -43.58 64.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.131 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -132.82 151.92 51.92 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -101.41 148.06 34.67 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.5 153.42 60.51 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.224 1.949 . . . . 0.0 112.606 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 56.3 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.503 179.701 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -70.61 -16.41 62.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.014 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . . . . . . . . . 99.0 mtp 43.26 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . . . . . . . . . 95.9 p -64.7 -16.96 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.49 95.09 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . . . . . . . . . 88.1 p -148.87 158.78 44.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.563 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -159.68 161.68 34.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.631 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -68.21 158.32 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.581 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.514 ' HB3' HD21 ' A' ' 849' ' ' LEU . 98.8 mtt180 -125.82 97.61 35.45 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.545 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.56 140.88 96.56 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.075 1.85 . . . . 0.0 111.905 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.893 ' HB1' HD13 ' A' ' 847' ' ' ILE . . . -135.17 155.83 50.02 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -117.54 133.66 55.72 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.451 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -79.41 127.07 31.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.203 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -91.99 -28.72 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.14 162.62 32.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.079 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 803' ' ' ASP . 54.5 p-10 -75.94 137.77 40.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.457 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -118.27 129.02 55.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.003 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -96.03 124.98 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.565 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 811' ' ' GLU . . . -70.72 137.88 50.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.801 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.7 -38.8 8.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.418 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 67.8 p -135.64 162.87 31.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.527 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.62 -34.35 7.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.656 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.21 -39.86 94.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.993 0.425 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.643 ' O ' ' HB1' ' A' ' 806' ' ' ALA . 3.6 mt-10 -92.83 128.33 38.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.977 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 811' ' ' GLU . 2.1 mm? -108.71 150.09 40.32 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.649 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.74 151.43 63.49 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.203 1.935 . . . . 0.0 113.023 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . . . . . . . . . 3.2 tp -135.82 151.26 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.612 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.19 137.86 53.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.47 0.652 . . . . 0.0 111.316 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.42 126.27 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 100.66 -23.64 34.97 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.294 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 819' ' ' ILE . 67.3 t0 -59.78 133.98 56.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.934 0.397 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . 0.47 ' N ' ' OD1' ' A' ' 818' ' ' ASP . 44.7 mm -91.82 130.11 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.588 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 798' ' ' ALA . 0.0 OUTLIER -118.99 145.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.222 179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.428 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 71.0 m-85 -107.51 104.86 14.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.6 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.45 130.89 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -100.35 -38.21 8.54 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.832 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -161.37 156.15 23.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.479 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.33 111.12 20.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.421 . . . . 0.0 111.026 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . 0.456 ' H ' ' HA ' ' A' ' 831' ' ' TYR . 48.0 mm -63.34 -47.35 92.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.278 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -148.88 177.12 9.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.62 -25.3 68.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -123.96 11.42 8.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -137.91 145.26 41.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.495 ' OH ' HG21 ' A' ' 847' ' ' ILE . 29.4 p90 -140.76 165.5 27.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -127.61 139.06 52.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.398 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -162.13 -172.24 29.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -111.83 138.84 47.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.921 0.391 . . . . 0.0 111.779 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.496 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 1.4 p-80 -141.71 133.74 27.57 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 836' ' ' HIS . 48.7 t-80 52.83 29.69 8.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.13 5.78 89.86 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.012 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -115.92 150.11 37.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 10.5 p -114.4 141.99 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.01 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . . . . . . . . . . . -171.01 -158.62 15.24 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.44 ' C ' ' CG ' ' A' ' 842' ' ' PHE . 49.4 pt -126.45 149.63 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.76 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 842' ' ' PHE . 0.1 OUTLIER -151.4 154.03 33.08 Favored Pre-proline 0 CA--C 1.529 0.166 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.45 125.8 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.623 1.548 . . . . 0.0 111.825 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -56.98 -27.67 61.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.174 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 78.8 p -66.82 -12.84 60.49 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.255 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -96.36 -1.32 47.96 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.893 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.4 pp -140.45 169.11 16.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.439 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . 0.636 ' N ' HD12 ' A' ' 847' ' ' ILE . 82.1 tt0 -130.42 120.26 23.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 796' ' ' ARG . 2.9 tt -63.2 115.79 4.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.897 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 849' ' ' LEU . 0.2 OUTLIER 44.62 77.22 0.46 Allowed Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.518 179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.89 161.09 16.23 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.653 2.236 . . . . 0.0 111.334 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.67 137.9 33.27 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 121.888 1.725 . . . . 0.0 112.033 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -101.19 48.88 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.525 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.5 -39.04 92.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.505 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . 0.644 ' O ' ' HB3' ' A' ' 856' ' ' ALA . 63.1 mttp -61.75 -39.62 92.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.484 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 855' ' ' LYS . . . 77.34 -169.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.496 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . 0.414 ' N ' ' CD ' ' A' ' 858' ' ' PRO . 96.0 mt-30 47.79 55.96 17.24 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 857' ' ' GLN . 58.8 Cg_endo -71.21 153.48 62.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.894 2.396 . . . . 0.0 111.906 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -90.58 109.92 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -94.95 -0.17 54.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.361 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.64 144.14 49.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 149.32 44.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.511 ' C ' ' H ' ' A' ' 865' ' ' GLN . 19.0 Cg_endo -62.02 -71.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.06 1.84 . . . . 0.0 112.228 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 863' ' ' PRO . 2.4 t 67.51 -38.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 863' ' ' PRO . 20.1 pt20 -68.17 146.37 53.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.313 . . . . 0.0 111.003 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.11 150.08 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.119 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.36 -12.54 19.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.48 -23.32 63.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -121.62 145.98 47.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.989 0.423 . . . . 0.0 111.364 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -84.32 179.47 51.71 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -135.04 147.17 49.56 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.503 0.192 . . . . 0.0 110.717 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 894' ' ' ILE . . . -152.67 154.14 34.7 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 92.9 mt -124.74 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.754 0.312 . . . . 0.0 110.436 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . . . . . . . . . . . -60.45 135.47 57.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.327 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -87.2 -29.67 21.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -137.94 145.48 42.07 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.708 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.437 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.3 p-10 -51.34 122.14 7.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -117.05 125.86 51.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.077 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -119.81 105.6 11.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.301 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . . . . . . . . . . . -65.26 137.97 38.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -102.89 1.14 33.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 70.9 p -130.5 163.09 27.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.966 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -62.01 -40.81 96.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 884' ' ' VAL . 14.0 m -67.62 -25.36 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.572 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -97.42 136.39 37.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.185 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 915' ' ' GLN . 0.0 OUTLIER -107.24 168.05 9.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 41.5 t -118.44 136.16 53.95 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.942 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.92 162.05 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -82.67 162.33 21.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.717 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 890' ' ' LYS . 10.6 pttt -73.09 42.36 0.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.267 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . -160.83 -0.38 0.07 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.069 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -79.68 143.18 34.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.795 0.798 . . . . 0.0 110.406 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -76.23 143.08 41.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.995 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 872' ' ' ALA . 92.0 mt -129.19 139.13 52.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.524 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 93.8 m -99.14 125.25 44.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.83 116.48 20.01 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.518 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . 0.563 HD11 ' HD2' ' A' ' 908' ' ' ARG . 86.6 mt -97.64 -46.07 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -166.18 164.61 17.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.984 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -103.91 118.41 36.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.465 ' H ' ' HA ' ' A' ' 905' ' ' TYR . 57.4 t -65.26 -45.31 94.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.647 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -152.03 -125.86 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.769 0.318 . . . . 0.0 111.047 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.08 -25.11 14.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.339 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -135.47 18.93 3.35 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.599 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -133.51 146.95 51.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.733 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.465 ' HA ' ' H ' ' A' ' 900' ' ' VAL . 15.0 p90 -156.42 161.29 40.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.053 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -106.65 133.89 50.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.502 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -147.91 172.96 28.12 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.557 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 897' ' ' LEU . 8.7 ptm180 -155.96 163.39 39.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.812 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 84.3 mt -94.01 139.26 22.55 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.96 141.52 36.48 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 120.214 1.112 . . . . 0.0 111.061 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . . . . . . . . . . . 95.59 -8.09 68.58 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.498 HG23 HH21 ' A' ' 908' ' ' ARG . 1.2 m 73.78 28.37 1.6 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 44.9 t -67.9 -50.14 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -135.19 148.07 49.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.885 0.374 . . . . 0.0 111.082 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.488 ' O ' ' SD ' ' A' ' 886' ' ' MET . 64.6 tt0 -151.24 135.18 16.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.278 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . 176.78 -174.89 47.37 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.487 ' C ' ' CD2' ' A' ' 918' ' ' PHE . 47.0 pt -115.47 146.76 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.36 0.6 . . . . 0.0 111.456 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.487 ' CD2' ' C ' ' A' ' 917' ' ' ILE . 0.1 OUTLIER -161.75 158.82 22.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.677 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.05 140.43 45.34 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.489 2.126 . . . . 0.0 114.452 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.19 -32.0 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.269 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . . . . . . . . . 93.7 m -57.62 -39.44 76.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.749 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.85 5.04 23.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.06 158.46 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.169 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -111.0 123.14 49.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.267 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.483 ' C ' HD12 ' A' ' 926' ' ' ILE . 4.7 m -95.04 141.53 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.011 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 925' ' ' VAL . 1.7 mp -107.47 -37.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.265 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -136.49 136.29 39.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.523 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -78.8 148.72 73.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.718 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.2 -23.71 45.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.069 1.846 . . . . 0.0 112.169 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -106.65 12.7 29.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.519 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' MET . . . . . 0.511 ' O ' ' CB ' ' A' ' 791' ' ' SER . 66.2 mtt -127.91 154.28 45.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.677 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' SER . . . . . 0.511 ' CB ' ' O ' ' A' ' 790' ' ' MET . 3.7 p 86.85 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.69 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' GLY . . . . . . . . . . . . . . . 83.3 1.31 90.38 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' SER . . . . . 0.429 ' H ' ' H ' ' A' ' 794' ' ' GLU . 0.0 OUTLIER -178.5 -6.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.077 0.465 . . . . 0.0 110.013 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' GLU . . . . . 0.429 ' H ' ' H ' ' A' ' 793' ' ' SER . 88.5 tt0 -62.16 -40.35 95.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.61 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 27.9 ptm -49.02 136.28 14.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.637 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.713 ' HB2' HD11 ' A' ' 849' ' ' LEU . 25.3 mmt180 -135.6 148.89 67.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.57 116.31 4.45 Favored 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 121.942 1.762 . . . . 0.0 111.987 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 820' ' ' VAL . . . -112.32 152.67 28.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' ARG . . . . . . . . . . . . . 79.8 ttt-85 -118.85 129.36 55.17 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.662 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' ALA . . . . . . . . . . . . . . . -73.19 112.66 9.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.97 -35.43 78.35 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.121 0.486 . . . . 0.0 110.154 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 802' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -137.81 162.63 33.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.668 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 803' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 814' ' ' LEU . 31.1 t70 -73.71 138.31 44.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.412 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 804' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -143.03 119.02 10.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.07 0.462 . . . . 0.0 110.632 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -84.48 144.87 28.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 806' ' ' ALA . . . . . . . . . . . . . . . -72.82 114.96 11.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 807' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -66.3 -39.92 89.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.449 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 808' ' ' THR . . . . . . . . . . . . . 57.9 p -134.29 162.26 32.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.482 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.27 -34.1 14.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.61 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 810' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -61.0 -43.88 98.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.381 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 811' ' ' GLU . . . . . 0.435 ' HA ' ' H ' ' A' ' 841' ' ' ILE . 7.9 mt-10 -77.3 162.87 26.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 812' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 840' ' ' GLY . 3.9 pp -125.27 150.13 66.29 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.7 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 813' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.14 146.92 32.73 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.118 1.879 . . . . 0.0 111.997 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 814' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 820' ' ' VAL . 13.0 mt -140.24 140.92 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.501 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 815' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -120.64 139.55 52.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.323 0.582 . . . . 0.0 110.521 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 816' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -43.8 124.02 3.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.215 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 817' ' ' GLY . . . . . . . . . . . . . . . 99.61 -19.44 53.59 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.09 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 818' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -59.8 136.0 57.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.936 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 819' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.88 134.31 38.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 820' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 798' ' ' ALA . 35.4 m -128.81 157.96 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 821' ' ' TYR . . . . . 0.43 ' O ' ' CA ' ' A' ' 833' ' ' GLY . 98.1 m-85 -115.12 111.14 20.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.475 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 822' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 831' ' ' TYR . 30.4 mm -79.73 96.12 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 823' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -85.29 -14.97 44.92 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.06 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 824' ' ' LYS . . . . . 0.516 ' NZ ' ' OE1' ' A' ' 832' ' ' GLU . 9.3 tttm -162.86 131.7 4.06 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.785 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 825' ' ' GLN . . . . . 0.711 HE21 ' N ' ' A' ' 827' ' ' ASP . 6.3 tm0? -85.12 127.46 34.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 826' ' ' ILE . . . . . . . . . . . . . 4.0 mm -82.31 -56.44 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.015 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 827' ' ' ASP . . . . . 0.711 ' N ' HE21 ' A' ' 825' ' ' GLN . 4.7 t70 -151.73 177.4 10.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.375 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 828' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -64.45 -23.72 67.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.377 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 829' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -111.74 -3.66 14.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.417 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 830' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -131.71 134.98 46.48 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.952 0.406 . . . . 0.0 111.277 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 831' ' ' TYR . . . . . 0.499 ' CD2' HG21 ' A' ' 822' ' ' ILE . 1.3 m-85 -124.21 160.35 28.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.887 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 832' ' ' GLU . . . . . 0.516 ' OE1' ' NZ ' ' A' ' 824' ' ' LYS . 9.7 tt0 -136.31 135.94 39.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 833' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 821' ' ' TYR . . . -157.25 -165.58 15.3 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 834' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -120.27 139.09 53.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.506 0.193 . . . . 0.0 110.898 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 835' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 835' ' ' HIS . 2.4 p-80 -143.68 134.46 25.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 836' ' ' HIS . . . . . . . . . . . . . 71.9 t60 50.21 31.95 5.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 837' ' ' GLY . . . . . . . . . . . . . . . 81.71 3.27 90.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.919 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 838' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -109.65 155.68 21.18 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 839' ' ' VAL . . . . . . . . . . . . . 96.2 t -124.21 135.01 65.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.17 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 840' ' ' GLY . . . . . 0.859 ' N ' HD23 ' A' ' 812' ' ' LEU . . . -166.08 -157.33 10.04 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 841' ' ' ILE . . . . . 0.435 ' H ' ' HA ' ' A' ' 811' ' ' GLU . 48.0 pt -131.42 154.13 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.226 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 842' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.53 148.9 14.45 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.83 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 843' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.57 126.11 21.23 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.303 1.335 . . . . 0.0 113.075 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 844' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -56.54 -28.04 59.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.319 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 845' ' ' THR . . . . . . . . . . . . . 82.7 p -70.76 -13.44 62.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 846' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -93.82 -0.79 55.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 847' ' ' ILE . . . . . 0.446 HD13 ' HB1' ' A' ' 798' ' ' ALA . 1.5 pp -139.61 167.08 20.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 848' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -135.9 126.71 27.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 849' ' ' LEU . . . . . 0.713 HD11 ' HB2' ' A' ' 796' ' ' ARG . 12.1 tp -78.46 113.65 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 850' ' ' LEU . . . . . . . . . . . . . 49.2 tp 51.97 73.49 0.95 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 851' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.37 117.3 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.466 2.111 . . . . 0.0 111.812 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 852' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.23 142.42 94.63 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.627 1.551 . . . . 0.0 112.159 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 853' ' ' ALA . . . . . . . . . . . . . . . -66.07 146.07 55.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.047 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 854' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -77.56 79.25 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.793 0.33 . . . . 0.0 110.721 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 855' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -93.34 -4.0 52.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.559 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 856' ' ' ALA . . . . . . . . . . . . . . . -103.03 129.03 49.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.489 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 857' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 46.5 64.91 7.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.648 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 858' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.56 141.45 83.14 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.374 2.05 . . . . 0.0 112.043 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 859' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -60.58 143.28 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.866 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 860' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -94.75 1.37 55.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.674 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 861' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.16 134.3 56.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 110.692 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 862' ' ' THR . . . . . . . . . . . . . 44.3 p -74.18 160.03 82.49 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.631 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 143.05 76.99 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.663 1.575 . . . . 0.0 112.638 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 864' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 866' ' ' VAL . 76.6 t -61.52 -44.31 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.463 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 865' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -57.06 88.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.537 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 864' ' ' VAL . 61.0 t -63.54 -43.42 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.244 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 867' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 868' ' ' GLU . 87.2 mt -59.78 -66.87 0.45 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.208 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 868' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 867' ' ' LEU . 14.8 mt-10 55.85 125.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.143 0.497 . . . . 0.0 111.338 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 869' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -71.85 145.53 48.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 870' ' ' GLY . . . . . . . . . . . . . . . -71.15 156.07 52.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 871' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -116.82 151.52 36.34 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 872' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 894' ' ' ILE . . . -152.82 146.98 25.5 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 873' ' ' ILE . . . . . . . . . . . . . 7.5 mm -125.3 127.95 72.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.01 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 874' ' ' ALA . . . . . 0.429 ' HB1' ' HE1' ' A' ' 922' ' ' TYR . . . -64.27 129.48 40.11 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 875' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 921' ' ' THR . 56.2 mtmt -85.37 -31.98 22.65 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.462 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 876' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -137.0 146.01 44.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.173 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 877' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 877' ' ' ASN . 40.0 p-10 -52.38 117.76 3.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 878' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -112.51 125.07 53.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.722 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 879' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -110.91 106.1 15.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.354 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 880' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 887' ' ' SER . . . -68.15 141.97 38.58 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 881' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -94.76 -9.43 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.673 0.273 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 882' ' ' THR . . . . . . . . . . . . . 60.9 p -134.15 163.27 29.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 111.184 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 883' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -61.58 -38.45 87.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.949 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 884' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.16 -41.8 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.084 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 885' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -87.37 104.73 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 886' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.64 146.07 50.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 880' ' ' GLY . 97.7 p -107.85 151.82 25.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.932 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 888' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 888' ' ' PHE . 0.1 OUTLIER -164.68 176.48 8.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.723 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 889' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -105.49 172.8 6.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.196 0.522 . . . . 0.0 111.149 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 890' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.25 136.43 57.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.046 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 891' ' ' GLY . . . . . . . . . . . . . . . 88.72 1.12 80.82 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.037 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 892' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -75.67 139.84 42.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.767 0.783 . . . . 0.0 109.949 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -80.39 141.39 35.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.099 0.476 . . . . 0.0 111.149 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 894' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 872' ' ' ALA . 96.6 mt -133.48 144.2 36.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.831 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 895' ' ' THR . . . . . . . . . . . . . 98.1 m -103.41 128.16 50.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.917 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.499 HD11 HG13 ' A' ' 925' ' ' VAL . 85.3 mt -85.15 126.92 34.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 897' ' ' LEU . . . . . . . . . . . . . 89.6 mt -108.73 -55.09 2.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.072 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 898' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -159.14 153.73 24.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.229 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 899' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -93.13 115.9 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.764 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 900' ' ' VAL . . . . . 0.447 ' O ' ' OD1' ' A' ' 901' ' ' ASP . 57.0 t -61.89 -47.46 93.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 901' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 900' ' ' VAL . 88.5 m-20 -143.39 -102.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 902' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 920' ' ' ILE . 24.3 pt-20 -130.83 -38.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.493 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 903' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -107.19 5.22 27.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.221 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 904' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.57 150.34 52.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.764 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 905' ' ' TYR . . . . . 0.48 ' OH ' HG11 ' A' ' 923' ' ' VAL . 25.7 p90 -152.08 159.98 43.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 917' ' ' ILE . 88.6 tt0 -103.12 133.91 47.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.499 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 907' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.72 30.35 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.167 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 908' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -149.8 157.34 43.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.957 0.408 . . . . 0.0 110.451 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 909' ' ' ILE . . . . . . . . . . . . . 49.5 mm -80.06 141.12 54.05 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 910' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.83 139.62 24.58 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.972 1.114 . . . . 0.0 111.184 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' GLY . . . . . 0.536 ' C ' HG23 ' A' ' 912' ' ' THR . . . 93.96 -8.08 73.31 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' THR . . . . . 0.536 HG23 ' C ' ' A' ' 911' ' ' GLY . 1.7 p 67.71 28.35 7.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.721 0.296 . . . . 0.0 111.129 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 96.0 p -63.78 -26.51 68.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.898 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.23 153.45 13.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' GLN . . . . . 0.507 ' NE2' ' OE2' ' A' ' 906' ' ' GLU . 46.2 tt0 -142.72 142.51 31.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.572 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' GLY . . . . . . . . . . . . . . . -177.17 179.12 48.17 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 906' ' ' GLU . 43.9 pt -117.74 145.24 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.945 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 917' ' ' ILE . 0.0 OUTLIER -153.27 166.07 16.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.699 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.19 132.74 35.15 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 122.345 2.03 . . . . 0.0 114.425 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 902' ' ' GLU . 96.4 mt -59.79 -40.14 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.993 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' THR . . . . . 0.507 ' O ' ' CE ' ' A' ' 875' ' ' LYS . 68.1 p -61.15 -25.46 67.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' TYR . . . . . 0.7 ' CD2' HG13 ' A' ' 923' ' ' VAL . 0.0 OUTLIER -82.6 -2.09 52.78 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.541 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' VAL . . . . . 0.7 HG13 ' CD2' ' A' ' 922' ' ' TYR . 27.6 m -129.43 155.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.494 0.664 . . . . 0.0 112.229 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -104.27 120.47 41.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.081 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 925' ' ' VAL . . . . . 0.499 HG13 HD11 ' A' ' 896' ' ' LEU . 78.3 t -90.71 99.46 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.273 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 926' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 926' ' ' ILE . 1.8 mp -64.62 -47.3 89.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.556 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 927' ' ' LYS . . . . . 0.481 ' HG3' HG22 ' A' ' 926' ' ' ILE . 59.8 mtpt -139.94 146.53 39.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.88 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 928' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.32 148.78 93.82 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.193 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 929' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.86 -23.56 54.86 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.119 1.879 . . . . 0.0 112.209 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 930' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.543 -179.891 . . . . . . . . 1 1 . 1 stop_ save_